<SEC-DOCUMENT>0001822479-21-000028.txt : 20210513
<SEC-HEADER>0001822479-21-000028.hdr.sgml : 20210513
<ACCEPTANCE-DATETIME>20210513160507
ACCESSION NUMBER:		0001822479-21-000028
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		91
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210513
DATE AS OF CHANGE:		20210513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sotera Health Co
		CENTRAL INDEX KEY:			0001822479
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				473531161
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39729
		FILM NUMBER:		21919552

	BUSINESS ADDRESS:	
		STREET 1:		9100 SOUTH HILLS BLVD, SUITE 300
		CITY:			BROADVIEW HEIGHTS
		STATE:			OH
		ZIP:			44147
		BUSINESS PHONE:		440-262-1410

	MAIL ADDRESS:	
		STREET 1:		9100 SOUTH HILLS BLVD, SUITE 300
		CITY:			BROADVIEW HEIGHTS
		STATE:			OH
		ZIP:			44147

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sotera Health Topco, Inc.
		DATE OF NAME CHANGE:	20200824
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>shc-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:f476bcce-754d-42a8-b141-c43fc168635e,g:3b9d91f5-244f-4b5e-861f-f8019b961431,d:15ef643796c34829b3bb28475338f021--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:shc="http://soterahealth.com/20210331" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>shc-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF8zLTEtMS0xLTI3OTg_bff99e3d-36be-4e65-82b0-a79f133b76f1">0001822479</ix:nonNumeric><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF81LTEtMS0xLTI4MDI_7de3a8a1-19ac-443e-bba3-e860b226ac68">12-31</ix:nonNumeric><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF82LTEtMS0xLTI4MDg_7ef13a28-535b-42f7-a11e-bb9a7a617c6d">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF85LTEtMS0xLTI4MDQ_5350bb19-55c1-4749-a746-6976d0fdb3da">2021</ix:nonNumeric><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF8xMC0xLTEtMS0yODA2_d2afb63d-bd93-4f94-96ed-adb6ab3b0e01">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM5MA_4d42cb8b-4533-485f-a39a-6ad44b9c22bd">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="icf6ab0133fd241ab95e886992abdac00_D20210101-20210331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzOA_90568ab0-c98d-42fa-bc3b-4bb90feeb83b">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="id25ab8929ae14c599f0efe8cf6b717e9_D20210101-20210331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM1Mg_eccb5a8b-a643-47c5-b42e-caa40b675d70">P1Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="id11e4447ffe14a53b4e1963b618ab6b0_I20210331" decimals="INF" name="shc:CashProceedsToSponsorsRatioToInvestedCapital" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NjYvZnJhZzo3ZjI5YjQ0M2E3ZWM0N2E1YTBiZWZjZmM3ZjFlMDYyYS90YWJsZTpjYTQzYTE3MjYzYTI0NWMzYWEzNjM4NjMwZTNjMmVhMS90YWJsZXJhbmdlOmNhNDNhMTcyNjNhMjQ1YzNhYTM2Mzg2MzBlM2MyZWExXzEtMC0xLTEtMTQyMTg_0bf73091-e884-49c9-b742-f470106e7280">2.5</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="shc-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iecb4c2bb33504c7dac5c01c3a9c0c6fb_I20210506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iec88d5b798444874850d669967cf4dbd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39349c5dcb984b15b4709ccb996bd176_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i8cf37fb79c6347f6a6f791184ce78acf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37232295f3745cd88694de59101666d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icee21de57c09410dbdb4e1d0c7cd6110_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cc06bf938484e99bfe9969660cc781c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0646aca58984456ab4ccef54f837d8d7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e003cc982634a42a6004e9be503ae52_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ca8f2e824984cde87c9e7c8204a7b3c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc054b078af443cbabc1b10fbff2443f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a49d2f4b5de474392adda95a3719a97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a52e4d931ab42eca6b2d9fca0916150_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i158e9c437afe4c1ca6ee15516e6628fc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d09c73619b54b50855522776180722f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i694c199e34a14464ac24dbb4f8527e0d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab8dbb45af8c49bd89a1796cc04d5e70_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2078cb13265412b8168c6ba2ce01286_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c7318711e8e4a54ab3c245d19523efd_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c04b66fafeb41b8a7342d389e9ffb71_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1b332a6da764fdc81bebeb5c634fb23_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i350dd74321534f789de5af89b9350730_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072ee7c12e4d4852a1510e20124323be_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6c27cc4a3a4ddfb486d016a99cf741_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcc158f820b8436c8ea3e1ae61ebfe29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id757d153aff04337af22c39b26a4d290_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64bb877dd58241488e79dcedccea8d76_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360689ad9dcc48f5ab2673194f9a3327_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i688702d19c584405b043c3524ab0a5af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54c2badaff0b467aa1febf6fb3e524e5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i661c83dafe2241a895b55e741b4436cf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief05232174e44d4d869bc9c7f6fa36c9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i908b264e6f8246ac9b4d3f7cd3fcaa0a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80b8173d43a74e3b9ec5e6fec2bb9ee4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i503e8eac77d34290ab10a01273a5714c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ba71926882446f4820f855c07651431_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7aa7a07423da4a209024274d4083e38e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1675ea82d0e47b5b55f50b716c600eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia09428b911314cc0ae886d99b666ca12_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>shc:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ibea64f5f1ac0490180fbbfae53b8d879_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94da5f943646463fac66bb29dfdd381e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>shc:subsidiary</xbrli:measure></xbrli:unit><xbrli:context id="ie80833d87f3a475c9d5cce381fd18476_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5def62b5b7f448059d757311fe268fc9_I20210311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib950bce5fb424f4ebc039f76379610fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ff278d560040b986f61d550e890c69_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd7503543e240e4b13682cf4007a74f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia271e03429544e7c88a278c25dc1246e_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">shc:UnnamedEBeamJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4e845ef858f4d2cbf8e34065ae83f9d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81508df42a2c41ae99039fb5550d92c7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e40cba4c0a04e228634ff48d54110b0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide0e38a11c4d4065969f8f8fe57c3865_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1abe226e0f964cdda9aa352b55dd6908_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73baed61d2934ccca236804cc00d4746_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538e36e8cbfb418baadf68b21ca433e2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d1ac8931a14b9689bbd93ab687cb9b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549e8b5be7d14c24ac0bd3a892096184_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i604e6f09c9514a4c92c9b88b13bbfd5e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44a1e9c62eb48bb91f1032b3dd61367_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74f51f9869464d0992847aa161928404_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42a63ee00aca4032b612c80c0fd3c9c1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i023f2492fe3d4a8d8430927b2fd77519_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c6aca23a9ae486a9eb582a53a5bb38b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffacfedf64e04109b53607b1570fdc92_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i842c27cb13e145de9f7c92ab5ea4f054_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieabfd129bc4847e8afad78a76824be56_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e574934364343aaad0a65c6a4d6628a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89a8f5f3a462461d9ff69850cfe543dc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ef6a0932a74cdc81d96d88f7ab2485_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0203680793e4fb8a12e0bdf8927352d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-08</xbrli:startDate><xbrli:endDate>2021-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95626988340341728b2d210065ff4f47_I20210308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica603348fe30465dae402c8b63a1b31a_D20210311-20210311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-11</xbrli:startDate><xbrli:endDate>2021-03-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie45025c772774d5c927c39b60442abf6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b6a3228292f4d16b55b1cd7b0695816_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i768d601b59aa4005863b05a9a1a4a15c_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i051178a4a64d449f87f75f6e19f87b98_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26503e2068d94590979ce52f141dc71c_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfbc21d1467d4e52911ec1b5501bcb5d_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia071d112ecca401ea6335a9263fe2923_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4fdf4d7028e46a4b31f337064b0f0bf_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i405041e3ed794abc80989f15142f5586_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7f4d0c263a04710a93bbf997b284b04_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae31afbafbf247098cb8c0b7be49d5c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ee65cf8cf1c49538dd47438eaedfb14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b8b3c8568084221a2ad859b39b4ec4a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i277f6af610934b6799af4e30a81fde49_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i374f363dae8d489884cfdb4e75c41f98_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bdf5bf26e504a519ba4925e4f6ced05_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1afc20edd0843bbac413280101a0cf3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d31ba294dc94afaa10dda2278f6ca6a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe58eb3f5c4b4d98b5e6c1018cd61690_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce030964ab24158949b016db0752797_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic300771a3ad848deb070c4b7e24f0b27_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f33513e6445440aa8f9b1d326db60e2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic516f52cc0d54267bc67844b537e37bf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2212b97b8ac44cbeaf403f3f51b943a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i037b6f7c3cde45289d3fd93f3e2ba9be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95577f1988ee4cab966e77b8d67597c8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia139b1975e0f4070816baaeeea37e6c0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:LandUseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00107b289eee42419e1bb39ab7132941_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:SealedSourceAndSupplyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic049f68a83744fcb8bbd9e1cd47188f5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a8a178bafa24d019046ae8de5f2a96b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a93896fea2f4955a83ecd9ec395ff33_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab06588a1964b429adbe61fa67fe076_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa84c55df11d4fb98f330425ef0ec73f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i462df889dd55483f9fdf2dc45ca34f95_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc279916c2484e4abfd94cbddb0b1947_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:LandUseRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93cec6a0dc8b4cc79fe185028e72ea4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:SealedSourceAndSupplyAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0efe039c4404f3db3ac7271abe88c92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb2734a552514580a66be829325e052e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15d20e25e2c404b9fa9ab9025017114_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f7a540829534df293806a8679ef9ba5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic654e0b7347f4135b94187587d072ac9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia780c72ea74742cb8f4ea0929abef198_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibff6b4bd9f5349269d862b32081e5981_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4941298f6979408a8566ea338611e02c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aedde424acd460ead3548c57b1da604_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632d789ade294a64b7daf856fe6f362a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e8995acb99a47cf96b979b522b8a240_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie582d45d5d3a4547a10610bd46cdaf41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd422b230de24395ba1b25c54a6db45d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie37562b8bb6f4f1fad61c5737f8165db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9d3cea4bc3043aa8b6fa40430ca9b03_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if060086f17a0456496054d58a49829b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa1598f78fa4665b7e784df6c4c3618_I20201216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3445e5d203564800970ed964c9915f69_I20201217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61b546722b35491d9fa5800657d6bb77_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie47cbeb3f51f4d44a3362102b9e364be_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9e4212789dc41669d654b48e51f12fe_D20210119-20210119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-19</xbrli:startDate><xbrli:endDate>2021-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3939ca87747f4af3ad4db922091cc08b_I20210119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62e37fc77ba14274a2e06c4a3ec51333_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a20972bbc3640e8b6a94b5727ca3aa3_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5076ff942fc745c6b7f8da2a4d66baf0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e8b4006d4e4eb994d25982e3a967b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec712ce357d5481ea60298bfc94462bd_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78ae87cbdee94046bcbcb6ab3f48b2d4_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013ecc2ca22e4d5bb0e44c54ecb51558_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e206e36be42444db67127b6b666b46c_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48427c3c8fee49e493e03f3f6a69e2d7_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if972f5c2e68f4b6e9c9b79e8bc599d2c_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74886e80842c43c2b575afa174c8f146_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i458ac54874ff437295ae19825c2e1ad6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0685810b83ff487580eda356557fd6bf_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff2dc57c0034141899eda7b55d9c143_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c05eb822b5410c8019ed6fe29b6ab8_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b900c87d68440d0aa7afa06a2cf13f9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58786296c5744b83985f9f2ad31ad009_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63b06a187344473bec2c467e8a1eaa8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife3ac8faabe645c99d73eb67ce7ce8b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5475791dc6254d89860104a417d03dfd_D20201124-20201124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-24</xbrli:startDate><xbrli:endDate>2020-11-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i028ae4ed27174f34989fbc5e78e51dce_I20201124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07c6f50405594b5592607e77121c0fa7_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SecondLienNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SecondLienNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4a180ea1b6d4c3bb6c80f76ff48a33a_D20201124-20201124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-24</xbrli:startDate><xbrli:endDate>2020-11-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97db1199d2ae496d86dba67906d75440_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e0882cfad7543dcbaf6ed1402ccfe46_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanAndSecondLienNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba2d514743dd41119e290276367c2fb1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb78af3c02b2463c9b7e74b792e5d62e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226897b7dda742f1b2b822fe5e2f5ed2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icebe580f12e2450aa32311d02bcd23d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fc782dbb0e49489e495a7aa71f62d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980a63340b96471687bdd40130dadc4e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82333f7ccf614eb1b010487872bbaad6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbcd4e4e0a0426389360304851d8b90_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75fb9f2f9ab743cf99a74ffa394e0fec_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a933469e6c4f0286ea390dbb12759b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5366f919647449e93ab9253d4a29029_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc32baf86d3348b285ed6d9464919955_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5986db8246ee4f9890cb846fcee620bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if57f220101a04dd081ed073252446f8d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i135a5815805f47c2b6d8423008b7e9eb_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9d81991fa044a8b0e369740ca0e420_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5bb92468604878bf5c2ea5357d059a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1332bd08855451b8303379ea937e071_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49f9e92f97cb43e7a611be42d5d2b76d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">shc:ShareBasedPaymentArrangementTrancheFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb0b3684d91465b91c4dbd708ec1220_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">shc:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d8961e3c6584f708b88ef82ee1078c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie79c75277ecb4c438785f138186141d9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec0fe360fc5a4fb9be9d970dce929cff_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i532429720d76464fb288ef6d7f8c4da4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e8d0ee307f4202ba503e68eb22522d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ab86e4b989f417494880063f915dc6d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9467f5d115d4bd28878ee4c52ac8b6c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i829eb019c2384385949420c934d9650c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbd8b853840d4d58a44be8b4f396efe6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">shc:A2020OmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ebc9f42a97466cbcc112179091d11f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">shc:A2020OmnibusIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4973995a8b649188261f6b9eb660a4a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">shc:A2020OmnibusIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6ab0133fd241ab95e886992abdac00_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id25ab8929ae14c599f0efe8cf6b717e9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea1bdce9661f4df4b25f0d61185bc957_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id702121c7c324bf6885a6bf80cae7fe4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2bd407df76c4d14a849c52897796383_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11e4447ffe14a53b4e1963b618ab6b0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if00ab087eb4046b2a954c121dda0b128_D20101022-20101022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">us-gaap:PositiveOutcomeOfLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-10-22</xbrli:startDate><xbrli:endDate>2010-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">us-gaap:PositiveOutcomeOfLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>shc:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i3056567d4b7944ee83f117f290349ae0_D20180901-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationIllinoisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>shc:claim</xbrli:measure></xbrli:unit><xbrli:context id="i2b7ab3687cab4a8e81d2d673d039bf1b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationIllinoisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f11af9e3301403b98a762a3a5ca629e_D20200519-20200519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationGeorgiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-19</xbrli:startDate><xbrli:endDate>2020-05-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2508d02cd384fa790ed8dda3ccb6e14_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationGeorgiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13271ac323454d0599f0910fc46fbaee_D20200817-20200817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationGeorgiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-17</xbrli:startDate><xbrli:endDate>2020-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="instrument"><xbrli:measure>shc:instrument</xbrli:measure></xbrli:unit><xbrli:context id="if41011b61b2c455085406c4d35f4b029_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c743685ac7e4b5eb6a0f423118724d0_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7710cf9b27a47e0b0c8712ace4267e6_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCapOctober2017Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2065da279504816835ffbc1e014f7ad_I20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08f77143efb4a438f9ac6fd9f28e16b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCapJune2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id090514efde94317af113816c3ec1bce_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99e7214bafc64b91bd10fb6c344d92fa_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCap1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb744f485b224be28617f3aba1a1cd06_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57dad9620c47433bb1a2a45a38b824b2_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCapFebruary2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e757215c724df1b4b2dbead002a317_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9939ca2be9548b480d25f00cfea7cb9_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie796349e2806499cb940f14083d11104_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6debae2625842d3aea289304287b04a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36a4d4ea180d473791afd4e893e822ca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0c33e7ec9945079c2630ef261167c1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55ed0869e08f4f768909753e2657522f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc5b766a46664492ac40f1cf7af1b926_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic30522771c8a4c2ca8b28897797aa79f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62085eeb658e46dd9eb6d857b79da630_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3f548aa16134334acbcc16023544496_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe8d5f4f0b7489bae88ace960e40d0e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e675f57e9d48bba3df5cba6d545d97_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2150bbbc748f44229562c8ec831ea1cf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01147b9ec0104587b5471c7226ea6552_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860d4a2deece4c239d322dec5ed3e62e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed3cf78f0d24298bc641938f88ea10f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8215ef184ce046bf92c78693a8b8af93_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5447c83f5dbc409a96088e361444a411_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8e15396c17b4617907472c2f4fade9b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5081d47552c47cb8088900905b4f829_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2f1e394ba7d4c1982b82751ef9eeb68_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf08e9f67a5d438db80fa3bec21b7105_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8f67cfa14e34836a09901949e8a6f78_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if94ed49fd1484dd19f80502049803ac1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic182088a125a4701b886f7b699c6ec3f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie31b8c09e1a04e3abd0d5865f45be488_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc39d33fbcf41d3be6a20574ae9f5e3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc03881b23174afb8aaf1b3b6857a78f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7219b8c57243488bb121b53bd3d7d3cf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcc5336d70c34ef689e5dbb4364e9943_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66e0ede22014573bd71c918b3740a70_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc835d02987343f4928bb15a4113279a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19990cadc7bf4e6eab87bd575dff569b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452aa60f46804ae7824cdb240c5048d4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4aa98cfa3374f178a69835db9e117bf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i272677a81acb465dad27e958b027480c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee05df50a75d477993f0144a1d299dfe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ace0d34fc84a82a4a8dd4561599885_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d9dd1bfbd544776a04462426d06480e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36f94f5ef6264fe1a1984794263117a2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36de9e2dd8ab40fc9b2ed92263ea4e84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if74455fdc1334818832b157f91fec355_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i585c891ef5c24f4f98a98256472bf2ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia08bd0ee1a164912afa76b9e27e176df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e84d185d63c421a9847d44f33a85663_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e84eddb6d54bfc9eb27fd468c46c12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fb62adf30e64a04ac7bbc2fce94d9c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i685874b622084b9fbc1d35045289e95a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba49c45ea854b6fa233cf1af5bbda94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87475347f6b64bf0a02e800f0af6deeb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i063954931d844af4a978fc5c7a468cf2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32014511dee4420784c09d1a73b0f794_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f8cf83b28b42adb2c968c7126c23b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4332841a17ae45d7ab5f8d5ccbb5a102_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78b7cb2bfc064b10a052025a86eea5f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id17e44686c4a444aa4f61e3a904dc55e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d64d815af524281b0cc85c6490417b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1c0685123d4f1dbe17dc0dcb90acb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79293a96e6644ab3afb669bba734bcc7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if197f04408d94ab68c955aa4b4a235fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81cd9ccf6a8a483399b03f856601a919_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15872309fe384ede99b59ae790fd6692_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9959285390451eb941cbc5aacef59e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d8483a806e144dc96f7e439adffab1a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35ac9047c5b543a3976685cc7c6f80bc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i019a710917314003bf051954e812e6f1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e3b0fca93a414f8267d4764139c900_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5e47f9b9f54685b7c4853c2ecaa92a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i060a27d3ce644a47a68d9a2bd5793f29_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if73b88809d084769a5f2a52b8afde703_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iababa48736c840818f39cbadfc3e0370_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie667bf6544f54f0790d703266225330a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b4e7cd3ba244ec68ee9e4a6d8ee9391_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i603326ebb8e04b33add577d701640115_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001822479</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i15ef643796c34829b3bb28475338f021_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzIx_d0bbb762-1d2b-46ae-85ae-fe6464c45435">10-Q</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDQ0Zjg2MWJiMmQ4NGMyZWExMWJhZjg1OTMzMDc4YTMvdGFibGVyYW5nZTo0NDRmODYxYmIyZDg0YzJlYTExYmFmODU5MzMwNzhhM18wLTAtMS0xLTI2ODg_0656d62f-2ac5-4b8f-98a9-b923212aa85b">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzM4_3b1c6f11-d498-47a0-b869-8a256f5325ba">March 31, 2021</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Webdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6Y2ZmZjIzOGNhZGZkNGNmZmJiNGUzNzBlMjNmMGU0NjgvdGFibGVyYW5nZTpjZmZmMjM4Y2FkZmQ0Y2ZmYmI0ZTM3MGUyM2YwZTQ2OF8wLTAtMS0xLTI2OTc_6b6e94ba-a058-4d5c-b514-fe1f90f7240a">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number&#160;&#160; <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzUz_44aa71ee-ff1c-4355-817d-45e7920702c6">001-39729</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><img src="shc-20210331_g1.jpg" alt="shc-20210331_g1.jpg" style="height:52px;margin-bottom:5pt;vertical-align:text-bottom;width:200px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:17pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU1_0924e116-a326-4871-9a7d-d0bd45a0f330">SOTERA HEALTH COMPANY</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18wLTAtMS0xLTI3NDA_cdb82441-0d98-47f3-9d82-d99cba8093f2">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18wLTItMS0xLTI3MTE_a0400b93-2ae2-4dc2-beac-93e425b551dd">47-3531161</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:7pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18zLTAtMS0xLTI3MjMvdGV4dHJlZ2lvbjo5MjI2OTJlNDM4ODc0YTM3YTEwM2FhOTI3MjY1MzIzMl8yNzQ4Nzc5MDY5NDk3_2731a653-f767-4dd6-8150-cdec205eaf20">9100 South Hills Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18zLTAtMS0xLTI3MjMvdGV4dHJlZ2lvbjo5MjI2OTJlNDM4ODc0YTM3YTEwM2FhOTI3MjY1MzIzMl8yNzQ4Nzc5MDY5NTA5_7622889b-21d0-4dbc-a7ad-ddb53710297b">Suite 300</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY180LTAtMS0xLTI3MzIvdGV4dHJlZ2lvbjo3YzI2NDBmYWE1ZWM0NjA4OTRjMWE3MDM0MTQxNThkMl8yNzQ4Nzc5MDY5NDg0_75c5f701-f33c-49bc-9b5b-e70ff7c2ff3f">Broadview Heights</ix:nonNumeric>, <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY180LTAtMS0xLTI3MzIvdGV4dHJlZ2lvbjo3YzI2NDBmYWE1ZWM0NjA4OTRjMWE3MDM0MTQxNThkMl8yNzQ4Nzc5MDY5NDkx_adc9e388-46e9-498a-9c8f-33297c21c22e">Ohio</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY180LTItMS0xLTI3MTM_7efb6ab8-f205-4943-a726-4e812ec9d599">44147</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Zip Code)</span></td></tr><tr style="height:7pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY183LTItMS0xLTI3MzgvdGV4dHJlZ2lvbjo0ZTM2ZGUxZjhhNTU0MWZmYTc0Mjk5MmJlNjRkZmQ0ZF8yNzQ4Nzc5MDY5NDUx_5b65984b-00cd-49a7-aee4-b04e26e23839">440</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY183LTQtMS0xLTI3NDM_49a29329-248a-4652-a949-654ea608b9d7">262-1409</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.165%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDI0ZjFiNTE4MTRmNDUwYTlmN2IwM2ViOTlkM2RiNmIvdGFibGVyYW5nZTo0MjRmMWI1MTgxNGY0NTBhOWY3YjAzZWI5OWQzZGI2Yl8xLTAtMS0xLTI3NDg_007b0de0-0f2c-4245-bddf-9f983c2cffd5">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDI0ZjFiNTE4MTRmNDUwYTlmN2IwM2ViOTlkM2RiNmIvdGFibGVyYW5nZTo0MjRmMWI1MTgxNGY0NTBhOWY3YjAzZWI5OWQzZGI2Yl8xLTEtMS0xLTI3NTE_051e294f-24bd-4807-b54d-37d9e69dc39a">SHC</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDI0ZjFiNTE4MTRmNDUwYTlmN2IwM2ViOTlkM2RiNmIvdGFibGVyYW5nZTo0MjRmMWI1MTgxNGY0NTBhOWY3YjAzZWI5OWQzZGI2Yl8xLTItMS0xLTI3NTM_61b7d971-9a0d-4046-9e7e-90da78321de8">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU2_86aaa3aa-2b23-4fb1-af60-521130b10216">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU3_e02b46d6-3758-47e0-a580-ad979cb1cb99">Yes</ix:nonNumeric>&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.&#160;&#160;See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6YTU0MjgzNTk3NzgzNGRlOWE1ZDE2NWUyZmM0ZTM5NTYvdGFibGVyYW5nZTphNTQyODM1OTc3ODM0ZGU5YTVkMTY1ZTJmYzRlMzk1Nl8xLTAtMS0xLTI3Njc_6db557ee-b0f2-4bad-9976-54a1a2df38ca">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6YTU0MjgzNTk3NzgzNGRlOWE1ZDE2NWUyZmM0ZTM5NTYvdGFibGVyYW5nZTphNTQyODM1OTc3ODM0ZGU5YTVkMTY1ZTJmYzRlMzk1Nl8xLTMtMS0xLTI3NzI_c72f7802-f666-4915-b695-18711c875a4a">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6YTU0MjgzNTk3NzgzNGRlOWE1ZDE2NWUyZmM0ZTM5NTYvdGFibGVyYW5nZTphNTQyODM1OTc3ODM0ZGU5YTVkMTY1ZTJmYzRlMzk1Nl8yLTMtMS0xLTI3NzQ_030652c4-5852-4625-9cb8-8dff2d276271">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange&#160;Act.&#160;</span><span style="color:#000000;font-family:'Webdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzY1_4c915114-2c9c-4771-8e1e-efa3c4d0edf0">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU4_a21b01f7-6516-495a-845d-a8e92f20d422">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;Yes &#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;No</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May 6, 2021, there were <ix:nonFraction unitRef="shares" contextRef="iecb4c2bb33504c7dac5c01c3a9c0c6fb_I20210506" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzg4_f55ffd86-2717-4141-b9b2-1e15e9d754ce">282,869,957</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.01 par value per share, outstanding.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOTERA HEALTH COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- TABLE OF CONTENTS -</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_13">Part I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_13">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_16">Item 1. Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_16">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_100">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_100">30</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_127">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_127">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_130">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_130">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_133">Part II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_133">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_136">Item 1. Legal Proceedings.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_136">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_139">Item 1A. Risk Factors.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_139">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_154">Item 6. Exhibits.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_154">44</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_157">SIGNATURES</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_157">45</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q includes &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Forward looking statements are often characterized by the use of the words such as &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;may,&#8221; &#8220;intends,&#8221; &#8220;plans&#8221; or &#8220;anticipates,&#8221; or by discussions of strategy, plans or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from historical results or any future results, performance or achievements expressed, suggested or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any disruption in the availability of, or increases in the price of, ethylene oxide (&#8220;EO&#8221;), cobalt-60 (&#8220;Co-60&#8221;) or our other direct materials, services and supplies, including as a result of current geopolitical instability arising from U.S. relations with Russia and related sanctions;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse changes in industry trends;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse changes in environmental, health and safety regulations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accidents resulting from the safety risks associated with the use and disposal of potentially hazardous materials such as EO and Co-60;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accidents resulting from the safety risks associated with the transportation of potentially hazardous materials such as EO and Co-60;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liability claims relating to health risks associated with the use of EO and Co-60;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">current and future legal proceedings;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the intensity of competition we face;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any market changes that impact our long-term supply contracts with variable price clauses;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">allegations of our failure to properly perform our services and any potential product liability claims, recalls, penalties and reputational harm;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the regulatory requirements to which we are subject, and any failures to receive or maintain, or delays in receiving, required clearance or approvals;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business continuity hazards and other risks associated with our operations, including our reliance on the use and sale of products and services from a single location;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to increase capacity at existing facilities and build new facilities in a timely and cost-effective manner;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to renew the long-term leases for our facilities at the end of their terms;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risks of doing business internationally;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">instability in global and regional economic and political conditions;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to retain key personnel and attract talent;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the significant regulatory oversight to which our import and export operations are subject, and any failure to comply with applicable regulations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any cyber security breaches and data leaks as a result of our dependence on information technology systems;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risks of pursuing strategic transactions, including acquisitions, and our ability to find suitable acquisition targets or integrate strategic acquisitions successfully into our business;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain effective internal controls over financial reporting;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on intellectual property to maintain our competitive position and the risk of claims from third parties that we infringe or misappropriate their intellectual property rights;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the data privacy and security laws and regulations to which we are subject, and any ineffective compliance efforts with such laws and regulations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain profitability in the future;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairment charges on our goodwill and other intangible assets with indefinite lives;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unionization efforts and labor regulations in certain countries in which we operate;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the variety of laws involving the cannabis industry to which we are subject, and any failure to comply with those laws;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risk of government or private civil antitrust actions;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse changes to our tax positions in U.S. or non-U.S. jurisdictions, the interpretation and application of recent U.S. tax legislation or other changes in U.S. or non-U.S. taxation of our operations;</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our substantial leverage could adversely affect our ability to raise additional capital, limit our ability to react to changes in the economy or our industry and prevent us from meeting our obligations under our existing and future indebtedness; and</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to generate sufficient cash flows or access sufficient additional capital to meet our debt obligations or to fund our other liquidity needs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These statements are based on current plans, estimates and projections, and therefore you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them publicly in light of new information or future events, except as required by law. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the above factors, as well as the factors discussed elsewhere in this Quarterly Report on Form 10-Q, including under Part II, Item 1A, &#8220;Risk Factors,&#8221; as well as Part I, Item 1A, &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;2020 10-K&#8221;). If any of these trends, risks or uncertainties actually occurs or continues, our business, financial condition or operating results could be materially adversely affected, the trading prices of our securities could decline and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless expressly indicated or the context requires otherwise, the terms &#8220;Sotera Health,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; in this document refer to Sotera Health Company, a Delaware corporation, and, where appropriate, its subsidiaries on a consolidated basis.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:161%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:161%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I&#8212;FINANCIAL INFORMATION</span></div><div id="i15ef643796c34829b3bb28475338f021_16"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="i15ef643796c34829b3bb28475338f021_19"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMy0xLTEtMS0w_7f49928e-76d6-496f-9f21-41fea873a7e7">108,009</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMy0zLTEtMS0w_5cccb9c9-9d40-47e4-991c-5b6c0fff41c6">102,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash short-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNC0xLTEtMS0w_b58d1607-2b5d-4ef6-8b2f-fe571e04b0ba">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="us-gaap:RestrictedCashCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNC0zLTEtMS0w_a9875cc2-f119-49bb-a5c1-924875a708de">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable, net of allowance for uncollectible accounts of $<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0wLTEtMS0yODIyL3RleHRyZWdpb246MmJiZTFkOWFlNmU3NGI3MGE4MDVlZDllY2MwOGI1OTNfMjc0ODc3OTA2OTU0OA_0aec102a-828a-4b01-8f3f-275f66aed090">603</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0wLTEtMS0yODIyL3RleHRyZWdpb246MmJiZTFkOWFlNmU3NGI3MGE4MDVlZDllY2MwOGI1OTNfMjc0ODc3OTA2OTU0Mw_77cfd398-b516-43ea-b1fc-ec28b7416485">708</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0xLTEtMS0w_f26eb0a2-6345-4898-94fc-b23e9577d79c">96,393</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0zLTEtMS0w_3cb13c98-27ff-4b84-8b07-1626bdd93ad1">91,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNi0xLTEtMS0w_d1eb933f-41a0-468c-adb4-479d3f4961b6">33,375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNi0zLTEtMS0w_c8d00782-3f13-4c81-b9a8-61276a769bc2">34,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNy0xLTEtMS0w_60108d92-9244-474d-b2f3-752d170b53c0">69,758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNy0zLTEtMS0w_5e11b7d2-a5b7-47e2-b7b6-8912ad919668">64,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income taxes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOC0xLTEtMS0w_1fff53b6-cda1-4dc1-9557-30aa58989da0">20,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOC0zLTEtMS0w_fb60ef91-0827-4063-86dc-d326491f4e4a">21,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOS0xLTEtMS0w_aed7dcf9-985c-4409-ac7c-af63d4e645c1">328,367</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOS0zLTEtMS0w_0678f049-d8de-4c42-b143-7f638728ec17">315,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTAtMS0xLTEtMA_1e9f31f3-d6df-4fb6-96cf-6fb64477c1b8">611,620</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTAtMy0xLTEtMA_0f5b8677-aeac-46fb-86b7-d0869b8cea90">609,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTEtMS0xLTEtMA_29300158-5275-4d2d-8260-3c4033ec7d09">47,117</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTEtMy0xLTEtMA_148ec66d-fe08-44aa-b97f-c89c82d42e29">45,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTItMS0xLTEtMA_53d82d87-380e-4c31-b1cf-3226cfacee3e">8,088</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTItMy0xLTEtMA_0a26c25b-3813-45e6-a84d-89de6947501a">8,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Investment in unconsolidated affiliate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTMtMS0xLTEtMA_ab635c58-e2e0-4ede-b7e5-c539a023a654">9,227</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTMtMy0xLTEtMA_9cb984e4-3dac-4b38-b14c-cf411c6afb80">13,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTQtMS0xLTEtMA_d59ed261-e594-4240-9685-62881bb0617c">9,281</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTQtMy0xLTEtMA_7f270f2d-1371-4849-b00a-53fd5e134086">9,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTUtMS0xLTEtMA_9c8e9d44-80dd-4b05-b8bc-3af18fc6cb56">656,572</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTUtMy0xLTEtMA_f85c748b-abc9-4b2e-8402-9d2a1aa535a6">643,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTYtMS0xLTEtMA_3b783fba-a30a-46b6-9d98-80a4dd8af354">1,106,728</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTYtMy0xLTEtMA_3e2aeb31-088c-41d6-be75-bf303334b1be">1,115,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTctMS0xLTEtMA_bb465bb1-8380-4600-b100-d25787f7a386">2,777,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTctMy0xLTEtMA_7acc780f-58ae-4f98-9dbb-ebcef669b157">2,761,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Liabilities and equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjAtMS0xLTEtMA_5e68c78e-a479-4591-aed7-45c40b0859a2">57,174</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjAtMy0xLTEtMA_acf7a978-ef20-4b08-b6cd-86fc31c66bb0">52,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjEtMS0xLTEtMA_dab8ea6d-e794-4f09-a4fc-82c709ce7e21">56,373</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjEtMy0xLTEtMA_cc8c8db5-28a9-4653-bb85-b695d8065115">60,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjItMS0xLTEtMA_cd81e3f2-d7cf-4d81-b7b6-59554a4ce20b">5,958</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjItMy0xLTEtMA_6d7b9e74-4ff6-46ad-802b-741739df422c">6,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current portion of finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjQtMS0xLTEtMA_77c3fce8-2f4e-4833-91b3-56a0c2f3ec24">1,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjQtMy0xLTEtMA_95817965-abf2-41c6-9c46-ff7c974b24cc">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current portion of operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjUtMS0xLTEtMA_997a735e-ddaa-4bb6-a185-55610c7275bc">9,631</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjUtMy0xLTEtMA_25b09354-f830-4247-8e3e-b906fad78764">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Current portion of asset retirement obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:AssetRetirementObligationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjYtMS0xLTEtMA_78f4d65d-8b51-4197-95c1-574d049f8506">391</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="us-gaap:AssetRetirementObligationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjYtMy0xLTEtMA_af3da6d7-d5e8-4c2a-b464-ab7ff532becf">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMS0xLTEtOTcwNA_099ace54-98db-47f5-a292-5a0b9a478e3a">7,384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMy0xLTEtOTcwNA_9c8335d2-ed3a-4cb9-8851-53e45bbd9748">10,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjctMS0xLTEtMA_d7a5a499-89d2-4aed-a1d9-0921a07bda21">138,019</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjctMy0xLTEtMA_8f169414-705c-4f98-877a-095ace3f3468">140,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Long-term debt, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMS0xLTEtMA_5f88aac7-72ee-4964-90c0-b9bf5450aa95">1,837,580</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMy0xLTEtMA_532d0df0-212b-4c57-9085-51e349942ac6">1,824,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Finance lease obligations, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjktMS0xLTEtMA_a015c2e1-db81-4062-ac0e-a014c20983fc">33,432</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjktMy0xLTEtMA_ffe083bb-492d-466d-8737-984751b1f5fc">34,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Operating lease obligations, less current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzAtMS0xLTEtMA_f487ac9b-61e0-41dd-a50e-20980e0579c0">39,806</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzAtMy0xLTEtMA_bf966e15-1242-42a4-943a-6cab4e50d3c5">38,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncurrent asset retirement obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetRetirementObligationsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzEtMS0xLTEtMA_81820897-c802-46e5-81ec-7f2b7f446fe8">45,633</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetRetirementObligationsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzEtMy0xLTEtMA_75ce770b-7ced-4db9-b7eb-74f2aa98ba46">45,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred lease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRentCreditNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzItMS0xLTEtMA_471af09e-ebfd-4caf-9ed7-aae6cff7ace9">21,362</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRentCreditNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzItMy0xLTEtMA_1dc778b9-4354-4b6c-a8c0-1f6b0e7993b0">21,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Post-retirement obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzMtMS0xLTEtMA_eaead6b3-1476-4bbc-8516-d4937f472c09">46,959</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzMtMy0xLTEtMA_38bd8997-9526-461a-8b30-ec0859de5ee3">48,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Mandatorily redeemable noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzQtMS0xLTEtMA_cd03bbf0-d9a6-4ac6-870a-2e0582030866">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzQtMy0xLTEtMA_11084f9e-b7be-451a-95fd-b4aeb3f808cf">13,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzUtMS0xLTEtMA_dd95d665-695d-455d-85e4-a14379be9f7d">18,795</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzUtMy0xLTEtMA_677e5f42-00da-43c3-b785-ebee4832168d">17,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzYtMS0xLTEtMA_958d2383-cce8-4a47-98fa-0e3b43533172">129,670</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzYtMy0xLTEtMA_843b2f1b-9f01-47c2-8544-280b4829ebb8">121,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzctMS0xLTEtMA_2daac28f-858f-4a56-860a-b82c6943029e">2,311,256</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzctMy0xLTEtMA_3856254a-34fb-4de5-ba7a-519cd2975697">2,306,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See Commitments and contingencies note</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzgtMS0xLTEtMjgzMg_6f0abd14-e67d-42cc-b7c0-fea93ce53582"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzgtMy0xLTEtMjgzNA_230812a9-fdcd-4914-86e7-df3aeeedeb77"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock, with $<ix:nonFraction unitRef="usdPerShare" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk1ODk_2f27af55-e76b-4d44-8569-2a2343f091d2"><ix:nonFraction unitRef="usdPerShare" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk1ODk_d60133ec-c789-4158-8361-cf2d2be3ca1b">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MDE_05e0b803-0cf3-4f8c-aea3-0ba13e7e1b55"><ix:nonFraction unitRef="shares" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MDE_0776b9c8-bc03-4d91-afbd-5d41c57e4acb">1,200,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MTE_8bbc909b-70dc-4ca4-8ae5-fa556238dc04"><ix:nonFraction unitRef="shares" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MTE_f0a58186-38c6-4788-9c44-04027ec38e80">285,990</ix:nonFraction></ix:nonFraction> shares issued at March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMS0xLTEtMA_2e5a8f3f-9115-44e8-af7d-c67e799e23df">2,860</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMy0xLTEtMA_551030ed-a776-4214-a0e3-d0ed8caae77f">2,860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred stock, with $<ix:nonFraction unitRef="usdPerShare" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1ODA_509ae540-488b-4f51-9435-0254f4454522"><ix:nonFraction unitRef="usdPerShare" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1ODA_57e8be93-bbf3-4064-8860-7d86f3822bee">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTA_72ba1bcc-907e-4dc3-8592-4b08b6d07ad7"><ix:nonFraction unitRef="shares" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTA_e1ff4b10-b789-4de9-9b4a-bc0e6fde99a9">120,000</ix:nonFraction></ix:nonFraction> authorized; <ix:nonFraction unitRef="shares" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTU_1f686274-9a44-4be2-ab07-a4103bace78b"><ix:nonFraction unitRef="shares" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTU_9fd2a68b-a29f-4504-859a-623a57ce51e3">no</ix:nonFraction></ix:nonFraction> shares issued at March 31, 2021 and </span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMS0xLTEtMA_b5a197ce-ba7b-439b-83c5-91a6f0d0dbf8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMy0xLTEtMA_d48bcd7f-1ae6-4985-b500-94646f847fc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Treasury stock, at cost (<ix:nonFraction unitRef="shares" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMC0xLTEtMjg5Ni90ZXh0cmVnaW9uOmZiNmIwNjliYmZjZTRiMWJhZTc5YzU3M2MxYWEwYzg5XzI3NDg3NzkwNjk1NTE_e7e5c051-2518-4fbb-9589-4bd26cbc4313">3,090</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMC0xLTEtMjg5Ni90ZXh0cmVnaW9uOmZiNmIwNjliYmZjZTRiMWJhZTc5YzU3M2MxYWEwYzg5XzI3NDg3NzkwNjk1NTk_56d87808-8896-4683-89f6-0135b6b235d3">2,742</ix:nonFraction> shares at March 31, 2021 and December 31, 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMS0xLTEtMA_6c7d9455-dc33-4a39-a92a-1d1bff9d40f3">34,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMy0xLTEtMA_549ee869-5de1-41a8-bf56-b8fc5b29e326">34,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDMtMS0xLTEtMA_bb00b9ab-39d5-4937-a203-2781b3acc141">1,169,852</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDMtMy0xLTEtMA_afc7607e-3949-4925-b9b1-60a727e9ac24">1,166,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Retained deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDQtMS0xLTEtMA_c7d1c35a-a6a7-4723-94bc-7203b033d869">578,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDQtMy0xLTEtMA_231fc471-2792-4360-aa55-2e6b7c5c90e1">589,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDUtMS0xLTEtMA_8c4c782b-e109-46a4-806b-d917ba11f79b">97,162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDUtMy0xLTEtMA_eab59f2c-68c6-4b52-b2cb-ccc1317dfb86">93,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total equity attributable to Sotera Health Company</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDYtMS0xLTEtMA_db107314-6cf1-43ea-89f7-c955d7a28e24">463,264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDYtMy0xLTEtMA_ff448c01-cd96-4c60-8042-f2bd3b5a6bf0">452,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDctMS0xLTEtMA_99b58b69-c1c6-4884-acfc-691f9ab9f4a3">2,480</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDctMy0xLTEtMA_bbe55e61-17fb-49ef-ac08-2710add71ded">2,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDgtMS0xLTEtMA_eef31c98-bfdb-4dd3-8d42-45b78cde5d1e">465,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDgtMy0xLTEtMA_3816c35d-37a8-4fd8-a2fa-28070dee6fbb">454,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Total liabilities and equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDktMS0xLTEtMA_7d0e9a10-40be-4fb0-8222-379ab4df36b8">2,777,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDktMy0xLTEtMA_cf7380bb-e0a1-4604-a61e-c42966cc84ec">2,761,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">5</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:161%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:161%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations and Comprehensive Income (Loss) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Service</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cf37fb79c6347f6a6f791184ce78acf_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMy0xLTEtMS0w_fd3ae527-329b-485b-8858-7fc082251653">188,698</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic37232295f3745cd88694de59101666d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMy0zLTEtMS0w_d0ed278e-1339-425d-8d12-ebc5bfa81974">167,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Product</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icee21de57c09410dbdb4e1d0c7cd6110_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNC0xLTEtMS0w_5145a0ad-2858-49be-83c3-5841b580f574">23,450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9cc06bf938484e99bfe9969660cc781c_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNC0zLTEtMS0w_ecd7cbd8-788a-4fd7-bd14-aed8381c3267">20,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total net revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNS0xLTEtMS0w_4e83b031-328d-498a-81c7-e50b35df39f4">212,148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNS0zLTEtMS0w_25bdea27-f331-495a-960c-871cc08e5a03">188,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Service</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cf37fb79c6347f6a6f791184ce78acf_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNy0xLTEtMS0w_ec88ad63-2e78-4b89-91db-22534b352eef">85,036</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic37232295f3745cd88694de59101666d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNy0zLTEtMS0w_3429a3c7-58fb-4f2d-a532-8466d6c63d96">83,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Product</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icee21de57c09410dbdb4e1d0c7cd6110_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOC0xLTEtMS0w_c773a1d3-e920-4dd1-b36e-497db141e2da">11,740</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9cc06bf938484e99bfe9969660cc781c_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOC0zLTEtMS0w_e34f5b11-9dc1-4f8a-bf62-d07d52fb4cab">8,614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOS0xLTEtMS0w_0c68c191-f066-419d-9892-11adb6651ec0">96,776</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOS0zLTEtMS0w_b57fd263-df40-4081-9ce3-3c52cd91475f">91,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTAtMS0xLTEtMA_41ccad40-1017-4631-b591-997e588f08ff">115,372</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTAtMy0xLTEtMA_5896826e-033d-44bd-92f4-6377c8760252">96,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTItMS0xLTEtMA_c2b85f82-b64b-4867-9aff-b003202eaea3">52,465</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTItMy0xLTEtMA_aaee6ddf-9eca-4a5f-95e5-dfa0af726871">37,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:AmortizationOfIntangibleAssetsNonproduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTMtMS0xLTEtMA_219add50-61bb-42fb-8414-647d4c7d1444">16,543</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:AmortizationOfIntangibleAssetsNonproduction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTMtMy0xLTEtMA_c96eaf9b-97c6-43fb-aa80-9563f6f9166b">14,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTUtMS0xLTEtMA_393c1e4b-e012-49c3-ac5e-f9f7afb9d8e5">69,008</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTUtMy0xLTEtMA_9e37482b-25d4-45db-a5c7-9a643c14c162">51,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTYtMS0xLTEtMA_7715b954-ddb5-43f3-b58f-f6e29e20c513">46,364</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTYtMy0xLTEtMA_aa577fdf-83cf-473e-9970-4e726f27a680">44,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTctMS0xLTEtMA_4451014f-4a65-4cf1-b80d-099eb04640d6">21,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTctMy0xLTEtMA_8840bf82-4fb2-49cf-81d4-edc629d2af57">56,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTgtMS0xLTEtMA_fb52b047-a1b9-49cb-a5c3-1bdcfc0b5f08">14,312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTgtMy0xLTEtMA_af2e5c6a-518a-4b23-a1b0-b5f5237663f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign exchange loss (gain)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTktMS0xLTEtMA_016df7c8-9e78-49bd-ad0d-ea2c7dd7fe1e">578</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTktMy0xLTEtMA_5b99a3fd-75a8-41b5-881c-be66c6abe3d5">627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjAtMS0xLTEtMA_7f12d3e8-8481-4e31-848a-5f16eb9cdf18">3,890</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjAtMy0xLTEtMA_4a0fbff8-12de-447a-ae59-4b0d1bd55880">3,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjEtMS0xLTEtMA_138062b6-3d0f-447b-ade5-aba011afdf6d">14,082</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjEtMy0xLTEtMA_2ae8db18-4434-4aac-a466-fd3a44739ea0">14,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjItMS0xLTEtMA_840af482-04fd-4280-b5d6-3a3a263affc8">3,017</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjItMy0xLTEtMA_d4f9b6c6-6a67-49c8-ab6e-81fd5bf3bac8">12,234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjMtMS0xLTEtMA_7606c82b-2b17-4882-82b1-83fc6e8e43f5">11,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjMtMy0xLTEtMA_f1ebfbf1-fd70-4763-a93c-643058b47578">1,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Less: Net income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjQtMS0xLTEtMA_3ea6a6e8-60b9-4eec-aea6-8217c4abf81e">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjQtMy0xLTEtMA_2570a7a4-4e20-49f5-84a8-e587c8568206">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income (loss) attributable to Sotera Health Company</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjUtMS0xLTEtMA_024b6dcf-ca4c-44d3-ba90-27a328402a55">10,842</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjUtMy0xLTEtMA_ba4317f4-ef79-4f85-b1f2-458d6d5c6dc4">1,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other comprehensive (loss) income net of tax:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pension and post-retirement benefits (net of taxes of $<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMC0xLTEtMzEzOS90ZXh0cmVnaW9uOmUyYmM5ZmQzOTgwYjQ2NmFiMjk0ZmEyNTI3ZWY2OTdkXzI3NDg3NzkwNjk1NDA_e768488d-482c-49c7-9850-c65b2632cd95">84</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMC0xLTEtMzEzOS90ZXh0cmVnaW9uOmUyYmM5ZmQzOTgwYjQ2NmFiMjk0ZmEyNTI3ZWY2OTdkXzI3NDg3NzkwNjk1MzQ_73dac2a5-5e0c-4976-a161-d4bab8548589">744</ix:nonFraction>), respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMS0xLTEtMA_4b3f4e9a-3c39-46ae-982b-7ffa4b4fbac9">249</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMy0xLTEtMA_5bb4cbb4-1f15-4e8f-989c-fb4ea27cf621">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest rate swaps (net of taxes of $<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMC0xLTEtMzEzNy90ZXh0cmVnaW9uOjg3YmJkNDM1MWU5MjQxMzc5ZGFjMGM5MGE2ZmNhNDFiXzI3NDg3NzkwNjk1MTE_3e02f30b-a18c-4f25-9616-b2b99b35dd96">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMC0xLTEtMzEzNy90ZXh0cmVnaW9uOjg3YmJkNDM1MWU5MjQxMzc5ZGFjMGM5MGE2ZmNhNDFiXzI3NDg3NzkwNjk1MjA_9cb7a566-2214-487e-8582-416084bdabe5">1,234</ix:nonFraction>, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMS0xLTEtMA_bcc307d9-7995-42d6-9911-4fc5991601f5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMy0xLTEtMA_9cde3eb2-7b70-4e99-9928-05263d9396a7">3,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjktMS0xLTEtMA_197826d4-a5b7-4e8d-b7c5-8545271191a3">3,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjktMy0xLTEtMA_52a895bb-7f85-43b2-8c42-9418ccbf3e8b">72,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzAtMS0xLTEtMA_3cee970f-b661-49ed-a4b9-cd7023ed8197">7,730</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzAtMy0xLTEtMA_fa88ea98-6a24-49cb-8445-a15df8c564fe">76,225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: comprehensive income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzEtMS0xLTEtMA_560c36ec-4bbe-4943-8899-ec9cb55e1a72">208</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzEtMy0xLTEtMA_671120cf-8d33-4524-9c06-bafcc55fd80c">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Comprehensive income (loss) attributable to Sotera Health Company</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzItMS0xLTEtMA_e8680b08-2592-4183-92a4-1eec711dbc9a">7,522</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzItMy0xLTEtMA_850d710d-9131-4d75-b4fd-23fe4073e79f">76,203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Earnings (loss) per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMS0xLTEtMTIzOQ_21dc60e1-e468-40e8-925f-03d5945aa4c6">0.04</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMy0xLTEtMTIzOQ_b6a844dd-98d0-4e69-a32e-7c189e3013f0">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMS0xLTEtMA_410108e3-7134-4848-a620-c7579cbde11d">0.04</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMy0xLTEtMA_68ff2ae0-d2a4-4061-8d0c-5e519cab3bad">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzctMS0xLTEtMTIzNA_73ca3b09-d5a0-4949-a566-957d48ea45a2">278,827</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzctMy0xLTEtMTIzNA_de9cc99b-4cfd-4132-b90c-184c28545daa">232,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzYtMS0xLTEtMA_fe9b737e-be12-4b80-8890-e54c0cb18fc9">278,968</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzYtMy0xLTEtMA_11298b78-cac5-4774-9a3c-9d7c3ebc38ce">232,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">6</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:161%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:161%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMy0xLTEtMS0w_120b4486-9886-4454-b774-f1e30d536c25">11,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMy0zLTEtMS0w_395de824-946c-426c-9663-acc753fd711e">1,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNS0xLTEtMS0w_842f21a3-5e28-4205-8d20-e8d243df4fb0">15,379</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNS0zLTEtMS0w_de2716ca-0290-4fcb-84e6-00ab776fbe55">16,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNi0xLTEtMS0w_c962532c-d7bf-4ca5-9266-dff617b9d18d">22,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNi0zLTEtMS0w_7379d8d3-8e45-4b1b-b670-1cd171a01e0c">19,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOC0xLTEtMS0w_76780219-86e1-48a9-a73e-5a8addb7ca5a">14,312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOC0zLTEtMS0w_4ad5f0bb-081c-4ea5-a8bc-f76c55c6a521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOS0xLTEtMS0w_ff24e0ef-3a41-4d52-9eeb-a58d20d1b010">3,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOS0zLTEtMS0w_72a00331-0e93-4a0d-bec4-7486d2eb7a7e">6,683</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTAtMS0xLTEtMA_2d48c34b-b076-452b-b497-4d4088a44a87">3,449</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTAtMy0xLTEtMA_f7e7381b-8f0e-4e5a-948d-c8500f7f07ba">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accretion of asset retirement obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTEtMS0xLTEtMA_a6221d6a-31ea-4c70-9a78-26fa2ed79b10">551</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTEtMy0xLTEtMA_e661f5d8-2510-474f-a921-532896b9c48b">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized foreign exchange (gains) / losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTItMS0xLTEtMA_a022a16f-7c14-4736-8206-33b6ce1ca2a4">2,354</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTItMy0xLTEtMA_3e0ba344-28d4-4718-9e7c-579386a49ea8">4,876</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Unrealized (gain) / loss on embedded derivative instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTMtMS0xLTEtMA_ad810440-584c-4866-b8f7-d332c4a0726a">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTMtMy0xLTEtMA_60b29e7d-6a35-4f0d-8fea-51281418d9a7">4,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Gain (loss) on interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMS0xLTEtMTc_2c7cf46a-f4ee-4394-970e-19f8b613587d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMy0xLTEtMTc_43b7dffb-51bb-4446-95f6-1809c633b522">4,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMS0xLTEtMA_2f291e5b-1a89-40a5-bfe9-793f981430ea">1,663</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMy0xLTEtMA_400662ec-2c97-4526-9dc4-338d36d45aab">2,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTUtMS0xLTEtMA_747dd9f4-8ac5-420b-b954-b1fa103a2dce">2,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTUtMy0xLTEtMA_d8747e4a-8e82-488a-b297-d97fd374149c">2,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTctMS0xLTEtMA_e3206cd1-5847-40a9-8bbb-6f0250a31b5b">4,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTctMy0xLTEtMA_1b755395-f3c5-4158-92b8-5828e48dd6ad">433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTgtMS0xLTEtMA_f498fdd5-7d9d-486c-be1e-8afef814dd81">1,099</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTgtMy0xLTEtMA_f9f94045-9c30-4997-ac7d-11aca5e95edf">1,553</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTktMS0xLTEtMA_98203c92-fcac-4520-887d-166a903543ef">2,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTktMy0xLTEtMA_c493b514-c4d7-427c-96db-27b355ca402b">1,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjAtMS0xLTEtMA_b11a8a39-1252-4cad-aa10-9eeaac02a579">6,625</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjAtMy0xLTEtMA_27189376-dc89-435a-b792-15f139dff193">733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjEtMS0xLTEtMA_a728d5b4-f301-4a6d-b935-1d3e57327562">5,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjEtMy0xLTEtMA_f85d0e83-e76f-4440-b231-16b17d452621">8,334</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Income taxes payable / receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjItMS0xLTEtMA_d8d26230-6bd8-404b-88d9-d4a801be7a85">4,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjItMy0xLTEtMA_fbdc8a03-f754-4d85-834a-83856279de65">8,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjMtMS0xLTEtMA_aa3333e3-061c-4ae7-8d34-f7270e86352c">1,513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjMtMy0xLTEtMA_5f3eddfc-35d2-421f-be9a-8892b2b854d8">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjQtMS0xLTEtMA_52f95bbc-022a-4ae0-b8dd-c62ec35405df">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjQtMy0xLTEtMA_618e3697-4683-4568-ba01-57dde7ce1df4">889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjUtMS0xLTEtMA_2ed59871-f128-4908-ad5f-47c47269ff0a">56,159</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjUtMy0xLTEtMA_a92d2595-834c-47cf-ab95-67a21c9b552c">5,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjctMS0xLTEtMA_5c23dc62-bf88-42fa-905f-21cf87e19baf">20,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjctMy0xLTEtMA_8ece7f83-00e2-4680-b650-6af663bdf271">12,989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzAtMS0xLTEtNzAzMg_6e8e0b8f-590c-4369-907a-68a4af95c443">12,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzAtMy0xLTEtNzAzMg_2a55d39a-a1e3-4cef-85f3-6e89ab0732e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Purchase of BioScience Laboratories, LLC, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjgtMS0xLTEtMA_39d9d341-155d-44e2-b7eb-773b234140a7">13,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjgtMy0xLTEtMA_f9405f80-4371-4616-bdde-0e0e4d911a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjktMS0xLTEtMA_18a3687c-2c36-4c86-8c0e-38b423822547">46,519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjktMy0xLTEtMA_7bd7cd6a-4eaa-420a-9777-fbf4a4581d6d">12,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzItMS0xLTEtMA_e19cf6b0-83c6-4ceb-89a0-01fcad1e7a12">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLongTermLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzItMy0xLTEtMA_3d234307-d5b4-4854-bb02-4682dee8e0ea">50,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payments of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzUtMS0xLTEtMA_b050e2bf-c9e4-4026-9372-c2f7abf3e0c9">3,435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzUtMy0xLTEtMA_299dc343-8f48-4eeb-a6a3-223da4ae5c2d">207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Payments on long-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzYtMS0xLTEtMA_ec8bc149-83a0-486a-a516-f79578c0d54a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzYtMy0xLTEtMA_66c58d76-7182-442e-b3e7-bdd085d6b5fb">142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzctMS0xLTEtMA_f7d29eb9-dad6-49f7-8f28-6fdb4831a689">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzctMy0xLTEtMA_e665c47c-cf83-47da-b138-2aa1f524cf19">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzgtMS0xLTEtMA_51fc155b-49be-497b-a590-002ee15d4af4">3,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzgtMy0xLTEtMA_511d742a-0aab-4212-8d09-dc78a8a1c813">49,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzktMS0xLTEtMA_6e3c76fd-b8c3-4707-b1a1-3289ac21cff5">295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzktMy0xLTEtMA_22e7006e-6962-4122-a912-91f9443eb5bb">154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents, including restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDAtMS0xLTEtMA_a95bcc08-e398-446a-8ee2-646ced5ba0b8">5,562</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDAtMy0xLTEtMA_ba162940-998d-4545-b841-7e5f047e33bf">42,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents, including restricted cash, at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDEtMS0xLTEtMA_1e46780b-804d-4741-841b-e296aee6d016">102,454</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0646aca58984456ab4ccef54f837d8d7_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDEtMy0xLTEtMA_28b71300-0f18-480e-89a6-788ac67f2e05">63,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash and cash equivalents, including restricted cash, at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDItMS0xLTEtMA_d5c0bc64-d2ea-4da7-aaaa-1f4c7b0ebab3">108,016</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDItMy0xLTEtMA_2e08bdd5-9b5e-4ce2-98ef-7c4b9a2d734d">105,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash paid during the period for interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDQtMS0xLTEtMA_eea36494-244a-4bdf-b64e-1189d547e8f7">19,745</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDQtMy0xLTEtMA_f24f979d-041e-4f38-8e98-005985ec06f8">63,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cash paid during the period for income taxes, net of tax refunds received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDUtMS0xLTEtMA_1b1f75a5-600f-4654-b7bf-2d8a543f6ef5">11,561</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDUtMy0xLTEtMA_3dc47611-e09b-47dc-a4f3-8819043a1043">1,868</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Equipment purchases included in accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDYtMS0xLTEtMA_b1441811-a4b0-455b-8e17-886ac7f31925">7,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDYtMy0xLTEtMA_d84d589d-6a7f-439c-949b-d155ed5c983d">5,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">7</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Equity (Deficit) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:139%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:139%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:139%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Earnings /</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Deficit)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(Loss) Income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Noncontrolling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Interests</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3e003cc982634a42a6004e9be503ae52_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xLTEtMS0w_c6181fce-a3b0-4a34-bb2f-30f937899e87">232,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3e003cc982634a42a6004e9be503ae52_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0zLTEtMS0w_d85d2e77-1246-45d4-a09b-b1c1332914be">2,324</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1ca8f2e824984cde87c9e7c8204a7b3c_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi01LTEtMS0w_ba6bed14-f403-4287-8459-13fe167cea2d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibc054b078af443cbabc1b10fbff2443f_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi03LTEtMS0w_d97fba40-74ec-45a5-aeb9-319abb780ae4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1a49d2f4b5de474392adda95a3719a97_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi05LTEtMS0w_d2071c55-9f22-4b5f-87ab-79732ac4ed3c">550,511</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4a52e4d931ab42eca6b2d9fca0916150_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xMS0xLTEtMA_a6ad77a0-734d-4244-9de4-710e6cc7b056">94,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i158e9c437afe4c1ca6ee15516e6628fc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xMy0xLTEtMA_96e10b97-c04d-4a48-bbe8-239f68cf4ce2">1,442</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i0646aca58984456ab4ccef54f837d8d7_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xNS0xLTEtMA_cc2afa46-eb38-41b1-b691-b896337d3b8b">641,132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8d09c73619b54b50855522776180722f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNS03LTEtMS0w_edc22e7b-9bc1-4e03-b66c-501425d40fbc">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNS0xNS0xLTEtMA_d87c27f3-dbfd-4773-b4db-ec043c7a47f6">1,725</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Pension and post-retirement plan adjustments, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNy0xMS0xLTEtMA_3d1aa9ae-8ba7-4943-9359-a20578580a9e">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNy0xNS0xLTEtMA_5c39fac0-0d38-4143-9ef0-24243abeab89">2,207</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOC0xMS0xLTEtMA_d4018074-f075-44ff-a6fd-f44bc1e353cb">72,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOC0xNS0xLTEtMA_e83c897e-de7e-40d6-ac80-acfa6c42c2ba">72,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOS0xMS0xLTEtMA_a179db47-346c-4453-870e-f11cc8f07e0f">3,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOS0xNS0xLTEtMA_f2124805-ac7b-43b5-a416-e95cdbd7c2f7">3,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i694c199e34a14464ac24dbb4f8527e0d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTAtOS0xLTEtMA_95c55aad-2e20-44ab-a172-74803e4c5dd2">1,964</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iab8dbb45af8c49bd89a1796cc04d5e70_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTAtMTMtMS0xLTA_f7315b3a-2177-41f7-b1af-94adae57b7d1">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTAtMTUtMS0xLTA_98f5d668-7ba7-4040-992a-48d47ca8fb3b">1,986</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ib2078cb13265412b8168c6ba2ce01286_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMS0xLTEtMA_2359b4e0-5df7-4ce1-8870-ee1b9758b1e9">232,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib2078cb13265412b8168c6ba2ce01286_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMy0xLTEtMA_a49db56e-80ea-4e06-8d40-fc7a610e2acb">2,324</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1c7318711e8e4a54ab3c245d19523efd_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtNS0xLTEtMA_2dd08e1b-2ac2-4d5a-bbcf-a5ee62c33473">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1c04b66fafeb41b8a7342d389e9ffb71_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtNy0xLTEtMA_5f17a8bb-0105-4be5-80f1-f8e4be6b644d">1,725</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia1b332a6da764fdc81bebeb5c634fb23_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtOS0xLTEtMA_d81a0c8f-5a40-489e-b7e5-4fce35216617">552,475</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i350dd74321534f789de5af89b9350730_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMTEtMS0xLTA_76677a49-3827-4959-8d2a-d9bb885ebb9d">168,626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i072ee7c12e4d4852a1510e20124323be_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMTMtMS0xLTA_b1ec1766-9d8c-4881-85ff-ae572fb669ba">1,420</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMTUtMS0xLTA_5a7ccaad-9e2b-4b6d-a7d3-6be48d3361b9">715,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:139%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:139%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:139%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Paid-In</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Retained</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Earnings /</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Deficit)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Comprehensive</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(Loss) Income</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Noncontrolling</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Interests</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Equity</span></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Stock</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifa6c27cc4a3a4ddfb486d016a99cf741_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xLTEtMS0w_d5ead018-b8e3-471d-b8be-e4191ea980ed">283,248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa6c27cc4a3a4ddfb486d016a99cf741_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0zLTEtMS0w_3c76e5a5-09e5-4b81-9085-8021fc641c5a">2,860</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ibcc158f820b8436c8ea3e1ae61ebfe29_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi01LTEtMS0w_5687825f-fab5-401a-813c-11fcffe8921a">34,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id757d153aff04337af22c39b26a4d290_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi03LTEtMS0w_41150559-f6d3-4590-9195-9ed39a54b929">1,166,412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i64bb877dd58241488e79dcedccea8d76_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi05LTEtMS0w_3b64d666-0357-4080-beb3-e558c303ea4a">589,128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i360689ad9dcc48f5ab2673194f9a3327_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xMS0xLTEtMA_39106ca6-ec35-4194-8ebe-17920d29fd29">93,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i688702d19c584405b043c3524ab0a5af_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xMy0xLTEtMA_4a6e1ac4-20ff-43a7-91db-dde9930a1c91">2,272</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xNS0xLTEtMA_f18d7b2e-f643-4ad9-b2ca-475f5ec155c9">454,574</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i54c2badaff0b467aa1febf6fb3e524e5_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNS0xLTEtMS0w_87fd1a1c-e774-4d1f-afe2-3adc21412d26">348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i661c83dafe2241a895b55e741b4436cf_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNS03LTEtMS0w_f1dac4ae-dbbc-4d16-913c-c58226cf8a0b">3,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNS0xNS0xLTEtMA_7cf5cca4-0971-4a7f-bbb7-2d691f96d4c4">3,440</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Pension and post-retirement plan adjustments, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNy0xMS0xLTEtMA_28eeb28e-ee98-449f-90aa-98a5dedecccc">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNy0xNS0xLTEtMA_0ca814a6-a1c7-4184-adad-0ccc6b692571">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfOC0xMS0xLTEtMA_c6e36512-bdad-497c-aea3-fa5826841ea2">3,071</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ief05232174e44d4d869bc9c7f6fa36c9_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfOC0xMy0xLTEtMA_52ba602d-6fd4-49ac-9143-164f066d1a91">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfOC0xNS0xLTEtMA_0ce01bd3-4420-4b1a-bf56-aaf64086e94e">3,086</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i908b264e6f8246ac9b4d3f7cd3fcaa0a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTAtOS0xLTEtMA_56b634e4-c807-44dc-a681-f73f8d3b2ae3">10,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ief05232174e44d4d869bc9c7f6fa36c9_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTAtMTMtMS0xLTA_af3df34b-767d-420e-ac8e-fccaca7a2c49">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTAtMTUtMS0xLTA_c7356e4b-61f4-4ddb-9f04-7f433cad1384">11,065</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i80b8173d43a74e3b9ec5e6fec2bb9ee4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMS0xLTEtMA_44834c42-3617-4132-b624-842c7e9da8b8">282,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i80b8173d43a74e3b9ec5e6fec2bb9ee4_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMy0xLTEtMA_3db0e564-553d-4629-8a8a-1d65fce21cd8">2,860</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i503e8eac77d34290ab10a01273a5714c_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtNS0xLTEtMA_3f7ac969-0655-4736-beaf-14922fa29c57">34,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9ba71926882446f4820f855c07651431_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtNy0xLTEtMA_13d9f4dd-bb3a-4ed4-98af-49c821768e2e">1,169,852</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7aa7a07423da4a209024274d4083e38e_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtOS0xLTEtMA_0bd27a81-6caf-4d90-af2f-efabdaeed31b">578,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id1675ea82d0e47b5b55f50b716c600eb_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMTEtMS0xLTA_9b12d221-bb97-4228-b7a5-0067feb728a7">97,162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia09428b911314cc0ae886d99b666ca12_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMTMtMS0xLTA_a13015c8-9e24-4263-8430-44f379cbc086">2,480</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMTUtMS0xLTA_a444d554-e1de-4a37-8806-1973d7371331">465,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">8</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_37"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div><span><br/></span></div><div id="i15ef643796c34829b3bb28475338f021_40"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3MzQ5NQ_965bdeb0-0dee-4634-9c8a-4b58badd06c8" continuedAt="iaf074c19b2524d618c4f4b123ced70c5" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="iaf074c19b2524d618c4f4b123ced70c5"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Sotera Health Company (also referred to herein as the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;its&#8221;), is a global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries with operations primarily in the Americas, Europe and Asia. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report in <ix:nonFraction unitRef="segment" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfNjQ0_a3d19339-06ad-4c88-ba4e-0453440c2118"><ix:nonFraction unitRef="segment" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfNjQ0_a67edfb1-83a7-4823-a8b8-91aca7f0e8e1">three</ix:nonFraction></ix:nonFraction> segments, Sterigenics, Nordion and Nelson Labs. We describe our reportable segments in Note 18, &#8220;Segment Information&#8221;. All significant intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the noncontrolling stockholders&#8217; proportionate share of the total equity in the Company&#8217;s consolidated subsidiaries. As of March&#160;31, 2021, our subsidiaries were wholly owned by us, except for noncontrolling interests of <ix:nonFraction unitRef="number" contextRef="ibea64f5f1ac0490180fbbfae53b8d879_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTEyMA_25d7388d-9b3f-42cc-94af-d0286576e02e">15</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i94da5f943646463fac66bb29dfdd381e_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTEyNw_d66be3ad-a967-4cf9-805f-9d99509857ff">33</ix:nonFraction>% in our <ix:nonFraction unitRef="subsidiary" contextRef="ie80833d87f3a475c9d5cce381fd18476_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="shc:NumberOfSubsidiariesWithNonControllingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3MzQ5Ng_a49e67d3-bb3a-4ad4-9f97-8d33361762c7">two</ix:nonFraction> China subsidiaries. We consolidate the results of operations of these subsidiaries with our results of operations and reflect the noncontrolling interests in our <ix:nonFraction unitRef="subsidiary" contextRef="ie80833d87f3a475c9d5cce381fd18476_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="shc:NumberOfSubsidiariesWithNonControllingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3NzM2OQ_71822073-38ed-434e-8c4f-ab1329abe6f9">two</ix:nonFraction> China subsidiaries on our Consolidated Statements of Operations and Comprehensive Income (Loss) as &#8220;Net income attributable to noncontrolling interests.&#8221; On March 11, 2021, we purchased the <ix:nonFraction unitRef="number" contextRef="i5def62b5b7f448059d757311fe268fc9_I20210311" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTY0OTI2NzQ0NzM1OQ_d0e04860-77cd-41eb-ac44-c1d40c09cb9b">15</ix:nonFraction>% noncontrolling interest that remained from the August 2018 acquisition of Nelson Laboratories Fairfield, Inc. (&#8220;Nelson Labs Fairfield&#8221;). This required future purchase was considered mandatorily redeemable, and therefore no earnings were allocated to this noncontrolling interest. See Note 4, &#8220;Acquisitions&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we entered into binding agreements to purchase the outstanding noncontrolling interests of <ix:nonFraction unitRef="number" contextRef="ib950bce5fb424f4ebc039f76379610fc_I20210331" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTk5NQ_7210fa93-9cc9-4555-9beb-ad0d1eabd153">15</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i90ff278d560040b986f61d550e890c69_D20210101-20210331" decimals="2" name="shc:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjAwMg_0350fa75-94ee-4434-bec8-cb89a7b0452d">33</ix:nonFraction>% of our <ix:nonFraction unitRef="subsidiary" contextRef="ie80833d87f3a475c9d5cce381fd18476_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="shc:NumberOfSubsidiariesWithNonControllingInterest" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3MzUwNQ_efd635cb-6037-4d0b-a235-a1ff89467d97">two</ix:nonFraction> China subsidiaries, respectively. The purchase transactions are expected to close in the second quarter of 2021 for a total purchase price of $<ix:nonFraction unitRef="usd" contextRef="i1fd7503543e240e4b13682cf4007a74f_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMzg0ODI5MDcwOTU4MQ_b86fcdaa-fbeb-4d90-8795-630f6bdea3af">8.6</ix:nonFraction> million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we acquired a <ix:nonFraction unitRef="number" contextRef="ia271e03429544e7c88a278c25dc1246e_I20200731" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjE2Nw_ce715d2d-5dd4-4721-b88a-40910e31aaba">60</ix:nonFraction>% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada in connection with our acquisition of Iotron Industries Canada, Inc. (&#8220;Iotron&#8221;). Refer to Note 4, &#8220;Acquisitions&#8221; for additional information. We have determined this to be an investment in a variable interest entity (&#8220;VIE&#8221;). The investment is not consolidated as the Company has concluded that we are not the primary beneficiary of the VIE. The Company accounts for the joint venture using the equity method. The investment is reflected within &#8220;Investment in unconsolidated affiliates&#8221; on the Consolidated Balance Sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA4MTc1NA_ede130f2-37f9-451d-a389-53e0b96f4a29" continuedAt="iaca843a444e94257bdcd008438596b29" escape="true">Use of Estimates</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaca843a444e94257bdcd008438596b29"> &#8211; In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles ("GAAP"), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; The accompanying consolidated financial statements include the assets, liabilities, operating results, and cash flows of the Company and its wholly owned subsidiaries. These financial statements are prepared in accordance with U.S. GAAP for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited interim financial statements should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes on Form 10-K for the year ended December&#160;31, 2020.</span></div></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_43"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:AccountingChangesAndErrorCorrectionsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80My9mcmFnOjZkNWFlMjg5NGI3OTQ2ZjRiNGVkNDcxOTA4YTMyOTE0L3RleHRyZWdpb246NmQ1YWUyODk0Yjc5NDZmNGI0ZWQ0NzE5MDhhMzI5MTRfMjc0ODc3OTA3OTUwMw_df9ba806-86c7-45f0-83b4-b5087a43f44d" continuedAt="i0239c08a63d54d1f95000d24688212b0" escape="true">Recent Accounting Standards</ix:nonNumeric></span></div><ix:continuation id="i0239c08a63d54d1f95000d24688212b0" continuedAt="ic1a6ce06a3d94e0cb7530a1931f708b0"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80My9mcmFnOjZkNWFlMjg5NGI3OTQ2ZjRiNGVkNDcxOTA4YTMyOTE0L3RleHRyZWdpb246NmQ1YWUyODk0Yjc5NDZmNGI0ZWQ0NzE5MDhhMzI5MTRfMjc0ODc3OTA3OTUwMg_ddedd24c-0892-4f6f-89b1-7d99f5a850b9" continuedAt="ib72066a0442a4ac2a30a054979edb6b4" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU&#8217;s Issued But Not Yet Adopted</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Jumpstart Our Business Startups Act of 2012, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. As an emerging growth company, we have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies or at which time we conclude it is appropriate to avail ourselves of early adoption provisions of applicable standards. As a result, our results of operations and financial statements may not be comparable to the results of operations and financial statements of other companies who have adopted the new or revised accounting standards. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="ic1a6ce06a3d94e0cb7530a1931f708b0"><ix:continuation id="ib72066a0442a4ac2a30a054979edb6b4"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(&#8220;ASU&#8221;) 2016-13, Financial Instruments &#8211; Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently issued additional guidance that modified ASU 2016-13. The standard requires an entity to change its accounting approach in determining impairment of certain financial instruments, including trade receivables, from an &#8220;incurred loss&#8221; to a &#8220;current expected credit loss&#8221; model. We intend to adopt the standard as of January 1, 2022. We are currently assessing the effect that ASU 2016-13 will have on our financial position, results of operations, and disclosures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the FASB issued </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard simplifies the accounting for income taxes and makes a number of changes meant to add or clarify guidance on accounting for income taxes. This update is effective for annual financial statement periods beginning after March 15, 2021 and interim periods beginning after March 15, 2022, with early adoption permitted in any interim period for which financial statements have not yet been filed. We are currently assessing the effect that ASU 2019-12 will have on our financial position, results of operations, and disclosures.</span></div></ix:continuation></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_46"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMjc0ODc3OTA3MDMxMA_441d0ce2-61f3-4012-ad9c-e53a98cb3582" continuedAt="ie21e823078984d38938c80f5d64a3911" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="ie21e823078984d38938c80f5d64a3911"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMjc0ODc3OTA3MDMxMQ_ef770d72-3027-45d6-be3d-91cfc14c1f9d" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows disaggregated net revenues from contracts with external customers by timing of revenue and by segment for the three months ended March&#160;31, 2021 and 2020:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic4e845ef858f4d2cbf8e34065ae83f9d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi0xLTEtMS0w_fe95062b-9d0a-4d3a-9308-e12738b3c6be">131,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i81508df42a2c41ae99039fb5550d92c7_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi0zLTEtMS0w_f7f56886-9737-4789-8534-834bb6f585dd">25,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3e40cba4c0a04e228634ff48d54110b0_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi01LTEtMS0w_908b14d1-2339-4887-8fb7-e28c65d1ff84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide0e38a11c4d4065969f8f8fe57c3865_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi03LTEtMS0w_97fcee00-77a6-4226-9614-913a95f130cf">157,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1abe226e0f964cdda9aa352b55dd6908_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy0xLTEtMS0w_6c6c0955-e5f2-493c-8c10-1455192042db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i73baed61d2934ccca236804cc00d4746_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy0zLTEtMS0w_b3751bab-ce74-4183-86ce-688b6a04c87a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i538e36e8cbfb418baadf68b21ca433e2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy01LTEtMS0w_11a8e010-1843-449c-91d5-a0b05dc4cdcb">55,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58d1ac8931a14b9689bbd93ab687cb9b_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy03LTEtMS0w_24958dc4-d674-4298-b906-997b0c0bf95c">55,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i549e8b5be7d14c24ac0bd3a892096184_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC0xLTEtMS0w_a0b41600-5a2a-4f92-8c7a-6665b98c5204">131,151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i604e6f09c9514a4c92c9b88b13bbfd5e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC0zLTEtMS0w_bc284ad0-6f45-491f-b5bf-c65b442be8a2">25,918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie44a1e9c62eb48bb91f1032b3dd61367_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC01LTEtMS0w_7e98b039-e132-4abe-b289-5411cfefe3b2">55,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC03LTEtMS0w_2297d619-4f49-48dc-a857-88bc083c548b">212,148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i74f51f9869464d0992847aa161928404_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi0xLTEtMS0w_1f47db5e-0bb8-4421-ae9a-c0ea57fbd81c">117,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i42a63ee00aca4032b612c80c0fd3c9c1_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi0zLTEtMS0w_01199b21-0c6c-4062-aa28-0aaabe6ad6e1">23,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i023f2492fe3d4a8d8430927b2fd77519_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi01LTEtMS0w_e052bea9-73bb-4aea-8b26-ab364976e212">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2c6aca23a9ae486a9eb582a53a5bb38b_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi03LTEtMS0w_d3f1d3b9-fada-4cea-bd9b-5e20d809932f">140,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iffacfedf64e04109b53607b1570fdc92_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy0xLTEtMS0w_ad7d5d45-7704-4a33-9455-49bd9c92d49c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i842c27cb13e145de9f7c92ab5ea4f054_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy0zLTEtMS0w_e96597a6-b318-46cd-b7ee-8c2484b9225e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieabfd129bc4847e8afad78a76824be56_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy01LTEtMS0w_2b8c2e4c-5b11-44f7-8bc3-d460f84ccf57">47,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e574934364343aaad0a65c6a4d6628a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy03LTEtMS0w_efab3e54-c00c-4bb8-ac5c-e5a6860dae79">47,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i89a8f5f3a462461d9ff69850cfe543dc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC0xLTEtMS0w_dc078854-dab1-4a4a-b716-2cbf23b3c2a1">117,280</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i50ef6a0932a74cdc81d96d88f7ab2485_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC0zLTEtMS0w_3e28c993-c105-4e3f-a633-28532aa2657b">23,625</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if0203680793e4fb8a12e0bdf8927352d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC01LTEtMS0w_6a9f9326-e5c6-485e-986a-7d9b14843f40">47,295</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC03LTEtMS0w_0bccb7c3-61f5-45a8-8416-6a62bc955dd8">188,200</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, and December&#160;31, 2020, contract assets included in prepaid expenses and other current assets on the Consolidated Balance Sheets totaled approximately $<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMzUw_a3b15def-07e6-469e-acb2-438ecf69e9aa">14.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMzU3_e2283cb6-780c-480b-88d2-195bd118526f">12.7</ix:nonFraction> million, respectively, resulting from revenue recognized over time in excess of the amount billed to the customer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we receive consideration from a customer prior to transferring goods or services under the terms of a sales contract, we record deferred revenue, which represents a contract liability. Deferred revenue totaled $<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfNjgz_35d58c0c-5730-490a-a592-570d98434174">6.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfNjkw_3e7c1b35-2fa6-4eab-bbd5-1992cab7e7b1">6.1</ix:nonFraction> million at March&#160;31, 2021 and December&#160;31, 2020, respectively. We recognize deferred revenue after all revenue recognition criteria are met.</span></div></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_49"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA3NjY4Nw_c506bed4-d4c1-4a1b-872d-bdf04893d7b8" continuedAt="i75e98b0ce3084939ac8412cfb0be8877" escape="true">Acquisitions</ix:nonNumeric></span></div><ix:continuation id="i75e98b0ce3084939ac8412cfb0be8877" continuedAt="i86ea648da3b343e9a3fb79c4b01c1ace"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of BioScience Laboratories, LLC</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On March 8, 2021, we acquired BioScience Laboratories, LLC (&#8220;BioScience&#8221;) for approximately $<ix:nonFraction unitRef="usd" contextRef="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfNDk0NzgwMjMzNzMyNQ_65e11a63-1515-4fa3-a552-b76b14a2d4d5">13.2</ix:nonFraction> million, net of $<ix:nonFraction unitRef="usd" contextRef="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308" decimals="-5" name="us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NjQyNA_ce429d0b-1152-41cb-b9a5-af04568ba7f4">0.8</ix:nonFraction> million of cash acquired plus the contemporaneous repayment of BioScience's outstanding debt of $<ix:nonFraction unitRef="usd" contextRef="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ0OTAzNw_ba9b46ab-e5c8-45c4-90f4-c67425356485">1.9</ix:nonFraction> million. BioScience is a provider of outsourced topical antimicrobial product testing in the pharmaceutical, medical device, and consumer products industries with one location in Bozeman, Montana.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of BioScience was allocated to the underlying assets acquired and liabilities assumed based upon management's estimated fair values at the date of acquisition. Changes to the allocation of the purchase price may occur as </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i86ea648da3b343e9a3fb79c4b01c1ace" continuedAt="ia7aa1c9c727344eeb839afa33b551fa0"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these measurements are completed. Approximately $<ix:nonFraction unitRef="usd" contextRef="i95626988340341728b2d210065ff4f47_I20210308" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1MTU4NA_8c5c147f-b0a2-4c8c-b73c-8524bdb53e97">8.4</ix:nonFraction> million of goodwill was recorded related to the BioScience acquisition, representing the excess of the purchase price over preliminary estimated fair values of all the assets acquired and liabilities assumed. The Company funded this acquisition using available cash. The acquisition price and the results of operations for this acquired entity are not material in relation to the Company's consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Mandatorily Redeemable Noncontrolling Interest - Nelson Labs Fairfield</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, we completed the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i5def62b5b7f448059d757311fe268fc9_I20210311" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA4MTcwMg_730b2c25-c168-4d50-a185-952771306213">15</ix:nonFraction>% ownership of Nelson Labs Fairfield for $<ix:nonFraction unitRef="usd" contextRef="ica603348fe30465dae402c8b63a1b31a_D20210311-20210311" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NDExNw_3b74ae35-e823-4e6e-b5c5-3de5ffbada75">12.4</ix:nonFraction> million, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="ica603348fe30465dae402c8b63a1b31a_D20210311-20210311" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NDEyMg_982495c9-b0f9-4ecc-86ae-f579471c0eca">1.2</ix:nonFraction> million included in &#8220;Other expense (income), net&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss) relative to the $<ix:nonFraction unitRef="usd" contextRef="ie45025c772774d5c927c39b60442abf6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NjM2NA_af548e08-2490-4a06-827c-c1282d5b5be9">13.6</ix:nonFraction> million previously accrued. Pursuant to the terms of the August 2018 acquisition, we initially acquired <ix:nonFraction unitRef="number" contextRef="i4b6a3228292f4d16b55b1cd7b0695816_I20180831" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA4MTcyMg_1b723425-b60f-4cd1-877f-a60f43357fd9">85</ix:nonFraction>% of the equity interests of Nelson Labs Fairfield in August 2018 and were obligated to acquire the remaining <ix:nonFraction unitRef="number" contextRef="i5def62b5b7f448059d757311fe268fc9_I20210311" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA4MTc0MQ_8eed5db9-6fa0-42a8-94ca-96ca9c301a04">15</ix:nonFraction>% noncontrolling interest within three years from the date of the acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Iotron Industries Canada, Inc.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, we acquired Iotron Industries Canada, Inc.(&#8220;Iotron&#8221;) for approximately $<ix:nonFraction unitRef="usd" contextRef="i768d601b59aa4005863b05a9a1a4a15c_D20200731-20200731" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NTYxMQ_bab950b4-db7f-4a05-a3a3-c1b7b20a8a43">105.2</ix:nonFraction> million. Iotron was an independent contact sterilizer with two North American locations in Vancouver, Canada, and Columbia City, Indiana. Each location uses proprietary high energy electron beam technology to process products for orthopedic, medical device, plastics, and agricultural businesses. The acquisition was financed by the issuance of $<ix:nonFraction unitRef="usd" contextRef="i051178a4a64d449f87f75f6e19f87b98_D20200731-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NjgxMQ_2d3e62fa-80c2-4db9-80dc-f9cccd601056">100.0</ix:nonFraction> million of First Lien Notes due 2026. Refer to Note 9, &#8220;Long-Term Debt&#8221; for additional details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this acquisition, we also acquired Iotron&#8217;s <ix:nonFraction unitRef="number" contextRef="ia271e03429544e7c88a278c25dc1246e_I20200731" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjE5OTAyMzI2MDI4NA_a776c331-bb87-45fd-bb44-10c379c13171">60</ix:nonFraction>% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada. The joint venture is accounted for using the equity method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance sheet for the Iotron acquisition reflects the net tangible and intangible assets acquired and liabilities assumed at their preliminary estimated fair values at the acquisition date.</span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA3NjY4OQ_15e1406e-334d-4cb0-8466-567eb9a5e5d3" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimated fair value of the underlying acquired assets and assumed liabilities of the Iotron acquisition and the measurement period adjustments recognized during the three months ended March&#160;31, 2021, were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allocation of purchase price to the fair value of </span></div><div style="margin-bottom:1.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">net assets acquired (net of cash acquired):</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount recognized as of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount recognized as of March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMi0xLTEtMS0w_f22f727f-c98b-4531-93d1-ddebe0d94e80">69,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMi0zLTEtMS0w_ebc163ea-0039-4010-83a4-90a9f1257966">17,142</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMi01LTEtMS0w_c892b221-b5de-4ce3-ad02-e72e8107bc49">51,904</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMy0xLTEtMS0w_a7ecee59-891e-4689-99f7-bdb620c76004">16,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMy0zLTEtMS0w_bcdc2d83-8be3-44a7-be35-0a289c4d7719">26,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMy01LTEtMS0w_f1ab9724-6ce2-4bf7-8658-d224b20cbf7b">42,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNC0xLTEtMS0w_429757fb-9be6-4e2b-a75a-5a92c50b2886">13,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNC0zLTEtMS0w_a2a4f0e7-19f3-491e-b210-8a222040d61f">4,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNC01LTEtMS0w_02c57f92-8ae6-4347-abe1-b6e80cc82897">18,158</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNS0xLTEtMS0w_708d39a2-c832-4a09-845c-249b38341e31">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" name="shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNS0zLTEtMS0w_4c5404c1-5b12-4dd2-8d8b-1654282efac7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNS01LTEtMS0w_0e9ef553-98f4-468a-bd43-8ab496a6d450">1,117</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in unconsolidated affiliate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNi0xLTEtMS0w_45d908f5-5132-4183-806a-6c0ce62ca489">12,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNi0zLTEtMS0w_7ec85c59-1e6a-4bed-a76b-de173e5bec76">4,181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNi01LTEtMS0w_cd7c1096-096b-4454-b681-90e357611504">8,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumed long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNy0xLTEtMS0w_5e990be4-9cdc-4cc4-8c2b-cf579e35150b">2,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNy0zLTEtMS0w_00d56189-27bd-4de3-9ea0-83dd2d29124c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNy01LTEtMS0w_fb3ffc9e-7935-4e50-aa82-16cc4ae88730">2,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets/liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOC0xLTEtMS0w_080deca9-a75d-494b-8da7-d796bfe1bd82">5,846</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOC0zLTEtMS0w_cbd22da5-b40d-4ac3-bb6d-bfa9eeda3cea">9,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOC01LTEtMS0w_6182571f-df3e-402d-8f06-f6f93b3c7127">15,144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total estimated purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOS0xLTEtMS0w_af0eb497-2174-4f33-8770-842b19f3fe86">105,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOS0zLTEtMS0w_7d6f8093-e9ce-4914-a964-80dfbcf2040a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOS01LTEtMS0w_0a0697cc-722e-429a-a056-fd3beca86755">105,187</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of all the above assets acquired and liabilities assumed are preliminary in nature since the fair value analyses are not yet complete, including finalizing third party appraisals and analyzing the tax attributes of the fair value adjustments. Changes to the allocation of the purchase price may occur as these analyses are completed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $<ix:nonFraction unitRef="usd" contextRef="i26503e2068d94590979ce52f141dc71c_I20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0NA_9030cc8b-d0b2-4ecc-b2c3-68b23a0aac1f"><ix:nonFraction unitRef="usd" contextRef="i768d601b59aa4005863b05a9a1a4a15c_D20200731-20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0NA_c43fb396-f48d-45b4-8e9e-425261558284">51.9</ix:nonFraction></ix:nonFraction> million of goodwill was recorded related to the Iotron acquisition, representing the excess of the purchase price over preliminary estimated fair values of all the assets acquired and liabilities assumed. The fair value allocated to goodwill and tangible and intangible assets are deductible for tax purposes. The qualitative elements of goodwill primarily represent the expanded future growth opportunities for the combined company and the addition of Iotron&#8217;s highly skilled workforce. A preliminary valuation was recorded of approximately $<ix:nonFraction unitRef="usd" contextRef="idfbc21d1467d4e52911ec1b5501bcb5d_I20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1MjcyOQ_670c362a-ee51-4226-bafa-1d1ef0477cb2">39.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia071d112ecca401ea6335a9263fe2923_I20200731" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjE5Mw_29ec8a27-5409-46c7-a77e-746e861adfca">3.6</ix:nonFraction> million for intangible assets as part of the acquisition related to customer relationships and employee non-compete agreements, respectively. The estimated useful lives of the identifiable finite-lived intangible assets range from <ix:nonNumeric contextRef="id4fdf4d7028e46a4b31f337064b0f0bf_D20200731-20200731" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjQ0NA_29e487ff-7158-4e55-a64a-dc5545bd3b70">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i405041e3ed794abc80989f15142f5586_D20200731-20200731" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjQ1MA_7ca98687-307d-48ef-ba3d-3386fa9efe85">15</ix:nonNumeric> years.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="ia7aa1c9c727344eeb839afa33b551fa0"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iotron&#8217;s results of operations are included in our consolidated financial statements from the date of the transaction within the Sterigenics segment. The unaudited pro forma consolidated results for the three months ended March&#160;31, 2020, are reflected in the pro forma table below had the transaction occurred on January 1, 2020. The following unaudited supplemental pro forma financial information is based on our historical consolidated financial statements and Iotron&#8217;s historical consolidated financial statements, as adjusted for amortization of acquired intangible assets, an increase in interest expense resulting from interest on the First Lien Notes to finance the acquisition, and to reflect the change in the estimated income tax rate for federal and state purposes.</span></div><div style="margin-top:12pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:BusinessAcquisitionProFormaInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA3NjY5MA_d050432b-8de8-4219-879a-b82a3e4741af" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmZhMzllNGYyZWI4ODRjOTc5ODNhMDY5ODIzZDEzMjhkL3RhYmxlcmFuZ2U6ZmEzOWU0ZjJlYjg4NGM5Nzk4M2EwNjk4MjNkMTMyOGRfMi0zLTEtMS0w_cfa3630d-3d84-4794-8660-c05b5f9495d1">194,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmZhMzllNGYyZWI4ODRjOTc5ODNhMDY5ODIzZDEzMjhkL3RhYmxlcmFuZ2U6ZmEzOWU0ZjJlYjg4NGM5Nzk4M2EwNjk4MjNkMTMyOGRfMy0zLTEtMS0w_c76f317b-dc63-4241-a1d0-24511909199e">889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Iotron acquisition, we incurred approximately $<ix:nonFraction unitRef="usd" contextRef="ie7f4d0c263a04710a93bbf997b284b04_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMzQ2MA_cdebd56f-3a89-40a9-b326-035a579e283e">1.0</ix:nonFraction>&#160;million in transaction costs for the three months ended March&#160;31, 2020, which were included in &#8220;Selling, general and administrative expenses&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_52"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RleHRyZWdpb246MzkzNDRmYTQxZDlmNDg2NWE5MGQ4ODc1YmRiZWUzNDZfMjc0ODc3OTA2OTUwNw_c876585f-d169-4682-8e32-d5d1c26038dc" continuedAt="id70d05e804fc4d6d8b484d19f7b02e29" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="id70d05e804fc4d6d8b484d19f7b02e29"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RleHRyZWdpb246MzkzNDRmYTQxZDlmNDg2NWE5MGQ4ODc1YmRiZWUzNDZfMjc0ODc3OTA2OTUwOA_69fdd3d9-8d4c-4444-8c34-b70328ad21de" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted primarily of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.814%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMi0xLTEtMS0w_5e260fab-4322-4da7-8597-23a5caad85e2">29,512</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSupplies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMi0zLTEtMS0w_26c5ebb9-ae7a-4415-80f1-5d0fb2b69e03">29,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMy0xLTEtMS0w_e59cf724-e0e8-4563-ae88-8e292057aa1b">1,371</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMy0zLTEtMS0w_c1446ad0-802e-4afb-911a-a26eef76a37c">846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNC0xLTEtMS0w_1ae605bd-4010-4825-a4e4-ba2c4f427822">2,617</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoods" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNC0zLTEtMS0w_254858e0-3268-4577-9ca2-cf85a1e9682c">4,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNS0xLTEtMS0w_b7b73023-5ccd-4af6-a489-cae956269fef">33,500</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNS0zLTEtMS0w_9e98e6fb-47a5-417d-b9d6-a713f15f8770">34,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve for excess and obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:InventoryAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNi0xLTEtMS0w_adac526e-a0e2-43b6-8e75-2887c85c700d">125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="us-gaap:InventoryAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNi0zLTEtMS0w_77734db1-96c0-4c6d-8561-63089e99ddb7">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNy0xLTEtMS0w_910ee344-5dca-462d-b06c-711316823b7f">33,375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNy0zLTEtMS0w_2a7cec6b-e845-41c4-80e1-757226da4b17">34,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_55"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:OtherCurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RleHRyZWdpb246Y2ZiZGU1ZWY4YWM3NDU4YjhlNmUyNWZmODA0OWJmZGFfMjc0ODc3OTA2OTU2OQ_97d6f6ed-64b6-47a3-959d-14834ba31a94" continuedAt="i428ef6e5c32046cca474930dca50b726" escape="true">Prepaid Expenses and Other Current Assets</ix:nonNumeric></span></div><ix:continuation id="i428ef6e5c32046cca474930dca50b726"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RleHRyZWdpb246Y2ZiZGU1ZWY4YWM3NDU4YjhlNmUyNWZmODA0OWJmZGFfMjc0ODc3OTA2OTU2Nw_f76c09ed-f3f1-46b6-ae2b-c9ba4dd91ce0" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted primarily of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMi0xLTEtMS0w_ed2b0c95-984d-4c38-9124-ba2f8de88c27">25,356</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMi0zLTEtMS0w_2ae62364-962f-4201-aa8d-f04ef5110b4b">22,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid business insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMy0xLTEtMS0w_fe82e055-e107-4e55-8969-caa608114c46">7,421</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMy0zLTEtMS0w_4c07bf56-9926-4e5b-a4d4-6ed9ea3d3d06">10,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNC0xLTEtMS0w_5a6d8c93-61f5-47a0-a791-9a57dc63886b">1,212</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNC0zLTEtMS0w_c72d2089-b67f-4bc8-9aa8-f92ecdf85a03">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNS0xLTEtMS0w_9c18aae1-4348-458b-bb24-00b7dd7e0918">14,133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNS0zLTEtMS0w_c0259bba-6e0d-49ab-8110-ca2aac10a433">12,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance and indemnification receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InsuranceSettlementsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNi0xLTEtMS0w_8df032fe-a303-4a43-b758-a4eca0c0d0e4">2,751</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InsuranceSettlementsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNi0zLTEtMS0w_7af764ca-3bb1-4cef-8912-346f2af47191">2,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:DepositsAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNy0xLTEtMS0w_7ba50425-2647-43a0-bdee-d251d31e73e0">797</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="us-gaap:DepositsAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNy0zLTEtMS0w_67ee480b-87e9-4d06-962b-81fe1a3ce99d">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid maintenance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="shc:PrepaidMaintenanceContractsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOC0xLTEtMS0w_c8be64dd-fe30-47c4-a2fb-8a630ffa6c3f">432</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" name="shc:PrepaidMaintenanceContractsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOC0zLTEtMS0w_8ed4b360-7ee2-4955-b0b2-ecde87194ddc">404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Value added tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOS0xLTEtMS0w_0857100e-5876-46ff-b170-62d6b694d97d">1,385</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ValueAddedTaxReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOS0zLTEtMS0w_92279463-3060-448d-8731-e21b9fe09710">2,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid software licensing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:PrepaidSoftwareLicensingCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTAtMS0xLTEtMA_e35f2755-d3c0-4048-93f4-9f3c6e792930">1,299</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="shc:PrepaidSoftwareLicensingCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTAtMy0xLTEtMA_2ddf09fc-c91b-46f3-a792-81861623df80">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Supplies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTEtMS0xLTEtMA_35d84bba-5246-4aba-9d85-5e9c1108e852">3,210</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Supplies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTEtMy0xLTEtMA_098ff70a-b176-42dd-88fc-2e1be12f0357">2,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTItMS0xLTEtMA_c85ddc9c-6614-4323-ba4c-a68fbd49a5b0">11,762</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTItMy0xLTEtMA_8779f754-e8c8-49c3-9498-fc4b0d2b2686">8,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTMtMS0xLTEtMA_a45468e9-0ecf-4e6f-bd9c-b64ca5243248">69,758</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTMtMy0xLTEtMA_10627f3f-de8f-46ec-bb0a-27e8838aa2de">64,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">12</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_61"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNA_9186ec8b-c212-4d81-9b7f-380caeb3751b" continuedAt="i45e0bdb8b80146498f8980da3ea69858" escape="true">Goodwill and Other Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i45e0bdb8b80146498f8980da3ea69858" continuedAt="i4096fdf9242e4fd3b54af65b5ded80bf"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNQ_7d38971a-7c50-485b-bc5d-1314c19c5c79" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to goodwill during the three months ended March&#160;31, 2021 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill at December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iae31afbafbf247098cb8c0b7be49d5c4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS0xLTEtMS0w_e7d54666-290e-4635-bd47-eeb2ede0579d">683,481</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5ee65cf8cf1c49538dd47438eaedfb14_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS0zLTEtMS0w_d0a75d67-d342-4c1c-b7fc-ce562c36a2a6">287,932</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b8b3c8568084221a2ad859b39b4ec4a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS01LTEtMS0w_e9f97614-bc55-402c-ac1b-e39af2fbd6e9">144,523</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS05LTEtMS0w_a80bf258-949e-47f2-956e-cf71a2bf4922">1,115,936</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">BioScience acquisition</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i277f6af610934b6799af4e30a81fde49_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0xLTEtMS0xMTUw_72176a5c-bec3-4f2a-8319-9e55bbbcae08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i374f363dae8d489884cfdb4e75c41f98_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0zLTEtMS0xMTUw_32039082-aa36-4ff3-8099-0488dc0bdbeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bdf5bf26e504a519ba4925e4f6ced05_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi01LTEtMS0xMTUw_88263318-11bb-4a96-b5bd-a0e86fd8aa29">8,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if1afc20edd0843bbac413280101a0cf3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi05LTEtMS0xMTUw_b36beb83-e493-4b42-892c-4e2ea6dc0fb2">8,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Iotron acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">measurement period adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6d31ba294dc94afaa10dda2278f6ca6a_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0xLTEtMS0w_8baecf02-7c12-4e66-b786-128aaf73e11b">17,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibe58eb3f5c4b4d98b5e6c1018cd61690_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0zLTEtMS0w_89f9a035-3c16-4ac3-a044-5e244761216e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4ce030964ab24158949b016db0752797_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi01LTEtMS0w_dcadeede-157a-4a14-8d03-5e65d213f5e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillPurchaseAccountingAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi05LTEtMS0w_203c4d58-32b5-490e-a0f4-758377e32b3a">17,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes due to foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i549e8b5be7d14c24ac0bd3a892096184_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy0xLTEtMS0w_76f5e33d-03ce-44b1-89bc-23aae63d65c6">2,252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i604e6f09c9514a4c92c9b88b13bbfd5e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy0zLTEtMS0w_4b46f4ba-3556-4852-bfcc-d70aa276f94d">3,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie44a1e9c62eb48bb91f1032b3dd61367_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy01LTEtMS0w_4ce71e5e-87be-4889-99a4-2eda138181b6">1,657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy05LTEtMS0w_d1b807be-6938-4bed-98e1-b9f3dac0ab43">501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic300771a3ad848deb070c4b7e24f0b27_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC0xLTEtMS0w_4b033d7a-75dc-4695-9011-29c2a6ee359f">664,087</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f33513e6445440aa8f9b1d326db60e2_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC0zLTEtMS0w_5997a1b6-cd3b-4234-96cd-4cee49606b80">291,340</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic516f52cc0d54267bc67844b537e37bf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC01LTEtMS0w_b4395f0d-cfef-4df6-9289-351b2849cd11">151,301</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC05LTEtMS0w_d0d1e7b6-61b9-4afe-8f9b-5743e0423e47">1,106,728</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNg_900ba6d1-64d2-442a-9619-02a8ffb86b23" continuedAt="i0d70a35396024036ac4a8521e5b6385c" escape="true"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNg_da370b4c-2db0-4fa1-9b40-cf0e8275202c" continuedAt="i4b3d828ac678482d836927e26d917fd3" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortization</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2212b97b8ac44cbeaf403f3f51b943a1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMy0xLTEtMS0w_d0a6b3e6-3734-40c4-972a-285c3025696f">662,509</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2212b97b8ac44cbeaf403f3f51b943a1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMy0zLTEtMS0w_314858b2-b10d-4178-8c3c-6ee69b50e98f">322,685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i037b6f7c3cde45289d3fd93f3e2ba9be_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNC0xLTEtMS0w_426356c4-bbc3-4b68-b1e5-bfd1e0795fde">89,604</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i037b6f7c3cde45289d3fd93f3e2ba9be_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNC0zLTEtMS0w_eac436eb-2c54-4c2b-979e-f85e3d06129b">39,707</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i95577f1988ee4cab966e77b8d67597c8_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNS0xLTEtMS0w_f5ac284f-ae0d-4f1e-b9d8-a05c2c9efcb8">142</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i95577f1988ee4cab966e77b8d67597c8_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNS0zLTEtMS0w_dedf8fbf-1599-49e1-8e96-91c959d66e15">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia139b1975e0f4070816baaeeea37e6c0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNi0xLTEtMS0w_382d2756-d4ea-4331-86d2-86598ee9f276">9,454</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia139b1975e0f4070816baaeeea37e6c0_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNi0zLTEtMS0w_1b8ba9e5-a0ec-459e-941a-0200f10fb935">1,364</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00107b289eee42419e1bb39ab7132941_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNy0xLTEtMS0w_f72ad7d3-cc22-48cc-98dc-220aa2f15685">243,660</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00107b289eee42419e1bb39ab7132941_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNy0zLTEtMS0w_f16d0e87-2345-41e6-bc35-0ed2c87f1cd9">98,237</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic049f68a83744fcb8bbd9e1cd47188f5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOC0xLTEtMS0w_b05d7857-d7be-4007-bb2e-e150465d6519">5,675</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic049f68a83744fcb8bbd9e1cd47188f5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOC0zLTEtMS0w_58be763b-9562-4ef4-a07c-353670e14f24">1,138</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOS0xLTEtMS0w_756a9e72-b333-484d-b73e-5b527afbab33">1,011,044</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOS0zLTEtMS0w_4d5b2742-4d4e-4467-9492-e2ae4f1c4f58">463,231</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1a8a178bafa24d019046ae8de5f2a96b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTItMS0xLTEtMA_fa7bfb23-d00d-4b55-8ded-c60fc54b7e2c">82,807</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2a93896fea2f4955a83ecd9ec395ff33_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTMtMS0xLTEtMA_707065cf-7124-4c40-a1ac-8f388706b1f8">25,952</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTQtMS0xLTEtMA_aa1d8b23-a609-4844-8b50-f3048ae8ab40">108,759</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTUtMS0xLTEtMA_9f0e027c-6f0e-4ef5-86a3-0350d1eff092">1,119,803</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTUtMy0xLTEtMA_38d1b98b-5271-47ce-b089-804144a53fe4">463,231</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i4096fdf9242e4fd3b54af65b5ded80bf"><ix:continuation id="i0d70a35396024036ac4a8521e5b6385c"><ix:continuation id="i4b3d828ac678482d836927e26d917fd3"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortization</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ab06588a1964b429adbe61fa67fe076_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMi0xLTEtMS0w_147b39ce-7c6c-4d24-810c-0d5035e9946d">634,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ab06588a1964b429adbe61fa67fe076_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMi0zLTEtMS0w_d920fcd1-120a-4c22-9e98-3e2212b8d654">309,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa84c55df11d4fb98f330425ef0ec73f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMy0xLTEtMS0w_9cb76da8-77a2-4c7b-8000-63136f71f9ce">90,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa84c55df11d4fb98f330425ef0ec73f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMy0zLTEtMS0w_a8959ca0-2a3f-4621-88da-9561a14b436d">38,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i462df889dd55483f9fdf2dc45ca34f95_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNC0xLTEtMS0w_71d1c501-cb34-415e-b7fb-0ba3b1375f80">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i462df889dd55483f9fdf2dc45ca34f95_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNC0zLTEtMS0w_4cd00b25-7123-4c78-8bbe-d36471068924">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idc279916c2484e4abfd94cbddb0b1947_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNS0xLTEtMS0w_85d6ac16-445b-424e-9cbb-6b5465d8682b">9,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idc279916c2484e4abfd94cbddb0b1947_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNS0zLTEtMS0w_295cdb4b-f6a1-41db-bf73-205ef2dbc5fb">1,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i93cec6a0dc8b4cc79fe185028e72ea4b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNi0xLTEtMS0w_0bd1c1c7-78d5-4eb2-b1cb-da251cd70110">240,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i93cec6a0dc8b4cc79fe185028e72ea4b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNi0zLTEtMS0w_8461939c-6c40-4b7f-a1cd-719d39e304e9">92,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if0efe039c4404f3db3ac7271abe88c92_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNy0xLTEtMS0w_42c8b13a-41bb-4d6c-9cd6-8df2357fc7cc">1,937</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if0efe039c4404f3db3ac7271abe88c92_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNy0zLTEtMS0w_510449b4-545e-421d-9c63-d6f91bf94ccb">519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfOC0xLTEtMS0w_770b9974-8ec8-41ea-bc6f-2d73543b20e4">977,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfOC0zLTEtMS0w_fdf51298-d3f7-4545-9884-d96dc76c4974">442,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icb2734a552514580a66be829325e052e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTEtMS0xLTEtMA_32cd4c6e-ed5c-4589-9c82-329059fd3ef2">81,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia15d20e25e2c404b9fa9ab9025017114_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTItMS0xLTEtMA_fe4ed3a6-d6cc-455a-8d98-af39ae13178c">26,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTMtMS0xLTEtMA_accd5e89-c612-41b2-a216-6a32fa3940df">107,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTQtMS0xLTEtMA_40feb2b2-dd0b-40fe-9e4e-01001c2a8c14">1,085,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTQtMy0xLTEtMA_5ce3c48e-481d-4d46-8b76-8d32dbef7e8a">442,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#8217;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another <ix:nonNumeric contextRef="i8f7a540829534df293806a8679ef9ba5_D20210101-20210331" format="ixt-sec:duryear" name="shc:LicensingAgreementsRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfODQw_00607e71-01a7-4330-9009-1c4bb782aa29">10</ix:nonNumeric> years license period as Nordion has demonstrated over its 70 years of history.</span></div></ix:continuation></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts include the impact of foreign currency translation. Fully amortized amounts are written off. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for other intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ic654e0b7347f4135b94187587d072ac9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTYxNQ_7a72654f-2072-4cd9-a019-de7f7058f160">22.3</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ia780c72ea74742cb8f4ea0929abef198_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTYxOQ_d7591167-cebe-4477-81f7-aaf36c79fb77">5.8</ix:nonFraction>&#160;million is included in &#8220;Cost of revenues&#8221; and $<ix:nonFraction unitRef="usd" contextRef="ibff6b4bd9f5349269d862b32081e5981_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk0NA_137353ca-cba5-4498-a6ae-9cfccf629334">16.5</ix:nonFraction>&#160;million in &#8220;Selling, general and administrative expenses&#8221;) in the Consolidated Statements of Operations and Comprehensive Income (Loss) and $<ix:nonFraction unitRef="usd" contextRef="i4941298f6979408a8566ea338611e02c_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk4Mg_7b495b1d-2eb1-4f6e-a5fe-a4504674ca8c">19.9</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i9aedde424acd460ead3548c57b1da604_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk4NQ_0bdcbe5a-8c40-4ad6-9378-b16b4266511a">5.3</ix:nonFraction>&#160;million is included in &#8220;Cost of revenues&#8221; and $<ix:nonFraction unitRef="usd" contextRef="i632d789ade294a64b7daf856fe6f362a_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk3OA_9023791c-92c6-402e-b5e6-80f0d21b243c">14.6</ix:nonFraction> million in &#8220;Selling, general and administrative expenses&#8221;) in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March&#160;31, 2021 and 2020, respectively. </span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNw_c31d55c0-6de4-4753-8c30-6919ec85d3ec" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated aggregate amortization expense for finite-lived intangible assets for each of the next five years and thereafter is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfMS0xLTEtMS0w_dc83318d-a10b-4277-b3e6-58cc39a9b12c">65,889</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfMi0xLTEtMS0w_10fc8fc2-7171-4940-aec7-2402ba3c1f9c">80,665</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfMy0xLTEtMS0w_3cd63c3e-cdf1-48dd-9375-eabfbe7ce12e">80,659</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNC0xLTEtMS0w_c5f0ac03-5e04-403b-b5ff-ec520ab1e1d9">79,882</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNS0xLTEtMS0w_1f6a00bf-8b63-4d30-993c-6f3fc56cbbcc">41,982</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNi0xLTEtMS0w_7272c11b-69e6-4ef5-b4c1-4aeec73dfbcf">198,736</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNy0xLTEtMS0w_53a9f554-7f76-4b37-a200-c7ab4350b941">547,813</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average remaining useful life of the finite-lived intangible assets was approximately <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjI1Mg_f475d00a-61c5-4f54-bf1e-5a8892e74922">10</ix:nonNumeric> years as of March&#160;31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">14</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_64"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RleHRyZWdpb246NjgyMWMyNmMwZjk1NGY4YmE5ZWI1MmRiNzU0OTYxNjhfMjc0ODc3OTA2OTUxNQ_887f1e37-259e-4e82-a001-556fa8cca20b" continuedAt="i53d76654964c4ce2976d35e9f9c9bcbe" escape="true">Accrued Liabilities</ix:nonNumeric></span></div><ix:continuation id="i53d76654964c4ce2976d35e9f9c9bcbe"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RleHRyZWdpb246NjgyMWMyNmMwZjk1NGY4YmE5ZWI1MmRiNzU0OTYxNjhfMjc0ODc3OTA2OTUxNA_d927124e-c0f3-4e72-8c6e-8cf27b5e2cca" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMi0xLTEtMS0w_8d01fdbf-4532-42db-9534-1aedf8d9243d">27,651</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMi0zLTEtMS0w_0a456edc-a089-47ab-ad32-405dac0be774">34,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMy0xLTEtMS0w_23979374-0036-4032-891d-e252a866ab71">2,751</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMy0zLTEtMS0w_5804585b-ad16-4d19-afdb-030a16bc259a">2,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="shc:AccruedInterestExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNC0xLTEtMS0w_8f67e1c2-ba01-49da-802a-e2045e55c2b0">764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" name="shc:AccruedInterestExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNC0zLTEtMS0w_3ea93989-91f7-48fd-8407-14b4519eb6d8">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNS0xLTEtMS0w_1ffe4a7c-1585-4f02-b9bb-b66494cc731b">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNS0zLTEtMS0w_54495094-499b-4d2a-a6ae-e6bb3351cdea">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNi0xLTEtMS0w_2f48515f-6359-4029-b26e-2a147274b4b8">13,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNi0zLTEtMS0w_6b69525f-aead-4492-91ea-f4296ab6620d">12,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued utilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedUtilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNy0xLTEtMS0w_068b659b-9279-4061-823b-fb80340ba3d7">2,397</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedUtilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNy0zLTEtMS0w_f8219f6c-5164-4ca3-b2e8-be25d30bd41d">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedInsuranceCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOC0xLTEtMS0w_74f0a750-1add-46da-82a2-bef2799e3b16">1,886</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedInsuranceCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOC0zLTEtMS0w_77cff311-1a32-4498-8dc4-b4a6d30a74cc">1,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOS0xLTEtMS0w_a7221510-12bf-4bba-82e4-c46ab75a5e11">3,332</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOS0zLTEtMS0w_be5d64d0-c684-45a0-bf3e-cd07a6cfcf0b">2,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTAtMS0xLTEtMA_453ab0ea-d235-459a-a8da-7915dd6099cb">3,619</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTAtMy0xLTEtMA_61aa052e-97ce-4778-95fd-757f9dd1753c">3,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTEtMS0xLTEtMA_0c05f91c-4a8a-40fe-b150-0c0e61dc5b41">56,373</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTEtMy0xLTEtMA_8af8c68d-9534-486f-a216-cc1d725d626b">60,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_67"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA4NjkwOA_1a26b70b-201b-4900-913e-83de9200e3a0" continuedAt="i8b624454ffcc4beea229c281cac906ee" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i8b624454ffcc4beea229c281cac906ee" continuedAt="i04fa4d37ec234d0aaaf4bd52db8388be"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA4NjkxMA_f980980e-945e-4a88-a219-05b0676d3642" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.791%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1e8995acb99a47cf96b979b522b8a240_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMi0xLTEtMS0w_81443fa3-53b5-467a-b46f-e7446adeddc9">1,763,100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie582d45d5d3a4547a10610bd46cdaf41_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMi0zLTEtMS0w_cd2c00ef-5f42-40a5-bd6a-e39a31ccc7de">1,763,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd422b230de24395ba1b25c54a6db45d_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMy0xLTEtMS0w_53199438-107a-4948-9add-79759b36c9cd">100,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie37562b8bb6f4f1fad61c5737f8165db_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMy0zLTEtMS0w_29804fd5-6e06-40e7-9836-6aead56a2176">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie9d3cea4bc3043aa8b6fa40430ca9b03_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNS0xLTEtMS0w_735aaf2b-a62f-4d88-a0b5-9607a19fcfc9">1,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if060086f17a0456496054d58a49829b9_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNS0zLTEtMS0w_3602865d-0f02-4492-8ec8-23a104ed28db">450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNi0xLTEtMS0w_ac2a8d4f-82b5-45e1-8319-f10e4275b5b4">1,864,159</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNi0zLTEtMS0w_e15c96b8-e886-4cdf-9c12-cc2168435f41">1,863,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less unamortized debt issuance costs and debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOC0xLTEtMS0w_3f484180-59a9-4453-9d7e-236fdb63149b">26,579</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOC0zLTEtMS0w_28f61182-a5c9-4fae-a26d-b135ea2e3e90">38,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt, less debt issuance costs and debt discounts</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOS0xLTEtMS0w_8b6c89e1-93b5-4328-b9aa-9717524c1312">1,837,580</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOS0zLTEtMS0w_f61c9331-a555-4dc8-ad58-e8456c110c5c">1,824,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;13, 2019, Sotera Health Holdings, LLC (&#8220;SHH&#8221;), our wholly owned subsidiary, entered into senior secured first lien credit facilities (the &#8220;Senior Secured Credit Facilities&#8221;), consisting of both a prepayable senior secured first lien term loan (the &#8220;Term Loan&#8221;) and a senior secured first lien revolving credit facility (the &#8220;Revolving Credit Facility&#8221;) pursuant to a first lien credit agreement (the &#8220;Credit Agreement&#8221;). The Term Loan matures on December 13, 2026, and the Revolving Credit Facility's original maturity date was December 13, 2024. On December 17, 2020, we increased the capacity of our Revolving Credit Facility from $<ix:nonFraction unitRef="usd" contextRef="i9aa1598f78fa4665b7e784df6c4c3618_I20201216" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NDU3Mg_92e282cb-07ae-40d5-a41a-70b71fbe5944">190.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i3445e5d203564800970ed964c9915f69_I20201217" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NDU3Ng_05ae3799-59ce-4558-a87e-ca35d15ace48">347.5</ix:nonFraction> million. The Senior Secured Credit Facilities also provide SHH the right at any time and under certain conditions to request incremental term loans or incremental revolving credit commitments based on a formula defined in the Senior Secured Credit Facilities. As of March&#160;31, 2021 and December&#160;31, 2020, total borrowings under the Term Loan were $<ix:nonFraction unitRef="usd" contextRef="i1e8995acb99a47cf96b979b522b8a240_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfOTgx_bbb50943-038a-4efd-a551-f52e913c2252">1,763.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie582d45d5d3a4547a10610bd46cdaf41_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODQ2NQ_cd2c00ef-5f42-40a5-bd6a-e39a31ccc7de">1,763.1</ix:nonFraction> million, respectively, and there were no borrowings outstanding on the Revolving Credit Facility. The weighted average interest rate on borrowings under the Term Loan for the three months ended March&#160;31, 2021 and March&#160;31, 2020 was <ix:nonFraction unitRef="number" contextRef="i61b546722b35491d9fa5800657d6bb77_D20210101-20210331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjE5OTAyMzMwNjg3MA_fa9f52bf-26a2-401e-8a19-0f26c3907da3">3.73</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie47cbeb3f51f4d44a3362102b9e364be_D20200101-20200331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODQ5Ng_909cce7a-673c-47aa-a94c-f4aa309935cc">6.18</ix:nonFraction>%, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, we closed on an amendment repricing our Term Loan. The interest rate spread over the London Interbank Offered Rate (&#8220;LIBOR&#8221;) on the facility was reduced from <ix:nonFraction unitRef="number" contextRef="if9e4212789dc41669d654b48e51f12fe_D20210119-20210119" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI2MA_e4a1ce27-3ddb-42a0-9091-010a5da14f75">450</ix:nonFraction> basis points to <ix:nonFraction unitRef="number" contextRef="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI2Ng_9b9c2639-ad31-4763-8b64-e8587bcf3bbd">275</ix:nonFraction> basis points, and the facility&#8217;s LIBOR floor was reduced from <ix:nonFraction unitRef="number" contextRef="i3939ca87747f4af3ad4db922091cc08b_I20210119" decimals="INF" name="shc:DebtInstrumentVariableRateFloor" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI3Mg_4667ac83-c486-42a4-be6b-7b575d0e57e7">100</ix:nonFraction> basis points to <ix:nonFraction unitRef="number" contextRef="i62e37fc77ba14274a2e06c4a3ec51333_I20210120" decimals="INF" name="shc:DebtInstrumentVariableRateFloor" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI3OA_ffc89198-42db-4de3-acfa-6eb64c851bc4">50</ix:nonFraction> basis points. The changes result in an effective reduction in current interest rates of <ix:nonFraction unitRef="number" contextRef="i4a20972bbc3640e8b6a94b5727ca3aa3_I20210120" decimals="4" name="shc:DebtInstrumentEffectiveReductionInCurrentInterestRates" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI4NA_b5acd400-08eb-419e-8ae1-5eb166e1dce4">2.25</ix:nonFraction>%.  In connection with this amendment, we wrote off $<ix:nonFraction unitRef="usd" contextRef="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="shc:WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDMwMg_7b8e632a-7867-4ca9-a05b-3ba20cee6c83">11.3</ix:nonFraction> million of unamortized debt issuance and discount costs and incurred an additional $<ix:nonFraction unitRef="usd" contextRef="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120" decimals="-3" format="ixt:numdotdecimal" name="shc:DebtIssuanceCostsRefinancingAdditionalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDMwOA_481c6a24-9b65-4b1b-806b-ebdb5bb9bc46">2.9</ix:nonFraction> million of expense related to debt issuance costs attributable to the refinancing. These costs were recorded to &#8220;Loss on extinguishment of debt&#8221; in our Consolidated Statements of Operations and Comprehensive Income (Loss). </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i04fa4d37ec234d0aaaf4bd52db8388be" continuedAt="i7f709597fe134b5cb9eae84d72d26b00"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs totaled $<ix:nonFraction unitRef="usd" contextRef="i5076ff942fc745c6b7f8da2a4d66baf0_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTYyMQ_6a01cb26-4228-4d65-9424-1fc89f49bb57">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i85e8b4006d4e4eb994d25982e3a967b0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODM4OQ_befa215a-49f4-44a5-9d0a-eacd22cca3d0">3.4</ix:nonFraction> million, respectively, and debt discounts totaled $<ix:nonFraction unitRef="usd" contextRef="i5076ff942fc745c6b7f8da2a4d66baf0_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTYyOA_3df65187-74f9-4e3a-80cf-30dc76198522">20.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i85e8b4006d4e4eb994d25982e3a967b0_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODQ0MQ_29552f02-d0a5-4a02-8e40-f8bcf1667f40">31.6</ix:nonFraction> million, respectively, related to the Senior Secured Credit Facilities. Such costs are recorded as a reduction of debt on our consolidated balance sheets and amortized as a component of interest expense over the term of the debt agreement. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2021, we amended the Revolving Credit Facility, to (i) decrease the Applicable Rate (as defined in the Credit Agreement) related to any Revolving Loans (as defined in the Credit Agreement) from a rate per annum that ranged from an alternative base rate (&#8220;ABR&#8221;) plus <ix:nonFraction unitRef="number" contextRef="iec712ce357d5481ea60298bfc94462bd_D20210326-20210326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQyMg_3167f9d8-22f1-4402-860f-3c0a8ebc5752">2.50</ix:nonFraction>% to ABR plus <ix:nonFraction unitRef="number" contextRef="i78ae87cbdee94046bcbcb6ab3f48b2d4_D20210326-20210326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQzMA_c8d7fac6-64aa-4007-a43c-c6c01b4ac0a1">3.00</ix:nonFraction>% depending on SHH&#8217;s Senior Secured First Lien Net Leverage Ratio to ABR plus <ix:nonFraction unitRef="number" contextRef="i013ecc2ca22e4d5bb0e44c54ecb51558_D20210326-20210326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQzOA_019db71f-f465-42d1-a126-8e106c059466">1.75</ix:nonFraction>%; and in the case of Eurodollar Loans (as defined in the Credit Agreement) from a rate per annum which ranged from the Adjusted LIBOR plus <ix:nonFraction unitRef="number" contextRef="i0e206e36be42444db67127b6b666b46c_D20210326-20210326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQ0Nw_f67be3d9-22b8-4c5c-a27f-19b4faf2dd01">3.50</ix:nonFraction>% to the Adjusted LIBOR plus <ix:nonFraction unitRef="number" contextRef="i48427c3c8fee49e493e03f3f6a69e2d7_D20210326-20210326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQ1NQ_a8514eaa-aa71-4d58-a6fd-a2fcce3b2068">4.00</ix:nonFraction>% depending on SHH&#8217;s Senior Secured First Lien Net Leverage Ratio (as defined in the Credit Agreement), to the Adjusted LIBOR (as defined in the Credit Agreement) plus <ix:nonFraction unitRef="number" contextRef="if972f5c2e68f4b6e9c9b79e8bc599d2c_D20210326-20210326" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQ2Mw_be1cd71a-b0ce-4e78-85ba-80b42dfe0a67">2.75</ix:nonFraction>%, and (ii) extend the maturity date of the Revolving Facility from December 13, 2024 to June 13, 2026. The other material terms of the Credit Agreement are unchanged and the amendment does not change the capacity of our Revolving Credit Facility, which is $<ix:nonFraction unitRef="usd" contextRef="i3445e5d203564800970ed964c9915f69_I20201217" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ4MzE4OA_05ae3799-59ce-4558-a87e-ca35d15ace48">347.5</ix:nonFraction> million. No unamortized debt issuance costs associated with the Revolving Credit Facility were written off and direct fees and costs incurred in connection with the amendment were immaterial.  </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, there were <ix:nonFraction unitRef="usd" contextRef="i74886e80842c43c2b575afa174c8f146_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA5MTQ3NQ_0d8c3471-7eef-4e58-bcda-ec7f76e3ff99"><ix:nonFraction unitRef="usd" contextRef="i458ac54874ff437295ae19825c2e1ad6_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtInstrumentCarryingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA5MTQ3NQ_cd2615b3-c0df-4ae6-a5f3-978df78daef5">no</ix:nonFraction></ix:nonFraction> borrowings on the Revolving Credit Facility. SHH borrowed $<ix:nonFraction unitRef="usd" contextRef="i0685810b83ff487580eda356557fd6bf_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTEzNQ_d5bdbf4c-ea25-40d0-afed-0d088ffc939b">50.0</ix:nonFraction> million on the Revolving Credit Facility during the first quarter of 2020 which was repaid in the second quarter of 2020. The interest rate on the borrowings under the Revolving Credit Facility during 2020 averaged approximately <ix:nonFraction unitRef="number" contextRef="i3ff2dc57c0034141899eda7b55d9c143_D20200101-20200331" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM1NQ_b22eae61-da11-4bf2-aa0c-559fb97aae4b">5.0</ix:nonFraction>%. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of SHH&#8217;s obligations under the Senior Secured Credit Facilities are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of the Company, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the Senior Secured Credit Facilities, and the guarantees of such obligations, are secured by substantially all assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the Senior Secured Credit Facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding letters of credit are collateralized by encumbrances against the Revolving Credit Facility and the collateral pledged thereunder, or by cash placed on deposit with the issuing bank. As of March&#160;31, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="i458ac54874ff437295ae19825c2e1ad6_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfNTE4Mw_30c2d125-0102-4fa9-8d01-2d821b435b29">65.8</ix:nonFraction> million of letters of credit issued against the Revolving Credit Facility, resulting in total availability under the Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i458ac54874ff437295ae19825c2e1ad6_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfNTMyNA_42853787-a525-411d-846f-66f5c33b4195">281.7</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Lien Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, SHH issued $<ix:nonFraction unitRef="usd" contextRef="ic0c05eb822b5410c8019ed6fe29b6ab8_I20200731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM4Mg_2baf6fbd-6654-449c-8923-9b2427d4f6e4">100.0</ix:nonFraction> million aggregate principal amount of senior secured first lien notes due 2026 (the &#8220;First Lien Notes&#8221;), which mature on December 13, 2026. The First Lien Notes bear interest at a rate equal to LIBOR subject to a <ix:nonFraction unitRef="number" contextRef="ic0c05eb822b5410c8019ed6fe29b6ab8_I20200731" decimals="INF" name="shc:DebtInstrumentVariableRateFloor" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM4Nw_e0f3da0b-2f68-4b01-b514-f5cb680aef0c">1.00</ix:nonFraction>% floor plus <ix:nonFraction unitRef="number" contextRef="i8b900c87d68440d0aa7afa06a2cf13f9_D20210101-20210331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM5MQ_fbb4ed72-de2c-4be0-985e-e50c2f5b7d38">6.00</ix:nonFraction>% per annum. Interest is payable on a quarterly basis with no principal due until maturity. The weighted average interest rate on the First Lien Notes for the three months ended March&#160;31, 2021 was <ix:nonFraction unitRef="number" contextRef="i58786296c5744b83985f9f2ad31ad009_D20210101-20210331" decimals="2" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfNzgxNw_93d22a69-92c0-4195-977b-9390604adc43">7.00</ix:nonFraction>%. </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SHH is entitled to redeem all or a portion of the First Lien Notes, at any time and from time to time, subject to certain premiums depending on the date of redemption; any time on or prior to July 31, 2021, a customary make-whole premium applies and, thereafter, specified premiums that decline to zero apply (in each case as described in the indenture governing the First Lien Notes). </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of SHH&#8217;s obligations under the First Lien Notes are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of SHH, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the First Lien Notes, and the guarantees of such obligations, are secured by substantially all of the assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the First Lien Notes. Such collateral is substantially the same collateral that secures the Senior Secured Credit Facilities. Such collateral securing the First Lien Notes ranks pari passu with that of the Senior Secured Credit Facilities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i7f709597fe134b5cb9eae84d72d26b00"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs were $<ix:nonFraction unitRef="usd" contextRef="if63b06a187344473bec2c467e8a1eaa8_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfOTE1Mw_bc64d52b-7076-43e2-b90f-09e360dd2a2e">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife3ac8faabe645c99d73eb67ce7ce8b9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODU2OA_36a61c1e-8d5a-48c5-8dd7-558eef40f56b">0.9</ix:nonFraction> million, respectively, and debt discounts were $<ix:nonFraction unitRef="usd" contextRef="if63b06a187344473bec2c467e8a1eaa8_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfOTE4MA_acc760fc-fde0-4aae-a5b7-58310da84333">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife3ac8faabe645c99d73eb67ce7ce8b9_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODU5OQ_f7946606-c6e1-4a79-b29d-908c4a84a228">2.8</ix:nonFraction> million, respectively, related to the First Lien Notes, which are recorded as a reduction of debt on our Consolidated Balance Sheets and amortized into interest expense over the term of the debt agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Debt Repayments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 24, 2020, we closed our initial public offering (the "IPO&#8221;), in which we sold <ix:nonFraction unitRef="shares" contextRef="i5475791dc6254d89860104a417d03dfd_D20201124-20201124" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM0MA_42356dce-5d5f-4097-be86-385073e1ed2b">53,590,000</ix:nonFraction> shares of our common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i028ae4ed27174f34989fbc5e78e51dce_I20201124" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM1MA_afe45dd8-973e-4b6b-bf74-35fd73a63539">23.00</ix:nonFraction> per share, which included the full exercise by the underwriters of their option to purchase up to an additional <ix:nonFraction unitRef="shares" contextRef="i5475791dc6254d89860104a417d03dfd_D20201124-20201124" decimals="INF" format="ixt:numdotdecimal" name="shc:SaleOfStockNumberOfAdditionalSharesToBeRepurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM2Mw_946a1f44-1b3b-4a48-98a0-3ecc7453cceb">6,990,000</ix:nonFraction> shares of common stock. We raised approximately $<ix:nonFraction unitRef="usd" contextRef="i5475791dc6254d89860104a417d03dfd_D20201124-20201124" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM3OA_5e9d15d2-37c5-421b-8ea1-bfaaab220d8a">1.2</ix:nonFraction> billion in net proceeds after deducting underwriters&#8217; discounts and commissions. We used the net proceeds received by us from the IPO to (i) redeem $<ix:nonFraction unitRef="usd" contextRef="i07c6f50405594b5592607e77121c0fa7_D20200301-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDMyNA_d6b826ee-86a6-4433-93ae-48eb3d6b104d">770.0</ix:nonFraction> million in aggregate principal amount of the Second Lien Senior Secured Notes with an original maturity date of December 13, 2027 (the "Second Lien Notes&#8221;), plus accrued and unpaid interest thereon and $<ix:nonFraction unitRef="usd" contextRef="i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:RecognitionOfDebtPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDMwNw_36a89f58-2b76-4e6b-8ef4-00b07bdd7594">15.4</ix:nonFraction> million of redemption premium, (ii) repurchase <ix:nonFraction unitRef="shares" contextRef="ia4a180ea1b6d4c3bb6c80f76ff48a33a_D20201124-20201124" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM5MQ_be122251-817c-42b3-b5b3-f034b4a98824">1,568,445</ix:nonFraction> shares of our common stock from certain of our executive officers at a purchase price per share equal to the IPO price per share of our common stock less an amount equal to the underwriting discounts and commissions payable thereon and (iii) repay $<ix:nonFraction unitRef="usd" contextRef="i97db1199d2ae496d86dba67906d75440_D20201101-20201130" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDM0MQ_5a8ada2c-a544-4eca-a926-ef408110d8ff">341.0</ix:nonFraction> million of the outstanding indebtedness under the Term Loan, plus accrued and unpaid interest thereon. In connection with the debt repayments, we wrote off $<ix:nonFraction unitRef="usd" contextRef="i7e0882cfad7543dcbaf6ed1402ccfe46_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDM1Nw_e3c578c4-90ad-4718-974e-ce84c00c06b8">28.9</ix:nonFraction> million of debt issuance and discount costs and recognized $<ix:nonFraction unitRef="usd" contextRef="i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:RecognitionOfDebtPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDM3NA_36a89f58-2b76-4e6b-8ef4-00b07bdd7594">15.4</ix:nonFraction> million in premiums paid for the early extinguishment of the Second Lien Notes. We recognized these costs within &#8220;Loss on extinguishment of debt&#8221; in our Consolidated Statements of Operations and Comprehensive Income (Loss) in the fourth quarter of 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aggregate Maturities </span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA4NjkwOQ_7af7045f-0dd1-458a-bd57-d8ae03d37061" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate maturities of the Company&#8217;s long-term debt, excluding debt discounts, as of March&#160;31, 2021, are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfMS0xLTEtMS0w_dd83d666-cdc2-4964-9dc2-dad22350f234">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfMi0xLTEtMS0w_6444b813-a326-49d0-b56d-15d629f665b7">609</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfMy0xLTEtMS0w_afaaf033-6261-45d4-893d-90e1c54dea45">450</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNC0xLTEtMS0w_fb296350-c3e3-41bb-814e-176c7aca4e22">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNS0xLTEtMS0w_5b88f234-84aa-4414-946a-947d3dcc8718">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:LongTermDebtMaturityAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNi0xLTEtMS0w_609a3dfb-780c-4ce0-a402-87ab95218414">1,863,100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNy0xLTEtMS0w_0ec9a92d-847b-4ed5-b95a-12b44b8a7a0c">1,864,159</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As referenced above, the Company utilized its IPO proceeds toward prepaying the Second Lien Notes in full as well as prepaying a portion of the Term Loan. The Term Loan prepayment amount eliminated all subsequent scheduled and outstanding repayments of the term borrowings resulting in no remaining short-term commitments.</span></div></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_70"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMjc0ODc3OTA3Njc3Nw_cfddbee8-7e98-402e-a25d-422de04e8b6f" continuedAt="icd9b16346e0744609fc1082593165171" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="icd9b16346e0744609fc1082593165171" continuedAt="i92136b9b6a6d4b5dbd2889deac166711"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense is provided on an interim basis based upon our estimate of the annual effective income tax rate. In determining the estimated annual effective income tax rate, we analyze various factors, including projections of our annual earnings and the taxing jurisdictions where the earnings will occur, the impact of state and local taxes, our ability to utilize tax credits and net operating loss carryforwards and available tax planning alternatives. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate was <ix:nonFraction unitRef="number" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfNTA4_ea7400c7-f952-40ed-9c36-07237e4cf403">21.4</ix:nonFraction> % and (<ix:nonFraction unitRef="number" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfNTE1_21a2ef6a-e9c6-465a-8976-6b68e0033390">86.0</ix:nonFraction>)% for the three months ended March&#160;31, 2021 and 2020, respectively. Income tax expense for the three months ended March&#160;31, 2021 differs from the statutory rate primarily due to the impact of the foreign rate differential, global intangible low-tax income (&#8220;GILTI&#8221;), and a net increase in the valuation allowance attributable to the limitation on the deductibility of interest expense. This was offset by a discrete item, which reversed the valuation allowance on deferred tax assets related to certain asset retirement obligations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the three months ended March&#160;31, 2020 differed from the statutory rate primarily due to the impact of the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), which increased the limitation on the deductibility of interest expense from <ix:nonFraction unitRef="number" contextRef="iba2d514743dd41119e290276367c2fb1_D20200101-20201231" decimals="INF" name="shc:LimitationOnDeductibilityOfInterestExpenseCARESAct" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUyNQ_440be472-e10a-4b25-b9fd-1b8f72e95247">30</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" name="shc:LimitationOnDeductibilityOfInterestExpenseCARESAct" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUzMQ_b35e749e-8e16-47f8-b369-ecc48821dbfc">50</ix:nonFraction>% for tax years beginning in 2019 or 2020, and other provisions. The increased limitation </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i92136b9b6a6d4b5dbd2889deac166711">resulted in a current tax benefit for the three months ended March 31, 2020 of $<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUwMw_43503a49-5177-4c6c-91d2-297ebb7b1154">9.1</ix:nonFraction> million. The increased limitation also resulted in a $<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUxOA_cd30dbca-7522-460f-a1b6-c4921e85f28d">5.6</ix:nonFraction> million valuation allowance reversal in the three months ended March&#160;31, 2020.</ix:continuation> </span></div><div id="i15ef643796c34829b3bb28475338f021_531"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzI3NDg3NzkwNzkzNDM_c6cd19b5-3c33-4245-852d-9e0df7a5f7cd" continuedAt="i1da737f12c994588b1c2e3bce380b618" escape="true">Employee Benefits</ix:nonNumeric></span></div><ix:continuation id="i1da737f12c994588b1c2e3bce380b618" continuedAt="i584cfd0459c54e308317d1963148051d"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various post-employment benefit plans including, in certain countries outside the U.S., defined benefit and defined contribution pension plans, retirement compensation arrangements, and plans that provide extended health care coverage to retired employees, the majority of which relate to Nordion. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined benefit pension plan </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest cost and expected return on plan assets are recorded in &#8220;Other income, net&#8221; and the service cost component is included in the same financial statement line item as the applicable employee&#8217;s wages in the Consolidated Statements of Operations and Comprehensive Income (Loss). <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzI3NDg3NzkwNzkzNDQ_d971fd04-cd29-4297-91ac-e39b656c9e94" continuedAt="i01f964bd6fbd4f39b31e969eee19caa6" escape="true">The components of net periodic pension cost for the defined benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i01f964bd6fbd4f39b31e969eee19caa6" continuedAt="i92809c695a4145d0a6747c417e7fcdd7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzItMS0xLTEtMTE4_cf92fbee-c541-48f1-a735-7b1e90c5af14">298</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzItMy0xLTEtMTE4_bbddadd6-e1e1-4d35-8e31-2a45cd376bef">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzMtMS0xLTEtMTE4_8787acbd-dc8c-4944-a0a6-e357a0bfb8bc">1,613</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzMtMy0xLTEtMTE4_f56a1a40-afb9-428e-9062-23f6e5927dde">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzQtMS0xLTEtMTE4_08de4232-2166-4fff-aafc-f16781968b3f">3,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzQtMy0xLTEtMTE4_efcb2791-8a8d-4f01-8a72-2e009c54a279">3,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzUtMS0xLTEtMTE4_69202ca4-8609-421e-91d3-9b00468fc7b7">267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzUtMy0xLTEtMTE4_86ad170b-0878-49a9-8c77-049ef6a16620">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net periodic benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzYtMS0xLTEtMTE4_8126d081-1377-47ad-9d52-fb1a43d40cc2">1,379</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzYtMy0xLTEtMTE4_86b99c9c-a423-40fc-a1a2-7f511bde7720">1,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other benefit plans </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other benefit plans include a supplemental retirement arrangement, a retirement and termination allowance, and post-retirement benefit plans, which include contributory health and dental care benefits and contributory life insurance coverage. All but one, non-pension post-employment benefit plans are unfunded. The components of net periodic pension cost for the other benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:12pt"><ix:continuation id="i92809c695a4145d0a6747c417e7fcdd7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzItMS0xLTEtMTE4_a469510e-dac0-43bd-a5dc-8e00a8d39bdb">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanServiceCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzItMy0xLTEtMTE4_8336a7b7-2ba9-4b26-ae7f-9beece00eef7">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzMtMS0xLTEtMTE4_8557f442-f254-4f0f-97ed-83526bb0ce47">59</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanInterestCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzMtMy0xLTEtMTE4_e550d4dc-457c-4190-ac6d-d968c8448b21">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzQtMS0xLTEtMTE4_8eaa53f2-8d0e-470a-bf51-874877852689">8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzQtMy0xLTEtMTE4_b16c59c3-5998-4e13-818f-85c59f9963de">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzUtMS0xLTEtMTE4_75fc8c5c-5c2c-48a6-8fea-a25f39b512d2">74</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331" decimals="-3" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzUtMy0xLTEtMTE4_2a315cee-3c7b-4b55-9485-9031f9c631d1">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect funding requirements of approximately $<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NTE1NjE_f08229eb-2e07-4881-b6ef-605ba6e89f01">2.8</ix:nonFraction>&#160;million in each of the next five years to fund the regulatory solvency deficit, as defined by Canadian federal regulation, which require solvency testing on defined benefit pension plans.</span></div></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i584cfd0459c54e308317d1963148051d">The Company may obtain a qualifying letter of credit for solvency payments, up to <ix:nonFraction unitRef="number" contextRef="ifb78af3c02b2463c9b7e74b792e5d62e_D20210101-20210331" decimals="INF" name="shc:LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NDI4NDY_a095ab84-0b8f-4c96-b945-1cf87ebbed7c">15</ix:nonFraction>% of the market value of solvency liabilities as determined on the valuation date, instead of paying cash into the pension fund. As of March&#160;31, 2021, and December&#160;31, 2020, we had letters of credit outstanding relating to the defined benefit plans totaling $<ix:nonFraction unitRef="usd" contextRef="i226897b7dda742f1b2b822fe5e2f5ed2_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NDMwODE_c4bbb402-c856-4ce9-8b5c-ffc9565f123e">42.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="icebe580f12e2450aa32311d02bcd23d5_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NDMwODk_87d87b6b-f0b6-4e4c-a5cd-dc4538889bbe">41.3</ix:nonFraction> million, respectively. The actual funding requirements over the five-year period will be dependent on subsequent annual actuarial valuations. These amounts are estimates, which may change with actual investment performance, changes in interest rates, any pertinent changes in Canadian government regulations and any voluntary contributions.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">18</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_73"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83My9mcmFnOjc1NGJlNjAzNTFiODRmZDY4MTU5Zjg3ODI0ZTY5MTI2L3RleHRyZWdpb246NzU0YmU2MDM1MWI4NGZkNjgxNTlmODc4MjRlNjkxMjZfMjc0ODc3OTA3MDU2Mg_a3d66f60-95d3-42cd-ae4c-eda837b9564f" continuedAt="ibd74aa872f7249449ff133653bf3a87f" escape="true">Related Parties</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibd74aa872f7249449ff133653bf3a87f">We do business with a number of companies affiliated with Warburg Pincus and GTCR, which we refer to collectively as the &#8220;Sponsors,&#8221; who continue to have substantial control over us. All transactions with these companies have been conducted in the ordinary course of our business and are not material to our operations.</ix:continuation></span></div><div id="i15ef643796c34829b3bb28475338f021_76"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RleHRyZWdpb246NDQ3NTZmZmRkNzJmNDZkM2JiNGFiOTNlZTg0OTZlNzZfMjc0ODc3OTA3MDE4NQ_d633e893-11f1-4246-99b6-27d55fbf825f" continuedAt="id7a05b1dcbf3412cb4f272eff5846b9c" escape="true">Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><ix:continuation id="id7a05b1dcbf3412cb4f272eff5846b9c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in accumulated other comprehensive income (loss) are presented net of the related tax. Foreign currency translation is not adjusted for income taxes. </span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RleHRyZWdpb246NDQ3NTZmZmRkNzJmNDZkM2JiNGFiOTNlZTg0OTZlNzZfMjc0ODc3OTA3MDE4Ng_5c137117-2dff-46ae-a37c-1c9204a186cf" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our accumulated other comprehensive income (loss) balances, net of applicable tax, were as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.431%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Translation</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Swaps</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beginning balance &#8211; January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i90fc782dbb0e49489e495a7aa71f62d4_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS0xLTEtMS0w_56825fb3-00b0-43c3-bd8f-ae0fab817ff7">44,143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i980a63340b96471687bdd40130dadc4e_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS0zLTEtMS0w_0f715a46-6bd4-4894-81bc-eb2ee1c4650a">49,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i82333f7ccf614eb1b010487872bbaad6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS01LTEtMS0w_b31ef46f-ee01-4fe6-b256-6bcb84dbbd99">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i360689ad9dcc48f5ab2673194f9a3327_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS03LTEtMS0w_0c17d67f-8ce7-43b6-a795-b602c9defd7c">93,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi0xLTEtMS0w_c8ae55b9-ca90-4bb7-9810-853515793c77">524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi0zLTEtMS0w_aede031c-9d83-4856-a0a3-a562f5005879">3,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi01LTEtMS0w_68d946cf-0670-4097-8f61-904c80346954">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi03LTEtMS0w_def2a67e-39e0-4630-b2d8-3ae6dc8607e7">3,595</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy0xLTEtMS0w_166da53a-95da-421c-aafb-aa1363dc0de9">275</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy0zLTEtMS0w_3f26b514-8811-431d-a5b2-b2b4adacc5cf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy01LTEtMS0w_bb2c52f8-737b-4c6e-8bcb-84e36ae16115">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy03LTEtMS0w_2b93cce4-67d4-42fc-9b0a-2dd075c56c55">275</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC0xLTEtMS0w_5363b1ad-f2b1-4ce6-9783-c0f1becf75a2">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC0zLTEtMS0w_a2310c47-084f-42bd-9605-fdfa0e7a4665">3,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC01LTEtMS0w_8b053c2d-195f-4eea-921c-c543cf2af4a3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC03LTEtMS0w_f376a548-66fe-4143-ab2e-6e8ecc539d37">3,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ending balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iffbcd4e4e0a0426389360304851d8b90_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS0xLTEtMS0w_b929810e-2731-4b8a-9cae-0c843e2ec3d2">44,392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i75fb9f2f9ab743cf99a74ffa394e0fec_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS0zLTEtMS0w_7843c2d6-a2d2-4ad6-b706-02865acab641">52,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id1a933469e6c4f0286ea390dbb12759b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS01LTEtMS0w_d3381293-3691-45e3-87bf-bf883e0cca5a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id1675ea82d0e47b5b55f50b716c600eb_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS03LTEtMS0w_640b0232-d069-45b8-869e-34e8a3ead104">97,162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beginning balance &#8211; January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic5366f919647449e93ab9253d4a29029_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy0xLTEtMS0w_6965924d-74ea-4b50-b1a9-1af47ebfa8a7">27,113</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idc32baf86d3348b285ed6d9464919955_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy0zLTEtMS0w_2751d707-b1c7-4ac4-817e-114f11d52e71">67,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5986db8246ee4f9890cb846fcee620bd_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy01LTEtMS0w_c385aa17-e302-4041-994c-7fd9a281a91e">179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4a52e4d931ab42eca6b2d9fca0916150_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy03LTEtMS0w_24ad2f7e-e2e8-4dc1-beb6-b8f427350983">94,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC0xLTEtMS0w_2808dbf8-9961-4345-8602-0fe08f18c8fe">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC0zLTEtMS0w_2747d278-31c4-4f0b-a479-1d038150a5d2">72,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if57f220101a04dd081ed073252446f8d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC01LTEtMS0w_97931022-067c-45c0-932a-f35d0530bc86">3,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC03LTEtMS0w_91fcb418-7225-48b1-bcfe-0f66ce94d21f">74,052</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS0xLTEtMS0w_221e842b-e57c-43d3-86cb-cd25409bb622">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS0zLTEtMS0w_7263e629-fc3c-4904-b511-75e7bd82bd18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if57f220101a04dd081ed073252446f8d_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS01LTEtMS0w_08a21325-84b1-4f81-a6d8-52228959175f">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS03LTEtMS0w_8dd5c3be-8c35-4943-81f9-780fdec28b4f">187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtMS0xLTEtMA_c5ca81eb-a3e0-4f19-9dba-7a2793cbc5b2">2,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtMy0xLTEtMA_1f51de9e-65a4-4847-b1d6-5e78427a7213">72,967</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if57f220101a04dd081ed073252446f8d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtNS0xLTEtMA_d5f0bab7-e69d-418c-8581-d4015ab24384">3,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtNy0xLTEtMA_b53cc5b4-f917-4f0e-8cb0-1adadf81e569">74,239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ending balance &#8211; March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i135a5815805f47c2b6d8423008b7e9eb_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtMS0xLTEtMA_0d00e92b-b5ea-42e7-8f18-d0a833328035">24,906</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i2d9d81991fa044a8b0e369740ca0e420_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtMy0xLTEtMA_02207b9b-5707-4e0d-b900-3b57acfd6406">140,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iff5bb92468604878bf5c2ea5357d059a_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtNS0xLTEtMA_52ab61fb-45c9-4018-b9ff-70b9d27917fe">3,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i350dd74321534f789de5af89b9350730_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtNy0xLTEtMA_2387b49e-60ba-4888-8e62-a5ad242ead7e">168,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">For defined benefit pension plans, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#8220;Other income, net&#8221; within the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">For interest rate swaps, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#8220;Interest expense, net&#8221; within the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div></ix:nonNumeric></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_79"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzNw_3705cd2d-4049-400d-bcd2-53578864af34" continuedAt="ia172fbc1654143cf9f077e6e086787fa" escape="true">Share-Based Compensation </ix:nonNumeric></span></div><ix:continuation id="ia172fbc1654143cf9f077e6e086787fa" continuedAt="i3d597ce3698b4991a8e68c1d203a352b"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-IPO Awards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock distributed in respect of pre-IPO Class&#160;B-1 time vesting units vests on a daily basis pro rata over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM5MA_4d42cb8b-4533-485f-a39a-6ad44b9c22bd">five</span>-year vesting period (<ix:nonFraction unitRef="number" contextRef="ia1332bd08855451b8303379ea937e071_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_03458937-cc60-4d8a-918e-726c3fff4048"><ix:nonFraction unitRef="number" contextRef="i49f9e92f97cb43e7a611be42d5d2b76d_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_15313445-4713-4632-bb08-448568d2b7d2"><ix:nonFraction unitRef="number" contextRef="ibfb0b3684d91465b91c4dbd708ec1220_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_a5c19888-bcc2-481e-a034-295dd716aa91"><ix:nonFraction unitRef="number" contextRef="i3d8961e3c6584f708b88ef82ee1078c5_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_bf82957a-e3cb-4a56-acb3-44b441f26487"><ix:nonFraction unitRef="number" contextRef="ie79c75277ecb4c438785f138186141d9_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_d5f89889-10e4-428f-ad58-ba26839c9474">20</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>% per year) beginning on the original vesting commencement date of the corresponding Class B-1 time vesting units, subject to the grantee&#8217;s continued services through each vesting date. Upon the occurrence of a change in control of the Company, all then outstanding unvested shares of our common stock distributed in respect of Class&#160;B-1 Units will become vested as of the date of consummation of such change in control, subject to the grantee&#8217;s continued services through the consummation of the change in control.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock distributed in respect of pre-IPO Class&#160;B-2 Units (which were considered performance vesting units) are scheduled to vest only upon satisfaction of certain thresholds. These units generally vest as of the first date on which (i) our Sponsors have received actual cash proceeds in an amount equal to or in excess of at least two and one-half times their invested capital in Sotera Health Topco Parent, L.P. (of which the Company was a direct wholly owned subsidiary prior to the IPO) and (ii) the Sponsors&#8217; internal rate of return exceeds twenty percent, subject to such grantee&#8217;s continued services through such date. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i3d597ce3698b4991a8e68c1d203a352b" continuedAt="ifa0d581ab878405e9ec2d4f234c491d9"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a change in control of the Company, any outstanding shares of our common stock distributed in respect of Class B-2 Units that remain unvested immediately following the consummation of such a change in control of the Company shall be immediately canceled and forfeited without compensation. Stock based compensation expense attributed to the pre-IPO Class B-2 awards was recorded in the fourth quarter of 2020 as the related performance conditions were considered probable of achievement and the implied service conditions were met. As of March&#160;31, 2021, these awards remain unvested.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $<ix:nonFraction unitRef="usd" contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMzU2OA_88e3a50a-8500-4c3f-baee-744b7caf375c">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iec0fe360fc5a4fb9be9d970dce929cff_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTY0OTI2NzQ0OTk4Nw_6cde2aea-a555-4c94-a0df-bf8f86279636">1.7</ix:nonFraction> million of share-based compensation expense related to the pre-IPO Class B-1 awards for the three months ended March&#160;31, 2021 and 2020, respectively.</span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM4MA_6d741eec-179e-49df-a074-1aad029d0276" continuedAt="i81e2ecb696084e61be1e19e193b2ad9a" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity for the three months ended March&#160;31, 2021 related to the restricted stock awards distributed to the Company service providers in respect of the pre-IPO awards (Class&#160;B-1 and B-2 Units) is presented below: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Restricted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock - Pre-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IPO B-1</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Restricted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock - Pre-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IPO B-2</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i532429720d76464fb288ef6d7f8c4da4_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMS0xLTEtMS0w_dbfdf133-b22b-4ea8-8bfd-d36ebe6f54aa">2,201,239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if4e8d0ee307f4202ba503e68eb22522d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMS0zLTEtMS0w_be2280f6-e550-4717-bfa4-5a3e7c5729ed">2,323,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMy0xLTEtMS0w_1a06020d-d6c2-46e0-8c1f-c5555404a2ad">43,361</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i0ab86e4b989f417494880063f915dc6d_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMy0zLTEtMS0w_d185dc96-3f44-47a1-8da1-41260e17126c">254,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNC0xLTEtMS0w_fc9e6c25-015b-4059-82cd-1bcd37dbb0bf">228,862</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0ab86e4b989f417494880063f915dc6d_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNC0zLTEtMS0w_9945e01e-6e2f-4533-b274-5d33977b7344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unvested at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie9467f5d115d4bd28878ee4c52ac8b6c_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNS0xLTEtMS0w_6acabc88-b358-45c7-9e38-2a272dfd88e2">1,929,016</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i829eb019c2384385949420c934d9650c_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNS0zLTEtMS0w_50923e88-ffd9-4f39-822a-ad929d094b9f">2,068,494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Omnibus Incentive Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a long-term incentive plan (the &#8220;2020 Omnibus Incentive Plan&#8221; or the &#8220;2020 Plan&#8221;) that allows for grants of incentive stock options to employees (including employees of any of our subsidiaries), nonstatutory stock options, restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;) and other cash-based, equity-based or equity-related awards to employees, directors, and consultants, including employees or consultants of our subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $<ix:nonFraction unitRef="usd" contextRef="ifbd8b853840d4d58a44be8b4f396efe6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNTI0NA_022dd116-3496-4cfb-a9c0-8e6355f0395d">2.8</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i72ebc9f42a97466cbcc112179091d11f_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNTI0OA_16be5faf-d7ac-494b-b67e-2b87e2af1f11">1.3</ix:nonFraction> million for stock options and $<ix:nonFraction unitRef="usd" contextRef="ib4973995a8b649188261f6b9eb660a4a_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNTI3Mw_10612752-4707-40e2-a4a2-0f07608fc5da">1.5</ix:nonFraction> million for RSUs) of share-based compensation expense for these awards in our Consolidated Statements of Operations and Comprehensive Income (Loss), in &#8220;Selling, general and administrative expenses,&#8221; for the three months ended March&#160;31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzOA_90568ab0-c98d-42fa-bc3b-4bb90feeb83b">four</span>-year vesting period, an exercise price equal to the fair market value of a share of common stock on the date of grant, and a contractual term of <ix:nonNumeric contextRef="icf6ab0133fd241ab95e886992abdac00_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNjIwNw_1ae22d4e-77d2-4e09-80d4-484f6fb01ec0">10</ix:nonNumeric> years. <ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM0OQ_8bb4fd6c-c008-4631-a695-00e801592d92" continuedAt="ia4768c8e49a84d69bd7e0f78294f15a1" escape="true">The following table summarizes our stock option activity:</ix:nonNumeric></span></div><div style="margin-top:6pt"><ix:continuation id="ia4768c8e49a84d69bd7e0f78294f15a1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMS0xLTEtMS0w_7f486826-aae9-4051-9d27-f7ddd9f0d1ff">2,389,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMS0zLTEtMS0w_67d4dc97-d0d5-4e97-a072-9218759b94ed">23.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMi0xLTEtMS0w_fb7615cc-6c1e-49c0-9bbd-b513b099b9b6">20,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMi0zLTEtMS0w_6e146da2-18f3-4d61-ad69-dbeec673629b">26.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMy0xLTEtMS0w_3a69e7b8-749d-489a-ad39-cdf192e1cf86">9,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMy0zLTEtMS0w_f47e1050-b196-4819-9619-219a7f9f4973">23.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNC0xLTEtMS0w_a4b11136-a414-419e-99ea-2a89a9facf60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNC0zLTEtMS0w_ad867203-72b8-4a77-87df-825e3a4bb949">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNS0xLTEtMS0w_84ca0c0f-d8ee-4b98-aca8-0e75723c8d5d">2,400,349</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNS0zLTEtMS0w_1183cacb-718d-47b6-85e3-460bc694414a">23.03</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="ifa0d581ab878405e9ec2d4f234c491d9"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs generally vest ratably over a period of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM1Mg_eccb5a8b-a643-47c5-b42e-caa40b675d70">one</span> to <ix:nonNumeric contextRef="iea1bdce9661f4df4b25f0d61185bc957_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM2Mg_a3acca41-10e4-4952-bb49-d5c347833a94">four years</ix:nonNumeric> and are valued based on our market price on the date of grant. <ix:continuation id="i81e2ecb696084e61be1e19e193b2ad9a" continuedAt="i50a5d37d8e104c50b55020e2b09ca536">The following table summarizes our unvested RSUs activity:</ix:continuation></span></div><div style="margin-top:6pt"><ix:continuation id="i50a5d37d8e104c50b55020e2b09ca536"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">average Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date Fair </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id702121c7c324bf6885a6bf80cae7fe4_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMS0xLTEtMS0w_c5a76d8c-27cd-4c4a-a684-3dd09c06522c">771,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="id702121c7c324bf6885a6bf80cae7fe4_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMS0zLTEtMS0w_d907e922-b82f-403b-b41d-4e2d09e3cf4f">23.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMi0xLTEtMS0w_f72ad27c-a6e3-4dd9-a02e-7598b55cc8cc">10,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMi0zLTEtMS0w_84fa78f6-dc79-4176-8a5a-54d4486755d9">26.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMy0xLTEtMS0w_40bc4eb3-6df6-4c9d-901d-bbe7a226f6e2">24,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMy0zLTEtMS0w_010cc339-b735-46d0-a250-aca5ddcf310a">23.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNC0xLTEtMS0w_93ccdee1-4f77-465d-8034-b08dc679833d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNC0zLTEtMS0w_d632ce0b-8841-4585-9740-e8f4b80a9fda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unvested at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if2bd407df76c4d14a849c52897796383_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNS0xLTEtMS0w_763d813b-e3a4-417a-a1e0-717e6db3291a">757,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2bd407df76c4d14a849c52897796383_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNS0zLTEtMS0w_bd09bbc0-7899-42ff-b218-5704ac56fbaa">23.05</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_82"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMjc0ODc3OTA3NDM5Mg_2a9bbfab-a65e-4f45-8451-6f706e917b69" continuedAt="i53ca91f53eee46b8a7cb668d809f1198" escape="true">Earnings (Loss) Per Share </ix:nonNumeric></span></div><ix:continuation id="i53ca91f53eee46b8a7cb668d809f1198"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per share represents the amount of income (loss) attributable to each common share outstanding. Diluted earnings (loss) per share represents the amount of income (loss) attributable to each common share outstanding adjusted for the effects of potentially dilutive common shares. Potentially dilutive common shares include stock options and other stock-based awards. In the periods where the effect would be antidilutive, potentially dilutive common shares are excluded from the calculation of diluted earnings per share. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In periods in which the Company has net income, earnings per share is calculated using the two-class method. This method is required as unvested restricted stock distributed in respect of pre-IPO Class&#160;B-1 and B-2 awards have the right to receive non-forfeitable dividends or dividend equivalents if the Company were to declare dividends on its common stock. Pursuant to the two-class method, earnings for each period are allocated on a pro-rata basis to common stockholders and unvested pre-IPO Class B-1 and B-2 restricted stock awards. Diluted earnings per share is computed using the more dilutive of (a) the two-class method, or (b) treasury stock method, as applicable, to the potentially dilutive instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In periods in which the Company has a net loss, the two-class method is not applicable because the pre-IPO Class B-1 and B-2 restricted stock awards do not participate in losses. </span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMjc0ODc3OTA3NDM5Mw_740a260a-b052-443b-a8e2-5e832b509868" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted earnings per common share are calculated as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">in thousands of U.S. dollars and share amounts (except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMy0xLTEtMS0w_83f5e39e-9f37-4c25-b7be-96cdbe785953">11,065</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMy0zLTEtMS0w_1b61503c-b71e-4d60-a924-2a2321663593">1,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Net income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNC0xLTEtMS0w_226aa2a4-0f09-4a36-86d3-100e657f03e3">223</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNC0zLTEtMS0w_4ee5d25d-4b65-4837-8bdb-f387d6dc31fb">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Allocation to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0yOTY0_b0364c75-321d-4d2d-bd06-5b034a24a311"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0yOTY0_e64e5ddb-9a80-41f2-b00b-0ebe2fab1c06">157</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0yOTY0_b65e3aea-9468-4fab-9591-6f356c8efc24"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0yOTY0_ca2f5673-98c0-43d4-aba6-bfdf370e7861">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0w_4fb58360-11bb-4ea3-ac40-9192104bcb87"><ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0w_b32c94a1-f949-4140-9a12-f614068c09ce">10,685</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0w_0eab2609-cfac-4a93-a0b7-a29fd630b9c4"><ix:nonFraction unitRef="usd" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0w_2b9b77b2-2bb3-4603-bb7b-aaf420a5e826">1,964</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Common Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.52pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average common shares outstanding - basic</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNy0xLTEtMS0w_0c018816-30ae-4225-830e-77bf368ac3f2">278,827</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNy0zLTEtMS0w_2042abf1-203a-4faf-a7c5-385d1b8c669c">232,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0xLTEtMS01MTc5_dda2137d-7362-4979-af45-0cf92a112d21">141</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0zLTEtMS01MTgz_4aebb884-f1bc-464a-8692-b380dea2c70b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average common shares outstanding - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOC0xLTEtMS0xMjU3_0556ef6c-ec9d-4c51-aa77-5442d14b129f">278,968</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOC0zLTEtMS0xMjU3_72359990-bf9e-4f6e-b01c-5ecfca03cce4">232,400</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (loss) per Common Share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMTAtMS0xLTEtMTI1MQ_64ea2fcf-098d-4aba-b914-b7648572c533">0.04</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMTAtMy0xLTEtMTI1MQ_ac3ad191-6636-4420-89b5-befe2effdac0">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0xLTEtMS0w_b8b1039a-e990-41dd-9e96-fe9498092ba6">0.04</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0zLTEtMS0w_efe2082f-9afe-428a-9a09-fadc99e90cfd">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.57pt">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">n additional <ix:nonFraction unitRef="shares" contextRef="i72ebc9f42a97466cbcc112179091d11f_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMTY0OTI2NzQ0NzY3MQ_7f3deb97-446c-4c5d-b844-29318e1c6fbc">2,400,349</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib4973995a8b649188261f6b9eb660a4a_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMTY0OTI2NzQ1MjEwMA_2314afde-0436-429d-a54c-d13b77e9768f">3,645</ix:nonFraction> equivalent shares related to stock options and RSUs, respectively, issued in connection with the 2020 Omnibus Incentive Plan were excluded from the calculation of diluted weighted average common shares outstanding for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">the three months ended March&#160;31, 2021 as they were anti-dilutive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. For the three months ended March&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMjc0ODc3OTA3OTc4NA_fac094c3-4730-4dbc-a7d7-c47743c1c263">no</ix:nonFraction> potentially dilutive common shares outstanding.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">21</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_85"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE1OA_cf4ab607-63ff-4066-9632-e042aa8ee439" continuedAt="i483541f5eba04b5aa5d7928a9d5a72ad" escape="true">Commitments and Contingencies </ix:nonNumeric></span></div><ix:continuation id="i483541f5eba04b5aa5d7928a9d5a72ad" continuedAt="i4e19417c9796447db390135fbc101208"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to various lawsuits and other claims in the ordinary course of our business. In addition, from time to time, we receive communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which we operate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We establish reserves for specific liabilities in connection with regulatory and legal actions that we determine to be both probable and reasonably estimable. No material amounts have been accrued in our consolidated financial statements with respect to any loss contingencies. In certain of the matters described below, we are not able to make a reasonable estimate of any liability because of the uncertainties related to the outcome and/or the amount or range of loss. While it is not possible to determine the ultimate disposition of each of these matters, we do not expect that the ultimate resolution of pending regulatory and legal matters in future periods, including the matters described below, will have a material effect on our financial condition or results of operations. Despite the above, the Company may incur material defense and settlement costs, diversion of management resources and other adverse effects on our business, financial condition, or results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FM Global Business Interruption Claim (NRU Outage) </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion, due to the shutdown of AECL&#8217;s NRU reactor in 2009, suffered a cessation of supply of radioisotopes and business interruption loss. Nordion, by Statement of Claim dated October&#160;22, 2010, issued in Ontario Superior Court an action against the insurer, Factory Mutual Insurance Company (FM Global), claiming $<ix:nonFraction unitRef="usd" contextRef="if00ab087eb4046b2a954c121dda0b128_D20101022-20101022" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjU3NQ_a059b2b8-8fcc-476f-bdd2-3cf6423f5ee5">25.0</ix:nonFraction> million USD in losses resulting from the shutdown of AECL&#8217;s reactor and its inability to supply radioisotopes through the specified period of approximately <ix:nonNumeric contextRef="if00ab087eb4046b2a954c121dda0b128_D20101022-20101022" format="ixt-sec:durmonth" name="shc:GainContingencyPeriodOfBusinessInterruption" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyNzI2OA_f4a6e073-fff2-4209-8df0-4288cd2935db">15</ix:nonNumeric> months. FM Global objected to Nordion&#8217;s claim. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trial commenced in March 2019 and was completed in September 2019. On March&#160;30, 2020, Nordion received a favorable judgment in the amount of $<ix:nonFraction unitRef="usd" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="-5" format="ixt:numdotdecimal" name="shc:LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjU5Mg_0e072ec9-b4f2-42fe-9eba-027c3403f33a">25.0</ix:nonFraction> million USD, plus pre-judgment interest, for a total judgment value of $<ix:nonFraction unitRef="usd" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjYxMg_80782395-1452-492c-8ce7-e55f1da10fd2">39.8</ix:nonFraction> million USD, or $<ix:nonFraction unitRef="cad" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjYzMg_c5dc3878-5426-4f7b-8329-714803447e92">56.4</ix:nonFraction> million CAD based on exchange rates approved by the trial court. In addition, costs and disbursements have been assessed and awarded by the trial court in favor of Nordion in the approximate amount of $<ix:nonFraction unitRef="cad" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="-5" format="ixt:numdotdecimal" name="shc:LitigationSettlementCostsAssessedAndAwardedInFavor" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY1MQ_27d4408d-aba4-4dc7-b21b-a120b15d53f2">1.1</ix:nonFraction> million CAD ($<ix:nonFraction unitRef="usd" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="-5" format="ixt:numdotdecimal" name="shc:LitigationSettlementCostsAssessedAndAwardedInFavor" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY2Ng_842fd102-5388-49ef-a310-ee93ff7135b1">0.8</ix:nonFraction> million USD) and $<ix:nonFraction unitRef="cad" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="0" format="ixt:numdotdecimal" name="shc:LitigationSettlementDisbursementsAssessedAndAwardedInFavor" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY3Ng_255de896-0ced-48c9-8bf9-2bd66822aa87">161,863</ix:nonFraction> CAD ($<ix:nonFraction unitRef="usd" contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330" decimals="-5" format="ixt:numdotdecimal" name="shc:LitigationSettlementDisbursementsAssessedAndAwardedInFavor" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY5MQ_d12c189f-cb50-4671-aa48-19786c46af37">0.1</ix:nonFraction> million USD), respectively. On April&#160;27, 2020, FM Global appealed the judgment. In January 2021, The Insurance Bureau of Canada was granted leave to intervene in the appeal. Hearing before the Court of Appeal was held on April 15, 2021. Pending a favorable judgment in the appellate court, any final proceeds would be subject to post judgment interest, a contingent fee owed to legal counsel and applicable taxes. As the judgment is considered a contingent gain, any favorable outcome will be recognized in a future period when all appeals are exhausted. It is anticipated that the overall appeal process could take a year or more to complete. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Willowbrook, Illinois &#8211; Government Litigation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 30, 2018, the Illinois Attorney General and the State&#8217;s Attorney of DuPage County, Illinois, sued Sterigenics U.S., LLC (the &#8220;IAG Action&#8221;), alleging that authorized EO air emissions from a commercial sterilization facility Sterigenics formerly operated in Willowbrook, Illinois &#8220;cause, threaten, or allow air pollution&#8221; in violation of the Illinois Environmental Protection Act. The IAG Action did not assert that Sterigenics violated its permit from the Illinois Environmental Protection Agency (&#8220;IEPA&#8221;) authorizing Sterigenics&#8217; release of regulated levels of EO at the Willowbrook facility.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2019, the acting IEPA director, John Kim, issued a &#8220;Seal Order&#8221; effectively precluding Sterigenics&#8217; operations at the Willowbrook facility based on many of the same allegations asserted in the IAG Action. Sterigenics disputed those allegations and opposed the IEPA&#8217;s Seal Order. The Seal Order was resolved by a Consent Order entered on September 6, 2019. The Consent Order provided that Sterigenics did not admit the allegations of the IAG Action, provided for the removal of the Seal Order and allowed the Willowbrook facility to reopen upon implementation of supplemental emissions control measures consistent with a new law that became effective in Illinois in June 2019 and an IEPA permit, which the IEPA approved in September 2019. Following entry of the Consent Order, the Seal Order was withdrawn.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, Sterigenics announced the closure of the Willowbrook facility due to the inability to reach an agreement with its landlord to renew the facility&#8217;s lease and the unstable legislative and regulatory landscape in Illinois. Sterigenics is in the process of decommissioning the facility and completing the work required by the terms of its lease to return the property to the landlord.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i4e19417c9796447db390135fbc101208" continuedAt="i378cf9e5726546d8a51bc02c369d0bb1"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2020 Sterigenics, the Illinois Attorney General and the State&#8217;s Attorney of DuPage County filed a Joint Motion to Terminate Consent Order, stating that the community projects which Sterigenics voluntarily agreed to fund have been completed and funded as required by the Consent Order, and that Sterigenics has permanently ceased operations and surrendered all permits for its operations in Willowbrook, Illinois. On October 27, 2020 the DuPage County Circuit Court entered the Agreed Order Terminating Consent Order.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethylene Oxide Tort Litigation - Illinois</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since September 2018, tort lawsuits on behalf of approximately <ix:nonFraction unitRef="plaintiff" contextRef="i3056567d4b7944ee83f117f290349ae0_D20180901-20210331" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjcxNA_bff504b6-71e0-45e2-bb48-7029d4e4136f">835</ix:nonFraction> personal injury plaintiffs (which are further described in the following paragraphs) have been filed in Illinois state courts against Sotera Health LLC, Sterigenics U.S., LLC, GTCR, LLC and other parties related to Sterigenics&#8217; Willowbrook, Illinois operations. Specifically, those plaintiffs allege that they suffered personal injuries including cancer and other diseases, or wrongful death, resulting from purported emissions and releases of EO from the Willowbrook facility. Additional derivative claims are alleged on behalf of other individuals related to these personal injury plaintiffs. Plaintiffs seek damages in an amount to be determined by the trier of fact. Sterigenics denies these allegations and intends to vigorously defend against these claims. Plaintiffs have voluntarily dismissed without prejudice a number of cases since September 2018, including certain individual cases alleging personal injuries and <ix:nonFraction unitRef="claim" contextRef="i2b7ab3687cab4a8e81d2d673d039bf1b_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyClaimsDismissedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE1OQ_737f62c6-eb5a-41d7-aef2-c6a5acb58e48">two</ix:nonFraction> class actions seeking damages for alleged diminution of property values.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics sought consolidation of the cases for pretrial purposes, and in October 2019 obtained an order consolidating the then-pending cases and related cases filed in the future before Judge Lawler in the Cook County Circuit Court, Illinois (the &#8220;Consolidated Case&#8221;). All plaintiffs in the Consolidated Case filed a single Master Complaint on October 24, 2019 by which Sotera Health LLC was added as a co-defendant, followed by a First Amended Master Complaint on January 31, 2020. On April 28, 2020, the defendants filed motions to dismiss the claims in the First Amended Master Complaint. On August 17, 2020, the Court entered an order largely denying the motions to dismiss, and the same day plaintiffs filed a Second Amended Master Complaint.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs filed a Third Amended Master Complaint on October 30, 2020 adding Griffith Foods Group, Inc., Griffith Foods, Inc., Griffith Foods International, Inc. and Griffith Foods Worldwide Inc. as defendants. Defendants&#8217; responses to the Third Amended Master Complaint were filed on or about December 1, 2020, including a motion to dismiss by Griffith Foods Group, Inc., Griffith Foods, Inc., Griffith Foods International, Inc. and Griffith Foods Worldwide, Inc. That motion was granted in part on March 16, 2021 and plaintiffs were granted leave to file a Fourth Amended Master Complaint. The Fourth Amended Master Complaint was filed on April 16, 2021, including claims against Griffith Foods International, Inc. but not the other Griffith entities. All defendants&#8217; responses to the Fourth Amended Master Complaint are due by May 14, 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written and deposition fact discovery is on-going in the Consolidated Case. Currently, there are no dates set for the close of fact discovery, for expert discovery or for dispositive motion practice. Plaintiffs have not yet made any specific damages claims.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials in five of the individual cases now included in the Consolidated Case had previously been scheduled to begin in 2021. Based on the Court's administrative orders related to the impact of COVID-19 on jury trials, however, and subject to the Court's discretion to make changes, we anticipate that the earliest any of the individual cases in the Consolidated Case will be tried will be 2022 and that trials will be scheduled in roughly the order in which the individual cases were filed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethylene Oxide Tort Litigation &#8211; Georgia </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2020, a lawsuit against Sotera Health LLC, Sterigenics U.S., LLC and other parties was filed in the State Court of Cobb County, Georgia by <ix:nonFraction unitRef="plaintiff" contextRef="i4f11af9e3301403b98a762a3a5ca629e_D20200519-20200519" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjcxOQ_bb404770-1713-4c26-83a5-885831917fe9">53</ix:nonFraction> employees of a contract sterilization customer of Sterigenics. In the operative complaint, Plaintiffs claim personal injuries resulting from alleged exposure to residual EO while working at the customer&#8217;s distribution center in Lithia Springs, Georgia, allege they were unaware that they were being exposed to EO in their workplace and seek damages in an amount to be determined by the trier of fact. Defendants filed motions to dismiss and answers to the Complaint on April 30, 2021. All defendants are being defended and indemnified by Sterigenics&#8217; contract sterilization customer (plaintiffs&#8217; employer and a co-defendant in the lawsuit).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Cobb County, Georgia Board of Tax Assessors reduced certain residential property value assessments around the Sterigenics Atlanta facility by <ix:nonFraction unitRef="number" contextRef="ic2508d02cd384fa790ed8dda3ccb6e14_D20200501-20200531" decimals="1" name="shc:PercentOfReductionInResidentialPropertyValueAssessment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE3OA_7de6564e-17ca-4727-bd12-bf96f111457f">10</ix:nonFraction>% citing an &#8220;Epd-identified environmental issue,&#8221; without supporting market data. On </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i378cf9e5726546d8a51bc02c369d0bb1" continuedAt="i9bda00ea94d14d91abbad853fa51ff81"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 14, 2020, Sterigenics U.S., LLC filed a lawsuit against members of the Cobb County Board of Tax Assessors in the U.S. District Court for the Northern District of Georgia, seeking a declaration that the reduction in property value assessments is arbitrary and unlawful and is causing Sterigenics reputational and imminent economic harm. On February 5, 2021 the Court issued an order finding that Sterigenics lacks standing to obtain the relief sought and dismissed the case. Sterigenics has appealed that decision to the 11th Circuit Court of Appeals and anticipates that appellate briefing will be completed before the end of August 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since August 17, 2020, <ix:nonFraction unitRef="claim" contextRef="i13271ac323454d0599f0910fc46fbaee_D20200817-20200817" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE2OA_11de67a9-e14b-43ef-8aa8-d0f030758a56">six</ix:nonFraction> lawsuits against Sotera Health LLC, Sterigenics U.S., LLC and other parties have been filed by plaintiffs in the State Court of Cobb County, Georgia and the State Court of Gwinnett County, Georgia in which plaintiffs allege that they suffered personal injuries and loss of consortium resulting from emissions and releases of EO from Sterigenics&#8217; Atlanta facility. Our subsidiaries are also defendants in lawsuits alleging that the Atlanta facility has devalued and harmed plaintiffs&#8217; use of real properties they own in Smyrna, Georgia and caused other damages. Plaintiffs in these cases seek various forms of relief including damages in amounts to be determined by the trier of fact. Sotera Health LLC filed motions to dismiss in each case on personal jurisdiction grounds. That motion was denied in one case pending in the State Court of Gwinnett County and the other motions remain pending. Sterigenics U.S., LLC and Sotera Health LLC filed a motion to dismiss the strict liability claim in each case. That motion was denied in one case pending in the State Court of Gwinnett County and the other motions remain pending. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Suspension of Georgia Facility Operations&#160;&amp; Related Litigation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2019, Sterigenics U.S., LLC entered into a voluntary Consent Order with the Georgia Environmental Protection Division (&#8220;EPD&#8221;) under which Sterigenics agreed to install emissions reduction enhancements at its Atlanta facility to further reduce the facility&#8217;s EO emissions below already permitted levels. Sterigenics voluntarily suspended operations at the facility in early September 2019 to expedite completion of the enhancements. Installation of these enhancements is complete, and Sterigenics successfully tested the enhanced emissions controls in cooperation with EPD during the second quarter of 2020 while the facility was in operation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, while Sterigenics had voluntarily suspended the facility&#8217;s operations, Cobb County, Georgia officials asserted that the facility had an incorrect &#8220;certificate of occupancy&#8221; and could not resume operations without obtaining a new certificate of occupancy after a third-party code compliance review they required.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the Cobb County officials would not allow Sterigenics to resume operations, on March 30, 2020, Sterigenics U.S., LLC filed a lawsuit in the United States District Court for the Northern District of Georgia against Cobb County, Georgia and Cobb County officials Nicholas Dawe and Kevin Gobble. In the lawsuit, Sterigenics sought immediate injunctive relief and permanent declaratory relief to resume normal operations of the Atlanta facility in the interest of public health and on the basis that the positions asserted by Cobb County were unfounded. On April 1, 2020 the Court entered a Temporary Restraining Order prohibiting Cobb County officials from precluding or interfering with the facility&#8217;s normal operations. On April 8, 2020, the Court entered a Consent Order extending the Temporary Restraining Order and allowing the facility to continue normal operations until entry of a final judgment in the case. Defendants filed a motion to dismiss the claims. On November 9, 2020, the Court held a hearing and denied the motion to dismiss. The parties are conducting discovery, which is presently scheduled to end on July 23, 2021. A settlement conference is scheduled to be held by September 27, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethylene Oxide Litigation &#8211; New Mexico</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020 the New Mexico Attorney General filed a lawsuit in the Third Judicial District Court, Do&#241;a Ana County, New Mexico (&#8220;the Third Judicial District&#8221;) against the Company, Sterigenics U.S., LLC and other subsidiaries alleging that emissions of EO from Sterigenics U.S., LLC&#8217;s sterilization facility in Santa Teresa, New Mexico constitute a public nuisance and have deteriorated the air quality in Santa Teresa and surrounding communities and materially contributed to increased health risks suffered by residents of those communities. The Complaint asserts claims for public nuisance, negligence, strict liability, violations of New Mexico&#8217;s Public Nuisance Statute and Unfair Practices Act and a request for a temporary restraining order and preliminary injunctive relief. On December 28, 2020 Sterigenics U.S., LLC removed the case to the United States District Court for the District of New Mexico. On April 13, 2021 the case was remanded to the Third Judicial District where Plaintiff&#8217;s Emergency Motion for Temporary Restraining Order and Preliminary Injunction has been scheduled for a preliminary injunction hearing on May 26, 2021.  </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i9bda00ea94d14d91abbad853fa51ff81"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Emergency Motion does not demand facility closure but seeks an order requiring Defendants to cease any and all uncontrolled emissions or releases of EO from the Santa Teresa facility, including by making certain modifications to sterilization processes at the facility.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry insurance for alleged environmental liabilities (including litigation like that pending in Illinois, Georgia and New Mexico described above), with limits of $<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="shc:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTc4Nzc_d30869a9-47f5-4f66-944b-f72f27ca9e01">10.0</ix:nonFraction> million per occurrence and $<ix:nonFraction unitRef="usd" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTc4OTk_9063d534-38e2-4b16-bef1-ca2c9c0e44de">20.0</ix:nonFraction> million in the aggregate. The per occurrence limit related to the Willowbrook government and EO tort litigation was fully utilized by June 30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional personal injury, property devaluation or other lawsuits may be filed in the future against us or our subsidiaries relating to Sterigenics&#8217; Willowbrook, Atlanta, Santa Teresa or other EO sterilization facilities. The Company, Sterigenics U.S., LLC and other Company subsidiaries intend to defend themselves vigorously in all such current or future EO litigation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While an adverse outcome in one or more of the proceedings could have a material adverse effect on our business, financial condition and results of operations, no contingency reserve has been reflected in our consolidated financial statements as a loss is not deemed probable, nor is a loss or range of losses reasonably estimable.</span></div></ix:continuation><div id="i15ef643796c34829b3bb28475338f021_88"></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDk0NzgwMjMzNTA1MA_2a289796-f876-43fc-b2c9-269c80461613" continuedAt="i225e2583b24443c6b70886d3ecc70053" escape="true">Financial Instruments and Financial Risk </ix:nonNumeric></span></div><ix:continuation id="i225e2583b24443c6b70886d3ecc70053" continuedAt="ief60d6cd73c24d8c99d32483519880f3"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not use derivatives for trading or speculative purposes and are not a party to leveraged derivatives. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated in Hedge Relationships</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, we entered into <ix:nonFraction unitRef="instrument" contextRef="if41011b61b2c455085406c4d35f4b029_I20190930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3Nzk4Mg_0b95f2ff-0730-46d9-a714-0475cd803e53">two</ix:nonFraction> interest rate swap agreements to hedge our exposure to interest rate movements and to manage interest expense related to our then outstanding variable-rate debt. The notional amount of the interest rate swap agreements totaled $<ix:nonFraction unitRef="usd" contextRef="i2c743685ac7e4b5eb6a0f423118724d0_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk2Mg_9cefcbd7-4ac8-4a18-baf7-0f92e120b9ab">1,000.0</ix:nonFraction> million. These swaps were designated as cash flow hedges and were designed to hedge the variability of cash flows attributable to changes in LIBOR, the benchmark interest rate being hedged. We received interest at one-month LIBOR and paid a fixed interest rate under the terms of the swap agreement. The swap agreements terminated on August&#160;31, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated in Hedge Relationships</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, we entered into <ix:nonFraction unitRef="instrument" contextRef="id7710cf9b27a47e0b0c8712ace4267e6_I20171031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3Nzk5MQ_f6c386d1-8203-4566-b7ce-9fc347519568">two</ix:nonFraction> interest rate cap agreements with a total notional amount of $<ix:nonFraction unitRef="usd" contextRef="ic2065da279504816835ffbc1e014f7ad_I20171031" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk2Ng_d81cca50-e286-43f6-be41-196815d75693">400.0</ix:nonFraction> million for a total option premium of $<ix:nonFraction unitRef="usd" contextRef="ic2065da279504816835ffbc1e014f7ad_I20171031" decimals="-5" format="ixt:numdotdecimal" name="shc:DerivativeOptionPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk3MA_df9d580c-1edb-44a8-a85c-7e2b5fc6e3be">0.6</ix:nonFraction> million; these agreements terminated on September 30, 2020. The interest rate caps limited the Company&#8217;s cash flow exposure related to LIBOR under the variable rate Term Loan borrowings to <ix:nonFraction unitRef="number" contextRef="ic2065da279504816835ffbc1e014f7ad_I20171031" decimals="INF" name="shc:PercentOfBorrowingLimitationDueToCashFlowExposure" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk5OQ_efff74ab-6412-4734-aa79-87ec37dc506f">3.0</ix:nonFraction>%. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, SHH entered into <ix:nonFraction unitRef="instrument" contextRef="ic08f77143efb4a438f9ac6fd9f28e16b_I20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAwMA_43ea22bb-af4b-41ad-b131-56470d00d494">two</ix:nonFraction> interest rate cap agreements with notional amounts of $<ix:nonFraction unitRef="usd" contextRef="id090514efde94317af113816c3ec1bce_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk4Nw_91a226e8-4add-4138-9ca6-eaafaac3d191">1,000.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i99e7214bafc64b91bd10fb6c344d92fa_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk4Mw_8cd24d66-7e94-4383-9402-52ea961e3963">500.0</ix:nonFraction> million, respectively, for a total option premium of $<ix:nonFraction unitRef="usd" contextRef="id090514efde94317af113816c3ec1bce_I20200630" decimals="-5" format="ixt:numdotdecimal" name="shc:DerivativeOptionPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk3NA_529855ec-13f6-4a10-a1a8-0c70be798b8e">0.3</ix:nonFraction> million. These instruments were initially scheduled to terminate on August 31, 2021 and February 28, 2022, respectively. The interest rate caps limit our cash flow exposure related to the LIBOR base rate under a portion of our variable rate borrowings to <ix:nonFraction unitRef="number" contextRef="idb744f485b224be28617f3aba1a1cd06_I20200630" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAwNA_584e2b48-1970-4115-a67a-794106a485ec">1.0</ix:nonFraction>%. In February 2021, we amended the <ix:nonFraction unitRef="instrument" contextRef="i57dad9620c47433bb1a2a45a38b824b2_I20210228" decimals="INF" format="ixt-sec:numwordsen" name="shc:DerivativeNumberOfInstrumentsAmended" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODE1NQ_981666d7-eaa8-400b-8fdb-c108c5c806d8">two</ix:nonFraction> interest rate cap agreements referenced above to reduce the strike rate from <ix:nonFraction unitRef="number" contextRef="idb744f485b224be28617f3aba1a1cd06_I20200630" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAwOQ_584e2b48-1970-4115-a67a-794106a485ec">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i93e757215c724df1b4b2dbead002a317_I20210228" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAxMw_c6e8899d-2418-477a-a855-69332dc9d156">0.5</ix:nonFraction>%, and extend the termination date of the $<ix:nonFraction unitRef="usd" contextRef="i2c743685ac7e4b5eb6a0f423118724d0_I20190930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAxNw_9cefcbd7-4ac8-4a18-baf7-0f92e120b9ab">1,000.0</ix:nonFraction> million notional cap to September 30, 2021. Premiums paid to amend the interest rate caps were immaterial. We also entered into <ix:nonFraction unitRef="instrument" contextRef="ie9939ca2be9548b480d25f00cfea7cb9_I20210228" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAxMA_b005cf02-f057-466f-91b5-bcd2f6df5a8c">two</ix:nonFraction> additional interest rate cap agreements in February 2021 with a combined notional amount of $<ix:nonFraction unitRef="usd" contextRef="ie9939ca2be9548b480d25f00cfea7cb9_I20210228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAyNQ_16eaf7fa-548e-407e-92d4-f477a7d08882">1,000.0</ix:nonFraction> million, for a total option premium of $<ix:nonFraction unitRef="usd" contextRef="ie9939ca2be9548b480d25f00cfea7cb9_I20210228" decimals="-5" format="ixt:numdotdecimal" name="shc:DerivativeOptionPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAyOQ_bcecb229-a1d2-4021-a8bc-f6c1fa86e335">0.4</ix:nonFraction> million. These instruments are effective September 30, 2021, and will terminate on March 31, 2022. The amended and new interest rate caps limit our cash flow exposure related to LIBOR under a portion of our variable rate borrowings to <ix:nonFraction unitRef="number" contextRef="ie796349e2806499cb940f14083d11104_I20210930" decimals="INF" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDk0NzgwMjMzNTA0NQ_941b590b-5824-40f9-ad95-922e78470fce">0.5</ix:nonFraction>%. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate caps were entered into to manage economic risks associated with our variable rate borrowings, but were not designated in hedge relationships. These instruments are recorded at fair value on the Consolidated Balance Sheets, with any changes in the value being recorded in &#8220;Interest expense, net&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="ief60d6cd73c24d8c99d32483519880f3" continuedAt="ie2a1560ec42e49afa85941de53a0f79b"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also entered into foreign currency forward contracts to manage foreign currency exchange rate risk of our intercompany loans in certain of our international subsidiaries. The foreign currency forward contracts expire on a monthly basis. The fair value of the outstanding foreign currency forward contracts was <ix:nonFraction unitRef="usd" contextRef="if6debae2625842d3aea289304287b04a_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMzAxNA_238f2ca6-a9f1-4e76-9e7b-9b86b3fe2d98"><ix:nonFraction unitRef="usd" contextRef="i36a4d4ea180d473791afd4e893e822ca_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMzAxNA_f918a87d-e9b8-4609-8a1f-39b29618c273">zero</ix:nonFraction></ix:nonFraction> as of March&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have embedded derivatives in certain of our customer and supply contracts as a result of the currency of the contract being different from the functional currency of the parties involved. Changes in the fair value of the embedded derivatives are recognized in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAxOA_11ec22bc-d2aa-4c93-a258-14ed39f14468" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the notional and fair values of our derivative instruments: </span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(in U.S. Dollars; notional in millions, fair value in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notional<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notional<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9b0c33e7ec9945079c2630ef261167c1_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi0xLTEtMS0w_7fa6f686-d307-4bd8-816c-b4d96f832eca">2,500.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9b0c33e7ec9945079c2630ef261167c1_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi0zLTEtMS0w_e21e047e-b182-4741-acc1-cba0b717ec69">9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9b0c33e7ec9945079c2630ef261167c1_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi01LTEtMS0w_9adf6474-cb91-4f1c-8db8-1a43c6673e9d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i55ed0869e08f4f768909753e2657522f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi03LTEtMS0w_11ab2030-c2ab-4960-b3bf-6955538f1383">1,500.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i55ed0869e08f4f768909753e2657522f_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi05LTEtMS0w_b794d3e5-6dc4-4d27-9e22-1e806a09d1bb">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i55ed0869e08f4f768909753e2657522f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi0xMS0xLTEtMA_892af89d-c1f2-4047-bbb3-4d7bdf5c94b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc5b766a46664492ac40f1cf7af1b926_I20210331" decimals="INF" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy0xLTEtMS0w_1c192e53-2795-40f3-8f11-066c6ee96d90">77.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc5b766a46664492ac40f1cf7af1b926_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy0zLTEtMS0w_93472e66-7028-43c4-aba9-62d75f0fe560">403</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc5b766a46664492ac40f1cf7af1b926_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy01LTEtMS0w_5306c9d1-047c-435f-bb39-23cb6f11bcdc">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231" decimals="INF" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy03LTEtMS0w_88bf197a-03fc-4d6b-8c21-8fa6909b8c3f">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy05LTEtMS0w_8c6d02d3-27bc-4659-83c5-e9067dfc1f49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy0xMS0xLTEtMA_e2429ecd-2e34-4cc3-a288-d273179e0862">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic30522771c8a4c2ca8b28897797aa79f_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC0xLTEtMS0w_729305a1-9326-4791-a4ef-5b0692ac34c7">2,577.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic30522771c8a4c2ca8b28897797aa79f_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC0zLTEtMS0w_6129059a-0414-408e-a9dd-755f44cc66e6">412</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic30522771c8a4c2ca8b28897797aa79f_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC01LTEtMS0w_d8c8f41b-abc5-4479-aa72-78c98086b739">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i62085eeb658e46dd9eb6d857b79da630_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC03LTEtMS0w_1b18737d-c51f-421b-9447-8c4988819d2f">1,583.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i62085eeb658e46dd9eb6d857b79da630_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC05LTEtMS0w_cb5c3248-7dbd-420d-b056-c21189755a61">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i62085eeb658e46dd9eb6d857b79da630_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC0xMS0xLTEtMA_e7827baf-fb7e-46a3-b69e-46e919e85d26">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt">Represents the total notional amounts for certain of the Company&#8217;s supply and sales contracts accounted for as embedded derivatives.</span></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate caps and embedded derivative assets are included in &#8220;Prepaid expenses and other current assets&#8221; on our consolidated balance sheets. Embedded derivative liabilities are included in &#8220;Accrued liabilities&#8221; on the Consolidated Balance Sheets. </span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAyMA_5e70db67-b581-4170-b06b-c1c1dc121fbf" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activities of our derivative instruments for the periods presented, and the line item they are recorded in in the Consolidated Statements of Operations and Comprehensive Income (Loss): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on interest rate caps recorded in interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia3f548aa16134334acbcc16023544496_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMi0xLTEtMS0w_0776c02c-ebc3-448c-bc2a-c5d80de0195f">90</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iabe8d5f4f0b7489bae88ace960e40d0e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMi0zLTEtMS0w_46629b00-d22b-4669-ac2c-80bdc8764d00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized (gain) loss on embedded derivatives recorded in other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia6e675f57e9d48bba3df5cba6d545d97_D20210101-20210331" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMy0xLTEtMS0w_d225fc86-4581-4d9e-b1e2-8d116ffc883f">853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2150bbbc748f44229562c8ec831ea1cf_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMy0zLTEtMS0w_254a0aa4-99b3-4d3d-9732-336234abee4b">4,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gain on foreign currency forward contracts recorded in foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i01147b9ec0104587b5471c7226ea6552_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfNS0xLTEtMS0w_9ff65775-2377-4a41-9f9f-093cf14c28e0">2,374</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i860d4a2deece4c239d322dec5ed3e62e_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfNS0zLTEtMS0w_f5161797-0dbb-4531-a99a-41a7b72769cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, during the three months ended March&#160;31, 2020, we recognized $<ix:nonFraction unitRef="usd" contextRef="i6ed3cf78f0d24298bc641938f88ea10f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDE2Nw_390cec2c-86b7-49ac-aeec-9d70b6ed2f76">3.5</ix:nonFraction> million of losses, net of tax, in accumulated other comprehensive income (loss) related to the change in fair value of the interest rate swaps.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our financial assets, including cash and cash equivalents, are exposed to credit risk. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed, in our normal course of business, to credit risk from our customers. As of March&#160;31, 2021 and December&#160;31, 2020, accounts receivable was net of an allowance for uncollectible accounts of $<ix:nonFraction unitRef="usd" contextRef="iec88d5b798444874850d669967cf4dbd_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDczNA_903762be-70a7-4358-99dc-ade92ddf732e">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDc0MQ_562bd649-0789-4e9f-87d4-e8f32d245a4d">0.7</ix:nonFraction> million, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk on financial instruments arises from the potential for counterparties to default on their contractual obligations to us. We are exposed to credit risk in the event of non-performance, but do not anticipate non-performance by any of the counterparties to our financial instruments. We limit our credit risk by dealing with counterparties that are considered to be of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="ie2a1560ec42e49afa85941de53a0f79b"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">high credit quality. In the event of non-performance by counterparties, the carrying value of our financial instruments represents the maximum amount of loss that would be incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our financial instruments is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques we would use to determine such fair values are described as follows: Level 1&#8212;fair values determined by inputs utilizing quoted prices in active markets for identical assets or liabilities; Level 2&#8212;fair values based on observable inputs other than quoted prices included in Level&#160;1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable; Level 3&#8212;fair values determined by unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants.</span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAyMQ_05218db3-0bc4-47d5-8582-cf90bd4a19a8" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the fair value of our financial assets and liabilities: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;1 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;2 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;3 </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8215ef184ce046bf92c78693a8b8af93_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy0xLTEtMS0w_1aab58d5-5702-4057-a8bd-61e24b524e83">9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5447c83f5dbc409a96088e361444a411_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy0zLTEtMS0w_08e4f2c0-aaf1-4a2b-8599-af5bb5ad94a6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia8e15396c17b4617907472c2f4fade9b_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy01LTEtMS0w_91752b40-bd09-4137-a11e-cd45bdc32f14">9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id5081d47552c47cb8088900905b4f829_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy03LTEtMS0w_f31b95bf-79b8-4130-be50-478931cd1ee7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie2f1e394ba7d4c1982b82751ef9eeb68_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0xLTEtMS01Njgw_6980e936-818e-4e67-a97e-d25c45c18643">403</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf08e9f67a5d438db80fa3bec21b7105_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0zLTEtMS01Njgw_be5ff7ac-7a14-4437-b4c4-c61cb80f8879">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id8f67cfa14e34836a09901949e8a6f78_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC01LTEtMS01Njgw_20ca0303-6764-4a04-b255-9673be12c9af">403</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if94ed49fd1484dd19f80502049803ac1_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC03LTEtMS01Njgw_c6de944d-e543-40eb-951f-ea9c373d2819">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie2f1e394ba7d4c1982b82751ef9eeb68_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0xLTEtMS0w_4e79d820-cb8e-4740-ba2f-fe70311a599c">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icf08e9f67a5d438db80fa3bec21b7105_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0zLTEtMS0w_6ec18fc9-eda4-40da-9d49-e7e769cb96d7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="id8f67cfa14e34836a09901949e8a6f78_I20210331" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC01LTEtMS0w_289ae3b0-9bd1-4bdc-8f8e-faf404677641">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if94ed49fd1484dd19f80502049803ac1_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC03LTEtMS0w_31b42415-c17d-4f51-962b-7011380619c6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic182088a125a4701b886f7b699c6ec3f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi0xLTEtMS0w_9b93a451-3ccb-47c9-bdf4-9d14d0aef0ab">1,740,071</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie31b8c09e1a04e3abd0d5865f45be488_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi0zLTEtMS0w_135d848a-1128-4f0d-b814-d04fad797ae2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifbc39d33fbcf41d3be6a20574ae9f5e3_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi01LTEtMS0w_d93d9763-0693-45c2-b178-18278b3343b9">1,760,896</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idc03881b23174afb8aaf1b3b6857a78f_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi03LTEtMS0w_e0400121-2249-4188-b795-e0e669124754">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7219b8c57243488bb121b53bd3d7d3cf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy0xLTEtMS0w_a508eeb9-8165-45e5-ab1a-4fdbbaffa496">96,458</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idcc5336d70c34ef689e5dbb4364e9943_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy0zLTEtMS0w_1d35db00-4fee-47db-965a-df3c1d831a00">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie66e0ede22014573bd71c918b3740a70_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy01LTEtMS0w_1727cf4c-a496-42ad-9e6f-13b98a4e1ed0">97,587</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc835d02987343f4928bb15a4113279a_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy03LTEtMS0w_cb48e05a-b016-4580-b099-1da9a9158045">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i19990cadc7bf4e6eab87bd575dff569b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC0xLTEtMS0w_567d866f-98a1-4d66-9e71-e37dc455b556">1,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i452aa60f46804ae7824cdb240c5048d4_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC0zLTEtMS0w_c444fa17-d3a8-4051-878c-1d8ab4772e91">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id4aa98cfa3374f178a69835db9e117bf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC01LTEtMS0w_13358110-1067-48ee-999c-3146d13b32f9">1,051</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i272677a81acb465dad27e958b027480c_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC03LTEtMS0w_f4d9b841-a6a4-4c34-bc89-a9faf68d86a8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Lease Obligations (with current portion)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iee05df50a75d477993f0144a1d299dfe_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS0xLTEtMS0w_ab98566b-d840-46e5-bf45-17df8e79e54a">34,540</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia0ace0d34fc84a82a4a8dd4561599885_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS0zLTEtMS0w_99928e91-f05e-428c-aa23-e0e2334b02de">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8d9dd1bfbd544776a04462426d06480e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS01LTEtMS0w_49c12e17-ae24-460e-b173-26f5f26501fe">34,540</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i36f94f5ef6264fe1a1984794263117a2_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS03LTEtMS0w_6b513a5e-e5a8-4404-a4f6-9ec7f178fe5d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;1 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;2 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;3 </span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i36de9e2dd8ab40fc9b2ed92263ea4e84_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS0xLTEtMS0w_3587b62a-3120-4ac3-9546-0fed384e5dbe">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if74455fdc1334818832b157f91fec355_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS0zLTEtMS0w_976c3645-a6c5-4370-8b23-c4e9f283a5c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i585c891ef5c24f4f98a98256472bf2ec_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS01LTEtMS0w_8a91d473-ebf4-4fa5-a07d-ab7cdf4fd539">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia08bd0ee1a164912afa76b9e27e176df_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS03LTEtMS0w_424de13e-4d42-4daf-85dd-10ccfb614461">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i7e84d185d63c421a9847d44f33a85663_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi0xLTEtMS0w_d843dd51-b888-4ada-96b5-58dc6bf0f312">670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i02e84eddb6d54bfc9eb27fd468c46c12_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi0zLTEtMS0w_1d43aa0d-9850-4688-a0ce-2825d8a57608">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fb62adf30e64a04ac7bbc2fce94d9c2_I20201231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi01LTEtMS0w_1db6b818-6058-4531-a871-87171a4e3f62">670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i685874b622084b9fbc1d35045289e95a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi03LTEtMS0w_c090e705-bec5-4e62-9d5f-490003c5be6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idba49c45ea854b6fa233cf1af5bbda94_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC0xLTEtMS0w_a9a6a471-5c70-4d78-8b64-89a71e9a7fe9">1,728,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87475347f6b64bf0a02e800f0af6deeb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC0zLTEtMS0w_9b4fc387-46d4-4bf6-b364-4ceaf8784de0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i063954931d844af4a978fc5c7a468cf2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC01LTEtMS0w_ee12d4cf-d369-4f86-a360-88228fe0ee74">1,772,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i32014511dee4420784c09d1a73b0f794_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC03LTEtMS0w_11010231-176b-4b4b-82fa-6b27b5dd9ac0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i76f8cf83b28b42adb2c968c7126c23b8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS0xLTEtMS0w_ed23221c-2993-4fc3-8096-e5831e389bcf">96,329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4332841a17ae45d7ab5f8d5ccbb5a102_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS0zLTEtMS0w_7147cbfb-51a5-41f7-8bd4-cbf9376ccfe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i78b7cb2bfc064b10a052025a86eea5f7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS01LTEtMS0w_686e76af-0935-4678-8178-ae2b1915805b">99,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id17e44686c4a444aa4f61e3a904dc55e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS03LTEtMS0w_b60de708-8f3f-48c6-8c0d-3902dff9c859">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4d64d815af524281b0cc85c6490417b2_I20201231" decimals="-3" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtMS0xLTEtMA_c9d76ac3-4675-4516-8234-f069017209d1">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ife1c0685123d4f1dbe17dc0dcb90acb9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtMy0xLTEtMA_f183e22f-cec5-41f0-8097-fd293b25c5be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79293a96e6644ab3afb669bba734bcc7_I20201231" decimals="-3" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtNS0xLTEtMA_faa904d3-dbec-429a-903f-d540e7879112">442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if197f04408d94ab68c955aa4b4a235fb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtNy0xLTEtMA_397bda29-5676-41d2-853f-ba6be8946ec8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Lease Obligations (with current portion)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i81cd9ccf6a8a483399b03f856601a919_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtMS0xLTEtMA_0ddd202a-2627-4ea7-b7e0-430bfa9f056a">36,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i15872309fe384ede99b59ae790fd6692_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtMy0xLTEtMA_22cba000-31ac-4101-9c29-021706f854bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5c9959285390451eb941cbc5aacef59e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtNS0xLTEtMA_256f864a-a54d-4e96-a9f5-b16924d26f3e">36,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8d8483a806e144dc96f7e439adffab1a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermDebtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtNy0xLTEtMA_eafa2309-4022-4244-acd1-873f2e1ad33e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Derivatives that are not designated as hedging instruments are measured at fair value with gains or losses recognized immediately in the Consolidated Statements of Operations and Comprehensive Income (Loss). Interest rate caps are valued using pricing models that incorporate observable market inputs including interest rate and yield curves. Embedded derivatives are valued using internally developed models that rely on observable market inputs including foreign currency forward curves.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Carrying amounts of long-term debt instruments are reported net of discounts and debt issuance costs. The estimated fair value of these instruments is based on information provided by the agent under the Company&#8217;s senior secured credit facility. Fair value approximates carrying value for &#8220;Other long-term debt.&#8221;</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Fair value approximates carrying value.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">27</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_94"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><div style="margin-top:18pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjc0ODc3OTA3NTk3Mg_af6a039b-46f8-4d42-b4f5-ae48bab8c172" continuedAt="i9deed5728c9c4a0a93f4845e554bad34" escape="true">Segment Information </ix:nonNumeric></span></div><ix:continuation id="i9deed5728c9c4a0a93f4845e554bad34" continuedAt="i0cab95fef2d7490288860054db44f55f"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify our operating segments based on the way we manage, evaluate and internally report our business activities for purposes of allocating resources and assessing performance. We have <ix:nonFraction unitRef="segment" contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjMx_49f3e44b-7507-40d8-a841-d4ee7053cad4">three</ix:nonFraction> reportable segments: Sterigenics, Nordion and Nelson Labs. We have determined our reportable segments based upon an assessment of organizational structure, service types, and internally prepared financial statements. Our chief operating decision maker evaluates performance and allocates resources based on net revenues and segment income after the elimination of intercompany activities. The accounting policies of our reportable segments are the same as those described in Note 1, &#8220;Significant Accounting Policies&#8221; of our 2020 Form 10-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Sterigenics</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sterigenics segment provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nordion </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion is a global provider of Co-60 and gamma irradiators, which are key components to the gamma sterilization process. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nelson Labs </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and biopharmaceutical industries. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, three customers reported within the Nordion segment individually represented 10% or more of the segment&#8217;s total net revenues. These customers represented <ix:nonFraction unitRef="number" contextRef="i35ac9047c5b543a3976685cc7c6f80bc_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTQyMg_c73fb79e-9294-458d-b03a-03ce74ab0e06">23.7</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i019a710917314003bf051954e812e6f1_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTQyNg_0ff791ba-dbff-40f7-9f0f-06c426eb9194">20.0</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="if4e3b0fca93a414f8267d4764139c900_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTQzNA_8b02efe5-7506-4301-a3ca-de17466ad896">12.2</ix:nonFraction>% of the total segment&#8217;s external net revenues for the three months ended March&#160;31, 2021. For the three months ended March&#160;31, 2020, two customers reported within the Nordion segment individually represented 10% or more of the segment's total net revenues. These customers represented <ix:nonFraction unitRef="number" contextRef="ibd5e47f9b9f54685b7c4853c2ecaa92a_D20200101-20200331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTY0OTI2NzQ0OTc2NA_00b4024b-9066-4c39-b242-3ccfaaba852a">18.7</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i060a27d3ce644a47a68d9a2bd5793f29_D20200101-20200331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTY0OTI2NzQ0OTc3Mg_c877d458-c4b5-47dc-95d5-da663ec9a3e4">11.6</ix:nonFraction>% of the total segment's external net revenues for the three months ended March&#160;31, 2020.</span></div><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjc0ODc3OTA3NjAyMg_d123f079-6732-442b-a069-58879fc6f947" continuedAt="i0a5d53f30eb841df86b59ea69164328a" escape="true"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Net revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi0xLTEtMS0w_c9f9bf87-91bd-4d21-ad2a-3cc9db314a6d">131,151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi0zLTEtMS0w_37bd1f47-9185-40e9-9100-48bd529106a6">25,918</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi01LTEtMS0w_e164323c-77bd-4ab2-bb9a-0a723cd979d0">55,079</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi03LTEtMS0w_c00311cf-1ed0-446d-8e21-9595fb69344e">212,148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Segment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy0xLTEtMS0w_4c5be54d-5e5b-43b3-a19a-b18d0f49956b">68,461</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy0zLTEtMS0w_a88830b1-63ae-4af6-a061-d451afc92e24">13,786</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy01LTEtMS0w_0f1dd5db-06cc-4925-9745-0e88b9225f3e">23,070</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy03LTEtMS0w_838642b8-11d7-4f89-8db9-3bbd9c92c8f3">105,317</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC0xLTEtMS0w_866e6a3d-b2c7-44c9-a504-dc3fd124e6c9">19,514</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC0zLTEtMS0w_968de98a-d0b4-48d9-b249-39ceaccac696">489</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC01LTEtMS0w_197f5cd9-e29e-4b49-9b44-74cd4cb97e2b">939</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC03LTEtMS0w_2659dd0a-b252-4491-becc-ecab440dc88a">20,942</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Sterigenics </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Nordion </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Nelson Labs </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Consolidated </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Net revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi0xLTEtMS0w_ac16fffe-9279-4ae4-951c-b38736296b46">117,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if73b88809d084769a5f2a52b8afde703_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi0zLTEtMS0w_fb08a142-f33f-4829-8d2e-8f8ed0dd4f3e">23,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iababa48736c840818f39cbadfc3e0370_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi01LTEtMS0w_fa906de4-5f87-4d30-a654-ad7b107a5324">47,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi03LTEtMS0w_28ce0901-47a1-4563-8240-b2b86c9e63b5">188,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Segment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy0xLTEtMS0w_08b488b7-167e-4763-a242-1654f1bb0123">61,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if73b88809d084769a5f2a52b8afde703_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy0zLTEtMS0w_3935c09c-9f34-4df8-b425-2966b9baba35">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iababa48736c840818f39cbadfc3e0370_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy01LTEtMS0w_cfed2dd6-f54c-49e7-b925-444b4eb23ca3">17,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy03LTEtMS0w_b628bb6e-9eb1-4ef4-baf0-d732e487e66a">91,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC0xLTEtMS0w_b49ffcd0-4248-4a03-8ae5-ce0739ce491d">10,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if73b88809d084769a5f2a52b8afde703_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC0zLTEtMS0w_d238fbd9-d211-4eeb-a15b-cc258d2fd812">1,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iababa48736c840818f39cbadfc3e0370_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC01LTEtMS0w_6d54f1fa-66c8-481a-a1ff-8411a4ba5a3d">815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC03LTEtMS0w_1a22ebe1-7e7f-421e-8ef0-4b175e0c81f9">12,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Revenues are reported net of intersegment sales. Our Nordion segment recognized $<ix:nonFraction unitRef="usd" contextRef="i2b4e7cd3ba244ec68ee9e4a6d8ee9391_D20210101-20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTU5MQ_6fb204de-f92a-4e1c-a324-68d661d41814">10.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i603326ebb8e04b33add577d701640115_D20200101-20200331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTU5OA_741f71e1-ba38-437a-b972-58737c2b59fd">10.9</ix:nonFraction> million in revenues from sales to our Sterigenics segment for the three months ended March&#160;31, 2021 and 2020, respectively, that is not reflected in net revenues in the table above. Intersegment sales for Sterigenics and Nelson Labs are immaterial for both periods. </span></div></ix:nonNumeric><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0a5d53f30eb841df86b59ea69164328a" continuedAt="i445e4946a168443e96ff0b8f307d9e7c">(b)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"><ix:continuation id="i445e4946a168443e96ff0b8f307d9e7c">Segment income is only provided on a net basis to the chief operating decision maker and is reported net of intersegment profits.</ix:continuation> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate operating expenses for executive management, accounting, information technology, legal, human resources, treasury, corporate development, tax, purchasing, and marketing are allocated to the segments based on total revenue. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and depreciation and amortization expense by segment are not readily available and are not reported separately to the chief operating decision maker. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%;text-decoration:underline" href="#i15ef643796c34829b3bb28475338f021_7">Table of Contents</a></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sotera Health Company </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div></div><ix:continuation id="i0cab95fef2d7490288860054db44f55f"><ix:nonNumeric contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjc0ODc3OTA3NjAyMw_105030df-3723-45e6-acf2-3a104afcac18" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of segment income to consolidated income (loss) before taxes is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMi0xLTEtMS0w_559f8456-e068-4932-9ee5-203dc940b333">105,317</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="shc:SegmentIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMi0zLTEtMS0w_d9fad473-5741-4436-81f7-15a9a1328cf9">91,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Less adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNC0xLTEtMS0w_807b8b8c-847f-4184-a541-3887f5b6a974">21,282</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNC0zLTEtMS0w_b5620000-7dfb-47f9-ac3e-323262fe2c8a">56,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNS0xLTEtMS0w_a49090be-9f6e-4d9a-b8e3-3731d5f86ce6">37,661</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNS0zLTEtMS0w_b093b255-febe-4588-bb1b-0d77940b7ffd">36,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNy0xLTEtMS0w_63683a79-ea79-467e-95a5-f7d9542c98fb">3,449</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNy0zLTEtMS0w_d58f6946-a7da-4231-bc24-1ecdc89e1d3a">1,725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Gain) loss on foreign currency and embedded derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" name="shc:ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfOS0xLTEtMS0w_fb72260b-f125-4288-a6d4-bc90df25bc3e">336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="shc:ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfOS0zLTEtMS0w_60abb9d0-6dd9-4fa5-a652-1a37f9e027e9">4,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and divestiture related charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" sign="-" name="shc:AcquisitionAndDivestitureRelatedChargesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTAtMS0xLTEtMA_fab0dc45-850f-4cf2-ab78-4122d40b32b2">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" name="shc:AcquisitionAndDivestitureRelatedChargesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTAtMy0xLTEtMA_92ddcf44-0c62-4e5d-b8e4-22822ce825e9">994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business optimization project expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" name="us-gaap:OtherRestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTEtMS0xLTEtMA_1b2a9a60-7cf7-40b9-80fc-6d0e48d9332f">261</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherRestructuringCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTEtMy0xLTEtMA_f86bf7c2-0f34-4aa1-9259-83ddb752af26">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plant closure expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" name="us-gaap:BusinessExitCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTItMS0xLTEtMA_49b51359-ca9c-43c5-b0f1-340935219046">542</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" name="us-gaap:BusinessExitCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTItMy0xLTEtMA_0c25edc5-cde4-47c4-8056-56d7e4743c77">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTMtMS0xLTEtMA_f78e568e-73d3-489b-99cf-b0f58744c041">14,312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTMtMy0xLTEtMA_7d9cca91-1f1f-448c-9b00-2ed8795dfeed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional services relating to EO sterilization facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(h)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTQtMS0xLTEtMA_c6869a4e-3fb0-4d72-9f30-57c7d5114976">13,399</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTQtMy0xLTEtMA_bd23efa2-7d23-4028-ad64-edfb35f8bb60">4,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accretion of asset retirement obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTUtMS0xLTEtMA_1fbf2b1b-b517-4c97-8537-2175d6beb056">551</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" name="us-gaap:AssetRetirementObligationAccretionExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTUtMy0xLTEtMA_ae414aa6-31e5-4743-8ee0-33186dd86304">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(j)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" name="shc:CostAndExpensesCOVID19" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTYtMS0xLTEtMA_70e8728a-9226-4d6b-bb0f-18dca236a568">299</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" name="shc:CostAndExpensesCOVID19" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTYtMy0xLTEtMA_27e90b85-a4f3-4583-8540-99896d603356">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated income (loss) before taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTctMS0xLTEtMA_1ad30717-c4b7-40cd-9faf-2be1634de8be">14,082</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTctMy0xLTEtMA_5808a899-3495-44f4-b17d-91082da0d834">14,220</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes depreciation of Co-60 held at gamma irradiation sites. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents non-cash share-based compensation expense.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents the effects of (i)&#160;fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#8217; functional currencies, and (ii)&#160;non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents (i) certain direct and incremental costs related to the acquisitions of BioScience in 2021, Iotron in July 2020 and Nelson Labs Fairfield in 2018 (including the first quarter 2021 gain on the mandatorily redeemable noncontrolling interest as described in Note 4, &#8220;Acquisitions&#8221;), and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.01pt">Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents expenses incurred in connection with the repricing of our Term Loan in January 2021 including accelerated amortization of prior debt issuance and discount costs. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees. See Note 16, &#8220;Commitments and Contingencies&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Represents non-recurring costs associated with the COVID-19 pandemic, including incremental costs to implement workplace health and safety measures.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">29</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis in conjunction with our consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and notes and Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations contained in our 2020 Form 10-K. This discussion and analysis contains forward-looking statements that are based on management&#8217;s current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements as a result of various factors, including the factors we describe in the section entitled Part II, Item 1A, &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q, as well as Part I, Item 1A, &#8220;Risk Factors&#8221; in our 2020 Form 10-K.</span></div><div id="i15ef643796c34829b3bb28475338f021_103"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. We are driven by our mission: Safeguarding Global Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world. Our services are an essential aspect of our customers&#8217; manufacturing process and supply chains, helping to ensure sterilized medical products reach healthcare practitioners and patients. Most of these services are necessary for our customers to satisfy applicable government requirements. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We serve our customers throughout their product lifecycles, from product design to manufacturing and delivery, helping to ensure the sterility, effectiveness and safety of their products for the end user. We operate across two core businesses: sterilization services and lab services. The combination of Sterigenics, our terminal sterilization business, and Nordion, our Co-60 supply business, makes us the only vertically integrated global gamma sterilization provider in the sterilization industry. For financial reporting purposes, our sterilization services business consists of two reportable segments, Sterigenics and Nordion, and our lab services business consists of one reportable segment, Nelson Labs.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, we recorded net revenues of $212.1 million, net income of $11.1 million, Adjusted Net Income of $51.5 million and Adjusted EBITDA of $105.3 million. For the definition of Adjusted Net Income and Adjusted EBITDA and the reconciliation of these non-GAAP measures from net income (loss), please see &#8220;Non-GAAP Financial Measures.&#8221; </span></div><div id="i15ef643796c34829b3bb28475338f021_106"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STRATEGIC DEVELOPMENTS AND KEY FACTORS AFFECTING OUR RESULTS OF OPERATIONS </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes strategic developments and key factors that have underpinned our operating results for the three months ended March&#160;31, 2021 and may continue to affect our performance and financial condition in future periods.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Driving organic growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the three months ended March&#160;31, 2021, we continued to make investments to expand capacity and implement EO facility enhancements in our Sterigenics business and expand our cobalt development resources in our Nordion business. In addition, we continue to expand capacity to meet demand for microbiological testing and extractables and leachables testing in our Nelson Labs business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Disciplined and strategic M&amp;A activity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We continue to pursue strategic acquisitions to grow our footprint and expand our capabilities. On March 8, 2021, we acquired BioScience Laboratories, LLC (&#8220;BioScience&#8221;) with one location in Bozeman, Montana for approximately $13.2 million, net of $0.8 million of cash acquired plus the repayment of BioScience's outstanding debt of $1.9 million. BioScience is a provider of outsourced topical antimicrobial product testing in the pharmaceutical, medical device, and consumer products industries. BioScience&#8217;s expertise in analytical testing and clinical trial services will complement Nelson Labs&#8217; existing strengths in antimicrobial and virology testing. On February 8, 2021, we entered into binding agreements to purchase the outstanding noncontrolling interests of 15% and 33% of our two China subsidiaries, respectively, for a total purchase price of $8.6 million. The purchase transactions are expected to close in the second quarter of 2021. In addition, on March 11, 2021, we completed the acquisition of the remaining 15% ownership of Nelson Labs Fairfield for $12.4 million. Pursuant to the terms of the transaction, we acquired 85% of the equity interests of Nelson Labs Fairfield in August 2018 and were required to acquire the 15% noncontrolling interest within three years from the date of the acquisition. In July 2020, we acquired Iotron Industries Canada, Inc. (&#8220;Iotron&#8221;), an E-beam processing services and equipment provider.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Borrowings and financing costs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A combination of lower outstanding borrowings and reduced pricing on our debt resulted in a reduction in cash interest expense for the three months ended March&#160;31, 2021 compared to the three </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">months ended March&#160;31, 2020. On January 20, 2021 we amended our Term Loan to reduce the interest rate spread over LIBOR from 4.50% to 2.75%, and the LIBOR floor from 1.00% to 0.50%. The changes resulted in an effective reduction in current interest rates of 2.25%. We expect the amendment to provide additional cash interest savings of approximately $40.0 million per year based on the outstanding principal balance as of the date of the amendment. Interest savings in 2021 will be offset by cash and non-cash charges associated with the repricing amendment. In connection with this transaction, we wrote off approximately $11.3 million in debt issuance costs and debt discounts and incurred approximately $2.9 million in costs directly related to the refinancing transaction. In addition, on March 26, 2021, we amended our Revolving Credit Facility to reduce the interest rate spread over LIBOR applicable to revolving loans from 3.50% to 2.75%. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impacts of our IPO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a newly public company, we continue to incur certain expenses on an ongoing basis that we did not incur as a private company including third-party and internal resources related to accounting, auditing, Sarbanes-Oxley Act compliance, legal, and investor and public relations expenses. These costs are primarily classified as selling, general&#160;and administrative (&#8220;SG&amp;A&#8221;) expenses. We continue to dedicate internal resources, hire additional personnel, and engage outside consultants to assess and document the adequacy of internal controls over financial reporting. In addition, we incurred costs related to a secondary offering of 25 million shares of our common stock offered by selling stockholders, which included certain affiliates of Warburg Pincus LLC and GTCR, LLC as well as certain current and former members of management of the Company.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Exit activities and litigation costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In connection with the ongoing litigation related to our Willowbrook, Illinois, Atlanta, Georgia and Santa Teresa, New Mexico facilities, as described in Note 16, &#8220;Commitments and Contingencies&#8221;, we recorded costs of $13.4 million for the three months ended March 31, 2021 relating to legal and other professional service costs, as well as $0.5 million related to the closure of the Willowbrook, Illinois facility.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Impact of COVID-19 pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We remain subject to risks and uncertainties as a result of  the COVID-19 pandemic. Our business continuity plans remain in effect and we have maintained certain measures to decrease exposure risk and manage our supply chain for critical materials. The extent to which our operations will continue to be impacted by the pandemic will largely depend on future developments, which still remain uncertain and cannot be predicted. </span></div><div id="i15ef643796c34829b3bb28475338f021_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED RESULTS OF OPERATIONS </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021 as compared to Three Months Ended March 31, 2020 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of our results of operations for the three months ended March&#160;31, 2021 and 2020. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:7pt;padding-right:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">%&#160;Change</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">212,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total cost of revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">96,776</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">69,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">46,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44,865&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,986)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">657.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted Net Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">51,506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,434&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.8pt">Adjusted Net Income and Adjusted EBITDA are non-GAAP financial measures. For more information regarding our calculation of Adjusted Net Income and Adjusted EBITDA, including information about their limitations as tools for analysis and a reconciliation of net income (loss), the most directly comparable financial measure calculated and presented in accordance with GAAP, to Adjusted Net Income and Adjusted EBITDA, please see the reconciliation included below in &#8220;Non-GAAP Financial Measures.&#8221; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Net Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table compares our revenues by type for the three months ended March&#160;31, 2021 to the three months ended March&#160;31, 2020.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:139%">(thousands of U.S. dollars)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;text-decoration:underline">Net revenues for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">$&#160;Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12.6pt;padding-right:12.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">%&#160;Change</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">188,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23,450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">212,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188,200&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,948&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues were $212.1 million in the three months ended March&#160;31, 2021, an increase of $23.9 million, or 12.7%, as compared with the three months ended March&#160;31, 2020. Excluding the impact of foreign currency exchange rates, net revenues in the three months ended March&#160;31, 2021 increased approximately 10.9% compared with the same period in the three months ended March&#160;31, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service revenues</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenues increased $21.3 million, or 12.7%, to $188.7 million in the three months ended March&#160;31, 2021 as compared to $167.4 million in the three months ended March&#160;31, 2020. The increase in net service revenues reflected a $5.8 million increase due to the July 31, 2020 acquisition of Iotron, coupled with favorable pricing and organic sales volume growth in our Sterigenics segment of $3.8 million and $2.7 million, respectively. Service revenue growth was also attributable to a $4.9 million increase in demand for testing services related to personal protective equipment used to provide protection against COVID-19 and a $1.6 million increase due to favorable pricing of laboratory and testing services in our Nelson Labs segment. The remainder of the increase is primarily due to a favorable impact from foreign exchange rates of $2.4 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues increased $2.7 million, or 12.8%, to $23.5 million in the three months ended March&#160;31, 2021 as compared to $20.8 million in the three months ended March&#160;31, 2020. The increase in product revenues was primarily attributable to a $1.3 million overall net volume increase driven largely by shipments of medical use Co-60 and a favorable impact from foreign exchange rates of $1.0 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Cost of Revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table compares our cost of revenues by type for the three months ended March&#160;31, 2021 to the three months ended March&#160;31, 2020. </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:139%">(thousands of U.S. dollars)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;text-decoration:underline">Cost of revenues for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">$&#160;Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.17pt;padding-right:11.17pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">%&#160;Change</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">85,036</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83,069&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11,740</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total cost of revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">96,776</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,683&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,093&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost of revenues accounted for approximately 45.6% and 48.7% of our consolidated net revenues for the three months ended March 31, 2021 and 2020, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of service revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenues increased $2.0 million, or 2.4%, for the three months ended March&#160;31, 2021 as compared to the three months ended March&#160;31, 2020. The increase was attributable to the Iotron acquisition and the impact of foreign currency exchange rates on cost of sales within our foreign subsidiaries.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of product revenues </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product revenues increased $3.1 million, or 36.3%, for the three months ended March&#160;31, 2021 as compared to the three months ended March&#160;31, 2020. The increase was primarily a result of incremental costs associated with increased sales volumes. The remainder of the increase is primarily due to an unfavorable impact from foreign exchange rates of $0.7 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table compares our operating expenses for the three months ended March&#160;31, 2021 to the three months ended March&#160;31, 2020: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:139%">(thousands of U.S. dollars)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%;text-decoration:underline">Operating expenses for the three months ended March 31,</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.55pt;padding-right:11.55pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:139%">%&#160;Change</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">52,465</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16,543</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total operating expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">69,008</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,652&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,356&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses accounted for approximately 32.5% and 27.4% of our consolidated net revenues for the three months ended March&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SG&amp;A </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A increased $15.4 million, or 41.6%, for the three months ended March&#160;31, 2021 as compared to the three months ended March&#160;31, 2020. The increase was driven primarily by the following: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $9.3 million increase in legal and other professional services expense associated with EO litigation; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">$4.0 million in incremental corporate expenses largely attributed to costs associated with being a public company. This includes $1.2 million in professional fees associated with the secondary offering of common shares by the selling stockholders in March 2021.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An increase in share-based compensation expense of $1.7 million related to our 2020 Omnibus Incentive Plan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amortization of intangible assets</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangible assets was $16.5 million for the three months ended March&#160;31, 2021, or 13.3% above the three months ended March&#160;31, 2020. The change was primarily attributable to amortization on newly acquired intangible assets related to the Iotron and BioScience acquisitions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense, Net </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net decreased $35.3 million, or 62.4%, for the three months ended March&#160;31, 2021 as compared to the three months ended March&#160;31, 2020. The decrease was largely due to a lower outstanding debt balance for the first quarter of 2021and lower interest rates subsequent to the January 2021 Term Loan refinancing.  The weighted average interest rate on our outstanding debt was 3.45% and 7.11% at March&#160;31, 2021 and 2020, respectively.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Loss (Gain) </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange loss was $0.6 million for the three months ended March&#160;31, 2021 as compared to a gain of $0.6 million in the three months ended March&#160;31, 2020. The foreign exchange loss (gain) in our Consolidated Statements of Operations and Comprehensive Income (Loss) relates primarily to U.S. dollar denominated intercompany indebtedness with certain of our European and Canadian subsidiaries. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income) Expense, Net </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net was $3.9 million for the three months ended March&#160;31, 2021 compared to $3.2 million of expense for the three months ended March&#160;31, 2020. The fluctuation was driven by changes in the fair value of the embedded derivatives in Nordion&#8217;s contracts. We recorded an unrealized gain on embedded derivatives of $0.9 million for the three months ended March&#160;31, 2021 as compared to an unrealized loss on embedded derivatives of $4.8 million for the three months ended March&#160;31, 2020. In addition, we recorded $1.2 million of other income related to the gain on purchase of the mandatorily redeemable noncontrolling interest of 15% of Nelson Labs Fairfield as compared to the amount previously accrued. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision (Benefit) for Income Taxes </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income tax increased $15.3 million, or 124.7%, to a net provision of $3.0 million for the three months ended March&#160;31, 2021 as compared to a $12.2 million benefit in the three months ended March&#160;31, 2020. The change was primarily attributable to pre-tax income in the three months ended March 31, 2021 compared to a pre-tax loss in the three months ended </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 31, 2020. In addition, the increased limitation on interest expense deduction provided by the CARES Act in March 2020 resulted in a $9.1 million discrete tax benefit in the three months ended March 31, 2020 as well as a reversal of a $5.6 million valuation allowance on deferred tax assets related to nondeductible interest expense. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes for the three months ended March&#160;31, 2021 differed from the statutory rate primarily due to the impact of the foreign rate differential, GILTI, and a net increase in the valuation allowance attributable to the limitation on the deductibility of interest expense. This was partially offset by a discrete item, which reversed the valuation allowance on deferred tax assets related to certain asset retirement obligations. Provision for income taxes for the three months ended March&#160;31, 2020 differed from the statutory rate primarily due to the impact of the CARES Act, including the increased limitation on interest expense deduction and valuation allowance reversal, as described above. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss), Adjusted Net Income and Adjusted EBITDA </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income for the three months ended March&#160;31, 2021 was $11.1 million, as compared to a net loss of $2.0 million for the three months ended March&#160;31, 2020. Adjusted Net Income was $51.5 million for the three months ended March&#160;31, 2021, as compared to $23.7 million for the three months ended March&#160;31, 2020, due to the factors described above. Adjusted EBITDA was $105.3 million for the three months ended March&#160;31, 2021, as compared to $91.9 million for the three months ended March&#160;31, 2020, due to the factors described above. Please see &#8220;Non-GAAP Financial Measures&#8221; below for a reconciliation of Adjusted Net Income and Adjusted EBITDA to their most directly comparable financial measure calculated and presented in accordance with GAAP. </span></div><div id="i15ef643796c34829b3bb28475338f021_112"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-GAAP FINANCIAL MEASURES</span></div><div style="margin-top:6pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our consolidated financial statements presented in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;), we consider Adjusted Net Income and Adjusted EBITDA, financial measures that are not based on any standardized methodology prescribed by GAAP. </span></div><div style="margin-top:12pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted Net Income as net income (loss) before amortization and certain other adjustments that we do not consider in our evaluation of our ongoing operating performance from period to period as discussed further below. We define Adjusted EBITDA as Adjusted Net Income before interest expense, depreciation (including depreciation of Co-60 used in our operations) and income tax provision applicable to Adjusted Net Income.</span></div><div style="margin-top:12pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Adjusted Net Income and Adjusted EBITDA, non-GAAP financial measures, as the principal measures of our operating performance. Management believes Adjusted Net Income and Adjusted EBITDA are useful because they allow management to more effectively evaluate our operating performance and compare the results of our operations from period to period without the impact of certain non-cash items and non-routine items that we do not expect to continue at the same level in the future and other items that are not core to our operations. We believe that these measures are useful to our investors because they provide a more complete understanding of the factors and trends affecting our business than could be obtained absent this disclosure. In addition, we believe Adjusted Net Income and Adjusted EBITDA will assist investors in making comparisons to our historical operating results and analyzing the underlying performance of our operations for the periods presented. Our management also uses Adjusted Net Income and Adjusted EBITDA in their financial analysis and operational decision-making, and Adjusted EBITDA serves as the basis for the metric we utilize to determine attainment of our primary annual incentive program. Adjusted Net Income and Adjusted EBITDA may be calculated differently from, and therefore may not be comparable to, a similarly titled measure used by other companies.</span></div><div style="margin-top:12pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted Net Income and Adjusted EBITDA should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. There are a number of limitations related to the use of Adjusted Net Income and Adjusted EBITDA rather than net income (loss), the nearest GAAP equivalent. For example, Adjusted Net Income and Adjusted EBITDA exclude: </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain recurring non-cash charges such as depreciation of fixed assets, although these assets may have to be replaced in the future, as well as amortization of acquired intangible assets and asset retirement obligations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs of acquiring and integrating businesses, which will continue to be a part of our growth strategy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">non-cash gains or losses from fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#8217; functional currencies, and the mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairment charges on long-lived assets and intangible assets;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses and charges related to the litigation and other activities associated with our EO sterilization facilities in Willowbrook, Illinois, Atlanta, Georgia and Santa Teresa, New Mexico, even though that litigation remains ongoing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of Adjusted EBITDA, interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">share-based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense and an important part of our compensation strategy.</span></div><div style="margin-top:12pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating Adjusted Net Income and Adjusted EBITDA, you should be aware that in the future, we will incur expenses similar to the adjustments in this presentation. Our presentations of Adjusted Net Income and Adjusted EBITDA should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider Adjusted Net Income and Adjusted EBITDA alongside other financial performance measures, including our net income (loss) and other GAAP measures.</span></div><div style="margin-top:12pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net income (loss), the most directly comparable financial measure calculated and presented in accordance with GAAP to Adjusted Net Income and Adjusted EBITDA, for each of the periods indicated:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">11,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,986)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">22,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">3,449</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Gain) loss on foreign currency and embedded derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and divestiture related charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Business optimization project expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Plant closure expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">14,312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Professional services relating to EO sterilization facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">13,399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accretion of asset retirement obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(h)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">551</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">COVID-19 expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax provision (benefit) associated with pre-tax adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(j)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(14,133)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,707)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Adjusted Net Income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">51,506</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">21,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(k)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">15,379</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income tax provision (benefit) applicable to Adjusted Net Income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(l)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">17,150</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,527)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">105,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">91,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Represents non-cash share-based compensation expense.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Represents the effects of (i)&#160;fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#8217; functional currencies, and (ii)&#160;non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Represents (i) certain direct and incremental costs related to the acquisitions of BioScience in 2021, Iotron in July 2020 and Nelson Labs Fairfield in 2018 (including the first quarter 2021 gain on the mandatorily redeemable noncontrolling interest as described in Note 4, &#8220;Acquisitions&#8221;), and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Represents expenses incurred in connection with the repricing of our Term Loan in January 2021 including accelerated amortization of prior debt issuance and discount costs.  </span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees. See Note 16, &#8220;Commitments and Contingencies&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Represents non-recurring costs associated with the COVID-19 pandemic, including incremental costs to implement workplace health and safety measures.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;Represents the tax benefit or provision associated with the reconciling items between net income (loss) and Adjusted Net Income. To determine the aggregate tax effect of the reconciling items, we utilized statutory income tax rates ranging from 0% to 35%, depending upon the applicable jurisdictions of each adjustment.</span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;Includes depreciation of Co-60 held at gamma irradiation sites.</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;Represents the difference between income tax provision or benefit as determined under U.S. GAAP and the income tax provision or benefit associated with pre-tax adjustments described in footnote (j).</span></div><div id="i15ef643796c34829b3bb28475338f021_115"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SEGMENT RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have three reportable segments: Sterigenics, Nordion and Nelson Labs. Our chief operating decision maker evaluates performance and allocates resources within our business based on Segment Income, which excludes certain items which are included in income (loss) before tax as determined in our Consolidated Statements of Operations and Comprehensive Income (Loss). The accounting policies for our reportable segments are the same as those for the consolidated Company. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Segments </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sterigenics </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three major technologies: gamma irradiation, EO processing and E-beam irradiation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nordion </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nordion business is a global provider of Co-60 and gamma irradiators, which are the key components to the gamma sterilization process. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the time required to meet regulatory and logistics requirements for delivery of radioactive products, combined with accommodations made to our customers to minimize disruptions to their operations during the installation of Co-60, Nordion sales patterns can often vary significantly from one quarter to the next. However, timing-related impacts on our sales performance tend to be resolved within several quarters, resulting in more consistent performance over longer periods of time. In addition, sales of production irradiators occur infrequently and tend to be for larger amounts. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results for our Nordion segment are also impacted by Co-60 supplier mix, harvest schedules and product and service mix. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nelson Labs </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding our reportable segments please refer to Note 18, &#8220;Segment Information&#8221; to our consolidated financial statements. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results for the Three Months Ended March 31, 2021 and 2020 </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables compare segment net revenue and segment income for the three months ended March&#160;31, 2021 to the three months ended March&#160;31, 2020: </span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.241%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.617%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Three Months Ended March 31,</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">$&#160;Change </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">%&#160;Change </span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 13pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">131,151</span></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 13pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,280</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,918</span></td><td colspan="3" style="background-color:#cceeff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,625</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">55,079</span></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 13pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">68,461</span></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 13pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,091</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,786</span></td><td colspan="3" style="background-color:#cceeff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23,070</span></td><td colspan="3" style="background-color:#ffffff;padding:0 13pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,770</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Income margin</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">52.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">53.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">41.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Revenues by Segment</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics net revenues were $131.2 million for the three months ended March&#160;31, 2021, an increase of $13.9 million, or 11.8%, as compared to the three months ended March&#160;31, 2020. The increase reflects a 5.0% increase in revenues attributable to the Iotron acquisition coupled with a 3.2% favorable impact from pricing and 2.3% growth in organic sales volume. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion net revenues were $25.9 million for the three months ended March&#160;31, 2021, an increase of $2.3 million, or 9.7%, as compared to the three months ended March&#160;31, 2020. The increase reflects a 4.2% impact from the strengthening of the Canadian dollar compared to the U.S. dollar for the three months ended March 31, 2021 as compared to the three months ended March 31, 2020, a 3.6% impact from favorable pricing, and a 1.9% impact from higher volumes primarily due to increases in shipments of medical-use Co-60. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs net revenues were $55.1 million for the three months ended March&#160;31, 2021, an increase of $7.8 million, or 16.5%, as compared to the three months ended March&#160;31, 2020. The increase was primarily driven by a 10.3% increase in testing services related to personal protective equipment used to provide protection against COVID-19 and a 3.5% impact from favorable pricing. The remainder of the increase is primarily due to a favorable impact from foreign exchange rates of 1.7%. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Income </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics segment income was $68.5 million for the three months ended March&#160;31, 2021, an increase of $7.4 million, or 12.1%, as compared to the three months ended March&#160;31, 2020. The increase in segment income was primarily a result of the contributions of the Iotron acquisition coupled with revenue growth stemming from both favorable pricing and volume, as referenced above. This was partially offset by incremental overhead associated with being a public company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion segment income was $13.8 million for the three months ended March&#160;31, 2021, an increase of $0.8 million, or 5.9%, as compared to the three months ended March&#160;31, 2020. The increase in segment income was primarily due to the favorable impact from foreign exchange rates as well as favorable customer pricing and increases in sales volume, referenced above. This was partially offset by incremental overhead associated with being a public company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs segment income was $23.1 million for the three months ended March&#160;31, 2021, an increase of $5.3 million, or 29.8%, as compared to the three months ended March&#160;31, 2020, due to the increase in sales volumes, driven largely by testing of personal protective equipment and favorable pricing. This increase was partially offset by incremental overhead associated with being a public company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">37</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary sources of liquidity for our business are cash flows from operations and borrowings under our credit facilities. We expect that our primary liquidity requirements will be to service our debt, to invest in fixed assets to build and/or expand existing facilities, to fund selective business acquisitions, make capital expenditures and for other general corporate purposes. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, we had $108.0 million of cash and cash equivalents. This is an increase of $5.6 million from the balance at December&#160;31, 2020. Our foreign subsidiaries held cash of approximately $101.8 million at March&#160;31, 2021 and&#160;$88.8 million at&#160;December&#160;31, 2020, to meet their liquidity needs. No material restrictions exist to accessing cash held by our foreign subsidiaries notwithstanding any potential tax consequences. Cash balances in the United States decreased in the three months ended March&#160;31, 2021 primarily as a result of the cash outflows for the BioScience acquisition and the purchase of the 15% mandatorily redeemable noncontrolling interest of Nelson Labs Fairfield, coupled with normal quarterly interest payments on our outstanding debt.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our capital expenditure program is a component of our long-term strategy. This program includes, among other things, investments in new and existing facilities, business expansion projects, Co-60 used by Sterigenics at its gamma irradiation facilities, cobalt development projects and information technology enhancements. During the three months ended March&#160;31, 2021, our capital expenditures amounted to $20.9 million, compared to $13.0 million for the three months ended March&#160;31, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash on hand, operating cash flows and amounts available under our credit facilities will provide sufficient working capital to operate our business, make expected capital expenditures, meet litigation costs and meet foreseeable liquidity requirements, including debt service on our long-term debt, for at least the next twelve months. As of March&#160;31, 2021, there were no outstanding borrowings on the Revolving Credit Facility. We expect to use cash provided by operations in excess of amounts needed for capital expenditures, to fund potential acquisitions, or for other general corporate purposes. Our ability to meet future working capital, capital expenditures and debt service requirements will depend on our future financial performance, which will be affected by a range of macroeconomic, competitive and business factors, including interest rate changes and changes in our industry, many of which are outside of our control. As of March&#160;31, 2021, the amended and new interest rate caps limit our cash flow exposure related to LIBOR for approximately 81% of our variable rate borrowings to the facility LIBOR floor of 0.5%. Refer to Note 17, &#8220;Financial Instruments and Financial Risk&#8221; under the heading &#8220;Derivative Instruments&#8221; for additional information regarding the interest rate caps used to manage economic risks associated with our variable rate borrowings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flow Information</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended March 31, 2021 compared to the Three Months Ended March 31, 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:76.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.779%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Cash Provided by (Used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">56,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(46,519)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,307&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of foreign currency exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(295)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net increase (decrease) in cash and cash equivalents, including restricted cash, during the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5,562</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating activities </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by operating activities increased $50.5 million to net cash provided of $56.2 million in the three months ended March&#160;31, 2021 compared to $5.7 million for the three months ended March&#160;31, 2020. Higher cash flows from operating activities in the three months ended March&#160;31, 2021 compared to the three months ended March&#160;31, 2020 were driven primarily by a decrease in cash paid for interest of $43.8 million, offset by an increase in cash paid for income taxes of $9.7 million. In addition, a decrease in net operating assets for the three months ended March&#160;31, 2021 resulted in a lower use of cash for operating activities of $7.6 million compared to $19.8 million for the three months ended March&#160;31, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing activities </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used by investing activities increased $33.5 million to net cash used of $46.5 million in the three months ended March&#160;31, 2021 compared to $13.0 million for the three months ended March&#160;31, 2020. The change was attributable to the acquisition of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioScience on March 8, 2021 for a net purchase price of approximately $13.2 million, the acquisition of the mandatorily redeemable noncontrolling interest in Nelson Labs Fairfield for $12.4 million and an increase in cash paid for capital expenditures of $8.0 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing activities </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, net cash used in financing activities was $3.8 million compared to net cash provided of $49.3 million for the three months ended March&#160;31, 2020. The primary use of cash from financing activities was the payment of $3.4 million of debt issuance costs in connection with our refinancing of the Senior Secured Credit Facilities as described in &#8220;Debt Facilities&#8221; below. Cash provided by financing activities for the three months ended March&#160;31, 2020 was primarily attributable to a $50.0 million borrowing on our Revolving Credit Facility, which was subsequently repaid in the second quarter of 2020.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Facilities </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;13, 2019, Sotera Health Holdings, LLC (&#8220;SHH&#8221;), our wholly owned subsidiary, entered into senior secured first lien credit facilities (the &#8220;Senior Secured Credit Facilities&#8221;), consisting of both a prepayable senior secured first lien term loan (the &#8220;Term Loan&#8221;) and a senior secured first lien revolving credit facility (the &#8220;Revolving Credit Facility&#8221;) pursuant to a first lien credit agreement (the &#8220;Credit Agreement&#8221;). The Term Loan matures on December 13, 2026, and the Revolving Credit Facility's original maturity date was December 13, 2024. On December 17, 2020, we increased the capacity of our Revolving Credit Facility from $190.0 million to $347.5 million. The Senior Secured Credit Facilities also provide SHH the right at any time and under certain conditions to request incremental term loans or incremental revolving credit commitments based on a formula defined in the Senior Secured Credit Facilities. As of March&#160;31, 2021 and December&#160;31, 2020, total borrowings under the Term Loan were $1,763.1 million and $1,763.1 million, respectively, and there were no borrowings outstanding on the Revolving Credit Facility. The weighted average interest rate on borrowings under the Term Loan for the three months ended March&#160;31, 2021 and March&#160;31, 2020 was 3.73% and 6.18%, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, we closed on an amendment repricing our Term Loan. The interest rate spread over the London Interbank Offered Rate (&#8220;LIBOR&#8221;) on the facility was reduced from 450 basis points to 275 basis points, and the facility&#8217;s LIBOR floor was reduced from 100 basis points to 50 basis points. The changes result in an effective reduction in current interest rates of 2.25%. As a result of the repricing, we expect cash interest savings of approximately $40.0 million per year based on the outstanding principal balance as of March&#160;31, 2021. In connection with this amendment, we wrote off $11.3 million of unamortized debt issuance and discount costs and incurred an additional $2.9 million of expense related to debt issuance costs attributable to the refinancing. These costs were recorded to &#8220;Loss on extinguishment of debt&#8221; in our Consolidated Statements of Operations and Comprehensive Income (Loss). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs totaled $3.1 million and $3.4 million, respectively, and debt discounts totaled $20.0 million and $31.6 million, respectively, related to the Senior Secured Credit Facilities. Such costs are recorded as a reduction of debt on our consolidated balance sheets and amortized as a component of interest expense over the term of the debt agreement.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2021, we amended the Revolving Credit Facility, to (i) decrease the Applicable Rate (as defined in the Credit Agreement) related to any Revolving Loans (as defined in the Credit Agreement) from a rate per annum that ranged from an alternative base rate (&#8220;ABR&#8221;) plus 2.50% to ABR plus 3.00% depending on SHH&#8217;s Senior Secured First Lien Net Leverage Ratio to ABR plus 1.75%; and in the case of Eurodollar Loans (as defined in the Credit Agreement) from a rate per annum which ranged from the Adjusted LIBOR plus 3.50% to the Adjusted LIBOR plus 4.00% depending on SHH&#8217;s Senior Secured First Lien Net Leverage Ratio (as defined in the Credit Agreement), to the Adjusted LIBOR (as defined in the Credit Agreement) plus 2.75% and (ii) extend the maturity date of the Revolving Facility from December 13, 2024 to June 13, 2026. The other material terms of the Credit Agreement are unchanged and the amendment does not change the capacity of our Revolving Credit Facility, which is $347.5 million. No unamortized debt issuance costs associated with the Revolving Credit Facility were written off and direct fees and costs incurred in connection with the amendment were immaterial. </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, there were no borrowings on the Revolving Credit Facility. SHH borrowed $50.0 million on the Revolving Credit Facility during the first quarter of 2020 which was repaid in the second quarter of 2020. The interest rate on the borrowings under the Revolving Credit Facility during 2020 averaged approximately 5.0%. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of SHH&#8217;s obligations under the Senior Secured Credit Facilities are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of the Company, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the Senior Secured Credit Facilities, and the guarantees of such obligations, are secured by substantially all assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the Senior Secured Credit Facilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding letters of credit are collateralized by encumbrances against the Revolving Credit Facility and the collateral pledged thereunder, or by cash placed on deposit with the issuing bank. As of March&#160;31, 2021, the Company had $65.8 million of letters of credit issued against the Revolving Credit Facility, resulting in total availability under the Revolving Credit Facility of $281.7 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Lien Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, SHH issued $100.0 million aggregate principal amount of senior secured first lien notes due 2026 (the &#8220;First Lien Notes&#8221;), which mature on December 13, 2026. The First Lien Notes bear interest at a rate equal to LIBOR subject to a 1.00% floor plus 6.00% per annum. Interest is payable on a quarterly basis with no principal due until maturity. The weighted average interest rate on the First Lien Notes for the three months ended March&#160;31, 2021 was 7.00%.  </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SHH is entitled to redeem all or a portion of the First Lien Notes, at any time and from time to time, subject to certain premiums depending on the date of redemption; any time on or prior to July 31, 2021, a customary make-whole premium applies and, thereafter, specified premiums that decline to zero apply (in each case as described in the indenture governing the First Lien Notes). </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of SHH&#8217;s obligations under the First Lien Notes are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of SHH, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the First Lien Notes, and the guarantees of such obligations, are secured by substantially all of the assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the First Lien Notes. Such collateral is substantially the same collateral that secures the Senior Secured Credit Facilities. Such collateral securing the First Lien Notes ranks pari passu with that of the Senior Secured Credit Facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs were $0.8 million and $0.9 million, respectively, and debt discounts were $2.7 million and $2.8 million, respectively, related to the First Lien Notes, which are recorded as a reduction of debt on our Consolidated Balance Sheets and amortized into interest expense over the term of the debt agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Debt Repayments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 24, 2020, we closed our initial public offering (the "IPO&#8221;), in which we sold 53,590,000 shares of our common stock at a price of $23.00 per share, which included the full exercise by the underwriters of their option to purchase up to an additional 6,990,000 shares of common stock. We raised approximately $1.2 billion in net proceeds after deducting underwriters&#8217; discounts and commissions. We used the net proceeds received by us from the IPO to (i) redeem $770.0 million in aggregate principal amount of the Second Lien Senior Secured Notes with an original maturity date of December 13, 2027 (the "Second Lien Notes&#8221;), plus accrued and unpaid interest thereon and $15.4 million of redemption premium, (ii) repurchase 1,568,445 shares of our common stock from certain of our executive officers at a purchase price per share equal to the IPO price per share of our common stock less an amount equal to the underwriting discounts and commissions payable thereon and (iii) repay $341.0 million of the outstanding indebtedness under the Term Loan, plus accrued and unpaid interest thereon. In connection with the debt repayments, we wrote off $28.9 million of debt issuance and discount costs and recognized $15.4 million in premiums paid for the early extinguishment of the Second Lien Notes. We recognized these costs within &#8220;Loss on extinguishment of debt&#8221; in our Consolidated Statements of Operations and Comprehensive Income (Loss) in the fourth quarter of 2020.</span></div><div id="i15ef643796c34829b3bb28475338f021_121"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions at a specific point in time and in certain circumstances that affect amounts reported in the accompanying consolidated financial statements. In preparing these consolidated financial statements, management has made its best estimates and judgments of certain amounts, giving due consideration to materiality. The application of accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A comprehensive discussion of the Company&#8217;s critical accounting policies and management estimates made in connection with  the preparation of the financial statements is included in Item 7 of our Annual Report on Form 10-K for the year ended December&#160;31, 2020. There have been no significant changes in critical accounting policies, management estimates or accounting policies since the year ended December&#160;31, 2020. </span></div><div id="i15ef643796c34829b3bb28475338f021_124"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recent accounting pronouncements applicable to our business, see Note 2, &#8220;Recent Accounting Standards&#8221;.</span></div><div id="i15ef643796c34829b3bb28475338f021_127"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risks are described within &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; in Part II, Item 7A of our 2020 Form 10-K. These market risks have not materially changed for the three months ended March&#160;31, 2021.</span></div><div id="i15ef643796c34829b3bb28475338f021_130"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures,&#8221; (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;)).  Based upon their evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (&#8220;SEC&#8221;), and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">41</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II&#8212;OTHER INFORMATION</span></div><div id="i15ef643796c34829b3bb28475338f021_136"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to various legal proceedings arising in the ordinary course of our business, including claims relating to personal injury, property damage, workers&#8217; compensation and employee safety. In addition, from time to time, we receive communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which we operate. At this time, and except as is noted herein, we are unable to predict the outcome of, and cannot reasonably estimate the impact of, any pending litigation matters, matters concerning allegations of non-compliance with laws or regulations and matters concerning other allegations of other improprieties, or the incidence of any such matters in the future. Information regarding our legal proceedings is included below. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings Described in Note 16 of Our Consolidated Financial Statements </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 16, &#8220;Commitments and Contingencies&#8221; to our consolidated financial statements for the three months ended March&#160;31, 2021 contained in this Quarterly Report on Form 10-Q includes information on legal proceedings that constitute material contingencies for financial reporting purposes that could have a material effect on our financial condition or results of operations. This item should be read in conjunction with Note 16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for information regarding the following legal proceedings, which information is incorporated into this item by reference:</span></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FM Global Business Interruption Claim (NRU Outage)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Willowbrook, Illinois &#8211; Government Litigation</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethylene Oxide Tort Litigation &#8211; Illinois</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethylene Oxide Tort Litigation &#8211; Georgia</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspension of Georgia Facility Operations &amp; Related Litigation; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ethylene Oxide Litigation &#8211; New Mexico</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings That Are Not Described in Note 16 to Our Consolidated Financial Statements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the matters that are identified in Note 16 to our consolidated financial statements for the three months ended March&#160;31, 2021 contained in this Quarterly Report on Form 10-Q, and incorporated into this item by reference, the following matter also constitutes a material pending legal proceeding, other than ordinary course litigation incidental to our business, to which we are or any of our subsidiaries is a party.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zoetermeer, Holland Criminal Proceedings and Criminal Financial Investigation</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2010, the Dutch Public Prosecution Service started criminal proceedings against DEROSS Holding B.V. (&#8220;DEROSS B.V.&#8221;), formerly known as Sterigenics Holland B.V., in relation to certain EO emissions and alleged environmental permit violations in the period from 2004 to 2009 at its Zoetermeer processing facility. On the basis of the final indictment issued in April 2017, assuming a rarely applied increasing mechanism is not applied in this case, fines in the amount of &#8364;0.8 million (US$0.9 million) may be imposed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2010, the Public Prosecution Service also started a criminal financial investigation against DEROSS B.V. to determine whether it has obtained illegal advantages by committing the alleged criminal offenses noted above. Any illegally obtained advantage could then be recovered from DEROSS B.V. in subsequent confiscation proceedings. According to the October 2013 report of this criminal financial investigation, the Public Prosecution Service estimates the illegally obtained advantage by DEROSS B.V. to be in the amount of &#8364;0.6 million (US$0.7 million).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the trial in first instance took place in the criminal case against DEROSS B.V., and in February 2018, the court discharged DEROSS B.V. from further prosecution on one of the two counts asserted and acquitted DEROSS B.V. on the other count. In March 2018, the public prosecutor filed an appeal against the favorable judgment in first instance for DEROSS B.V., as well as the favorable judgments in first instance for the two individuals overseeing environmental compliance during the time period of the alleged claims and the municipality of Zoetermeer. The appeal procedure is pending.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEROSS B.V. has agreed to defend and indemnify the two individuals overseeing environmental compliance during the time period of the alleged claims by the Public Prosecutor. Assuming a rarely applied increasing mechanism is not applied in this case, the possible monetary penalties relating to the individuals currently are estimated at a maximum of &#8364;0.2 million (US$0.2 million).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2011, former shareholders established an escrow account to satisfy indemnity claims for losses resulting from governmental claims related to this matter, including those relating to environmental law violations, financial advantage claims, as well as criminal and civil fines and penalties. The balance of the special escrow at March&#160;31, 2021, was approximately US$2.1 million and the cash collateral held by ABN Amro to provide security for the claims against us was approximately &#8364;2.4 million (US$2.8 million) as of March&#160;31, 2021. These amounts are available to satisfy claims relating to the ongoing matter through its anticipated resolution. At this time, we expect that the appeal of this matter will likely take several years to resolve, barring unforeseen delays. However, we believe the indemnification receivable continues to be recoverable and plan to ensure escrow funds remain in place to cover outcomes of an appeal.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that individuals living in the vicinity of our former Zoetermeer facility may file civil claims at some time in the future. While we have received letters from a small number of individuals claiming to live or work in the vicinity of the Zoetermeer facility, no civil claims have been filed against DEROSS B.V. or us. We have not provided for a contingency reserve in connection with any civil claims as we are unable to determine the likelihood of an unfavorable outcome and no reasonable estimate of a loss or range of losses, if any, can be made.</span></div><div id="i15ef643796c34829b3bb28475338f021_139"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in our 2020 Form 10-K. Refer to Part I, Item 1A of our 2020 Form 10-K for a detailed discussion of risk factors affecting us.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">43</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in the following Exhibit Index are filed, furnished, or incorporated by reference as part of this Quarterly Report on Form 10-Q. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;No</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">File No.</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Furnished/Filed <br/>Herewith</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1822479/000182247921000018/shc_20201231xexhibitx10x28.htm">Refinancing Amendment to the First Lien Credit Agreement, dated as of January 20, 2021, among Sotera Health Company, Sotera Health Holdings, LLC, the Refinancing Lenders Party thereto, the Revolving Lenders party to the First Lien Credit Agreement and Jefferies Finance LLC, as First Lien Administrative Agent and First Lien Collateral Agent</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-39729</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.28</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021-03-09</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">R</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">ev</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">olving Facilities</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm"> Amendment to the First Lien Credit Agreement, dated as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">M</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">arch 26,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">2021</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc-20210331_exhibitx10x2.htm">, among Sotera Health Company, Sotera Health Holdings, LLC, the Refinancing Lenders Party thereto, the Revolving Lenders party to the First Lien Credit Agreement and Jefferies Finance LLC, as First Lien Administrative Agent and First Lien Collateral Agent</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc_20210331xexhibitx31x1.htm">Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 </a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc20210331_exhibitx31x2.htm">Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="shc20210331_exhibitx32x1.htm">Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document - The XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed Herewith</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished Herewith</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">44</span></div></div></div><div id="i15ef643796c34829b3bb28475338f021_157"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOTERA HEALTH COMPANY</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Scott J. Leffler</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scott J. Leffler</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer and Treasurer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial Officer)</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: May 13, 2021</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">45</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>shc-20210331_exhibitx10x2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iaab464944f4e470daaf77a3c1562e9f4_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.2</font></div></div><div style="margin-top:3.9pt;padding-right:10.9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXECUTION VERSION</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:3.9pt;padding-right:10.9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">REVOLVING FACILITIES AMENDMENT TO FIRST LIEN CREDIT AGREEMENT,</font></div><div style="padding-left:60pt;padding-right:10.6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">dated as of March 26, 2021 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), is made and entered into by and among Sotera Health Company (f&#47;k&#47;a Sotera Health Topco, Inc.), a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Holdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), Sotera Health Holdings, LLC, a Delaware limited liability company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Borrower</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each of the entities listed under the caption &#8220;Extending Revolving Lenders&#8221; on the signature pages hereto (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Extending Revolving</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Extending Revolving Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), each of the entities listed under the caption &#8220;Consenting Issuing Banks&#8221; on the signature pages hereto (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consenting Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consenting Issuing Banks</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), JPMorgan Chase Bank, N.A., as First Lien Administrative Agent (solely in such capacity, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and, for purposes of Sections 6 and 8 hereof only, the other Loan Parties as of the date hereof.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:240.65pt;padding-right:240.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">RECITALS&#58;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:60pt;padding-right:10.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, reference is made to the First Lien Credit Agreement dated as of December 13, 2019, by and among Holdings, the Borrower, the lenders from time to time party thereto and the Administrative Agent, as amended by that certain Incremental Facility Amendment to First Lien Credit Agreement, dated as of December 17, 2020, among the Borrower, Holdings, the Subsidiary Guarantors party thereto, Jefferies Finance LLC (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Jefferies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), as administrative agent, as further amended by that certain Refinancing Amendment to First Lien Credit Agreement, dated as of January 20, 2021, among the Borrower, Holdings, the Subsidiary Guarantors party thereto, Jefferies and the Refinancing Lenders party thereto, as further amended by that certain Resignation, Consent and Appointment Agreement, dated as of January 20, 2021, among Jefferies, the Borrower, Holdings and JPMorgan Chase Bank, N.A., as the successor administrative agent and collateral agent (as it may be further amended, supplemented or otherwise modified to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div><font><br></font></div><div style="margin-top:4.6pt;padding-left:60pt;padding-right:10.6pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Borrower has (i) pursuant to Section 2.24(a) of the Credit Agreement, by written notice to the Administrative Agent, made a Loan Modification Offer (as defined in the Credit Agreement) to the Revolving Lenders to effect Permitted Amendments (as defined in the Credit Agreement) that shall (a) modify the Revolving Maturity Date (as defined in the Credit Agreement) with respect to each Revolving Commitment (as defined in the Credit Agreement) and each Revolving Loan (as defined in the Credit Agreement) of such Extending Revolving Lenders (as defined below) to be June 13, 2026 (or if such day is not a Business Day, the immediately preceding Business Day) and (b) modify the Applicable Rate (as defined in the Credit Agreement) in the manner described below with respect to each Revolving Commitment and each Revolving Loan of such Extending Revolving Lenders, which Loan Modification Offer sets forth the date hereof as the date on which such Permitted Amendments are requested to become effective, and (ii) requested that each of the Issuing Banks (as defined in the Credit Agreement) consent to such extension of maturity and modification of rate and agree to the Permitted Amendments set forth herein (the transactions described in this paragraph, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-top:12pt;padding-left:60pt;padding-right:10.95pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, subject to the terms and conditions of the Credit Agreement, and pursuant to the foregoing, the Borrower has requested that the Credit Agreement be amended in the manner provided for herein&#59; and</font></div><div style="margin-top:12pt;padding-left:60pt;padding-right:10.9pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the parties hereto wish to amend the Credit Agreement on the terms and subject to the conditions set forth herein and in the Credit Agreement.</font></div><div style="margin-top:12pt;padding-left:58.5pt;padding-right:10.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the mutual agreements herein contained and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties hereto agree as follows&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_4"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:60pt;padding-right:10.75pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">SECTION 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:117%">Defined Terms&#59; Interpretation&#59; Etc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. Capitalized terms used and not defined herein shall have the meanings assigned to such terms in the Credit Agreement. This Amendment is a &#8220;First Lien Loan Document&#8221; as defined in the Credit Agreement.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:132pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Amendments to Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each of the parties hereby agrees that&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:159pt;padding-right:10.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.8pt">Section 1.01 of the Credit Agreement is hereby amended by inserting the following new definitions in their correct alphabetical order&#58;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:96pt;padding-right:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Consenting Issuing Bank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means each Issuing Bank that has consented and agreed to the Transactions set forth in the Revolving Facilities Amendment by delivering an executed counterpart thereof to the First Lien Administrative Agent on or prior to March 26, 2021.&#8221;</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:96pt;padding-right:10.75pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Extended Revolving Commitment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Revolving Commitments extended on the Revolving Facilities Amendment Effective Date.&#8221;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:96pt;padding-right:10.85pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Extended Revolving Loan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; means a Revolving Loan made with respect to an Extended Revolving Commitment.&#8221;</font></div><div><font><br></font></div><div style="padding-left:96pt;padding-right:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Extending Revolving Lender</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means each Revolving Lender that voted in favor of the Revolving Facilities Amendment by delivering an executed counterpart thereof to the First Lien Administrative Agent on or prior to March 26, 2021.&#8221;</font></div><div><font><br></font></div><div style="padding-left:96pt;padding-right:10.7pt;text-align:justify;text-indent:38.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Facilities Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Revolving Facilities Amendment to this Agreement, dated as of March 26, 2021 among the Borrower, the Extending Revolving Lenders party thereto, the Consenting Issuing Banks party thereto, the Administrative Agent and the other parties thereto.&#8221;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:96pt;padding-right:10.8pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;text-decoration:underline">Revolving Facilities Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">&#8221; means the date set forth in the definition of Revolving Facilities Amendment.&#8221;</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.18pt">The definition of &#8220;Applicable Rate&#8221; in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety as follows&#8221;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:96pt;padding-right:10.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">Applicable Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">&#8221; means, for any day, with respect to any Loan, (i) ABR plus 1.75% per annum, in the case of an ABR Loan, or (ii) the Adjusted LIBO Rate plus 2.75% per annum, in the case of a Eurodollar Loan.&#8221;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:8.8pt">The definition of &#8220;Revolving Commitment&#8221; in Section 1.01 of the Credit Agreement is hereby amended and restated in its entirety as follows&#58;</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:96pt;padding-right:10.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Commitmen</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">t&#8221; means, with respect to each Lender, the commitment, if any, of such Lender to make Revolving Loans and to acquire participations in Letters of Credit and Swingline Loans hereunder, expressed as an amount representing the maximum possible aggregate amount of such Lender&#8217;s Revolving Exposure hereunder, as such commitment may be</font></div><div style="padding-left:96pt;padding-right:10.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:35.8pt">reduced from time to time pursuant to Section 2.08 and (b) reduced or increased from time to time pursuant to (i) assignments by or to such Lender pursuant to an Assignment and Assumption, (ii) an Incremental Facility Amendment, (iii) a Refinancing Amendment, (iv) an Incremental Revolving Commitment Increase, (v) without duplication of the foregoing clause (v),</font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_7"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:96pt;padding-right:10.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Amendment No. 1 Revolving Commitment Increase, (vi) without duplication of the following clause (vii), the Extended Revolving Commitments, (vii) a Loan Modification Agreement or (viii) an Additional&#47;Replacement Revolving Commitment. The initial amount of each Lender&#8217;s Revolving Commitment is set forth on Schedule 2.01(A), with respect to the Amendment No. 1 Revolving Commitment Increase, Schedule I of Amendment No. 1, or, in each case, in the Assignment and Assumption, Loan Modification Agreement or Refinancing Amendment pursuant to which such Lender shall have assumed its Revolving Commitment, as the case may be. As of the Amendment No. 1 Effective Date, the aggregate amount of the Lenders&#8217; Revolving Commitments is $347,500,000.&#8221;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:30.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21pt">The definition of &#8220;Revolving Maturity Date&#8221; in Section 1.01 of the Credit Agreement is hereby amended by replacing &#8220;December 13, 2024&#8221; therein with &#8220;June 13, 2026&#8221;.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:60pt;padding-right:10.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Type of Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower and the Administrative Agent hereby agree that all amendments set forth herein are Permitted Amendments, this Amendment is a Loan Modification Agreement and, in the opinion of the Administrative Agent and the Borrower, necessary and&#47;or appropriate to effectuate the provisions of Section 2.24 of the Credit Agreement.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:60pt;padding-right:10.65pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 4. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Conditions to the Effectiveness of the Revolving Facilities Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Amendment shall become effective as of the date on which the following conditions are satisfied or waived (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Facilities Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:4.6pt;padding-left:159pt;padding-right:10.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.75pt">The Administrative Agent (or its counsel) shall have received from Holdings, the Borrower, each other Loan Party and each Extending Revolving Lender and each Consenting Issuing Bank either (i) a counterpart of this Amendment signed on behalf of such party or (ii) written evidence satisfactory to the Administrative Agent (which may include facsimile or other electronic transmission of a signed counterpart of this Amendment) that such party has signed a counterpart of this Amendment.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.75pt">The Administrative Agent shall have received a written opinion (addressed to the Administrative Agent, the Extending Revolving Lenders and the Consenting Issuing Banks and dated the Revolving Facilities Amendment Effective Date) of each of (i) Cleary Gottlieb Steen &#38; Hamilton LLP, New York counsel for the Loan Parties and (ii) Richards, Layton &#38; Finger, P.A., Delaware counsel for the Loan Parties, in each case in form and substance reasonably satisfactory to the Administrative Agent.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.75pt">The Administrative Agent shall have received a certificate of each Loan Party, dated the Revolving Facilities Amendment Effective Date, in form and substance reasonably satisfactory to the Administrative Agent, executed by any Responsible Officer of such Loan Party and including or attaching the documents or certifications, as applicable, referred to in paragraph (d) of this Section below.</font></div><div><font><br></font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.75pt">The Administrative Agent shall have received (i) as to each Loan Party, either (x) a copy of each Organizational Document of such Loan Party certified, to the extent applicable, as of a recent date by the applicable Governmental Authority or (y) written certification by such Loan Party&#8217;s secretary,</font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_10"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">assistant secretary or other Responsible Officer that such Loan Party&#8217;s Organizational Documents most recently certified and delivered to the Administrative Agent prior to the Revolving Facilities Amendment Effective Date pursuant to the First Lien Loan Documents remain in full force and effect on the Revolving Facilities Amendment Effective Date without modification or amendment since such original delivery, (ii) as to each Loan Party, either (x) signature and incumbency certificates of the Responsible Officers of such Loan Party executing the First Lien Loan Documents to which it is a party or (y) written certification by such Loan Party&#8217;s secretary, assistant secretary or other Responsible Officer that such Loan Party&#8217;s signature and incumbency certificates most recently delivered to the Administrative Agent prior to the Revolving Facilities Amendment Effective Date pursuant to the First Lien Loan Documents remain true and correct as of the Revolving Facilities Amendment Effective Date,</font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii) copies of resolutions of the board of directors and&#47;or similar governing bodies of each Loan Party approving and authorizing the execution, delivery and performance of this Amendment, certified as of the Revolving Facilities Amendment Effective Date by a secretary, an assistant secretary or a Responsible Officer of such Loan Party as being in full force and effect without modification or amendment, and (iv) a good standing certificate (to the extent such concept exists) from the applicable Governmental Authority of each Loan Party&#8217;s jurisdiction of incorporation, organization or formation as of a reasonably recent date.</font></div><div><font><br></font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.75pt">The Administrative Agent shall have received a certificate from the chief financial officer of the Borrower certifying as to the solvency of the Borrower and its Subsidiaries on a consolidated basis after giving effect to the Transactions, substantially in the form of Exhibit P to the Credit Agreement (as updated to reflect Loan Party name changes and current Administrative Agent).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.75pt">The Administrative Agent shall have received, at least three Business Days prior to the Revolving Facilities Amendment Effective Date, all documentation and other information about the Borrower and the other Loan Parties as shall have been reasonably requested in writing at least ten Business Days prior to the Revolving Facilities Amendment Effective Date by the Administrative Agent that they shall have reasonably determined is required by regulatory authorities under applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including without limitation the USA PATRIOT Act.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:118%;padding-left:12.75pt">Each of the representations set forth in Section 5 of this Amendment shall be true and correct.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:60pt;padding-right:17.4pt;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrative Agent shall notify Holdings, the Borrower and the Lenders of the Revolving Facilities Amendment Effective Date, and such notice shall be conclusive and binding.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:60pt;padding-right:10.65pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Representations and Warranties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Borrower hereby represents and warrants that, after giving effect to this Amendment, (i) no Event of Default has occurred and is continuing and (ii) the representations and warranties of each Loan Party set forth in the First Lien Loan Documents are true and correct in all material respects on and as of the Revolving Facilities Amendment Effective Date&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that, in each case, to the extent that such representations and warranties specifically refer to an earlier date, they are true and correct in all material respects as of such earlier date&#59;</font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_13"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:60pt;padding-right:10.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%"> that, in each case, any representation and warranty that is qualified as to &#8220;materiality,&#8221; &#8220;Material Adverse Effect&#8221; or similar language is true and correct in all respects on the Revolving Facilities Amendment Effective Date or on such earlier date, as the case may be.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:60pt;padding-right:10.65pt;text-align:justify;text-indent:35.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Reaffirmation of Guarantees and Security Interests</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Loan Party hereby acknowledges its receipt of a copy of this Amendment and its review of the terms and conditions hereof and consents to the terms and conditions of this Amendment and the transactions contemplated hereby. Each Loan Party hereby (a) affirms and confirms its guarantees, pledges, grants and other undertakings under the Credit Agreement and the other First Lien Loan Documents to which it is a party, (b) agrees that (i) each First Lien Loan Document to which it is a party shall continue to be in full force and effect and (ii) all guarantees, pledges, grants and other undertakings thereunder shall continue to be in full force and effect and shall accrue to the benefit of the Secured Parties and (c) acknowledges that from and after the date hereof, all Revolving Loans from time to time outstanding shall be deemed to be Secured Obligations.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:60pt;padding-right:10.8pt;text-align:justify;text-indent:71.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Expenses&#59; Indemnity&#59; Damage Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Sections 9.03(a), (b), (d), (e), (f) and (g) of the Credit Agreement are hereby incorporated, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">mutatis mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, by reference as if such Sections were set forth in full herein&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that, notwithstanding anything else therein, such expense reimbursement provisions of Section 9.03(a) of the Credit Agreement shall only apply as provided hereinabove if the Revolving Facilities Amendment Effective Date occurs.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:132pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SECTION 8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.8pt">Recordation of Revolving Loans and Revolving Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Upon execution and delivery hereof, the Administrative Agent will record in the Register the Revolving Loans that are Extended Revolving Loans and the Revolving Commitments that are Extended Revolving Commitments (all as set forth on Schedule I hereto).</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:117%;padding-left:8.18pt">Amendment, Modification and Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">. This Amendment may not be amended nor may any provision hereof be waived except pursuant to a writing signed by each of the parties hereto.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.8pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Amendment, the Credit Agreement (as amended hereby) and the other First Lien Loan Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.8pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:117%;padding-left:8.18pt">Governing Law. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:117%">This Amendment shall be construed in accordance with and governed by the laws of the State of New York.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.8pt">Jurisdiction. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each party hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of the Supreme Court of the State of New York sitting in New York County and of the United States District Court of the Southern District of New York, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Amendment, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in</font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_16"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">such New York State or, to the extent permitted by law, in such Federal court. Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law. Nothing in any First Lien Loan Document shall affect any right that the Administrative Agent, any Extending Revolving Lender or any Consenting Issuing Bank may otherwise have to bring any action or proceeding relating to this Amendment against Holdings or the Borrower or their respective properties in the courts of any jurisdiction.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.37pt">Waiver of Objection to Venue and Forum Non Conveniens</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each party hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Amendment in any court referred to in Section 10(e) above. Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.75pt">Consent to Service of Process. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Each party to this Amendment irrevocably consents to service of process in the manner provided for notices in Section 9.01 of the Credit Agreement. Nothing in any First Lien Loan Document will affect the right of any party to this Amendment to serve process in any other manner permitted by law.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.75pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.37pt">WAIVER OF JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AMENDMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AMENDMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.75pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any term or provision of this Amendment which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Amendment or affecting the validity or enforceability of any of the terms or provisions of this Amendment in any other jurisdiction. If any provision of this Amendment is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as would be enforceable.</font></div><div style="padding-left:123pt;padding-right:10.85pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="padding-left:123pt;padding-right:10.85pt;text-align:justify;text-indent:90pt"><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:123pt;padding-right:10.85pt;text-align:right;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.85pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.37pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Amendment may be executed in counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page of this Amendment by facsimile or electronic transmission shall be as effective as delivery of a manually executed counterpart hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.59pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The headings of this Amendment are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.7pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.75pt">Continued Effectiveness</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything contained herein, the terms of this Amendment are not intended to and do not serve to effect a novation as to the Credit Agreement. The parties hereto expressly do not intend to extinguish the Credit Agreement. Instead, it is the express intention of the parties hereto to reaffirm the indebtedness created under the Credit Agreement which is secured by the Collateral and the Liens and guarantees thereunder. The Credit Agreement (as amended hereby) and each of the First Lien Loan Documents remain in full force and effect.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:12.75pt">Electronic Signatures.   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Delivery of an executed counterpart of a signature page of this Amendment, that is an Electronic Signature (as defined below) transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page shall be effective as delivery of a manually executed counterpart of this Amendment. The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include Electronic Signatures, deliveries or the keeping of records in any electronic form (including deliveries by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page), each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be&#59; provided that nothing herein shall require the Administrative Agent to accept Electronic Signatures in any form or format without its prior written consent and pursuant to procedures approved by it&#59; provided, further, without limiting the foregoing, (i) to the extent the Administrative Agent has agreed to accept any Electronic Signature, the Administrative Agent and each of the Lenders (including the Extending Revolving Lenders) shall be entitled to rely on such Electronic Signature purportedly given by or on behalf of the Borrower or any other Loan Party without further verification thereof and without any obligation to review the appearance or form of any such Electronic Signature and (ii) upon the request of the Administrative Agent or any Lender (including any Extending Revolving Lender), any Electronic Signature shall be promptly followed by a manually executed counterpart. Without limiting the generality of the foregoing, the Borrower hereby (i) agrees that, for all purposes, including without limitation, in connection with any workout, restructuring, enforcement of remedies, bankruptcy proceedings or litigation among the Administrative Agent, the Lenders (including the Extending Revolving Lenders), and the Borrower, Electronic Signatures transmitted by telecopy, emailed pdf. or any other electronic means that reproduces an image of an actual executed signature page and&#47;or any electronic images of this Amendment, any other First Lien Loan Document and&#47;or any other document</font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_19"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">signed in connection with this Amendment and the transactions contemplated thereby, shall have the same legal effect, validity and enforceability as any paper original, and (ii) waives any argument, defense or right to contest the legal effect, validity or enforceability of this Amendment, any other First Lien Loan Document and&#47;or any Ancillary Document based solely on the lack of paper original copies of this Amendment, such other First Lien Loan Document and&#47;or such Ancillary Document, respectively, including with respect to any signature pages thereto. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Signature</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means an electronic sound, symbol, or process attached to, or associated with, a contract or other record and adopted by a Person with the intent to sign, authenticate or accept such contract or record.</font></div><div style="padding-left:159pt;padding-right:10.65pt;text-align:justify"><font><br></font></div><div style="padding-left:122.32pt;padding-right:122.32pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Remainder of this page intentionally left blank</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font></div><div style="padding-left:234pt"><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_22"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:72pt;padding-right:10.65pt;text-indent:36pt"><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.</font></div><div style="padding-left:72pt;padding-right:10.65pt;text-indent:36pt"><font><br></font></div><div style="text-align:right;text-indent:243pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.092%"><tr><td style="width:1.0%"></td><td style="width:13.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SOTERA HEALTH HOLDINGS, LLC,</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Borrower</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Scott J. Leffler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Scott J. Leffler</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:10.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer and Treasurer</font></div></td></tr></table></div><div style="text-align:right;text-indent:243pt"><font><br></font></div><div style="text-align:right;text-indent:243pt"><font><br></font></div><div style="text-align:right;text-indent:243pt"><font><br></font></div><div style="text-align:right;text-indent:243pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.092%"><tr><td style="width:1.0%"></td><td style="width:13.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SOTERA HEALTH COMPANY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">as Holdings</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Scott J. Leffler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Scott J. Leffler</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:10.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer and Treasurer</font></div></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_25"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.092%"><tr><td style="width:1.0%"></td><td style="width:13.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">JPMORGAN CHASE BANK N.A., as Administrative Agent, Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Dawn Lee Lum</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:113%">Name&#58; Dawn Lee Lum</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">Title&#58;&#160;&#160;&#160;&#160;Executive Director</font></div></td></tr></table></div><div><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_28"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">CREDIT SUISSE AG, CAYMAN ISLANDS</font></div><div style="padding-right:9.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BRANCH, as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10pt;padding-right:-35.3pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Whitney Gaston</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">Name&#58; Whitney Gaston</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Title&#58; Authorized Signatory</font></div></td></tr></table></div><div style="margin-top:0.45pt;padding-left:36pt;text-align:right"><font><br></font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.092%"><tr><td style="width:1.0%"></td><td style="width:13.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-83.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Andrew Griffin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">Name&#58; Andrew Griffin</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Title&#58; Authorized Signatory</font></div></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_31"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:0.05pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">GOLDMAN SACHS BANK USA, as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Jacob Elder</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:50.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:108%">Name&#58; Jacob Elder</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Title&#58; Authorized Signatory</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_34"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:10pt;padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">JEFFERIES FINANCE LLC, as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10pt;padding-right:-35.3pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; J.R. Young</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; J.R. Young</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div><font><br></font></div><div style="height:60.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:0.05pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">BNP PARIBAS, as Extending Revolving Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10pt;padding-right:-35.3pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Uzo Arinzeh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Uzo Arinzeh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.092%"><tr><td style="width:1.0%"></td><td style="width:13.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Albert Arencibia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Albert Arencibia</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:104%">Title&#58; Director</font></div></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_43"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">KEYBANK NATIONAL ASSOCIATION, as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:10pt;padding-right:-35.3pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Matthew D. Dunson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Matthew D. Dunson</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_49"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">PSP INVESTMENTS CREDIT USA LLC, as Extending Revolving Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Kerry Dolan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Kerry Dolan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><font><br></font></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Alyssa Roland</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Alyssa Roland</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_52"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:110%">BARCLAYS BANK PLC, as Extending Revolving Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Evan Moriarty</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Evan Moriarty</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_55"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CITIBANK, N.A., as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Stanislav Andreev</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Stanislav Andreev</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:right"><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_58"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ROYAL BANK OF CANADA, as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Diana Lee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Diana Lee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_61"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CITIZENS BANK, N.A., as Extending Revolving Lender and Consenting Issuing Bank</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Matt Kuchta</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Matt Kuchta</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Senior Vice President</font></td></tr></table></div><div style="margin-top:0.2pt"><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_549755814475"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:9.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ING CAPITAL LLC, as Extending Revolving Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Roy De Jongh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Roy De Jongh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-left:36pt;text-align:right"><font><br></font></div><div style="margin-bottom:6pt;margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Michael Kim</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; Michael Kim</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="margin-top:0.2pt"><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_64"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">With respect only to Section 6 and Section 8&#58;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SOTERA HEALTH LLC</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">STERIGENICS U.S., LLC</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NELSON LABORATORIES, LLC </font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SOTERA HEALTH SERVICES, LLC</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scott J. Leffler</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scott J. Leffler</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer and </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Treasurer</font></div></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_549755814494"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">With respect only to Section 6 and Section 8&#58;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NELSON LABORATORIES HOLDINGS, LLC</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NELSON LABORATORIES FAIRFIELD HOLDINGS, LLC</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Bruce T. Krarup</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bruce T. Krarup</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Treasurer and Secretary</font></div></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_549755814510"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:36pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.953%"><tr><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.137%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">With respect only to Section 6 and Section 8&#58;</font></td></tr><tr><td colspan="6" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">STERIGENICS RADIATION TECHNOLOGIES HOLDINGS, LLC</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">STERIGENICS RADIATION TECHNOLOGIES, LLC </font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">STERIGENICS RADIATION TECHNOLOGIES IN, INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Matthew D. Shimkus</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name&#58; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Matthew D. Shimkus</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58; </font><font style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vice President, Treasurer and Secretary</font></div></td></tr></table></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature Page to Revolving Facilities Amendment to Credit Agreement&#93;</font></div></div></div><div id="iaab464944f4e470daaf77a3c1562e9f4_67"></div><hr style="page-break-after:always"><div style="min-height:32pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:3.9pt;padding-right:10.85pt;text-align:right"><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:85.5pt;padding-right:85.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule I</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.657%"><tr><td style="width:1.0%"></td><td style="width:50.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:24.82pt;padding-right:24.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Extending Revolving Lender</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:24.75pt;padding-right:24.75pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Extending Revolving Commitment</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.72pt;padding-right:24.72pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">JPMorgan Chase Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$75,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.82pt;padding-right:24.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Credit Suisse AG, Cayman Islands Branch</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$35,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.82pt;padding-right:24.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Goldman Sachs Bank USA</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$35,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Jefferies Finance LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$35,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.82pt;padding-right:24.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BNP Paribas</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$25,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.77pt;padding-right:24.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">KeyBank National Association</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$25,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:24.77pt;padding-right:24.77pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PSP Investments Credit USA LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.15pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$25,000,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.82pt;padding-right:24.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Barclays Bank PLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$22,500,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Citibank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$22,500,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Royal Bank of Canada</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$22,500,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Citizens Bank, N.A.</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$12,500,000</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ING Capital LLC</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$12,500,000</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.82pt;padding-right:24.82pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TOTAL</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.05pt;padding-left:24.8pt;padding-right:24.8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">$347,500,000</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:60pt"><font><br></font></div><div style="height:60pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">#4829-8936-7265v4</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>shc_20210331xexhibitx31x1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic775f030272f4da58fcfa2269ead5beb_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, Michael B. Petras, Jr., certify that&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">I have reviewed this quarterly report on Form 10-Q of Sotera Health Company&#59;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;May 13, 2021&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Michael B. Petras, Jr.&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Michael B. Petras, Jr.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chairman and Chief Executive Officer</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer) </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>shc20210331_exhibitx31x2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1e1693f4d0664617b1744f5b76027866_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I, Scott J. Leffler, certify that&#58;</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">I have reviewed this quarterly report on Form 10-Q of Sotera Health Company&#59;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:9pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;May 13, 2021</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Scott J. Leffler&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Scott J. Leffler</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer and Treasurer</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer) </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>shc20210331_exhibitx32x1.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia7b74e729579425ea5a39b020d36ce9e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Sotera Health Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), do hereby certify, to each such officer&#8217;s knowledge, that the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58; May 13, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Michael B. Petras, Jr.                                     &#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Michael B. Petras, Jr.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;    Chairman and Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dated&#58; May 13, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Scott J. Leffler                                                </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Scott J. Leffler</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;    Chief Financial Officer and Treasurer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The foregoing certifications are furnished and are not deemed filed with the Securities and Exchange Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), and are not deemed to be incorporated by reference into any filing of Sotera Health Company under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that Sotera Health Company specifically incorporates them by reference.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>shc-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f476bcce-754d-42a8-b141-c43fc168635e,g:3b9d91f5-244f-4b5e-861f-f8019b961431-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:shc="http://soterahealth.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://soterahealth.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="shc-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="shc-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="shc-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="shc-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://soterahealth.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss">
        <link:definition>1003004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical">
        <link:definition>1004005 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityDeficit" roleURI="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit">
        <link:definition>1006007 - Statement - Consolidated Statements of Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://soterahealth.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://soterahealth.com/role/BasisofPresentationPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetails" roleURI="http://soterahealth.com/role/BasisofPresentationDetails">
        <link:definition>2403401 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecentAccountingStandards" roleURI="http://soterahealth.com/role/RecentAccountingStandards">
        <link:definition>2104102 - Disclosure - Recent Accounting Standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://soterahealth.com/role/RevenueRecognition">
        <link:definition>2105103 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://soterahealth.com/role/RevenueRecognitionTables">
        <link:definition>2306301 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDetails" roleURI="http://soterahealth.com/role/RevenueRecognitionDetails">
        <link:definition>2407402 - Disclosure - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://soterahealth.com/role/Acquisitions">
        <link:definition>2108104 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://soterahealth.com/role/AcquisitionsTables">
        <link:definition>2309302 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAdditionalInformationDetails" roleURI="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails">
        <link:definition>2410403 - Disclosure - Acquisitions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsPurchasePriceAllocationDetails" roleURI="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails">
        <link:definition>2411404 - Disclosure - Acquisitions - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsProFormaInformationDetails" roleURI="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails">
        <link:definition>2412405 - Disclosure - Acquisitions - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://soterahealth.com/role/Inventories">
        <link:definition>2113105 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://soterahealth.com/role/InventoriesTables">
        <link:definition>2314303 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://soterahealth.com/role/InventoriesDetails">
        <link:definition>2415406 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherCurrentAssets" roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets">
        <link:definition>2116106 - Disclosure - Prepaid Expenses and Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherCurrentAssetsTables" roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables">
        <link:definition>2317304 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2418407 - Disclosure - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2119107 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>2320305 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillDetails" roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails">
        <link:definition>2421408 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsIntangiblesDetails" roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails">
        <link:definition>2422409 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails">
        <link:definition>2423410 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails">
        <link:definition>2424411 - Disclosure - Goodwill and Other Intangible Assets - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://soterahealth.com/role/AccruedLiabilities">
        <link:definition>2125108 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://soterahealth.com/role/AccruedLiabilitiesTables">
        <link:definition>2326306 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://soterahealth.com/role/AccruedLiabilitiesDetails">
        <link:definition>2427412 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://soterahealth.com/role/LongTermDebt">
        <link:definition>2128109 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://soterahealth.com/role/LongTermDebtTables">
        <link:definition>2329307 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofDebtDetails" roleURI="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails">
        <link:definition>2430413 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSeniorSecuredCreditFacilitiesDetails" roleURI="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails">
        <link:definition>2431414 - Disclosure - Long-Term Debt - Senior Secured Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtFirstLienNotesDetails" roleURI="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails">
        <link:definition>2432415 - Disclosure - Long-Term Debt - First Lien Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtRepaymentsofDebtDetails" roleURI="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails">
        <link:definition>2433416 - Disclosure - Long-Term Debt - Repayments of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAggregateMaturitiesDetails" roleURI="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails">
        <link:definition>2434417 - Disclosure - Long-Term Debt - Aggregate Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://soterahealth.com/role/IncomeTaxes">
        <link:definition>2135110 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://soterahealth.com/role/IncomeTaxesDetails">
        <link:definition>2436418 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefits" roleURI="http://soterahealth.com/role/EmployeeBenefits">
        <link:definition>2137111 - Disclosure - Employee Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsTables" roleURI="http://soterahealth.com/role/EmployeeBenefitsTables">
        <link:definition>2338308 - Disclosure - Employee Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsNetPeriodicBenefitCostDetails" roleURI="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails">
        <link:definition>2439419 - Disclosure - Employee Benefits - Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitsAdditionalInformationDetails" roleURI="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails">
        <link:definition>2440420 - Disclosure - Employee Benefits - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedParties" roleURI="http://soterahealth.com/role/RelatedParties">
        <link:definition>2141112 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLoss" roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLoss">
        <link:definition>2142113 - Disclosure - Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLossTables" roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables">
        <link:definition>2343309 - Disclosure - Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeLossDetails" roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails">
        <link:definition>2444421 - Disclosure - Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://soterahealth.com/role/ShareBasedCompensation">
        <link:definition>2145114 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://soterahealth.com/role/ShareBasedCompensationTables">
        <link:definition>2346310 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalInformationDetails" roleURI="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails">
        <link:definition>2447422 - Disclosure - Share-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPreIPOAwardsClassB1andB2Details" roleURI="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details">
        <link:definition>2448423 - Disclosure - Share-Based Compensation - Pre-IPO Awards (Class&#160;B-1 and B-2) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionsDetails" roleURI="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails">
        <link:definition>2449424 - Disclosure - Share-Based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRSUsDetails" roleURI="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails">
        <link:definition>2450425 - Disclosure - Share-Based Compensation - RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShare" roleURI="http://soterahealth.com/role/EarningsLossPerShare">
        <link:definition>2151115 - Disclosure - Earnings (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareTables" roleURI="http://soterahealth.com/role/EarningsLossPerShareTables">
        <link:definition>2352311 - Disclosure - Earnings (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareDetails" roleURI="http://soterahealth.com/role/EarningsLossPerShareDetails">
        <link:definition>2453426 - Disclosure - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://soterahealth.com/role/CommitmentandContingencies">
        <link:definition>2154116 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://soterahealth.com/role/CommitmentandContingenciesDetails">
        <link:definition>2455427 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFinancialRisk" roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk">
        <link:definition>2156117 - Disclosure - Financial Instruments and Financial Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFinancialRiskTables" roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables">
        <link:definition>2357312 - Disclosure - Financial Instruments and Financial Risk (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails">
        <link:definition>2458428 - Disclosure - Financial Instruments and Financial Risk - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails">
        <link:definition>2459429 - Disclosure - Financial Instruments and Financial Risk - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails">
        <link:definition>2460430 - Disclosure - Financial Instruments and Financial Risk - Activities of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>2461431 - Disclosure - Financial Instruments and Financial Risk - Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://soterahealth.com/role/SegmentInformation">
        <link:definition>2162118 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://soterahealth.com/role/SegmentInformationTables">
        <link:definition>2363313 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationAdditionalInformationDetails" roleURI="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails">
        <link:definition>2464432 - Disclosure - Segment Information - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSegmentOperatingResultsDetails" roleURI="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails">
        <link:definition>2465433 - Disclosure - Segment Information - Segment Operating Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationReconciliationofReportableSegmentAmountsDetails" roleURI="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails">
        <link:definition>2466434 - Disclosure - Segment Information - Reconciliation of Reportable Segment Amounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" abstract="true" name="NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_PreIPOB1Member" abstract="true" name="PreIPOB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_ShareBasedPaymentArrangementTrancheFourMember" abstract="true" name="ShareBasedPaymentArrangementTrancheFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_LitigationSettlementCostsAssessedAndAwardedInFavor" abstract="false" name="LitigationSettlementCostsAssessedAndAwardedInFavor" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_AccruedInterestExpenseCurrent" abstract="false" name="AccruedInterestExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" abstract="false" name="LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_LandUseRightsMember" abstract="true" name="LandUseRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_TermLoanDue2026Member" abstract="true" name="TermLoanDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_RecognitionOfDebtPremium" abstract="false" name="RecognitionOfDebtPremium" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_CostAndExpensesCOVID19" abstract="false" name="CostAndExpensesCOVID19" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_InterestRateCap1Member" abstract="true" name="InterestRateCap1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_A2020OmnibusIncentivePlanMember" abstract="true" name="A2020OmnibusIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_PrepaidSoftwareLicensingCurrent" abstract="false" name="PrepaidSoftwareLicensingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_GainContingencyPeriodOfBusinessInterruption" abstract="false" name="GainContingencyPeriodOfBusinessInterruption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="shc_ShareBasedPaymentArrangementTrancheFiveMember" abstract="true" name="ShareBasedPaymentArrangementTrancheFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_PreIPOB2Member" abstract="true" name="PreIPOB2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_SubsidiaryTwoMember" abstract="true" name="SubsidiaryTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_InterestRateCapOctober2017Member" abstract="true" name="InterestRateCapOctober2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_SealedSourceAndSupplyAgreementsMember" abstract="true" name="SealedSourceAndSupplyAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_InterestRateCapFebruary2021Member" abstract="true" name="InterestRateCapFebruary2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_FinanceLeaseLiabilityMember" abstract="true" name="FinanceLeaseLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" abstract="false" name="LimitationOnDeductibilityOfInterestExpenseCARESAct" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_SegmentIncomeLoss" abstract="false" name="SegmentIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" abstract="false" name="SaleOfStockNumberOfAdditionalSharesToBeRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="shc_SeniorNotesDue2026Member" abstract="true" name="SeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_PrepaidMaintenanceContractsCurrent" abstract="false" name="PrepaidMaintenanceContractsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_SecondLienNotesMember" abstract="true" name="SecondLienNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_OtherLongTermDebtMember" abstract="true" name="OtherLongTermDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_LongTermDebtMaturityAfterYearFour" abstract="false" name="LongTermDebtMaturityAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" abstract="false" name="LitigationSettlementDisbursementsAssessedAndAwardedInFavor" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_CustomerThreeMember" abstract="true" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" abstract="false" name="DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_BioScienceLaboratoriesLLCBioScienceMember" abstract="true" name="BioScienceLaboratoriesLLCBioScienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_EthyleneOxideTortLitigationIllinoisMember" abstract="true" name="EthyleneOxideTortLitigationIllinoisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_AcquisitionAndDivestitureRelatedChargesNet" abstract="false" name="AcquisitionAndDivestitureRelatedChargesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_TermLoanAndSecondLienNotesMember" abstract="true" name="TermLoanAndSecondLienNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_LicensingAgreementsRenewalTerm" abstract="false" name="LicensingAgreementsRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="shc_NordionMember" abstract="true" name="NordionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_NelsonLabsMember" abstract="true" name="NelsonLabsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_AmortizationOfIntangibleAssetsNonproduction" abstract="false" name="AmortizationOfIntangibleAssetsNonproduction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" abstract="false" name="LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_DebtInstrumentVariableRateFloor" abstract="false" name="DebtInstrumentVariableRateFloor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_FirstLienNotesDue2026Member" abstract="true" name="FirstLienNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_DebtIssuanceCostsRefinancingAdditionalExpense" abstract="false" name="DebtIssuanceCostsRefinancingAdditionalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" abstract="false" name="DebtInstrumentEffectiveReductionInCurrentInterestRates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_NelsonFairfieldIncNelsonFairfieldMember" abstract="true" name="NelsonFairfieldIncNelsonFairfieldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_DerivativeNumberOfInstrumentsAmended" abstract="false" name="DerivativeNumberOfInstrumentsAmended" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_NumberOfSubsidiariesWithNonControllingInterest" abstract="false" name="NumberOfSubsidiariesWithNonControllingInterest" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="shc_DerivativeOptionPremium" abstract="false" name="DerivativeOptionPremium" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_SterigenicsMember" abstract="true" name="SterigenicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_UnnamedEBeamJointVentureMember" abstract="true" name="UnnamedEBeamJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_SubsidiaryOneMember" abstract="true" name="SubsidiaryOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_PercentOfBorrowingLimitationDueToCashFlowExposure" abstract="false" name="PercentOfBorrowingLimitationDueToCashFlowExposure" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_PercentOfReductionInResidentialPropertyValueAssessment" abstract="false" name="PercentOfReductionInResidentialPropertyValueAssessment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" abstract="false" name="ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_IotronIndustriesCanadaIncIotronMember" abstract="true" name="IotronIndustriesCanadaIncIotronMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" abstract="false" name="ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" abstract="false" name="WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_SeniorNotesDue2027Member" abstract="true" name="SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" abstract="false" name="LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="shc_InterestRateCapJune2020Member" abstract="true" name="InterestRateCapJune2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="shc_CashProceedsToSponsorsRatioToInvestedCapital" abstract="false" name="CashProceedsToSponsorsRatioToInvestedCapital" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="shc_EthyleneOxideTortLitigationGeorgiaMember" abstract="true" name="EthyleneOxideTortLitigationGeorgiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>shc-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f476bcce-754d-42a8-b141-c43fc168635e,g:3b9d91f5-244f-4b5e-861f-f8019b961431-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://soterahealth.com/role/Cover" xlink:type="simple" xlink:href="shc-20210331.xsd#Cover"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ed5f0e5-cfca-4d46-a960-9605d0b8558c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d1d0099c-db96-402d-8b90-5d3fdadf33f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ed5f0e5-cfca-4d46-a960-9605d0b8558c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d1d0099c-db96-402d-8b90-5d3fdadf33f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d61dd920-309e-4ec0-bb76-5bdc66e5f4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ed5f0e5-cfca-4d46-a960-9605d0b8558c" xlink:to="loc_us-gaap_Liabilities_d61dd920-309e-4ec0-bb76-5bdc66e5f4a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c9bf11de-ad18-4636-98d8-b955ee75852c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9ed5f0e5-cfca-4d46-a960-9605d0b8558c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c9bf11de-ad18-4636-98d8-b955ee75852c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0e07e0c9-b11b-4e19-b335-83c8706201e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0e07e0c9-b11b-4e19-b335-83c8706201e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationsNoncurrent_40bb651e-c42b-46c5-ab7a-8435bb89712d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_AssetRetirementObligationsNoncurrent_40bb651e-c42b-46c5-ab7a-8435bb89712d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_f50046be-94d9-487a-8bf6-30c5a0b82809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_f50046be-94d9-487a-8bf6-30c5a0b82809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_9a3a2e0b-1054-460a-aec1-c03a9820f883" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_9a3a2e0b-1054-460a-aec1-c03a9820f883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f82b5163-71aa-48d9-b121-a9aca1a1b3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f82b5163-71aa-48d9-b121-a9aca1a1b3cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d6fd81df-ea31-4885-99aa-0d5e27267610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_LiabilitiesCurrent_d6fd81df-ea31-4885-99aa-0d5e27267610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_07c71ef4-b1c5-44e1-a55d-510efc71b94a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_07c71ef4-b1c5-44e1-a55d-510efc71b94a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent_5cec1392-7e5e-4f88-b204-cd50fd64e909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent_5cec1392-7e5e-4f88-b204-cd50fd64e909" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6b61454c-8e03-430f-9bd0-2402ff624c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6b61454c-8e03-430f-9bd0-2402ff624c65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f03620db-d8f3-40ec-bde3-3a060f210a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_dbbc7fef-9ff5-41b9-b933-682b1eafdb40" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f03620db-d8f3-40ec-bde3-3a060f210a20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_0a406646-87b4-4dd9-aae9-0bb648d12116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:to="loc_us-gaap_RestrictedCashCurrent_0a406646-87b4-4dd9-aae9-0bb648d12116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1a9d383-fde9-43a9-872d-43867d4f161a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1a9d383-fde9-43a9-872d-43867d4f161a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e6df07fe-6c2e-40d9-958a-efb6855f07e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e6df07fe-6c2e-40d9-958a-efb6855f07e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b1a7e76e-1b3e-4225-8d1b-bbce72c62fee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:to="loc_us-gaap_InventoryNet_b1a7e76e-1b3e-4225-8d1b-bbce72c62fee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_85cf06f0-f385-4f52-9488-3e6c2bedc378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_85cf06f0-f385-4f52-9488-3e6c2bedc378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_d73434f1-03e6-4f54-9d19-3abf5583e549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_9aa16d6e-56ad-4602-bcf4-380a70f1df0b" xlink:to="loc_us-gaap_IncomeTaxesReceivable_d73434f1-03e6-4f54-9d19-3abf5583e549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1476a4a8-0710-44c2-a70b-cc0b1279ed77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:to="loc_us-gaap_PreferredStockValue_1476a4a8-0710-44c2-a70b-cc0b1279ed77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f17f48b1-0e9d-4e47-960f-a12a8f03a9a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f17f48b1-0e9d-4e47-960f-a12a8f03a9a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_52af2fa6-dfc7-405b-a6f6-f01055a66f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_52af2fa6-dfc7-405b-a6f6-f01055a66f03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f4ddca2e-845f-4138-9942-e9a0dc8cb78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:to="loc_us-gaap_CommonStockValue_f4ddca2e-845f-4138-9942-e9a0dc8cb78d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_6b9fa596-b083-46bf-9c3f-46bec03aa3e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:to="loc_us-gaap_TreasuryStockValue_6b9fa596-b083-46bf-9c3f-46bec03aa3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a2dc93c8-307d-4a4e-a1ac-b6044cd61b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_edfd087e-dc57-40ba-976a-d9336edf09f3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a2dc93c8-307d-4a4e-a1ac-b6044cd61b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b02f93d0-9b17-4159-8bb7-58eaae9f0bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b02f93d0-9b17-4159-8bb7-58eaae9f0bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_14c34335-9933-4ced-b7c0-d94efab502c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_EquityMethodInvestments_14c34335-9933-4ced-b7c0-d94efab502c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4cc0221e-dd4b-4bad-a48b-b82823ba8583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4cc0221e-dd4b-4bad-a48b-b82823ba8583" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7c516598-fab7-4aa2-822a-85fea4514850" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7c516598-fab7-4aa2-822a-85fea4514850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b8bd0f1f-fba3-4c29-9c4d-49dda73be33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_AssetsCurrent_b8bd0f1f-fba3-4c29-9c4d-49dda73be33b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bb922b28-c1fd-49cd-a2a4-52775a00af58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bb922b28-c1fd-49cd-a2a4-52775a00af58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a361d19a-68c5-4df4-9379-7bd2456a63ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a361d19a-68c5-4df4-9379-7bd2456a63ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_066d36eb-871a-430b-9b10-d38c1cdfa52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4c0f72a-91ec-48e8-8af6-76f39e8f6032" xlink:to="loc_us-gaap_Goodwill_066d36eb-871a-430b-9b10-d38c1cdfa52d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationCurrent_7025e9fb-b2e1-4f3b-838b-ca4b33290e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_AssetRetirementObligationCurrent_7025e9fb-b2e1-4f3b-838b-ca4b33290e68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c95d48c9-599f-4201-8c51-eccbdcba44ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c95d48c9-599f-4201-8c51-eccbdcba44ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_285f7f37-c289-41e9-b7be-655443806038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_AccountsPayableCurrent_285f7f37-c289-41e9-b7be-655443806038" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_401cd330-7096-47a3-b0e5-b3d1d0371762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_401cd330-7096-47a3-b0e5-b3d1d0371762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d1aa872c-1d84-4c03-b22c-a892aa00528f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d1aa872c-1d84-4c03-b22c-a892aa00528f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7c47b1b2-b5ab-4b2c-8188-5ffe5fb5e4e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7c47b1b2-b5ab-4b2c-8188-5ffe5fb5e4e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_66c9d381-0816-47b9-ac7b-d4cddcfa6e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_30807d14-b77b-415c-8cc9-a16889c435a3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_66c9d381-0816-47b9-ac7b-d4cddcfa6e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f0f53d18-80c3-42f3-a06d-5bbe6aac9071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_56f3c54e-9382-4a02-be70-7f329140b9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f0f53d18-80c3-42f3-a06d-5bbe6aac9071" xlink:to="loc_us-gaap_MinorityInterest_56f3c54e-9382-4a02-be70-7f329140b9e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cd7b346a-843e-418e-aa71-891151bfde73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f0f53d18-80c3-42f3-a06d-5bbe6aac9071" xlink:to="loc_us-gaap_StockholdersEquity_cd7b346a-843e-418e-aa71-891151bfde73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e2e1a9fd-da5a-4749-aa47-3152ba3ecdcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cab6eed3-d048-4c01-80f2-ee059ad0507a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e2e1a9fd-da5a-4749-aa47-3152ba3ecdcd" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_cab6eed3-d048-4c01-80f2-ee059ad0507a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AmortizationOfIntangibleAssetsNonproduction_d46060cb-647c-493f-94b7-a3a621d7e1b7" xlink:href="shc-20210331.xsd#shc_AmortizationOfIntangibleAssetsNonproduction"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_e2e1a9fd-da5a-4749-aa47-3152ba3ecdcd" xlink:to="loc_shc_AmortizationOfIntangibleAssetsNonproduction_d46060cb-647c-493f-94b7-a3a621d7e1b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1da34be6-09fb-420b-9198-58b318baa667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_9cabf502-5ab4-4ca7-8124-e120c87ba359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1da34be6-09fb-420b-9198-58b318baa667" xlink:to="loc_us-gaap_CostOfRevenue_9cabf502-5ab4-4ca7-8124-e120c87ba359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_13632d19-cac7-4e06-ad3c-1fc7be487035" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_1da34be6-09fb-420b-9198-58b318baa667" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_13632d19-cac7-4e06-ad3c-1fc7be487035" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3b8c8170-8f7a-4948-89d4-f044955393b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_24993b52-4c6e-4353-ae18-fe12b2d78de8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3b8c8170-8f7a-4948-89d4-f044955393b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_24993b52-4c6e-4353-ae18-fe12b2d78de8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e0d9120e-9eee-4307-8444-623156472361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3b8c8170-8f7a-4948-89d4-f044955393b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_e0d9120e-9eee-4307-8444-623156472361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1cb997dd-1290-4215-8208-fe4b3ede96be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3b8c8170-8f7a-4948-89d4-f044955393b7" xlink:to="loc_us-gaap_ProfitLoss_1cb997dd-1290-4215-8208-fe4b3ede96be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d1d68639-7bd8-47ce-b046-d3dffab6a039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3b8c8170-8f7a-4948-89d4-f044955393b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_d1d68639-7bd8-47ce-b046-d3dffab6a039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_aabf8291-a6ad-419b-880a-9eb7961e1638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2c43fdbe-2b6a-47e5-b407-8a878834d56a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aabf8291-a6ad-419b-880a-9eb7961e1638" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2c43fdbe-2b6a-47e5-b407-8a878834d56a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9fa89ea8-461a-4b5d-b76e-ea3d059ca610" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aabf8291-a6ad-419b-880a-9eb7961e1638" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_9fa89ea8-461a-4b5d-b76e-ea3d059ca610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d57b4584-22fe-4e3a-b798-9433bc353837" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_421c7cfa-f7e5-4bea-9f44-935db53576ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d57b4584-22fe-4e3a-b798-9433bc353837" xlink:to="loc_us-gaap_OperatingExpenses_421c7cfa-f7e5-4bea-9f44-935db53576ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0d8423b8-4f7f-496b-a701-d6072fe1b41c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_d57b4584-22fe-4e3a-b798-9433bc353837" xlink:to="loc_us-gaap_GrossProfit_0d8423b8-4f7f-496b-a701-d6072fe1b41c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9d98682b-9fae-4946-aaf3-23f8ccc21dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cfe59ba1-a309-498f-81e5-d6ca92df02af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_9d98682b-9fae-4946-aaf3-23f8ccc21dcd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cfe59ba1-a309-498f-81e5-d6ca92df02af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8505c297-5297-4ccc-855a-651373b4fb2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_9d98682b-9fae-4946-aaf3-23f8ccc21dcd" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8505c297-5297-4ccc-855a-651373b4fb2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c4cb15fb-b949-493e-9df3-055c92f03a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_0af7419e-d4cd-498e-9f09-088ebc029203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c4cb15fb-b949-493e-9df3-055c92f03a0d" xlink:to="loc_us-gaap_ProfitLoss_0af7419e-d4cd-498e-9f09-088ebc029203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3aa75046-6720-49d1-87c9-79cba95b9f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c4cb15fb-b949-493e-9df3-055c92f03a0d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3aa75046-6720-49d1-87c9-79cba95b9f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bccf5b6a-b398-4b21-9eca-35ee0af7e14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cca9d80e-6732-4556-8f79-2cb14527f221" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bccf5b6a-b398-4b21-9eca-35ee0af7e14c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cca9d80e-6732-4556-8f79-2cb14527f221" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_807e29b9-dc78-4ccd-996f-c2c23f25ac5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bccf5b6a-b398-4b21-9eca-35ee0af7e14c" xlink:to="loc_us-gaap_OperatingIncomeLoss_807e29b9-dc78-4ccd-996f-c2c23f25ac5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_b772f5b5-c93d-4667-9d67-d98d383443e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bccf5b6a-b398-4b21-9eca-35ee0af7e14c" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_b772f5b5-c93d-4667-9d67-d98d383443e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e5b5d2dd-c651-4b87-b3d3-c389cdb0a2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bccf5b6a-b398-4b21-9eca-35ee0af7e14c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e5b5d2dd-c651-4b87-b3d3-c389cdb0a2ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9f4fda4e-38d0-4a63-9e7c-99b6520a9ecc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_bccf5b6a-b398-4b21-9eca-35ee0af7e14c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9f4fda4e-38d0-4a63-9e7c-99b6520a9ecc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32955cca-a323-4c3a-90f3-48aee764f657" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6095b48-0b7a-4e9a-973e-3266acbdc3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32955cca-a323-4c3a-90f3-48aee764f657" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6095b48-0b7a-4e9a-973e-3266acbdc3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_749f45fc-f818-40b0-8b03-898bdae51372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32955cca-a323-4c3a-90f3-48aee764f657" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_749f45fc-f818-40b0-8b03-898bdae51372" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75ef8a5e-3d1e-4e9a-ac46-b3600661be5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32955cca-a323-4c3a-90f3-48aee764f657" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_75ef8a5e-3d1e-4e9a-ac46-b3600661be5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f3a48bb-111a-495c-959a-1e024d7efd2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_32955cca-a323-4c3a-90f3-48aee764f657" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f3a48bb-111a-495c-959a-1e024d7efd2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a6768326-65bc-42ad-a9fc-868128406367" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_ProfitLoss_a6768326-65bc-42ad-a9fc-868128406367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_063a1f96-0051-4b12-a0ca-634567e0761b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_063a1f96-0051-4b12-a0ca-634567e0761b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4b3efc7b-2bd9-443f-88b7-f9a8c12dbceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_4b3efc7b-2bd9-443f-88b7-f9a8c12dbceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_11270940-d96e-4523-be52-b7777053d63f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_11270940-d96e-4523-be52-b7777053d63f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_253e80a4-fe65-431b-8dac-cc0d396961a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_253e80a4-fe65-431b-8dac-cc0d396961a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ccbeb5e9-c37f-4eb2-a522-c9cfe0766a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ccbeb5e9-c37f-4eb2-a522-c9cfe0766a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_85df58a2-7634-404a-8f06-239a2e4c36c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_85df58a2-7634-404a-8f06-239a2e4c36c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1a11b289-a0f4-4af4-8f8d-37f2a77335ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1a11b289-a0f4-4af4-8f8d-37f2a77335ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fbde14a4-4b05-46e1-8da5-407efc889b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_Depreciation_fbde14a4-4b05-46e1-8da5-407efc889b94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_032b4427-bf59-4bde-972f-d8e5e060ac7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_032b4427-bf59-4bde-972f-d8e5e060ac7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e0638d2d-79ce-4e11-9bc0-c68d0545f791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e0638d2d-79ce-4e11-9bc0-c68d0545f791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_dba68ea9-50e8-4ed8-9044-14f88ff7bff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_dba68ea9-50e8-4ed8-9044-14f88ff7bff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_bb4879f5-e115-49d3-8434-e985da48d528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_bb4879f5-e115-49d3-8434-e985da48d528" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_fdda9e2e-784c-4776-baf1-bac23aa848ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_fdda9e2e-784c-4776-baf1-bac23aa848ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5ef760c7-e32d-498b-8b16-53f3bc3a693e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_5ef760c7-e32d-498b-8b16-53f3bc3a693e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c847f11f-6759-4ece-8f38-2bc54d534b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c847f11f-6759-4ece-8f38-2bc54d534b1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f83adedf-37e4-432f-900a-58d352948ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f83adedf-37e4-432f-900a-58d352948ba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f02ed456-6caf-4c86-8ce9-f9902737d24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="18" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f02ed456-6caf-4c86-8ce9-f9902737d24c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1975f254-e573-4ba5-abd4-2e65077147d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_ShareBasedCompensation_1975f254-e573-4ba5-abd4-2e65077147d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3053ef8a-0387-4a89-ade8-77ceece5baf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_38227f9c-bf34-4ad6-8d9f-df3aabc6e262" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3053ef8a-0387-4a89-ade8-77ceece5baf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bcb76ff-e6fe-4ad1-b9e7-e997c68ae0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de2cba2c-c3b3-4e5d-8476-98f2272815ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bcb76ff-e6fe-4ad1-b9e7-e997c68ae0ac" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de2cba2c-c3b3-4e5d-8476-98f2272815ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_c9100f30-5b38-456d-8a04-8555cb947076" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bcb76ff-e6fe-4ad1-b9e7-e997c68ae0ac" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_c9100f30-5b38-456d-8a04-8555cb947076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_67d75263-2cec-47c3-8da3-a9a87ad33919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bcb76ff-e6fe-4ad1-b9e7-e997c68ae0ac" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_67d75263-2cec-47c3-8da3-a9a87ad33919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_35e27f77-d7e5-4116-83c5-693f61e88c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_dc27b193-89c0-443a-b7a3-53b4d38bb5cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_35e27f77-d7e5-4116-83c5-693f61e88c92" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_dc27b193-89c0-443a-b7a3-53b4d38bb5cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_e38dedec-d055-43c6-a3c6-bc46a13e383c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_35e27f77-d7e5-4116-83c5-693f61e88c92" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_e38dedec-d055-43c6-a3c6-bc46a13e383c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ce4fd3a4-c6da-440d-b662-229ee05f234c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_35e27f77-d7e5-4116-83c5-693f61e88c92" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_ce4fd3a4-c6da-440d-b662-229ee05f234c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8531a966-88fa-42c2-a276-5dac6f720f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_35e27f77-d7e5-4116-83c5-693f61e88c92" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_8531a966-88fa-42c2-a276-5dac6f720f91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofEquityDeficit"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentation" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentation"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/BasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentationPolicies"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/BasisofPresentationPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/BasisofPresentationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RecentAccountingStandards" xlink:type="simple" xlink:href="shc-20210331.xsd#RecentAccountingStandards"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/RecentAccountingStandards" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognition" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognition"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/RevenueRecognition" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognitionTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/RevenueRecognitionTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognitionDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/RevenueRecognitionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/Acquisitions" xlink:type="simple" xlink:href="shc-20210331.xsd#Acquisitions"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/Acquisitions" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AcquisitionsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_bb047d7a-36d5-48cc-b757-dd47dd0046bb" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_bb047d7a-36d5-48cc-b757-dd47dd0046bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d6c0b897-ca19-4a97-8cf3-4af03a5b7de5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_us-gaap_Goodwill_d6c0b897-ca19-4a97-8cf3-4af03a5b7de5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_acd8c2e4-688e-494e-923c-ae747bb53767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_acd8c2e4-688e-494e-923c-ae747bb53767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_58b995cb-f698-4697-ac95-6d234249b526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_58b995cb-f698-4697-ac95-6d234249b526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_26a266f0-1dfe-4035-8309-f5cb3e43aed9" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_26a266f0-1dfe-4035-8309-f5cb3e43aed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_7db1654d-54e8-4d5b-808d-b79d0b82a2e6" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_7db1654d-54e8-4d5b-808d-b79d0b82a2e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9a2c6b68-22e9-48f4-a880-d06c3f58a680" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_6ce14926-1e25-4ff7-9164-2900c6d143e7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_9a2c6b68-22e9-48f4-a880-d06c3f58a680" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_af6e5e8b-2172-47c3-8fee-4223ab4d5d38" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_af6e5e8b-2172-47c3-8fee-4223ab4d5d38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_8ffba376-86a6-4b57-8e88-5826539b8dca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_8ffba376-86a6-4b57-8e88-5826539b8dca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_abb4945c-b395-4fab-905c-b32ffb4431e3" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_abb4945c-b395-4fab-905c-b32ffb4431e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_08950135-ab6a-46b9-a0b5-bdaea764cf3b" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_08950135-ab6a-46b9-a0b5-bdaea764cf3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_b501c061-36bc-4bb7-91cb-389a93db7347" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_b501c061-36bc-4bb7-91cb-389a93db7347" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_069240c4-37a1-4890-ba29-1b17147084f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_069240c4-37a1-4890-ba29-1b17147084f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3a93a966-2a20-4098-b961-ddbe93dc55a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_2f120cff-9742-4036-81b6-09dcbe366782" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_3a93a966-2a20-4098-b961-ddbe93dc55a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsProFormaInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/Inventories" xlink:type="simple" xlink:href="shc-20210331.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/InventoriesTables" xlink:type="simple" xlink:href="shc-20210331.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/InventoriesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_ddb2e259-b10c-44f3-af4b-7dbe5f22a8f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_40ce11d0-bbb8-4322-99e1-1368df653051" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_ddb2e259-b10c-44f3-af4b-7dbe5f22a8f7" xlink:to="loc_us-gaap_InventoryFinishedGoods_40ce11d0-bbb8-4322-99e1-1368df653051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_9baa8d3c-2ad4-46cd-a53b-2195cbba387a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_ddb2e259-b10c-44f3-af4b-7dbe5f22a8f7" xlink:to="loc_us-gaap_InventoryWorkInProcess_9baa8d3c-2ad4-46cd-a53b-2195cbba387a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_c203269c-e499-4afe-a67b-ef7e30eef44c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_ddb2e259-b10c-44f3-af4b-7dbe5f22a8f7" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_c203269c-e499-4afe-a67b-ef7e30eef44c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ae7b2771-9981-4788-90df-677f9527ad93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_492bd5bf-59ea-4856-be1b-0e900e63aeb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ae7b2771-9981-4788-90df-677f9527ad93" xlink:to="loc_us-gaap_InventoryGross_492bd5bf-59ea-4856-be1b-0e900e63aeb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments_bc2c9267-a24b-4e2c-a877-036afa45993e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_ae7b2771-9981-4788-90df-677f9527ad93" xlink:to="loc_us-gaap_InventoryAdjustments_bc2c9267-a24b-4e2c-a877-036afa45993e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssets"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_7a8b3c5e-ee50-48f6-8335-3cb657c8ab0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_7a8b3c5e-ee50-48f6-8335-3cb657c8ab0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PrepaidSoftwareLicensingCurrent_591ac057-0c41-4ec9-b69d-e9df6f4d5513" xlink:href="shc-20210331.xsd#shc_PrepaidSoftwareLicensingCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_shc_PrepaidSoftwareLicensingCurrent_591ac057-0c41-4ec9-b69d-e9df6f4d5513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_c4dbfdce-0dae-43be-96e9-cf398c333d5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_PrepaidInsurance_c4dbfdce-0dae-43be-96e9-cf398c333d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRent_313e948a-8aea-4698-aa60-10dfc1e73e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidRent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_PrepaidRent_313e948a-8aea-4698-aa60-10dfc1e73e88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_8ec40cf0-378e-44fd-9dd4-d4da719bda6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_8ec40cf0-378e-44fd-9dd4-d4da719bda6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_0bfaccf7-5739-46d7-9ac2-ebf0ff3501eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_PrepaidTaxes_0bfaccf7-5739-46d7-9ac2-ebf0ff3501eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PrepaidMaintenanceContractsCurrent_4a7ae77b-b922-47cd-bdc2-541716b709ba" xlink:href="shc-20210331.xsd#shc_PrepaidMaintenanceContractsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_shc_PrepaidMaintenanceContractsCurrent_4a7ae77b-b922-47cd-bdc2-541716b709ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_a44fc20e-33da-49b3-8ab0-15c305944fd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_a44fc20e-33da-49b3-8ab0-15c305944fd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Supplies_be78fd1a-e97f-40b3-8529-8f45492d1b7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Supplies"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_Supplies_be78fd1a-e97f-40b3-8529-8f45492d1b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_2a87620b-f79f-4e74-b2c4-736258018339" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_OtherAssetsCurrent_2a87620b-f79f-4e74-b2c4-736258018339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_341572cc-df64-482d-9be4-e8f6ca6ff8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_adf7f50d-7019-40d6-94b8-1cd82c3a27d9" xlink:to="loc_us-gaap_DepositsAssetsCurrent_341572cc-df64-482d-9be4-e8f6ca6ff8ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangiblesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e7ad8d88-6b00-4d6a-9ddd-d3836c578d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d75d1e2c-06ed-49d2-9a19-867c1c451eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e7ad8d88-6b00-4d6a-9ddd-d3836c578d88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_d75d1e2c-06ed-49d2-9a19-867c1c451eef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c2bb207c-525a-4fe0-bb2f-d76890317fab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_e7ad8d88-6b00-4d6a-9ddd-d3836c578d88" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_c2bb207c-525a-4fe0-bb2f-d76890317fab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_10831245-d173-48e7-a166-01047547e5f8" xlink:href="shc-20210331.xsd#shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:to="loc_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_10831245-d173-48e7-a166-01047547e5f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4f7a0e7b-e6f6-4201-886a-a49b5c38b70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4f7a0e7b-e6f6-4201-886a-a49b5c38b70e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_502c45e5-90d3-46d3-985c-581b2799f313" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_502c45e5-90d3-46d3-985c-581b2799f313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2c0db690-f838-4c59-998c-5db93aa25820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2c0db690-f838-4c59-998c-5db93aa25820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c0db1a91-d937-424a-89a3-31977da34533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_c0db1a91-d937-424a-89a3-31977da34533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a4fb1d15-0802-49a1-bc6e-56715c4bb41a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1b056bb0-57e3-49ba-a6f1-14038bec5e2e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_a4fb1d15-0802-49a1-bc6e-56715c4bb41a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilities"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AccruedLiabilities" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilitiesTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AccruedLiabilitiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_27218f2c-b866-463b-a114-e2e67f9f10db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_27218f2c-b866-463b-a114-e2e67f9f10db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_d4acb79f-052f-4b89-b724-49dbcc7d9432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_d4acb79f-052f-4b89-b724-49dbcc7d9432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_91e366c5-5526-428a-816d-fe8f73223753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_TaxesPayableCurrent_91e366c5-5526-428a-816d-fe8f73223753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_219da114-21e6-4a24-8db6-33f2bdbf860d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_219da114-21e6-4a24-8db6-33f2bdbf860d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4d0c5c1b-ec80-4eb2-8eaf-b9662ca25396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_4d0c5c1b-ec80-4eb2-8eaf-b9662ca25396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_17a5311e-78e9-4f6e-b547-d75f13af2dc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_LitigationReserveCurrent_17a5311e-78e9-4f6e-b547-d75f13af2dc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d905d239-3a94-4d2b-bc14-54a127351dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d905d239-3a94-4d2b-bc14-54a127351dc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_ae7a2082-8c07-49e1-9179-3744bdac0e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_ae7a2082-8c07-49e1-9179-3744bdac0e75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AccruedInterestExpenseCurrent_a49fc480-4ca4-469c-8913-7a6d79011ac0" xlink:href="shc-20210331.xsd#shc_AccruedInterestExpenseCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_b6fa1d4a-50ed-4d2b-bff5-1d1eaf150be8" xlink:to="loc_shc_AccruedInterestExpenseCurrent_a49fc480-4ca4-469c-8913-7a6d79011ac0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebt" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebt"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebt" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_830a209c-ff08-4d4f-8f68-c1e4cfeacff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_bd0e92f1-d0da-4fb0-b039-136f5d9d9fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_830a209c-ff08-4d4f-8f68-c1e4cfeacff7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_bd0e92f1-d0da-4fb0-b039-136f5d9d9fca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_694be09f-a13f-4495-99a5-87ca971b70e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_830a209c-ff08-4d4f-8f68-c1e4cfeacff7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_694be09f-a13f-4495-99a5-87ca971b70e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtSeniorSecuredCreditFacilitiesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtFirstLienNotesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtRepaymentsofDebtDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtAggregateMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_27f417e3-7c2d-436b-82ff-f79e2d162285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_27f417e3-7c2d-436b-82ff-f79e2d162285" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6fb1d8e5-1cec-4fca-a24d-77a659cff9fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6fb1d8e5-1cec-4fca-a24d-77a659cff9fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LongTermDebtMaturityAfterYearFour_1272abe4-d466-475a-b1ae-7182abdf61e8" xlink:href="shc-20210331.xsd#shc_LongTermDebtMaturityAfterYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:to="loc_shc_LongTermDebtMaturityAfterYearFour_1272abe4-d466-475a-b1ae-7182abdf61e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_deb84529-d706-4716-97f8-96efd5c30a42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_deb84529-d706-4716-97f8-96efd5c30a42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_4d8fc581-7770-4f89-aac0-8717c6709e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_4d8fc581-7770-4f89-aac0-8717c6709e51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0ef75d67-a9f6-4432-a94a-cbec423fd6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e88d2e23-44a5-488c-a147-b6370714d427" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0ef75d67-a9f6-4432-a94a-cbec423fd6ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="shc-20210331.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefits"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EmployeeBenefits" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_25c00b69-2bf3-41ae-bada-20ec5973b1bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_f3b8f46e-ed46-45b3-af90-2d871545f946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_25c00b69-2bf3-41ae-bada-20ec5973b1bc" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_f3b8f46e-ed46-45b3-af90-2d871545f946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c7d5ebc6-5ae3-436e-b369-c5dbcef5aeea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_25c00b69-2bf3-41ae-bada-20ec5973b1bc" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c7d5ebc6-5ae3-436e-b369-c5dbcef5aeea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8f981e5c-6aea-4fc9-8c05-899cd291e0e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_25c00b69-2bf3-41ae-bada-20ec5973b1bc" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8f981e5c-6aea-4fc9-8c05-899cd291e0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_cdd5c34e-67ec-4280-a42f-eea6d7421c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_25c00b69-2bf3-41ae-bada-20ec5973b1bc" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_cdd5c34e-67ec-4280-a42f-eea6d7421c43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RelatedParties" xlink:type="simple" xlink:href="shc-20210331.xsd#RelatedParties"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/RelatedParties" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLossTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47462975-39a4-484e-be9a-037215760882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_03046efd-517c-4b37-9c54-cb401e8cc78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47462975-39a4-484e-be9a-037215760882" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_03046efd-517c-4b37-9c54-cb401e8cc78f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4c04b399-91e0-4388-a18f-f3f702248144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_47462975-39a4-484e-be9a-037215760882" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_4c04b399-91e0-4388-a18f-f3f702248144" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensation"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationPreIPOAwardsClassB1andB2Details"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationStockOptionsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationRSUsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShare"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EarningsLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShareTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EarningsLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/EarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5e9906a4-cbc2-4f6e-9e48-3ead39a89abf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8679ed95-2b1d-4dab-8cf0-d632fbd54bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5e9906a4-cbc2-4f6e-9e48-3ead39a89abf" xlink:to="loc_us-gaap_ProfitLoss_8679ed95-2b1d-4dab-8cf0-d632fbd54bc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_aa1875af-2c37-4e09-a853-a8fdf3cca99d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5e9906a4-cbc2-4f6e-9e48-3ead39a89abf" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_aa1875af-2c37-4e09-a853-a8fdf3cca99d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a21a7360-f239-481b-9dfe-00dcfa018853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_5e9906a4-cbc2-4f6e-9e48-3ead39a89abf" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a21a7360-f239-481b-9dfe-00dcfa018853" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c8121c9c-cc0c-4245-aec4-c02a6a161d41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_7dc3a383-0550-47fe-a0fc-c79a8a8cea46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c8121c9c-cc0c-4245-aec4-c02a6a161d41" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_7dc3a383-0550-47fe-a0fc-c79a8a8cea46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_74f3762a-e642-4a38-b330-45d1bb2d2d30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c8121c9c-cc0c-4245-aec4-c02a6a161d41" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_74f3762a-e642-4a38-b330-45d1bb2d2d30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b55a9002-033b-4d33-9fcd-4c35c4cbf97f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c8121c9c-cc0c-4245-aec4-c02a6a161d41" xlink:to="loc_us-gaap_ProfitLoss_b55a9002-033b-4d33-9fcd-4c35c4cbf97f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="shc-20210331.xsd#CommitmentandContingencies"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/CommitmentandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#CommitmentandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/CommitmentandContingenciesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRisk"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformation" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformation"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/SegmentInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationTables"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/SegmentInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationSegmentOperatingResultsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationReconciliationofReportableSegmentAmountsDetails"/>
  <link:calculationLink xlink:role="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_17cbba78-4a58-4cf8-8c87-80038bec5d35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_17cbba78-4a58-4cf8-8c87-80038bec5d35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_80fe3cc8-8d46-4ee2-ad1b-5a168b508019" xlink:href="shc-20210331.xsd#shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_80fe3cc8-8d46-4ee2-ad1b-5a168b508019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CostAndExpensesCOVID19_a2d84bb6-503d-46ca-88a8-24af1d776dce" xlink:href="shc-20210331.xsd#shc_CostAndExpensesCOVID19"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_shc_CostAndExpensesCOVID19_a2d84bb6-503d-46ca-88a8-24af1d776dce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SegmentIncomeLoss_3a3d0081-7b6f-4c3d-a759-ef30bfd4701e" xlink:href="shc-20210331.xsd#shc_SegmentIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_shc_SegmentIncomeLoss_3a3d0081-7b6f-4c3d-a759-ef30bfd4701e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_f96055b7-218a-404f-b264-8494e8e70237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_BusinessExitCosts1_f96055b7-218a-404f-b264-8494e8e70237" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_26b76ed7-4b71-41ec-8e2f-323e2985c343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_LitigationSettlementExpense_26b76ed7-4b71-41ec-8e2f-323e2985c343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e2854dee-554b-4e74-a9b3-84523afda375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_InterestExpense_e2854dee-554b-4e74-a9b3-84523afda375" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5f9dd197-638e-4258-9d6b-5a654f4e9276" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_ShareBasedCompensation_5f9dd197-638e-4258-9d6b-5a654f4e9276" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AcquisitionAndDivestitureRelatedChargesNet_8235bd93-1b9a-47ab-b1a7-10f342171385" xlink:href="shc-20210331.xsd#shc_AcquisitionAndDivestitureRelatedChargesNet"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_shc_AcquisitionAndDivestitureRelatedChargesNet_8235bd93-1b9a-47ab-b1a7-10f342171385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_072373db-5740-4ce1-bf44-469f286dac8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_OtherRestructuringCosts_072373db-5740-4ce1-bf44-469f286dac8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_53448530-5a57-4089-83e1-cfee6841a240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_53448530-5a57-4089-83e1-cfee6841a240" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b8c85546-446a-4c80-80fd-27e46d9d916c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6c72e828-d7f1-4b4f-9302-3623ae36b66b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b8c85546-446a-4c80-80fd-27e46d9d916c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>shc-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f476bcce-754d-42a8-b141-c43fc168635e,g:3b9d91f5-244f-4b5e-861f-f8019b961431-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://soterahealth.com/role/Cover" xlink:type="simple" xlink:href="shc-20210331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/Cover" xlink:type="extended" id="ic7f7962090b649f0884458227be7c998_Cover"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i34917d963c4f45b791824e6861aee11d_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i642e4e0a7c9a4306b172203d00aea005_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="extended" id="i7211fe3169b34bb79450fa6ad880038e_ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ec9b2208-c0a5-4eb2-b36e-f2a5b18d70e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_RevenuesAbstract_ec9b2208-c0a5-4eb2-b36e-f2a5b18d70e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a7b19e1-7b11-4163-94ab-4c4538eca0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ec9b2208-c0a5-4eb2-b36e-f2a5b18d70e4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a7b19e1-7b11-4163-94ab-4c4538eca0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_560e55fc-11d3-44d2-b337-6ad63342eb7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_CostOfRevenueAbstract_560e55fc-11d3-44d2-b337-6ad63342eb7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_e6005bfd-e90a-4e64-a0d9-694217fa54df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_560e55fc-11d3-44d2-b337-6ad63342eb7d" xlink:to="loc_us-gaap_CostOfRevenue_e6005bfd-e90a-4e64-a0d9-694217fa54df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0b8244bb-0041-40d6-8320-727cdb8a9f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_GrossProfit_0b8244bb-0041-40d6-8320-727cdb8a9f2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d98b396f-7b95-4bfd-b610-43f422567a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d98b396f-7b95-4bfd-b610-43f422567a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AmortizationOfIntangibleAssetsNonproduction_c85481d2-6cab-4244-a51f-11c18632278a" xlink:href="shc-20210331.xsd#shc_AmortizationOfIntangibleAssetsNonproduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:to="loc_shc_AmortizationOfIntangibleAssetsNonproduction_c85481d2-6cab-4244-a51f-11c18632278a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_108aff43-68e1-4c2e-b770-030432ff456b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:to="loc_us-gaap_OperatingExpenses_108aff43-68e1-4c2e-b770-030432ff456b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0fbfcbc5-2419-40f7-941a-18883808174e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OperatingIncomeLoss_0fbfcbc5-2419-40f7-941a-18883808174e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4d24a1f3-62ab-4950-a4af-84609cb24940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4d24a1f3-62ab-4950-a4af-84609cb24940" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_89245183-4f9d-451f-9853-5d048fe5e5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_89245183-4f9d-451f-9853-5d048fe5e5b6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3d04a810-6809-41e8-bca2-297952529fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3d04a810-6809-41e8-bca2-297952529fdf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_43380007-dc4f-43c8-b611-005e09f2f938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_43380007-dc4f-43c8-b611-005e09f2f938" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_58b535a7-7e31-4d53-9873-b4111807c162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_58b535a7-7e31-4d53-9873-b4111807c162" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d709310d-b236-413c-ada5-c7998e7e9e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d709310d-b236-413c-ada5-c7998e7e9e24" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_310cceaf-d055-4472-b0c4-e954711b6b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ProfitLoss_310cceaf-d055-4472-b0c4-e954711b6b34" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1c726bb3-1210-4436-b55d-dbd001f8d3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1c726bb3-1210-4436-b55d-dbd001f8d3a8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2398753-7392-468b-a752-fa13cc816477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_NetIncomeLoss_c2398753-7392-468b-a752-fa13cc816477" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1394a3ff-15bc-4f35-a194-efbceb8efe75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1394a3ff-15bc-4f35-a194-efbceb8efe75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_07f44405-6e55-4ec2-bb6a-1d9e3b5d5944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_07f44405-6e55-4ec2-bb6a-1d9e3b5d5944" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b9d1bf46-dcb1-4c6b-b735-956ba9b91fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b9d1bf46-dcb1-4c6b-b735-956ba9b91fe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7791ca0-3031-4d07-a43c-210d1a50ac02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7791ca0-3031-4d07-a43c-210d1a50ac02" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_954bce5d-0bc2-4e74-971b-9ed8e842f0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_954bce5d-0bc2-4e74-971b-9ed8e842f0a4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe31d9f5-3f1c-4f17-a440-6ca521f97ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe31d9f5-3f1c-4f17-a440-6ca521f97ae4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c94c4403-93ab-46f6-ad16-067d28b3aa70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:to="loc_us-gaap_EarningsPerShareBasic_c94c4403-93ab-46f6-ad16-067d28b3aa70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4f2a96c7-031f-4049-a6ca-460433a79f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4f2a96c7-031f-4049-a6ca-460433a79f2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f235099-c7bf-4012-9ce5-835c59dffeac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f235099-c7bf-4012-9ce5-835c59dffeac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e371e0d9-6db7-42fa-8535-b33900a52b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e371e0d9-6db7-42fa-8535-b33900a52b31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:to="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e90c1304-acab-4795-8557-97d6f6f9691b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:to="loc_srt_ProductsAndServicesDomain_e90c1304-acab-4795-8557-97d6f6f9691b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:to="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_75438de7-e24e-4722-9966-7bb089297d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:to="loc_us-gaap_ServiceMember_75438de7-e24e-4722-9966-7bb089297d74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_de8c89a3-9d71-4da7-a713-762e944c6cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:to="loc_us-gaap_ProductMember_de8c89a3-9d71-4da7-a713-762e944c6cbc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" xlink:type="extended" id="iad7d76d06aad4fe48e78b0f4b745f6f2_ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="ib1b26455a6f647cf8e02bfc53d3e7d61_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofEquityDeficit"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit" xlink:type="extended" id="i56a3348e6e0a481e9355ebd93ce12803_ConsolidatedStatementsofEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_77ec6ce2-8ee0-4914-8f04-d4f29ced0b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_77ec6ce2-8ee0-4914-8f04-d4f29ced0b05" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2c5a0f07-f9fe-4007-83ff-3fc19143c230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_SharesOutstanding_2c5a0f07-f9fe-4007-83ff-3fc19143c230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_498cb9ae-3b0f-4ed5-ab78-6733b2726a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_498cb9ae-3b0f-4ed5-ab78-6733b2726a2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_abe32694-1774-4d18-b6a4-18e36cbbedd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_abe32694-1774-4d18-b6a4-18e36cbbedd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c832552b-3a57-4640-a1cd-d669003bba9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c832552b-3a57-4640-a1cd-d669003bba9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f3f4949c-5be2-4062-b7fb-31331b37c881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f3f4949c-5be2-4062-b7fb-31331b37c881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4e926efa-f9a9-4488-88a7-3260dbdd0056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4e926efa-f9a9-4488-88a7-3260dbdd0056" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7ae7cb48-04cc-45b8-bd66-e61a47b88540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7ae7cb48-04cc-45b8-bd66-e61a47b88540" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_14032c15-7740-4a52-8939-35fa0e96072e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_ProfitLoss_14032c15-7740-4a52-8939-35fa0e96072e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4e0fcc2e-05dd-4b78-9794-87d6ca25d89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ae10cc52-2378-413f-89cd-a7bcf6d9a148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_77ec6ce2-8ee0-4914-8f04-d4f29ced0b05" xlink:to="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a558fa24-1a53-43ae-9d60-b5fce488f48b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:to="loc_us-gaap_EquityComponentDomain_a558fa24-1a53-43ae-9d60-b5fce488f48b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:to="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_508766ba-1a61-489f-89bc-d8c3540cff43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_CommonStockMember_508766ba-1a61-489f-89bc-d8c3540cff43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ce1a94b1-6672-43ea-b026-f6718b04d912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_TreasuryStockMember_ce1a94b1-6672-43ea-b026-f6718b04d912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_378e8851-926d-4dc9-a194-cbf31bdafe19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_378e8851-926d-4dc9-a194-cbf31bdafe19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_986fa9c4-f0e6-48eb-97b4-8f9db2f41cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_RetainedEarningsMember_986fa9c4-f0e6-48eb-97b4-8f9db2f41cb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88172cb0-afc0-4f41-a76e-5b8c0b69f736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88172cb0-afc0-4f41-a76e-5b8c0b69f736" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_34a13368-75a7-4765-8f77-9f251a248236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_NoncontrollingInterestMember_34a13368-75a7-4765-8f77-9f251a248236" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentation" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentation"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/BasisofPresentation" xlink:type="extended" id="id3254de8f67448e6a36c5bdfb9bbeb66_BasisofPresentation"/>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/BasisofPresentationPolicies" xlink:type="extended" id="i29512a6d5eac4956a604dcb5a35e0c4c_BasisofPresentationPolicies"/>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/BasisofPresentationDetails" xlink:type="extended" id="i24e0ab83c4ea453893081688adfa46d9_BasisofPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d1a72882-7904-4974-bd18-86cecd2d9928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d1a72882-7904-4974-bd18-86cecd2d9928" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NumberOfSubsidiariesWithNonControllingInterest_eb366b69-4848-4122-b98e-d9170c52bcf1" xlink:href="shc-20210331.xsd#shc_NumberOfSubsidiariesWithNonControllingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_shc_NumberOfSubsidiariesWithNonControllingInterest_eb366b69-4848-4122-b98e-d9170c52bcf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a142722e-6734-4cc9-a122-9ab508b1e161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a142722e-6734-4cc9-a122-9ab508b1e161" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_1c14257a-42b0-4dee-9774-c6001fdb4ae8" xlink:href="shc-20210331.xsd#shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_1c14257a-42b0-4dee-9774-c6001fdb4ae8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_061a14ef-1617-4f77-94b9-245963644c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_061a14ef-1617-4f77-94b9-245963644c87" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74c270eb-6128-4d7d-9b0d-09fd91aafbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74c270eb-6128-4d7d-9b0d-09fd91aafbed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4887318d-8e71-43bd-b419-965c3bdf7e0c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:to="loc_srt_SegmentGeographicalDomain_4887318d-8e71-43bd-b419-965c3bdf7e0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bdbd2d60-10c6-418a-8e1c-b70700d6c9b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:to="loc_srt_SegmentGeographicalDomain_bdbd2d60-10c6-418a-8e1c-b70700d6c9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_d470c663-da87-4083-b918-e2b7725aa003" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bdbd2d60-10c6-418a-8e1c-b70700d6c9b2" xlink:to="loc_country_CN_d470c663-da87-4083-b918-e2b7725aa003" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d694ee64-6fde-413c-9d04-3714769f0adb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:to="loc_srt_OwnershipDomain_d694ee64-6fde-413c-9d04-3714769f0adb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:to="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SubsidiaryOneMember_20d116a5-63c9-4335-8ec9-e7445915eb7c" xlink:href="shc-20210331.xsd#shc_SubsidiaryOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:to="loc_shc_SubsidiaryOneMember_20d116a5-63c9-4335-8ec9-e7445915eb7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SubsidiaryTwoMember_4689e20f-8b3a-4180-9c10-99cb955984e0" xlink:href="shc-20210331.xsd#shc_SubsidiaryTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:to="loc_shc_SubsidiaryTwoMember_4689e20f-8b3a-4180-9c10-99cb955984e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64b85e3a-173f-43bd-b265-1c76509ce0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64b85e3a-173f-43bd-b265-1c76509ce0d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_7504f502-6702-4a25-add5-e7f92231df74" xlink:href="shc-20210331.xsd#shc_NelsonFairfieldIncNelsonFairfieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64b85e3a-173f-43bd-b265-1c76509ce0d0" xlink:to="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_7504f502-6702-4a25-add5-e7f92231df74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_44b313d7-db7a-4a76-8a5e-60ff5d95ce67_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:to="loc_srt_ScenarioUnspecifiedDomain_44b313d7-db7a-4a76-8a5e-60ff5d95ce67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7f26feb4-2e80-4c85-99e7-6e64f37a1027" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7f26feb4-2e80-4c85-99e7-6e64f37a1027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_72951929-8828-49f6-b13a-c5bf7a1747f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_7f26feb4-2e80-4c85-99e7-6e64f37a1027" xlink:to="loc_srt_ScenarioForecastMember_72951929-8828-49f6-b13a-c5bf7a1747f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f661d7fb-c2a1-4c60-8561-2434a445a321_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f661d7fb-c2a1-4c60-8561-2434a445a321_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_39460770-60c1-4177-a6ef-457a88b3d841" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_39460770-60c1-4177-a6ef-457a88b3d841" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_UnnamedEBeamJointVentureMember_549a9a83-0e8f-4667-ae3f-02d10da5d895" xlink:href="shc-20210331.xsd#shc_UnnamedEBeamJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_39460770-60c1-4177-a6ef-457a88b3d841" xlink:to="loc_shc_UnnamedEBeamJointVentureMember_549a9a83-0e8f-4667-ae3f-02d10da5d895" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RecentAccountingStandards" xlink:type="simple" xlink:href="shc-20210331.xsd#RecentAccountingStandards"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/RecentAccountingStandards" xlink:type="extended" id="i79fda9b60eaa42d9a2432ac84a2ac864_RecentAccountingStandards"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognition" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognition"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/RevenueRecognition" xlink:type="extended" id="i560c4667edf84ab58f99559fee7fdb2c_RevenueRecognition"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognitionTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/RevenueRecognitionTables" xlink:type="extended" id="i792672abce484e6ba97a8a2049680bc8_RevenueRecognitionTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/RevenueRecognitionDetails" xlink:type="extended" id="icad6b7797f824cc2bdfe94e87c447500_RevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_548d3c29-0329-467f-8833-9ae291066381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_721e59a5-7ebd-46fe-8a13-72b643c822f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_548d3c29-0329-467f-8833-9ae291066381" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_721e59a5-7ebd-46fe-8a13-72b643c822f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_548d3c29-0329-467f-8833-9ae291066381" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0aaac185-2609-4dcd-acf5-80e20bcaeafa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:to="loc_us-gaap_SegmentDomain_0aaac185-2609-4dcd-acf5-80e20bcaeafa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:to="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember_aa6d9cec-58ac-4844-b0b3-c3d21713fa2c" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:to="loc_shc_SterigenicsMember_aa6d9cec-58ac-4844-b0b3-c3d21713fa2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_217278ce-b12c-41ca-b22c-b70fde877a95" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:to="loc_shc_NordionMember_217278ce-b12c-41ca-b22c-b70fde877a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember_74307968-a6f6-4d90-a49b-12da6b5fbb6d" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:to="loc_shc_NelsonLabsMember_74307968-a6f6-4d90-a49b-12da6b5fbb6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_f9f48d3f-db56-4acd-94a5-28c4575fca4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_f9f48d3f-db56-4acd-94a5-28c4575fca4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_f987665e-3a53-4619-8c65-f18f2489fae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:to="loc_us-gaap_TransferredOverTimeMember_f987665e-3a53-4619-8c65-f18f2489fae7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/Acquisitions" xlink:type="simple" xlink:href="shc-20210331.xsd#Acquisitions"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/Acquisitions" xlink:type="extended" id="i8671fdacb6a14c8883bf09a0f971ca2a_Acquisitions"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AcquisitionsTables" xlink:type="extended" id="id8de2a4f47394d3cab2208106b3e20d7_AcquisitionsTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="extended" id="icd353ed6de5b400bb3de4fa4b9cb7b8a_AcquisitionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2fd112bb-0677-44e2-b0e7-70d7cc0709b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2fd112bb-0677-44e2-b0e7-70d7cc0709b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness_b5cf0074-6f8f-4d87-8db9-312d74b4462d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness_b5cf0074-6f8f-4d87-8db9-312d74b4462d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_92c8838f-16fe-449f-9e81-361863fa6b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_92c8838f-16fe-449f-9e81-361863fa6b93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_39722d28-219c-4ec0-987c-fc7073082d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_Goodwill_39722d28-219c-4ec0-987c-fc7073082d22" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b528cfc5-8c21-4595-913e-c20425d832a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b528cfc5-8c21-4595-913e-c20425d832a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fb54fe44-fbea-40b3-95a9-2ffc342a8c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fb54fe44-fbea-40b3-95a9-2ffc342a8c20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_2aadbe32-a48e-4902-808f-fd264ec37614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_2aadbe32-a48e-4902-808f-fd264ec37614" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount_ed63e26d-5ddb-41c3-bc9f-ea350615e85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount_ed63e26d-5ddb-41c3-bc9f-ea350615e85b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_798ee1dc-5711-4e53-a914-b6be37f80bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_798ee1dc-5711-4e53-a914-b6be37f80bc9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a2f838a1-99c0-4ed3-a263-05f423b18da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a2f838a1-99c0-4ed3-a263-05f423b18da9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_54572666-ef0d-425c-84e6-ec3032c0ef43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_54572666-ef0d-425c-84e6-ec3032c0ef43" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2ff31469-e80b-4b37-82d3-9f84e592d790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2ff31469-e80b-4b37-82d3-9f84e592d790" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7acca6ab-6025-4eab-bc2a-991bb0801e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7acca6ab-6025-4eab-bc2a-991bb0801e79" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ca3f652a-39fa-4d36-a035-2079845d9b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ca3f652a-39fa-4d36-a035-2079845d9b27" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dc2b0ad8-0f72-403f-a7dd-d9487fafe3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dc2b0ad8-0f72-403f-a7dd-d9487fafe3ec" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab0a798a-513a-465c-8e05-5efe5a06d3df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab0a798a-513a-465c-8e05-5efe5a06d3df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_39db57db-49ff-4863-9439-c0795c705333" xlink:href="shc-20210331.xsd#shc_BioScienceLaboratoriesLLCBioScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:to="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_39db57db-49ff-4863-9439-c0795c705333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_dc5f8682-d8a3-42b8-9869-ff15865b1fc9" xlink:href="shc-20210331.xsd#shc_NelsonFairfieldIncNelsonFairfieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:to="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_dc5f8682-d8a3-42b8-9869-ff15865b1fc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember_cffc4c2d-7615-4e93-9dfb-4803324ffb26" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:to="loc_shc_IotronIndustriesCanadaIncIotronMember_cffc4c2d-7615-4e93-9dfb-4803324ffb26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c1207f78-3c69-4a4b-80b9-ab4f03189b72" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c1207f78-3c69-4a4b-80b9-ab4f03189b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_UnnamedEBeamJointVentureMember_ea0c8c83-d87b-4f3c-9f42-56c08ccf0a8c" xlink:href="shc-20210331.xsd#shc_UnnamedEBeamJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c1207f78-3c69-4a4b-80b9-ab4f03189b72" xlink:to="loc_shc_UnnamedEBeamJointVentureMember_ea0c8c83-d87b-4f3c-9f42-56c08ccf0a8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8d725c1-3c84-47eb-969c-565ad9900658_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b8d725c1-3c84-47eb-969c-565ad9900658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4c59854f-a058-4ada-b1f3-c03183504471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4c59854f-a058-4ada-b1f3-c03183504471" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_05b9904c-29c6-4966-8dc4-1d077a91811e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_05b9904c-29c6-4966-8dc4-1d077a91811e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ea2a29ae-d330-4c3b-8913-efc0907a58e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ea2a29ae-d330-4c3b-8913-efc0907a58e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_246ee616-32ec-4886-8719-8963f2ddf04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_246ee616-32ec-4886-8719-8963f2ddf04b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member_5930256a-e76b-4bb6-b5fe-4377a420b654" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_246ee616-32ec-4886-8719-8963f2ddf04b" xlink:to="loc_shc_FirstLienNotesDue2026Member_5930256a-e76b-4bb6-b5fe-4377a420b654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d66da08f-4810-4870-aa3d-ed14b675c8e8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:to="loc_srt_RangeMember_d66da08f-4810-4870-aa3d-ed14b675c8e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:to="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d3b58bb6-c8c6-4ce7-9c68-f24829e40395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:to="loc_srt_MinimumMember_d3b58bb6-c8c6-4ce7-9c68-f24829e40395" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5953a41f-2742-4e80-868d-f11962096468" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:to="loc_srt_MaximumMember_5953a41f-2742-4e80-868d-f11962096468" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails" xlink:type="extended" id="i88364cbbc8e04857887115e80058e2bc_AcquisitionsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_89b639f0-95ee-4b1f-b559-0ce10afe2557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_Goodwill_89b639f0-95ee-4b1f-b559-0ce10afe2557" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a0262877-ad04-4c10-a542-fa161d978bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a0262877-ad04-4c10-a542-fa161d978bf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_05683e57-0e7a-4356-b3f7-f07f9856d00c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_05683e57-0e7a-4356-b3f7-f07f9856d00c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_7307bd18-df53-4f11-88a7-8579e387ac9c" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_7307bd18-df53-4f11-88a7-8579e387ac9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_aaea97ed-b521-4412-b3e3-081490c51c10" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_aaea97ed-b521-4412-b3e3-081490c51c10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0066cc8f-61be-4d31-aa86-e6ba46381c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0066cc8f-61be-4d31-aa86-e6ba46381c7c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_2712f9a1-e867-4066-b937-1555565dd2b9" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_2712f9a1-e867-4066-b937-1555565dd2b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b2ec9084-e800-4301-b49c-f0edb1c7e4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b2ec9084-e800-4301-b49c-f0edb1c7e4ad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9d5b3f20-246d-4119-8213-b40b6cd05f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9d5b3f20-246d-4119-8213-b40b6cd05f8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e9091c4d-c8f1-4c5b-a40a-589f2120b86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e9091c4d-c8f1-4c5b-a40a-589f2120b86a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_4cef8f3a-a687-4f02-90c7-8c8f980efd1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_4cef8f3a-a687-4f02-90c7-8c8f980efd1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_35d0f461-103f-405c-924a-94e2ed208e9e" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_35d0f461-103f-405c-924a-94e2ed208e9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_634bac62-f94e-400f-b0b0-2f3673757a6c" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_634bac62-f94e-400f-b0b0-2f3673757a6c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_218f983b-edfa-421b-a02e-26e8c1342d77" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_218f983b-edfa-421b-a02e-26e8c1342d77" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_1cd650af-7c1e-4185-a323-bede63e977d0" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_1cd650af-7c1e-4185-a323-bede63e977d0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_bb2c92db-04c5-46b6-b10c-99b0e8cbec65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_bb2c92db-04c5-46b6-b10c-99b0e8cbec65" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_553e5bb7-1019-4f4e-8066-ad33b854b0a7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_553e5bb7-1019-4f4e-8066-ad33b854b0a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3980af61-c276-42d3-b8f1-0a489ac9e19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3980af61-c276-42d3-b8f1-0a489ac9e19e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember_1056e20d-d93a-4ee7-89cf-76840291353a" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3980af61-c276-42d3-b8f1-0a489ac9e19e" xlink:to="loc_shc_IotronIndustriesCanadaIncIotronMember_1056e20d-d93a-4ee7-89cf-76840291353a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsProFormaInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails" xlink:type="extended" id="iaab19a6cfdbb4fd483fae1a760bcf521_AcquisitionsProFormaInformationDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/Inventories" xlink:type="simple" xlink:href="shc-20210331.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/Inventories" xlink:type="extended" id="i0e8fd6ed6e1b4898854325b8314eb82a_Inventories"/>
  <link:roleRef roleURI="http://soterahealth.com/role/InventoriesTables" xlink:type="simple" xlink:href="shc-20210331.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/InventoriesTables" xlink:type="extended" id="i1a4cf368f08943838a47392615f4549e_InventoriesTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/InventoriesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/InventoriesDetails" xlink:type="extended" id="i869f2d220e3c4969bc9fff6d2c428392_InventoriesDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssets"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="extended" id="iaf725d238123475980d88caf634e83f4_PrepaidExpensesandOtherCurrentAssets"/>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="extended" id="ic49e50408b68498389dc78fff740291b_PrepaidExpensesandOtherCurrentAssetsTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended" id="i82c2912c83cf47a8827771b961210bd4_PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="if7885fbc0ee74914873340a1c4ea4627_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended" id="i0e546b96437249508df508924a269b10_GoodwillandOtherIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended" id="iaabd2b7038054464815e46d1a5d09002_GoodwillandOtherIntangibleAssetsGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c07900bd-17e9-440c-b783-c28c89ed8243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_c07900bd-17e9-440c-b783-c28c89ed8243" xlink:to="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7b40ebe8-0d1c-4dfd-911c-0e06222961f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_Goodwill_7b40ebe8-0d1c-4dfd-911c-0e06222961f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_45343ff8-5d6f-4633-a9f5-903ae7cfb3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_45343ff8-5d6f-4633-a9f5-903ae7cfb3d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_5dabd18d-6ad3-4704-88d5-4cfbd08c268d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_5dabd18d-6ad3-4704-88d5-4cfbd08c268d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3f2b72ac-f2ec-4d9d-bebe-be80fc437b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_c07900bd-17e9-440c-b783-c28c89ed8243" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4ea2c1a-fac3-40a0-abaa-1f5850179615_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:to="loc_us-gaap_SegmentDomain_e4ea2c1a-fac3-40a0-abaa-1f5850179615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:to="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember_acc79a11-6d68-4ebc-9882-31d6b6ea4dc3" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:to="loc_shc_SterigenicsMember_acc79a11-6d68-4ebc-9882-31d6b6ea4dc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_3565b387-f04c-4723-baac-44f0e60e793d" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:to="loc_shc_NordionMember_3565b387-f04c-4723-baac-44f0e60e793d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember_4c37cd8d-1612-4dd0-8d6d-9c42c9b12d67" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:to="loc_shc_NelsonLabsMember_4c37cd8d-1612-4dd0-8d6d-9c42c9b12d67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5ef45df6-64d8-4886-8125-51c47208c4a7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5ef45df6-64d8-4886-8125-51c47208c4a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_807e4270-08bd-4546-95a9-8f282a428c41" xlink:href="shc-20210331.xsd#shc_BioScienceLaboratoriesLLCBioScienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:to="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_807e4270-08bd-4546-95a9-8f282a428c41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember_a0859775-5a76-4420-81bd-dfebbf48e480" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:to="loc_shc_IotronIndustriesCanadaIncIotronMember_a0859775-5a76-4420-81bd-dfebbf48e480" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangiblesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails" xlink:type="extended" id="ie23f44f4cd5141debf7bbd1d429af34f_GoodwillandOtherIntangibleAssetsIntangiblesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9d687966-ccc5-4e1d-aad4-4ac37ecf63ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9d687966-ccc5-4e1d-aad4-4ac37ecf63ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_95f032fc-fe9b-43be-8391-821e00c644e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_95f032fc-fe9b-43be-8391-821e00c644e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_925007bc-412d-45c9-a628-eee46f20f94d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_925007bc-412d-45c9-a628-eee46f20f94d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7d1c7bff-9a6c-4458-a92f-d3351996e18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7d1c7bff-9a6c-4458-a92f-d3351996e18e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_cbcdac04-4ac1-4509-804f-9344c3c9850e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_cbcdac04-4ac1-4509-804f-9344c3c9850e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_cf95d4fb-2b21-4eec-bf54-2488f2fa8c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_TradeNamesMember_cf95d4fb-2b21-4eec-bf54-2488f2fa8c7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LandUseRightsMember_3498e242-491e-4f4e-bad6-2e0a5d881bac" xlink:href="shc-20210331.xsd#shc_LandUseRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_shc_LandUseRightsMember_3498e242-491e-4f4e-bad6-2e0a5d881bac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SealedSourceAndSupplyAgreementsMember_6ba449d1-48ee-4ffc-b816-828824d79e79" xlink:href="shc-20210331.xsd#shc_SealedSourceAndSupplyAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_shc_SealedSourceAndSupplyAgreementsMember_6ba449d1-48ee-4ffc-b816-828824d79e79" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_97a10051-f927-4336-97e4-63ee8c670bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_97a10051-f927-4336-97e4-63ee8c670bf9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0ba4f2a3-2627-4c88-9a8e-94e6554ed20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0ba4f2a3-2627-4c88-9a8e-94e6554ed20b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LicensingAgreementsRenewalTerm_8e728466-3969-4f25-931e-73df0bb05815" xlink:href="shc-20210331.xsd#shc_LicensingAgreementsRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:to="loc_shc_LicensingAgreementsRenewalTerm_8e728466-3969-4f25-931e-73df0bb05815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:to="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b43935e2-07dc-4754-9bfb-347144954919_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b43935e2-07dc-4754-9bfb-347144954919_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_6d7f723a-6283-49f0-a002-561118be0833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:to="loc_us-gaap_LicensingAgreementsMember_6d7f723a-6283-49f0-a002-561118be0833" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0b8af519-cec5-45ab-9824-8b5f5928a02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_0b8af519-cec5-45ab-9824-8b5f5928a02d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="extended" id="ic4593270373a4e11af96045f68b7595b_GoodwillandOtherIntangibleAssetsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d5672a08-f928-442f-8a6a-d93be4eca924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d5672a08-f928-442f-8a6a-d93be4eca924" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_67fd0140-23a7-41c6-a91a-d3fded975fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_67fd0140-23a7-41c6-a91a-d3fded975fc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6377ff2d-dcb8-4359-a7bc-bc865742ab52_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6377ff2d-dcb8-4359-a7bc-bc865742ab52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_20f803e6-9f91-47ac-8406-7953afe5be93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_20f803e6-9f91-47ac-8406-7953afe5be93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_488d1cde-522d-43e1-881f-16d643808dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_20f803e6-9f91-47ac-8406-7953afe5be93" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_488d1cde-522d-43e1-881f-16d643808dcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_a7ef80e6-fc8a-4acd-8449-54108c807d1c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_a7ef80e6-fc8a-4acd-8449-54108c807d1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_71bcc500-f173-4a39-860e-a865f1d11fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:to="loc_us-gaap_CostOfSalesMember_71bcc500-f173-4a39-860e-a865f1d11fe1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f3cdf7d4-7ffb-47aa-af36-cbce02a23ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f3cdf7d4-7ffb-47aa-af36-cbce02a23ca2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended" id="ica31b6c28f544f76b6f79fddfb57c209_GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilities"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AccruedLiabilities" xlink:type="extended" id="ib298a3419a814b9fab513793134b7dcb_AccruedLiabilities"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilitiesTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AccruedLiabilitiesTables" xlink:type="extended" id="i21d3d58d18824855920b047f17a97d6a_AccruedLiabilitiesTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/AccruedLiabilitiesDetails" xlink:type="extended" id="ieb4fba9cd524486d85930c9ba6eff4ec_AccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebt" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebt"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebt" xlink:type="extended" id="id0416e6490064318b390863b942282a7_LongTermDebt"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebtTables" xlink:type="extended" id="i3b927394e6f44431929068a521277dce_LongTermDebtTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended" id="i3e33c553aa2a4381845d0774fadb27df_LongTermDebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_217c50da-3a57-4409-b3e7-9f0a5b1dc784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_217c50da-3a57-4409-b3e7-9f0a5b1dc784" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_86c1ac82-487b-4fd8-b296-d9268640c4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_86c1ac82-487b-4fd8-b296-d9268640c4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_adad8cee-236d-4696-a09a-b15d0ed8abd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_LongTermDebt_adad8cee-236d-4696-a09a-b15d0ed8abd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8f96d09d-ca5a-448c-9277-0557aa489fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8f96d09d-ca5a-448c-9277-0557aa489fd9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_99995849-b7af-4ac2-a074-178372a7b76c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_99995849-b7af-4ac2-a074-178372a7b76c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember_0c7b0361-f582-4eb8-bca9-93c6691bc636" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:to="loc_shc_TermLoanMember_0c7b0361-f582-4eb8-bca9-93c6691bc636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_54cb5efc-e570-4b02-bac6-12ec00c3c414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:to="loc_us-gaap_SeniorNotesMember_54cb5efc-e570-4b02-bac6-12ec00c3c414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_OtherLongTermDebtMember_8292a915-c7e5-48e1-b7ac-f053f47f36f6" xlink:href="shc-20210331.xsd#shc_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:to="loc_shc_OtherLongTermDebtMember_8292a915-c7e5-48e1-b7ac-f053f47f36f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:to="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_09261653-5c01-41f0-8e9d-058352497f27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_09261653-5c01-41f0-8e9d-058352497f27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_e100165d-0b0c-4734-88b7-553a1e43fdbf" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:to="loc_shc_TermLoanDue2026Member_e100165d-0b0c-4734-88b7-553a1e43fdbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2026Member_15a74346-8627-4fd8-87f2-2e23a97728cb" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:to="loc_shc_SeniorNotesDue2026Member_15a74346-8627-4fd8-87f2-2e23a97728cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtSeniorSecuredCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails" xlink:type="extended" id="i9957c89076714cc3b711bc2646a4eefa_LongTermDebtSeniorSecuredCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_55c84f8b-e9fa-4724-8d12-ff2ea73de78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_55c84f8b-e9fa-4724-8d12-ff2ea73de78a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_884262ec-77fa-42b8-be0f-c4c0b5127a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_884262ec-77fa-42b8-be0f-c4c0b5127a3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_7311a965-2af8-4951-8b06-2d0d4d3e1a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_7311a965-2af8-4951-8b06-2d0d4d3e1a59" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8e91ba16-e8ff-4831-aae8-57fd1c3af18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8e91ba16-e8ff-4831-aae8-57fd1c3af18e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentVariableRateFloor_c6489cc4-bfc6-496a-a7d6-cf78375a0dc3" xlink:href="shc-20210331.xsd#shc_DebtInstrumentVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_DebtInstrumentVariableRateFloor_c6489cc4-bfc6-496a-a7d6-cf78375a0dc3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_0463be77-b77e-46a2-9d39-8ff0d1410216" xlink:href="shc-20210331.xsd#shc_DebtInstrumentEffectiveReductionInCurrentInterestRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_0463be77-b77e-46a2-9d39-8ff0d1410216" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_61e24cb0-91c4-4b7b-8493-54a003fd383a" xlink:href="shc-20210331.xsd#shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_61e24cb0-91c4-4b7b-8493-54a003fd383a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtIssuanceCostsRefinancingAdditionalExpense_7451469b-c003-42ed-835d-a6a541d59f89" xlink:href="shc-20210331.xsd#shc_DebtIssuanceCostsRefinancingAdditionalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_DebtIssuanceCostsRefinancingAdditionalExpense_7451469b-c003-42ed-835d-a6a541d59f89" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f649385b-de06-40ff-a01a-9360a843199e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f649385b-de06-40ff-a01a-9360a843199e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79262beb-402b-4d77-9658-2953849a67ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79262beb-402b-4d77-9658-2953849a67ff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_b4a30999-538b-4331-99e8-08e344440c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_b4a30999-538b-4331-99e8-08e344440c2c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_b4758992-237f-4162-bb32-5068efe0bb66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_b4758992-237f-4162-bb32-5068efe0bb66" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:to="loc_us-gaap_CreditFacilityDomain_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_79ce335a-d459-4f1d-af22-dfa984f617cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:to="loc_us-gaap_CreditFacilityDomain_79ce335a-d459-4f1d-af22-dfa984f617cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4cc4a9e0-98f5-4610-bf6c-c8df57b116b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_79ce335a-d459-4f1d-af22-dfa984f617cb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4cc4a9e0-98f5-4610-bf6c-c8df57b116b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9570f735-e758-4fe8-bc6d-b5a8e67178f8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9570f735-e758-4fe8-bc6d-b5a8e67178f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorSecuredCreditFacilitiesMember_46499db9-887c-4762-8c5d-61c0f5e7b635" xlink:href="shc-20210331.xsd#shc_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:to="loc_shc_SeniorSecuredCreditFacilitiesMember_46499db9-887c-4762-8c5d-61c0f5e7b635" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_a21b2237-eb96-4427-8da1-489178180b3d" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:to="loc_shc_TermLoanDue2026Member_a21b2237-eb96-4427-8da1-489178180b3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member_a943052e-638c-486a-b621-a626c8b05d68" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:to="loc_shc_FirstLienNotesDue2026Member_a943052e-638c-486a-b621-a626c8b05d68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fb3ab50c-839d-4dd8-9479-b3b9884eeffc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fb3ab50c-839d-4dd8-9479-b3b9884eeffc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember_b3f4abdb-ec48-46c0-9719-b03d410b65e4" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:to="loc_shc_TermLoanMember_b3f4abdb-ec48-46c0-9719-b03d410b65e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6143f0ac-e70b-47b4-8826-46bd3f07033b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:to="loc_us-gaap_SecuredDebtMember_6143f0ac-e70b-47b4-8826-46bd3f07033b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b13e23d5-40f7-4701-bcee-7c49d7101a75_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:to="loc_us-gaap_VariableRateDomain_b13e23d5-40f7-4701-bcee-7c49d7101a75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:to="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_e8bd9bce-5a9f-469e-aad8-7f68976a721d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_e8bd9bce-5a9f-469e-aad8-7f68976a721d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_86486161-c4f2-4a7c-9807-6ac4d2747ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:to="loc_us-gaap_BaseRateMember_86486161-c4f2-4a7c-9807-6ac4d2747ddd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_0051293b-4756-435c-bbc5-1c0a5a36487f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:to="loc_us-gaap_EurodollarMember_0051293b-4756-435c-bbc5-1c0a5a36487f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b94cb1a-85bd-4684-b455-2f04526b46b2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:to="loc_srt_RangeMember_4b94cb1a-85bd-4684-b455-2f04526b46b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:to="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_61c68b61-2468-43e4-ba71-7141aee7463d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:to="loc_srt_MinimumMember_61c68b61-2468-43e4-ba71-7141aee7463d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0319a9ac-db28-492e-bcb6-60b6569fcf06" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:to="loc_srt_MaximumMember_0319a9ac-db28-492e-bcb6-60b6569fcf06" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtFirstLienNotesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails" xlink:type="extended" id="i91d64e9ae4924acca6101de720449ce8_LongTermDebtFirstLienNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6b9f99b1-0510-48cc-97d8-1f342095f4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6b9f99b1-0510-48cc-97d8-1f342095f4ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentVariableRateFloor_a59d767a-f894-4925-bc6a-448d5b67b6b7" xlink:href="shc-20210331.xsd#shc_DebtInstrumentVariableRateFloor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_shc_DebtInstrumentVariableRateFloor_a59d767a-f894-4925-bc6a-448d5b67b6b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f07180d1-dc04-4db8-b8d9-3b4022ebdbac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f07180d1-dc04-4db8-b8d9-3b4022ebdbac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_5120a128-c347-4a89-9a4a-49e6c6b62871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_5120a128-c347-4a89-9a4a-49e6c6b62871" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8ff8868f-f475-4f70-8050-de518747db0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8ff8868f-f475-4f70-8050-de518747db0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e372c7b4-45c7-40a3-8c5a-bba77dacf198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e372c7b4-45c7-40a3-8c5a-bba77dacf198" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f9d5292f-29ac-4a47-bc07-7a419393593e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f9d5292f-29ac-4a47-bc07-7a419393593e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3bf82d7d-8d7a-4eb7-822e-fe3e57e9f303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3bf82d7d-8d7a-4eb7-822e-fe3e57e9f303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_dac0ee98-5a23-49a7-82de-2fb57dbae5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3bf82d7d-8d7a-4eb7-822e-fe3e57e9f303" xlink:to="loc_us-gaap_SecuredDebtMember_dac0ee98-5a23-49a7-82de-2fb57dbae5a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4be27a78-3d81-4712-a96b-35611ab2c87b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4be27a78-3d81-4712-a96b-35611ab2c87b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bf7a56cd-0faa-413a-b211-12f410388514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bf7a56cd-0faa-413a-b211-12f410388514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member_1fe4c971-cc1d-4dc5-8e53-e2602ad978aa" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bf7a56cd-0faa-413a-b211-12f410388514" xlink:to="loc_shc_FirstLienNotesDue2026Member_1fe4c971-cc1d-4dc5-8e53-e2602ad978aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_af231a92-39ca-4f8f-9cf3-29399ab9fe91_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:to="loc_us-gaap_VariableRateDomain_af231a92-39ca-4f8f-9cf3-29399ab9fe91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_525693b3-2c53-4243-8466-be0b54fb53ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:to="loc_us-gaap_VariableRateDomain_525693b3-2c53-4243-8466-be0b54fb53ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_170a3d0e-7085-4d6e-a412-72357a3620d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_525693b3-2c53-4243-8466-be0b54fb53ce" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_170a3d0e-7085-4d6e-a412-72357a3620d4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtRepaymentsofDebtDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails" xlink:type="extended" id="i2b8c85899840459a8aaf442b8ed32326_LongTermDebtRepaymentsofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f688484a-afe1-4e57-ab53-283184c543f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f688484a-afe1-4e57-ab53-283184c543f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_05d5382c-7132-4c53-b2a4-f9844ef6f107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_05d5382c-7132-4c53-b2a4-f9844ef6f107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_aa599ac5-7956-401a-b501-00852386d549" xlink:href="shc-20210331.xsd#shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_aa599ac5-7956-401a-b501-00852386d549" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_623c51a6-9a4f-4b7d-bc50-b648d2a1f6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_623c51a6-9a4f-4b7d-bc50-b648d2a1f6b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_7bb12659-30b8-4f69-b629-7f8bb58d2c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_7bb12659-30b8-4f69-b629-7f8bb58d2c21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_RecognitionOfDebtPremium_22f5eed1-e5fb-4094-a4e9-e53c1bd5bdc2" xlink:href="shc-20210331.xsd#shc_RecognitionOfDebtPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_shc_RecognitionOfDebtPremium_22f5eed1-e5fb-4094-a4e9-e53c1bd5bdc2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_99bf7dd5-78b4-4100-af7d-c63ff97cf27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_99bf7dd5-78b4-4100-af7d-c63ff97cf27c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_98be589b-3f33-43b2-88a3-95e4f9422fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_98be589b-3f33-43b2-88a3-95e4f9422fef" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd9bb704-f0bb-441b-ad32-948b5312d3d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_dd9bb704-f0bb-441b-ad32-948b5312d3d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a894626a-eeca-42a9-9453-0f68f7e39a98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a894626a-eeca-42a9-9453-0f68f7e39a98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_ab2f0b4c-3cc6-4e51-8e8d-ae97d36c4834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a894626a-eeca-42a9-9453-0f68f7e39a98" xlink:to="loc_us-gaap_IPOMember_ab2f0b4c-3cc6-4e51-8e8d-ae97d36c4834" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:to="loc_us-gaap_EquityComponentDomain_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f2e5fa05-7262-46ed-8cf9-6bbf0b67d05b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:to="loc_us-gaap_EquityComponentDomain_f2e5fa05-7262-46ed-8cf9-6bbf0b67d05b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6676c634-23ca-4da6-a7fe-d19c5fe71b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f2e5fa05-7262-46ed-8cf9-6bbf0b67d05b" xlink:to="loc_us-gaap_CommonStockMember_6676c634-23ca-4da6-a7fe-d19c5fe71b9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_95474433-2cca-43f1-a3fc-79c4a97e6475_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_95474433-2cca-43f1-a3fc-79c4a97e6475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_260d760b-cfe6-475c-86c4-8b06f5de12fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_260d760b-cfe6-475c-86c4-8b06f5de12fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember_13be9e4c-03e7-4350-a598-68ea901d4951" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_260d760b-cfe6-475c-86c4-8b06f5de12fe" xlink:to="loc_shc_TermLoanMember_13be9e4c-03e7-4350-a598-68ea901d4951" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4dbeb782-975e-4e85-bf89-25475e46b2cc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4dbeb782-975e-4e85-bf89-25475e46b2cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SecondLienNotesMember_3d16f512-f4cd-4e85-afc2-56173d871424" xlink:href="shc-20210331.xsd#shc_SecondLienNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:to="loc_shc_SecondLienNotesMember_3d16f512-f4cd-4e85-afc2-56173d871424" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_37c3b3bc-35f3-4bfe-aabc-d7d226ea1e04" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:to="loc_shc_TermLoanDue2026Member_37c3b3bc-35f3-4bfe-aabc-d7d226ea1e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanAndSecondLienNotesMember_32f60ce8-07c9-49af-872b-e17f5457a522" xlink:href="shc-20210331.xsd#shc_TermLoanAndSecondLienNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:to="loc_shc_TermLoanAndSecondLienNotesMember_32f60ce8-07c9-49af-872b-e17f5457a522" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ca31fe58-3810-4961-889a-bce68a2a05ea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ca31fe58-3810-4961-889a-bce68a2a05ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_154e52cd-7e7c-4ca5-8aca-509c00455fd2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_154e52cd-7e7c-4ca5-8aca-509c00455fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_4ce5d326-7f5c-44ea-a012-2486d6602495" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_154e52cd-7e7c-4ca5-8aca-509c00455fd2" xlink:to="loc_srt_OfficerMember_4ce5d326-7f5c-44ea-a012-2486d6602495" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtAggregateMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails" xlink:type="extended" id="i7aa62b00caeb4ba6944ac0fca0f5f0b4_LongTermDebtAggregateMaturitiesDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="shc-20210331.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/IncomeTaxes" xlink:type="extended" id="i0a21e8b8063149c7adc93a8bd0dc1818_IncomeTaxes"/>
  <link:roleRef roleURI="http://soterahealth.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/IncomeTaxesDetails" xlink:type="extended" id="iba7d30ad85974d009e3412e4ce0c3ecd_IncomeTaxesDetails"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefits"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EmployeeBenefits" xlink:type="extended" id="i84e9c0734f274cb4a69e92b5a2f7fb21_EmployeeBenefits"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsTables" xlink:type="extended" id="i518174dd8d234365b5875a70409c7a40_EmployeeBenefitsTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails" xlink:type="extended" id="icfc57af95200409e97176791e221622e_EmployeeBenefitsNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_8956f2f8-9452-4a0c-be4e-7904ce160d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_8956f2f8-9452-4a0c-be4e-7904ce160d36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_0bdf448c-08e4-48e0-940b-249e7d947a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_0bdf448c-08e4-48e0-940b-249e7d947a73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_336e9f9a-0f67-4793-8ea5-442aef537fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_336e9f9a-0f67-4793-8ea5-442aef537fb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_33b75dbb-5a5a-40d0-94b1-b412fd2853d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_33b75dbb-5a5a-40d0-94b1-b412fd2853d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ea096f82-6486-4121-9eb2-d1d5e24d5728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ea096f82-6486-4121-9eb2-d1d5e24d5728" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_21885bb5-0774-448f-be34-6153a6a0c0f3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_21885bb5-0774-448f-be34-6153a6a0c0f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4f217a47-d4d7-4c20-8c87-f34f2e3f2036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4f217a47-d4d7-4c20-8c87-f34f2e3f2036" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9f8296d6-e247-4ba6-9c48-90dade17ffd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9f8296d6-e247-4ba6-9c48-90dade17ffd6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails" xlink:type="extended" id="i53c2fda5cc044533af6417a684a6f895_EmployeeBenefitsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_3af6e620-e3c2-42fb-9d13-8cfaba46c316" xlink:href="shc-20210331.xsd#shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:to="loc_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_3af6e620-e3c2-42fb-9d13-8cfaba46c316" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_555b97d8-c4f4-4afd-976e-daab7b147074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_555b97d8-c4f4-4afd-976e-daab7b147074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_91405c7b-3711-48e9-a6d0-794158104d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_91405c7b-3711-48e9-a6d0-794158104d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_bccad299-ec20-41b0-bc0d-47e2cb9a1a57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_91405c7b-3711-48e9-a6d0-794158104d0d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_bccad299-ec20-41b0-bc0d-47e2cb9a1a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:to="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7f17712-687c-4ab4-8986-e8a3e5968422_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:to="loc_srt_RangeMember_d7f17712-687c-4ab4-8986-e8a3e5968422_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d86f0d48-acec-43e8-9457-20d09fa3e63d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:to="loc_srt_RangeMember_d86f0d48-acec-43e8-9457-20d09fa3e63d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3f058822-06b4-421a-b47a-c6e61cc0d602" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d86f0d48-acec-43e8-9457-20d09fa3e63d" xlink:to="loc_srt_MaximumMember_3f058822-06b4-421a-b47a-c6e61cc0d602" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RelatedParties" xlink:type="simple" xlink:href="shc-20210331.xsd#RelatedParties"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/RelatedParties" xlink:type="extended" id="i8469997b057b4f638edf01c2d80081d3_RelatedParties"/>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="extended" id="i528a3f913664400a92a647fdf40d1ff7_OtherComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLossTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="extended" id="i9fc93e7e8a254dbfa4e084e72a4ddec8_OtherComprehensiveIncomeLossTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended" id="id05d9f0869b9476ba0aacc0d49455d24_OtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f0e8cbc-d19b-4594-9fe2-173de5278c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f0e8cbc-d19b-4594-9fe2-173de5278c6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f3c260ac-b7ca-4a0c-913b-07fc628b915d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f3c260ac-b7ca-4a0c-913b-07fc628b915d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_224e7c59-6c62-488e-984c-7dc7e38cde06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_224e7c59-6c62-488e-984c-7dc7e38cde06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d9e77d65-9867-44a5-8691-1f686311b217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d9e77d65-9867-44a5-8691-1f686311b217" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_91c8dba7-62ac-4849-9493-b42df75462c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:to="loc_us-gaap_EquityComponentDomain_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7e4ab0b8-51b8-4f8c-aaa4-c437ea2deb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:to="loc_us-gaap_EquityComponentDomain_7e4ab0b8-51b8-4f8c-aaa4-c437ea2deb20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7e4ab0b8-51b8-4f8c-aaa4-c437ea2deb20" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e00def66-e01a-4a8a-8b82-36527f3c747b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e00def66-e01a-4a8a-8b82-36527f3c747b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_829f6d23-1742-4eaa-89f4-623648af0c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_829f6d23-1742-4eaa-89f4-623648af0c12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_14a8c360-d4ac-49d8-a872-9433f6bb3e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_14a8c360-d4ac-49d8-a872-9433f6bb3e4f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensation"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ShareBasedCompensation" xlink:type="extended" id="i5c91c6ffd6bb4d16b0ef096d4e0ca256_ShareBasedCompensation"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationTables" xlink:type="extended" id="ia14f25c95edb49488483fd935fa96d8d_ShareBasedCompensationTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended" id="iefad2faa4db845778990a1d3a82fad2a_ShareBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e517924b-6a07-43cf-87f5-51a72c706fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e517924b-6a07-43cf-87f5-51a72c706fe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7a7a4e25-3472-4d6b-9462-1c7387215d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7a7a4e25-3472-4d6b-9462-1c7387215d83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CashProceedsToSponsorsRatioToInvestedCapital_fde8f52b-338a-443c-bf91-3693fda24a78" xlink:href="shc-20210331.xsd#shc_CashProceedsToSponsorsRatioToInvestedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_shc_CashProceedsToSponsorsRatioToInvestedCapital_fde8f52b-338a-443c-bf91-3693fda24a78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_47da4fa3-9468-4297-a870-f2460faa65c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_47da4fa3-9468-4297-a870-f2460faa65c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bd161fc7-9ef2-498d-b5fd-66d30c851a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bd161fc7-9ef2-498d-b5fd-66d30c851a6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a260ad8-6868-4b11-89d1-d25a596abc50_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4a260ad8-6868-4b11-89d1-d25a596abc50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2906eba5-c576-4b91-9fdb-e86b00c35dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:to="loc_us-gaap_RestrictedStockMember_2906eba5-c576-4b91-9fdb-e86b00c35dc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0820d8f3-22d4-44af-81e3-363e7ee07823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0820d8f3-22d4-44af-81e3-363e7ee07823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_044bc001-ba4e-4b33-a62b-a64d32b4763c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_044bc001-ba4e-4b33-a62b-a64d32b4763c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a8404989-8c6a-4697-801d-9552c3418d00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:to="loc_us-gaap_ClassOfStockDomain_a8404989-8c6a-4697-801d-9552c3418d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:to="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB1Member_99e02f64-ed92-412b-9363-55acf7a3f078" xlink:href="shc-20210331.xsd#shc_PreIPOB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:to="loc_shc_PreIPOB1Member_99e02f64-ed92-412b-9363-55acf7a3f078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB2Member_ef7054b3-524e-4811-924b-7d96f5997e52" xlink:href="shc-20210331.xsd#shc_PreIPOB2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:to="loc_shc_PreIPOB2Member_ef7054b3-524e-4811-924b-7d96f5997e52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_cbb82d08-3a72-4e2b-bbac-2299d334eb67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:to="loc_us-gaap_VestingDomain_cbb82d08-3a72-4e2b-bbac-2299d334eb67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:to="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_13c0d6ce-fcff-40b6-b90f-0b12b32e38d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_13c0d6ce-fcff-40b6-b90f-0b12b32e38d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97f4b686-bf1c-417a-bb2a-285593fefae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97f4b686-bf1c-417a-bb2a-285593fefae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_d456df4e-de68-43e5-8ef7-2fb76c746a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_d456df4e-de68-43e5-8ef7-2fb76c746a2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ShareBasedPaymentArrangementTrancheFourMember_6986f26a-bcd8-41f1-b3ea-3cd9f76f23f2" xlink:href="shc-20210331.xsd#shc_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_shc_ShareBasedPaymentArrangementTrancheFourMember_6986f26a-bcd8-41f1-b3ea-3cd9f76f23f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ShareBasedPaymentArrangementTrancheFiveMember_d1be054a-3780-48b1-a0b9-ce366308f22a" xlink:href="shc-20210331.xsd#shc_ShareBasedPaymentArrangementTrancheFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_shc_ShareBasedPaymentArrangementTrancheFiveMember_d1be054a-3780-48b1-a0b9-ce366308f22a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_52ba72cf-bc79-41ef-9579-5d82d5a19949_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:to="loc_us-gaap_PlanNameDomain_52ba72cf-bc79-41ef-9579-5d82d5a19949_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_74315127-af2a-4fd7-9cfa-3e4d1667d7a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:to="loc_us-gaap_PlanNameDomain_74315127-af2a-4fd7-9cfa-3e4d1667d7a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_A2020OmnibusIncentivePlanMember_d6c1568f-867d-437e-9198-d0783ed7a1f0" xlink:href="shc-20210331.xsd#shc_A2020OmnibusIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_74315127-af2a-4fd7-9cfa-3e4d1667d7a0" xlink:to="loc_shc_A2020OmnibusIncentivePlanMember_d6c1568f-867d-437e-9198-d0783ed7a1f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_46de337d-3778-42ad-a706-1162970bd524_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:to="loc_srt_RangeMember_46de337d-3778-42ad-a706-1162970bd524_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:to="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_11e413bb-db67-47aa-8cdf-4bcbd43dd19e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:to="loc_srt_MinimumMember_11e413bb-db67-47aa-8cdf-4bcbd43dd19e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a61e79ed-c9ef-4fc2-8fbc-1fe6e6e623db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:to="loc_srt_MaximumMember_a61e79ed-c9ef-4fc2-8fbc-1fe6e6e623db" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationPreIPOAwardsClassB1andB2Details"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details" xlink:type="extended" id="i3343844d0d464c70babe912e6d7bbb44_ShareBasedCompensationPreIPOAwardsClassB1andB2Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b3ede8-2299-4bad-b935-25cfe9665159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b3ede8-2299-4bad-b935-25cfe9665159" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7612266-8af6-4bd8-9273-63b69c85a2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7612266-8af6-4bd8-9273-63b69c85a2fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5ed9b5da-66af-479d-b759-f19dbd85e949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5ed9b5da-66af-479d-b759-f19dbd85e949" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9236ceff-49a2-44c5-abbc-a6ac82745b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9236ceff-49a2-44c5-abbc-a6ac82745b19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e59e2d4d-4bb2-4e2d-9d35-7e1c1e61167e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b3ede8-2299-4bad-b935-25cfe9665159" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:to="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0d24d61-e8be-46c4-84f1-edcb9462cbb2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a0d24d61-e8be-46c4-84f1-edcb9462cbb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4a08ee-400d-4bae-bc1f-2fe30d3c5762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4a08ee-400d-4bae-bc1f-2fe30d3c5762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_5ebb5927-2bd3-45de-9de3-e97c33546f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4a08ee-400d-4bae-bc1f-2fe30d3c5762" xlink:to="loc_us-gaap_RestrictedStockMember_5ebb5927-2bd3-45de-9de3-e97c33546f48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6f7f5a94-2782-40d8-b1a8-13151f997d6f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:to="loc_us-gaap_ClassOfStockDomain_6f7f5a94-2782-40d8-b1a8-13151f997d6f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:to="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB1Member_14384d18-0fde-4666-b1d5-de0adddd5444" xlink:href="shc-20210331.xsd#shc_PreIPOB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:to="loc_shc_PreIPOB1Member_14384d18-0fde-4666-b1d5-de0adddd5444" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB2Member_a5dcf212-16c1-40ff-9694-cdcf0d1dea27" xlink:href="shc-20210331.xsd#shc_PreIPOB2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:to="loc_shc_PreIPOB2Member_a5dcf212-16c1-40ff-9694-cdcf0d1dea27" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="extended" id="i28c6e4d952c34e098933e5850143569e_ShareBasedCompensationStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_47856eb1-956b-459f-8323-2a9b65e43eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_47856eb1-956b-459f-8323-2a9b65e43eb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_109309de-33cb-41a3-ba78-8ae906480150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_109309de-33cb-41a3-ba78-8ae906480150" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_a73d7766-c3ac-43b5-b5ea-dbfad3d8acba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_a73d7766-c3ac-43b5-b5ea-dbfad3d8acba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_44a71ae9-fb18-457a-bb9d-e44c99ec30c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_44a71ae9-fb18-457a-bb9d-e44c99ec30c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4055829d-1e74-473b-a441-35f542f2b4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_55fb290f-7c3e-4f45-b199-fd3169466bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_55fb290f-7c3e-4f45-b199-fd3169466bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19fdf025-5e0b-44e4-858b-62ef9fc374ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19fdf025-5e0b-44e4-858b-62ef9fc374ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0d058213-0938-41a9-9139-4c3e4473f6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0d058213-0938-41a9-9139-4c3e4473f6ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2a84300a-19ab-4fa0-9d1f-971e8f69fea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2a84300a-19ab-4fa0-9d1f-971e8f69fea3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f8588a78-a3b7-4d60-8c17-c24b37dc84d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:to="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5adb08cb-221e-4886-a607-2a9e844b056e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5adb08cb-221e-4886-a607-2a9e844b056e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae417562-b633-4099-a786-f14251c549a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae417562-b633-4099-a786-f14251c549a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_edb511a2-6b33-4b85-a541-841c2a5348e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae417562-b633-4099-a786-f14251c549a9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_edb511a2-6b33-4b85-a541-841c2a5348e8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationRSUsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails" xlink:type="extended" id="i4090532aebd64972a806af135d9023af_ShareBasedCompensationRSUsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5483d420-ba6f-4fbb-983b-52f26f258a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5483d420-ba6f-4fbb-983b-52f26f258a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eb014c3-e0c1-4410-8560-314df0b3eca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eb014c3-e0c1-4410-8560-314df0b3eca9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_dffbe6f9-24d1-4529-896e-9c188bf3010c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_dffbe6f9-24d1-4529-896e-9c188bf3010c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d2adc45-400a-4560-811c-b37507df89be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d2adc45-400a-4560-811c-b37507df89be" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7d8b14fe-8490-4522-8fe0-1edee5680c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8601fcfe-1be7-48d5-8df2-987c3e439c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8601fcfe-1be7-48d5-8df2-987c3e439c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23164ab1-28e0-4023-8672-942893e3f1b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23164ab1-28e0-4023-8672-942893e3f1b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_214c30a6-a5eb-4ae7-80dc-9d672f14b0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_214c30a6-a5eb-4ae7-80dc-9d672f14b0c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5e9a8266-02fa-441e-9b2c-c2cc4cc7e734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5e9a8266-02fa-441e-9b2c-c2cc4cc7e734" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_264b41af-471d-4dab-8938-339633a2a990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:to="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c00614a0-1b58-46cc-9983-44c2b54950f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c00614a0-1b58-46cc-9983-44c2b54950f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_441774f4-76e4-4357-bab1-55c04fd25726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c00614a0-1b58-46cc-9983-44c2b54950f9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_441774f4-76e4-4357-bab1-55c04fd25726" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShare"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EarningsLossPerShare" xlink:type="extended" id="i588b064539704458ab2662f7dd991c15_EarningsLossPerShare"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShareTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EarningsLossPerShareTables" xlink:type="extended" id="ic97ca9870ac841c19ae03561a13a87ad_EarningsLossPerShareTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/EarningsLossPerShareDetails" xlink:type="extended" id="if9717198b8734abe882c54a24cfdde4d_EarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0404a843-3bb1-4773-9c0a-9e039438d7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_22299748-19ab-42f9-8692-b1fcc4ea440e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0404a843-3bb1-4773-9c0a-9e039438d7e5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_22299748-19ab-42f9-8692-b1fcc4ea440e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0404a843-3bb1-4773-9c0a-9e039438d7e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:to="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b9e1d15c-e594-491f-be94-ad06d14c3df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b9e1d15c-e594-491f-be94-ad06d14c3df0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c9b9301d-e6ac-44a4-bbac-b614afb78feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c9b9301d-e6ac-44a4-bbac-b614afb78feb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:to="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:to="loc_us-gaap_PlanNameDomain_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6dc3b33f-7873-47c4-a05d-1bbccf3c1293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:to="loc_us-gaap_PlanNameDomain_6dc3b33f-7873-47c4-a05d-1bbccf3c1293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_A2020OmnibusIncentivePlanMember_831a8566-7150-4698-a03e-3445eb424f0c" xlink:href="shc-20210331.xsd#shc_A2020OmnibusIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_6dc3b33f-7873-47c4-a05d-1bbccf3c1293" xlink:to="loc_shc_A2020OmnibusIncentivePlanMember_831a8566-7150-4698-a03e-3445eb424f0c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="shc-20210331.xsd#CommitmentandContingencies"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/CommitmentandContingencies" xlink:type="extended" id="iab8145e8c95d441481ea1ae433bffb9a_CommitmentandContingencies"/>
  <link:roleRef roleURI="http://soterahealth.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#CommitmentandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/CommitmentandContingenciesDetails" xlink:type="extended" id="i39b104a792ef4bba99c7073951ec40b1_CommitmentandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a469bd86-7b2d-468b-844a-97fff6c474d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a469bd86-7b2d-468b-844a-97fff6c474d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_GainContingencyPeriodOfBusinessInterruption_9553893a-3db1-40cb-8e1c-28e9dddfeb93" xlink:href="shc-20210331.xsd#shc_GainContingencyPeriodOfBusinessInterruption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_GainContingencyPeriodOfBusinessInterruption_9553893a-3db1-40cb-8e1c-28e9dddfeb93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_20ebf7ac-8b14-49b9-9e47-5ca8604b3b27" xlink:href="shc-20210331.xsd#shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_20ebf7ac-8b14-49b9-9e47-5ca8604b3b27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_df5a1706-473a-4a17-b617-9db3c11d6c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_df5a1706-473a-4a17-b617-9db3c11d6c7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_3faff20e-1fd6-4b43-858c-9f0396ea0805" xlink:href="shc-20210331.xsd#shc_LitigationSettlementCostsAssessedAndAwardedInFavor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_3faff20e-1fd6-4b43-858c-9f0396ea0805" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_4a0368df-a094-46c0-8c86-76596f5d1160" xlink:href="shc-20210331.xsd#shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_4a0368df-a094-46c0-8c86-76596f5d1160" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e101ae9e-f69e-415f-831b-ce63c3781aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e101ae9e-f69e-415f-831b-ce63c3781aa8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b289342c-f780-4773-b6f0-897b228b3a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b289342c-f780-4773-b6f0-897b228b3a20" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_44c06e7e-d849-4fd8-a847-a6826995f55d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_44c06e7e-d849-4fd8-a847-a6826995f55d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PercentOfReductionInResidentialPropertyValueAssessment_1e624c73-5934-4937-86e0-6704f787fc11" xlink:href="shc-20210331.xsd#shc_PercentOfReductionInResidentialPropertyValueAssessment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_PercentOfReductionInResidentialPropertyValueAssessment_1e624c73-5934-4937-86e0-6704f787fc11" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_035b700f-794a-439a-b2d2-db23efcfca6c" xlink:href="shc-20210331.xsd#shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_035b700f-794a-439a-b2d2-db23efcfca6c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability_e0adac6d-6de4-483a-8a55-cf5d5c6039f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability_e0adac6d-6de4-483a-8a55-cf5d5c6039f2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesByNatureAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain_5827e589-90fd-4cce-b4f2-8ea06314daaa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:to="loc_us-gaap_GainContingencyNatureDomain_5827e589-90fd-4cce-b4f2-8ea06314daaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain_996be4b2-96d5-41cf-89f8-4e5f814de536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:to="loc_us-gaap_GainContingencyNatureDomain_996be4b2-96d5-41cf-89f8-4e5f814de536" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositiveOutcomeOfLitigationMember_27f13ae5-74b1-4434-a8f4-a9da4fef10d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositiveOutcomeOfLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GainContingencyNatureDomain_996be4b2-96d5-41cf-89f8-4e5f814de536" xlink:to="loc_us-gaap_PositiveOutcomeOfLitigationMember_27f13ae5-74b1-4434-a8f4-a9da4fef10d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_786e6d0b-e659-4ecf-9313-c2093d752e70_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:to="loc_srt_LitigationCaseTypeDomain_786e6d0b-e659-4ecf-9313-c2093d752e70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:to="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_bab11e95-a604-4785-919f-029ecb0562f3" xlink:href="shc-20210331.xsd#shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:to="loc_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_bab11e95-a604-4785-919f-029ecb0562f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_EthyleneOxideTortLitigationIllinoisMember_be63d8bb-ddda-4849-b39c-0ef78470ddd8" xlink:href="shc-20210331.xsd#shc_EthyleneOxideTortLitigationIllinoisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:to="loc_shc_EthyleneOxideTortLitigationIllinoisMember_be63d8bb-ddda-4849-b39c-0ef78470ddd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_EthyleneOxideTortLitigationGeorgiaMember_9769ccf2-4d22-4ed8-bad6-4780ad008c46" xlink:href="shc-20210331.xsd#shc_EthyleneOxideTortLitigationGeorgiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:to="loc_shc_EthyleneOxideTortLitigationGeorgiaMember_9769ccf2-4d22-4ed8-bad6-4780ad008c46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_63ae3e5d-1d49-4df5-93a1-d9a0dad96500_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:to="loc_us-gaap_LitigationStatusDomain_63ae3e5d-1d49-4df5-93a1-d9a0dad96500_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_edaee1a2-69b8-4998-80b5-d3c298412133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:to="loc_us-gaap_LitigationStatusDomain_edaee1a2-69b8-4998-80b5-d3c298412133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_76f75681-c632-4649-be53-af9be330c89f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_edaee1a2-69b8-4998-80b5-d3c298412133" xlink:to="loc_us-gaap_PendingLitigationMember_76f75681-c632-4649-be53-af9be330c89f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRisk"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk" xlink:type="extended" id="ia73a8ca9638646efaace44cb56a29843_FinancialInstrumentsandFinancialRisk"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables" xlink:type="extended" id="i823e1863d4b9486a93fea27502aaf25d_FinancialInstrumentsandFinancialRiskTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" xlink:type="extended" id="i291dba0596344d6da7ee5c8d0e1341c4_FinancialInstrumentsandFinancialRiskAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_1c61660d-b6da-47e7-8b04-7cc00fb8cb89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_1c61660d-b6da-47e7-8b04-7cc00fb8cb89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7a4b0520-ee37-40e5-87bb-accf3678415c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7a4b0520-ee37-40e5-87bb-accf3678415c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DerivativeOptionPremium_6c6a47a9-59ac-4eac-8703-dcb03951439b" xlink:href="shc-20210331.xsd#shc_DerivativeOptionPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_shc_DerivativeOptionPremium_6c6a47a9-59ac-4eac-8703-dcb03951439b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_71cf0637-3a59-423a-9c2c-bc19cb05759b" xlink:href="shc-20210331.xsd#shc_PercentOfBorrowingLimitationDueToCashFlowExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_71cf0637-3a59-423a-9c2c-bc19cb05759b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_d690f723-94dd-4e9b-abb0-e9d5e015c281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_d690f723-94dd-4e9b-abb0-e9d5e015c281" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DerivativeNumberOfInstrumentsAmended_9320ddfb-0af6-4019-8699-182ad8b7356e" xlink:href="shc-20210331.xsd#shc_DerivativeNumberOfInstrumentsAmended"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_shc_DerivativeNumberOfInstrumentsAmended_9320ddfb-0af6-4019-8699-182ad8b7356e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_b3e192ab-4a37-4b7c-9a95-80d7ca370597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_b3e192ab-4a37-4b7c-9a95-80d7ca370597" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c44064c6-46b4-48f4-92fe-ceede8a4282b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c44064c6-46b4-48f4-92fe-ceede8a4282b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b49a942d-5f8e-4f29-a1c6-bcc15de89970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b49a942d-5f8e-4f29-a1c6-bcc15de89970" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2dd5cc1e-d560-422f-bc3c-8905aebab31b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:to="loc_us-gaap_HedgingDesignationDomain_2dd5cc1e-d560-422f-bc3c-8905aebab31b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:to="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4d634a66-94a0-4d16-a8eb-8734cc97ec72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4d634a66-94a0-4d16-a8eb-8734cc97ec72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d753f3f6-c985-4195-9eab-99cc31b240f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:to="loc_us-gaap_NondesignatedMember_d753f3f6-c985-4195-9eab-99cc31b240f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_df3fdfef-d94e-4b80-b3be-a6091c5e1a74_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_df3fdfef-d94e-4b80-b3be-a6091c5e1a74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cfb54820-e837-434c-bc82-86a785fdad98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_us-gaap_InterestRateSwapMember_cfb54820-e837-434c-bc82-86a785fdad98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_8af7ef4f-0093-40cc-90b7-04529f54f1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_us-gaap_InterestRateCapMember_8af7ef4f-0093-40cc-90b7-04529f54f1ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapOctober2017Member_cd27be81-bdde-42c2-87f2-c4e15c13f2c0" xlink:href="shc-20210331.xsd#shc_InterestRateCapOctober2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCapOctober2017Member_cd27be81-bdde-42c2-87f2-c4e15c13f2c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapJune2020Member_96bd048d-e03d-4709-ac4b-2b46dc2ab5ae" xlink:href="shc-20210331.xsd#shc_InterestRateCapJune2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCapJune2020Member_96bd048d-e03d-4709-ac4b-2b46dc2ab5ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCap1Member_16edfc80-45c5-4134-999c-f33d62f5bb19" xlink:href="shc-20210331.xsd#shc_InterestRateCap1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCap1Member_16edfc80-45c5-4134-999c-f33d62f5bb19" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapFebruary2021Member_20ca1252-054c-4aff-b06b-2a769dfa20e6" xlink:href="shc-20210331.xsd#shc_InterestRateCapFebruary2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCapFebruary2021Member_20ca1252-054c-4aff-b06b-2a769dfa20e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e8d4087b-26c6-4dad-b31f-1e4814345bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e8d4087b-26c6-4dad-b31f-1e4814345bb8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_c1c55123-85e0-4a91-9948-c168d36a3e87_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:to="loc_us-gaap_VariableRateDomain_c1c55123-85e0-4a91-9948-c168d36a3e87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1e6f60f8-35ce-4e6a-a120-7fc9f0f9cdef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:to="loc_us-gaap_VariableRateDomain_1e6f60f8-35ce-4e6a-a120-7fc9f0f9cdef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_edde1875-c3b7-4bbc-aed5-fd5cfb4fde99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1e6f60f8-35ce-4e6a-a120-7fc9f0f9cdef" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_edde1875-c3b7-4bbc-aed5-fd5cfb4fde99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d24e3d8d-15af-43db-9586-f4658a122bc5_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_d24e3d8d-15af-43db-9586-f4658a122bc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4adc9b83-8bc3-4c87-8e91-e8a015351aae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4adc9b83-8bc3-4c87-8e91-e8a015351aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_ac1b0efc-55fb-4dd7-b874-f830e9762b38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4adc9b83-8bc3-4c87-8e91-e8a015351aae" xlink:to="loc_srt_ScenarioForecastMember_ac1b0efc-55fb-4dd7-b874-f830e9762b38" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" xlink:type="extended" id="ibf41aced4aeb4a38ac6c8adda4da1348_FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b0424cbe-022a-4bd9-9b5c-3399de7056b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b0424cbe-022a-4bd9-9b5c-3399de7056b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fc2b7a5f-da1e-4fa8-96a3-c0c7dfd90873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fc2b7a5f-da1e-4fa8-96a3-c0c7dfd90873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d1bcda1f-3a48-4f42-a534-9825d20782e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d1bcda1f-3a48-4f42-a534-9825d20782e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:to="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_99d193aa-a9ae-4163-a6b6-9e1b695000a1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:to="loc_us-gaap_HedgingDesignationDomain_99d193aa-a9ae-4163-a6b6-9e1b695000a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6146123d-5975-4029-8e26-486265466197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:to="loc_us-gaap_HedgingDesignationDomain_6146123d-5975-4029-8e26-486265466197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_af339b22-80b1-4a16-93a9-380357772463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_6146123d-5975-4029-8e26-486265466197" xlink:to="loc_us-gaap_NondesignatedMember_af339b22-80b1-4a16-93a9-380357772463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4d0bfe89-81d7-4b6b-b22d-556e9b7de795_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4d0bfe89-81d7-4b6b-b22d-556e9b7de795_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c70f21c5-fc70-4ffe-b426-1e824f039ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:to="loc_us-gaap_InterestRateCapMember_c70f21c5-fc70-4ffe-b426-1e824f039ae1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_7824bbca-4db3-4d81-8775-07ced73568e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_7824bbca-4db3-4d81-8775-07ced73568e6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" xlink:type="extended" id="i3df7e0ab8cf446ccbe3b39f90694e93c_FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_cc3035e1-97b0-452d-8651-7d45ac95cd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_cc3035e1-97b0-452d-8651-7d45ac95cd8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c46dc341-37ec-4155-b9d0-b47f4e83296d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c46dc341-37ec-4155-b9d0-b47f4e83296d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_fa785dfd-3926-4667-aca7-0a3db874e523_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_fa785dfd-3926-4667-aca7-0a3db874e523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_ed70e372-1801-4fcf-9a80-7b5767823f8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:to="loc_us-gaap_InterestRateCapMember_ed70e372-1801-4fcf-9a80-7b5767823f8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_43fa6119-194a-477b-85b2-da12d93c63d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_43fa6119-194a-477b-85b2-da12d93c63d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_931ee079-43c6-417f-a41c-a3eb48656038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:to="loc_us-gaap_ForeignExchangeContractMember_931ee079-43c6-417f-a41c-a3eb48656038" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f950e905-e47f-4a05-beff-d06079b12714_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f950e905-e47f-4a05-beff-d06079b12714_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_48b2c0ed-70e7-452a-874d-e94827f15c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:to="loc_us-gaap_InterestExpenseMember_48b2c0ed-70e7-452a-874d-e94827f15c6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1a2d76ef-2f67-469e-a34b-167536ba6f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1a2d76ef-2f67-469e-a34b-167536ba6f39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_ae0dcf54-a147-45ee-9c00-e325c8db5bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_ae0dcf54-a147-45ee-9c00-e325c8db5bd4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended" id="ide43291159df4480b10f0aa08e5d3377_FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_f980b4ce-1db5-4c05-ba54-8bf8ac63ebc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_f980b4ce-1db5-4c05-ba54-8bf8ac63ebc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d466e8f2-f410-41e7-a2e3-967fe8e915ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d466e8f2-f410-41e7-a2e3-967fe8e915ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8ca00582-7777-4c93-a4b7-b552ae919365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_LongTermDebtFairValue_8ca00582-7777-4c93-a4b7-b552ae919365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_16b3d290-1ee3-4a80-b63a-39e1637545d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:to="loc_us-gaap_HedgingDesignationDomain_16b3d290-1ee3-4a80-b63a-39e1637545d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ccdcfdb1-3f68-46fe-bb21-88262d60a9c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:to="loc_us-gaap_HedgingDesignationDomain_ccdcfdb1-3f68-46fe-bb21-88262d60a9c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ce9f51a4-08d5-45ee-8d98-272413160794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ccdcfdb1-3f68-46fe-bb21-88262d60a9c3" xlink:to="loc_us-gaap_NondesignatedMember_ce9f51a4-08d5-45ee-8d98-272413160794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fe8ddabf-2700-46e1-a407-b38f71aea98d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_fe8ddabf-2700-46e1-a407-b38f71aea98d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf62d1ec-e469-4d13-88fa-7e0cb963c896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf62d1ec-e469-4d13-88fa-7e0cb963c896" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7e20fc7a-da1a-47a1-acaa-4e897d1e1d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7e20fc7a-da1a-47a1-acaa-4e897d1e1d92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9266cd1a-5ba6-47e5-98b3-1d8c618f3752_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9266cd1a-5ba6-47e5-98b3-1d8c618f3752_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d1152754-8001-4000-99db-fb1f17f4b6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:to="loc_us-gaap_InterestRateCapMember_d1152754-8001-4000-99db-fb1f17f4b6cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_d649ef9d-22a3-4e4e-a528-a2c814ee55e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_d649ef9d-22a3-4e4e-a528-a2c814ee55e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_75cf61ee-6c53-4a26-a7a7-7bef6b514bea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_75cf61ee-6c53-4a26-a7a7-7bef6b514bea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_9b126a87-019a-4a2e-968f-416d0ae97a1b" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_TermLoanDue2026Member_9b126a87-019a-4a2e-968f-416d0ae97a1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2026Member_3f8c6300-292f-4271-b136-a11dbb1b6d1c" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_SeniorNotesDue2026Member_3f8c6300-292f-4271-b136-a11dbb1b6d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2027Member_eeafeff5-b9d1-463f-a83c-8adc0ccca8b0" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_SeniorNotesDue2027Member_eeafeff5-b9d1-463f-a83c-8adc0ccca8b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_OtherLongTermDebtMember_d063cd60-deb1-4641-9a14-5cd748289f63" xlink:href="shc-20210331.xsd#shc_OtherLongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_OtherLongTermDebtMember_d063cd60-deb1-4641-9a14-5cd748289f63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FinanceLeaseLiabilityMember_cd8cae3a-d815-45f1-9b69-49b0f2e1b7bf" xlink:href="shc-20210331.xsd#shc_FinanceLeaseLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_FinanceLeaseLiabilityMember_cd8cae3a-d815-45f1-9b69-49b0f2e1b7bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_65b90a7f-6956-4e6a-9718-24e33a5d8b22_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_65b90a7f-6956-4e6a-9718-24e33a5d8b22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fb91b9e2-6772-46da-b6cc-916f6f036eec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fb91b9e2-6772-46da-b6cc-916f6f036eec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_00de6bc9-75ec-4f3c-a000-4a022cd58447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_00de6bc9-75ec-4f3c-a000-4a022cd58447" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ff623bb6-9c29-41af-9a6a-54e94b76fee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ff623bb6-9c29-41af-9a6a-54e94b76fee3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformation" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformation"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/SegmentInformation" xlink:type="extended" id="i150b3d0441b847e3b97fba890d54aea1_SegmentInformation"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationTables"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/SegmentInformationTables" xlink:type="extended" id="ibfea0571b9414cafbdf9186cae408dfb_SegmentInformationTables"/>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails" xlink:type="extended" id="i21267d3db4884700bf3d0efe65732cb9_SegmentInformationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dbc9b577-78ec-431d-9ab6-2039ccfefcba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_eb47e21b-9b8f-4a73-a818-af6f2b591e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dbc9b577-78ec-431d-9ab6-2039ccfefcba" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_eb47e21b-9b8f-4a73-a818-af6f2b591e38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dbc9b577-78ec-431d-9ab6-2039ccfefcba" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_079ac8b4-2646-4d07-82cc-14cd3fa84535_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:to="loc_srt_ConsolidationItemsDomain_079ac8b4-2646-4d07-82cc-14cd3fa84535_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4a3f57c0-2e83-4f39-a57d-1e567eefdc54" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:to="loc_srt_ConsolidationItemsDomain_4a3f57c0-2e83-4f39-a57d-1e567eefdc54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_edb78133-f26f-4241-a12b-5fb13aabadfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_4a3f57c0-2e83-4f39-a57d-1e567eefdc54" xlink:to="loc_us-gaap_OperatingSegmentsMember_edb78133-f26f-4241-a12b-5fb13aabadfe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_48648112-10e6-49c5-bb12-4613536c5997_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:to="loc_us-gaap_SegmentDomain_48648112-10e6-49c5-bb12-4613536c5997_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dc5d554b-7654-4c32-ae09-79f659770f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:to="loc_us-gaap_SegmentDomain_dc5d554b-7654-4c32-ae09-79f659770f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_3197aeef-c997-4f5d-aee3-764f48ba7599" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dc5d554b-7654-4c32-ae09-79f659770f09" xlink:to="loc_shc_NordionMember_3197aeef-c997-4f5d-aee3-764f48ba7599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2b4771e3-3796-49fb-9e7c-818deead2c44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2b4771e3-3796-49fb-9e7c-818deead2c44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1c62718-6bd9-4fe0-8ba4-7839ae2b1af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1c62718-6bd9-4fe0-8ba4-7839ae2b1af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_f337bb75-c905-492f-bc08-422765c048fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1c62718-6bd9-4fe0-8ba4-7839ae2b1af2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_f337bb75-c905-492f-bc08-422765c048fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d67bcc68-3110-4bb4-ad91-6bc9841569ae_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:to="loc_srt_NameOfMajorCustomerDomain_d67bcc68-3110-4bb4-ad91-6bc9841569ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:to="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerOneMember_be9950e9-b421-4814-98bd-a8ac057daa4d" xlink:href="shc-20210331.xsd#shc_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:to="loc_shc_CustomerOneMember_be9950e9-b421-4814-98bd-a8ac057daa4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerTwoMember_f15c5125-22b7-4e36-9861-c33bc4f7145e" xlink:href="shc-20210331.xsd#shc_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:to="loc_shc_CustomerTwoMember_f15c5125-22b7-4e36-9861-c33bc4f7145e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerThreeMember_dfda2be2-9da1-4fed-a849-7e99fe8dc94c" xlink:href="shc-20210331.xsd#shc_CustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:to="loc_shc_CustomerThreeMember_dfda2be2-9da1-4fed-a849-7e99fe8dc94c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationSegmentOperatingResultsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails" xlink:type="extended" id="iec0cd3fcfce141eca1aea2604b38d9cb_SegmentInformationSegmentOperatingResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f37b85f-ae63-438d-9f88-ac6ed3ef507e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f37b85f-ae63-438d-9f88-ac6ed3ef507e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SegmentIncomeLoss_5d0a9f9e-35d3-416b-93d5-c02adc34ce4e" xlink:href="shc-20210331.xsd#shc_SegmentIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_shc_SegmentIncomeLoss_5d0a9f9e-35d3-416b-93d5-c02adc34ce4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_133e73db-03a1-46f5-937e-a421407a645b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_133e73db-03a1-46f5-937e-a421407a645b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:to="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:to="loc_srt_ConsolidationItemsDomain_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:to="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b5af5381-8dfb-4b38-8847-a8869cd58ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:to="loc_us-gaap_OperatingSegmentsMember_b5af5381-8dfb-4b38-8847-a8869cd58ef0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_0d0d5c5b-dafb-4917-95fb-93dbe78db990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:to="loc_us-gaap_IntersegmentEliminationMember_0d0d5c5b-dafb-4917-95fb-93dbe78db990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c399be1f-c368-42a4-99d2-d823825fc107_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:to="loc_us-gaap_SegmentDomain_c399be1f-c368-42a4-99d2-d823825fc107_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:to="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember_d9bdefb2-3913-485e-8f3c-fc16256b2879" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:to="loc_shc_SterigenicsMember_d9bdefb2-3913-485e-8f3c-fc16256b2879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_0f4cd287-7afd-4dd0-aabb-c5afa0869262" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:to="loc_shc_NordionMember_0f4cd287-7afd-4dd0-aabb-c5afa0869262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember_6c0fa0a0-5284-4b94-a086-8f7c52d4bc1d" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:to="loc_shc_NelsonLabsMember_6c0fa0a0-5284-4b94-a086-8f7c52d4bc1d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationReconciliationofReportableSegmentAmountsDetails"/>
  <link:definitionLink xlink:role="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails" xlink:type="extended" id="i0bf18b5a345245dfb56ea5ef6adcda98_SegmentInformationReconciliationofReportableSegmentAmountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SegmentIncomeLoss_372fea79-3193-425b-8b6d-740cb8cfe3d9" xlink:href="shc-20210331.xsd#shc_SegmentIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_SegmentIncomeLoss_372fea79-3193-425b-8b6d-740cb8cfe3d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5fed2931-1aa4-40d0-8f3c-78d7796edeea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_InterestExpense_5fed2931-1aa4-40d0-8f3c-78d7796edeea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fe4bcb0a-e7f8-41db-99b1-efa59a4f4da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fe4bcb0a-e7f8-41db-99b1-efa59a4f4da9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ede6a86e-330e-49ea-9173-6c36d393a33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_ShareBasedCompensation_ede6a86e-330e-49ea-9173-6c36d393a33e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_df485ff6-276d-4ff9-ae6f-a017df8559e2" xlink:href="shc-20210331.xsd#shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_df485ff6-276d-4ff9-ae6f-a017df8559e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AcquisitionAndDivestitureRelatedChargesNet_bc04d2c7-5620-4337-9d9c-16e16463c87e" xlink:href="shc-20210331.xsd#shc_AcquisitionAndDivestitureRelatedChargesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_AcquisitionAndDivestitureRelatedChargesNet_bc04d2c7-5620-4337-9d9c-16e16463c87e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_61db37cc-0be5-4017-a6cd-57776351cd57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_OtherRestructuringCosts_61db37cc-0be5-4017-a6cd-57776351cd57" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_3c126ea1-0248-4797-965c-7329f5397023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_BusinessExitCosts1_3c126ea1-0248-4797-965c-7329f5397023" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_830f52ed-51aa-4d0f-a51f-f9ac983a52f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_830f52ed-51aa-4d0f-a51f-f9ac983a52f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_0f64515c-9be9-460e-a6f9-a85dc295695d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_LitigationSettlementExpense_0f64515c-9be9-460e-a6f9-a85dc295695d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_b4cae5e4-832f-4659-bd33-aa9d7e64403e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_b4cae5e4-832f-4659-bd33-aa9d7e64403e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CostAndExpensesCOVID19_477e5ef2-ea0a-4459-a529-be5980ed5df7" xlink:href="shc-20210331.xsd#shc_CostAndExpensesCOVID19"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_CostAndExpensesCOVID19_477e5ef2-ea0a-4459-a529-be5980ed5df7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c7700414-6674-4537-9043-2025918e5b57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_NetIncomeLoss_c7700414-6674-4537-9043-2025918e5b57" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:to="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e7dc149c-a95e-44f4-8b74-a2ef6a340122_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:to="loc_srt_ConsolidationItemsDomain_e7dc149c-a95e-44f4-8b74-a2ef6a340122_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:to="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c710cbf3-ee40-4e27-ac6d-5a1182f40191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:to="loc_us-gaap_OperatingSegmentsMember_c710cbf3-ee40-4e27-ac6d-5a1182f40191" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_f8d6f3ab-e055-43e5-875a-e84525f6e324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_f8d6f3ab-e055-43e5-875a-e84525f6e324" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>shc-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f476bcce-754d-42a8-b141-c43fc168635e,g:3b9d91f5-244f-4b5e-861f-f8019b961431-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_da6c16de-93b7-4ec2-b482-7a0fa3761d47_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a5314a95-56b1-4786-84c5-157c32757f73_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_DerivativeOptionPremium_cf2d2fd1-6ad7-4897-8893-4248305f8682_terseLabel_en-US" xlink:label="lab_shc_DerivativeOptionPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option premium</link:label>
    <link:label id="lab_shc_DerivativeOptionPremium_label_en-US" xlink:label="lab_shc_DerivativeOptionPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Option Premium</link:label>
    <link:label id="lab_shc_DerivativeOptionPremium_documentation_en-US" xlink:label="lab_shc_DerivativeOptionPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Option Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DerivativeOptionPremium" xlink:href="shc-20210331.xsd#shc_DerivativeOptionPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_DerivativeOptionPremium" xlink:to="lab_shc_DerivativeOptionPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_FinanceLeaseLiabilityMember_97c05ed0-4e57-4dbc-b972-96465ab90b4d_terseLabel_en-US" xlink:label="lab_shc_FinanceLeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Obligations (with current portion)</link:label>
    <link:label id="lab_shc_FinanceLeaseLiabilityMember_label_en-US" xlink:label="lab_shc_FinanceLeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability [Member]</link:label>
    <link:label id="lab_shc_FinanceLeaseLiabilityMember_documentation_en-US" xlink:label="lab_shc_FinanceLeaseLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FinanceLeaseLiabilityMember" xlink:href="shc-20210331.xsd#shc_FinanceLeaseLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_FinanceLeaseLiabilityMember" xlink:to="lab_shc_FinanceLeaseLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5bf5bbea-65ed-41be-ba80-ec440770f76e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_8af85b6a-e4b0-4233-a271-51423aae8656_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_267ef54c-e408-44e5-91ff-05089565c425_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_28e6ca3b-2947-46d4-9c5f-87c8ec84eeaf_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_20617810-73ea-4578-908a-5d15f71082c3_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_OtherLongTermDebtMember_70204d6c-413b-457d-825e-9cdcc2169538_terseLabel_en-US" xlink:label="lab_shc_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term debt</link:label>
    <link:label id="lab_shc_OtherLongTermDebtMember_label_en-US" xlink:label="lab_shc_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt [Member]</link:label>
    <link:label id="lab_shc_OtherLongTermDebtMember_documentation_en-US" xlink:label="lab_shc_OtherLongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_OtherLongTermDebtMember" xlink:href="shc-20210331.xsd#shc_OtherLongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_OtherLongTermDebtMember" xlink:to="lab_shc_OtherLongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_4337305e-5c1d-4646-81af-aa6365b0ac56_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_44d4f782-8bab-43b2-9c50-5e7009d2e410_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e0d81721-87b0-4146-984c-09c6d119311e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_821822e0-56ca-499c-a446-3f83e1603047_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_2733aafe-72e2-4fa4-aab2-49038a031ce1_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d13e4b2e-451b-4122-9b02-d0e049c6f8a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_b0a30308-9387-4e71-84ae-a4373d59b96c_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_6e58771a-4b0c-4548-8524-6082f3de9a00_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_3cbac41b-8bff-4acc-98a0-4cce684cc258_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_1306beab-e2bf-402f-92c4-42769ca414c0_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory licenses and other</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3b2e7b84-5543-4667-ad72-3dc832b457d3_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bbf3e569-6217-4944-8400-e4b6d054a2a7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f425b0b-535c-4182-8df8-65697d81a5eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0f38c4e1-1a09-41fb-b3e3-f3f49b138363_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4cd65926-eec2-4f8f-bd84-f093672f3b91_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_a8dd69c2-8b84-4a59-b8e6-80f35668e996_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments and Financial Risk</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_8ea6d55a-91f1-41ea-b4ab-ef2cd3d4c6e4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_e22138a0-8532-4545-ba07-6b29b7411daa_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_666c2aa7-9871-4894-86ee-b9dc69c9b669_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_a0cf9e36-0388-4299-b077-16dcaf6fef8f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused borrowing capacity</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_45dfcd66-6451-4b1b-b113-d4b81363ad46_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names / trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_782982a7-f0de-49e5-849a-f69fd08efcdd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_1d748b0b-3088-47a9-a068-855d801e3e44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_efb4a86b-e8ed-4197-b32c-b7bbc49112c5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_43d27599-43c4-47e7-8b90-65dc42d6db8e_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ec8bbcd0-fa31-49c0-bde5-639cdc508203_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_83fbbae2-ecaf-4667-92fa-3ccb342f191c_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_619a125c-2812-4cf5-9da1-28fc0a8622de_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3a525c35-d86b-4acf-850f-f0e03258d4ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f995373f-8c5d-4da4-b9a6-6f5f08f9f11a_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_0a3beb63-6674-4e3a-a3e3-776e7ca3fabd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_03aaae68-97e4-42e7-b315-43c8e63690bc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b8a55420-e6fc-4cd5-9c2b-a3df760afe54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_894d72dc-54e5-4b0b-b538-e4ea315dd7fc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">See Commitments and contingencies note</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_0de6c45a-f333-4920-b73d-b21e77650d48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_931d50f1-ddf1-4ca9-b572-7438416d40f2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c24a421-3db6-4912-aa0c-5d424f451741_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f3dbb766-3dca-44d1-bb10-9184fcc42202_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_112940c2-5973-4163-82fc-50d0c5c200db_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fca176ef-be40-469e-be1d-cddbb4d818af_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3d6577a8-cf1b-4959-a241-01db43d597b2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_887a2345-107a-4303-adcc-db4575de7cf8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_22adbaf3-3839-4505-a64f-ae967e84fa57_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes due to foreign currency exchange rates</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_400dabcc-b5d0-440f-9e90-f8d660efc66d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_9c8fe4e7-6c6f-47a9-8aff-2e243adea7c6_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_80679a81-218f-436d-b9f8-d32ff48d35b7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_c70bc07b-4e48-4fc5-9c58-cebce7e11117_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_d1b71c71-d1c1-44eb-b28a-2c874fed9ff2_terseLabel_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital, net</link:label>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_label_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net</link:label>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_documentation_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" xlink:to="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ef29931b-4eb2-43d9-9e28-3b9bfcc9db76_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_fbb16d4c-cf55-4b11-b51c-f56c1fbf5544_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_f0e60951-b514-4493-8245-2ed30c216a9a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_fa1631ef-089c-4bc4-b1e5-0e2934823486_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_02613cba-cd64-479d-99a2-d5dae4c06048_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_NordionMember_7574eeb7-8b57-4bae-b7b2-1018b170672f_terseLabel_en-US" xlink:label="lab_shc_NordionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nordion</link:label>
    <link:label id="lab_shc_NordionMember_label_en-US" xlink:label="lab_shc_NordionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nordion [Member]</link:label>
    <link:label id="lab_shc_NordionMember_documentation_en-US" xlink:label="lab_shc_NordionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nordion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_NordionMember" xlink:to="lab_shc_NordionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_e7fb46c2-54ba-4965-a173-8c70c3f9af32_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Allocation to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6a22ad80-b5a2-490d-a627-1373fd0368bd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e5c5e4fa-0d8c-4363-8afc-4a9338adae90_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c5e74d70-38b9-4245-8ab8-cf255c1098f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a7648e8f-3635-44f5-a8ff-67e3faedea1e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears_11d11a5f-41e8-4bed-8ac3-c85a8498d05a_terseLabel_en-US" xlink:label="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expect funding requirements in each of the next five years</link:label>
    <link:label id="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears_label_en-US" xlink:label="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Annual Funding Requirements For Next Five Years</link:label>
    <link:label id="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears_documentation_en-US" xlink:label="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Annual Funding Requirements For Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" xlink:href="shc-20210331.xsd#shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" xlink:to="lab_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_42cde99e-c8e2-4ad8-b610-724027f045fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SeniorSecuredCreditFacilitiesMember_8e1cdac1-ac45-444b-a3c2-d52cf3f4b1a8_terseLabel_en-US" xlink:label="lab_shc_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_shc_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_shc_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_shc_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_shc_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorSecuredCreditFacilitiesMember" xlink:href="shc-20210331.xsd#shc_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_shc_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_9a6004f1-f0c7-4a7e-a2ea-39aad72e199d_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Allocation to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_018f4c8c-0b4a-442f-9f13-4cbf19184726_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_2a0344ec-1548-4128-857a-86b554957227_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_60fb720c-67a0-4307-8639-72fbf6eab62a_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b52027b8-9045-4442-9565-a7e29d108c79_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, with $0.01 par value, 120,000 authorized; no shares issued at March 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_6efe12bd-74b2-4f76-b44d-c9a69e76a1eb_terseLabel_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in unconsolidated affiliate</link:label>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_label_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment in Unconsolidated Affiliate</link:label>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_documentation_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment in Unconsolidated Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" xlink:to="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_277dda7c-48a4-43ab-9095-7d26d4f69314_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_bc2fffa1-af44-4312-9a8b-72ea749a9786_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_dd9d882f-71a7-4cc2-944a-416fa96531b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_5b185236-319a-41ea-be81-09d15c8dc7e6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_07bf88fb-76f1-4655-bb49-66589e428fd8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_670b7e28-3474-4fb8-80d7-7cd183c898b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_1773473f-c63a-4c0e-bb94-b788f3afbabe_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_ShareBasedPaymentArrangementTrancheFourMember_4daaffa7-af82-4719-8ad3-96fc7e1a0e61_terseLabel_en-US" xlink:label="lab_shc_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Four</link:label>
    <link:label id="lab_shc_ShareBasedPaymentArrangementTrancheFourMember_label_en-US" xlink:label="lab_shc_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Four [Member]</link:label>
    <link:label id="lab_shc_ShareBasedPaymentArrangementTrancheFourMember_documentation_en-US" xlink:label="lab_shc_ShareBasedPaymentArrangementTrancheFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ShareBasedPaymentArrangementTrancheFourMember" xlink:href="shc-20210331.xsd#shc_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_ShareBasedPaymentArrangementTrancheFourMember" xlink:to="lab_shc_ShareBasedPaymentArrangementTrancheFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_dba9120a-7b9b-43a6-b389-930db3aa0682_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Supplies_9886a015-1cda-4c80-8e96-682c740bbfe5_terseLabel_en-US" xlink:label="lab_us-gaap_Supplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock supplies</link:label>
    <link:label id="lab_us-gaap_Supplies_label_en-US" xlink:label="lab_us-gaap_Supplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Supplies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Supplies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Supplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Supplies" xlink:to="lab_us-gaap_Supplies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_b547d205-a5f2-4bf0-9ae2-a1735e647761_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_GainContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesLineItems" xlink:to="lab_us-gaap_GainContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a7641ee-dc65-43e3-8dda-17e9799839fa_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_eb32e8ac-26d0-47c9-8abd-36a44a8babb0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_7056fa07-cf8f-4f55-85f6-070a237f4dab_terseLabel_en-US" xlink:label="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss</link:label>
    <link:label id="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_label_en-US" xlink:label="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss [Member]</link:label>
    <link:label id="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_documentation_en-US" xlink:label="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" xlink:href="shc-20210331.xsd#shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" xlink:to="lab_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_8b1c5e12-0922-48b7-b0e9-0a83e655db81_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b635e3c3-eac3-404c-b76b-01f3b468caa2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_319efe23-2f62-4128-a24b-6301dfe71e51_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_8403f0a0-3a37-4c64-a8dc-8b4f28957b79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b18619d2-ef6d-42c4-bd54-b8af0cb61c45_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_37b4154d-69ab-4776-990e-0a4a026aa808_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesByNatureAxis_7b29bcda-ab78-4ba8-833c-d1fcfbddc8ab_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies, Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesByNatureAxis_label_en-US" xlink:label="lab_us-gaap_GainContingenciesByNatureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies, Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesByNatureAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesByNatureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis" xlink:to="lab_us-gaap_GainContingenciesByNatureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6b7769c8-3807-4a9a-bc51-89fcc3ab9b39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_66297fb5-ee62-4c93-9d39-7829bce82d74_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_d71595d6-dadd-403a-9965-8bed16cd9101_terseLabel_en-US" xlink:label="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="shc-20210331.xsd#shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_350b0116-7214-482f-872f-43a33be070ca_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_d03c9e48-5899-4ee3-acf6-c4502c9b99ed_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f4bf302c-4608-42a2-8f88-62ef603b52f4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_424944ce-83d4-4d11-8bdc-8cce414f2c9b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_b9298dfa-cd87-4491-aa5f-86fdf030dc72_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_822937ee-1e1d-4c63-9c01-07bd69c3a5df_terseLabel_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital, net</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_label_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets (Liabilities), Net</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_documentation_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets (Liabilities), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" xlink:to="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_9a3a76e9-d785-441c-948c-b7531b5b7fdc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_0290414d-1688-4c70-afdc-11cb9688ed74_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_8fb3b839-1e74-4191-9162-9c4b6b9533fc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per Common Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_7fbf1d8f-373b-428f-ba38-9badf3392ef2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_b4ffdd2b-dec7-474a-9c4f-473128a6f380_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and indemnification receivables</link:label>
    <link:label id="lab_us-gaap_InsuranceSettlementsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Settlements Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:to="lab_us-gaap_InsuranceSettlementsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_52dcc406-b364-448b-9560-fff178ff2227_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cdca46ba-e501-42bc-940c-cd855f6bca85_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_InterestRateCapOctober2017Member_32de761c-3979-4f62-b127-9c969eb6958a_terseLabel_en-US" xlink:label="lab_shc_InterestRateCapOctober2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap October 2017</link:label>
    <link:label id="lab_shc_InterestRateCapOctober2017Member_label_en-US" xlink:label="lab_shc_InterestRateCapOctober2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap October 2017 [Member]</link:label>
    <link:label id="lab_shc_InterestRateCapOctober2017Member_documentation_en-US" xlink:label="lab_shc_InterestRateCapOctober2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap October 2017</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapOctober2017Member" xlink:href="shc-20210331.xsd#shc_InterestRateCapOctober2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_InterestRateCapOctober2017Member" xlink:to="lab_shc_InterestRateCapOctober2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_9af8f670-5976-4a68-9ef4-1de02ea0a7b1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_cb35cfbf-1900-49ae-a1d7-5dcc7d08695e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_5e0e667c-1ffa-4737-9d86-c732742f582a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_90839798-b3db-4721-aea7-a06a2bd660c6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange (Gain) Loss</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyGainLossMember_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyGainLossMember" xlink:to="lab_us-gaap_ForeignCurrencyGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_35cecbd9-921d-4204-9986-1999d5c65e6c_terseLabel_en-US" xlink:label="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares to be repurchased (in shares)</link:label>
    <link:label id="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_label_en-US" xlink:label="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Additional Shares To Be Repurchased</link:label>
    <link:label id="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_documentation_en-US" xlink:label="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Additional Shares To Be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" xlink:href="shc-20210331.xsd#shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" xlink:to="lab_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_60a94153-8062-4b13-94e7-bdff2f29460f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_InterestRateCapJune2020Member_97b0e7c9-09ed-477e-98ca-8344d95e731a_terseLabel_en-US" xlink:label="lab_shc_InterestRateCapJune2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap June 2020</link:label>
    <link:label id="lab_shc_InterestRateCapJune2020Member_label_en-US" xlink:label="lab_shc_InterestRateCapJune2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap June 2020 [Member]</link:label>
    <link:label id="lab_shc_InterestRateCapJune2020Member_documentation_en-US" xlink:label="lab_shc_InterestRateCapJune2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap June 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapJune2020Member" xlink:href="shc-20210331.xsd#shc_InterestRateCapJune2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_InterestRateCapJune2020Member" xlink:to="lab_shc_InterestRateCapJune2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_f6316898-82bb-4bb2-93df-34e30559915a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc.</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_51509d29-b818-4952-8eb7-91e128b383da_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_85de661c-7f0a-4e7a-a1e1-7f3e324a2db7_terseLabel_en-US" xlink:label="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of borrowing limitation due to cash flow exposure</link:label>
    <link:label id="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_label_en-US" xlink:label="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Borrowing Limitation Due To Cash Flow Exposure</link:label>
    <link:label id="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_documentation_en-US" xlink:label="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of Borrowing Limitation Due To Cash Flow Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PercentOfBorrowingLimitationDueToCashFlowExposure" xlink:href="shc-20210331.xsd#shc_PercentOfBorrowingLimitationDueToCashFlowExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_PercentOfBorrowingLimitationDueToCashFlowExposure" xlink:to="lab_shc_PercentOfBorrowingLimitationDueToCashFlowExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cee53531-fa51-4261-9445-bd3ce7704359_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyNatureDomain_868100b0-9797-4c81-b014-9ec29c01cfd5_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_GainContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_GainContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyNatureDomain" xlink:to="lab_us-gaap_GainContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_839029c3-8d46-4264-9c0a-99cb10f83eab_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3b7c723a-1889-48c2-b5e4-751b6ab419a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_f43c0d23-3ff5-4607-a57f-45be00bf41e3_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_d3808ce7-e031-4e94-aa6a-95ad3b6b6d54_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationCurrent_68753b7a-cde6-4903-a184-1f64d3aeeb93_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of asset retirement obligations</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationCurrent" xlink:to="lab_us-gaap_AssetRetirementObligationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_a38a4e9a-d3cd-4e5d-98a8-8191d1a0bf8a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_d5aae733-b0d7-427d-b46c-733408869dca_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_81306f8c-ff80-4f45-95eb-d71e7de75362_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments held</link:label>
    <link:label id="lab_us-gaap_DerivativeNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_ced9e83e-feef-4895-89f0-66ca38bcf782_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_e3588b6d-ecdb-4ab7-9f04-4c8b4ccad22b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cd66f0a2-3d71-4676-b563-638e1b3c3f93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidRent_f7c52ee7-58c8-4e31-9f62-897f260c51f3_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid rent</link:label>
    <link:label id="lab_us-gaap_PrepaidRent_label_en-US" xlink:label="lab_us-gaap_PrepaidRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidRent" xlink:to="lab_us-gaap_PrepaidRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9e0a77d9-beaf-46ba-b3e1-166599083ef0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_a867cfab-54e5-4bb2-9d24-c92f963522db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_5a2a60eb-33af-453b-af78-969d71bb727a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_a5988f92-6ccc-4251-90d3-809e956ae5de_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and post-retirement benefits, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_fedca19b-1a3f-4771-9e6b-eb243a3e64c1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_2408f459-74ec-4a4c-bfaa-2e987685c2f2_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_A2020OmnibusIncentivePlanMember_cfefd5dc-0270-4b72-a0e4-a989fe7751be_terseLabel_en-US" xlink:label="lab_shc_A2020OmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Incentive Plan</link:label>
    <link:label id="lab_shc_A2020OmnibusIncentivePlanMember_label_en-US" xlink:label="lab_shc_A2020OmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Incentive Plan [Member]</link:label>
    <link:label id="lab_shc_A2020OmnibusIncentivePlanMember_documentation_en-US" xlink:label="lab_shc_A2020OmnibusIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_A2020OmnibusIncentivePlanMember" xlink:href="shc-20210331.xsd#shc_A2020OmnibusIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_A2020OmnibusIncentivePlanMember" xlink:to="lab_shc_A2020OmnibusIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_689ea778-78e7-4371-adfd-5cfcc7998378_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_e9fc0a9d-f0bd-4141-8dc6-5314379cfce2_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional services relating to EO sterilization facilities</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_16467dc7-caa0-49d1-a764-844dd543cf39_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eccc839c-1cdf-4d44-9b48-45d4e1b7541b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_c63629d7-c519-4dc6-9114-6bae5fa06161_terseLabel_en-US" xlink:label="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Solvency payment as percent of market value</link:label>
    <link:label id="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_label_en-US" xlink:label="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit, Solvency Payment as Percent of Market Value</link:label>
    <link:label id="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_documentation_en-US" xlink:label="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit, Solvency Payment as Percent of Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" xlink:href="shc-20210331.xsd#shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" xlink:to="lab_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_95e484e8-8631-425d-8ae9-1d4ba4e33f88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_8f9cb963-f134-4552-a0d9-545a2176af02_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized loss</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_39da12c7-71ec-4fa7-a2df-ca102fa3f197_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_d7a63e96-6006-4e75-9fe4-e3d5f638d5c5_negatedTerseLabel_en-US" xlink:label="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on foreign currency and embedded derivatives</link:label>
    <link:label id="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_label_en-US" xlink:label="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) and Gain (Loss) on Embedded Derivative</link:label>
    <link:label id="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_documentation_en-US" xlink:label="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Gain (Loss) and Gain (Loss) on Embedded Derivative</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" xlink:href="shc-20210331.xsd#shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" xlink:to="lab_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_000cb7ca-b971-47ae-923b-6c6998ff2f6b_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_84a57899-b12d-4331-aa9f-8cf3100cb4bf_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment purchases included in accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_a2d63b99-26ea-484a-84f6-a3b7fba3a691_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_f0d628c0-e1e3-40ce-b7b4-24f4b2f0c39e_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SubsidiaryOneMember_e7f4023c-8504-49d3-b80e-9351d51074cf_terseLabel_en-US" xlink:label="lab_shc_SubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary One</link:label>
    <link:label id="lab_shc_SubsidiaryOneMember_label_en-US" xlink:label="lab_shc_SubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary One [Member]</link:label>
    <link:label id="lab_shc_SubsidiaryOneMember_documentation_en-US" xlink:label="lab_shc_SubsidiaryOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SubsidiaryOneMember" xlink:href="shc-20210331.xsd#shc_SubsidiaryOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SubsidiaryOneMember" xlink:to="lab_shc_SubsidiaryOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_07bfca8d-bded-4f7e-b227-e4aae0fde4aa_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_ec023d2f-8c73-4e7e-ac81-d618238dbde8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_78b04b65-cae1-4664-91b2-ee6b9bfb5d6d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_bb2084eb-341c-4ac4-a89b-08d2ccfafc0c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of potential common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_8ca9f33b-b932-4b56-a2ff-d45b47d2bd57_terseLabel_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital, net</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_label_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital, Net</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_documentation_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" xlink:to="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_bb62d8b9-78d2-4a10-9ad9-18531757c66a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_DebtInstrumentVariableRateFloor_63539910-10fc-495f-859b-c52f0b727623_terseLabel_en-US" xlink:label="lab_shc_DebtInstrumentVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR floor</link:label>
    <link:label id="lab_shc_DebtInstrumentVariableRateFloor_label_en-US" xlink:label="lab_shc_DebtInstrumentVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate Floor</link:label>
    <link:label id="lab_shc_DebtInstrumentVariableRateFloor_documentation_en-US" xlink:label="lab_shc_DebtInstrumentVariableRateFloor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Variable Rate Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentVariableRateFloor" xlink:href="shc-20210331.xsd#shc_DebtInstrumentVariableRateFloor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_DebtInstrumentVariableRateFloor" xlink:to="lab_shc_DebtInstrumentVariableRateFloor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_8871cba9-4383-461c-8849-5c3a806dd019_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_20707cbe-0454-4dc2-b075-cb6b8dcbebe4_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent" xlink:to="lab_us-gaap_DepositsAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_503aa25d-2243-4388-aaac-01c6fb1ea523_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for uncollectible accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_f80e01b8-ea99-43e0-955f-303b09f16e58_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_82e4671e-99e3-4953-80d1-299eedbd622e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b639e097-463e-4160-b53c-c701ba57ce3d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_462be0bc-12ba-41c9-919c-35f9401d848a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_eedf449a-0f41-4b0a-ad88-b1675c76f008_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Costs, Capitalized, Prepaid, and Other Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_1fdd8361-24d2-407c-a8a7-c82cae184f62_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_5d3522bb-3f02-41a7-8184-c2d6c70fdef3_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_cf5df73b-867a-4b35-8d49-ca48e7eeeed9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_fcc37e1e-9b5a-46e8-b2da-a4943e58b305_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_2d2a5abe-3044-44e7-b784-d90da3709990_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_17a66db5-d8a1-450b-b2c3-204b3b7440d8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of outstanding contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3620f819-c015-4fb9-bc09-95e2516f9a39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_476f7511-a58b-4239-8022-88a99b15a01b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_b19c944e-e7b5-4ea3-97bc-f9386e2e4c5b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SegmentIncomeLoss_78faa614-d9c9-4c5b-bff6-54e9a0e1429c_terseLabel_en-US" xlink:label="lab_shc_SegmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment income</link:label>
    <link:label id="lab_shc_SegmentIncomeLoss_label_en-US" xlink:label="lab_shc_SegmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Income (Loss)</link:label>
    <link:label id="lab_shc_SegmentIncomeLoss_documentation_en-US" xlink:label="lab_shc_SegmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SegmentIncomeLoss" xlink:href="shc-20210331.xsd#shc_SegmentIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SegmentIncomeLoss" xlink:to="lab_shc_SegmentIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_PreIPOB1Member_4323667b-0124-4458-8be6-fda6e157b31c_terseLabel_en-US" xlink:label="lab_shc_PreIPOB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-IPO B-1</link:label>
    <link:label id="lab_shc_PreIPOB1Member_label_en-US" xlink:label="lab_shc_PreIPOB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-IPO B-1 [Member]</link:label>
    <link:label id="lab_shc_PreIPOB1Member_documentation_en-US" xlink:label="lab_shc_PreIPOB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-IPO B-1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB1Member" xlink:href="shc-20210331.xsd#shc_PreIPOB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_PreIPOB1Member" xlink:to="lab_shc_PreIPOB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6ddf81d1-86f3-4179-8594-aed548d4a712_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_46d68c14-00ff-4af5-a5d1-71a16279c0d3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Parties</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_50633f63-6e2e-4fb9-b39a-4cdd14dbd713_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_31221c57-7587-4727-8da8-74f9d1868f90_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_8bc8c4c5-502f-4d8b-81b4-34f36d9ba010_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6807d300-190f-4e5a-8ef0-d74929e627ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_05af1386-ca92-4c28-ab0e-24ffd25304a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_7b56ae58-747e-4e23-858e-fbe8aee809f0_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_48d5b529-63dd-45f2-8bb3-ebec2cf1a862_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8f74cf0e-a222-47c2-b753-54ab65d3a17a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_80d2ddc6-8781-4eb1-b2e9-9f677b176904_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plant closure expenses</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LicensingAgreementsRenewalTerm_24e6824b-ca19-45f5-b3dd-4c0d97c44106_terseLabel_en-US" xlink:label="lab_shc_LicensingAgreementsRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_shc_LicensingAgreementsRenewalTerm_label_en-US" xlink:label="lab_shc_LicensingAgreementsRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements, Renewal Term</link:label>
    <link:label id="lab_shc_LicensingAgreementsRenewalTerm_documentation_en-US" xlink:label="lab_shc_LicensingAgreementsRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LicensingAgreementsRenewalTerm" xlink:href="shc-20210331.xsd#shc_LicensingAgreementsRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LicensingAgreementsRenewalTerm" xlink:to="lab_shc_LicensingAgreementsRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_f0576bc4-4629-4a6a-8313-f7da683ea534_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_CustomerTwoMember_8bdec72a-8eb3-4d71-8f5a-42cbca57c776_terseLabel_en-US" xlink:label="lab_shc_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:label id="lab_shc_CustomerTwoMember_label_en-US" xlink:label="lab_shc_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two [Member]</link:label>
    <link:label id="lab_shc_CustomerTwoMember_documentation_en-US" xlink:label="lab_shc_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerTwoMember" xlink:href="shc-20210331.xsd#shc_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_CustomerTwoMember" xlink:to="lab_shc_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_9e123fe7-d065-443e-b483-8c3efe02dbf7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_f7465ff9-d2b0-49fc-bd1c-200468adc956_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7e9378f4-34d3-437e-b812-813fc6859160_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_5f8a4b9d-7d12-4ff6-9e7d-5ea2000995d7_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration received</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_4377e5e9-647b-43cf-b49b-7a022129004c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_RecognitionOfDebtPremium_c66ed4c9-62a5-4cb1-826e-4162c1b8a990_terseLabel_en-US" xlink:label="lab_shc_RecognitionOfDebtPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of debt premium</link:label>
    <link:label id="lab_shc_RecognitionOfDebtPremium_label_en-US" xlink:label="lab_shc_RecognitionOfDebtPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition Of Debt Premium</link:label>
    <link:label id="lab_shc_RecognitionOfDebtPremium_documentation_en-US" xlink:label="lab_shc_RecognitionOfDebtPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition Of Debt Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_RecognitionOfDebtPremium" xlink:href="shc-20210331.xsd#shc_RecognitionOfDebtPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_RecognitionOfDebtPremium" xlink:to="lab_shc_RecognitionOfDebtPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_418d1004-7d41-4e2c-8bd8-f3ad4ea69907_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_947b03f3-752c-46ab-814d-d730964666b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_9c613e54-931d-4379-8647-0e3c37d84fc0_terseLabel_en-US" xlink:label="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of purchase of interest</link:label>
    <link:label id="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_label_en-US" xlink:label="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent , Percentage</link:label>
    <link:label id="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_documentation_en-US" xlink:label="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent , Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" xlink:href="shc-20210331.xsd#shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" xlink:to="lab_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_cdfa5776-efe1-4c2e-8d10-2ffee243f7a0_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_4c9d5359-e1d3-4d0c-9bd4-fd028a99927c_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_AmortizationOfIntangibleAssetsNonproduction_cd1a6dd1-879c-494f-a30f-ed79d1af14ef_terseLabel_en-US" xlink:label="lab_shc_AmortizationOfIntangibleAssetsNonproduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_shc_AmortizationOfIntangibleAssetsNonproduction_label_en-US" xlink:label="lab_shc_AmortizationOfIntangibleAssetsNonproduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets, Nonproduction</link:label>
    <link:label id="lab_shc_AmortizationOfIntangibleAssetsNonproduction_documentation_en-US" xlink:label="lab_shc_AmortizationOfIntangibleAssetsNonproduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AmortizationOfIntangibleAssetsNonproduction" xlink:href="shc-20210331.xsd#shc_AmortizationOfIntangibleAssetsNonproduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_AmortizationOfIntangibleAssetsNonproduction" xlink:to="lab_shc_AmortizationOfIntangibleAssetsNonproduction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_75a27fd4-cb2a-4ee5-8283-882ee15458ec_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Point in time</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_TermLoanDue2026Member_12629469-ece5-4230-a398-64f81c1ad1aa_terseLabel_en-US" xlink:label="lab_shc_TermLoanDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan, due 2026</link:label>
    <link:label id="lab_shc_TermLoanDue2026Member_label_en-US" xlink:label="lab_shc_TermLoanDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Due 2026 [Member]</link:label>
    <link:label id="lab_shc_TermLoanDue2026Member_documentation_en-US" xlink:label="lab_shc_TermLoanDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan, Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_TermLoanDue2026Member" xlink:to="lab_shc_TermLoanDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_ff673d99-e95a-4cea-8775-c17677dd6ef1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_f60d080c-a103-41ac-bf49-a913639c6edd_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_6f690b3d-1d5e-4d03-8d61-2aa5bc19d933_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_38f0c647-5b5c-4019-ae95-a55bb00e22b9_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Sotera Health Company common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_aed04b90-5fd7-48c8-a18b-efa2914fb917_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_249ec509-9e71-4d96-a427-50919024745a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_d0cc4045-311b-4831-9b4e-097fcd07d120_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued utilities</link:label>
    <link:label id="lab_us-gaap_AccruedUtilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedUtilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Utilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedUtilitiesCurrent" xlink:to="lab_us-gaap_AccruedUtilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_23c8cc08-5e6e-4d4d-b9a4-0d60478e4e37_terseLabel_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value added tax receivable</link:label>
    <link:label id="lab_us-gaap_ValueAddedTaxReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValueAddedTaxReceivableCurrent" xlink:to="lab_us-gaap_ValueAddedTaxReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_16918ea4-e18c-4d61-8587-d15b6da4e8bd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_ee858503-8aed-4e45-b07e-3b90543536fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_5f692a4b-566b-48df-9d4f-6b8a89ea1520_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss (gain)</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_4a8f072e-23c4-488a-8eaa-507b766c3b6b_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_7d683824-d940-433f-8cbe-e17cac14b4da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_1ba1213c-4a9b-47ca-959b-e4fc499834a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_567accdc-ca21-4ac8-bdd0-851eb22397f3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryGross_5025b516-c1e3-42f2-8b24-e2760e044b5d_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, gross</link:label>
    <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_2fdccddd-a5cb-4f91-9b81-0884c26288da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_a2780126-1970-4f63-892f-d441647a4aff_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_b6706b14-b234-4601-bf3a-bee9212b5e20_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e2fe642b-555d-411d-8f05-332f769683ef_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_3313c628-d191-4524-a277-159b770a49e8_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_NelsonFairfieldIncNelsonFairfieldMember_6579b0f1-f245-4686-a02f-2d23dde42275_terseLabel_en-US" xlink:label="lab_shc_NelsonFairfieldIncNelsonFairfieldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nelson Fairfield</link:label>
    <link:label id="lab_shc_NelsonFairfieldIncNelsonFairfieldMember_label_en-US" xlink:label="lab_shc_NelsonFairfieldIncNelsonFairfieldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nelson Fairfield, Inc. (Nelson Fairfield) [Member]</link:label>
    <link:label id="lab_shc_NelsonFairfieldIncNelsonFairfieldMember_documentation_en-US" xlink:label="lab_shc_NelsonFairfieldIncNelsonFairfieldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nelson Fairfield, Inc. (Nelson Fairfield)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonFairfieldIncNelsonFairfieldMember" xlink:href="shc-20210331.xsd#shc_NelsonFairfieldIncNelsonFairfieldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_NelsonFairfieldIncNelsonFairfieldMember" xlink:to="lab_shc_NelsonFairfieldIncNelsonFairfieldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_6de42dac-c9e2-4256-b324-c8ec5547edf8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in unconsolidated affiliate</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_74972871-37b2-4d25-846f-d93e06daca8b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_b775bc9d-6cc2-419b-a2e5-28e4c5e2b1cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_8af3a38f-736d-4c1a-bc22-e71a24fa5c56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_545c63c8-6457-4d42-995f-f462b4105904_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_1697a33e-19d4-4114-bea2-c601d41b3b10_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_887bc05f-423a-47de-aae6-cba1f2af74ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_747c3a55-57ac-4a4f-ba02-0cd282441aa1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_fa209e22-0e6f-4887-a763-66401bac0875_terseLabel_en-US" xlink:label="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective reduction in current interest rates</link:label>
    <link:label id="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_label_en-US" xlink:label="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Effective Reduction In Current Interest Rates</link:label>
    <link:label id="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_documentation_en-US" xlink:label="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Effective Reduction In Current Interest Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" xlink:href="shc-20210331.xsd#shc_DebtInstrumentEffectiveReductionInCurrentInterestRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" xlink:to="lab_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_eb8f881c-00d2-4f51-9c60-e6d41f8cc99c_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9b2588a7-9695-4523-b21c-2a2d10c306c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of BioScience Laboratories, LLC, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2f301f15-f6f0-4969-93a2-a79c7badb37a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b37daa9a-5a02-4a70-a21f-ab359eca37cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_5c668658-635a-496e-a2a5-75b22755ccd5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PositiveOutcomeOfLitigationMember_290e47dd-23d9-4f03-a814-9a76439c8c00_terseLabel_en-US" xlink:label="lab_us-gaap_PositiveOutcomeOfLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positive Outcome of Litigation</link:label>
    <link:label id="lab_us-gaap_PositiveOutcomeOfLitigationMember_label_en-US" xlink:label="lab_us-gaap_PositiveOutcomeOfLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positive Outcome of Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositiveOutcomeOfLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositiveOutcomeOfLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PositiveOutcomeOfLitigationMember" xlink:to="lab_us-gaap_PositiveOutcomeOfLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_653ba5b8-4371-4850-a3b2-b675b1db5c8b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_AcquisitionAndDivestitureRelatedChargesNet_ba31943a-adef-4182-8944-a7d73dd40ca6_terseLabel_en-US" xlink:label="lab_shc_AcquisitionAndDivestitureRelatedChargesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and divestiture related charges, net</link:label>
    <link:label id="lab_shc_AcquisitionAndDivestitureRelatedChargesNet_label_en-US" xlink:label="lab_shc_AcquisitionAndDivestitureRelatedChargesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition And Divestiture Related Charges, Net</link:label>
    <link:label id="lab_shc_AcquisitionAndDivestitureRelatedChargesNet_documentation_en-US" xlink:label="lab_shc_AcquisitionAndDivestitureRelatedChargesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition And Divestiture Related Charges, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AcquisitionAndDivestitureRelatedChargesNet" xlink:href="shc-20210331.xsd#shc_AcquisitionAndDivestitureRelatedChargesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_AcquisitionAndDivestitureRelatedChargesNet" xlink:to="lab_shc_AcquisitionAndDivestitureRelatedChargesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_510dab7e-7c6c-4cb7-b1a6-5038ad11c286_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities incurred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b888186b-2e42-43e4-9808-1b775295857b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ce9369c1-06bc-48a9-9792-f73bafa0e62a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent_10ee4cf5-0644-4aa2-95c0-ed7ee200f1b6_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post-retirement obligations</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_35c021fe-b724-466b-8a68-90a5b2a9bdd0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_baec3fc4-cd68-4956-9827-b673d7ce585f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance accrual</link:label>
    <link:label id="lab_us-gaap_AccruedInsuranceCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedInsuranceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Insurance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedInsuranceCurrent" xlink:to="lab_us-gaap_AccruedInsuranceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_b237fdc7-7978-46bb-9bd7-636d916668ec_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_299726ea-1e9e-49fd-ade9-dfe8f6c1f3b0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_cd2c7fbb-f90d-4173-b3e4-77880c01787f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and post-retirement benefits (net of taxes of $84 and $(744), respectively)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_493c5eda-e9ae-4afb-806f-e26c25dde53b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and post-retirement plan adjustments, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a2f28d62-466e-4f7d-a31f-b0a05877870c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_ce905f0c-7d8d-49ee-8e14-3d14bf0264a5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred lease income</link:label>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentCreditNoncurrent" xlink:to="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_2416fda8-abc9-46df-8df8-c7236956c34e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less unamortized debt issuance costs and debt discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_71c34f93-0558-4dcc-9142-62fae870ebb7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs and debt discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9eb8cf4d-f83a-4952-8afb-1e03eb9e8fe6_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a9ff4bef-656f-4cd8-8c7f-56b66b6bed21_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_42487abd-68bc-4375-87bb-535f5e112371_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible amount</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficerMember_f42a1684-d5cf-468c-a99f-0d1ab9c533e6_terseLabel_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer</link:label>
    <link:label id="lab_srt_OfficerMember_label_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficerMember" xlink:to="lab_srt_OfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2902f494-5c48-4b28-82ca-9d0f7f40188c_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss) attributable to Sotera Health Company</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_82408c6f-fce3-4033-b965-1dd845d29023_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_76d2c029-367b-47a3-8533-65b73dd25ef8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_6b4987a6-d684-4c13-96a2-e74e38e6f470_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_9524ebcc-be39-4be0-8f12-0b0ee3810638_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_99b373f7-553d-486b-acc2-cfe031cb4321_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_cb745c06-cdaa-4f7a-bb1f-9f9d7f45dbd6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_b6ade022-3230-41b8-974d-99e60c2f18fb_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_91b16d81-aff0-44d9-8dde-cd2cc1c260dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_b51c5522-153e-4952-8a8d-7f0e2b757d9f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (gain) / loss on embedded derivative instruments</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Gain (Loss) on Embedded Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:to="lab_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a6201ebf-13d8-44ca-842d-5f3f0ff95948_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e8996c7e-3d09-42cb-96b1-5f81d74f269e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_4b12a2db-da09-4934-8e21-6ff3e21ea313_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Standards</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_InterestRateCapFebruary2021Member_24a47add-caba-4346-b290-0165f3cc6663_terseLabel_en-US" xlink:label="lab_shc_InterestRateCapFebruary2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap February 2021</link:label>
    <link:label id="lab_shc_InterestRateCapFebruary2021Member_label_en-US" xlink:label="lab_shc_InterestRateCapFebruary2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap February 2021 [Member]</link:label>
    <link:label id="lab_shc_InterestRateCapFebruary2021Member_documentation_en-US" xlink:label="lab_shc_InterestRateCapFebruary2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap February 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapFebruary2021Member" xlink:href="shc-20210331.xsd#shc_InterestRateCapFebruary2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_InterestRateCapFebruary2021Member" xlink:to="lab_shc_InterestRateCapFebruary2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_21211b24-d1d5-4607-b8e5-be43455a3d58_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_1240a207-5249-44b5-9474-87abcfe002da_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_90e716cd-bdf1-4b1d-929e-bf8f6fc31014_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_a97a2f56-65e8-47fd-afb8-e6c5db905582_terseLabel_en-US" xlink:label="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disbursements assessed and awarded in favor</link:label>
    <link:label id="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_label_en-US" xlink:label="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Disbursements Assessed And Awarded In Favor</link:label>
    <link:label id="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_documentation_en-US" xlink:label="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Disbursements Assessed And Awarded In Favor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" xlink:href="shc-20210331.xsd#shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" xlink:to="lab_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_a7276dfc-fa5c-4177-9bd5-31d7a8de8e98_terseLabel_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in unconsolidated affiliate</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_label_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Investment in Unconsolidated Affiliate</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_documentation_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Investment in Unconsolidated Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" xlink:to="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_840a283e-dcde-4e89-a2f6-da05346034dd_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_415ca00d-e93c-4161-9e05-be93f13160bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_3dd9d360-55a5-423f-8c29-25f2a95f8d31_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ae0809fd-bafb-4b66-8ee8-506c6a08f1f1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_27d0e564-f405-4dce-bbb4-d62c14526118_terseLabel_en-US" xlink:label="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of unamortized debt issuance costs and debt discounts</link:label>
    <link:label id="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_label_en-US" xlink:label="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Debt Discount</link:label>
    <link:label id="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_documentation_en-US" xlink:label="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off of Deferred Debt Issuance Cost and Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" xlink:href="shc-20210331.xsd#shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" xlink:to="lab_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b1c48e40-5a7c-411a-bf86-bf8bfcd93ff4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8f0d32c5-033a-452f-9cf3-3c3d6b6abe03_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_24edbf10-b35a-4523-a990-450b2db372f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_369a37fb-3d29-4422-ac2d-75d4bc1ed8d3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense_9c1dcbcc-b250-4571-8473-8bcaaab9be93_terseLabel_en-US" xlink:label="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional expense</link:label>
    <link:label id="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense_label_en-US" xlink:label="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Refinancing, Additional Expense</link:label>
    <link:label id="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense_documentation_en-US" xlink:label="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Refinancing, Additional Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtIssuanceCostsRefinancingAdditionalExpense" xlink:href="shc-20210331.xsd#shc_DebtIssuanceCostsRefinancingAdditionalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_DebtIssuanceCostsRefinancingAdditionalExpense" xlink:to="lab_shc_DebtIssuanceCostsRefinancingAdditionalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_e59e9b04-9ecb-47c4-ab3b-048c6dec4a98_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_aeeea877-85f1-4900-931c-ba39cd319545_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_9f2ace29-4065-4caa-b3dc-3043ec351ea8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Period Adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a9ee2c51-9dc0-463a-8496-729654f78b61_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_3aa8e85a-8c3e-414b-b528-a515b723e3af_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated in Hedge Relationships</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_1ecacdb0-5411-4d0d-9eef-2257c689b6d0_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alternative Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BioScienceLaboratoriesLLCBioScienceMember_480317ae-9cc1-4bb4-a991-80cf9ac0520f_terseLabel_en-US" xlink:label="lab_shc_BioScienceLaboratoriesLLCBioScienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioScience</link:label>
    <link:label id="lab_shc_BioScienceLaboratoriesLLCBioScienceMember_label_en-US" xlink:label="lab_shc_BioScienceLaboratoriesLLCBioScienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioScience Laboratories, LLC (BioScience) [Member]</link:label>
    <link:label id="lab_shc_BioScienceLaboratoriesLLCBioScienceMember_documentation_en-US" xlink:label="lab_shc_BioScienceLaboratoriesLLCBioScienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BioScience Laboratories, LLC (BioScience)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BioScienceLaboratoriesLLCBioScienceMember" xlink:href="shc-20210331.xsd#shc_BioScienceLaboratoriesLLCBioScienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BioScienceLaboratoriesLLCBioScienceMember" xlink:to="lab_shc_BioScienceLaboratoriesLLCBioScienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_7ea9d1c7-7be7-4bac-97d4-5ef6d9965fb8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c255ca95-a9d8-4cfc-8338-54bb86abcc33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_e0b9315f-2c16-4a53-9eb9-c66d59e070b8_terseLabel_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Working capital, net</link:label>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_label_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital, Net</link:label>
    <link:label id="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_documentation_en-US" xlink:label="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:to="lab_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_751c8cfd-c408-4c29-81eb-2b29d8e2a0d4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_428ae050-9283-4476-b708-0c0a06e29095_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_3f33fad7-fd44-417a-bb91-fb4fd5ea9296_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_235806dc-1cf2-454a-ad1f-3a89501bc742_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_d3115e30-2e4c-458b-88bd-2632d953ba73_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationsNoncurrent_bba53670-b54a-4ff1-a06d-8b71f8feeb97_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent asset retirement obligations</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationsNoncurrent" xlink:to="lab_us-gaap_AssetRetirementObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_8b7eec9e-9ed8-4bf0-9a3e-83df20e40fa2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_60032583-a26e-4b1b-b5bb-975b995557a5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_9fc9ca2a-52dc-4e5e-998e-407b15540a0b_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_EthyleneOxideTortLitigationGeorgiaMember_2d090dc5-03ec-464d-8f37-486eeb2a1e90_terseLabel_en-US" xlink:label="lab_shc_EthyleneOxideTortLitigationGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethylene Oxide Tort Litigation &#8211; Georgia</link:label>
    <link:label id="lab_shc_EthyleneOxideTortLitigationGeorgiaMember_label_en-US" xlink:label="lab_shc_EthyleneOxideTortLitigationGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethylene Oxide Tort Litigation &#8211; Georgia [Member]</link:label>
    <link:label id="lab_shc_EthyleneOxideTortLitigationGeorgiaMember_documentation_en-US" xlink:label="lab_shc_EthyleneOxideTortLitigationGeorgiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethylene Oxide Tort Litigation &#8211; Georgia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_EthyleneOxideTortLitigationGeorgiaMember" xlink:href="shc-20210331.xsd#shc_EthyleneOxideTortLitigationGeorgiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_EthyleneOxideTortLitigationGeorgiaMember" xlink:to="lab_shc_EthyleneOxideTortLitigationGeorgiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_dda26855-b88a-42f2-9722-51d6df0f5e9a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_81e899b1-0e97-46dd-9025-fe7cd4d7832a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps (net of taxes of $0 and $1,234, respectively)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_4e54a399-3d6a-4fdd-b85a-2442f690fb1f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_2498555d-7dc1-465f-ab4d-893e6f6b70cf_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative loss, net of tax recognized in accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_a7a90851-8333-4e77-b010-b3e3f8fe02f5_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a49cd246-5d3c-4bf9-9835-c4905aae524a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0c102921-b91f-4306-a1b3-fe98cc8803e1_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_FirstLienNotesDue2026Member_10484f96-45e1-48a7-add5-3c4562666b97_terseLabel_en-US" xlink:label="lab_shc_FirstLienNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Notes due 2026</link:label>
    <link:label id="lab_shc_FirstLienNotesDue2026Member_label_en-US" xlink:label="lab_shc_FirstLienNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Notes due 2026 [Member]</link:label>
    <link:label id="lab_shc_FirstLienNotesDue2026Member_documentation_en-US" xlink:label="lab_shc_FirstLienNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_FirstLienNotesDue2026Member" xlink:to="lab_shc_FirstLienNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_AccruedInterestExpenseCurrent_ce7eed70-9824-4819-bd7b-40d36eaa71b8_terseLabel_en-US" xlink:label="lab_shc_AccruedInterestExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest expense</link:label>
    <link:label id="lab_shc_AccruedInterestExpenseCurrent_label_en-US" xlink:label="lab_shc_AccruedInterestExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest Expense, Current</link:label>
    <link:label id="lab_shc_AccruedInterestExpenseCurrent_documentation_en-US" xlink:label="lab_shc_AccruedInterestExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AccruedInterestExpenseCurrent" xlink:href="shc-20210331.xsd#shc_AccruedInterestExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_AccruedInterestExpenseCurrent" xlink:to="lab_shc_AccruedInterestExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_70fbbb2c-2886-464e-bb2f-4ef66ecf24ba_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_bcf8afea-a53b-4104-bade-2c371e540fe0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness_e0a84dea-e6c3-4c05-bb97-db0495db023f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness_label_en-US" xlink:label="lab_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired in Excess of Payments to Acquire Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness" xlink:to="lab_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_fb7d5cee-ff94-42a4-841d-1a38f59989eb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_5432383b-114d-4665-aacf-f7348736389b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1babd9f0-0323-4ac0-9209-7524ca1e351f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_7a708837-246f-4eb4-8caf-2c1c13980bdc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_45d66980-dfda-4fc5-817e-276fc9b8cc1b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_99d09bf5-f0ab-409c-bb8a-28cbed10454b_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_40fde48b-824a-47d2-a7af-5e0f40eb0726_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1c311f53-0b78-4a1d-ac83-0fe6e64a7e73_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_83ef93e2-2589-4229-b9a5-9899d210001e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d99d786c-b284-485e-8053-a144cba7dddb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ac140f22-e2cf-4f3f-97f4-f741b075e557_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a613de36-fdce-442e-94dd-5fd2d3068b20_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, remaining amortization period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_6a86e6ae-68ac-4f83-87c0-fa94a2e4c777_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_02e72522-9458-4dd4-885f-1da8ea95ea30_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">For the remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_0226b979-74ca-481c-b3f3-579fcd0d7527_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_26b74a75-f90c-4be2-9559-818d7fe60121_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_53d63731-3433-4f65-8b04-7b48c636133d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d4e31bf2-97a8-419a-9726-e3b9a5842451_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1dc4601e-7cd7-4c87-80e5-dc5670ba99c4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_95c310c6-2110-4075-b864-2e78ac48a1b6_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_5b0769c9-43b6-43e6-823c-a2875508d375_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_03ced84e-ccee-4fdc-990d-bd1e1ff30197_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Step acquisition, gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_79113f27-7a85-445f-a1b0-d0d2d2bc7943_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_d58563cf-87c1-40ce-afe5-b135d36a47a0_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_725dbea4-de78-4661-b630-4d46ea7ea52b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_03fd2cae-0afb-43ac-89df-9ddfaf56faf0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_de7a97c8-edc6-43d4-af7b-caff3a1917c8_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_1c4422e4-837e-483f-a723-3fc28c262774_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_0791986e-0ff0-4c08-a82f-19876cc36087_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_f254954e-4fc6-4022-ba5c-67b9740eeac9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryAdjustments_de372c09-fc86-499a-8f03-0ddef74c4bed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InventoryAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryAdjustments_label_en-US" xlink:label="lab_us-gaap_InventoryAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryAdjustments" xlink:to="lab_us-gaap_InventoryAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_038c53c7-fcc7-474f-964e-8d8f01b27196_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_GainContingencyPeriodOfBusinessInterruption_ad73d59a-ba27-4b63-b447-4dc0363c3e74_terseLabel_en-US" xlink:label="lab_shc_GainContingencyPeriodOfBusinessInterruption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of inability</link:label>
    <link:label id="lab_shc_GainContingencyPeriodOfBusinessInterruption_label_en-US" xlink:label="lab_shc_GainContingencyPeriodOfBusinessInterruption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Period Of Business Interruption</link:label>
    <link:label id="lab_shc_GainContingencyPeriodOfBusinessInterruption_documentation_en-US" xlink:label="lab_shc_GainContingencyPeriodOfBusinessInterruption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Period Of Business Interruption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_GainContingencyPeriodOfBusinessInterruption" xlink:href="shc-20210331.xsd#shc_GainContingencyPeriodOfBusinessInterruption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_GainContingencyPeriodOfBusinessInterruption" xlink:to="lab_shc_GainContingencyPeriodOfBusinessInterruption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_2f0ce6ba-1605-4715-b0d2-80d804bea19d_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated in Hedge Relationships</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember_643e9bc4-e387-4a27-bd9d-65e5bceb8aa7_terseLabel_en-US" xlink:label="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Five</link:label>
    <link:label id="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember_label_en-US" xlink:label="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Five [Member]</link:label>
    <link:label id="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember_documentation_en-US" xlink:label="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ShareBasedPaymentArrangementTrancheFiveMember" xlink:href="shc-20210331.xsd#shc_ShareBasedPaymentArrangementTrancheFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_ShareBasedPaymentArrangementTrancheFiveMember" xlink:to="lab_shc_ShareBasedPaymentArrangementTrancheFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e5d12ecc-6b95-4c1f-92cd-8b5932f1cb0c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e5bed9f1-9d92-4951-b919-8ec44436d5c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for uncollectible accounts of $603 and $708, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_9724201d-4da9-414c-8e2e-df2b9547339d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SubsidiaryTwoMember_3326219d-19a8-4ec8-a077-72832d4cc0f5_terseLabel_en-US" xlink:label="lab_shc_SubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Two</link:label>
    <link:label id="lab_shc_SubsidiaryTwoMember_label_en-US" xlink:label="lab_shc_SubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Two [Member]</link:label>
    <link:label id="lab_shc_SubsidiaryTwoMember_documentation_en-US" xlink:label="lab_shc_SubsidiaryTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SubsidiaryTwoMember" xlink:href="shc-20210331.xsd#shc_SubsidiaryTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SubsidiaryTwoMember" xlink:to="lab_shc_SubsidiaryTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_39e306ed-e957-4bb2-94a8-f131d7e5b2f2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c4930950-5dab-4c30-af31-7e891283f2c7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_10729ba1-0ffd-4123-b44b-fd5b082012e0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_f8a73a25-026f-487e-89a8-360353c8df44_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d79f998b-f6ee-4f2f-bfa4-229be892e091_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_a28c232a-4b25-47ad-81ad-d7f771b091f4_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_8e7bb5c3-8e70-43c5-9aad-b4c6704d99ad_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_2626a1f2-76dc-44e9-83f5-1b287d46edc5_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6644e732-ee1f-476f-ac2a-d2d08634f604_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_a0a1fde8-d20e-4675-b299-f84e0d20cbce_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Derivative Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_df5dcc4e-1717-41f3-9753-e740dace6137_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_cbc8e9a6-af30-4a46-8eea-6b062843fa86_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_dc374ab3-bf90-4df7-94f0-9a0fcca82d2b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable / receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_96466f4f-f93a-43f3-aeff-4a893eff9837_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ae47996e-fd8b-4ea0-adb4-1b32aa7fc1fc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_a96b2a26-9dff-4c42-acd6-92db585125f7_negatedTerseLabel_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed long-term liabilities</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other</link:label>
    <link:label id="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_documentation_en-US" xlink:label="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" xlink:to="lab_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_68d299ba-65b3-4368-9851-e1aa7685a667_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_265b4ce7-dcdc-46c6-a5c3-641f6ad531f4_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_ea90287f-b937-4373-98a7-b50c31519fec_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_aef82439-3c4a-4f76-b66e-44ae4bcd1c2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_da1499b4-7cc2-45d5-94ae-b719e7ee8f00_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_8e9f63fd-4db4-40c2-947c-ef5396308f95_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_bb574482-2fbd-41e3-9c62-7bea7b870ecd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bdb26d8f-189a-4557-82a5-731d19afc502_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_e697d6c2-0f3c-4601-a06f-af68610f023e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_42fa8f90-8882-480d-b106-833e145384c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e2ed2ff6-c6a9-4674-910f-f0b4b69759a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1fa9a783-31a0-47f2-9834-ae25588ce7c9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ff9ebe45-bbc1-471d-a92e-b98a9eaa0299_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_807b5c14-5918-4017-a7c6-cd780e88ab91_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f4e11d11-907f-47a1-9861-641f1277f806_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8f22a356-842c-4215-8343-f76932debd74_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Sotera Health Company common shareholders - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_0c3a386f-1f14-4ab8-903d-58830ab25bb5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_4b405ae3-7f41-4ca1-89ed-9dac924c7556_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7142b80e-daa9-4bab-87e6-5a2ce532365c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital_f0007f45-8d5c-4092-9dda-96ac00e9865e_terseLabel_en-US" xlink:label="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds to sponsors, ratio to invested capital</link:label>
    <link:label id="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital_label_en-US" xlink:label="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Proceeds to Sponsors, Ratio to Invested Capital</link:label>
    <link:label id="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital_documentation_en-US" xlink:label="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Proceeds to Sponsors, Ratio to Invested Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CashProceedsToSponsorsRatioToInvestedCapital" xlink:href="shc-20210331.xsd#shc_CashProceedsToSponsorsRatioToInvestedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_CashProceedsToSponsorsRatioToInvestedCapital" xlink:to="lab_shc_CashProceedsToSponsorsRatioToInvestedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SecondLienNotesMember_5d4e358b-dee0-4b82-82ce-6eea1228dd2e_terseLabel_en-US" xlink:label="lab_shc_SecondLienNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Lien Notes</link:label>
    <link:label id="lab_shc_SecondLienNotesMember_label_en-US" xlink:label="lab_shc_SecondLienNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Lien Notes [Member]</link:label>
    <link:label id="lab_shc_SecondLienNotesMember_documentation_en-US" xlink:label="lab_shc_SecondLienNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Second Lien Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SecondLienNotesMember" xlink:href="shc-20210331.xsd#shc_SecondLienNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SecondLienNotesMember" xlink:to="lab_shc_SecondLienNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_827ab041-dd92-433b-b0cd-397c02f7ea49_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_16e32199-b074-4d12-9da7-5c681208a84e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_169e3b9a-8766-4bac-916c-588e9373967d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_98658d42-3c55-46aa-98aa-b27d830e4f0a_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_ecc27325-67b2-49ae-99b7-89e0f77cfa70_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_da04309b-81bd-410a-9ee3-cf3905d42be4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_550e5c6e-517d-4e69-b6eb-5170ffab8ef9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Common Shares:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_42a4d26b-d164-4614-a36f-d8a029b181d1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, with $0.01 par value, 1,200,000 shares authorized; 285,990 shares issued at March 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8a5e55f2-87ff-4da5-9d7e-21964618c6ba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4da4cf36-fcb6-47d5-8452-908f118887bf_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_767f6177-ade8-46e6-bb86-446c41df8886_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_c97a0542-ebeb-465b-b158-7117d51470ef_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash short-term</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_90df0a70-0a5b-49fd-9a53-aae05177f29e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_aab14996-9426-43cb-ab08-5b87d58f6fed_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_22d411e5-00e0-4987-9655-c9a29355995a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_TermLoanAndSecondLienNotesMember_d19ea431-e847-4967-8aba-d480641ed2c9_terseLabel_en-US" xlink:label="lab_shc_TermLoanAndSecondLienNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan and Second Lien Notes</link:label>
    <link:label id="lab_shc_TermLoanAndSecondLienNotesMember_label_en-US" xlink:label="lab_shc_TermLoanAndSecondLienNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan and Second Lien Notes [Member]</link:label>
    <link:label id="lab_shc_TermLoanAndSecondLienNotesMember_documentation_en-US" xlink:label="lab_shc_TermLoanAndSecondLienNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan and Second Lien Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanAndSecondLienNotesMember" xlink:href="shc-20210331.xsd#shc_TermLoanAndSecondLienNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_TermLoanAndSecondLienNotesMember" xlink:to="lab_shc_TermLoanAndSecondLienNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_DerivativeNumberOfInstrumentsAmended_cd43ca6d-4a15-4e77-bb86-53fed26cd5ad_terseLabel_en-US" xlink:label="lab_shc_DerivativeNumberOfInstrumentsAmended" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments amended</link:label>
    <link:label id="lab_shc_DerivativeNumberOfInstrumentsAmended_label_en-US" xlink:label="lab_shc_DerivativeNumberOfInstrumentsAmended" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Amended</link:label>
    <link:label id="lab_shc_DerivativeNumberOfInstrumentsAmended_documentation_en-US" xlink:label="lab_shc_DerivativeNumberOfInstrumentsAmended" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Number of Instruments Amended</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DerivativeNumberOfInstrumentsAmended" xlink:href="shc-20210331.xsd#shc_DerivativeNumberOfInstrumentsAmended"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_DerivativeNumberOfInstrumentsAmended" xlink:to="lab_shc_DerivativeNumberOfInstrumentsAmended" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment_bb01ee13-87c7-48e5-9349-82c59a52fb87_terseLabel_en-US" xlink:label="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of reduction in residential property value assessment</link:label>
    <link:label id="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment_label_en-US" xlink:label="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Reduction In Residential Property Value Assessment</link:label>
    <link:label id="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment_documentation_en-US" xlink:label="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Of Reduction In Residential Property Value Assessment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PercentOfReductionInResidentialPropertyValueAssessment" xlink:href="shc-20210331.xsd#shc_PercentOfReductionInResidentialPropertyValueAssessment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_PercentOfReductionInResidentialPropertyValueAssessment" xlink:to="lab_shc_PercentOfReductionInResidentialPropertyValueAssessment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_171ebf03-6d62-44f1-91b0-efde76c972e6_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_54c6471b-b2ac-4ca2-a438-cc5473a70790_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_7f342618-0230-4ea3-96a8-dc1b654e6739_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c036ac91-5fa8-4500-bd88-65ee8d52013a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_PrepaidSoftwareLicensingCurrent_db7d29bf-85b8-4f8d-a1c0-f8207a0aec99_terseLabel_en-US" xlink:label="lab_shc_PrepaidSoftwareLicensingCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid software licensing</link:label>
    <link:label id="lab_shc_PrepaidSoftwareLicensingCurrent_label_en-US" xlink:label="lab_shc_PrepaidSoftwareLicensingCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Software Licensing, Current</link:label>
    <link:label id="lab_shc_PrepaidSoftwareLicensingCurrent_documentation_en-US" xlink:label="lab_shc_PrepaidSoftwareLicensingCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Software Licensing, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PrepaidSoftwareLicensingCurrent" xlink:href="shc-20210331.xsd#shc_PrepaidSoftwareLicensingCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_PrepaidSoftwareLicensingCurrent" xlink:to="lab_shc_PrepaidSoftwareLicensingCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_ebca0ce6-2274-463f-b205-709f4b5489cb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e32c0ba4-cb46-4e98-a5d3-5d1c68d09ca9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_cf2e02da-8e6c-427b-88f1-cac905544ca3_terseLabel_en-US" xlink:label="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded from other party, before pre-judgment interest</link:label>
    <link:label id="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_label_en-US" xlink:label="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded From Other Party, Before Pre-Judgment Interest</link:label>
    <link:label id="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_documentation_en-US" xlink:label="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded From Other Party, Before Pre-Judgment Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" xlink:href="shc-20210331.xsd#shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" xlink:to="lab_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7ccee90b-bf38-4359-a7ae-d521a48943bb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_dcb7d12d-680a-4916-abc7-17514fefc350_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9de645b5-1e42-4b01-8d6e-fd7e8be98314_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_76a25af1-b9b1-4c99-b25c-fa2fc5c585ef_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_57f89979-373e-438b-8b7c-3ceceeb05de7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_77888040-b582-4361-b26d-ff6ddb94ede7_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_0b30c367-d17d-4bda-b09d-4d86f73ed02b_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_18acf1e5-c727-43b8-8586-e7bcc53ab369_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, less debt issuance costs and debt discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_f712662b-a5d3-4660-941f-e361c5c74fc7_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt, less debt issuance costs and debt discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_1636bf4e-c262-4384-a552-11708c0abf39_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a45d0d16-d2ba-4ca3-a61a-ace1768c4c13_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5e00a01e-7d92-42d2-a930-a38fc8b02d30_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_20ded41b-332a-4af2-907a-1da70c5a0d8c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity attributable to Sotera Health Company</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_f9fda2ee-0682-4185-bb85-8ef987638f38_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_IotronIndustriesCanadaIncIotronMember_d1e44815-910f-4bcb-8851-f06b95d2f376_terseLabel_en-US" xlink:label="lab_shc_IotronIndustriesCanadaIncIotronMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iotron</link:label>
    <link:label id="lab_shc_IotronIndustriesCanadaIncIotronMember_label_en-US" xlink:label="lab_shc_IotronIndustriesCanadaIncIotronMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iotron Industries Canada, Inc. (Iotron) [Member]</link:label>
    <link:label id="lab_shc_IotronIndustriesCanadaIncIotronMember_documentation_en-US" xlink:label="lab_shc_IotronIndustriesCanadaIncIotronMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iotron Industries Canada, Inc. (Iotron)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_IotronIndustriesCanadaIncIotronMember" xlink:to="lab_shc_IotronIndustriesCanadaIncIotronMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_881044a7-cd29-4565-92c7-b53bb1570852_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on interest rate swap</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Cash Flow Hedging Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:to="lab_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_60f6c81d-8751-4a41-91c9-8e713fdcff97_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0af0537-3ada-4960-99a7-dcc4807cf708_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_98b27c40-a24d-4cfb-8121-b21e95968739_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_8d8e9d00-1310-4ff7-a671-f58c19534bfd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_142dfec9-8abd-44c3-8164-d74f41132127_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_944226f0-0fc9-4976-b2c7-70cf6036ea19_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_a97a74d7-0393-4396-b5c5-276e065b2ad8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_48642030-4f1f-4f28-bbf0-05511f6dfb2d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_EthyleneOxideTortLitigationIllinoisMember_2d5f3148-3e51-4c53-8335-36b8372d6ea0_terseLabel_en-US" xlink:label="lab_shc_EthyleneOxideTortLitigationIllinoisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethylene Oxide Tort Litigation - Illinois</link:label>
    <link:label id="lab_shc_EthyleneOxideTortLitigationIllinoisMember_label_en-US" xlink:label="lab_shc_EthyleneOxideTortLitigationIllinoisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethylene Oxide Tort Litigation - Illinois [Member]</link:label>
    <link:label id="lab_shc_EthyleneOxideTortLitigationIllinoisMember_documentation_en-US" xlink:label="lab_shc_EthyleneOxideTortLitigationIllinoisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ethylene Oxide Tort Litigation - Illinois</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_EthyleneOxideTortLitigationIllinoisMember" xlink:href="shc-20210331.xsd#shc_EthyleneOxideTortLitigationIllinoisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_EthyleneOxideTortLitigationIllinoisMember" xlink:to="lab_shc_EthyleneOxideTortLitigationIllinoisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8b76a16e-3d77-4b27-9bfe-04826a024488_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_3fa476f8-7b7c-49cc-876f-f1df69637b94_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount_b74dcf86-dea1-4dc8-82ec-504f5702e179_terseLabel_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mandatorily redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount_label_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_7b5678dd-ad9e-4399-8b55-65a5eb2f3acf_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_a00ac073-b066-4fbc-bcee-01bc37a09304_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business optimization project expenses</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_48739d74-8bb4-4d5e-8429-9d1b2ab2bc32_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_PreIPOB2Member_e4936da6-1183-4bc7-8692-3a4e703770a6_terseLabel_en-US" xlink:label="lab_shc_PreIPOB2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-IPO B-2</link:label>
    <link:label id="lab_shc_PreIPOB2Member_label_en-US" xlink:label="lab_shc_PreIPOB2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-IPO B-2 [Member]</link:label>
    <link:label id="lab_shc_PreIPOB2Member_documentation_en-US" xlink:label="lab_shc_PreIPOB2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-IPO B-2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB2Member" xlink:href="shc-20210331.xsd#shc_PreIPOB2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_PreIPOB2Member" xlink:to="lab_shc_PreIPOB2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_80fee679-82c8-4d87-a2a1-fd895dbc0db1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax benefit</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_f58ab393-43c3-4732-868e-ef9242599613_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_5186c834-dbdd-44dc-82f1-452d4537f513_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_c59bd0c0-db58-4205-8f96-8917d42a9831_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_44a1cb14-e5d5-4638-8dec-4337992f00a6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ee1ad23c-eb4e-4598-beb7-048adac9243c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e676f6f9-b729-448c-8541-5de6ebfec2df_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_7c42f1be-4e71-424c-8054-cc93c3019dba_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_baa3a3e3-e893-4647-b39f-a101611624f7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_83b5c93f-bce9-499a-97a8-0f0bd7795d4b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_33f5ddbe-034d-49e7-8fbb-1ce4b774c4a9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_8ea45f81-dd39-4c28-a6f7-697692ec816f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid business insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_7913bc5b-f7f9-48f4-8218-aa9ea407d29a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c7d595ac-c99b-4fbd-bdda-51227b2eed6e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_UnnamedEBeamJointVentureMember_2cbf6a22-ebff-40fc-9fff-2f7f3ac4f687_terseLabel_en-US" xlink:label="lab_shc_UnnamedEBeamJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unnamed E-Beam Joint Venture</link:label>
    <link:label id="lab_shc_UnnamedEBeamJointVentureMember_label_en-US" xlink:label="lab_shc_UnnamedEBeamJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unnamed E-Beam Joint Venture [Member]</link:label>
    <link:label id="lab_shc_UnnamedEBeamJointVentureMember_documentation_en-US" xlink:label="lab_shc_UnnamedEBeamJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unnamed E-Beam Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_UnnamedEBeamJointVentureMember" xlink:href="shc-20210331.xsd#shc_UnnamedEBeamJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_UnnamedEBeamJointVentureMember" xlink:to="lab_shc_UnnamedEBeamJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_fa270f84-d702-49b8-aae4-ddbf5f997508_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Sotera Health Company</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_3a14fa3c-117c-45d3-8ea7-e7bb1f9c3ec9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations, less current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a76da060-8ae5-473a-aa13-9bb92229c71b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability_d19eae9a-7413-4085-a0b0-eb4b8c9e8fe8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, insurance limits</link:label>
    <link:label id="lab_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability_label_en-US" xlink:label="lab_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability" xlink:to="lab_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77c3a8a4-b300-433f-a138-8769e4e832dd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_179d02e4-63e3-4e3b-9fa8-61dc8ac28dcf_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_2c6a9621-d3a8-45d4-8570-f48963e041d6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_f02fa578-2568-4cb2-90bf-1803bf3e9b14_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_08d65533-1500-4ba5-8309-08625827be87_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_9616b3d6-11ac-4c41-a3e6-70f1cefe879e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2e5fe737-0186-435e-adcb-16b0ad493f59_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_05403238-bdd3-4a9c-8adc-ca245be74093_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_e80f789c-3982-4a95-ae13-73f09dc4fb43_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a3c41ab3-160c-4c21-be6c-b6cfc334a030_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_21fa069b-b7fa-4971-998f-4181a1cfe825_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f8df991a-7fc5-4dd4-bb13-0d99ed6ee403_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8e96f02d-f049-47fb-a13f-be32021ac64d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign exchange (gains) / losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_ef25abd6-14c9-4d5d-86bc-53111b869b92_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_79560e96-1c71-419c-9a6c-255e5b93408b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_167c98c4-ca1c-4b20-a06f-554b3e69ccb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e6fb0701-5164-40a3-a287-11adb26855e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_48b9d437-1d20-42f9-a93d-de92a9fb3c17_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proprietary technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7e25747c-7bde-4fc1-814f-982493eb7dbc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e729e1b4-c943-43cc-8354-ea38b4519f16_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_36cf95c5-9b87-49a5-b9fd-7cbe8cdb7b32_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Indefinite-lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_166bd321-7610-47c8-a950-77ca8e8f9cfd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Sotera Health Company common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_9c44c8c1-bb8a-4613-8ff1-061b2470f4ff_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_560b1589-a777-4e55-8c1a-e9c5ac09a29a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_060d0944-3ac8-42a8-bec9-0b7816f91999_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5e6b1ea4-a91c-4bf4-8a11-9d0be7213e10_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_d3397b4e-598c-4f75-986c-45b54cf7a37f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cda74707-c5a5-4f3f-9c04-b09c7ed505e3_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_5246c228-f5a8-425e-b8ac-8f6ac174ebb9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_CustomerOneMember_17f3a6bd-8a22-4574-a165-002fbbfc6b22_terseLabel_en-US" xlink:label="lab_shc_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_shc_CustomerOneMember_label_en-US" xlink:label="lab_shc_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_shc_CustomerOneMember_documentation_en-US" xlink:label="lab_shc_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerOneMember" xlink:href="shc-20210331.xsd#shc_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_CustomerOneMember" xlink:to="lab_shc_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SealedSourceAndSupplyAgreementsMember_ef4b420b-0126-4b3a-996b-4163eb2c98b7_terseLabel_en-US" xlink:label="lab_shc_SealedSourceAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sealed source and supply agreements</link:label>
    <link:label id="lab_shc_SealedSourceAndSupplyAgreementsMember_label_en-US" xlink:label="lab_shc_SealedSourceAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sealed Source And Supply Agreements [Member]</link:label>
    <link:label id="lab_shc_SealedSourceAndSupplyAgreementsMember_documentation_en-US" xlink:label="lab_shc_SealedSourceAndSupplyAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sealed Source And Supply Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SealedSourceAndSupplyAgreementsMember" xlink:href="shc-20210331.xsd#shc_SealedSourceAndSupplyAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SealedSourceAndSupplyAgreementsMember" xlink:to="lab_shc_SealedSourceAndSupplyAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_PrepaidMaintenanceContractsCurrent_cd0aebec-987b-41a3-b06d-3bf53d0d9992_terseLabel_en-US" xlink:label="lab_shc_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid maintenance contracts</link:label>
    <link:label id="lab_shc_PrepaidMaintenanceContractsCurrent_label_en-US" xlink:label="lab_shc_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Maintenance Contracts, Current</link:label>
    <link:label id="lab_shc_PrepaidMaintenanceContractsCurrent_documentation_en-US" xlink:label="lab_shc_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Maintenance Contracts, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PrepaidMaintenanceContractsCurrent" xlink:href="shc-20210331.xsd#shc_PrepaidMaintenanceContractsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_PrepaidMaintenanceContractsCurrent" xlink:to="lab_shc_PrepaidMaintenanceContractsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_837f6064-207a-4c48-93cf-cac461634dc6_terseLabel_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mandatorily redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_label_en-US" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_3ffeb452-3180-4626-9cad-2d51292447a4_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_TermLoanMember_03998e45-6963-4cbb-8745-faf057b820f0_terseLabel_en-US" xlink:label="lab_shc_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_shc_TermLoanMember_label_en-US" xlink:label="lab_shc_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_shc_TermLoanMember_documentation_en-US" xlink:label="lab_shc_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_TermLoanMember" xlink:to="lab_shc_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_bca78bff-dd8e-4b6a-ad59-cdf9d662618e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross&#160;Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_NelsonLabsMember_b217c7e5-70c0-4dca-85c3-5f8bf09e09ee_terseLabel_en-US" xlink:label="lab_shc_NelsonLabsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nelson&#160;Labs</link:label>
    <link:label id="lab_shc_NelsonLabsMember_label_en-US" xlink:label="lab_shc_NelsonLabsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nelson&#160;Labs [Member]</link:label>
    <link:label id="lab_shc_NelsonLabsMember_documentation_en-US" xlink:label="lab_shc_NelsonLabsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nelson&#160;Labs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_NelsonLabsMember" xlink:to="lab_shc_NelsonLabsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_9a6904ae-50b9-470f-8855-00544d6311bb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, Net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_d48b4df7-2db6-4607-a51c-08eb093928e3_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_d0853735-20ca-4672-a48e-e25e621d4b1a_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_CostAndExpensesCOVID19_f87d7fbe-63b7-432c-8da2-71ea5ba22b61_terseLabel_en-US" xlink:label="lab_shc_CostAndExpensesCOVID19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 expenses</link:label>
    <link:label id="lab_shc_CostAndExpensesCOVID19_label_en-US" xlink:label="lab_shc_CostAndExpensesCOVID19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost And Expenses, COVID-19</link:label>
    <link:label id="lab_shc_CostAndExpensesCOVID19_documentation_en-US" xlink:label="lab_shc_CostAndExpensesCOVID19" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost And Expenses, COVID-19</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CostAndExpensesCOVID19" xlink:href="shc-20210331.xsd#shc_CostAndExpensesCOVID19"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_CostAndExpensesCOVID19" xlink:to="lab_shc_CostAndExpensesCOVID19" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ede7ad5a-d091-4d44-9320-3050a6d5af1e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_CustomerThreeMember_85a70f17-3894-408e-aa08-990bd8696223_terseLabel_en-US" xlink:label="lab_shc_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:label id="lab_shc_CustomerThreeMember_label_en-US" xlink:label="lab_shc_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three [Member]</link:label>
    <link:label id="lab_shc_CustomerThreeMember_documentation_en-US" xlink:label="lab_shc_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerThreeMember" xlink:href="shc-20210331.xsd#shc_CustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_CustomerThreeMember" xlink:to="lab_shc_CustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2530cc49-9991-4450-ab8b-ca5ab34ba759_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents, including restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b28dc7f1-ac1e-4c1c-b437-206005d783b7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_7f098087-818b-481f-ba57-0bdf2d5bba3a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingenciesTable_c1f2d8e2-21ef-4872-9e96-3192885e3fc9_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_GainContingenciesTable_label_en-US" xlink:label="lab_us-gaap_GainContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingenciesTable" xlink:to="lab_us-gaap_GainContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4bfca93-2941-4e47-bd3e-d8a4ae33014e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4086083e-ebed-4b09-9034-ab4cdec3bad1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9c634a2c-c802-4558-9fd8-5cfef3924b0e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_InterestRateCap1Member_dc4873e1-9725-47e4-8861-c5581ccd99f5_terseLabel_en-US" xlink:label="lab_shc_InterestRateCap1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap</link:label>
    <link:label id="lab_shc_InterestRateCap1Member_label_en-US" xlink:label="lab_shc_InterestRateCap1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap1 [Member]</link:label>
    <link:label id="lab_shc_InterestRateCap1Member_documentation_en-US" xlink:label="lab_shc_InterestRateCap1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCap1Member" xlink:href="shc-20210331.xsd#shc_InterestRateCap1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_InterestRateCap1Member" xlink:to="lab_shc_InterestRateCap1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_b27a8b99-21ee-4328-af32-c4b1506d36a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_9e3ede94-1afd-4290-980a-3ef7d4024337_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_04274d38-5ed5-4ee1-8030-f9fbfe877e97_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_8bec78a4-d581-48c4-9969-63c081eba5f1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_ad1f6dda-240b-4e4d-b6b9-0fb189b32446_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_aa71531a-733b-48fa-a2a2-cd718f44f70a_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative Financial Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:to="lab_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_7677f241-ce9d-45d3-b4fb-5d00055791b8_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a75a2d82-4663-48d7-878a-d2983625cd3e_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_26ef532e-725e-4415-8010-05c86d41e66d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a412b3b6-3a2b-40d3-b039-6a0fba38d614_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_17387c46-0ecf-4d0f-8e08-d9f70b6a4636_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f5217192-fc29-438a-a624-d9bac307a91e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e74eb719-c54f-4d91-9073-911e408edbf3_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_183c9d7f-1f06-411a-a899-5f65c3ef381e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a9a915b9-7a85-484d-98df-a112277d2dcc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_d5677564-25de-4aa3-95d1-e0fc37d70183_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_65b4e5c6-2cb3-4c28-b675-c209a521b122_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fdcbc20f-27f1-4a4f-ae14-719ab9d1d6c0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_6d23bc79-a3d1-4f9e-9252-cf9733f9daee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_774f7acb-c6f0-4575-bd52-c3c49a7cef5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange loss (gain)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_658c897e-b5b7-4058-b1aa-9879648612a6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_160509dc-b892-4cf8-955c-01edf20cd8b7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_b818c695-8577-4152-8d15-2ec4c3fe36ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes, net of tax refunds received</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fce9c231-7fd2-4841-8d63-63eb2a79d226_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, including restricted cash, at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c179eaa-2062-4afa-ba4a-dc0d05c9295e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, including restricted cash, at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_e2dfe7e8-91c1-493e-ac2f-80c8e42c6891_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_2f3d3c65-9d77-4033-8d9d-df7d318eddd8_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_bdb5c565-1547-48ce-8bd8-845260dc47e1_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3eba8198-ee5f-4f8a-9c11-f05e87b9d284_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f0c82c1c-c45b-4a45-b1e7-6a4732c20b82_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_1f3af5cd-2280-47b5-8f46-fca935b101bf_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LongTermDebtMaturityAfterYearFour_700e07ca-c505-485e-8048-51358098a8a0_terseLabel_en-US" xlink:label="lab_shc_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_shc_LongTermDebtMaturityAfterYearFour_label_en-US" xlink:label="lab_shc_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:label id="lab_shc_LongTermDebtMaturityAfterYearFour_documentation_en-US" xlink:label="lab_shc_LongTermDebtMaturityAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LongTermDebtMaturityAfterYearFour" xlink:href="shc-20210331.xsd#shc_LongTermDebtMaturityAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LongTermDebtMaturityAfterYearFour" xlink:to="lab_shc_LongTermDebtMaturityAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e932a81f-a0de-4619-947a-dd9e696c35b4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_38837ee8-6b95-4537-8c19-aaf88a73b441_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Sotera Health Company common shareholders - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_4116208e-7a1f-415a-9f9a-947b82ecad95_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_66395dba-b0ff-4fb6-886b-a8c6a6d41ff3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_136ba648-1ab3-4f70-8fc7-229d3af2268a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_56354dd9-0d41-4499-add2-f312a8a4a65e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_b70737ad-0e26-4be0-a698-922631381379_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_NumberOfSubsidiariesWithNonControllingInterest_74f0106c-ac98-4d93-b9eb-649e78a4979f_terseLabel_en-US" xlink:label="lab_shc_NumberOfSubsidiariesWithNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of subsidiaries with non-controlling interest</link:label>
    <link:label id="lab_shc_NumberOfSubsidiariesWithNonControllingInterest_label_en-US" xlink:label="lab_shc_NumberOfSubsidiariesWithNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Subsidiaries With Non-Controlling Interest</link:label>
    <link:label id="lab_shc_NumberOfSubsidiariesWithNonControllingInterest_documentation_en-US" xlink:label="lab_shc_NumberOfSubsidiariesWithNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Subsidiaries With Non-Controlling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NumberOfSubsidiariesWithNonControllingInterest" xlink:href="shc-20210331.xsd#shc_NumberOfSubsidiariesWithNonControllingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_NumberOfSubsidiariesWithNonControllingInterest" xlink:to="lab_shc_NumberOfSubsidiariesWithNonControllingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_d7672d2d-2558-471b-9c88-43f54065389c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_87362d64-b065-4b00-94dd-7d96758b22e0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f69f30c6-5f6c-4f76-8700-db6a8a88718a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_f5c96f80-85e7-49c3-9b58-2cf817d20293_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2d197304-9dbe-46bd-9df4-fd5d1c10dc28_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_fc76f3de-c2f8-4ff7-9554-b440d0dfd513_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Non-compete Agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6cfb0652-b6e3-4c6d-8c93-8024da26118d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e5c30060-cf8b-4a97-b5fd-b3bb3ae9d176_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_18416639-7c55-4b7f-8c50-086b628397fb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_882e5397-e070-4cd2-93bf-24e739cbb5ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_b9516d97-37b5-42e8-b705-589a9b4b87d1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_aa72e8e2-9aa6-42fc-9b40-608fdc53ebd0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_b9cd09a6-1cb6-4be8-a940-a8c1c1e96ee7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_3cbca0b1-fa7a-4197-a5ec-a8f8a1de40d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_824be64e-28e6-4cd3-9859-47d2b5e8c03d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_478f4033-63e9-4863-ad94-0a1b929155ef_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_761fb1e4-2384-43d5-8f68-24e99b574502_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_1f5416d3-c351-4df6-99fa-4fcd9432e2e8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_17829f0e-722d-47eb-8f78-9ed4d5205876_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9204f34f-d8ab-4868-b617-42554055aa73_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_dd96d6a9-217a-4c2a-b880-8ba4b4f3cf81_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_30c231d0-e4ed-4c4b-bf4a-7c406e08f731_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LandUseRightsMember_bcd68124-a62f-4b02-b159-1ab534ebfeec_terseLabel_en-US" xlink:label="lab_shc_LandUseRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land-use rights</link:label>
    <link:label id="lab_shc_LandUseRightsMember_label_en-US" xlink:label="lab_shc_LandUseRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land-Use Rights [Member]</link:label>
    <link:label id="lab_shc_LandUseRightsMember_documentation_en-US" xlink:label="lab_shc_LandUseRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land-Use Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LandUseRightsMember" xlink:href="shc-20210331.xsd#shc_LandUseRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LandUseRightsMember" xlink:to="lab_shc_LandUseRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_7928501a-a32b-4b4f-8e70-ee76b7444ddd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSupplies_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSupplies" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_80e6263c-28fb-4442-bb41-037fb9056ef9_terseLabel_en-US" xlink:label="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs assessed and awarded in favor</link:label>
    <link:label id="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_label_en-US" xlink:label="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Costs Assessed And Awarded In Favor</link:label>
    <link:label id="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_documentation_en-US" xlink:label="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Costs Assessed And Awarded In Favor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementCostsAssessedAndAwardedInFavor" xlink:href="shc-20210331.xsd#shc_LitigationSettlementCostsAssessedAndAwardedInFavor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LitigationSettlementCostsAssessedAndAwardedInFavor" xlink:to="lab_shc_LitigationSettlementCostsAssessedAndAwardedInFavor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f4e1f091-74eb-4a0a-b7de-be2096f4a75f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings / (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_aa47b237-dd94-47b4-9325-a6abba08e77a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_a39d744a-ee63-4c5c-8808-d38a71980d00_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of new claims filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_648b9de6-f5a0-4725-bc1a-5d93d0669dca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2a065a5d-1397-48aa-aba0-09b049b6460b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_849c9de8-4825-475a-9768-71486066f3ef_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SeniorNotesDue2027Member_851afd99-21f5-4768-86a2-ec9acde6f9b8_terseLabel_en-US" xlink:label="lab_shc_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, due 2027</link:label>
    <link:label id="lab_shc_SeniorNotesDue2027Member_label_en-US" xlink:label="lab_shc_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due 2027 [Member]</link:label>
    <link:label id="lab_shc_SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_shc_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2027Member" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SeniorNotesDue2027Member" xlink:to="lab_shc_SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_896e9292-0f7d-4869-b3c0-82dfef1052b4_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7375d190-c712-47b1-9a3e-c0801c466bd1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct_f3008ac1-040d-42c0-a981-389f24606c1c_terseLabel_en-US" xlink:label="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation on deductibility of interest expense</link:label>
    <link:label id="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct_label_en-US" xlink:label="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation On Deductibility Of Interest Expense, CARES Act</link:label>
    <link:label id="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct_documentation_en-US" xlink:label="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limitation On Deductibility Of Interest Expense, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" xlink:href="shc-20210331.xsd#shc_LimitationOnDeductibilityOfInterestExpenseCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" xlink:to="lab_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_40125d40-fcaf-4884-b803-68dbd9d845de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SterigenicsMember_37c1c0e5-f4da-4343-b79c-e9bb17d53f28_terseLabel_en-US" xlink:label="lab_shc_SterigenicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterigenics</link:label>
    <link:label id="lab_shc_SterigenicsMember_label_en-US" xlink:label="lab_shc_SterigenicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterigenics [Member]</link:label>
    <link:label id="lab_shc_SterigenicsMember_documentation_en-US" xlink:label="lab_shc_SterigenicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sterigenics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SterigenicsMember" xlink:to="lab_shc_SterigenicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b9fe366a-04b6-4648-a1f8-c3884957e265_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other benefits plans</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_8700caf8-e2be-4566-8127-8e528f7c6395_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4b7531cd-36d5-4db5-8847-520a08c077c8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_0cb9495b-dab6-463c-8cd4-eedef08f0764_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_98e9f719-6e8c-4ef1-bf2a-e8787f850695_terseLabel_en-US" xlink:label="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, insurance limits per occurrence</link:label>
    <link:label id="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_label_en-US" xlink:label="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Undiscounted Amount Of Insurance-Related Assessment Liability Per Occurrence</link:label>
    <link:label id="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_documentation_en-US" xlink:label="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Undiscounted Amount Of Insurance-Related Assessment Liability Per Occurrence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" xlink:href="shc-20210331.xsd#shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" xlink:to="lab_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_d7cc54c1-18fd-4577-bc42-a4460f29a2a9_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost (3,090 and 2,742 shares at March 31, 2021 and December 31, 2020, respectively)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5e4c21b2-2322-4027-b19e-ed1bb3e9d11a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_5b191ef3-657b-4a6b-9263-3c766a3e7122_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit pension plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_shc_SeniorNotesDue2026Member_030fc0a8-44fe-49a0-850a-1ca26814eaf9_terseLabel_en-US" xlink:label="lab_shc_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, due 2026</link:label>
    <link:label id="lab_shc_SeniorNotesDue2026Member_label_en-US" xlink:label="lab_shc_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due 2026 [Member]</link:label>
    <link:label id="lab_shc_SeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_shc_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2026Member" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_shc_SeniorNotesDue2026Member" xlink:to="lab_shc_SeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_846c48dc-15d0-4ab1-b608-7fd5594a0c86_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_cca2a871-2403-4b3b-83a7-47a8be8ac0e9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_b826b7b9-97a5-44a7-9887-524a70f48f4a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_e0fb05da-5bce-4a42-8456-03484886f63c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of asset retirement obligations</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligationAccretionExpense_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligation, Accretion Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligationAccretionExpense" xlink:to="lab_us-gaap_AssetRetirementObligationAccretionExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c059dfd5-694e-4db2-8f4f-ead5f0d30bf6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU&#8217;s Issued But Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>shc-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f476bcce-754d-42a8-b141-c43fc168635e,g:3b9d91f5-244f-4b5e-861f-f8019b961431-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://soterahealth.com/role/Cover" xlink:type="simple" xlink:href="shc-20210331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_babce2db-1ab7-41e4-93b9-fcb33e4aa370" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_DocumentType_babce2db-1ab7-41e4-93b9-fcb33e4aa370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_40bc9a6b-e114-461b-a7e5-d28f822177ef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_DocumentQuarterlyReport_40bc9a6b-e114-461b-a7e5-d28f822177ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7aeadbee-22da-4a85-b47c-7d0f3ef52b9d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_DocumentPeriodEndDate_7aeadbee-22da-4a85-b47c-7d0f3ef52b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9d6d54ca-f8b5-4d9c-8e58-d3b8d93be614" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_DocumentTransitionReport_9d6d54ca-f8b5-4d9c-8e58-d3b8d93be614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3fea556d-f27e-4f4c-aac8-5c44d1a95fe2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityFileNumber_3fea556d-f27e-4f4c-aac8-5c44d1a95fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b2206dc8-7526-4fb4-b83f-064e2a37c191" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityRegistrantName_b2206dc8-7526-4fb4-b83f-064e2a37c191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f1b87d31-a725-403d-b003-8f1d58bb89b1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f1b87d31-a725-403d-b003-8f1d58bb89b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_8f67d4f2-76b5-4a90-a21f-4fc7adac40d1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityTaxIdentificationNumber_8f67d4f2-76b5-4a90-a21f-4fc7adac40d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_08858840-5145-4ffc-a7b7-86ea8f95a80c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityAddressAddressLine1_08858840-5145-4ffc-a7b7-86ea8f95a80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_9634d875-d0f9-4672-87db-e35b465cacfe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityAddressAddressLine2_9634d875-d0f9-4672-87db-e35b465cacfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e1d01675-d11d-4103-b118-c7692f30093d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityAddressCityOrTown_e1d01675-d11d-4103-b118-c7692f30093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f6411dd1-931f-4898-971c-1a561924c5b5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityAddressStateOrProvince_f6411dd1-931f-4898-971c-1a561924c5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b932a719-0aa0-4269-bb0c-2b91d74c0c1a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityAddressPostalZipCode_b932a719-0aa0-4269-bb0c-2b91d74c0c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_308b586b-e8ca-4068-8485-c0658cb7da2c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_CityAreaCode_308b586b-e8ca-4068-8485-c0658cb7da2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5f85e0f6-0d2b-4a4b-b877-a71e70542f1a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_LocalPhoneNumber_5f85e0f6-0d2b-4a4b-b877-a71e70542f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_1e1fed74-c391-4c6a-b0f1-49f500e4d8df" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_Security12bTitle_1e1fed74-c391-4c6a-b0f1-49f500e4d8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_6795283d-d3ea-4437-9862-b55dd7137a83" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_TradingSymbol_6795283d-d3ea-4437-9862-b55dd7137a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4ca26dfa-9024-45c4-a523-7c05682d8236" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_SecurityExchangeName_4ca26dfa-9024-45c4-a523-7c05682d8236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_bae11303-21cf-4bae-97bb-506d8a9a601f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityCurrentReportingStatus_bae11303-21cf-4bae-97bb-506d8a9a601f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_6fe6d8af-112a-4fe5-9f64-7cabd84b37eb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityInteractiveDataCurrent_6fe6d8af-112a-4fe5-9f64-7cabd84b37eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_db7a4954-80ba-4b8f-b0a2-29c3e2a533ab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityFilerCategory_db7a4954-80ba-4b8f-b0a2-29c3e2a533ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0323d6b6-ccf1-4fc2-a006-8494de09977a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntitySmallBusiness_0323d6b6-ccf1-4fc2-a006-8494de09977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7771a099-f53e-487d-ae02-d668300e1c7e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityEmergingGrowthCompany_7771a099-f53e-487d-ae02-d668300e1c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_4e25ba5f-96d2-463a-ba93-eba3c70b75d5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityExTransitionPeriod_4e25ba5f-96d2-463a-ba93-eba3c70b75d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f21fe46e-92a7-4fe9-b682-4b369365f53f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityShellCompany_f21fe46e-92a7-4fe9-b682-4b369365f53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_a6927e19-4aa1-4799-b3d2-b23a2b22192f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_a6927e19-4aa1-4799-b3d2-b23a2b22192f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_31beb68f-7103-4e07-bb21-d92d3d832862" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_EntityCentralIndexKey_31beb68f-7103-4e07-bb21-d92d3d832862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_5806aa47-38fa-445d-b3a8-9cbd5ddbd3f2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_CurrentFiscalYearEndDate_5806aa47-38fa-445d-b3a8-9cbd5ddbd3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_71c785a2-710f-44d3-a2a2-a49a789bde81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_DocumentFiscalYearFocus_71c785a2-710f-44d3-a2a2-a49a789bde81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d4a7fd86-6c5f-45b2-bb07-fafbdc7f17cf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d4a7fd86-6c5f-45b2-bb07-fafbdc7f17cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ce20123b-d069-46b3-95a4-b8099f5b387e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4700fd4f-7cb2-4eb0-90e7-4e7216264dff" xlink:to="loc_dei_AmendmentFlag_ce20123b-d069-46b3-95a4-b8099f5b387e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5032004d-f45a-4692-bb57-201da21212d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5032004d-f45a-4692-bb57-201da21212d4" xlink:to="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_47080245-cda9-4c8e-ab64-f6c97f446be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_47080245-cda9-4c8e-ab64-f6c97f446be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_0276b248-190a-4c7a-8e86-813b25b58cfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_RestrictedCashCurrent_0276b248-190a-4c7a-8e86-813b25b58cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ed5f8289-3e23-4778-a061-387e578dc48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ed5f8289-3e23-4778-a061-387e578dc48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4b91bb96-731b-440a-bc2f-bd5646fece77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_InventoryNet_4b91bb96-731b-440a-bc2f-bd5646fece77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eecbc114-8783-40ff-9ba5-493390836812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eecbc114-8783-40ff-9ba5-493390836812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_3a99c330-3d73-4dec-a9e6-c210153149db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_IncomeTaxesReceivable_3a99c330-3d73-4dec-a9e6-c210153149db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6ebb124c-1f49-4d35-b5d5-9b593fa49a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_41c7efa4-79eb-4151-addf-ec1ae9a2b87e" xlink:to="loc_us-gaap_AssetsCurrent_6ebb124c-1f49-4d35-b5d5-9b593fa49a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_249b7ef5-1089-483d-9dc5-a3a2ca8c6be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_249b7ef5-1089-483d-9dc5-a3a2ca8c6be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ab13517f-4d22-4a2e-951a-196b0d02f65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ab13517f-4d22-4a2e-951a-196b0d02f65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fdb49880-1636-4178-872c-72a895a3063d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fdb49880-1636-4178-872c-72a895a3063d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_439180e8-7dd6-4c2a-bda7-f833802befd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_EquityMethodInvestments_439180e8-7dd6-4c2a-bda7-f833802befd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ecea85c3-27f9-413e-a6ee-ba3101a918b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ecea85c3-27f9-413e-a6ee-ba3101a918b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_840507ea-1dd6-4dd6-8016-ebe3ca7a6614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_840507ea-1dd6-4dd6-8016-ebe3ca7a6614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4611efe1-5e90-4949-8208-dc1d093ccb0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_Goodwill_4611efe1-5e90-4949-8208-dc1d093ccb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_669849b1-57b9-4da8-8baf-3509dd9916ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3e93fcbc-bb02-470a-9c8d-810b91cce04e" xlink:to="loc_us-gaap_Assets_669849b1-57b9-4da8-8baf-3509dd9916ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5032004d-f45a-4692-bb57-201da21212d4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d2415f5d-836d-4e24-95e0-2e33c3b25516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_AccountsPayableCurrent_d2415f5d-836d-4e24-95e0-2e33c3b25516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_065a636d-9a6a-43f0-bcf2-79d4951a9c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_065a636d-9a6a-43f0-bcf2-79d4951a9c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c785509b-4131-4d06-ac9e-dc410e4e3687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c785509b-4131-4d06-ac9e-dc410e4e3687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_c8ebcb52-3d8e-4a2b-a16b-2ba4495a870a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_c8ebcb52-3d8e-4a2b-a16b-2ba4495a870a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_443ef644-fe9b-4408-9ae0-888ee33090e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_443ef644-fe9b-4408-9ae0-888ee33090e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationCurrent_297a1d0b-aa40-427c-9ed2-38ac72f80dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_AssetRetirementObligationCurrent_297a1d0b-aa40-427c-9ed2-38ac72f80dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_97ac0a15-8202-4a0f-b605-136f1e9afb11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_97ac0a15-8202-4a0f-b605-136f1e9afb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_73720a24-dfde-4bfa-b801-46d97c443853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_23681a9b-f4f1-435a-b360-f9fe03b0b1ad" xlink:to="loc_us-gaap_LiabilitiesCurrent_73720a24-dfde-4bfa-b801-46d97c443853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_9fd878fc-fd1d-4eb6-be0b-a8c920c40e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_9fd878fc-fd1d-4eb6-be0b-a8c920c40e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_54dca2d1-bd92-4d96-b9ae-ac21189f017f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_54dca2d1-bd92-4d96-b9ae-ac21189f017f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9054f3ec-a695-44e8-9fdb-1629403023ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9054f3ec-a695-44e8-9fdb-1629403023ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationsNoncurrent_5ffd26c8-05e8-41b1-8b82-837f3825140a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_AssetRetirementObligationsNoncurrent_5ffd26c8-05e8-41b1-8b82-837f3825140a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_6362bae6-d6f7-4b2e-adf2-9472718bbfa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_6362bae6-d6f7-4b2e-adf2-9472718bbfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent_8320ae3f-532c-4158-9713-de7ebbb15229" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent_8320ae3f-532c-4158-9713-de7ebbb15229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_6bca0e31-8a9b-43d1-acda-508e94922b1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_6bca0e31-8a9b-43d1-acda-508e94922b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e8b0af64-8ebd-40ba-9e60-9a205c3a2eb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e8b0af64-8ebd-40ba-9e60-9a205c3a2eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4c8fe295-e527-4ddf-a9aa-d91d23637e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4c8fe295-e527-4ddf-a9aa-d91d23637e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b8bb3edb-02bf-4503-aba4-758d31fe71c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_Liabilities_b8bb3edb-02bf-4503-aba4-758d31fe71c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_5d37b39f-6db7-4ec1-abed-1cb536181782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_5d37b39f-6db7-4ec1-abed-1cb536181782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_39eb363b-1ddc-4716-8822-f7e995c6be7f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_bc0d10d7-20f6-4b60-9669-865f1e3cc5c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_CommonStockValue_bc0d10d7-20f6-4b60-9669-865f1e3cc5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b659558c-86b4-43f0-8b81-1fa86fac6cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_PreferredStockValue_b659558c-86b4-43f0-8b81-1fa86fac6cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_828d4787-7943-4e84-8aaa-edbe38e28ec0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_TreasuryStockValue_828d4787-7943-4e84-8aaa-edbe38e28ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7145da2c-ca83-4f67-99b3-ef928b97f981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7145da2c-ca83-4f67-99b3-ef928b97f981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a429ab61-28af-4a36-89f7-2c11e93cb56b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a429ab61-28af-4a36-89f7-2c11e93cb56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2aff60ea-1a32-486d-ac05-ab16f8472548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2aff60ea-1a32-486d-ac05-ab16f8472548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d98ded46-b52f-438d-b3d1-a2b69b0aa4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_StockholdersEquity_d98ded46-b52f-438d-b3d1-a2b69b0aa4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_94854cec-43ad-4027-9053-3c79d1f04329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_MinorityInterest_94854cec-43ad-4027-9053-3c79d1f04329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e709c3b1-4491-4092-bd52-a9111b9cf501" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e709c3b1-4491-4092-bd52-a9111b9cf501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fcac287f-beb1-438a-baf9-943da3890274" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a6dcc2fa-f468-483e-81d8-0ffa9d1d839c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_fcac287f-beb1-438a-baf9-943da3890274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_846ed197-8733-4af1-a2f6-67d304c86e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_846ed197-8733-4af1-a2f6-67d304c86e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_05693f93-5b8c-4053-86b2-1dfb9fb6851c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_05693f93-5b8c-4053-86b2-1dfb9fb6851c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_78a60538-87dc-4188-856e-bf896a6b7d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_78a60538-87dc-4188-856e-bf896a6b7d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d5e95ee4-924e-4a00-96b1-cbcab33adf04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_CommonStockSharesIssued_d5e95ee4-924e-4a00-96b1-cbcab33adf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ec7c33b3-e94b-4260-b6d2-eeab5159a3d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_ec7c33b3-e94b-4260-b6d2-eeab5159a3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_efef515a-e3cc-4741-b048-17f936c923de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_efef515a-e3cc-4741-b048-17f936c923de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_7df3f052-cd6a-4012-aa72-24c6241300e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_7df3f052-cd6a-4012-aa72-24c6241300e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_b1335d96-95a3-4fbb-9705-d103eb238194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7b37dd6a-faae-4bfe-888a-3c14a2e6cda3" xlink:to="loc_us-gaap_TreasuryStockShares_b1335d96-95a3-4fbb-9705-d103eb238194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9f9917ca-ef61-4e8a-a537-12e0b3c6bb3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f9917ca-ef61-4e8a-a537-12e0b3c6bb3e" xlink:to="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:to="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e90c1304-acab-4795-8557-97d6f6f9691b" xlink:to="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_75438de7-e24e-4722-9966-7bb089297d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:to="loc_us-gaap_ServiceMember_75438de7-e24e-4722-9966-7bb089297d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_de8c89a3-9d71-4da7-a713-762e944c6cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d893e3f5-1122-4ef4-bb10-9356a0ae9331" xlink:to="loc_us-gaap_ProductMember_de8c89a3-9d71-4da7-a713-762e944c6cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_78ae6d80-6ca2-4a97-80e0-9963b44d919c" xlink:to="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ec9b2208-c0a5-4eb2-b36e-f2a5b18d70e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_RevenuesAbstract_ec9b2208-c0a5-4eb2-b36e-f2a5b18d70e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a7b19e1-7b11-4163-94ab-4c4538eca0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ec9b2208-c0a5-4eb2-b36e-f2a5b18d70e4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3a7b19e1-7b11-4163-94ab-4c4538eca0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_560e55fc-11d3-44d2-b337-6ad63342eb7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_CostOfRevenueAbstract_560e55fc-11d3-44d2-b337-6ad63342eb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_e6005bfd-e90a-4e64-a0d9-694217fa54df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_560e55fc-11d3-44d2-b337-6ad63342eb7d" xlink:to="loc_us-gaap_CostOfRevenue_e6005bfd-e90a-4e64-a0d9-694217fa54df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0b8244bb-0041-40d6-8320-727cdb8a9f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_GrossProfit_0b8244bb-0041-40d6-8320-727cdb8a9f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d98b396f-7b95-4bfd-b610-43f422567a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d98b396f-7b95-4bfd-b610-43f422567a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AmortizationOfIntangibleAssetsNonproduction_c85481d2-6cab-4244-a51f-11c18632278a" xlink:href="shc-20210331.xsd#shc_AmortizationOfIntangibleAssetsNonproduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:to="loc_shc_AmortizationOfIntangibleAssetsNonproduction_c85481d2-6cab-4244-a51f-11c18632278a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_108aff43-68e1-4c2e-b770-030432ff456b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_9c3a4e4d-3fe2-4599-bd08-4f6e5f277981" xlink:to="loc_us-gaap_OperatingExpenses_108aff43-68e1-4c2e-b770-030432ff456b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0fbfcbc5-2419-40f7-941a-18883808174e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OperatingIncomeLoss_0fbfcbc5-2419-40f7-941a-18883808174e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4d24a1f3-62ab-4950-a4af-84609cb24940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_4d24a1f3-62ab-4950-a4af-84609cb24940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_89245183-4f9d-451f-9853-5d048fe5e5b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_89245183-4f9d-451f-9853-5d048fe5e5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3d04a810-6809-41e8-bca2-297952529fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_3d04a810-6809-41e8-bca2-297952529fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_43380007-dc4f-43c8-b611-005e09f2f938" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_43380007-dc4f-43c8-b611-005e09f2f938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_58b535a7-7e31-4d53-9873-b4111807c162" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_58b535a7-7e31-4d53-9873-b4111807c162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d709310d-b236-413c-ada5-c7998e7e9e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d709310d-b236-413c-ada5-c7998e7e9e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_310cceaf-d055-4472-b0c4-e954711b6b34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ProfitLoss_310cceaf-d055-4472-b0c4-e954711b6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1c726bb3-1210-4436-b55d-dbd001f8d3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1c726bb3-1210-4436-b55d-dbd001f8d3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2398753-7392-468b-a752-fa13cc816477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_NetIncomeLoss_c2398753-7392-468b-a752-fa13cc816477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1394a3ff-15bc-4f35-a194-efbceb8efe75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1394a3ff-15bc-4f35-a194-efbceb8efe75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_07f44405-6e55-4ec2-bb6a-1d9e3b5d5944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_07f44405-6e55-4ec2-bb6a-1d9e3b5d5944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b9d1bf46-dcb1-4c6b-b735-956ba9b91fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_d9ce365a-ff78-4523-a0e1-26f6a55e2782" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b9d1bf46-dcb1-4c6b-b735-956ba9b91fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7791ca0-3031-4d07-a43c-210d1a50ac02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d7791ca0-3031-4d07-a43c-210d1a50ac02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_954bce5d-0bc2-4e74-971b-9ed8e842f0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_954bce5d-0bc2-4e74-971b-9ed8e842f0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe31d9f5-3f1c-4f17-a440-6ca521f97ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fe31d9f5-3f1c-4f17-a440-6ca521f97ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c94c4403-93ab-46f6-ad16-067d28b3aa70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:to="loc_us-gaap_EarningsPerShareBasic_c94c4403-93ab-46f6-ad16-067d28b3aa70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4f2a96c7-031f-4049-a6ca-460433a79f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7e9db1dd-59b7-4fb5-b19c-fb96552480fd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4f2a96c7-031f-4049-a6ca-460433a79f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dea1982d-bde1-4974-a2f1-ce432980ba62" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f235099-c7bf-4012-9ce5-835c59dffeac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f235099-c7bf-4012-9ce5-835c59dffeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e371e0d9-6db7-42fa-8535-b33900a52b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_d158164f-190c-4bc9-845c-f4a56383d867" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e371e0d9-6db7-42fa-8535-b33900a52b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_1116380c-524c-41b7-b6f4-1296935eb2e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8447dd52-9fef-4e1d-9882-332b20b2cc16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1116380c-524c-41b7-b6f4-1296935eb2e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8447dd52-9fef-4e1d-9882-332b20b2cc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_57ae6fbd-df2f-4d27-87f8-689397b6deee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_1116380c-524c-41b7-b6f4-1296935eb2e5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_57ae6fbd-df2f-4d27-87f8-689397b6deee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b018b48-2979-4d37-92a0-f19915ea66da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b018b48-2979-4d37-92a0-f19915ea66da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b011b2ad-c13f-49cd-8128-e8311f295083" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b018b48-2979-4d37-92a0-f19915ea66da" xlink:to="loc_us-gaap_ProfitLoss_b011b2ad-c13f-49cd-8128-e8311f295083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b018b48-2979-4d37-92a0-f19915ea66da" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_03164558-8f1d-4967-80ae-aeee6aeda451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_Depreciation_03164558-8f1d-4967-80ae-aeee6aeda451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ae8a9694-3e7b-4330-8309-893dab4b0660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ae8a9694-3e7b-4330-8309-893dab4b0660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93304a46-bc8d-4858-a242-fff8e3d23e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93304a46-bc8d-4858-a242-fff8e3d23e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_842564c1-bd1a-4803-b35c-5c67b0f14ab0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_842564c1-bd1a-4803-b35c-5c67b0f14ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_86ecfc5b-69d9-466e-b2a5-2ee538a7d411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_ShareBasedCompensation_86ecfc5b-69d9-466e-b2a5-2ee538a7d411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_d54789e4-bd0c-4161-9d44-72a4d6172773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_d54789e4-bd0c-4161-9d44-72a4d6172773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_a8c15d3c-ee0e-4436-901d-d3b42b95424c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_a8c15d3c-ee0e-4436-901d-d3b42b95424c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_44d0dbc9-d788-4dd8-b6d5-80ebd9eea9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet_44d0dbc9-d788-4dd8-b6d5-80ebd9eea9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_bd19122e-bf7e-483c-8e64-ff2ac6c7315d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_bd19122e-bf7e-483c-8e64-ff2ac6c7315d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_c60c9e41-f042-4248-8e0b-5b4c6811dc36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments_c60c9e41-f042-4248-8e0b-5b4c6811dc36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_7efeeef0-ba0e-4564-b7d2-ec7b78333e0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_7efeeef0-ba0e-4564-b7d2-ec7b78333e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_44c28e10-35ce-4f07-a65c-6eb1ac498f83" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ba849691-471f-4ef0-8e72-a05c0f54dcd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ba849691-471f-4ef0-8e72-a05c0f54dcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_987c59c4-612d-4c5d-826a-9f38c5c15bf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_987c59c4-612d-4c5d-826a-9f38c5c15bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_0e878797-417a-475b-9cad-92ab03257ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_0e878797-417a-475b-9cad-92ab03257ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e8350e45-34b5-47fd-9dbd-c8a5453ced41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e8350e45-34b5-47fd-9dbd-c8a5453ced41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3f31699f-66a3-4078-bc8f-5a19313a50cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3f31699f-66a3-4078-bc8f-5a19313a50cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ccc1cad7-129e-4ec9-aaab-f852c46c441d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ccc1cad7-129e-4ec9-aaab-f852c46c441d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b8032e29-0ff5-44c4-8185-0c8557dd1d11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_b8032e29-0ff5-44c4-8185-0c8557dd1d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_706dfc57-159d-4774-8343-4628249c5fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_faf2fa12-f835-42fa-bf45-e7d5f6e73c3f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_706dfc57-159d-4774-8343-4628249c5fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13eec7af-de49-48c0-b4dd-8b04f6e0c8d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5b018b48-2979-4d37-92a0-f19915ea66da" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_13eec7af-de49-48c0-b4dd-8b04f6e0c8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b03ea691-d51a-4bec-ad28-ab2ed088fe79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b03ea691-d51a-4bec-ad28-ab2ed088fe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_94b5cec3-e4fd-4ccd-826a-cffa2fe72e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b03ea691-d51a-4bec-ad28-ab2ed088fe79" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_94b5cec3-e4fd-4ccd-826a-cffa2fe72e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_576d8078-6874-4798-8c8e-7ad22fd68ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b03ea691-d51a-4bec-ad28-ab2ed088fe79" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_576d8078-6874-4798-8c8e-7ad22fd68ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93ba56fd-4d72-468a-82a5-129c17464e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b03ea691-d51a-4bec-ad28-ab2ed088fe79" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_93ba56fd-4d72-468a-82a5-129c17464e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_186cd717-f9ce-4b44-ae90-c8193803e627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b03ea691-d51a-4bec-ad28-ab2ed088fe79" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_186cd717-f9ce-4b44-ae90-c8193803e627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_654e0ee3-8265-4f15-95eb-1a4563fb8120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_654e0ee3-8265-4f15-95eb-1a4563fb8120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d410df28-80ab-4599-b409-967f9a197ac2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d410df28-80ab-4599-b409-967f9a197ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2245fb10-5a07-4780-8739-be3f86a8c532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2245fb10-5a07-4780-8739-be3f86a8c532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3127340d-7092-46a0-99f4-52d41a186c56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_3127340d-7092-46a0-99f4-52d41a186c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c9a339b8-5b2f-4931-8ddc-a8e42651d156" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28fa7686-b243-4d64-ba08-3264136e241d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c9a339b8-5b2f-4931-8ddc-a8e42651d156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ac49cd8-15fa-4886-91d7-9848c6189d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ac49cd8-15fa-4886-91d7-9848c6189d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5722149c-2a65-4de6-8357-9956304bbdfb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5722149c-2a65-4de6-8357-9956304bbdfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4cbf3d89-5728-4554-a339-59874846fbdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4cbf3d89-5728-4554-a339-59874846fbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b7468b3-5a75-407c-a566-323b00cd37a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b7468b3-5a75-407c-a566-323b00cd37a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_80896615-f877-49ea-81c4-f77bb1f9196d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cd6e5ba9-e9ac-4c1a-9ab8-7c13b757593a" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_80896615-f877-49ea-81c4-f77bb1f9196d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e656f571-c68c-4a44-922c-3e1280585416" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_80896615-f877-49ea-81c4-f77bb1f9196d" xlink:to="loc_us-gaap_InterestPaidNet_e656f571-c68c-4a44-922c-3e1280585416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_f75ebcba-a398-4647-958a-f044558d0244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_80896615-f877-49ea-81c4-f77bb1f9196d" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_f75ebcba-a398-4647-958a-f044558d0244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3ad62f9b-ad76-48b3-a76e-c0d37b9f5cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_80896615-f877-49ea-81c4-f77bb1f9196d" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_3ad62f9b-ad76-48b3-a76e-c0d37b9f5cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit" xlink:type="simple" xlink:href="shc-20210331.xsd#ConsolidatedStatementsofEquityDeficit"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_371e66d1-9a67-4953-abfb-49b0afac3917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_371e66d1-9a67-4953-abfb-49b0afac3917" xlink:to="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a558fa24-1a53-43ae-9d60-b5fce488f48b" xlink:to="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_508766ba-1a61-489f-89bc-d8c3540cff43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_CommonStockMember_508766ba-1a61-489f-89bc-d8c3540cff43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ce1a94b1-6672-43ea-b026-f6718b04d912" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_TreasuryStockMember_ce1a94b1-6672-43ea-b026-f6718b04d912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_378e8851-926d-4dc9-a194-cbf31bdafe19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_378e8851-926d-4dc9-a194-cbf31bdafe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_986fa9c4-f0e6-48eb-97b4-8f9db2f41cb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_RetainedEarningsMember_986fa9c4-f0e6-48eb-97b4-8f9db2f41cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88172cb0-afc0-4f41-a76e-5b8c0b69f736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_88172cb0-afc0-4f41-a76e-5b8c0b69f736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_34a13368-75a7-4765-8f77-9f251a248236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8d0652a6-b5c1-4b5b-b7d2-3b02e1a007e2" xlink:to="loc_us-gaap_NoncontrollingInterestMember_34a13368-75a7-4765-8f77-9f251a248236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_77ec6ce2-8ee0-4914-8f04-d4f29ced0b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3d5ca883-b895-4672-959f-eb45be1eefdb" xlink:to="loc_us-gaap_StatementLineItems_77ec6ce2-8ee0-4914-8f04-d4f29ced0b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_77ec6ce2-8ee0-4914-8f04-d4f29ced0b05" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2c5a0f07-f9fe-4007-83ff-3fc19143c230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_SharesOutstanding_2c5a0f07-f9fe-4007-83ff-3fc19143c230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_498cb9ae-3b0f-4ed5-ab78-6733b2726a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_498cb9ae-3b0f-4ed5-ab78-6733b2726a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_abe32694-1774-4d18-b6a4-18e36cbbedd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_abe32694-1774-4d18-b6a4-18e36cbbedd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c832552b-3a57-4640-a1cd-d669003bba9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c832552b-3a57-4640-a1cd-d669003bba9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f3f4949c-5be2-4062-b7fb-31331b37c881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f3f4949c-5be2-4062-b7fb-31331b37c881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4e926efa-f9a9-4488-88a7-3260dbdd0056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4e926efa-f9a9-4488-88a7-3260dbdd0056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7ae7cb48-04cc-45b8-bd66-e61a47b88540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_14c91753-ae76-434b-9cf5-8148480a4b9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_7ae7cb48-04cc-45b8-bd66-e61a47b88540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_14032c15-7740-4a52-8939-35fa0e96072e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_ProfitLoss_14032c15-7740-4a52-8939-35fa0e96072e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_4e0fcc2e-05dd-4b78-9794-87d6ca25d89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_SharesOutstanding_4e0fcc2e-05dd-4b78-9794-87d6ca25d89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ae10cc52-2378-413f-89cd-a7bcf6d9a148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_08aaf167-208f-43b2-b1ac-03325f86af61" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ae10cc52-2378-413f-89cd-a7bcf6d9a148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentation" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_068084d2-abaa-4221-bc56-5a4f9a88474b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_155aa93d-1ecf-467e-8143-9da3eace36ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_068084d2-abaa-4221-bc56-5a4f9a88474b" xlink:to="loc_us-gaap_BasisOfAccounting_155aa93d-1ecf-467e-8143-9da3eace36ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_602bc4b8-c861-46db-8dbf-e14de8b1abee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6049076d-91be-48df-a019-2910be651f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_602bc4b8-c861-46db-8dbf-e14de8b1abee" xlink:to="loc_us-gaap_UseOfEstimates_6049076d-91be-48df-a019-2910be651f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5436e626-9831-44e0-9d6a-eee9dd5f3cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_602bc4b8-c861-46db-8dbf-e14de8b1abee" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5436e626-9831-44e0-9d6a-eee9dd5f3cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#BasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/BasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_596de396-99f6-4365-8f39-3159c3e76070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_2230078e-1da8-4d4d-b961-72b5125902a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_596de396-99f6-4365-8f39-3159c3e76070" xlink:to="loc_us-gaap_NumberOfOperatingSegments_2230078e-1da8-4d4d-b961-72b5125902a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a9684819-9eb5-4dd9-abb4-801b90299ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_596de396-99f6-4365-8f39-3159c3e76070" xlink:to="loc_us-gaap_NumberOfReportableSegments_a9684819-9eb5-4dd9-abb4-801b90299ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_596de396-99f6-4365-8f39-3159c3e76070" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bdbd2d60-10c6-418a-8e1c-b70700d6c9b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_4887318d-8e71-43bd-b419-965c3bdf7e0c" xlink:to="loc_srt_SegmentGeographicalDomain_bdbd2d60-10c6-418a-8e1c-b70700d6c9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_d470c663-da87-4083-b918-e2b7725aa003" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bdbd2d60-10c6-418a-8e1c-b70700d6c9b2" xlink:to="loc_country_CN_d470c663-da87-4083-b918-e2b7725aa003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_d694ee64-6fde-413c-9d04-3714769f0adb" xlink:to="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SubsidiaryOneMember_20d116a5-63c9-4335-8ec9-e7445915eb7c" xlink:href="shc-20210331.xsd#shc_SubsidiaryOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:to="loc_shc_SubsidiaryOneMember_20d116a5-63c9-4335-8ec9-e7445915eb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SubsidiaryTwoMember_4689e20f-8b3a-4180-9c10-99cb955984e0" xlink:href="shc-20210331.xsd#shc_SubsidiaryTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_eafd5352-a3e1-4c63-9b04-1b0b197aa377" xlink:to="loc_shc_SubsidiaryTwoMember_4689e20f-8b3a-4180-9c10-99cb955984e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64b85e3a-173f-43bd-b265-1c76509ce0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1e1a08e1-b968-4d66-8d6b-2b39a1261a9d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64b85e3a-173f-43bd-b265-1c76509ce0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_7504f502-6702-4a25-add5-e7f92231df74" xlink:href="shc-20210331.xsd#shc_NelsonFairfieldIncNelsonFairfieldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_64b85e3a-173f-43bd-b265-1c76509ce0d0" xlink:to="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_7504f502-6702-4a25-add5-e7f92231df74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7f26feb4-2e80-4c85-99e7-6e64f37a1027" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_44b313d7-db7a-4a76-8a5e-60ff5d95ce67" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7f26feb4-2e80-4c85-99e7-6e64f37a1027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_72951929-8828-49f6-b13a-c5bf7a1747f0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_7f26feb4-2e80-4c85-99e7-6e64f37a1027" xlink:to="loc_srt_ScenarioForecastMember_72951929-8828-49f6-b13a-c5bf7a1747f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_39460770-60c1-4177-a6ef-457a88b3d841" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f661d7fb-c2a1-4c60-8561-2434a445a321" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_39460770-60c1-4177-a6ef-457a88b3d841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_UnnamedEBeamJointVentureMember_549a9a83-0e8f-4667-ae3f-02d10da5d895" xlink:href="shc-20210331.xsd#shc_UnnamedEBeamJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_39460770-60c1-4177-a6ef-457a88b3d841" xlink:to="loc_shc_UnnamedEBeamJointVentureMember_549a9a83-0e8f-4667-ae3f-02d10da5d895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable_487d336f-f677-4d5e-ab13-f3b992b7f405" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d1a72882-7904-4974-bd18-86cecd2d9928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_d1a72882-7904-4974-bd18-86cecd2d9928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NumberOfSubsidiariesWithNonControllingInterest_eb366b69-4848-4122-b98e-d9170c52bcf1" xlink:href="shc-20210331.xsd#shc_NumberOfSubsidiariesWithNonControllingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_shc_NumberOfSubsidiariesWithNonControllingInterest_eb366b69-4848-4122-b98e-d9170c52bcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a142722e-6734-4cc9-a122-9ab508b1e161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a142722e-6734-4cc9-a122-9ab508b1e161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_1c14257a-42b0-4dee-9774-c6001fdb4ae8" xlink:href="shc-20210331.xsd#shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage_1c14257a-42b0-4dee-9774-c6001fdb4ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_061a14ef-1617-4f77-94b9-245963644c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_061a14ef-1617-4f77-94b9-245963644c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74c270eb-6128-4d7d-9b0d-09fd91aafbed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems_660046f0-f801-4d4b-9b19-df78e08ab605" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_74c270eb-6128-4d7d-9b0d-09fd91aafbed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RecentAccountingStandards" xlink:type="simple" xlink:href="shc-20210331.xsd#RecentAccountingStandards"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/RecentAccountingStandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_a992c8b7-9d5e-4298-ab77-28615d257b90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_45757f18-b0e6-46ca-a5f0-0d1b9baa9ab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingChangesAndErrorCorrectionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_a992c8b7-9d5e-4298-ab77-28615d257b90" xlink:to="loc_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock_45757f18-b0e6-46ca-a5f0-0d1b9baa9ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognition" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8574d35a-e795-438b-8ca3-da2292e06ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9fba48d0-782d-45fd-8755-4c865e0b2244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8574d35a-e795-438b-8ca3-da2292e06ef4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_9fba48d0-782d-45fd-8755-4c865e0b2244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_503c2010-2f18-4ba4-bd30-f904f7845cfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_42abc9eb-a842-4c12-ac47-f2919f7d2e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_503c2010-2f18-4ba4-bd30-f904f7845cfc" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_42abc9eb-a842-4c12-ac47-f2919f7d2e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RevenueRecognitionDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#RevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/RevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ca9d24d9-c81d-4b57-b204-e8922c95ab35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ca9d24d9-c81d-4b57-b204-e8922c95ab35" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0aaac185-2609-4dcd-acf5-80e20bcaeafa" xlink:to="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember_aa6d9cec-58ac-4844-b0b3-c3d21713fa2c" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:to="loc_shc_SterigenicsMember_aa6d9cec-58ac-4844-b0b3-c3d21713fa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_217278ce-b12c-41ca-b22c-b70fde877a95" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:to="loc_shc_NordionMember_217278ce-b12c-41ca-b22c-b70fde877a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember_74307968-a6f6-4d90-a49b-12da6b5fbb6d" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_eb63bb67-b767-4352-b36d-7a1b7ad29d61" xlink:to="loc_shc_NelsonLabsMember_74307968-a6f6-4d90-a49b-12da6b5fbb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_1d0ccc05-a4c2-463f-8b70-daa8537fcb2e" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_f9f48d3f-db56-4acd-94a5-28c4575fca4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_f9f48d3f-db56-4acd-94a5-28c4575fca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_f987665e-3a53-4619-8c65-f18f2489fae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_1ded5d2f-8090-4401-91e4-c365c79ef9b6" xlink:to="loc_us-gaap_TransferredOverTimeMember_f987665e-3a53-4619-8c65-f18f2489fae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_548d3c29-0329-467f-8833-9ae291066381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_39ef3434-511d-4758-b0a1-79e096de32ff" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_548d3c29-0329-467f-8833-9ae291066381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_721e59a5-7ebd-46fe-8a13-72b643c822f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_548d3c29-0329-467f-8833-9ae291066381" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_721e59a5-7ebd-46fe-8a13-72b643c822f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_9e441db4-42ad-48f4-a448-a0e1dc31a5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ca9d24d9-c81d-4b57-b204-e8922c95ab35" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_9e441db4-42ad-48f4-a448-a0e1dc31a5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8989ae6d-0622-4ae0-919e-41b7500929b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ca9d24d9-c81d-4b57-b204-e8922c95ab35" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8989ae6d-0622-4ae0-919e-41b7500929b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/Acquisitions" xlink:type="simple" xlink:href="shc-20210331.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e83b221e-05b8-4fb0-93b0-38f3392d165c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2108436d-d660-4d65-81b7-58620c05bbfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e83b221e-05b8-4fb0-93b0-38f3392d165c" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2108436d-d660-4d65-81b7-58620c05bbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_cd617842-ddda-43d7-8548-9a0885efe35a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3de22cb4-aedd-48ac-a243-4ffe1d823ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cd617842-ddda-43d7-8548-9a0885efe35a" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3de22cb4-aedd-48ac-a243-4ffe1d823ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_debb877b-b42a-4f76-928e-bb40c123e62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_cd617842-ddda-43d7-8548-9a0885efe35a" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_debb877b-b42a-4f76-928e-bb40c123e62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a0088b93-a60c-43f7-ab03-5177d4d286fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a0088b93-a60c-43f7-ab03-5177d4d286fc" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab0a798a-513a-465c-8e05-5efe5a06d3df" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_39db57db-49ff-4863-9439-c0795c705333" xlink:href="shc-20210331.xsd#shc_BioScienceLaboratoriesLLCBioScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:to="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_39db57db-49ff-4863-9439-c0795c705333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_dc5f8682-d8a3-42b8-9869-ff15865b1fc9" xlink:href="shc-20210331.xsd#shc_NelsonFairfieldIncNelsonFairfieldMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:to="loc_shc_NelsonFairfieldIncNelsonFairfieldMember_dc5f8682-d8a3-42b8-9869-ff15865b1fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember_cffc4c2d-7615-4e93-9dfb-4803324ffb26" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_45854a7f-ef7d-45e5-9ab0-2a8e35716b66" xlink:to="loc_shc_IotronIndustriesCanadaIncIotronMember_cffc4c2d-7615-4e93-9dfb-4803324ffb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c1207f78-3c69-4a4b-80b9-ab4f03189b72" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7bfddffa-53b8-4c9d-aca8-f4adce8fafc5" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c1207f78-3c69-4a4b-80b9-ab4f03189b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_UnnamedEBeamJointVentureMember_ea0c8c83-d87b-4f3c-9f42-56c08ccf0a8c" xlink:href="shc-20210331.xsd#shc_UnnamedEBeamJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c1207f78-3c69-4a4b-80b9-ab4f03189b72" xlink:to="loc_shc_UnnamedEBeamJointVentureMember_ea0c8c83-d87b-4f3c-9f42-56c08ccf0a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b8d725c1-3c84-47eb-969c-565ad9900658" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4c59854f-a058-4ada-b1f3-c03183504471" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4c59854f-a058-4ada-b1f3-c03183504471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_05b9904c-29c6-4966-8dc4-1d077a91811e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cbb93044-12c6-4e2a-91ca-6c48c069baf5" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_05b9904c-29c6-4966-8dc4-1d077a91811e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_246ee616-32ec-4886-8719-8963f2ddf04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ea2a29ae-d330-4c3b-8913-efc0907a58e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_246ee616-32ec-4886-8719-8963f2ddf04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member_5930256a-e76b-4bb6-b5fe-4377a420b654" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_246ee616-32ec-4886-8719-8963f2ddf04b" xlink:to="loc_shc_FirstLienNotesDue2026Member_5930256a-e76b-4bb6-b5fe-4377a420b654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d66da08f-4810-4870-aa3d-ed14b675c8e8" xlink:to="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d3b58bb6-c8c6-4ce7-9c68-f24829e40395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:to="loc_srt_MinimumMember_d3b58bb6-c8c6-4ce7-9c68-f24829e40395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5953a41f-2742-4e80-868d-f11962096468" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_58c48564-7319-41e0-84e8-1e69e7614512" xlink:to="loc_srt_MaximumMember_5953a41f-2742-4e80-868d-f11962096468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_878cb272-49ca-4558-a177-e362c1f963dd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2fd112bb-0677-44e2-b0e7-70d7cc0709b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2fd112bb-0677-44e2-b0e7-70d7cc0709b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness_b5cf0074-6f8f-4d87-8db9-312d74b4462d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness_b5cf0074-6f8f-4d87-8db9-312d74b4462d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_92c8838f-16fe-449f-9e81-361863fa6b93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_92c8838f-16fe-449f-9e81-361863fa6b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_39722d28-219c-4ec0-987c-fc7073082d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_Goodwill_39722d28-219c-4ec0-987c-fc7073082d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b528cfc5-8c21-4595-913e-c20425d832a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_b528cfc5-8c21-4595-913e-c20425d832a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fb54fe44-fbea-40b3-95a9-2ffc342a8c20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fb54fe44-fbea-40b3-95a9-2ffc342a8c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_2aadbe32-a48e-4902-808f-fd264ec37614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss_2aadbe32-a48e-4902-808f-fd264ec37614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount_ed63e26d-5ddb-41c3-bc9f-ea350615e85b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount_ed63e26d-5ddb-41c3-bc9f-ea350615e85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_798ee1dc-5711-4e53-a914-b6be37f80bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_798ee1dc-5711-4e53-a914-b6be37f80bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a2f838a1-99c0-4ed3-a263-05f423b18da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a2f838a1-99c0-4ed3-a263-05f423b18da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_54572666-ef0d-425c-84e6-ec3032c0ef43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_54572666-ef0d-425c-84e6-ec3032c0ef43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2ff31469-e80b-4b37-82d3-9f84e592d790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_2ff31469-e80b-4b37-82d3-9f84e592d790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7acca6ab-6025-4eab-bc2a-991bb0801e79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_7acca6ab-6025-4eab-bc2a-991bb0801e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ca3f652a-39fa-4d36-a035-2079845d9b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ca3f652a-39fa-4d36-a035-2079845d9b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dc2b0ad8-0f72-403f-a7dd-d9487fafe3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_10a3bdc0-0f10-486c-997d-b209b5c67190" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_dc2b0ad8-0f72-403f-a7dd-d9487fafe3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b05221b9-2dd3-4d66-b005-182e62e32444" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b05221b9-2dd3-4d66-b005-182e62e32444" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3980af61-c276-42d3-b8f1-0a489ac9e19e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_553e5bb7-1019-4f4e-8066-ad33b854b0a7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3980af61-c276-42d3-b8f1-0a489ac9e19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember_1056e20d-d93a-4ee7-89cf-76840291353a" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3980af61-c276-42d3-b8f1-0a489ac9e19e" xlink:to="loc_shc_IotronIndustriesCanadaIncIotronMember_1056e20d-d93a-4ee7-89cf-76840291353a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b7aae22-fb4b-4213-8127-090d2447655f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_89b639f0-95ee-4b1f-b559-0ce10afe2557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_Goodwill_89b639f0-95ee-4b1f-b559-0ce10afe2557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a0262877-ad04-4c10-a542-fa161d978bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a0262877-ad04-4c10-a542-fa161d978bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_05683e57-0e7a-4356-b3f7-f07f9856d00c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_05683e57-0e7a-4356-b3f7-f07f9856d00c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_7307bd18-df53-4f11-88a7-8579e387ac9c" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet_7307bd18-df53-4f11-88a7-8579e387ac9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_aaea97ed-b521-4412-b3e3-081490c51c10" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate_aaea97ed-b521-4412-b3e3-081490c51c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0066cc8f-61be-4d31-aa86-e6ba46381c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_0066cc8f-61be-4d31-aa86-e6ba46381c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_2712f9a1-e867-4066-b937-1555565dd2b9" xlink:href="shc-20210331.xsd#shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet_2712f9a1-e867-4066-b937-1555565dd2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b2ec9084-e800-4301-b49c-f0edb1c7e4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_b2ec9084-e800-4301-b49c-f0edb1c7e4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1a2daba9-b549-4e5f-8381-58d9240228e8" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9d5b3f20-246d-4119-8213-b40b6cd05f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_9d5b3f20-246d-4119-8213-b40b6cd05f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e9091c4d-c8f1-4c5b-a40a-589f2120b86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles_e9091c4d-c8f1-4c5b-a40a-589f2120b86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_4cef8f3a-a687-4f02-90c7-8c8f980efd1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment_4cef8f3a-a687-4f02-90c7-8c8f980efd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_35d0f461-103f-405c-924a-94e2ed208e9e" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet_35d0f461-103f-405c-924a-94e2ed208e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_634bac62-f94e-400f-b0b0-2f3673757a6c" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate_634bac62-f94e-400f-b0b0-2f3673757a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_218f983b-edfa-421b-a02e-26e8c1342d77" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther_218f983b-edfa-421b-a02e-26e8c1342d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_1cd650af-7c1e-4185-a323-bede63e977d0" xlink:href="shc-20210331.xsd#shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet_1cd650af-7c1e-4185-a323-bede63e977d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_bb2c92db-04c5-46b6-b10c-99b0e8cbec65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_90bb2511-7e1a-4c8b-9b66-550ec6c32337" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred_bb2c92db-04c5-46b6-b10c-99b0e8cbec65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AcquisitionsProFormaInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AcquisitionsProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3d801b66-9b35-4a3d-a3c0-1a7288ade536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_26bef279-84ce-4e16-a797-5bd2932f5265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3d801b66-9b35-4a3d-a3c0-1a7288ade536" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_26bef279-84ce-4e16-a797-5bd2932f5265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0256eaef-b09f-4116-a2ce-f0a8b29f687e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3d801b66-9b35-4a3d-a3c0-1a7288ade536" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_0256eaef-b09f-4116-a2ce-f0a8b29f687e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/Inventories" xlink:type="simple" xlink:href="shc-20210331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_232346c2-1f5a-4c8d-a987-122ef6c7f56c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_e1651367-61b0-4547-90ca-2330ab85966d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_232346c2-1f5a-4c8d-a987-122ef6c7f56c" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_e1651367-61b0-4547-90ca-2330ab85966d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/InventoriesTables" xlink:type="simple" xlink:href="shc-20210331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_181c81b6-ad8c-44d6-be1b-762c6dc612cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_191617fd-0e95-4e85-840e-457e568e89b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_181c81b6-ad8c-44d6-be1b-762c6dc612cd" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_191617fd-0e95-4e85-840e-457e568e89b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/InventoriesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSupplies_420efcea-d281-4e50-a85b-e589f7a64025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSupplies_420efcea-d281-4e50-a85b-e589f7a64025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_363f5f88-b067-402e-b74c-9733f9ffa240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:to="loc_us-gaap_InventoryWorkInProcess_363f5f88-b067-402e-b74c-9733f9ffa240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_e213d2a6-db7a-4fb6-a858-132f49fb87c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:to="loc_us-gaap_InventoryFinishedGoods_e213d2a6-db7a-4fb6-a858-132f49fb87c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_40e3d7d3-b1ac-498d-9c23-23abf89b9c7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:to="loc_us-gaap_InventoryGross_40e3d7d3-b1ac-498d-9c23-23abf89b9c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryAdjustments_28646e7f-0bbd-4013-9256-57fa5bac46c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:to="loc_us-gaap_InventoryAdjustments_28646e7f-0bbd-4013-9256-57fa5bac46c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_47263a28-ae49-4586-8f67-12a7e906342f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5168804a-61ca-420b-9a14-c7d5e0658fce" xlink:to="loc_us-gaap_InventoryNet_47263a28-ae49-4586-8f67-12a7e906342f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssets"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_51a90fab-6f41-4252-8843-7cdebff97145" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_9d9fa567-26f0-4d24-910e-302b1779c098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_51a90fab-6f41-4252-8843-7cdebff97145" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_9d9fa567-26f0-4d24-910e-302b1779c098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_29545393-4638-4f38-8c4f-102e50f099a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_d21212a5-e332-4ebd-b5e9-ab511348cd7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_29545393-4638-4f38-8c4f-102e50f099a3" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_d21212a5-e332-4ebd-b5e9-ab511348cd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_81c92820-1887-46b5-992a-44b84873cbc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_PrepaidTaxes_81c92820-1887-46b5-992a-44b84873cbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_07871298-226a-4526-aa91-faea358b8d5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_PrepaidInsurance_07871298-226a-4526-aa91-faea358b8d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidRent_9fbb79a5-f3c9-405c-bbba-79209bb15ea9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidRent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_PrepaidRent_9fbb79a5-f3c9-405c-bbba-79209bb15ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d83f25b5-f069-46d6-8811-726896716cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_d83f25b5-f069-46d6-8811-726896716cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceSettlementsReceivableCurrent_54506b68-5556-4b6d-897a-a78215b1fd5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InsuranceSettlementsReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_InsuranceSettlementsReceivableCurrent_54506b68-5556-4b6d-897a-a78215b1fd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_ac17ae90-e77a-4e7d-88e4-6b1b3e67332e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_DepositsAssetsCurrent_ac17ae90-e77a-4e7d-88e4-6b1b3e67332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PrepaidMaintenanceContractsCurrent_db7b92b8-3d45-414b-9350-17a5a264c8ec" xlink:href="shc-20210331.xsd#shc_PrepaidMaintenanceContractsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_shc_PrepaidMaintenanceContractsCurrent_db7b92b8-3d45-414b-9350-17a5a264c8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValueAddedTaxReceivableCurrent_bb8ab0e0-76d9-4c47-8afb-f846cdd140eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValueAddedTaxReceivableCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_ValueAddedTaxReceivableCurrent_bb8ab0e0-76d9-4c47-8afb-f846cdd140eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PrepaidSoftwareLicensingCurrent_db86be95-11c9-45c6-88bb-ce75f6cbb990" xlink:href="shc-20210331.xsd#shc_PrepaidSoftwareLicensingCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_shc_PrepaidSoftwareLicensingCurrent_db86be95-11c9-45c6-88bb-ce75f6cbb990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Supplies_92591084-76d9-4170-9868-8df9e4e8fe7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Supplies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_Supplies_92591084-76d9-4170-9868-8df9e4e8fe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_eb1fe2a5-8642-4201-ad12-18a82ab5935b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_OtherAssetsCurrent_eb1fe2a5-8642-4201-ad12-18a82ab5935b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0dd8bca5-3e37-46bf-8cc8-8c2c13fb5c38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_2f9591c0-e775-498b-b9da-758977478ab8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0dd8bca5-3e37-46bf-8cc8-8c2c13fb5c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18567b26-fb25-49c1-a974-f3a912dd39a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_18a369b3-df80-4112-b9fc-ab6148b1e9d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18567b26-fb25-49c1-a974-f3a912dd39a1" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_18a369b3-df80-4112-b9fc-ab6148b1e9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5ac30c7-15d2-4026-a178-5add92725f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_cd6e6895-e848-490f-8844-5e58d59afa2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5ac30c7-15d2-4026-a178-5add92725f4a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_cd6e6895-e848-490f-8844-5e58d59afa2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_b6753c71-1ad2-488c-8b26-22c8b237d5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5ac30c7-15d2-4026-a178-5add92725f4a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock_b6753c71-1ad2-488c-8b26-22c8b237d5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_21540f4c-2ec2-45ce-86ab-db0a823bc3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5ac30c7-15d2-4026-a178-5add92725f4a" xlink:to="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_21540f4c-2ec2-45ce-86ab-db0a823bc3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cad56545-d97f-430d-b670-d71e9fd5d16f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b5ac30c7-15d2-4026-a178-5add92725f4a" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cad56545-d97f-430d-b670-d71e9fd5d16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6de18278-def9-4e36-97f0-fc8b5b27fda6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6de18278-def9-4e36-97f0-fc8b5b27fda6" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4ea2c1a-fac3-40a0-abaa-1f5850179615" xlink:to="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember_acc79a11-6d68-4ebc-9882-31d6b6ea4dc3" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:to="loc_shc_SterigenicsMember_acc79a11-6d68-4ebc-9882-31d6b6ea4dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_3565b387-f04c-4723-baac-44f0e60e793d" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:to="loc_shc_NordionMember_3565b387-f04c-4723-baac-44f0e60e793d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember_4c37cd8d-1612-4dd0-8d6d-9c42c9b12d67" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_acacda3a-d217-4b9e-9c22-15346747b080" xlink:to="loc_shc_NelsonLabsMember_4c37cd8d-1612-4dd0-8d6d-9c42c9b12d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5ef45df6-64d8-4886-8125-51c47208c4a7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_807e4270-08bd-4546-95a9-8f282a428c41" xlink:href="shc-20210331.xsd#shc_BioScienceLaboratoriesLLCBioScienceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:to="loc_shc_BioScienceLaboratoriesLLCBioScienceMember_807e4270-08bd-4546-95a9-8f282a428c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_IotronIndustriesCanadaIncIotronMember_a0859775-5a76-4420-81bd-dfebbf48e480" xlink:href="shc-20210331.xsd#shc_IotronIndustriesCanadaIncIotronMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6c35feb9-0790-4f0b-a681-d2e52e2fdba9" xlink:to="loc_shc_IotronIndustriesCanadaIncIotronMember_a0859775-5a76-4420-81bd-dfebbf48e480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_c07900bd-17e9-440c-b783-c28c89ed8243" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_4adac949-bbf2-40a3-9118-14d1e50ac37a" xlink:to="loc_us-gaap_GoodwillLineItems_c07900bd-17e9-440c-b783-c28c89ed8243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_c07900bd-17e9-440c-b783-c28c89ed8243" xlink:to="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7b40ebe8-0d1c-4dfd-911c-0e06222961f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_Goodwill_7b40ebe8-0d1c-4dfd-911c-0e06222961f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_45343ff8-5d6f-4633-a9f5-903ae7cfb3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_GoodwillPurchaseAccountingAdjustments_45343ff8-5d6f-4633-a9f5-903ae7cfb3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_5dabd18d-6ad3-4704-88d5-4cfbd08c268d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_5dabd18d-6ad3-4704-88d5-4cfbd08c268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3f2b72ac-f2ec-4d9d-bebe-be80fc437b1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7e8b1a06-6956-4182-a23f-2400ad68f9ee" xlink:to="loc_us-gaap_Goodwill_3f2b72ac-f2ec-4d9d-bebe-be80fc437b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangiblesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf9da310-0136-4a86-bd7c-6a4280587d10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf9da310-0136-4a86-bd7c-6a4280587d10" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_925007bc-412d-45c9-a628-eee46f20f94d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_7d1c7bff-9a6c-4458-a92f-d3351996e18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_CustomerRelationshipsMember_7d1c7bff-9a6c-4458-a92f-d3351996e18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_cbcdac04-4ac1-4509-804f-9344c3c9850e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_cbcdac04-4ac1-4509-804f-9344c3c9850e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_cf95d4fb-2b21-4eec-bf54-2488f2fa8c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_TradeNamesMember_cf95d4fb-2b21-4eec-bf54-2488f2fa8c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LandUseRightsMember_3498e242-491e-4f4e-bad6-2e0a5d881bac" xlink:href="shc-20210331.xsd#shc_LandUseRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_shc_LandUseRightsMember_3498e242-491e-4f4e-bad6-2e0a5d881bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SealedSourceAndSupplyAgreementsMember_6ba449d1-48ee-4ffc-b816-828824d79e79" xlink:href="shc-20210331.xsd#shc_SealedSourceAndSupplyAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_shc_SealedSourceAndSupplyAgreementsMember_6ba449d1-48ee-4ffc-b816-828824d79e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_97a10051-f927-4336-97e4-63ee8c670bf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ae83a61e-5234-4dd1-87a2-5b2ebe9a6627" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_97a10051-f927-4336-97e4-63ee8c670bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_9f351c80-c2f1-46b7-966c-c71c734bafa8" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9d687966-ccc5-4e1d-aad4-4ac37ecf63ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9d687966-ccc5-4e1d-aad4-4ac37ecf63ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_95f032fc-fe9b-43be-8391-821e00c644e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_26007d57-482a-411a-b996-4affca7be1cf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_95f032fc-fe9b-43be-8391-821e00c644e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf9da310-0136-4a86-bd7c-6a4280587d10" xlink:to="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b43935e2-07dc-4754-9bfb-347144954919" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_6d7f723a-6283-49f0-a002-561118be0833" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:to="loc_us-gaap_LicensingAgreementsMember_6d7f723a-6283-49f0-a002-561118be0833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_0b8af519-cec5-45ab-9824-8b5f5928a02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f7ec671e-9131-4112-8a75-4e16759440c9" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_0b8af519-cec5-45ab-9824-8b5f5928a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable_155c2e72-1db1-43fc-afc8-d042f7ca5097" xlink:to="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0ba4f2a3-2627-4c88-9a8e-94e6554ed20b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0ba4f2a3-2627-4c88-9a8e-94e6554ed20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LicensingAgreementsRenewalTerm_8e728466-3969-4f25-931e-73df0bb05815" xlink:href="shc-20210331.xsd#shc_LicensingAgreementsRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems_0860ce0e-f574-4a0b-ae2d-b2c33baeac3d" xlink:to="loc_shc_LicensingAgreementsRenewalTerm_8e728466-3969-4f25-931e-73df0bb05815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_170158a4-1d61-4ba6-b285-9d90643ba54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf9da310-0136-4a86-bd7c-6a4280587d10" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_170158a4-1d61-4ba6-b285-9d90643ba54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc131cd8-6fd3-4f70-a742-da6600600e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dc131cd8-6fd3-4f70-a742-da6600600e00" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_20f803e6-9f91-47ac-8406-7953afe5be93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6377ff2d-dcb8-4359-a7bc-bc865742ab52" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_20f803e6-9f91-47ac-8406-7953afe5be93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_488d1cde-522d-43e1-881f-16d643808dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_20f803e6-9f91-47ac-8406-7953afe5be93" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_488d1cde-522d-43e1-881f-16d643808dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_a7ef80e6-fc8a-4acd-8449-54108c807d1c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_71bcc500-f173-4a39-860e-a865f1d11fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:to="loc_us-gaap_CostOfSalesMember_71bcc500-f173-4a39-860e-a865f1d11fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f3cdf7d4-7ffb-47aa-af36-cbce02a23ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_23aeaaa5-e647-4b5e-80a3-19bb061e94ec" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f3cdf7d4-7ffb-47aa-af36-cbce02a23ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_fb6d46e6-8fc8-48ae-9a28-37c7a1533ba6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d5672a08-f928-442f-8a6a-d93be4eca924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d5672a08-f928-442f-8a6a-d93be4eca924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_67fd0140-23a7-41c6-a91a-d3fded975fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_adbc6285-dd50-4242-92ff-15708a5f0558" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_67fd0140-23a7-41c6-a91a-d3fded975fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d727a19b-24d0-400d-aee8-4db63f0358a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d727a19b-24d0-400d-aee8-4db63f0358a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_39bbbda8-ea5f-4846-ac42-338eaf140bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_39bbbda8-ea5f-4846-ac42-338eaf140bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5011e3e9-c4dd-4c18-aff2-7464651d93c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_5011e3e9-c4dd-4c18-aff2-7464651d93c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28bebc8d-68ff-4483-98bd-e93af47305cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_28bebc8d-68ff-4483-98bd-e93af47305cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_072c30e2-7426-46f8-b65e-74861b104a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_072c30e2-7426-46f8-b65e-74861b104a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_a8d5d5eb-937d-4ff1-b839-f4703fe81f1d" xlink:href="shc-20210331.xsd#shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_a8d5d5eb-937d-4ff1-b839-f4703fe81f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11aa66d1-87f9-4fd0-9275-e8551e3e5ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d407a8b3-20bf-4e75-8cb5-17cf2da2249f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_11aa66d1-87f9-4fd0-9275-e8551e3e5ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_5f23da38-8259-4a5f-a57b-7ac41f696cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_fdb7c66e-879d-4a99-9a88-95f5beeda249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_5f23da38-8259-4a5f-a57b-7ac41f696cc0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_fdb7c66e-879d-4a99-9a88-95f5beeda249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_72d82cd3-7c18-4327-8e03-a337646c1ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_770d3abf-6fc7-473c-8835-2fd484e5e748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_72d82cd3-7c18-4327-8e03-a337646c1ee5" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_770d3abf-6fc7-473c-8835-2fd484e5e748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_956e09f0-6749-4991-ab33-39f8971597b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_956e09f0-6749-4991-ab33-39f8971597b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_558240ac-e493-44b9-b751-5bebb4e7bcb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_LitigationReserveCurrent_558240ac-e493-44b9-b751-5bebb4e7bcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AccruedInterestExpenseCurrent_2987f83f-e59f-4ad9-9cd0-9d3afecc9039" xlink:href="shc-20210331.xsd#shc_AccruedInterestExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_shc_AccruedInterestExpenseCurrent_2987f83f-e59f-4ad9-9cd0-9d3afecc9039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_8a379304-c0f9-4a1f-b7bb-12495b0f0567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_8a379304-c0f9-4a1f-b7bb-12495b0f0567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_8f2d3984-4d55-4530-a0da-60f3edacab81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_8f2d3984-4d55-4530-a0da-60f3edacab81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedUtilitiesCurrent_3dc866e9-5ae3-4ff5-8e82-bc3334ee9aa6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedUtilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_AccruedUtilitiesCurrent_3dc866e9-5ae3-4ff5-8e82-bc3334ee9aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedInsuranceCurrent_f0b4d83c-494e-462e-96dc-d5f955c35d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedInsuranceCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_AccruedInsuranceCurrent_f0b4d83c-494e-462e-96dc-d5f955c35d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_36fb8f66-7f4e-4274-be49-ca1552d0bce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_TaxesPayableCurrent_36fb8f66-7f4e-4274-be49-ca1552d0bce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5531d6ba-2cb3-4731-9134-df8bfe2a3836" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5531d6ba-2cb3-4731-9134-df8bfe2a3836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_6e99f512-444a-46cc-8108-9e440b468755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_daaf499c-88cd-43c7-b9ac-60ae5d9bc6b1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_6e99f512-444a-46cc-8108-9e440b468755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebt" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3d3e1739-9fcd-4750-858f-3db48a2f5648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_0b094a2d-af2d-430e-9caf-45e4e671b115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3d3e1739-9fcd-4750-858f-3db48a2f5648" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_0b094a2d-af2d-430e-9caf-45e4e671b115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5fe379c3-84f3-43b5-87ae-a5c535b16e5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2e38ffb7-9e2b-476b-8459-cf2062280b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5fe379c3-84f3-43b5-87ae-a5c535b16e5b" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2e38ffb7-9e2b-476b-8459-cf2062280b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_955e6ccb-9504-487d-8651-160950b67ce3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5fe379c3-84f3-43b5-87ae-a5c535b16e5b" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_955e6ccb-9504-487d-8651-160950b67ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5dd2aa4a-ff06-470c-ae88-02d0387c8832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5dd2aa4a-ff06-470c-ae88-02d0387c8832" xlink:to="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_99995849-b7af-4ac2-a074-178372a7b76c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember_0c7b0361-f582-4eb8-bca9-93c6691bc636" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:to="loc_shc_TermLoanMember_0c7b0361-f582-4eb8-bca9-93c6691bc636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_54cb5efc-e570-4b02-bac6-12ec00c3c414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:to="loc_us-gaap_SeniorNotesMember_54cb5efc-e570-4b02-bac6-12ec00c3c414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_OtherLongTermDebtMember_8292a915-c7e5-48e1-b7ac-f053f47f36f6" xlink:href="shc-20210331.xsd#shc_OtherLongTermDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d46fc818-5ad1-424f-bf3a-17d4fa6424fd" xlink:to="loc_shc_OtherLongTermDebtMember_8292a915-c7e5-48e1-b7ac-f053f47f36f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:to="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_09261653-5c01-41f0-8e9d-058352497f27" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_e100165d-0b0c-4734-88b7-553a1e43fdbf" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:to="loc_shc_TermLoanDue2026Member_e100165d-0b0c-4734-88b7-553a1e43fdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2026Member_15a74346-8627-4fd8-87f2-2e23a97728cb" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_52055f81-20ba-4313-852e-e335ff278579" xlink:to="loc_shc_SeniorNotesDue2026Member_15a74346-8627-4fd8-87f2-2e23a97728cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5ffaa606-7aee-4bdd-97c9-e036d90c58d1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_217c50da-3a57-4409-b3e7-9f0a5b1dc784" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_217c50da-3a57-4409-b3e7-9f0a5b1dc784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_86c1ac82-487b-4fd8-b296-d9268640c4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_86c1ac82-487b-4fd8-b296-d9268640c4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_adad8cee-236d-4696-a09a-b15d0ed8abd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_LongTermDebt_adad8cee-236d-4696-a09a-b15d0ed8abd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8f96d09d-ca5a-448c-9277-0557aa489fd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc6b47a3-883b-46fc-83ee-b239c901ed51" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8f96d09d-ca5a-448c-9277-0557aa489fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtSeniorSecuredCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_da6ff90d-dac8-4c2b-9aaa-47e52b4929a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_da6ff90d-dac8-4c2b-9aaa-47e52b4929a4" xlink:to="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_79ce335a-d459-4f1d-af22-dfa984f617cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7c26c7b0-bc2b-46c2-9035-5c8e8ad96182" xlink:to="loc_us-gaap_CreditFacilityDomain_79ce335a-d459-4f1d-af22-dfa984f617cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4cc4a9e0-98f5-4610-bf6c-c8df57b116b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_79ce335a-d459-4f1d-af22-dfa984f617cb" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4cc4a9e0-98f5-4610-bf6c-c8df57b116b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9570f735-e758-4fe8-bc6d-b5a8e67178f8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorSecuredCreditFacilitiesMember_46499db9-887c-4762-8c5d-61c0f5e7b635" xlink:href="shc-20210331.xsd#shc_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:to="loc_shc_SeniorSecuredCreditFacilitiesMember_46499db9-887c-4762-8c5d-61c0f5e7b635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_a21b2237-eb96-4427-8da1-489178180b3d" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:to="loc_shc_TermLoanDue2026Member_a21b2237-eb96-4427-8da1-489178180b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member_a943052e-638c-486a-b621-a626c8b05d68" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_502bf1de-44fa-4ff9-82e9-a5bac4bde4a8" xlink:to="loc_shc_FirstLienNotesDue2026Member_a943052e-638c-486a-b621-a626c8b05d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fb3ab50c-839d-4dd8-9479-b3b9884eeffc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember_b3f4abdb-ec48-46c0-9719-b03d410b65e4" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:to="loc_shc_TermLoanMember_b3f4abdb-ec48-46c0-9719-b03d410b65e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_6143f0ac-e70b-47b4-8826-46bd3f07033b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_ee62c69f-c31f-435e-ab61-6ac8d5e4b95f" xlink:to="loc_us-gaap_SecuredDebtMember_6143f0ac-e70b-47b4-8826-46bd3f07033b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_b13e23d5-40f7-4701-bcee-7c49d7101a75" xlink:to="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_e8bd9bce-5a9f-469e-aad8-7f68976a721d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_e8bd9bce-5a9f-469e-aad8-7f68976a721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_86486161-c4f2-4a7c-9807-6ac4d2747ddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:to="loc_us-gaap_BaseRateMember_86486161-c4f2-4a7c-9807-6ac4d2747ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_0051293b-4756-435c-bbc5-1c0a5a36487f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_b040daee-8c0f-43d1-a0ed-b649eff2588a" xlink:to="loc_us-gaap_EurodollarMember_0051293b-4756-435c-bbc5-1c0a5a36487f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4b94cb1a-85bd-4684-b455-2f04526b46b2" xlink:to="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_61c68b61-2468-43e4-ba71-7141aee7463d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:to="loc_srt_MinimumMember_61c68b61-2468-43e4-ba71-7141aee7463d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0319a9ac-db28-492e-bcb6-60b6569fcf06" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3459bfa6-0f77-4768-90c6-951a38d70c31" xlink:to="loc_srt_MaximumMember_0319a9ac-db28-492e-bcb6-60b6569fcf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_8bfeaa97-6b88-462b-b4a9-4e3cd5d6f8cd" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_55c84f8b-e9fa-4724-8d12-ff2ea73de78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_55c84f8b-e9fa-4724-8d12-ff2ea73de78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_884262ec-77fa-42b8-be0f-c4c0b5127a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_884262ec-77fa-42b8-be0f-c4c0b5127a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_7311a965-2af8-4951-8b06-2d0d4d3e1a59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_7311a965-2af8-4951-8b06-2d0d4d3e1a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8e91ba16-e8ff-4831-aae8-57fd1c3af18e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8e91ba16-e8ff-4831-aae8-57fd1c3af18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentVariableRateFloor_c6489cc4-bfc6-496a-a7d6-cf78375a0dc3" xlink:href="shc-20210331.xsd#shc_DebtInstrumentVariableRateFloor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_DebtInstrumentVariableRateFloor_c6489cc4-bfc6-496a-a7d6-cf78375a0dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_0463be77-b77e-46a2-9d39-8ff0d1410216" xlink:href="shc-20210331.xsd#shc_DebtInstrumentEffectiveReductionInCurrentInterestRates"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates_0463be77-b77e-46a2-9d39-8ff0d1410216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_61e24cb0-91c4-4b7b-8493-54a003fd383a" xlink:href="shc-20210331.xsd#shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount_61e24cb0-91c4-4b7b-8493-54a003fd383a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtIssuanceCostsRefinancingAdditionalExpense_7451469b-c003-42ed-835d-a6a541d59f89" xlink:href="shc-20210331.xsd#shc_DebtIssuanceCostsRefinancingAdditionalExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_shc_DebtIssuanceCostsRefinancingAdditionalExpense_7451469b-c003-42ed-835d-a6a541d59f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_f649385b-de06-40ff-a01a-9360a843199e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_f649385b-de06-40ff-a01a-9360a843199e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79262beb-402b-4d77-9658-2953849a67ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_79262beb-402b-4d77-9658-2953849a67ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_b4a30999-538b-4331-99e8-08e344440c2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_b4a30999-538b-4331-99e8-08e344440c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_b4758992-237f-4162-bb32-5068efe0bb66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b8ca3172-0bde-4cc9-9baf-72887c820060" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_b4758992-237f-4162-bb32-5068efe0bb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtFirstLienNotesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_edb6894b-cee0-4cb6-aed2-91f73da0d0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_edb6894b-cee0-4cb6-aed2-91f73da0d0a6" xlink:to="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3bf82d7d-8d7a-4eb7-822e-fe3e57e9f303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f9d5292f-29ac-4a47-bc07-7a419393593e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3bf82d7d-8d7a-4eb7-822e-fe3e57e9f303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_dac0ee98-5a23-49a7-82de-2fb57dbae5a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3bf82d7d-8d7a-4eb7-822e-fe3e57e9f303" xlink:to="loc_us-gaap_SecuredDebtMember_dac0ee98-5a23-49a7-82de-2fb57dbae5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bf7a56cd-0faa-413a-b211-12f410388514" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4be27a78-3d81-4712-a96b-35611ab2c87b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bf7a56cd-0faa-413a-b211-12f410388514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FirstLienNotesDue2026Member_1fe4c971-cc1d-4dc5-8e53-e2602ad978aa" xlink:href="shc-20210331.xsd#shc_FirstLienNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bf7a56cd-0faa-413a-b211-12f410388514" xlink:to="loc_shc_FirstLienNotesDue2026Member_1fe4c971-cc1d-4dc5-8e53-e2602ad978aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_525693b3-2c53-4243-8466-be0b54fb53ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_af231a92-39ca-4f8f-9cf3-29399ab9fe91" xlink:to="loc_us-gaap_VariableRateDomain_525693b3-2c53-4243-8466-be0b54fb53ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_170a3d0e-7085-4d6e-a412-72357a3620d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_525693b3-2c53-4243-8466-be0b54fb53ce" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_170a3d0e-7085-4d6e-a412-72357a3620d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1b9f0ef5-b0b2-437f-b14a-2944bbdd0aab" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_6b9f99b1-0510-48cc-97d8-1f342095f4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_6b9f99b1-0510-48cc-97d8-1f342095f4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DebtInstrumentVariableRateFloor_a59d767a-f894-4925-bc6a-448d5b67b6b7" xlink:href="shc-20210331.xsd#shc_DebtInstrumentVariableRateFloor"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_shc_DebtInstrumentVariableRateFloor_a59d767a-f894-4925-bc6a-448d5b67b6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f07180d1-dc04-4db8-b8d9-3b4022ebdbac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_f07180d1-dc04-4db8-b8d9-3b4022ebdbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_5120a128-c347-4a89-9a4a-49e6c6b62871" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_5120a128-c347-4a89-9a4a-49e6c6b62871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_8ff8868f-f475-4f70-8050-de518747db0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_8ff8868f-f475-4f70-8050-de518747db0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e372c7b4-45c7-40a3-8c5a-bba77dacf198" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a0229be0-358e-4c9a-94f9-569ee1943f31" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e372c7b4-45c7-40a3-8c5a-bba77dacf198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtRepaymentsofDebtDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5ab55fa6-4a0a-474f-96de-7cab5b0f27b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5ab55fa6-4a0a-474f-96de-7cab5b0f27b9" xlink:to="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a894626a-eeca-42a9-9453-0f68f7e39a98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_dd9bb704-f0bb-441b-ad32-948b5312d3d7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a894626a-eeca-42a9-9453-0f68f7e39a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_ab2f0b4c-3cc6-4e51-8e8d-ae97d36c4834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a894626a-eeca-42a9-9453-0f68f7e39a98" xlink:to="loc_us-gaap_IPOMember_ab2f0b4c-3cc6-4e51-8e8d-ae97d36c4834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f2e5fa05-7262-46ed-8cf9-6bbf0b67d05b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e7d094e7-bed0-4d9a-bbf2-0a16bf7ccb91" xlink:to="loc_us-gaap_EquityComponentDomain_f2e5fa05-7262-46ed-8cf9-6bbf0b67d05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6676c634-23ca-4da6-a7fe-d19c5fe71b9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f2e5fa05-7262-46ed-8cf9-6bbf0b67d05b" xlink:to="loc_us-gaap_CommonStockMember_6676c634-23ca-4da6-a7fe-d19c5fe71b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_260d760b-cfe6-475c-86c4-8b06f5de12fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_95474433-2cca-43f1-a3fc-79c4a97e6475" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_260d760b-cfe6-475c-86c4-8b06f5de12fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanMember_13be9e4c-03e7-4350-a598-68ea901d4951" xlink:href="shc-20210331.xsd#shc_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_260d760b-cfe6-475c-86c4-8b06f5de12fe" xlink:to="loc_shc_TermLoanMember_13be9e4c-03e7-4350-a598-68ea901d4951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4dbeb782-975e-4e85-bf89-25475e46b2cc" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SecondLienNotesMember_3d16f512-f4cd-4e85-afc2-56173d871424" xlink:href="shc-20210331.xsd#shc_SecondLienNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:to="loc_shc_SecondLienNotesMember_3d16f512-f4cd-4e85-afc2-56173d871424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_37c3b3bc-35f3-4bfe-aabc-d7d226ea1e04" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:to="loc_shc_TermLoanDue2026Member_37c3b3bc-35f3-4bfe-aabc-d7d226ea1e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanAndSecondLienNotesMember_32f60ce8-07c9-49af-872b-e17f5457a522" xlink:href="shc-20210331.xsd#shc_TermLoanAndSecondLienNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7dc8604-03f7-4d85-8831-c9caa1976e42" xlink:to="loc_shc_TermLoanAndSecondLienNotesMember_32f60ce8-07c9-49af-872b-e17f5457a522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_154e52cd-7e7c-4ca5-8aca-509c00455fd2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_ca31fe58-3810-4961-889a-bce68a2a05ea" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_154e52cd-7e7c-4ca5-8aca-509c00455fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_4ce5d326-7f5c-44ea-a012-2486d6602495" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_154e52cd-7e7c-4ca5-8aca-509c00455fd2" xlink:to="loc_srt_OfficerMember_4ce5d326-7f5c-44ea-a012-2486d6602495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bbc43114-d6b9-4006-8462-193fd3396122" xlink:to="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f688484a-afe1-4e57-ab53-283184c543f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f688484a-afe1-4e57-ab53-283184c543f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_05d5382c-7132-4c53-b2a4-f9844ef6f107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_05d5382c-7132-4c53-b2a4-f9844ef6f107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_aa599ac5-7956-401a-b501-00852386d549" xlink:href="shc-20210331.xsd#shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased_aa599ac5-7956-401a-b501-00852386d549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_623c51a6-9a4f-4b7d-bc50-b648d2a1f6b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_623c51a6-9a4f-4b7d-bc50-b648d2a1f6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_7bb12659-30b8-4f69-b629-7f8bb58d2c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_7bb12659-30b8-4f69-b629-7f8bb58d2c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_RecognitionOfDebtPremium_22f5eed1-e5fb-4094-a4e9-e53c1bd5bdc2" xlink:href="shc-20210331.xsd#shc_RecognitionOfDebtPremium"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_shc_RecognitionOfDebtPremium_22f5eed1-e5fb-4094-a4e9-e53c1bd5bdc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_99bf7dd5-78b4-4100-af7d-c63ff97cf27c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_99bf7dd5-78b4-4100-af7d-c63ff97cf27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_98be589b-3f33-43b2-88a3-95e4f9422fef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_1f382183-0b87-47bc-98ea-3ad38a52dd42" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_98be589b-3f33-43b2-88a3-95e4f9422fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#LongTermDebtAggregateMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_35610c9e-832f-41e3-9525-1aaf6ae824cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_35610c9e-832f-41e3-9525-1aaf6ae824cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2bdcc356-df04-4ca1-83ae-e52da7d989bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2bdcc356-df04-4ca1-83ae-e52da7d989bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0de09af1-bc4e-4fcb-b9ac-a13bedd4fd8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0de09af1-bc4e-4fcb-b9ac-a13bedd4fd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b1153322-30aa-4a52-acae-8bce801fa97e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_b1153322-30aa-4a52-acae-8bce801fa97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d718596d-e422-4f73-9369-d21f0d946b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d718596d-e422-4f73-9369-d21f0d946b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LongTermDebtMaturityAfterYearFour_ae7f1d89-92fb-438b-9f95-8ac42d080c8c" xlink:href="shc-20210331.xsd#shc_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_shc_LongTermDebtMaturityAfterYearFour_ae7f1d89-92fb-438b-9f95-8ac42d080c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f4585a91-e486-4ae3-8923-8230498c1bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eaddf939-62b1-48b1-8a69-4b7bce8f895b" xlink:to="loc_us-gaap_LongTermDebt_f4585a91-e486-4ae3-8923-8230498c1bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="shc-20210331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_09598c65-e269-4eb1-b1d3-905b0339e40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9bd627dc-d20d-4be7-9b80-eb512295e87b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_09598c65-e269-4eb1-b1d3-905b0339e40d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9bd627dc-d20d-4be7-9b80-eb512295e87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_79a2c468-c719-4cbb-a5b6-254ef4c66829" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_770d6638-08cd-473c-8c9d-ddc9b50a6b3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_79a2c468-c719-4cbb-a5b6-254ef4c66829" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_770d6638-08cd-473c-8c9d-ddc9b50a6b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct_d6f4a0e5-5042-4382-8241-30e568b6b218" xlink:href="shc-20210331.xsd#shc_LimitationOnDeductibilityOfInterestExpenseCARESAct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_79a2c468-c719-4cbb-a5b6-254ef4c66829" xlink:to="loc_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct_d6f4a0e5-5042-4382-8241-30e568b6b218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b9474b80-56ae-47ae-92b6-33a6329c2a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_79a2c468-c719-4cbb-a5b6-254ef4c66829" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_b9474b80-56ae-47ae-92b6-33a6329c2a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_fbd66f67-97c3-4df3-a4e9-cc49a48d4cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_79a2c468-c719-4cbb-a5b6-254ef4c66829" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_fbd66f67-97c3-4df3-a4e9-cc49a48d4cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefits" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefits"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EmployeeBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_1cc14fbc-8441-4a61-b1f6-63a939192584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6a27a4e1-6923-4434-8ff7-3c47e2c09b53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_1cc14fbc-8441-4a61-b1f6-63a939192584" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6a27a4e1-6923-4434-8ff7-3c47e2c09b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsTables" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_591a1303-a13e-4c99-9943-7cd4278e430a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_d975b10a-892c-448e-a9ea-eb37bdfebc64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_591a1303-a13e-4c99-9943-7cd4278e430a" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_d975b10a-892c-448e-a9ea-eb37bdfebc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_d9da4e5d-9f0f-4ffa-974e-79487356dfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_d9da4e5d-9f0f-4ffa-974e-79487356dfeb" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_21885bb5-0774-448f-be34-6153a6a0c0f3" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4f217a47-d4d7-4c20-8c87-f34f2e3f2036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4f217a47-d4d7-4c20-8c87-f34f2e3f2036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9f8296d6-e247-4ba6-9c48-90dade17ffd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_94edbb90-9d2c-466f-b344-be0d2db96c5a" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_9f8296d6-e247-4ba6-9c48-90dade17ffd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a5f356fb-cac8-4d61-8648-438805a0b070" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_8956f2f8-9452-4a0c-be4e-7904ce160d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_8956f2f8-9452-4a0c-be4e-7904ce160d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_0bdf448c-08e4-48e0-940b-249e7d947a73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_0bdf448c-08e4-48e0-940b-249e7d947a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_336e9f9a-0f67-4793-8ea5-442aef537fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_336e9f9a-0f67-4793-8ea5-442aef537fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_33b75dbb-5a5a-40d0-94b1-b412fd2853d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_33b75dbb-5a5a-40d0-94b1-b412fd2853d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ea096f82-6486-4121-9eb2-d1d5e24d5728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c3e2e79-3fbf-42b6-87fe-02b16fc03a21" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ea096f82-6486-4121-9eb2-d1d5e24d5728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EmployeeBenefitsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_fe13e706-30e7-476a-9eae-4e673319e027" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears_904e0505-84bc-4825-9f9d-86f6b724b9a7" xlink:href="shc-20210331.xsd#shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_fe13e706-30e7-476a-9eae-4e673319e027" xlink:to="loc_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears_904e0505-84bc-4825-9f9d-86f6b724b9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_fe13e706-30e7-476a-9eae-4e673319e027" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_91405c7b-3711-48e9-a6d0-794158104d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_ff035e53-4a2c-41f3-9bab-0ffcadf5c62a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_91405c7b-3711-48e9-a6d0-794158104d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_bccad299-ec20-41b0-bc0d-47e2cb9a1a57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_91405c7b-3711-48e9-a6d0-794158104d0d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_bccad299-ec20-41b0-bc0d-47e2cb9a1a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:to="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d86f0d48-acec-43e8-9457-20d09fa3e63d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d7f17712-687c-4ab4-8986-e8a3e5968422" xlink:to="loc_srt_RangeMember_d86f0d48-acec-43e8-9457-20d09fa3e63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3f058822-06b4-421a-b47a-c6e61cc0d602" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d86f0d48-acec-43e8-9457-20d09fa3e63d" xlink:to="loc_srt_MaximumMember_3f058822-06b4-421a-b47a-c6e61cc0d602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_58bd824b-8405-4362-885b-15444768270d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_3af6e620-e3c2-42fb-9d13-8cfaba46c316" xlink:href="shc-20210331.xsd#shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:to="loc_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue_3af6e620-e3c2-42fb-9d13-8cfaba46c316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_555b97d8-c4f4-4afd-976e-daab7b147074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1a1791d2-ae2e-49eb-9144-03643f224012" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_555b97d8-c4f4-4afd-976e-daab7b147074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/RelatedParties" xlink:type="simple" xlink:href="shc-20210331.xsd#RelatedParties"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/RelatedParties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b2fccfd9-ec4c-472a-8c07-d13769b32a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_278c89bc-709d-4e99-9af9-98bf69a1ee1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b2fccfd9-ec4c-472a-8c07-d13769b32a2f" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_278c89bc-709d-4e99-9af9-98bf69a1ee1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7209fb55-db6b-4029-85e8-4da2b6bb63f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_85285875-4b4c-4808-bb8b-a992a9cf6098" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7209fb55-db6b-4029-85e8-4da2b6bb63f5" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_85285875-4b4c-4808-bb8b-a992a9cf6098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLossTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_858cf54c-65d1-43ca-9f29-aa0b8018f0de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6493bd5d-df1a-4bf9-a8e6-56a5971dbe50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_858cf54c-65d1-43ca-9f29-aa0b8018f0de" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6493bd5d-df1a-4bf9-a8e6-56a5971dbe50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#OtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1f4c56de-a550-43c4-82e5-2a789acda433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1f4c56de-a550-43c4-82e5-2a789acda433" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7e4ab0b8-51b8-4f8c-aaa4-c437ea2deb20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e46fb8bb-a1b4-4c2e-8a54-bc47a0377714" xlink:to="loc_us-gaap_EquityComponentDomain_7e4ab0b8-51b8-4f8c-aaa4-c437ea2deb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7e4ab0b8-51b8-4f8c-aaa4-c437ea2deb20" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e00def66-e01a-4a8a-8b82-36527f3c747b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_e00def66-e01a-4a8a-8b82-36527f3c747b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_829f6d23-1742-4eaa-89f4-623648af0c12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_829f6d23-1742-4eaa-89f4-623648af0c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_14a8c360-d4ac-49d8-a872-9433f6bb3e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41511607-7e8a-4e76-a425-e41ca519cb3d" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_14a8c360-d4ac-49d8-a872-9433f6bb3e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_61bff41b-c11a-4dd2-8e60-fa1d84cdb9b8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f0e8cbc-d19b-4594-9fe2-173de5278c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9f0e8cbc-d19b-4594-9fe2-173de5278c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f3c260ac-b7ca-4a0c-913b-07fc628b915d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f3c260ac-b7ca-4a0c-913b-07fc628b915d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_224e7c59-6c62-488e-984c-7dc7e38cde06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_224e7c59-6c62-488e-984c-7dc7e38cde06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d9e77d65-9867-44a5-8691-1f686311b217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d9e77d65-9867-44a5-8691-1f686311b217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_91c8dba7-62ac-4849-9493-b42df75462c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0333617b-ff69-41a7-b6a8-d467a84b0806" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_91c8dba7-62ac-4849-9493-b42df75462c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4e8c90b7-ec7a-407e-8961-282dea1dd047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7dc3dc32-23b6-40d6-b94c-cbe1795ad379" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4e8c90b7-ec7a-407e-8961-282dea1dd047" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7dc3dc32-23b6-40d6-b94c-cbe1795ad379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e584820-c664-482c-9583-42aad3d18a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_8641cfe3-a492-4c23-901c-af813b28f2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e584820-c664-482c-9583-42aad3d18a6b" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_8641cfe3-a492-4c23-901c-af813b28f2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f15ac9f9-93f5-4031-ade1-ddb07c635a75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2e584820-c664-482c-9583-42aad3d18a6b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f15ac9f9-93f5-4031-ade1-ddb07c635a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e3af4175-9849-4efd-894f-de65ff544b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e3af4175-9849-4efd-894f-de65ff544b05" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4a260ad8-6868-4b11-89d1-d25a596abc50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_2906eba5-c576-4b91-9fdb-e86b00c35dc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:to="loc_us-gaap_RestrictedStockMember_2906eba5-c576-4b91-9fdb-e86b00c35dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0820d8f3-22d4-44af-81e3-363e7ee07823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0820d8f3-22d4-44af-81e3-363e7ee07823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_044bc001-ba4e-4b33-a62b-a64d32b4763c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e68b395e-3581-4643-9b12-4e8ba53e5d2d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_044bc001-ba4e-4b33-a62b-a64d32b4763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a8404989-8c6a-4697-801d-9552c3418d00" xlink:to="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB1Member_99e02f64-ed92-412b-9363-55acf7a3f078" xlink:href="shc-20210331.xsd#shc_PreIPOB1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:to="loc_shc_PreIPOB1Member_99e02f64-ed92-412b-9363-55acf7a3f078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB2Member_ef7054b3-524e-4811-924b-7d96f5997e52" xlink:href="shc-20210331.xsd#shc_PreIPOB2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6aaeb112-5269-4159-a76c-aa972b42d0d3" xlink:to="loc_shc_PreIPOB2Member_ef7054b3-524e-4811-924b-7d96f5997e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_cbb82d08-3a72-4e2b-bbac-2299d334eb67" xlink:to="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_13c0d6ce-fcff-40b6-b90f-0b12b32e38d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_13c0d6ce-fcff-40b6-b90f-0b12b32e38d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97f4b686-bf1c-417a-bb2a-285593fefae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_97f4b686-bf1c-417a-bb2a-285593fefae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_d456df4e-de68-43e5-8ef7-2fb76c746a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_d456df4e-de68-43e5-8ef7-2fb76c746a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ShareBasedPaymentArrangementTrancheFourMember_6986f26a-bcd8-41f1-b3ea-3cd9f76f23f2" xlink:href="shc-20210331.xsd#shc_ShareBasedPaymentArrangementTrancheFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_shc_ShareBasedPaymentArrangementTrancheFourMember_6986f26a-bcd8-41f1-b3ea-3cd9f76f23f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ShareBasedPaymentArrangementTrancheFiveMember_d1be054a-3780-48b1-a0b9-ce366308f22a" xlink:href="shc-20210331.xsd#shc_ShareBasedPaymentArrangementTrancheFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_22eee5b9-ffa3-47a7-a052-63dde308b53e" xlink:to="loc_shc_ShareBasedPaymentArrangementTrancheFiveMember_d1be054a-3780-48b1-a0b9-ce366308f22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_74315127-af2a-4fd7-9cfa-3e4d1667d7a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_52ba72cf-bc79-41ef-9579-5d82d5a19949" xlink:to="loc_us-gaap_PlanNameDomain_74315127-af2a-4fd7-9cfa-3e4d1667d7a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_A2020OmnibusIncentivePlanMember_d6c1568f-867d-437e-9198-d0783ed7a1f0" xlink:href="shc-20210331.xsd#shc_A2020OmnibusIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_74315127-af2a-4fd7-9cfa-3e4d1667d7a0" xlink:to="loc_shc_A2020OmnibusIncentivePlanMember_d6c1568f-867d-437e-9198-d0783ed7a1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_46de337d-3778-42ad-a706-1162970bd524" xlink:to="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_11e413bb-db67-47aa-8cdf-4bcbd43dd19e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:to="loc_srt_MinimumMember_11e413bb-db67-47aa-8cdf-4bcbd43dd19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a61e79ed-c9ef-4fc2-8fbc-1fe6e6e623db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_98fd9535-c71e-405b-b8ac-45c91aa4dddf" xlink:to="loc_srt_MaximumMember_a61e79ed-c9ef-4fc2-8fbc-1fe6e6e623db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6b29b392-0d2b-41d6-8cbc-ca7c12292c0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e517924b-6a07-43cf-87f5-51a72c706fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e517924b-6a07-43cf-87f5-51a72c706fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7a7a4e25-3472-4d6b-9462-1c7387215d83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7a7a4e25-3472-4d6b-9462-1c7387215d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CashProceedsToSponsorsRatioToInvestedCapital_fde8f52b-338a-443c-bf91-3693fda24a78" xlink:href="shc-20210331.xsd#shc_CashProceedsToSponsorsRatioToInvestedCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_shc_CashProceedsToSponsorsRatioToInvestedCapital_fde8f52b-338a-443c-bf91-3693fda24a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_47da4fa3-9468-4297-a870-f2460faa65c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_47da4fa3-9468-4297-a870-f2460faa65c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bd161fc7-9ef2-498d-b5fd-66d30c851a6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_605efbca-375f-4770-a622-a17a9c053d9f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bd161fc7-9ef2-498d-b5fd-66d30c851a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationPreIPOAwardsClassB1andB2Details"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a691bc18-8ef3-4721-b914-494c7a6c6bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a691bc18-8ef3-4721-b914-494c7a6c6bea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:to="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4a08ee-400d-4bae-bc1f-2fe30d3c5762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a0d24d61-e8be-46c4-84f1-edcb9462cbb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4a08ee-400d-4bae-bc1f-2fe30d3c5762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_5ebb5927-2bd3-45de-9de3-e97c33546f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9c4a08ee-400d-4bae-bc1f-2fe30d3c5762" xlink:to="loc_us-gaap_RestrictedStockMember_5ebb5927-2bd3-45de-9de3-e97c33546f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6f7f5a94-2782-40d8-b1a8-13151f997d6f" xlink:to="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB1Member_14384d18-0fde-4666-b1d5-de0adddd5444" xlink:href="shc-20210331.xsd#shc_PreIPOB1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:to="loc_shc_PreIPOB1Member_14384d18-0fde-4666-b1d5-de0adddd5444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PreIPOB2Member_a5dcf212-16c1-40ff-9694-cdcf0d1dea27" xlink:href="shc-20210331.xsd#shc_PreIPOB2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3c9b42f8-c8ef-4861-8bdc-1030a78d8f05" xlink:to="loc_shc_PreIPOB2Member_a5dcf212-16c1-40ff-9694-cdcf0d1dea27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b3ede8-2299-4bad-b935-25cfe9665159" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8dc379b2-dcd1-46ba-afca-4ee4f8b9da74" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b3ede8-2299-4bad-b935-25cfe9665159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f7b3ede8-2299-4bad-b935-25cfe9665159" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7612266-8af6-4bd8-9273-63b69c85a2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7612266-8af6-4bd8-9273-63b69c85a2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5ed9b5da-66af-479d-b759-f19dbd85e949" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_5ed9b5da-66af-479d-b759-f19dbd85e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9236ceff-49a2-44c5-abbc-a6ac82745b19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_9236ceff-49a2-44c5-abbc-a6ac82745b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e59e2d4d-4bb2-4e2d-9d35-7e1c1e61167e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7c5d2a63-3f22-47f4-b251-4a08fa34a957" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e59e2d4d-4bb2-4e2d-9d35-7e1c1e61167e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_277ad945-9475-4c2c-941b-823818cb3561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_277ad945-9475-4c2c-941b-823818cb3561" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:to="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae417562-b633-4099-a786-f14251c549a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5adb08cb-221e-4886-a607-2a9e844b056e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae417562-b633-4099-a786-f14251c549a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_edb511a2-6b33-4b85-a541-841c2a5348e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae417562-b633-4099-a786-f14251c549a9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_edb511a2-6b33-4b85-a541-841c2a5348e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35d27814-b7d0-4ac9-8c76-319ce734a127" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_47856eb1-956b-459f-8323-2a9b65e43eb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_47856eb1-956b-459f-8323-2a9b65e43eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_109309de-33cb-41a3-ba78-8ae906480150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_109309de-33cb-41a3-ba78-8ae906480150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_a73d7766-c3ac-43b5-b5ea-dbfad3d8acba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_a73d7766-c3ac-43b5-b5ea-dbfad3d8acba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_44a71ae9-fb18-457a-bb9d-e44c99ec30c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_44a71ae9-fb18-457a-bb9d-e44c99ec30c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4055829d-1e74-473b-a441-35f542f2b4c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_c77c5897-37de-4c52-a4d4-224aa98c4eef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4055829d-1e74-473b-a441-35f542f2b4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8e92e850-f784-4990-8f67-ea96a41d5a4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_55fb290f-7c3e-4f45-b199-fd3169466bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_55fb290f-7c3e-4f45-b199-fd3169466bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19fdf025-5e0b-44e4-858b-62ef9fc374ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_19fdf025-5e0b-44e4-858b-62ef9fc374ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0d058213-0938-41a9-9139-4c3e4473f6ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_0d058213-0938-41a9-9139-4c3e4473f6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2a84300a-19ab-4fa0-9d1f-971e8f69fea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2a84300a-19ab-4fa0-9d1f-971e8f69fea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f8588a78-a3b7-4d60-8c17-c24b37dc84d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_cef0a446-dc91-4bcc-acd4-eae20776e40d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_f8588a78-a3b7-4d60-8c17-c24b37dc84d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#ShareBasedCompensationRSUsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/ShareBasedCompensationRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11f24753-74b7-4e39-b0ae-537a4a4952bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11f24753-74b7-4e39-b0ae-537a4a4952bb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:to="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c00614a0-1b58-46cc-9983-44c2b54950f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f8ff5e3d-eeb6-4e82-838d-cc6242d73a58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c00614a0-1b58-46cc-9983-44c2b54950f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_441774f4-76e4-4357-bab1-55c04fd25726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c00614a0-1b58-46cc-9983-44c2b54950f9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_441774f4-76e4-4357-bab1-55c04fd25726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_392b5563-95fd-47d5-8a3a-326781118cb2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5483d420-ba6f-4fbb-983b-52f26f258a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5483d420-ba6f-4fbb-983b-52f26f258a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eb014c3-e0c1-4410-8560-314df0b3eca9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eb014c3-e0c1-4410-8560-314df0b3eca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_dffbe6f9-24d1-4529-896e-9c188bf3010c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_dffbe6f9-24d1-4529-896e-9c188bf3010c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d2adc45-400a-4560-811c-b37507df89be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2d2adc45-400a-4560-811c-b37507df89be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7d8b14fe-8490-4522-8fe0-1edee5680c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c3581076-a5f4-425b-98d0-0634a15f7ccc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7d8b14fe-8490-4522-8fe0-1edee5680c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27769f7f-8a27-443a-a178-1bb2f571ad4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8601fcfe-1be7-48d5-8df2-987c3e439c77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8601fcfe-1be7-48d5-8df2-987c3e439c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23164ab1-28e0-4023-8672-942893e3f1b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_23164ab1-28e0-4023-8672-942893e3f1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_214c30a6-a5eb-4ae7-80dc-9d672f14b0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_214c30a6-a5eb-4ae7-80dc-9d672f14b0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5e9a8266-02fa-441e-9b2c-c2cc4cc7e734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5e9a8266-02fa-441e-9b2c-c2cc4cc7e734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_264b41af-471d-4dab-8938-339633a2a990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_a6d87b83-e572-4249-943b-76042862a4d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_264b41af-471d-4dab-8938-339633a2a990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShare"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EarningsLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f2f0bc7b-400c-4149-9388-bef953dad897" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_f2660ac9-962c-41c2-84ea-40e852864202" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f2f0bc7b-400c-4149-9388-bef953dad897" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_f2660ac9-962c-41c2-84ea-40e852864202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShareTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EarningsLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2be4e4dd-f2ac-4d9c-94de-da9d1d60a97a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9ff9219c-ee19-456f-b4f9-8e656e69ecad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2be4e4dd-f2ac-4d9c-94de-da9d1d60a97a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9ff9219c-ee19-456f-b4f9-8e656e69ecad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#EarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/EarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_dd85cd43-0c62-40d9-8727-7672a2bb1698" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dd85cd43-0c62-40d9-8727-7672a2bb1698" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9bc0a768-745d-4b56-8e37-e0427348ea66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_ProfitLoss_9bc0a768-745d-4b56-8e37-e0427348ea66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c8ed7c3d-37d6-4c91-be35-d93bcfffb8ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c8ed7c3d-37d6-4c91-be35-d93bcfffb8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_20ff37d6-0288-4734-baf1-564399a4d641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_20ff37d6-0288-4734-baf1-564399a4d641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_f936f0b0-2aa8-4821-8c21-37b685527591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_f936f0b0-2aa8-4821-8c21-37b685527591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_38a76987-df5e-43a7-befa-edfdc30bd4c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_38a76987-df5e-43a7-befa-edfdc30bd4c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_96956169-27af-4975-914c-ecae6f7bdc20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_96956169-27af-4975-914c-ecae6f7bdc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_570f74b6-ffb1-485a-b36d-4ad98f0aec88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_570f74b6-ffb1-485a-b36d-4ad98f0aec88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_90592bb8-3ab6-49fc-a27a-a4a9b1533001" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_570f74b6-ffb1-485a-b36d-4ad98f0aec88" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_90592bb8-3ab6-49fc-a27a-a4a9b1533001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ea43c828-ad18-46cf-98ae-7f22f043acf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_570f74b6-ffb1-485a-b36d-4ad98f0aec88" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ea43c828-ad18-46cf-98ae-7f22f043acf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_768764bb-444b-4a44-90f2-41c25b7e93bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_570f74b6-ffb1-485a-b36d-4ad98f0aec88" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_768764bb-444b-4a44-90f2-41c25b7e93bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ee863e17-8db8-419d-93b5-f69ec297da39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_74d37927-fb73-4e93-b149-80f8c03697da" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ee863e17-8db8-419d-93b5-f69ec297da39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6485d38b-d414-4b1e-ac2d-925776b81c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ee863e17-8db8-419d-93b5-f69ec297da39" xlink:to="loc_us-gaap_EarningsPerShareBasic_6485d38b-d414-4b1e-ac2d-925776b81c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7169eea1-80c6-4178-bdaf-1855f1c73c39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ee863e17-8db8-419d-93b5-f69ec297da39" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7169eea1-80c6-4178-bdaf-1855f1c73c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_dd85cd43-0c62-40d9-8727-7672a2bb1698" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:to="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4d55cd5d-ee8b-465f-ae65-c2e46cdf737b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_b9e1d15c-e594-491f-be94-ad06d14c3df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:to="loc_us-gaap_EmployeeStockOptionMember_b9e1d15c-e594-491f-be94-ad06d14c3df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c9b9301d-e6ac-44a4-bbac-b614afb78feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32146d7a-fd42-4746-9aa4-ace093f86e95" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c9b9301d-e6ac-44a4-bbac-b614afb78feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:to="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6dc3b33f-7873-47c4-a05d-1bbccf3c1293" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_d98fcb3f-5a7f-4f25-bcee-0636fa0bdd4b" xlink:to="loc_us-gaap_PlanNameDomain_6dc3b33f-7873-47c4-a05d-1bbccf3c1293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_A2020OmnibusIncentivePlanMember_831a8566-7150-4698-a03e-3445eb424f0c" xlink:href="shc-20210331.xsd#shc_A2020OmnibusIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_6dc3b33f-7873-47c4-a05d-1bbccf3c1293" xlink:to="loc_shc_A2020OmnibusIncentivePlanMember_831a8566-7150-4698-a03e-3445eb424f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0404a843-3bb1-4773-9c0a-9e039438d7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1acaed34-664e-4908-9cf7-ddd4adb43b0b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0404a843-3bb1-4773-9c0a-9e039438d7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_22299748-19ab-42f9-8692-b1fcc4ea440e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0404a843-3bb1-4773-9c0a-9e039438d7e5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_22299748-19ab-42f9-8692-b1fcc4ea440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="shc-20210331.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a628d056-81ad-4a0b-a39a-94ba5e2049eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_74e45dc9-580e-496e-af6a-1113c7c4424a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a628d056-81ad-4a0b-a39a-94ba5e2049eb" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_74e45dc9-580e-496e-af6a-1113c7c4424a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5af63297-d904-4e9d-bc9a-e157717d0075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5af63297-d904-4e9d-bc9a-e157717d0075" xlink:to="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesByNatureAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyNatureDomain_996be4b2-96d5-41cf-89f8-4e5f814de536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesByNatureAxis_5827e589-90fd-4cce-b4f2-8ea06314daaa" xlink:to="loc_us-gaap_GainContingencyNatureDomain_996be4b2-96d5-41cf-89f8-4e5f814de536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PositiveOutcomeOfLitigationMember_27f13ae5-74b1-4434-a8f4-a9da4fef10d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PositiveOutcomeOfLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingencyNatureDomain_996be4b2-96d5-41cf-89f8-4e5f814de536" xlink:to="loc_us-gaap_PositiveOutcomeOfLitigationMember_27f13ae5-74b1-4434-a8f4-a9da4fef10d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_786e6d0b-e659-4ecf-9313-c2093d752e70" xlink:to="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_bab11e95-a604-4785-919f-029ecb0562f3" xlink:href="shc-20210331.xsd#shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:to="loc_shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember_bab11e95-a604-4785-919f-029ecb0562f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_EthyleneOxideTortLitigationIllinoisMember_be63d8bb-ddda-4849-b39c-0ef78470ddd8" xlink:href="shc-20210331.xsd#shc_EthyleneOxideTortLitigationIllinoisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:to="loc_shc_EthyleneOxideTortLitigationIllinoisMember_be63d8bb-ddda-4849-b39c-0ef78470ddd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_EthyleneOxideTortLitigationGeorgiaMember_9769ccf2-4d22-4ed8-bad6-4780ad008c46" xlink:href="shc-20210331.xsd#shc_EthyleneOxideTortLitigationGeorgiaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f2a31afb-8eda-4abb-84e1-202067c0a5ee" xlink:to="loc_shc_EthyleneOxideTortLitigationGeorgiaMember_9769ccf2-4d22-4ed8-bad6-4780ad008c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_edaee1a2-69b8-4998-80b5-d3c298412133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_63ae3e5d-1d49-4df5-93a1-d9a0dad96500" xlink:to="loc_us-gaap_LitigationStatusDomain_edaee1a2-69b8-4998-80b5-d3c298412133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_76f75681-c632-4649-be53-af9be330c89f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_edaee1a2-69b8-4998-80b5-d3c298412133" xlink:to="loc_us-gaap_PendingLitigationMember_76f75681-c632-4649-be53-af9be330c89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesTable_b6433dd1-9031-4505-a4db-1d6e15cbed90" xlink:to="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_a469bd86-7b2d-468b-844a-97fff6c474d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_a469bd86-7b2d-468b-844a-97fff6c474d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_GainContingencyPeriodOfBusinessInterruption_9553893a-3db1-40cb-8e1c-28e9dddfeb93" xlink:href="shc-20210331.xsd#shc_GainContingencyPeriodOfBusinessInterruption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_GainContingencyPeriodOfBusinessInterruption_9553893a-3db1-40cb-8e1c-28e9dddfeb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_20ebf7ac-8b14-49b9-9e47-5ca8604b3b27" xlink:href="shc-20210331.xsd#shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest_20ebf7ac-8b14-49b9-9e47-5ca8604b3b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_df5a1706-473a-4a17-b617-9db3c11d6c7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_df5a1706-473a-4a17-b617-9db3c11d6c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_3faff20e-1fd6-4b43-858c-9f0396ea0805" xlink:href="shc-20210331.xsd#shc_LitigationSettlementCostsAssessedAndAwardedInFavor"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LitigationSettlementCostsAssessedAndAwardedInFavor_3faff20e-1fd6-4b43-858c-9f0396ea0805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_4a0368df-a094-46c0-8c86-76596f5d1160" xlink:href="shc-20210331.xsd#shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor_4a0368df-a094-46c0-8c86-76596f5d1160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e101ae9e-f69e-415f-831b-ce63c3781aa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_e101ae9e-f69e-415f-831b-ce63c3781aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b289342c-f780-4773-b6f0-897b228b3a20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_b289342c-f780-4773-b6f0-897b228b3a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_44c06e7e-d849-4fd8-a847-a6826995f55d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_44c06e7e-d849-4fd8-a847-a6826995f55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PercentOfReductionInResidentialPropertyValueAssessment_1e624c73-5934-4937-86e0-6704f787fc11" xlink:href="shc-20210331.xsd#shc_PercentOfReductionInResidentialPropertyValueAssessment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_PercentOfReductionInResidentialPropertyValueAssessment_1e624c73-5934-4937-86e0-6704f787fc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_035b700f-794a-439a-b2d2-db23efcfca6c" xlink:href="shc-20210331.xsd#shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence_035b700f-794a-439a-b2d2-db23efcfca6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability_e0adac6d-6de4-483a-8a55-cf5d5c6039f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GainContingenciesLineItems_7fc9b0f1-a19a-41d6-9faf-8190ffaae1c0" xlink:to="loc_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability_e0adac6d-6de4-483a-8a55-cf5d5c6039f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRisk"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68c99712-27d9-43ad-b81c-44da670b8db0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90539fba-0223-4dd4-8b6e-80c20721463e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_68c99712-27d9-43ad-b81c-44da670b8db0" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_90539fba-0223-4dd4-8b6e-80c20721463e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70666e4d-8d92-474b-9208-848b78640d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_59378645-78c0-4788-90a1-97b50efce4be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70666e4d-8d92-474b-9208-848b78640d0b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_59378645-78c0-4788-90a1-97b50efce4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_317e0e56-263b-4606-8fb7-a5c59e0ac5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70666e4d-8d92-474b-9208-848b78640d0b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_317e0e56-263b-4606-8fb7-a5c59e0ac5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_952b14d4-f8bd-4c63-8de0-d6a5a8fdd67e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_70666e4d-8d92-474b-9208-848b78640d0b" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_952b14d4-f8bd-4c63-8de0-d6a5a8fdd67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2a927090-57be-4a97-a363-e09e6128e02e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2a927090-57be-4a97-a363-e09e6128e02e" xlink:to="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2dd5cc1e-d560-422f-bc3c-8905aebab31b" xlink:to="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4d634a66-94a0-4d16-a8eb-8734cc97ec72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_4d634a66-94a0-4d16-a8eb-8734cc97ec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d753f3f6-c985-4195-9eab-99cc31b240f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_383c4b16-9aa1-4bd6-bf59-ff5f6cae7046" xlink:to="loc_us-gaap_NondesignatedMember_d753f3f6-c985-4195-9eab-99cc31b240f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_df3fdfef-d94e-4b80-b3be-a6091c5e1a74" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_cfb54820-e837-434c-bc82-86a785fdad98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_us-gaap_InterestRateSwapMember_cfb54820-e837-434c-bc82-86a785fdad98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_8af7ef4f-0093-40cc-90b7-04529f54f1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_us-gaap_InterestRateCapMember_8af7ef4f-0093-40cc-90b7-04529f54f1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapOctober2017Member_cd27be81-bdde-42c2-87f2-c4e15c13f2c0" xlink:href="shc-20210331.xsd#shc_InterestRateCapOctober2017Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCapOctober2017Member_cd27be81-bdde-42c2-87f2-c4e15c13f2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapJune2020Member_96bd048d-e03d-4709-ac4b-2b46dc2ab5ae" xlink:href="shc-20210331.xsd#shc_InterestRateCapJune2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCapJune2020Member_96bd048d-e03d-4709-ac4b-2b46dc2ab5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCap1Member_16edfc80-45c5-4134-999c-f33d62f5bb19" xlink:href="shc-20210331.xsd#shc_InterestRateCap1Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCap1Member_16edfc80-45c5-4134-999c-f33d62f5bb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_InterestRateCapFebruary2021Member_20ca1252-054c-4aff-b06b-2a769dfa20e6" xlink:href="shc-20210331.xsd#shc_InterestRateCapFebruary2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_shc_InterestRateCapFebruary2021Member_20ca1252-054c-4aff-b06b-2a769dfa20e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e8d4087b-26c6-4dad-b31f-1e4814345bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c35e6fab-f56e-4f9b-88f1-94d7347f22c6" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e8d4087b-26c6-4dad-b31f-1e4814345bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1e6f60f8-35ce-4e6a-a120-7fc9f0f9cdef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_c1c55123-85e0-4a91-9948-c168d36a3e87" xlink:to="loc_us-gaap_VariableRateDomain_1e6f60f8-35ce-4e6a-a120-7fc9f0f9cdef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_edde1875-c3b7-4bbc-aed5-fd5cfb4fde99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1e6f60f8-35ce-4e6a-a120-7fc9f0f9cdef" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_edde1875-c3b7-4bbc-aed5-fd5cfb4fde99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4adc9b83-8bc3-4c87-8e91-e8a015351aae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_d24e3d8d-15af-43db-9586-f4658a122bc5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4adc9b83-8bc3-4c87-8e91-e8a015351aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_ac1b0efc-55fb-4dd7-b874-f830e9762b38" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4adc9b83-8bc3-4c87-8e91-e8a015351aae" xlink:to="loc_srt_ScenarioForecastMember_ac1b0efc-55fb-4dd7-b874-f830e9762b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4f84a693-5c72-4e6a-92ae-b70271fd7144" xlink:to="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_1c61660d-b6da-47e7-8b04-7cc00fb8cb89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNumberOfInstrumentsHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeNumberOfInstrumentsHeld_1c61660d-b6da-47e7-8b04-7cc00fb8cb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7a4b0520-ee37-40e5-87bb-accf3678415c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7a4b0520-ee37-40e5-87bb-accf3678415c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DerivativeOptionPremium_6c6a47a9-59ac-4eac-8703-dcb03951439b" xlink:href="shc-20210331.xsd#shc_DerivativeOptionPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_shc_DerivativeOptionPremium_6c6a47a9-59ac-4eac-8703-dcb03951439b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_71cf0637-3a59-423a-9c2c-bc19cb05759b" xlink:href="shc-20210331.xsd#shc_PercentOfBorrowingLimitationDueToCashFlowExposure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_shc_PercentOfBorrowingLimitationDueToCashFlowExposure_71cf0637-3a59-423a-9c2c-bc19cb05759b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_d690f723-94dd-4e9b-abb0-e9d5e015c281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_d690f723-94dd-4e9b-abb0-e9d5e015c281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_DerivativeNumberOfInstrumentsAmended_9320ddfb-0af6-4019-8699-182ad8b7356e" xlink:href="shc-20210331.xsd#shc_DerivativeNumberOfInstrumentsAmended"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_shc_DerivativeNumberOfInstrumentsAmended_9320ddfb-0af6-4019-8699-182ad8b7356e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_b3e192ab-4a37-4b7c-9a95-80d7ca370597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_b3e192ab-4a37-4b7c-9a95-80d7ca370597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c44064c6-46b4-48f4-92fe-ceede8a4282b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_c44064c6-46b4-48f4-92fe-ceede8a4282b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b49a942d-5f8e-4f29-a1c6-bcc15de89970" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9df9a3e8-11df-4f43-b7d1-6b8b1f5e5b86" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b49a942d-5f8e-4f29-a1c6-bcc15de89970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_96c7775c-b770-4a37-ae5c-eba2d92b9b8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_96c7775c-b770-4a37-ae5c-eba2d92b9b8e" xlink:to="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:to="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_6146123d-5975-4029-8e26-486265466197" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_99d193aa-a9ae-4163-a6b6-9e1b695000a1" xlink:to="loc_us-gaap_HedgingDesignationDomain_6146123d-5975-4029-8e26-486265466197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_af339b22-80b1-4a16-93a9-380357772463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_6146123d-5975-4029-8e26-486265466197" xlink:to="loc_us-gaap_NondesignatedMember_af339b22-80b1-4a16-93a9-380357772463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4d0bfe89-81d7-4b6b-b22d-556e9b7de795" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_c70f21c5-fc70-4ffe-b426-1e824f039ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:to="loc_us-gaap_InterestRateCapMember_c70f21c5-fc70-4ffe-b426-1e824f039ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_7824bbca-4db3-4d81-8775-07ced73568e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b51ae27c-1f32-4924-bcb5-e2cbe6c1db1c" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_7824bbca-4db3-4d81-8775-07ced73568e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2d244c76-1f0d-4119-af58-f4933df5122c" xlink:to="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b0424cbe-022a-4bd9-9b5c-3399de7056b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b0424cbe-022a-4bd9-9b5c-3399de7056b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fc2b7a5f-da1e-4fa8-96a3-c0c7dfd90873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_fc2b7a5f-da1e-4fa8-96a3-c0c7dfd90873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d1bcda1f-3a48-4f42-a534-9825d20782e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_4da75402-44e5-4d56-802f-1755fdf6bb64" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d1bcda1f-3a48-4f42-a534-9825d20782e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c93d4a23-c309-4003-8caa-beadfdc5795d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c93d4a23-c309-4003-8caa-beadfdc5795d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_fa785dfd-3926-4667-aca7-0a3db874e523" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_ed70e372-1801-4fcf-9a80-7b5767823f8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:to="loc_us-gaap_InterestRateCapMember_ed70e372-1801-4fcf-9a80-7b5767823f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_43fa6119-194a-477b-85b2-da12d93c63d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_43fa6119-194a-477b-85b2-da12d93c63d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_931ee079-43c6-417f-a41c-a3eb48656038" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_48406e2a-7a97-45c0-90d3-0213ebfae2de" xlink:to="loc_us-gaap_ForeignExchangeContractMember_931ee079-43c6-417f-a41c-a3eb48656038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f950e905-e47f-4a05-beff-d06079b12714" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_48b2c0ed-70e7-452a-874d-e94827f15c6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:to="loc_us-gaap_InterestExpenseMember_48b2c0ed-70e7-452a-874d-e94827f15c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1a2d76ef-2f67-469e-a34b-167536ba6f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_1a2d76ef-2f67-469e-a34b-167536ba6f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyGainLossMember_ae0dcf54-a147-45ee-9c00-e325c8db5bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyGainLossMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ede63bf6-ce59-4b00-95df-0b351c1630cf" xlink:to="loc_us-gaap_ForeignCurrencyGainLossMember_ae0dcf54-a147-45ee-9c00-e325c8db5bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_362a7996-0353-4edd-804f-b6066f348f20" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_cc3035e1-97b0-452d-8651-7d45ac95cd8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_cc3035e1-97b0-452d-8651-7d45ac95cd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c46dc341-37ec-4155-b9d0-b47f4e83296d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_caa7dc43-6e38-48db-9e8a-4711b4751ada" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_c46dc341-37ec-4155-b9d0-b47f4e83296d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b7a52df-2dcb-4112-9a03-544a7466d4c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5b7a52df-2dcb-4112-9a03-544a7466d4c7" xlink:to="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ccdcfdb1-3f68-46fe-bb21-88262d60a9c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_16b3d290-1ee3-4a80-b63a-39e1637545d7" xlink:to="loc_us-gaap_HedgingDesignationDomain_ccdcfdb1-3f68-46fe-bb21-88262d60a9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ce9f51a4-08d5-45ee-8d98-272413160794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ccdcfdb1-3f68-46fe-bb21-88262d60a9c3" xlink:to="loc_us-gaap_NondesignatedMember_ce9f51a4-08d5-45ee-8d98-272413160794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_fe8ddabf-2700-46e1-a407-b38f71aea98d" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf62d1ec-e469-4d13-88fa-7e0cb963c896" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf62d1ec-e469-4d13-88fa-7e0cb963c896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7e20fc7a-da1a-47a1-acaa-4e897d1e1d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_b99c70a6-bd64-4fb2-90b5-066a4a27b41b" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_7e20fc7a-da1a-47a1-acaa-4e897d1e1d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9266cd1a-5ba6-47e5-98b3-1d8c618f3752" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d1152754-8001-4000-99db-fb1f17f4b6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:to="loc_us-gaap_InterestRateCapMember_d1152754-8001-4000-99db-fb1f17f4b6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_d649ef9d-22a3-4e4e-a528-a2c814ee55e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFinancialInstrumentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4f2d101a-5ba7-436d-bd22-45cf893e63c1" xlink:to="loc_us-gaap_EmbeddedDerivativeFinancialInstrumentsMember_d649ef9d-22a3-4e4e-a528-a2c814ee55e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_75cf61ee-6c53-4a26-a7a7-7bef6b514bea" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_TermLoanDue2026Member_9b126a87-019a-4a2e-968f-416d0ae97a1b" xlink:href="shc-20210331.xsd#shc_TermLoanDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_TermLoanDue2026Member_9b126a87-019a-4a2e-968f-416d0ae97a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2026Member_3f8c6300-292f-4271-b136-a11dbb1b6d1c" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_SeniorNotesDue2026Member_3f8c6300-292f-4271-b136-a11dbb1b6d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SeniorNotesDue2027Member_eeafeff5-b9d1-463f-a83c-8adc0ccca8b0" xlink:href="shc-20210331.xsd#shc_SeniorNotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_SeniorNotesDue2027Member_eeafeff5-b9d1-463f-a83c-8adc0ccca8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_OtherLongTermDebtMember_d063cd60-deb1-4641-9a14-5cd748289f63" xlink:href="shc-20210331.xsd#shc_OtherLongTermDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_OtherLongTermDebtMember_d063cd60-deb1-4641-9a14-5cd748289f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_FinanceLeaseLiabilityMember_cd8cae3a-d815-45f1-9b69-49b0f2e1b7bf" xlink:href="shc-20210331.xsd#shc_FinanceLeaseLiabilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9919929e-597f-4b23-babb-55885b9f956e" xlink:to="loc_shc_FinanceLeaseLiabilityMember_cd8cae3a-d815-45f1-9b69-49b0f2e1b7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_65b90a7f-6956-4e6a-9718-24e33a5d8b22" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fb91b9e2-6772-46da-b6cc-916f6f036eec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fb91b9e2-6772-46da-b6cc-916f6f036eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_00de6bc9-75ec-4f3c-a000-4a022cd58447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_00de6bc9-75ec-4f3c-a000-4a022cd58447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ff623bb6-9c29-41af-9a6a-54e94b76fee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0166f992-54f5-4a9f-a9af-487ca2fb4baf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ff623bb6-9c29-41af-9a6a-54e94b76fee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d86c43c-7021-44e5-84c9-238ae5e888a1" xlink:to="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_f980b4ce-1db5-4c05-ba54-8bf8ac63ebc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_f980b4ce-1db5-4c05-ba54-8bf8ac63ebc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d466e8f2-f410-41e7-a2e3-967fe8e915ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_d466e8f2-f410-41e7-a2e3-967fe8e915ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_8ca00582-7777-4c93-a4b7-b552ae919365" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_0a71a8ce-dcdb-4346-a44c-de7b6a94977d" xlink:to="loc_us-gaap_LongTermDebtFairValue_8ca00582-7777-4c93-a4b7-b552ae919365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformation" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_748d2087-fdcb-4bff-874d-b04349ef290a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_89beb2d0-6e26-42b9-bf34-8771b0bb5a24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_748d2087-fdcb-4bff-874d-b04349ef290a" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_89beb2d0-6e26-42b9-bf34-8771b0bb5a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f34b92a0-0ca4-4655-9f55-92891601700d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8ae330f1-b6be-4956-9519-b64086f4b72f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f34b92a0-0ca4-4655-9f55-92891601700d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_8ae330f1-b6be-4956-9519-b64086f4b72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_8149a499-4f71-4d4e-a858-897845f5c662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f34b92a0-0ca4-4655-9f55-92891601700d" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_8149a499-4f71-4d4e-a858-897845f5c662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c1ef96b0-160e-4c0f-bc69-629889f8430f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_24ddf12d-7277-416b-be4f-787e8e18c1ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c1ef96b0-160e-4c0f-bc69-629889f8430f" xlink:to="loc_us-gaap_NumberOfOperatingSegments_24ddf12d-7277-416b-be4f-787e8e18c1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_a69b93f5-5bfc-4309-9bb4-5cad23d03a25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c1ef96b0-160e-4c0f-bc69-629889f8430f" xlink:to="loc_us-gaap_NumberOfReportableSegments_a69b93f5-5bfc-4309-9bb4-5cad23d03a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c1ef96b0-160e-4c0f-bc69-629889f8430f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4a3f57c0-2e83-4f39-a57d-1e567eefdc54" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_079ac8b4-2646-4d07-82cc-14cd3fa84535" xlink:to="loc_srt_ConsolidationItemsDomain_4a3f57c0-2e83-4f39-a57d-1e567eefdc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_edb78133-f26f-4241-a12b-5fb13aabadfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_4a3f57c0-2e83-4f39-a57d-1e567eefdc54" xlink:to="loc_us-gaap_OperatingSegmentsMember_edb78133-f26f-4241-a12b-5fb13aabadfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dc5d554b-7654-4c32-ae09-79f659770f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_48648112-10e6-49c5-bb12-4613536c5997" xlink:to="loc_us-gaap_SegmentDomain_dc5d554b-7654-4c32-ae09-79f659770f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_3197aeef-c997-4f5d-aee3-764f48ba7599" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dc5d554b-7654-4c32-ae09-79f659770f09" xlink:to="loc_shc_NordionMember_3197aeef-c997-4f5d-aee3-764f48ba7599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1c62718-6bd9-4fe0-8ba4-7839ae2b1af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2b4771e3-3796-49fb-9e7c-818deead2c44" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1c62718-6bd9-4fe0-8ba4-7839ae2b1af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_f337bb75-c905-492f-bc08-422765c048fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a1c62718-6bd9-4fe0-8ba4-7839ae2b1af2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_f337bb75-c905-492f-bc08-422765c048fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d67bcc68-3110-4bb4-ad91-6bc9841569ae" xlink:to="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerOneMember_be9950e9-b421-4814-98bd-a8ac057daa4d" xlink:href="shc-20210331.xsd#shc_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:to="loc_shc_CustomerOneMember_be9950e9-b421-4814-98bd-a8ac057daa4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerTwoMember_f15c5125-22b7-4e36-9861-c33bc4f7145e" xlink:href="shc-20210331.xsd#shc_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:to="loc_shc_CustomerTwoMember_f15c5125-22b7-4e36-9861-c33bc4f7145e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CustomerThreeMember_dfda2be2-9da1-4fed-a849-7e99fe8dc94c" xlink:href="shc-20210331.xsd#shc_CustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4ebf3551-6c8a-4987-b97d-4027823139a1" xlink:to="loc_shc_CustomerThreeMember_dfda2be2-9da1-4fed-a849-7e99fe8dc94c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_dbc9b577-78ec-431d-9ab6-2039ccfefcba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6bc3216e-8cb8-47a2-a1bf-e561941da0f6" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_dbc9b577-78ec-431d-9ab6-2039ccfefcba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_eb47e21b-9b8f-4a73-a818-af6f2b591e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_dbc9b577-78ec-431d-9ab6-2039ccfefcba" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_eb47e21b-9b8f-4a73-a818-af6f2b591e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationSegmentOperatingResultsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c8e7610b-6166-4986-9506-4575a781d5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c8e7610b-6166-4986-9506-4575a781d5d2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:to="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6ce9c0e5-f464-46e4-b7bf-f6ff156f94f1" xlink:to="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b5af5381-8dfb-4b38-8847-a8869cd58ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:to="loc_us-gaap_OperatingSegmentsMember_b5af5381-8dfb-4b38-8847-a8869cd58ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_0d0d5c5b-dafb-4917-95fb-93dbe78db990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_12f2791e-14d3-4716-b700-7075000213c3" xlink:to="loc_us-gaap_IntersegmentEliminationMember_0d0d5c5b-dafb-4917-95fb-93dbe78db990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c399be1f-c368-42a4-99d2-d823825fc107" xlink:to="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SterigenicsMember_d9bdefb2-3913-485e-8f3c-fc16256b2879" xlink:href="shc-20210331.xsd#shc_SterigenicsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:to="loc_shc_SterigenicsMember_d9bdefb2-3913-485e-8f3c-fc16256b2879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NordionMember_0f4cd287-7afd-4dd0-aabb-c5afa0869262" xlink:href="shc-20210331.xsd#shc_NordionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:to="loc_shc_NordionMember_0f4cd287-7afd-4dd0-aabb-c5afa0869262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_NelsonLabsMember_6c0fa0a0-5284-4b94-a086-8f7c52d4bc1d" xlink:href="shc-20210331.xsd#shc_NelsonLabsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_fd91814e-c7a8-486a-88f2-7cdd2f2381e6" xlink:to="loc_shc_NelsonLabsMember_6c0fa0a0-5284-4b94-a086-8f7c52d4bc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ab136989-84af-4254-a73d-979a0a951e38" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f37b85f-ae63-438d-9f88-ac6ed3ef507e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2f37b85f-ae63-438d-9f88-ac6ed3ef507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SegmentIncomeLoss_5d0a9f9e-35d3-416b-93d5-c02adc34ce4e" xlink:href="shc-20210331.xsd#shc_SegmentIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_shc_SegmentIncomeLoss_5d0a9f9e-35d3-416b-93d5-c02adc34ce4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_133e73db-03a1-46f5-937e-a421407a645b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6325f9ec-95f6-4a0b-ac58-12b7abdca4cf" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_133e73db-03a1-46f5-937e-a421407a645b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails" xlink:type="simple" xlink:href="shc-20210331.xsd#SegmentInformationReconciliationofReportableSegmentAmountsDetails"/>
  <link:presentationLink xlink:role="http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_efd6dd15-e090-49cf-abbb-beaffd3f8e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_efd6dd15-e090-49cf-abbb-beaffd3f8e02" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:to="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_e7dc149c-a95e-44f4-8b74-a2ef6a340122" xlink:to="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c710cbf3-ee40-4e27-ac6d-5a1182f40191" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:to="loc_us-gaap_OperatingSegmentsMember_c710cbf3-ee40-4e27-ac6d-5a1182f40191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_f8d6f3ab-e055-43e5-875a-e84525f6e324" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3a1220c0-caac-482f-8ae0-d1d775af4adf" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_f8d6f3ab-e055-43e5-875a-e84525f6e324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_252c17d4-b9bc-43cc-9973-dff8ed116650" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_SegmentIncomeLoss_372fea79-3193-425b-8b6d-740cb8cfe3d9" xlink:href="shc-20210331.xsd#shc_SegmentIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_SegmentIncomeLoss_372fea79-3193-425b-8b6d-740cb8cfe3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_5fed2931-1aa4-40d0-8f3c-78d7796edeea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_InterestExpense_5fed2931-1aa4-40d0-8f3c-78d7796edeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fe4bcb0a-e7f8-41db-99b1-efa59a4f4da9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fe4bcb0a-e7f8-41db-99b1-efa59a4f4da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ede6a86e-330e-49ea-9173-6c36d393a33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_ShareBasedCompensation_ede6a86e-330e-49ea-9173-6c36d393a33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_df485ff6-276d-4ff9-ae6f-a017df8559e2" xlink:href="shc-20210331.xsd#shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative_df485ff6-276d-4ff9-ae6f-a017df8559e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_AcquisitionAndDivestitureRelatedChargesNet_bc04d2c7-5620-4337-9d9c-16e16463c87e" xlink:href="shc-20210331.xsd#shc_AcquisitionAndDivestitureRelatedChargesNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_AcquisitionAndDivestitureRelatedChargesNet_bc04d2c7-5620-4337-9d9c-16e16463c87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_61db37cc-0be5-4017-a6cd-57776351cd57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_OtherRestructuringCosts_61db37cc-0be5-4017-a6cd-57776351cd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_3c126ea1-0248-4797-965c-7329f5397023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_BusinessExitCosts1_3c126ea1-0248-4797-965c-7329f5397023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_830f52ed-51aa-4d0f-a51f-f9ac983a52f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_830f52ed-51aa-4d0f-a51f-f9ac983a52f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_0f64515c-9be9-460e-a6f9-a85dc295695d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_LitigationSettlementExpense_0f64515c-9be9-460e-a6f9-a85dc295695d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligationAccretionExpense_b4cae5e4-832f-4659-bd33-aa9d7e64403e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetRetirementObligationAccretionExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_AssetRetirementObligationAccretionExpense_b4cae5e4-832f-4659-bd33-aa9d7e64403e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_shc_CostAndExpensesCOVID19_477e5ef2-ea0a-4459-a529-be5980ed5df7" xlink:href="shc-20210331.xsd#shc_CostAndExpensesCOVID19"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_shc_CostAndExpensesCOVID19_477e5ef2-ea0a-4459-a529-be5980ed5df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c7700414-6674-4537-9043-2025918e5b57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_698cc9e1-c181-40f9-851c-f445f0bc4e8f" xlink:to="loc_us-gaap_NetIncomeLoss_c7700414-6674-4537-9043-2025918e5b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>shc-20210331_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 shc-20210331_g1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /?Z***
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M6'<WNS>-2]SH+1<6D(_V!_*N&^+?C&3PGX4;[*VV]NB8XC_='<_J*[V,;8U
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MKXD_#,^.VMYDU$V[VZL$4KD$G'^%>C450SY<N_@#XL@8_9I+.=>Q\S::J1_
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M;1M<K*SG8VX8('?\*9X=\)7>D>/-<UN:5&@OU C4=1R#S^5=ICC X'M2XYH
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DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>shc-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:shc="http://soterahealth.com/20210331"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="shc-20210331.xsd" xlink:type="simple"/>
    <context id="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iecb4c2bb33504c7dac5c01c3a9c0c6fb_I20210506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <instant>2021-05-06</instant>
        </period>
    </context>
    <context id="iec88d5b798444874850d669967cf4dbd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i39349c5dcb984b15b4709ccb996bd176_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cf37fb79c6347f6a6f791184ce78acf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic37232295f3745cd88694de59101666d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icee21de57c09410dbdb4e1d0c7cd6110_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9cc06bf938484e99bfe9969660cc781c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0646aca58984456ab4ccef54f837d8d7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4ed80b0cb834107bc2b1bac91b37db5_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3e003cc982634a42a6004e9be503ae52_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1ca8f2e824984cde87c9e7c8204a7b3c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc054b078af443cbabc1b10fbff2443f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1a49d2f4b5de474392adda95a3719a97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4a52e4d931ab42eca6b2d9fca0916150_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i158e9c437afe4c1ca6ee15516e6628fc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8d09c73619b54b50855522776180722f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i694c199e34a14464ac24dbb4f8527e0d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iab8dbb45af8c49bd89a1796cc04d5e70_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib2078cb13265412b8168c6ba2ce01286_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1c7318711e8e4a54ab3c245d19523efd_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1c04b66fafeb41b8a7342d389e9ffb71_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia1b332a6da764fdc81bebeb5c634fb23_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i350dd74321534f789de5af89b9350730_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i072ee7c12e4d4852a1510e20124323be_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifa6c27cc4a3a4ddfb486d016a99cf741_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibcc158f820b8436c8ea3e1ae61ebfe29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id757d153aff04337af22c39b26a4d290_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64bb877dd58241488e79dcedccea8d76_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i360689ad9dcc48f5ab2673194f9a3327_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i688702d19c584405b043c3524ab0a5af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54c2badaff0b467aa1febf6fb3e524e5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i661c83dafe2241a895b55e741b4436cf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ief05232174e44d4d869bc9c7f6fa36c9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i908b264e6f8246ac9b4d3f7cd3fcaa0a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i80b8173d43a74e3b9ec5e6fec2bb9ee4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i503e8eac77d34290ab10a01273a5714c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9ba71926882446f4820f855c07651431_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7aa7a07423da4a209024274d4083e38e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id1675ea82d0e47b5b55f50b716c600eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia09428b911314cc0ae886d99b666ca12_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibea64f5f1ac0490180fbbfae53b8d879_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94da5f943646463fac66bb29dfdd381e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie80833d87f3a475c9d5cce381fd18476_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5def62b5b7f448059d757311fe268fc9_I20210311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-11</instant>
        </period>
    </context>
    <context id="ib950bce5fb424f4ebc039f76379610fc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i90ff278d560040b986f61d550e890c69_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">shc:SubsidiaryTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1fd7503543e240e4b13682cf4007a74f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia271e03429544e7c88a278c25dc1246e_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">shc:UnnamedEBeamJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ic4e845ef858f4d2cbf8e34065ae83f9d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i81508df42a2c41ae99039fb5550d92c7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3e40cba4c0a04e228634ff48d54110b0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ide0e38a11c4d4065969f8f8fe57c3865_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1abe226e0f964cdda9aa352b55dd6908_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i73baed61d2934ccca236804cc00d4746_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i538e36e8cbfb418baadf68b21ca433e2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58d1ac8931a14b9689bbd93ab687cb9b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i549e8b5be7d14c24ac0bd3a892096184_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i604e6f09c9514a4c92c9b88b13bbfd5e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie44a1e9c62eb48bb91f1032b3dd61367_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i74f51f9869464d0992847aa161928404_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i42a63ee00aca4032b612c80c0fd3c9c1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i023f2492fe3d4a8d8430927b2fd77519_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2c6aca23a9ae486a9eb582a53a5bb38b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iffacfedf64e04109b53607b1570fdc92_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i842c27cb13e145de9f7c92ab5ea4f054_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieabfd129bc4847e8afad78a76824be56_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9e574934364343aaad0a65c6a4d6628a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i89a8f5f3a462461d9ff69850cfe543dc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i50ef6a0932a74cdc81d96d88f7ab2485_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if0203680793e4fb8a12e0bdf8927352d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-08</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <context id="i95626988340341728b2d210065ff4f47_I20210308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-08</instant>
        </period>
    </context>
    <context id="ica603348fe30465dae402c8b63a1b31a_D20210311-20210311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-11</startDate>
            <endDate>2021-03-11</endDate>
        </period>
    </context>
    <context id="ie45025c772774d5c927c39b60442abf6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b6a3228292f4d16b55b1cd7b0695816_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:NelsonFairfieldIncNelsonFairfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i768d601b59aa4005863b05a9a1a4a15c_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i051178a4a64d449f87f75f6e19f87b98_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i1a15b1fe0510401b9e96b9115f0dd667_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i26503e2068d94590979ce52f141dc71c_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="idfbc21d1467d4e52911ec1b5501bcb5d_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="ia071d112ecca401ea6335a9263fe2923_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="id4fdf4d7028e46a4b31f337064b0f0bf_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i405041e3ed794abc80989f15142f5586_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ie7f4d0c263a04710a93bbf997b284b04_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iae31afbafbf247098cb8c0b7be49d5c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5ee65cf8cf1c49538dd47438eaedfb14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b8b3c8568084221a2ad859b39b4ec4a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i277f6af610934b6799af4e30a81fde49_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i374f363dae8d489884cfdb4e75c41f98_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4bdf5bf26e504a519ba4925e4f6ced05_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if1afc20edd0843bbac413280101a0cf3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:BioScienceLaboratoriesLLCBioScienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6d31ba294dc94afaa10dda2278f6ca6a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibe58eb3f5c4b4d98b5e6c1018cd61690_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4ce030964ab24158949b016db0752797_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">shc:IotronIndustriesCanadaIncIotronMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic300771a3ad848deb070c4b7e24f0b27_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4f33513e6445440aa8f9b1d326db60e2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic516f52cc0d54267bc67844b537e37bf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2212b97b8ac44cbeaf403f3f51b943a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i037b6f7c3cde45289d3fd93f3e2ba9be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i95577f1988ee4cab966e77b8d67597c8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia139b1975e0f4070816baaeeea37e6c0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:LandUseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i00107b289eee42419e1bb39ab7132941_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:SealedSourceAndSupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic049f68a83744fcb8bbd9e1cd47188f5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1a8a178bafa24d019046ae8de5f2a96b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2a93896fea2f4955a83ecd9ec395ff33_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0ab06588a1964b429adbe61fa67fe076_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa84c55df11d4fb98f330425ef0ec73f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i462df889dd55483f9fdf2dc45ca34f95_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc279916c2484e4abfd94cbddb0b1947_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:LandUseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i93cec6a0dc8b4cc79fe185028e72ea4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">shc:SealedSourceAndSupplyAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0efe039c4404f3db3ac7271abe88c92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb2734a552514580a66be829325e052e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia15d20e25e2c404b9fa9ab9025017114_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f7a540829534df293806a8679ef9ba5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic654e0b7347f4135b94187587d072ac9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia780c72ea74742cb8f4ea0929abef198_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibff6b4bd9f5349269d862b32081e5981_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4941298f6979408a8566ea338611e02c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i9aedde424acd460ead3548c57b1da604_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i632d789ade294a64b7daf856fe6f362a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1e8995acb99a47cf96b979b522b8a240_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie582d45d5d3a4547a10610bd46cdaf41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd422b230de24395ba1b25c54a6db45d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie37562b8bb6f4f1fad61c5737f8165db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9d3cea4bc3043aa8b6fa40430ca9b03_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if060086f17a0456496054d58a49829b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9aa1598f78fa4665b7e784df6c4c3618_I20201216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-16</instant>
        </period>
    </context>
    <context id="i3445e5d203564800970ed964c9915f69_I20201217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-17</instant>
        </period>
    </context>
    <context id="i61b546722b35491d9fa5800657d6bb77_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie47cbeb3f51f4d44a3362102b9e364be_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if9e4212789dc41669d654b48e51f12fe_D20210119-20210119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-19</startDate>
            <endDate>2021-01-19</endDate>
        </period>
    </context>
    <context id="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i3939ca87747f4af3ad4db922091cc08b_I20210119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-19</instant>
        </period>
    </context>
    <context id="i62e37fc77ba14274a2e06c4a3ec51333_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i4a20972bbc3640e8b6a94b5727ca3aa3_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i5076ff942fc745c6b7f8da2a4d66baf0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i85e8b4006d4e4eb994d25982e3a967b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec712ce357d5481ea60298bfc94462bd_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="i78ae87cbdee94046bcbcb6ab3f48b2d4_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="i013ecc2ca22e4d5bb0e44c54ecb51558_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="i0e206e36be42444db67127b6b666b46c_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="i48427c3c8fee49e493e03f3f6a69e2d7_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="if972f5c2e68f4b6e9c9b79e8bc599d2c_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="i74886e80842c43c2b575afa174c8f146_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i458ac54874ff437295ae19825c2e1ad6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0685810b83ff487580eda356557fd6bf_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3ff2dc57c0034141899eda7b55d9c143_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic0c05eb822b5410c8019ed6fe29b6ab8_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i8b900c87d68440d0aa7afa06a2cf13f9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i58786296c5744b83985f9f2ad31ad009_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if63b06a187344473bec2c467e8a1eaa8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ife3ac8faabe645c99d73eb67ce7ce8b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FirstLienNotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5475791dc6254d89860104a417d03dfd_D20201124-20201124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-24</startDate>
            <endDate>2020-11-24</endDate>
        </period>
    </context>
    <context id="i028ae4ed27174f34989fbc5e78e51dce_I20201124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-24</instant>
        </period>
    </context>
    <context id="i07c6f50405594b5592607e77121c0fa7_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SecondLienNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SecondLienNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia4a180ea1b6d4c3bb6c80f76ff48a33a_D20201124-20201124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-24</startDate>
            <endDate>2020-11-24</endDate>
        </period>
    </context>
    <context id="i97db1199d2ae496d86dba67906d75440_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">shc:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i7e0882cfad7543dcbaf6ed1402ccfe46_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanAndSecondLienNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iba2d514743dd41119e290276367c2fb1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb78af3c02b2463c9b7e74b792e5d62e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i226897b7dda742f1b2b822fe5e2f5ed2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icebe580f12e2450aa32311d02bcd23d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90fc782dbb0e49489e495a7aa71f62d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i980a63340b96471687bdd40130dadc4e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82333f7ccf614eb1b010487872bbaad6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iffbcd4e4e0a0426389360304851d8b90_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75fb9f2f9ab743cf99a74ffa394e0fec_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id1a933469e6c4f0286ea390dbb12759b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic5366f919647449e93ab9253d4a29029_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc32baf86d3348b285ed6d9464919955_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5986db8246ee4f9890cb846fcee620bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if57f220101a04dd081ed073252446f8d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i135a5815805f47c2b6d8423008b7e9eb_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2d9d81991fa044a8b0e369740ca0e420_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iff5bb92468604878bf5c2ea5357d059a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1332bd08855451b8303379ea937e071_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i49f9e92f97cb43e7a611be42d5d2b76d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">shc:ShareBasedPaymentArrangementTrancheFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibfb0b3684d91465b91c4dbd708ec1220_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">shc:ShareBasedPaymentArrangementTrancheFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3d8961e3c6584f708b88ef82ee1078c5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie79c75277ecb4c438785f138186141d9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iec0fe360fc5a4fb9be9d970dce929cff_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i532429720d76464fb288ef6d7f8c4da4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4e8d0ee307f4202ba503e68eb22522d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ab86e4b989f417494880063f915dc6d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie9467f5d115d4bd28878ee4c52ac8b6c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i829eb019c2384385949420c934d9650c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifbd8b853840d4d58a44be8b4f396efe6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">shc:A2020OmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i72ebc9f42a97466cbcc112179091d11f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">shc:A2020OmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib4973995a8b649188261f6b9eb660a4a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">shc:A2020OmnibusIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icf6ab0133fd241ab95e886992abdac00_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id25ab8929ae14c599f0efe8cf6b717e9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iea1bdce9661f4df4b25f0d61185bc957_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id702121c7c324bf6885a6bf80cae7fe4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if2bd407df76c4d14a849c52897796383_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id11e4447ffe14a53b4e1963b618ab6b0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">shc:PreIPOB2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if00ab087eb4046b2a954c121dda0b128_D20101022-20101022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">us-gaap:PositiveOutcomeOfLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-10-22</startDate>
            <endDate>2010-10-22</endDate>
        </period>
    </context>
    <context id="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GainContingenciesByNatureAxis">us-gaap:PositiveOutcomeOfLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-03-30</endDate>
        </period>
    </context>
    <context id="i3056567d4b7944ee83f117f290349ae0_D20180901-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationIllinoisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2b7ab3687cab4a8e81d2d673d039bf1b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationIllinoisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f11af9e3301403b98a762a3a5ca629e_D20200519-20200519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationGeorgiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-19</startDate>
            <endDate>2020-05-19</endDate>
        </period>
    </context>
    <context id="ic2508d02cd384fa790ed8dda3ccb6e14_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationGeorgiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i13271ac323454d0599f0910fc46fbaee_D20200817-20200817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">shc:EthyleneOxideTortLitigationGeorgiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-17</startDate>
            <endDate>2020-08-17</endDate>
        </period>
    </context>
    <context id="if41011b61b2c455085406c4d35f4b029_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i2c743685ac7e4b5eb6a0f423118724d0_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="id7710cf9b27a47e0b0c8712ace4267e6_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCapOctober2017Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="ic2065da279504816835ffbc1e014f7ad_I20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="ic08f77143efb4a438f9ac6fd9f28e16b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCapJune2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id090514efde94317af113816c3ec1bce_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i99e7214bafc64b91bd10fb6c344d92fa_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCap1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="idb744f485b224be28617f3aba1a1cd06_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i57dad9620c47433bb1a2a45a38b824b2_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">shc:InterestRateCapFebruary2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i93e757215c724df1b4b2dbead002a317_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="ie9939ca2be9548b480d25f00cfea7cb9_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="ie796349e2806499cb940f14083d11104_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6debae2625842d3aea289304287b04a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36a4d4ea180d473791afd4e893e822ca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9b0c33e7ec9945079c2630ef261167c1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i55ed0869e08f4f768909753e2657522f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc5b766a46664492ac40f1cf7af1b926_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic30522771c8a4c2ca8b28897797aa79f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i62085eeb658e46dd9eb6d857b79da630_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia3f548aa16134334acbcc16023544496_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iabe8d5f4f0b7489bae88ace960e40d0e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia6e675f57e9d48bba3df5cba6d545d97_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2150bbbc748f44229562c8ec831ea1cf_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i01147b9ec0104587b5471c7226ea6552_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i860d4a2deece4c239d322dec5ed3e62e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ForeignCurrencyGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6ed3cf78f0d24298bc641938f88ea10f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8215ef184ce046bf92c78693a8b8af93_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5447c83f5dbc409a96088e361444a411_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia8e15396c17b4617907472c2f4fade9b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id5081d47552c47cb8088900905b4f829_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie2f1e394ba7d4c1982b82751ef9eeb68_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icf08e9f67a5d438db80fa3bec21b7105_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id8f67cfa14e34836a09901949e8a6f78_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if94ed49fd1484dd19f80502049803ac1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic182088a125a4701b886f7b699c6ec3f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie31b8c09e1a04e3abd0d5865f45be488_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifbc39d33fbcf41d3be6a20574ae9f5e3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idc03881b23174afb8aaf1b3b6857a78f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7219b8c57243488bb121b53bd3d7d3cf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="idcc5336d70c34ef689e5dbb4364e9943_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie66e0ede22014573bd71c918b3740a70_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifc835d02987343f4928bb15a4113279a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i19990cadc7bf4e6eab87bd575dff569b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i452aa60f46804ae7824cdb240c5048d4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id4aa98cfa3374f178a69835db9e117bf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i272677a81acb465dad27e958b027480c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iee05df50a75d477993f0144a1d299dfe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia0ace0d34fc84a82a4a8dd4561599885_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8d9dd1bfbd544776a04462426d06480e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i36f94f5ef6264fe1a1984794263117a2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i36de9e2dd8ab40fc9b2ed92263ea4e84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if74455fdc1334818832b157f91fec355_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i585c891ef5c24f4f98a98256472bf2ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia08bd0ee1a164912afa76b9e27e176df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7e84d185d63c421a9847d44f33a85663_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02e84eddb6d54bfc9eb27fd468c46c12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5fb62adf30e64a04ac7bbc2fce94d9c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i685874b622084b9fbc1d35045289e95a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:EmbeddedDerivativeFinancialInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idba49c45ea854b6fa233cf1af5bbda94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87475347f6b64bf0a02e800f0af6deeb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i063954931d844af4a978fc5c7a468cf2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i32014511dee4420784c09d1a73b0f794_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:TermLoanDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76f8cf83b28b42adb2c968c7126c23b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4332841a17ae45d7ab5f8d5ccbb5a102_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78b7cb2bfc064b10a052025a86eea5f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id17e44686c4a444aa4f61e3a904dc55e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d64d815af524281b0cc85c6490417b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife1c0685123d4f1dbe17dc0dcb90acb9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79293a96e6644ab3afb669bba734bcc7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if197f04408d94ab68c955aa4b4a235fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:OtherLongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i81cd9ccf6a8a483399b03f856601a919_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i15872309fe384ede99b59ae790fd6692_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c9959285390451eb941cbc5aacef59e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d8483a806e144dc96f7e439adffab1a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">shc:FinanceLeaseLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35ac9047c5b543a3976685cc7c6f80bc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i019a710917314003bf051954e812e6f1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if4e3b0fca93a414f8267d4764139c900_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd5e47f9b9f54685b7c4853c2ecaa92a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i060a27d3ce644a47a68d9a2bd5793f29_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">shc:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:SterigenicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if73b88809d084769a5f2a52b8afde703_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NordionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iababa48736c840818f39cbadfc3e0370_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">shc:NelsonLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie667bf6544f54f0790d703266225330a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2b4e7cd3ba244ec68ee9e4a6d8ee9391_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i603326ebb8e04b33add577d701640115_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001822479</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>shc:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="subsidiary">
        <measure>shc:subsidiary</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="plaintiff">
        <measure>shc:plaintiff</measure>
    </unit>
    <unit id="claim">
        <measure>shc:claim</measure>
    </unit>
    <unit id="instrument">
        <measure>shc:instrument</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF8zLTEtMS0xLTI3OTg_bff99e3d-36be-4e65-82b0-a79f133b76f1">0001822479</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF81LTEtMS0xLTI4MDI_7de3a8a1-19ac-443e-bba3-e860b226ac68">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF82LTEtMS0xLTI4MDg_7ef13a28-535b-42f7-a11e-bb9a7a617c6d">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF85LTEtMS0xLTI4MDQ_5350bb19-55c1-4749-a746-6976d0fdb3da">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80L2ZyYWc6ZTRjODA1MjJlNGMxNGY4MDk4ZWJlZjY5YzU3NDg1MTIvdGFibGU6NTgyMDJlNzM5NTI4NDM1MmEzZjAzNDJhMTcyNGMxYzQvdGFibGVyYW5nZTo1ODIwMmU3Mzk1Mjg0MzUyYTNmMDM0MmExNzI0YzFjNF8xMC0xLTEtMS0yODA2_d2afb63d-bd93-4f94-96ed-adb6ab3b0e01">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM5MA_4d42cb8b-4533-485f-a39a-6ad44b9c22bd">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="icf6ab0133fd241ab95e886992abdac00_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzOA_90568ab0-c98d-42fa-bc3b-4bb90feeb83b">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id25ab8929ae14c599f0efe8cf6b717e9_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM1Mg_eccb5a8b-a643-47c5-b42e-caa40b675d70">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <shc:CashProceedsToSponsorsRatioToInvestedCapital
      contextRef="id11e4447ffe14a53b4e1963b618ab6b0_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NjYvZnJhZzo3ZjI5YjQ0M2E3ZWM0N2E1YTBiZWZjZmM3ZjFlMDYyYS90YWJsZTpjYTQzYTE3MjYzYTI0NWMzYWEzNjM4NjMwZTNjMmVhMS90YWJsZXJhbmdlOmNhNDNhMTcyNjNhMjQ1YzNhYTM2Mzg2MzBlM2MyZWExXzEtMC0xLTEtMTQyMTg_0bf73091-e884-49c9-b742-f470106e7280"
      unitRef="number">2.5</shc:CashProceedsToSponsorsRatioToInvestedCapital>
    <dei:DocumentType
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzIx_d0bbb762-1d2b-46ae-85ae-fe6464c45435">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDQ0Zjg2MWJiMmQ4NGMyZWExMWJhZjg1OTMzMDc4YTMvdGFibGVyYW5nZTo0NDRmODYxYmIyZDg0YzJlYTExYmFmODU5MzMwNzhhM18wLTAtMS0xLTI2ODg_0656d62f-2ac5-4b8f-98a9-b923212aa85b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzM4_3b1c6f11-d498-47a0-b869-8a256f5325ba">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6Y2ZmZjIzOGNhZGZkNGNmZmJiNGUzNzBlMjNmMGU0NjgvdGFibGVyYW5nZTpjZmZmMjM4Y2FkZmQ0Y2ZmYmI0ZTM3MGUyM2YwZTQ2OF8wLTAtMS0xLTI2OTc_6b6e94ba-a058-4d5c-b514-fe1f90f7240a">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzUz_44aa71ee-ff1c-4355-817d-45e7920702c6">001-39729</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU1_0924e116-a326-4871-9a7d-d0bd45a0f330">SOTERA HEALTH COMPANY</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18wLTAtMS0xLTI3NDA_cdb82441-0d98-47f3-9d82-d99cba8093f2">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18wLTItMS0xLTI3MTE_a0400b93-2ae2-4dc2-beac-93e425b551dd">47-3531161</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18zLTAtMS0xLTI3MjMvdGV4dHJlZ2lvbjo5MjI2OTJlNDM4ODc0YTM3YTEwM2FhOTI3MjY1MzIzMl8yNzQ4Nzc5MDY5NDk3_2731a653-f767-4dd6-8150-cdec205eaf20">9100 South Hills Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY18zLTAtMS0xLTI3MjMvdGV4dHJlZ2lvbjo5MjI2OTJlNDM4ODc0YTM3YTEwM2FhOTI3MjY1MzIzMl8yNzQ4Nzc5MDY5NTA5_7622889b-21d0-4dbc-a7ad-ddb53710297b">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY180LTAtMS0xLTI3MzIvdGV4dHJlZ2lvbjo3YzI2NDBmYWE1ZWM0NjA4OTRjMWE3MDM0MTQxNThkMl8yNzQ4Nzc5MDY5NDg0_75c5f701-f33c-49bc-9b5b-e70ff7c2ff3f">Broadview Heights</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY180LTAtMS0xLTI3MzIvdGV4dHJlZ2lvbjo3YzI2NDBmYWE1ZWM0NjA4OTRjMWE3MDM0MTQxNThkMl8yNzQ4Nzc5MDY5NDkx_adc9e388-46e9-498a-9c8f-33297c21c22e">OH</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY180LTItMS0xLTI3MTM_7efb6ab8-f205-4943-a726-4e812ec9d599">44147</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY183LTItMS0xLTI3MzgvdGV4dHJlZ2lvbjo0ZTM2ZGUxZjhhNTU0MWZmYTc0Mjk5MmJlNjRkZmQ0ZF8yNzQ4Nzc5MDY5NDUx_5b65984b-00cd-49a7-aee4-b04e26e23839">440</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NjE4NDMzYTJkZjJjNDRmMGJkOTFhYzFhM2E3NDVhMWMvdGFibGVyYW5nZTo2MTg0MzNhMmRmMmM0NGYwYmQ5MWFjMWEzYTc0NWExY183LTQtMS0xLTI3NDM_49a29329-248a-4652-a949-654ea608b9d7">262-1409</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDI0ZjFiNTE4MTRmNDUwYTlmN2IwM2ViOTlkM2RiNmIvdGFibGVyYW5nZTo0MjRmMWI1MTgxNGY0NTBhOWY3YjAzZWI5OWQzZGI2Yl8xLTAtMS0xLTI3NDg_007b0de0-0f2c-4245-bddf-9f983c2cffd5">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDI0ZjFiNTE4MTRmNDUwYTlmN2IwM2ViOTlkM2RiNmIvdGFibGVyYW5nZTo0MjRmMWI1MTgxNGY0NTBhOWY3YjAzZWI5OWQzZGI2Yl8xLTEtMS0xLTI3NTE_051e294f-24bd-4807-b54d-37d9e69dc39a">SHC</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6NDI0ZjFiNTE4MTRmNDUwYTlmN2IwM2ViOTlkM2RiNmIvdGFibGVyYW5nZTo0MjRmMWI1MTgxNGY0NTBhOWY3YjAzZWI5OWQzZGI2Yl8xLTItMS0xLTI3NTM_61b7d971-9a0d-4046-9e7e-90da78321de8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU2_86aaa3aa-2b23-4fb1-af60-521130b10216">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU3_e02b46d6-3758-47e0-a580-ad979cb1cb99">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6YTU0MjgzNTk3NzgzNGRlOWE1ZDE2NWUyZmM0ZTM5NTYvdGFibGVyYW5nZTphNTQyODM1OTc3ODM0ZGU5YTVkMTY1ZTJmYzRlMzk1Nl8xLTAtMS0xLTI3Njc_6db557ee-b0f2-4bad-9976-54a1a2df38ca">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6YTU0MjgzNTk3NzgzNGRlOWE1ZDE2NWUyZmM0ZTM5NTYvdGFibGVyYW5nZTphNTQyODM1OTc3ODM0ZGU5YTVkMTY1ZTJmYzRlMzk1Nl8xLTMtMS0xLTI3NzI_c72f7802-f666-4915-b695-18711c875a4a">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGFibGU6YTU0MjgzNTk3NzgzNGRlOWE1ZDE2NWUyZmM0ZTM5NTYvdGFibGVyYW5nZTphNTQyODM1OTc3ODM0ZGU5YTVkMTY1ZTJmYzRlMzk1Nl8yLTMtMS0xLTI3NzQ_030652c4-5852-4625-9cb8-8dff2d276271">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzY1_4c915114-2c9c-4771-8e1e-efa3c4d0edf0">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzU4_a21b01f7-6516-495a-845d-a8e92f20d422">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iecb4c2bb33504c7dac5c01c3a9c0c6fb_I20210506"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xL2ZyYWc6M2M2NWMwY2IxNGQ3NDUyNjljMDhhZTZhZjIxNDEwNTkvdGV4dHJlZ2lvbjozYzY1YzBjYjE0ZDc0NTI2OWMwOGFlNmFmMjE0MTA1OV8yNzQ4Nzc5MDcxMzg4_f55ffd86-2717-4141-b9b2-1e15e9d754ce"
      unitRef="shares">282869957</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMy0xLTEtMS0w_7f49928e-76d6-496f-9f21-41fea873a7e7"
      unitRef="usd">108009000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMy0zLTEtMS0w_5cccb9c9-9d40-47e4-991c-5b6c0fff41c6"
      unitRef="usd">102447000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNC0xLTEtMS0w_b58d1607-2b5d-4ef6-8b2f-fe571e04b0ba"
      unitRef="usd">7000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNC0zLTEtMS0w_a9875cc2-f119-49bb-a5c1-924875a708de"
      unitRef="usd">7000</us-gaap:RestrictedCashCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0wLTEtMS0yODIyL3RleHRyZWdpb246MmJiZTFkOWFlNmU3NGI3MGE4MDVlZDllY2MwOGI1OTNfMjc0ODc3OTA2OTU0OA_0aec102a-828a-4b01-8f3f-275f66aed090"
      unitRef="usd">603000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0wLTEtMS0yODIyL3RleHRyZWdpb246MmJiZTFkOWFlNmU3NGI3MGE4MDVlZDllY2MwOGI1OTNfMjc0ODc3OTA2OTU0Mw_77cfd398-b516-43ea-b1fc-ec28b7416485"
      unitRef="usd">708000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0xLTEtMS0w_f26eb0a2-6345-4898-94fc-b23e9577d79c"
      unitRef="usd">96393000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNS0zLTEtMS0w_3cb13c98-27ff-4b84-8b07-1626bdd93ad1"
      unitRef="usd">91735000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNi0xLTEtMS0w_d1eb933f-41a0-468c-adb4-479d3f4961b6"
      unitRef="usd">33375000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNi0zLTEtMS0w_c8d00782-3f13-4c81-b9a8-61276a769bc2"
      unitRef="usd">34093000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNy0xLTEtMS0w_60108d92-9244-474d-b2f3-752d170b53c0"
      unitRef="usd">69758000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNy0zLTEtMS0w_5e11b7d2-a5b7-47e2-b7b6-8912ad919668"
      unitRef="usd">64964000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOC0xLTEtMS0w_1fff53b6-cda1-4dc1-9557-30aa58989da0"
      unitRef="usd">20825000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOC0zLTEtMS0w_fb60ef91-0827-4063-86dc-d326491f4e4a"
      unitRef="usd">21769000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOS0xLTEtMS0w_aed7dcf9-985c-4409-ac7c-af63d4e645c1"
      unitRef="usd">328367000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfOS0zLTEtMS0w_0678f049-d8de-4c42-b143-7f638728ec17"
      unitRef="usd">315015000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTAtMS0xLTEtMA_1e9f31f3-d6df-4fb6-96cf-6fb64477c1b8"
      unitRef="usd">611620000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTAtMy0xLTEtMA_0f5b8677-aeac-46fb-86b7-d0869b8cea90"
      unitRef="usd">609814000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTEtMS0xLTEtMA_29300158-5275-4d2d-8260-3c4033ec7d09"
      unitRef="usd">47117000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTEtMy0xLTEtMA_148ec66d-fe08-44aa-b97f-c89c82d42e29"
      unitRef="usd">45963000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTItMS0xLTEtMA_53d82d87-380e-4c31-b1cf-3226cfacee3e"
      unitRef="usd">8088000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTItMy0xLTEtMA_0a26c25b-3813-45e6-a84d-89de6947501a"
      unitRef="usd">8424000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:EquityMethodInvestments
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTMtMS0xLTEtMA_ab635c58-e2e0-4ede-b7e5-c539a023a654"
      unitRef="usd">9227000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTMtMy0xLTEtMA_9cb984e4-3dac-4b38-b14c-cf411c6afb80"
      unitRef="usd">13457000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTQtMS0xLTEtMA_d59ed261-e594-4240-9685-62881bb0617c"
      unitRef="usd">9281000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTQtMy0xLTEtMA_7f270f2d-1371-4849-b00a-53fd5e134086"
      unitRef="usd">9304000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTUtMS0xLTEtMA_9c8e9d44-80dd-4b05-b8bc-3af18fc6cb56"
      unitRef="usd">656572000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTUtMy0xLTEtMA_f85c748b-abc9-4b2e-8402-9d2a1aa535a6"
      unitRef="usd">643366000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTYtMS0xLTEtMA_3b783fba-a30a-46b6-9d98-80a4dd8af354"
      unitRef="usd">1106728000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTYtMy0xLTEtMA_3e2aeb31-088c-41d6-be75-bf303334b1be"
      unitRef="usd">1115936000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTctMS0xLTEtMA_bb465bb1-8380-4600-b100-d25787f7a386"
      unitRef="usd">2777000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMTctMy0xLTEtMA_7acc780f-58ae-4f98-9dbb-ebcef669b157"
      unitRef="usd">2761279000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjAtMS0xLTEtMA_5e68c78e-a479-4591-aed7-45c40b0859a2"
      unitRef="usd">57174000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjAtMy0xLTEtMA_acf7a978-ef20-4b08-b6cd-86fc31c66bb0"
      unitRef="usd">52400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjEtMS0xLTEtMA_dab8ea6d-e794-4f09-a4fc-82c709ce7e21"
      unitRef="usd">56373000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjEtMy0xLTEtMA_cc8c8db5-28a9-4653-bb85-b695d8065115"
      unitRef="usd">60518000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjItMS0xLTEtMA_cd81e3f2-d7cf-4d81-b7b6-59554a4ce20b"
      unitRef="usd">5958000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjItMy0xLTEtMA_6d7b9e74-4ff6-46ad-802b-741739df422c"
      unitRef="usd">6056000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjQtMS0xLTEtMA_77c3fce8-2f4e-4833-91b3-56a0c2f3ec24"
      unitRef="usd">1108000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjQtMy0xLTEtMA_95817965-abf2-41c6-9c46-ff7c974b24cc"
      unitRef="usd">1173000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjUtMS0xLTEtMA_997a735e-ddaa-4bb6-a185-55610c7275bc"
      unitRef="usd">9631000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjUtMy0xLTEtMA_25b09354-f830-4247-8e3e-b906fad78764"
      unitRef="usd">9383000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AssetRetirementObligationCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjYtMS0xLTEtMA_78f4d65d-8b51-4197-95c1-574d049f8506"
      unitRef="usd">391000</us-gaap:AssetRetirementObligationCurrent>
    <us-gaap:AssetRetirementObligationCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjYtMy0xLTEtMA_af3da6d7-d5e8-4c2a-b464-ab7ff532becf"
      unitRef="usd">620000</us-gaap:AssetRetirementObligationCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMS0xLTEtOTcwNA_099ace54-98db-47f5-a292-5a0b9a478e3a"
      unitRef="usd">7384000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMy0xLTEtOTcwNA_9c8335d2-ed3a-4cb9-8851-53e45bbd9748"
      unitRef="usd">10448000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjctMS0xLTEtMA_d7a5a499-89d2-4aed-a1d9-0921a07bda21"
      unitRef="usd">138019000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjctMy0xLTEtMA_8f169414-705c-4f98-877a-095ace3f3468"
      unitRef="usd">140598000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMS0xLTEtMA_5f88aac7-72ee-4964-90c0-b9bf5450aa95"
      unitRef="usd">1837580000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjgtMy0xLTEtMA_532d0df0-212b-4c57-9085-51e349942ac6"
      unitRef="usd">1824789000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjktMS0xLTEtMA_a015c2e1-db81-4062-ac0e-a014c20983fc"
      unitRef="usd">33432000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMjktMy0xLTEtMA_ffe083bb-492d-466d-8737-984751b1f5fc"
      unitRef="usd">34939000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzAtMS0xLTEtMA_f487ac9b-61e0-41dd-a50e-20980e0579c0"
      unitRef="usd">39806000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzAtMy0xLTEtMA_bf966e15-1242-42a4-943a-6cab4e50d3c5"
      unitRef="usd">38941000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzEtMS0xLTEtMA_81820897-c802-46e5-81ec-7f2b7f446fe8"
      unitRef="usd">45633000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:AssetRetirementObligationsNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzEtMy0xLTEtMA_75ce770b-7ced-4db9-b7eb-74f2aa98ba46"
      unitRef="usd">45013000</us-gaap:AssetRetirementObligationsNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzItMS0xLTEtMA_471af09e-ebfd-4caf-9ed7-aae6cff7ace9"
      unitRef="usd">21362000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzItMy0xLTEtMA_1dc778b9-4354-4b6c-a8c0-1f6b0e7993b0"
      unitRef="usd">21255000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzMtMS0xLTEtMA_eaead6b3-1476-4bbc-8516-d4937f472c09"
      unitRef="usd">46959000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzMtMy0xLTEtMA_38bd8997-9526-461a-8b30-ec0859de5ee3"
      unitRef="usd">48223000</us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzQtMS0xLTEtMA_cd03bbf0-d9a6-4ac6-870a-2e0582030866"
      unitRef="usd">0</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzQtMy0xLTEtMA_11084f9e-b7be-451a-95fd-b4aeb3f808cf"
      unitRef="usd">13625000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzUtMS0xLTEtMA_dd95d665-695d-455d-85e4-a14379be9f7d"
      unitRef="usd">18795000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzUtMy0xLTEtMA_677e5f42-00da-43c3-b785-ebee4832168d"
      unitRef="usd">17506000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzYtMS0xLTEtMA_958d2383-cce8-4a47-98fa-0e3b43533172"
      unitRef="usd">129670000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzYtMy0xLTEtMA_843b2f1b-9f01-47c2-8544-280b4829ebb8"
      unitRef="usd">121816000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzctMS0xLTEtMA_2daac28f-858f-4a56-860a-b82c6943029e"
      unitRef="usd">2311256000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzctMy0xLTEtMA_3856254a-34fb-4de5-ba7a-519cd2975697"
      unitRef="usd">2306705000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzgtMS0xLTEtMjgzMg_6f0abd14-e67d-42cc-b7c0-fea93ce53582"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfMzgtMy0xLTEtMjgzNA_230812a9-fdcd-4914-86e7-df3aeeedeb77"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk1ODk_2f27af55-e76b-4d44-8569-2a2343f091d2"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk1ODk_d60133ec-c789-4158-8361-cf2d2be3ca1b"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MDE_05e0b803-0cf3-4f8c-aea3-0ba13e7e1b55"
      unitRef="shares">1200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MDE_0776b9c8-bc03-4d91-afbd-5d41c57e4acb"
      unitRef="shares">1200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MTE_8bbc909b-70dc-4ca4-8ae5-fa556238dc04"
      unitRef="shares">285990000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMC0xLTEtMjg5Mi90ZXh0cmVnaW9uOjVmMWQ4ZDEwMWMyMDRhYzZiN2YzNjE5NjY1NGIxOTUyXzI3NDg3NzkwNjk2MTE_f0a58186-38c6-4788-9c44-04027ec38e80"
      unitRef="shares">285990000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMS0xLTEtMA_2e5a8f3f-9115-44e8-af7d-c67e799e23df"
      unitRef="usd">2860000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDAtMy0xLTEtMA_551030ed-a776-4214-a0e3-d0ed8caae77f"
      unitRef="usd">2860000</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1ODA_509ae540-488b-4f51-9435-0254f4454522"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1ODA_57e8be93-bbf3-4064-8860-7d86f3822bee"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTA_72ba1bcc-907e-4dc3-8592-4b08b6d07ad7"
      unitRef="shares">120000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTA_e1ff4b10-b789-4de9-9b4a-bc0e6fde99a9"
      unitRef="shares">120000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTU_1f686274-9a44-4be2-ab07-a4103bace78b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMC0xLTEtMjg5NC90ZXh0cmVnaW9uOmM2Y2U5ZmI5ZTlkNTRkOGM4ZTIwMjMwY2FjZDc0MDYwXzI3NDg3NzkwNjk1OTU_9fd2a68b-a29f-4504-859a-623a57ce51e3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMS0xLTEtMA_b5a197ce-ba7b-439b-83c5-91a6f0d0dbf8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDEtMy0xLTEtMA_d48bcd7f-1ae6-4985-b500-94646f847fc8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:TreasuryStockShares
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMC0xLTEtMjg5Ni90ZXh0cmVnaW9uOmZiNmIwNjliYmZjZTRiMWJhZTc5YzU3M2MxYWEwYzg5XzI3NDg3NzkwNjk1NTE_e7e5c051-2518-4fbb-9589-4bd26cbc4313"
      unitRef="shares">3090000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMC0xLTEtMjg5Ni90ZXh0cmVnaW9uOmZiNmIwNjliYmZjZTRiMWJhZTc5YzU3M2MxYWEwYzg5XzI3NDg3NzkwNjk1NTk_56d87808-8896-4683-89f6-0135b6b235d3"
      unitRef="shares">2742000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMS0xLTEtMA_6c7d9455-dc33-4a39-a92a-1d1bff9d40f3"
      unitRef="usd">34000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDItMy0xLTEtMA_549ee869-5de1-41a8-bf56-b8fc5b29e326"
      unitRef="usd">34000000</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDMtMS0xLTEtMA_bb00b9ab-39d5-4937-a203-2781b3acc141"
      unitRef="usd">1169852000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDMtMy0xLTEtMA_afc7607e-3949-4925-b9b1-60a727e9ac24"
      unitRef="usd">1166412000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDQtMS0xLTEtMA_c7d1c35a-a6a7-4723-94bc-7203b033d869"
      unitRef="usd">-578286000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDQtMy0xLTEtMA_231fc471-2792-4360-aa55-2e6b7c5c90e1"
      unitRef="usd">-589128000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDUtMS0xLTEtMA_8c4c782b-e109-46a4-806b-d917ba11f79b"
      unitRef="usd">-97162000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDUtMy0xLTEtMA_eab59f2c-68c6-4b52-b2cb-ccc1317dfb86"
      unitRef="usd">-93842000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDYtMS0xLTEtMA_db107314-6cf1-43ea-89f7-c955d7a28e24"
      unitRef="usd">463264000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDYtMy0xLTEtMA_ff448c01-cd96-4c60-8042-f2bd3b5a6bf0"
      unitRef="usd">452302000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDctMS0xLTEtMA_99b58b69-c1c6-4884-acfc-691f9ab9f4a3"
      unitRef="usd">2480000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDctMy0xLTEtMA_bbe55e61-17fb-49ef-ac08-2710add71ded"
      unitRef="usd">2272000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDgtMS0xLTEtMA_eef31c98-bfdb-4dd3-8d42-45b78cde5d1e"
      unitRef="usd">465744000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDgtMy0xLTEtMA_3816c35d-37a8-4fd8-a2fa-28070dee6fbb"
      unitRef="usd">454574000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDktMS0xLTEtMA_7d0e9a10-40be-4fb0-8222-379ab4df36b8"
      unitRef="usd">2777000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8xOS9mcmFnOmU1ZmM4ZTZlOWZlYzRmYWNiYjZmMjg5MDcyMjUxZTY5L3RhYmxlOjk4MTE5ZjAyMGUzYzRlNjVhNjc2NTdhOWI5MmE0NjlkL3RhYmxlcmFuZ2U6OTgxMTlmMDIwZTNjNGU2NWE2NzY1N2E5YjkyYTQ2OWRfNDktMy0xLTEtMA_cf7380bb-e0a1-4604-a61e-c42966cc84ec"
      unitRef="usd">2761279000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cf37fb79c6347f6a6f791184ce78acf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMy0xLTEtMS0w_fd3ae527-329b-485b-8858-7fc082251653"
      unitRef="usd">188698000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic37232295f3745cd88694de59101666d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMy0zLTEtMS0w_d0ed278e-1339-425d-8d12-ebc5bfa81974"
      unitRef="usd">167405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icee21de57c09410dbdb4e1d0c7cd6110_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNC0xLTEtMS0w_5145a0ad-2858-49be-83c3-5841b580f574"
      unitRef="usd">23450000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9cc06bf938484e99bfe9969660cc781c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNC0zLTEtMS0w_ecd7cbd8-788a-4fd7-bd14-aed8381c3267"
      unitRef="usd">20795000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNS0xLTEtMS0w_4e83b031-328d-498a-81c7-e50b35df39f4"
      unitRef="usd">212148000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNS0zLTEtMS0w_25bdea27-f331-495a-960c-871cc08e5a03"
      unitRef="usd">188200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i8cf37fb79c6347f6a6f791184ce78acf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNy0xLTEtMS0w_ec88ad63-2e78-4b89-91db-22534b352eef"
      unitRef="usd">85036000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic37232295f3745cd88694de59101666d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfNy0zLTEtMS0w_3429a3c7-58fb-4f2d-a532-8466d6c63d96"
      unitRef="usd">83069000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="icee21de57c09410dbdb4e1d0c7cd6110_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOC0xLTEtMS0w_c773a1d3-e920-4dd1-b36e-497db141e2da"
      unitRef="usd">11740000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9cc06bf938484e99bfe9969660cc781c_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOC0zLTEtMS0w_e34f5b11-9dc1-4f8a-bf62-d07d52fb4cab"
      unitRef="usd">8614000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOS0xLTEtMS0w_0c68c191-f066-419d-9892-11adb6651ec0"
      unitRef="usd">96776000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfOS0zLTEtMS0w_b57fd263-df40-4081-9ce3-3c52cd91475f"
      unitRef="usd">91683000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTAtMS0xLTEtMA_41ccad40-1017-4631-b591-997e588f08ff"
      unitRef="usd">115372000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTAtMy0xLTEtMA_5896826e-033d-44bd-92f4-6377c8760252"
      unitRef="usd">96517000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTItMS0xLTEtMA_c2b85f82-b64b-4867-9aff-b003202eaea3"
      unitRef="usd">52465000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTItMy0xLTEtMA_aaee6ddf-9eca-4a5f-95e5-dfa0af726871"
      unitRef="usd">37053000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <shc:AmortizationOfIntangibleAssetsNonproduction
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTMtMS0xLTEtMA_219add50-61bb-42fb-8414-647d4c7d1444"
      unitRef="usd">16543000</shc:AmortizationOfIntangibleAssetsNonproduction>
    <shc:AmortizationOfIntangibleAssetsNonproduction
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTMtMy0xLTEtMA_c96eaf9b-97c6-43fb-aa80-9563f6f9166b"
      unitRef="usd">14599000</shc:AmortizationOfIntangibleAssetsNonproduction>
    <us-gaap:OperatingExpenses
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTUtMS0xLTEtMA_393c1e4b-e012-49c3-ac5e-f9f7afb9d8e5"
      unitRef="usd">69008000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTUtMy0xLTEtMA_9e37482b-25d4-45db-a5c7-9a643c14c162"
      unitRef="usd">51652000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTYtMS0xLTEtMA_7715b954-ddb5-43f3-b58f-f6e29e20c513"
      unitRef="usd">46364000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTYtMy0xLTEtMA_aa577fdf-83cf-473e-9970-4e726f27a680"
      unitRef="usd">44865000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTctMS0xLTEtMA_4451014f-4a65-4cf1-b80d-099eb04640d6"
      unitRef="usd">-21282000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTctMy0xLTEtMA_8840bf82-4fb2-49cf-81d4-edc629d2af57"
      unitRef="usd">-56562000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTgtMS0xLTEtMA_fb52b047-a1b9-49cb-a5c3-1bdcfc0b5f08"
      unitRef="usd">-14312000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTgtMy0xLTEtMA_af2e5c6a-518a-4b23-a1b0-b5f5237663f3"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTktMS0xLTEtMA_016df7c8-9e78-49bd-ad0d-ea2c7dd7fe1e"
      unitRef="usd">-578000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMTktMy0xLTEtMA_5b99a3fd-75a8-41b5-881c-be66c6abe3d5"
      unitRef="usd">627000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjAtMS0xLTEtMA_7f12d3e8-8481-4e31-848a-5f16eb9cdf18"
      unitRef="usd">3890000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjAtMy0xLTEtMA_4a0fbff8-12de-447a-ae59-4b0d1bd55880"
      unitRef="usd">-3150000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjEtMS0xLTEtMA_138062b6-3d0f-447b-ade5-aba011afdf6d"
      unitRef="usd">14082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjEtMy0xLTEtMA_2ae8db18-4434-4aac-a466-fd3a44739ea0"
      unitRef="usd">-14220000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjItMS0xLTEtMA_840af482-04fd-4280-b5d6-3a3a263affc8"
      unitRef="usd">3017000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjItMy0xLTEtMA_d4f9b6c6-6a67-49c8-ab6e-81fd5bf3bac8"
      unitRef="usd">-12234000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjMtMS0xLTEtMA_7606c82b-2b17-4882-82b1-83fc6e8e43f5"
      unitRef="usd">11065000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjMtMy0xLTEtMA_f1ebfbf1-fd70-4763-a93c-643058b47578"
      unitRef="usd">-1986000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjQtMS0xLTEtMA_3ea6a6e8-60b9-4eec-aea6-8217c4abf81e"
      unitRef="usd">223000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjQtMy0xLTEtMA_2570a7a4-4e20-49f5-84a8-e587c8568206"
      unitRef="usd">-22000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjUtMS0xLTEtMA_024b6dcf-ca4c-44d3-ba90-27a328402a55"
      unitRef="usd">10842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjUtMy0xLTEtMA_ba4317f4-ef79-4f85-b1f2-458d6d5c6dc4"
      unitRef="usd">-1964000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMC0xLTEtMzEzOS90ZXh0cmVnaW9uOmUyYmM5ZmQzOTgwYjQ2NmFiMjk0ZmEyNTI3ZWY2OTdkXzI3NDg3NzkwNjk1NDA_e768488d-482c-49c7-9850-c65b2632cd95"
      unitRef="usd">-84000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMC0xLTEtMzEzOS90ZXh0cmVnaW9uOmUyYmM5ZmQzOTgwYjQ2NmFiMjk0ZmEyNTI3ZWY2OTdkXzI3NDg3NzkwNjk1MzQ_73dac2a5-5e0c-4976-a161-d4bab8548589"
      unitRef="usd">744000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMS0xLTEtMA_4b3f4e9a-3c39-46ae-982b-7ffa4b4fbac9"
      unitRef="usd">249000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjctMy0xLTEtMA_5bb4cbb4-1f15-4e8f-989c-fb4ea27cf621"
      unitRef="usd">-2207000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMC0xLTEtMzEzNy90ZXh0cmVnaW9uOjg3YmJkNDM1MWU5MjQxMzc5ZGFjMGM5MGE2ZmNhNDFiXzI3NDg3NzkwNjk1MTE_3e02f30b-a18c-4f25-9616-b2b99b35dd96"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMC0xLTEtMzEzNy90ZXh0cmVnaW9uOjg3YmJkNDM1MWU5MjQxMzc5ZGFjMGM5MGE2ZmNhNDFiXzI3NDg3NzkwNjk1MjA_9cb7a566-2214-487e-8582-416084bdabe5"
      unitRef="usd">1234000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMS0xLTEtMA_bcc307d9-7995-42d6-9911-4fc5991601f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjgtMy0xLTEtMA_9cde3eb2-7b70-4e99-9928-05263d9396a7"
      unitRef="usd">-3479000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjktMS0xLTEtMA_197826d4-a5b7-4e8d-b7c5-8545271191a3"
      unitRef="usd">-3086000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMjktMy0xLTEtMA_52a895bb-7f85-43b2-8c42-9418ccbf3e8b"
      unitRef="usd">-72967000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzAtMS0xLTEtMA_3cee970f-b661-49ed-a4b9-cd7023ed8197"
      unitRef="usd">7730000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzAtMy0xLTEtMA_fa88ea98-6a24-49cb-8445-a15df8c564fe"
      unitRef="usd">-76225000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzEtMS0xLTEtMA_560c36ec-4bbe-4943-8899-ec9cb55e1a72"
      unitRef="usd">208000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzEtMy0xLTEtMA_671120cf-8d33-4524-9c06-bafcc55fd80c"
      unitRef="usd">-22000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzItMS0xLTEtMA_e8680b08-2592-4183-92a4-1eec711dbc9a"
      unitRef="usd">7522000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzItMy0xLTEtMA_850d710d-9131-4d75-b4fd-23fe4073e79f"
      unitRef="usd">-76203000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMS0xLTEtMTIzOQ_21dc60e1-e468-40e8-925f-03d5945aa4c6"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMy0xLTEtMTIzOQ_b6a844dd-98d0-4e69-a32e-7c189e3013f0"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMS0xLTEtMA_410108e3-7134-4848-a620-c7579cbde11d"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzQtMy0xLTEtMA_68ff2ae0-d2a4-4061-8d0c-5e519cab3bad"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzctMS0xLTEtMTIzNA_73ca3b09-d5a0-4949-a566-957d48ea45a2"
      unitRef="shares">278827000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzctMy0xLTEtMTIzNA_de9cc99b-4cfd-4132-b90c-184c28545daa"
      unitRef="shares">232400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzYtMS0xLTEtMA_fe9b737e-be12-4b80-8890-e54c0cb18fc9"
      unitRef="shares">278968000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8yNS9mcmFnOjljYzdmOTQyYTAyYTQyMjZiZDQxMDkzMjg3NDkwYzU5L3RhYmxlOmY0NTA2ZjQ3N2NjNjQ3ZDU4YjYzMmE2ZGM4MmRhYTRjL3RhYmxlcmFuZ2U6ZjQ1MDZmNDc3Y2M2NDdkNThiNjMyYTZkYzgyZGFhNGNfMzYtMy0xLTEtMA_11298b78-cac5-4774-9a3c-9d7c3ebc38ce"
      unitRef="shares">232400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMy0xLTEtMS0w_120b4486-9886-4454-b774-f1e30d536c25"
      unitRef="usd">11065000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMy0zLTEtMS0w_395de824-946c-426c-9663-acc753fd711e"
      unitRef="usd">-1986000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNS0xLTEtMS0w_842f21a3-5e28-4205-8d20-e8d243df4fb0"
      unitRef="usd">15379000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNS0zLTEtMS0w_de2716ca-0290-4fcb-84e6-00ab776fbe55"
      unitRef="usd">16110000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNi0xLTEtMS0w_c962532c-d7bf-4ca5-9266-dff617b9d18d"
      unitRef="usd">22282000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNi0zLTEtMS0w_7379d8d3-8e45-4b1b-b670-1cd171a01e0c"
      unitRef="usd">19913000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOC0xLTEtMS0w_76780219-86e1-48a9-a73e-5a8addb7ca5a"
      unitRef="usd">-14312000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOC0zLTEtMS0w_4ad5f0bb-081c-4ea5-a8bc-f76c55c6a521"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOS0xLTEtMS0w_ff24e0ef-3a41-4d52-9eeb-a58d20d1b010"
      unitRef="usd">-3637000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfOS0zLTEtMS0w_72a00331-0e93-4a0d-bec4-7486d2eb7a7e"
      unitRef="usd">-6683000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTAtMS0xLTEtMA_2d48c34b-b076-452b-b497-4d4088a44a87"
      unitRef="usd">3449000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTAtMy0xLTEtMA_f7e7381b-8f0e-4e5a-948d-c8500f7f07ba"
      unitRef="usd">1725000</us-gaap:ShareBasedCompensation>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTEtMS0xLTEtMA_a6221d6a-31ea-4c70-9a78-26fa2ed79b10"
      unitRef="usd">551000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTEtMy0xLTEtMA_e661f5d8-2510-474f-a921-532896b9c48b"
      unitRef="usd">471000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTItMS0xLTEtMA_a022a16f-7c14-4736-8206-33b6ce1ca2a4"
      unitRef="usd">-2354000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTItMy0xLTEtMA_3e0ba344-28d4-4718-9e7c-579386a49ea8"
      unitRef="usd">4876000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTMtMS0xLTEtMA_ad810440-584c-4866-b8f7-d332c4a0726a"
      unitRef="usd">853000</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTMtMy0xLTEtMA_60b29e7d-6a35-4f0d-8fea-51281418d9a7"
      unitRef="usd">-4819000</us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet>
    <us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMS0xLTEtMTc_2c7cf46a-f4ee-4394-970e-19f8b613587d"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments>
    <us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMy0xLTEtMTc_43b7dffb-51bb-4446-95f6-1809c633b522"
      unitRef="usd">4713000</us-gaap:UnrealizedGainLossOnCashFlowHedgingInstruments>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMS0xLTEtMA_2f291e5b-1a89-40a5-bfe9-793f981430ea"
      unitRef="usd">1663000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTQtMy0xLTEtMA_400662ec-2c97-4526-9dc4-338d36d45aab"
      unitRef="usd">2977000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTUtMS0xLTEtMA_747dd9f4-8ac5-420b-b954-b1fa103a2dce"
      unitRef="usd">2843000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTUtMy0xLTEtMA_d8747e4a-8e82-488a-b297-d97fd374149c"
      unitRef="usd">2306000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTctMS0xLTEtMA_e3206cd1-5847-40a9-8bbb-6f0250a31b5b"
      unitRef="usd">4134000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTctMy0xLTEtMA_1b755395-f3c5-4158-92b8-5828e48dd6ad"
      unitRef="usd">433000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTgtMS0xLTEtMA_f498fdd5-7d9d-486c-be1e-8afef814dd81"
      unitRef="usd">-1099000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTgtMy0xLTEtMA_f9f94045-9c30-4997-ac7d-11aca5e95edf"
      unitRef="usd">1553000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTktMS0xLTEtMA_98203c92-fcac-4520-887d-166a903543ef"
      unitRef="usd">2324000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMTktMy0xLTEtMA_c493b514-c4d7-427c-96db-27b355ca402b"
      unitRef="usd">1404000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjAtMS0xLTEtMA_b11a8a39-1252-4cad-aa10-9eeaac02a579"
      unitRef="usd">6625000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjAtMy0xLTEtMA_27189376-dc89-435a-b792-15f139dff193"
      unitRef="usd">-733000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjEtMS0xLTEtMA_a728d5b4-f301-4a6d-b935-1d3e57327562"
      unitRef="usd">-5542000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjEtMy0xLTEtMA_f85d0e83-e76f-4440-b231-16b17d452621"
      unitRef="usd">-8334000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjItMS0xLTEtMA_d8d26230-6bd8-404b-88d9-d4a801be7a85"
      unitRef="usd">-4518000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjItMy0xLTEtMA_fbdc8a03-f754-4d85-834a-83856279de65"
      unitRef="usd">-8132000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjMtMS0xLTEtMA_aa3333e3-061c-4ae7-8d34-f7270e86352c"
      unitRef="usd">1513000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjMtMy0xLTEtMA_5f3eddfc-35d2-421f-be9a-8892b2b854d8"
      unitRef="usd">-61000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjQtMS0xLTEtMA_52f95bbc-022a-4ae0-b8dd-c62ec35405df"
      unitRef="usd">282000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjQtMy0xLTEtMA_618e3697-4683-4568-ba01-57dde7ce1df4"
      unitRef="usd">-889000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjUtMS0xLTEtMA_2ed59871-f128-4908-ad5f-47c47269ff0a"
      unitRef="usd">56159000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjUtMy0xLTEtMA_a92d2595-834c-47cf-ab95-67a21c9b552c"
      unitRef="usd">5690000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjctMS0xLTEtMA_5c23dc62-bf88-42fa-905f-21cf87e19baf"
      unitRef="usd">20942000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjctMy0xLTEtMA_8ece7f83-00e2-4680-b650-6af663bdf271"
      unitRef="usd">12989000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzAtMS0xLTEtNzAzMg_6e8e0b8f-590c-4369-907a-68a4af95c443"
      unitRef="usd">12425000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzAtMy0xLTEtNzAzMg_2a55d39a-a1e3-4cef-85f3-6e89ab0732e0"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjgtMS0xLTEtMA_39d9d341-155d-44e2-b7eb-773b234140a7"
      unitRef="usd">13152000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjgtMy0xLTEtMA_f9405f80-4371-4616-bdde-0e0e4d911a2f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjktMS0xLTEtMA_18a3687c-2c36-4c86-8c0e-38b423822547"
      unitRef="usd">-46519000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMjktMy0xLTEtMA_7bd7cd6a-4eaa-420a-9777-fbf4a4581d6d"
      unitRef="usd">-12989000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzItMS0xLTEtMA_e19cf6b0-83c6-4ceb-89a0-01fcad1e7a12"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzItMy0xLTEtMA_3d234307-d5b4-4854-bb02-4682dee8e0ea"
      unitRef="usd">50000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzUtMS0xLTEtMA_b050e2bf-c9e4-4026-9372-c2f7abf3e0c9"
      unitRef="usd">3435000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzUtMy0xLTEtMA_299dc343-8f48-4eeb-a6a3-223da4ae5c2d"
      unitRef="usd">207000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzYtMS0xLTEtMA_ec8bc149-83a0-486a-a516-f79578c0d54a"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzYtMy0xLTEtMA_66c58d76-7182-442e-b3e7-bdd085d6b5fb"
      unitRef="usd">142000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzctMS0xLTEtMA_f7d29eb9-dad6-49f7-8f28-6fdb4831a689"
      unitRef="usd">-348000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzctMy0xLTEtMA_e665c47c-cf83-47da-b138-2aa1f524cf19"
      unitRef="usd">-344000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzgtMS0xLTEtMA_51fc155b-49be-497b-a590-002ee15d4af4"
      unitRef="usd">-3783000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzgtMy0xLTEtMA_511d742a-0aab-4212-8d09-dc78a8a1c813"
      unitRef="usd">49307000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzktMS0xLTEtMA_6e3c76fd-b8c3-4707-b1a1-3289ac21cff5"
      unitRef="usd">-295000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfMzktMy0xLTEtMA_22e7006e-6962-4122-a912-91f9443eb5bb"
      unitRef="usd">154000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDAtMS0xLTEtMA_a95bcc08-e398-446a-8ee2-646ced5ba0b8"
      unitRef="usd">5562000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDAtMy0xLTEtMA_ba162940-998d-4545-b841-7e5f047e33bf"
      unitRef="usd">42162000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDEtMS0xLTEtMA_1e46780b-804d-4741-841b-e296aee6d016"
      unitRef="usd">102454000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0646aca58984456ab4ccef54f837d8d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDEtMy0xLTEtMA_28b71300-0f18-480e-89a6-788ac67f2e05"
      unitRef="usd">63025000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDItMS0xLTEtMA_d5c0bc64-d2ea-4da7-aaaa-1f4c7b0ebab3"
      unitRef="usd">108016000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDItMy0xLTEtMA_2e08bdd5-9b5e-4ce2-98ef-7c4b9a2d734d"
      unitRef="usd">105187000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDQtMS0xLTEtMA_eea36494-244a-4bdf-b64e-1189d547e8f7"
      unitRef="usd">19745000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDQtMy0xLTEtMA_f24f979d-041e-4f38-8e98-005985ec06f8"
      unitRef="usd">63570000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDUtMS0xLTEtMA_1b1f75a5-600f-4654-b7bf-2d8a543f6ef5"
      unitRef="usd">11561000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDUtMy0xLTEtMA_3dc47611-e09b-47dc-a4f3-8819043a1043"
      unitRef="usd">1868000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDYtMS0xLTEtMA_b1441811-a4b0-455b-8e17-886ac7f31925"
      unitRef="usd">7389000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zMS9mcmFnOjViNDZhOTllMzMyMjQwNzc4NzI5YzdkODk2MGI0NTkwL3RhYmxlOjc3NmM3OTExNTZhYzRmMjE4M2I4ZWMwYmQwZTJhNzNmL3RhYmxlcmFuZ2U6Nzc2Yzc5MTE1NmFjNGYyMTgzYjhlYzBiZDBlMmE3M2ZfNDYtMy0xLTEtMA_d84d589d-6a7f-439c-949b-d155ed5c983d"
      unitRef="usd">5100000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:SharesOutstanding
      contextRef="i3e003cc982634a42a6004e9be503ae52_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xLTEtMS0w_c6181fce-a3b0-4a34-bb2f-30f937899e87"
      unitRef="shares">232400000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3e003cc982634a42a6004e9be503ae52_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0zLTEtMS0w_d85d2e77-1246-45d4-a09b-b1c1332914be"
      unitRef="usd">2324000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ca8f2e824984cde87c9e7c8204a7b3c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi01LTEtMS0w_ba6bed14-f403-4287-8459-13fe167cea2d"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibc054b078af443cbabc1b10fbff2443f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi03LTEtMS0w_d97fba40-74ec-45a5-aeb9-319abb780ae4"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a49d2f4b5de474392adda95a3719a97_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi05LTEtMS0w_d2071c55-9f22-4b5f-87ab-79732ac4ed3c"
      unitRef="usd">-550511000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a52e4d931ab42eca6b2d9fca0916150_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xMS0xLTEtMA_a6ad77a0-734d-4244-9de4-710e6cc7b056"
      unitRef="usd">-94387000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i158e9c437afe4c1ca6ee15516e6628fc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xMy0xLTEtMA_96e10b97-c04d-4a48-bbe8-239f68cf4ce2"
      unitRef="usd">1442000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0646aca58984456ab4ccef54f837d8d7_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMi0xNS0xLTEtMA_cc2afa46-eb38-41b1-b691-b896337d3b8b"
      unitRef="usd">-641132000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8d09c73619b54b50855522776180722f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNS03LTEtMS0w_edc22e7b-9bc1-4e03-b66c-501425d40fbc"
      unitRef="usd">1725000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNS0xNS0xLTEtMA_d87c27f3-dbfd-4773-b4db-ec043c7a47f6"
      unitRef="usd">1725000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNy0xMS0xLTEtMA_3d1aa9ae-8ba7-4943-9359-a20578580a9e"
      unitRef="usd">-2207000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfNy0xNS0xLTEtMA_5c39fac0-0d38-4143-9ef0-24243abeab89"
      unitRef="usd">-2207000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOC0xMS0xLTEtMA_d4018074-f075-44ff-a6fd-f44bc1e353cb"
      unitRef="usd">-72967000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOC0xNS0xLTEtMA_e83c897e-de7e-40d6-ac80-acfa6c42c2ba"
      unitRef="usd">-72967000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOS0xMS0xLTEtMA_a179db47-346c-4453-870e-f11cc8f07e0f"
      unitRef="usd">-3479000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfOS0xNS0xLTEtMA_f2124805-ac7b-43b5-a416-e95cdbd7c2f7"
      unitRef="usd">-3479000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:ProfitLoss
      contextRef="i694c199e34a14464ac24dbb4f8527e0d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTAtOS0xLTEtMA_95c55aad-2e20-44ab-a172-74803e4c5dd2"
      unitRef="usd">-1964000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iab8dbb45af8c49bd89a1796cc04d5e70_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTAtMTMtMS0xLTA_f7315b3a-2177-41f7-b1af-94adae57b7d1"
      unitRef="usd">-22000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTAtMTUtMS0xLTA_98f5d668-7ba7-4040-992a-48d47ca8fb3b"
      unitRef="usd">-1986000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ib2078cb13265412b8168c6ba2ce01286_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMS0xLTEtMA_2359b4e0-5df7-4ce1-8870-ee1b9758b1e9"
      unitRef="shares">232400000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib2078cb13265412b8168c6ba2ce01286_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMy0xLTEtMA_a49db56e-80ea-4e06-8d40-fc7a610e2acb"
      unitRef="usd">2324000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c7318711e8e4a54ab3c245d19523efd_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtNS0xLTEtMA_2dd08e1b-2ac2-4d5a-bbcf-a5ee62c33473"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c04b66fafeb41b8a7342d389e9ffb71_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtNy0xLTEtMA_5f17a8bb-0105-4be5-80f1-f8e4be6b644d"
      unitRef="usd">1725000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1b332a6da764fdc81bebeb5c634fb23_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtOS0xLTEtMA_d81a0c8f-5a40-489e-b7e5-4fce35216617"
      unitRef="usd">-552475000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i350dd74321534f789de5af89b9350730_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMTEtMS0xLTA_76677a49-3827-4959-8d2a-d9bb885ebb9d"
      unitRef="usd">-168626000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i072ee7c12e4d4852a1510e20124323be_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMTMtMS0xLTA_b1ec1766-9d8c-4881-85ff-ae572fb669ba"
      unitRef="usd">1420000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOjQ0ZjNkMGRmYjIwNjQyOWQ4NWQ3MmU4NDRjZWU1Y2MxL3RhYmxlcmFuZ2U6NDRmM2QwZGZiMjA2NDI5ZDg1ZDcyZTg0NGNlZTVjYzFfMTEtMTUtMS0xLTA_5a7ccaad-9e2b-4b6d-a7d3-6be48d3361b9"
      unitRef="usd">-715632000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ifa6c27cc4a3a4ddfb486d016a99cf741_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xLTEtMS0w_d5ead018-b8e3-471d-b8be-e4191ea980ed"
      unitRef="shares">283248000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifa6c27cc4a3a4ddfb486d016a99cf741_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0zLTEtMS0w_3c76e5a5-09e5-4b81-9085-8021fc641c5a"
      unitRef="usd">2860000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcc158f820b8436c8ea3e1ae61ebfe29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi01LTEtMS0w_5687825f-fab5-401a-813c-11fcffe8921a"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id757d153aff04337af22c39b26a4d290_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi03LTEtMS0w_41150559-f6d3-4590-9195-9ed39a54b929"
      unitRef="usd">1166412000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64bb877dd58241488e79dcedccea8d76_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi05LTEtMS0w_3b64d666-0357-4080-beb3-e558c303ea4a"
      unitRef="usd">-589128000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i360689ad9dcc48f5ab2673194f9a3327_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xMS0xLTEtMA_39106ca6-ec35-4194-8ebe-17920d29fd29"
      unitRef="usd">-93842000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i688702d19c584405b043c3524ab0a5af_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xMy0xLTEtMA_4a6e1ac4-20ff-43a7-91db-dde9930a1c91"
      unitRef="usd">2272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMi0xNS0xLTEtMA_f18d7b2e-f643-4ad9-b2ca-475f5ec155c9"
      unitRef="usd">454574000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i54c2badaff0b467aa1febf6fb3e524e5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNS0xLTEtMS0w_87fd1a1c-e774-4d1f-afe2-3adc21412d26"
      unitRef="usd">348000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i661c83dafe2241a895b55e741b4436cf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNS03LTEtMS0w_f1dac4ae-dbbc-4d16-913c-c58226cf8a0b"
      unitRef="usd">3440000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNS0xNS0xLTEtMA_7cf5cca4-0971-4a7f-bbb7-2d691f96d4c4"
      unitRef="usd">3440000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNy0xMS0xLTEtMA_28eeb28e-ee98-449f-90aa-98a5dedecccc"
      unitRef="usd">249000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfNy0xNS0xLTEtMA_0ca814a6-a1c7-4184-adad-0ccc6b692571"
      unitRef="usd">249000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfOC0xMS0xLTEtMA_c6e36512-bdad-497c-aea3-fa5826841ea2"
      unitRef="usd">-3071000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ief05232174e44d4d869bc9c7f6fa36c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfOC0xMy0xLTEtMA_52ba602d-6fd4-49ac-9143-164f066d1a91"
      unitRef="usd">-15000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfOC0xNS0xLTEtMA_0ce01bd3-4420-4b1a-bf56-aaf64086e94e"
      unitRef="usd">-3086000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ProfitLoss
      contextRef="i908b264e6f8246ac9b4d3f7cd3fcaa0a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTAtOS0xLTEtMA_56b634e4-c807-44dc-a681-f73f8d3b2ae3"
      unitRef="usd">10842000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ief05232174e44d4d869bc9c7f6fa36c9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTAtMTMtMS0xLTA_af3df34b-767d-420e-ac8e-fccaca7a2c49"
      unitRef="usd">223000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTAtMTUtMS0xLTA_c7356e4b-61f4-4ddb-9f04-7f433cad1384"
      unitRef="usd">11065000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="i80b8173d43a74e3b9ec5e6fec2bb9ee4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMS0xLTEtMA_44834c42-3617-4132-b624-842c7e9da8b8"
      unitRef="shares">282900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80b8173d43a74e3b9ec5e6fec2bb9ee4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMy0xLTEtMA_3db0e564-553d-4629-8a8a-1d65fce21cd8"
      unitRef="usd">2860000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i503e8eac77d34290ab10a01273a5714c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtNS0xLTEtMA_3f7ac969-0655-4736-beaf-14922fa29c57"
      unitRef="usd">-34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9ba71926882446f4820f855c07651431_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtNy0xLTEtMA_13d9f4dd-bb3a-4ed4-98af-49c821768e2e"
      unitRef="usd">1169852000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7aa7a07423da4a209024274d4083e38e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtOS0xLTEtMA_0bd27a81-6caf-4d90-af2f-efabdaeed31b"
      unitRef="usd">-578286000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1675ea82d0e47b5b55f50b716c600eb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMTEtMS0xLTA_9b12d221-bb97-4228-b7a5-0067feb728a7"
      unitRef="usd">-97162000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia09428b911314cc0ae886d99b666ca12_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMTMtMS0xLTA_a13015c8-9e24-4263-8430-44f379cbc086"
      unitRef="usd">2480000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV8zNC9mcmFnOmQ3NGFmY2YyNGJiNjRjYmZiYmNmMTA3N2JmMzA1MTY5L3RhYmxlOmMyNDI4NGJhNWRhYjQyODdhZjU3ODMxYTY5ZDU5Y2I5L3RhYmxlcmFuZ2U6YzI0Mjg0YmE1ZGFiNDI4N2FmNTc4MzFhNjlkNTljYjlfMTEtMTUtMS0xLTA_a444d554-e1de-4a37-8806-1973d7371331"
      unitRef="usd">465744000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:BasisOfAccounting
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3MzQ5NQ_965bdeb0-0dee-4634-9c8a-4b58badd06c8">Basis of Presentation&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Sotera Health Company (also referred to herein as the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; &#x201c;us&#x201d; or &#x201c;its&#x201d;), is a global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries with operations primarily in the Americas, Europe and Asia. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate and report in three segments, Sterigenics, Nordion and Nelson Labs. We describe our reportable segments in Note 18, &#x201c;Segment Information&#x201d;. All significant intercompany balances and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent the noncontrolling stockholders&#x2019; proportionate share of the total equity in the Company&#x2019;s consolidated subsidiaries. As of March&#160;31, 2021, our subsidiaries were wholly owned by us, except for noncontrolling interests of 15% and 33% in our two China subsidiaries. We consolidate the results of operations of these subsidiaries with our results of operations and reflect the noncontrolling interests in our two China subsidiaries on our Consolidated Statements of Operations and Comprehensive Income (Loss) as &#x201c;Net income attributable to noncontrolling interests.&#x201d; On March 11, 2021, we purchased the 15% noncontrolling interest that remained from the August 2018 acquisition of Nelson Laboratories Fairfield, Inc. (&#x201c;Nelson Labs Fairfield&#x201d;). This required future purchase was considered mandatorily redeemable, and therefore no earnings were allocated to this noncontrolling interest. See Note 4, &#x201c;Acquisitions&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, we entered into binding agreements to purchase the outstanding noncontrolling interests of 15% and 33% of our two China subsidiaries, respectively. The purchase transactions are expected to close in the second quarter of 2021 for a total purchase price of $8.6 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, we acquired a 60% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada in connection with our acquisition of Iotron Industries Canada, Inc. (&#x201c;Iotron&#x201d;). Refer to Note 4, &#x201c;Acquisitions&#x201d; for additional information. We have determined this to be an investment in a variable interest entity (&#x201c;VIE&#x201d;). The investment is not consolidated as the Company has concluded that we are not the primary beneficiary of the VIE. The Company accounts for the joint venture using the equity method. The investment is reflected within &#x201c;Investment in unconsolidated affiliates&#x201d; on the Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles ("GAAP"), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Interim Financial Statements &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; The accompanying consolidated financial statements include the assets, liabilities, operating results, and cash flows of the Company and its wholly owned subsidiaries. These financial statements are prepared in accordance with U.S. GAAP for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited interim financial statements should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes on Form 10-K for the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfNjQ0_a3d19339-06ad-4c88-ba4e-0453440c2118"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfNjQ0_a67edfb1-83a7-4823-a8b8-91aca7f0e8e1"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ibea64f5f1ac0490180fbbfae53b8d879_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTEyMA_25d7388d-9b3f-42cc-94af-d0286576e02e"
      unitRef="number">0.15</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i94da5f943646463fac66bb29dfdd381e_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTEyNw_d66be3ad-a967-4cf9-805f-9d99509857ff"
      unitRef="number">0.33</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <shc:NumberOfSubsidiariesWithNonControllingInterest
      contextRef="ie80833d87f3a475c9d5cce381fd18476_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3MzQ5Ng_a49e67d3-bb3a-4ad4-9f97-8d33361762c7"
      unitRef="subsidiary">2</shc:NumberOfSubsidiariesWithNonControllingInterest>
    <shc:NumberOfSubsidiariesWithNonControllingInterest
      contextRef="ie80833d87f3a475c9d5cce381fd18476_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3NzM2OQ_71822073-38ed-434e-8c4f-ab1329abe6f9"
      unitRef="subsidiary">2</shc:NumberOfSubsidiariesWithNonControllingInterest>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i5def62b5b7f448059d757311fe268fc9_I20210311"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTY0OTI2NzQ0NzM1OQ_d0e04860-77cd-41eb-ac44-c1d40c09cb9b"
      unitRef="number">0.15</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="ib950bce5fb424f4ebc039f76379610fc_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMTk5NQ_7210fa93-9cc9-4555-9beb-ad0d1eabd153"
      unitRef="number">0.15</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <shc:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage
      contextRef="i90ff278d560040b986f61d550e890c69_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjAwMg_0350fa75-94ee-4434-bec8-cb89a7b0452d"
      unitRef="number">0.33</shc:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage>
    <shc:NumberOfSubsidiariesWithNonControllingInterest
      contextRef="ie80833d87f3a475c9d5cce381fd18476_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA3MzUwNQ_efd635cb-6037-4d0b-a235-a1ff89467d97"
      unitRef="subsidiary">2</shc:NumberOfSubsidiariesWithNonControllingInterest>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1fd7503543e240e4b13682cf4007a74f_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMzg0ODI5MDcwOTU4MQ_b86fcdaa-fbeb-4d90-8795-630f6bdea3af"
      unitRef="usd">8600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia271e03429544e7c88a278c25dc1246e_I20200731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjE2Nw_ce715d2d-5dd4-4721-b88a-40910e31aaba"
      unitRef="number">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:UseOfEstimates
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80MC9mcmFnOjU1OGNjZmJmMmNlZTQ4NDNhOGRiYmUyN2E1ZGNmYmUyL3RleHRyZWdpb246NTU4Y2NmYmYyY2VlNDg0M2E4ZGJiZTI3YTVkY2ZiZTJfMjc0ODc3OTA4MTc1NA_ede130f2-37f9-451d-a389-53e0b96f4a29">Use of Estimates &#x2013; In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles ("GAAP"), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:AccountingChangesAndErrorCorrectionsTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80My9mcmFnOjZkNWFlMjg5NGI3OTQ2ZjRiNGVkNDcxOTA4YTMyOTE0L3RleHRyZWdpb246NmQ1YWUyODk0Yjc5NDZmNGI0ZWQ0NzE5MDhhMzI5MTRfMjc0ODc3OTA3OTUwMw_df9ba806-86c7-45f0-83b4-b5087a43f44d">Recent Accounting Standards&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASU&#x2019;s Issued But Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Jumpstart Our Business Startups Act of 2012, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. As an emerging growth company, we have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies or at which time we conclude it is appropriate to avail ourselves of early adoption provisions of applicable standards. As a result, our results of operations and financial statements may not be comparable to the results of operations and financial statements of other companies who have adopted the new or revised accounting standards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(&#x201c;ASU&#x201d;) 2016-13, Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2016-13&#x201d;): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and subsequently issued additional guidance that modified ASU 2016-13. The standard requires an entity to change its accounting approach in determining impairment of certain financial instruments, including trade receivables, from an &#x201c;incurred loss&#x201d; to a &#x201c;current expected credit loss&#x201d; model. We intend to adopt the standard as of January 1, 2022. We are currently assessing the effect that ASU 2016-13 will have on our financial position, results of operations, and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, the FASB issued &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard simplifies the accounting for income taxes and makes a number of changes meant to add or clarify guidance on accounting for income taxes. This update is effective for annual financial statement periods beginning after March 15, 2021 and interim periods beginning after March 15, 2022, with early adoption permitted in any interim period for which financial statements have not yet been filed. We are currently assessing the effect that ASU 2019-12 will have on our financial position, results of operations, and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountingChangesAndErrorCorrectionsTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80My9mcmFnOjZkNWFlMjg5NGI3OTQ2ZjRiNGVkNDcxOTA4YTMyOTE0L3RleHRyZWdpb246NmQ1YWUyODk0Yjc5NDZmNGI0ZWQ0NzE5MDhhMzI5MTRfMjc0ODc3OTA3OTUwMg_ddedd24c-0892-4f6f-89b1-7d99f5a850b9">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ASU&#x2019;s Issued But Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Jumpstart Our Business Startups Act of 2012, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. As an emerging growth company, we have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies or at which time we conclude it is appropriate to avail ourselves of early adoption provisions of applicable standards. As a result, our results of operations and financial statements may not be comparable to the results of operations and financial statements of other companies who have adopted the new or revised accounting standards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(&#x201c;ASU&#x201d;) 2016-13, Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASU 2016-13&#x201d;): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Measurement of Credit Losses on Financial Instruments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and subsequently issued additional guidance that modified ASU 2016-13. The standard requires an entity to change its accounting approach in determining impairment of certain financial instruments, including trade receivables, from an &#x201c;incurred loss&#x201d; to a &#x201c;current expected credit loss&#x201d; model. We intend to adopt the standard as of January 1, 2022. We are currently assessing the effect that ASU 2016-13 will have on our financial position, results of operations, and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, the FASB issued &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The standard simplifies the accounting for income taxes and makes a number of changes meant to add or clarify guidance on accounting for income taxes. This update is effective for annual financial statement periods beginning after March 15, 2021 and interim periods beginning after March 15, 2022, with early adoption permitted in any interim period for which financial statements have not yet been filed. We are currently assessing the effect that ASU 2019-12 will have on our financial position, results of operations, and disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMjc0ODc3OTA3MDMxMA_441d0ce2-61f3-4012-ad9c-e53a98cb3582">Revenue Recognition&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows disaggregated net revenues from contracts with external customers by timing of revenue and by segment for the three months ended March&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;131,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;157,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;131,151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;55,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;212,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;117,280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23,625&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;47,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;188,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, and December&#160;31, 2020, contract assets included in prepaid expenses and other current assets on the Consolidated Balance Sheets totaled approximately $14.1 million and $12.7 million, respectively, resulting from revenue recognized over time in excess of the amount billed to the customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When we receive consideration from a customer prior to transferring goods or services under the terms of a sales contract, we record deferred revenue, which represents a contract liability. Deferred revenue totaled $6.0 million and $6.1 million at March&#160;31, 2021 and December&#160;31, 2020, respectively. We recognize deferred revenue after all revenue recognition criteria are met.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMjc0ODc3OTA3MDMxMQ_ef770d72-3027-45d6-be3d-91cfc14c1f9d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows disaggregated net revenues from contracts with external customers by timing of revenue and by segment for the three months ended March&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;131,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;157,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;131,151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;55,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;212,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Point in time&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;140,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Over time&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;117,280&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23,625&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;47,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;188,200&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4e845ef858f4d2cbf8e34065ae83f9d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi0xLTEtMS0w_fe95062b-9d0a-4d3a-9308-e12738b3c6be"
      unitRef="usd">131151000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81508df42a2c41ae99039fb5550d92c7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi0zLTEtMS0w_f7f56886-9737-4789-8534-834bb6f585dd"
      unitRef="usd">25918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e40cba4c0a04e228634ff48d54110b0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi01LTEtMS0w_908b14d1-2339-4887-8fb7-e28c65d1ff84"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide0e38a11c4d4065969f8f8fe57c3865_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMi03LTEtMS0w_97fcee00-77a6-4226-9614-913a95f130cf"
      unitRef="usd">157069000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1abe226e0f964cdda9aa352b55dd6908_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy0xLTEtMS0w_6c6c0955-e5f2-493c-8c10-1455192042db"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73baed61d2934ccca236804cc00d4746_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy0zLTEtMS0w_b3751bab-ce74-4183-86ce-688b6a04c87a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i538e36e8cbfb418baadf68b21ca433e2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy01LTEtMS0w_11a8e010-1843-449c-91d5-a0b05dc4cdcb"
      unitRef="usd">55079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58d1ac8931a14b9689bbd93ab687cb9b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfMy03LTEtMS0w_24958dc4-d674-4298-b906-997b0c0bf95c"
      unitRef="usd">55079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i549e8b5be7d14c24ac0bd3a892096184_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC0xLTEtMS0w_a0b41600-5a2a-4f92-8c7a-6665b98c5204"
      unitRef="usd">131151000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i604e6f09c9514a4c92c9b88b13bbfd5e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC0zLTEtMS0w_bc284ad0-6f45-491f-b5bf-c65b442be8a2"
      unitRef="usd">25918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie44a1e9c62eb48bb91f1032b3dd61367_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC01LTEtMS0w_7e98b039-e132-4abe-b289-5411cfefe3b2"
      unitRef="usd">55079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmVkNjVlNTllZTNmZTQ0YjdiOTA3NWE5ZDk1MWEzMWUxL3RhYmxlcmFuZ2U6ZWQ2NWU1OWVlM2ZlNDRiN2I5MDc1YTlkOTUxYTMxZTFfNC03LTEtMS0w_2297d619-4f49-48dc-a857-88bc083c548b"
      unitRef="usd">212148000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74f51f9869464d0992847aa161928404_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi0xLTEtMS0w_1f47db5e-0bb8-4421-ae9a-c0ea57fbd81c"
      unitRef="usd">117280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42a63ee00aca4032b612c80c0fd3c9c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi0zLTEtMS0w_01199b21-0c6c-4062-aa28-0aaabe6ad6e1"
      unitRef="usd">23625000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i023f2492fe3d4a8d8430927b2fd77519_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi01LTEtMS0w_e052bea9-73bb-4aea-8b26-ab364976e212"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c6aca23a9ae486a9eb582a53a5bb38b_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMi03LTEtMS0w_d3f1d3b9-fada-4cea-bd9b-5e20d809932f"
      unitRef="usd">140905000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffacfedf64e04109b53607b1570fdc92_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy0xLTEtMS0w_ad7d5d45-7704-4a33-9455-49bd9c92d49c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i842c27cb13e145de9f7c92ab5ea4f054_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy0zLTEtMS0w_e96597a6-b318-46cd-b7ee-8c2484b9225e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieabfd129bc4847e8afad78a76824be56_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy01LTEtMS0w_2b8c2e4c-5b11-44f7-8bc3-d460f84ccf57"
      unitRef="usd">47295000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e574934364343aaad0a65c6a4d6628a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfMy03LTEtMS0w_efab3e54-c00c-4bb8-ac5c-e5a6860dae79"
      unitRef="usd">47295000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89a8f5f3a462461d9ff69850cfe543dc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC0xLTEtMS0w_dc078854-dab1-4a4a-b716-2cbf23b3c2a1"
      unitRef="usd">117280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50ef6a0932a74cdc81d96d88f7ab2485_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC0zLTEtMS0w_3e28c993-c105-4e3f-a633-28532aa2657b"
      unitRef="usd">23625000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0203680793e4fb8a12e0bdf8927352d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC01LTEtMS0w_6a9f9326-e5c6-485e-986a-7d9b14843f40"
      unitRef="usd">47295000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RhYmxlOmNlOGEwMzc3YjY4MjQ1YTZiNzNiYWZhYWEyNTUzNjY3L3RhYmxlcmFuZ2U6Y2U4YTAzNzdiNjgyNDVhNmI3M2JhZmFhYTI1NTM2NjdfNC03LTEtMS0w_0bccb7c3-61f5-45a8-8416-6a62bc955dd8"
      unitRef="usd">188200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMzUw_a3b15def-07e6-469e-acb2-438ecf69e9aa"
      unitRef="usd">14100000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfMzU3_e2283cb6-780c-480b-88d2-195bd118526f"
      unitRef="usd">12700000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfNjgz_35d58c0c-5730-490a-a592-570d98434174"
      unitRef="usd">6000000.0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80Ni9mcmFnOjZlN2YwZGVhZmJkNjRhMDk4NTJjZmY0ODYzZjRmYzIzL3RleHRyZWdpb246NmU3ZjBkZWFmYmQ2NGEwOTg1MmNmZjQ4NjNmNGZjMjNfNjkw_3e7c1b35-2fa6-4eab-bbd5-1992cab7e7b1"
      unitRef="usd">6100000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA3NjY4Nw_c506bed4-d4c1-4a1b-872d-bdf04893d7b8">Acquisitions&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of BioScience Laboratories, LLC&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On March 8, 2021, we acquired BioScience Laboratories, LLC (&#x201c;BioScience&#x201d;) for approximately $13.2 million, net of $0.8 million of cash acquired plus the contemporaneous repayment of BioScience's outstanding debt of $1.9 million. BioScience is a provider of outsourced topical antimicrobial product testing in the pharmaceutical, medical device, and consumer products industries with one location in Bozeman, Montana.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The purchase price of BioScience was allocated to the underlying assets acquired and liabilities assumed based upon management's estimated fair values at the date of acquisition. Changes to the allocation of the purchase price may occur as &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;these measurements are completed. Approximately $8.4 million of goodwill was recorded related to the BioScience acquisition, representing the excess of the purchase price over preliminary estimated fair values of all the assets acquired and liabilities assumed. The Company funded this acquisition using available cash. The acquisition price and the results of operations for this acquired entity are not material in relation to the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Mandatorily Redeemable Noncontrolling Interest - Nelson Labs Fairfield&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11, 2021, we completed the acquisition of the remaining 15% ownership of Nelson Labs Fairfield for $12.4 million, resulting in a gain of $1.2 million included in &#x201c;Other expense (income), net&#x201d; in the Consolidated Statements of Operations and Comprehensive Income (Loss) relative to the $13.6 million previously accrued. Pursuant to the terms of the August 2018 acquisition, we initially acquired 85% of the equity interests of Nelson Labs Fairfield in August 2018 and were obligated to acquire the remaining 15% noncontrolling interest within three years from the date of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acquisition of Iotron Industries Canada, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2020, we acquired Iotron Industries Canada, Inc.(&#x201c;Iotron&#x201d;) for approximately $105.2 million. Iotron was an independent contact sterilizer with two North American locations in Vancouver, Canada, and Columbia City, Indiana. Each location uses proprietary high energy electron beam technology to process products for orthopedic, medical device, plastics, and agricultural businesses. The acquisition was financed by the issuance of $100.0 million of First Lien Notes due 2026. Refer to Note 9, &#x201c;Long-Term Debt&#x201d; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of this acquisition, we also acquired Iotron&#x2019;s 60% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada. The joint venture is accounted for using the equity method. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The opening balance sheet for the Iotron acquisition reflects the net tangible and intangible assets acquired and liabilities assumed at their preliminary estimated fair values at the acquisition date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary estimated fair value of the underlying acquired assets and assumed liabilities of the Iotron acquisition and the measurement period adjustments recognized during the three months ended March&#160;31, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Allocation of purchase price to the fair value of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;net assets acquired (net of cash acquired):&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount recognized as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount recognized as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;69,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;51,904&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;42,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;18,158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Working capital, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in unconsolidated affiliate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumed long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(2,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets/liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(15,144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total estimated purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;105,187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of all the above assets acquired and liabilities assumed are preliminary in nature since the fair value analyses are not yet complete, including finalizing third party appraisals and analyzing the tax attributes of the fair value adjustments. Changes to the allocation of the purchase price may occur as these analyses are completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately $51.9 million of goodwill was recorded related to the Iotron acquisition, representing the excess of the purchase price over preliminary estimated fair values of all the assets acquired and liabilities assumed. The fair value allocated to goodwill and tangible and intangible assets are deductible for tax purposes. The qualitative elements of goodwill primarily represent the expanded future growth opportunities for the combined company and the addition of Iotron&#x2019;s highly skilled workforce. A preliminary valuation was recorded of approximately $39.1 million and $3.6 million for intangible assets as part of the acquisition related to customer relationships and employee non-compete agreements, respectively. The estimated useful lives of the identifiable finite-lived intangible assets range from 5 to 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Iotron&#x2019;s results of operations are included in our consolidated financial statements from the date of the transaction within the Sterigenics segment. The unaudited pro forma consolidated results for the three months ended March&#160;31, 2020, are reflected in the pro forma table below had the transaction occurred on January 1, 2020. The following unaudited supplemental pro forma financial information is based on our historical consolidated financial statements and Iotron&#x2019;s historical consolidated financial statements, as adjusted for amortization of acquired intangible assets, an increase in interest expense resulting from interest on the First Lien Notes to finance the acquisition, and to reflect the change in the estimated income tax rate for federal and state purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Iotron acquisition, we incurred approximately $1.0&#160;million in transaction costs for the three months ended March&#160;31, 2020, which were included in &#x201c;Selling, general and administrative expenses&#x201d; in the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfNDk0NzgwMjMzNzMyNQ_65e11a63-1515-4fa3-a552-b76b14a2d4d5"
      unitRef="usd">13200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness
      contextRef="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NjQyNA_ce429d0b-1152-41cb-b9a5-af04568ba7f4"
      unitRef="usd">800000</us-gaap:CashAcquiredInExcessOfPaymentsToAcquireBusiness>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ0OTAzNw_ba9b46ab-e5c8-45c4-90f4-c67425356485"
      unitRef="usd">1900000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:Goodwill
      contextRef="i95626988340341728b2d210065ff4f47_I20210308"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1MTU4NA_8c5c147f-b0a2-4c8c-b73c-8524bdb53e97"
      unitRef="usd">8400000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i5def62b5b7f448059d757311fe268fc9_I20210311"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA4MTcwMg_730b2c25-c168-4d50-a185-952771306213"
      unitRef="number">0.15</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ica603348fe30465dae402c8b63a1b31a_D20210311-20210311"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NDExNw_3b74ae35-e823-4e6e-b5c5-3de5ffbada75"
      unitRef="usd">12400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
      contextRef="ica603348fe30465dae402c8b63a1b31a_D20210311-20210311"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NDEyMg_982495c9-b0f9-4ecc-86ae-f579471c0eca"
      unitRef="usd">1200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmount
      contextRef="ie45025c772774d5c927c39b60442abf6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NjM2NA_af548e08-2490-4a06-827c-c1282d5b5be9"
      unitRef="usd">13600000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmount>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i4b6a3228292f4d16b55b1cd7b0695816_I20180831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA4MTcyMg_1b723425-b60f-4cd1-877f-a60f43357fd9"
      unitRef="number">0.85</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i5def62b5b7f448059d757311fe268fc9_I20210311"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA4MTc0MQ_8eed5db9-6fa0-42a8-94ca-96ca9c301a04"
      unitRef="number">0.15</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i768d601b59aa4005863b05a9a1a4a15c_D20200731-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NTYxMQ_bab950b4-db7f-4a05-a3a3-c1b7b20a8a43"
      unitRef="usd">105200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i051178a4a64d449f87f75f6e19f87b98_D20200731-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1NjgxMQ_2d3e62fa-80c2-4db9-80dc-f9cccd601056"
      unitRef="usd">100000000.0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ia271e03429544e7c88a278c25dc1246e_I20200731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjE5OTAyMzI2MDI4NA_a776c331-bb87-45fd-bb44-10c379c13171"
      unitRef="number">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA3NjY4OQ_15e1406e-334d-4cb0-8466-567eb9a5e5d3">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary estimated fair value of the underlying acquired assets and assumed liabilities of the Iotron acquisition and the measurement period adjustments recognized during the three months ended March&#160;31, 2021, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.423%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Allocation of purchase price to the fair value of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;net assets acquired (net of cash acquired):&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount recognized as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Measurement Period Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount recognized as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;69,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;51,904&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;42,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;18,158&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Working capital, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,117&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment in unconsolidated affiliate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumed long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(2,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets/liabilities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(15,144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total estimated purchase price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;105,187&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMi0xLTEtMS0w_f22f727f-c98b-4531-93d1-ddebe0d94e80"
      unitRef="usd">69046000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMi0zLTEtMS0w_ebc163ea-0039-4010-83a4-90a9f1257966"
      unitRef="usd">-17142000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMi01LTEtMS0w_c892b221-b5de-4ce3-ad02-e72e8107bc49"
      unitRef="usd">51904000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMy0xLTEtMS0w_a7ecee59-891e-4689-99f7-bdb620c76004"
      unitRef="usd">16427000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMy0zLTEtMS0w_bcdc2d83-8be3-44a7-be35-0a289c4d7719"
      unitRef="usd">26273000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfMy01LTEtMS0w_f1ab9724-6ce2-4bf7-8658-d224b20cbf7b"
      unitRef="usd">42700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNC0xLTEtMS0w_429757fb-9be6-4e2b-a75a-5a92c50b2886"
      unitRef="usd">13812000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNC0zLTEtMS0w_a2a4f0e7-19f3-491e-b210-8a222040d61f"
      unitRef="usd">4346000</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNC01LTEtMS0w_02c57f92-8ae6-4347-abe1-b6e80cc82897"
      unitRef="usd">18158000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNS0xLTEtMS0w_708d39a2-c832-4a09-845c-249b38341e31"
      unitRef="usd">1115000</shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet>
    <shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNS0zLTEtMS0w_4c5404c1-5b12-4dd2-8d8b-1654282efac7"
      unitRef="usd">2000</shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet>
    <shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNS01LTEtMS0w_0e9ef553-98f4-468a-bd43-8ab496a6d450"
      unitRef="usd">1117000</shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet>
    <shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNi0xLTEtMS0w_45d908f5-5132-4183-806a-6c0ce62ca489"
      unitRef="usd">12881000</shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate>
    <shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNi0zLTEtMS0w_7ec85c59-1e6a-4bed-a76b-de173e5bec76"
      unitRef="usd">-4181000</shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate>
    <shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNi01LTEtMS0w_cd7c1096-096b-4454-b681-90e357611504"
      unitRef="usd">8700000</shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNy0xLTEtMS0w_5e990be4-9cdc-4cc4-8c2b-cf579e35150b"
      unitRef="usd">2248000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNy0zLTEtMS0w_00d56189-27bd-4de3-9ea0-83dd2d29124c"
      unitRef="usd">0</shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfNy01LTEtMS0w_fb3ffc9e-7935-4e50-aa82-16cc4ae88730"
      unitRef="usd">2248000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOC0xLTEtMS0w_080deca9-a75d-494b-8da7-d796bfe1bd82"
      unitRef="usd">-5846000</shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet>
    <shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOC0zLTEtMS0w_cbd22da5-b40d-4ac3-bb6d-bfa9eeda3cea"
      unitRef="usd">-9298000</shc:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet>
    <shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOC01LTEtMS0w_6182571f-df3e-402d-8f06-f6f93b3c7127"
      unitRef="usd">-15144000</shc:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i1a15b1fe0510401b9e96b9115f0dd667_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOS0xLTEtMS0w_af0eb497-2174-4f33-8770-842b19f3fe86"
      unitRef="usd">105187000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOS0zLTEtMS0w_7d6f8093-e9ce-4914-a964-80dfbcf2040a"
      unitRef="usd">0</us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmFmOWVmNGU2ZGEwODRlZjBhODQxOGEyNmEzZmQ1ZjUxL3RhYmxlcmFuZ2U6YWY5ZWY0ZTZkYTA4NGVmMGE4NDE4YTI2YTNmZDVmNTFfOS01LTEtMS0w_0a0697cc-722e-429a-a056-fd3beca86755"
      unitRef="usd">105187000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="i26503e2068d94590979ce52f141dc71c_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0NA_9030cc8b-d0b2-4ecc-b2c3-68b23a0aac1f"
      unitRef="usd">51900000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i768d601b59aa4005863b05a9a1a4a15c_D20200731-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0NA_c43fb396-f48d-45b4-8e9e-425261558284"
      unitRef="usd">51900000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="idfbc21d1467d4e52911ec1b5501bcb5d_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMTY0OTI2NzQ1MjcyOQ_670c362a-ee51-4226-bafa-1d1ef0477cb2"
      unitRef="usd">39100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ia071d112ecca401ea6335a9263fe2923_I20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjE5Mw_29ec8a27-5409-46c7-a77e-746e861adfca"
      unitRef="usd">3600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="id4fdf4d7028e46a4b31f337064b0f0bf_D20200731-20200731"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjQ0NA_29e487ff-7158-4e55-a64a-dc5545bd3b70">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i405041e3ed794abc80989f15142f5586_D20200731-20200731"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjQ1MA_7ca98687-307d-48ef-ba3d-3386fa9efe85">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMjc0ODc3OTA3NjY5MA_d050432b-8de8-4219-879a-b82a3e4741af">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;194,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmZhMzllNGYyZWI4ODRjOTc5ODNhMDY5ODIzZDEzMjhkL3RhYmxlcmFuZ2U6ZmEzOWU0ZjJlYjg4NGM5Nzk4M2EwNjk4MjNkMTMyOGRfMi0zLTEtMS0w_cfa3630d-3d84-4794-8660-c05b5f9495d1"
      unitRef="usd">194402000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RhYmxlOmZhMzllNGYyZWI4ODRjOTc5ODNhMDY5ODIzZDEzMjhkL3RhYmxlcmFuZ2U6ZmEzOWU0ZjJlYjg4NGM5Nzk4M2EwNjk4MjNkMTMyOGRfMy0zLTEtMS0w_c76f317b-dc63-4241-a1d0-24511909199e"
      unitRef="usd">-889000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie7f4d0c263a04710a93bbf997b284b04_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV80OS9mcmFnOmFkN2E2MDhhMWEwNTRiZGM4NWE5NzY0YTA2YmM1MjBmL3RleHRyZWdpb246YWQ3YTYwOGExYTA1NGJkYzg1YTk3NjRhMDZiYzUyMGZfMzQ2MA_cdebd56f-3a89-40a9-b326-035a579e283e"
      unitRef="usd">1000000.0</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RleHRyZWdpb246MzkzNDRmYTQxZDlmNDg2NWE5MGQ4ODc1YmRiZWUzNDZfMjc0ODc3OTA2OTUwNw_c876585f-d169-4682-8e32-d5d1c26038dc">Inventories&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;29,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,617&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;33,500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserve for excess and obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;33,375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RleHRyZWdpb246MzkzNDRmYTQxZDlmNDg2NWE5MGQ4ODc1YmRiZWUzNDZfMjc0ODc3OTA2OTUwOA_69fdd3d9-8d4c-4444-8c34-b70328ad21de">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;29,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,617&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;33,500&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserve for excess and obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;33,375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMi0xLTEtMS0w_5e260fab-4322-4da7-8597-23a5caad85e2"
      unitRef="usd">29512000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMi0zLTEtMS0w_26c5ebb9-ae7a-4415-80f1-5d0fb2b69e03"
      unitRef="usd">29114000</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryWorkInProcess
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMy0xLTEtMS0w_e59cf724-e0e8-4563-ae88-8e292057aa1b"
      unitRef="usd">1371000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfMy0zLTEtMS0w_c1446ad0-802e-4afb-911a-a26eef76a37c"
      unitRef="usd">846000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoods
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNC0xLTEtMS0w_1ae605bd-4010-4825-a4e4-ba2c4f427822"
      unitRef="usd">2617000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNC0zLTEtMS0w_254858e0-3268-4577-9ca2-cf85a1e9682c"
      unitRef="usd">4256000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryGross
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNS0xLTEtMS0w_b7b73023-5ccd-4af6-a489-cae956269fef"
      unitRef="usd">33500000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNS0zLTEtMS0w_9e98e6fb-47a5-417d-b9d6-a713f15f8770"
      unitRef="usd">34216000</us-gaap:InventoryGross>
    <us-gaap:InventoryAdjustments
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNi0xLTEtMS0w_adac526e-a0e2-43b6-8e75-2887c85c700d"
      unitRef="usd">125000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryAdjustments
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNi0zLTEtMS0w_77734db1-96c0-4c6d-8561-63089e99ddb7"
      unitRef="usd">123000</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNy0xLTEtMS0w_910ee344-5dca-462d-b06c-711316823b7f"
      unitRef="usd">33375000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81Mi9mcmFnOjM5MzQ0ZmE0MWQ5ZjQ4NjVhOTBkODg3NWJkYmVlMzQ2L3RhYmxlOmRkNTRmYTQzMTk5OTRlZWRiMjY2ZTdjZTZmNTIwNGE1L3RhYmxlcmFuZ2U6ZGQ1NGZhNDMxOTk5NGVlZGIyNjZlN2NlNmY1MjA0YTVfNy0zLTEtMS0w_2a7cec6b-e845-41c4-80e1-757226da4b17"
      unitRef="usd">34093000</us-gaap:InventoryNet>
    <us-gaap:OtherCurrentAssetsTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RleHRyZWdpb246Y2ZiZGU1ZWY4YWM3NDU4YjhlNmUyNWZmODA0OWJmZGFfMjc0ODc3OTA2OTU2OQ_97d6f6ed-64b6-47a3-959d-14834ba31a94">Prepaid Expenses and Other Current Assets&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consisted primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,356&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid business insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,212&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14,133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance and indemnification receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid maintenance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;432&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Value added tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid software licensing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;69,758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RleHRyZWdpb246Y2ZiZGU1ZWY4YWM3NDU4YjhlNmUyNWZmODA0OWJmZGFfMjc0ODc3OTA2OTU2Nw_f76c09ed-f3f1-46b6-ae2b-c9ba4dd91ce0">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consisted primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.642%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,356&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid business insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid rent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,212&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer contract assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14,133&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance and indemnification receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid maintenance contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;432&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Value added tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,385&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid software licensing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;69,758&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMi0xLTEtMS0w_ed2b0c95-984d-4c38-9124-ba2f8de88c27"
      unitRef="usd">25356000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMi0zLTEtMS0w_2ae62364-962f-4201-aa8d-f04ef5110b4b"
      unitRef="usd">22883000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidInsurance
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMy0xLTEtMS0w_fe82e055-e107-4e55-8969-caa608114c46"
      unitRef="usd">7421000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMy0zLTEtMS0w_4c07bf56-9926-4e5b-a4d4-6ed9ea3d3d06"
      unitRef="usd">10403000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidRent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNC0xLTEtMS0w_5a6d8c93-61f5-47a0-a791-9a57dc63886b"
      unitRef="usd">1212000</us-gaap:PrepaidRent>
    <us-gaap:PrepaidRent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNC0zLTEtMS0w_c72d2089-b67f-4bc8-9aa8-f92ecdf85a03"
      unitRef="usd">1170000</us-gaap:PrepaidRent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNS0xLTEtMS0w_9c18aae1-4348-458b-bb24-00b7dd7e0918"
      unitRef="usd">14133000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNS0zLTEtMS0w_c0259bba-6e0d-49ab-8110-ca2aac10a433"
      unitRef="usd">12670000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNi0xLTEtMS0w_8df032fe-a303-4a43-b758-a4eca0c0d0e4"
      unitRef="usd">2751000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:InsuranceSettlementsReceivableCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNi0zLTEtMS0w_7af764ca-3bb1-4cef-8912-346f2af47191"
      unitRef="usd">2751000</us-gaap:InsuranceSettlementsReceivableCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNy0xLTEtMS0w_7ba50425-2647-43a0-bdee-d251d31e73e0"
      unitRef="usd">797000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfNy0zLTEtMS0w_67ee480b-87e9-4d06-962b-81fe1a3ce99d"
      unitRef="usd">673000</us-gaap:DepositsAssetsCurrent>
    <shc:PrepaidMaintenanceContractsCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOC0xLTEtMS0w_c8be64dd-fe30-47c4-a2fb-8a630ffa6c3f"
      unitRef="usd">432000</shc:PrepaidMaintenanceContractsCurrent>
    <shc:PrepaidMaintenanceContractsCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOC0zLTEtMS0w_8ed4b360-7ee2-4955-b0b2-ecde87194ddc"
      unitRef="usd">404000</shc:PrepaidMaintenanceContractsCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOS0xLTEtMS0w_0857100e-5876-46ff-b170-62d6b694d97d"
      unitRef="usd">1385000</us-gaap:ValueAddedTaxReceivableCurrent>
    <us-gaap:ValueAddedTaxReceivableCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfOS0zLTEtMS0w_92279463-3060-448d-8731-e21b9fe09710"
      unitRef="usd">2094000</us-gaap:ValueAddedTaxReceivableCurrent>
    <shc:PrepaidSoftwareLicensingCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTAtMS0xLTEtMA_e35f2755-d3c0-4048-93f4-9f3c6e792930"
      unitRef="usd">1299000</shc:PrepaidSoftwareLicensingCurrent>
    <shc:PrepaidSoftwareLicensingCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTAtMy0xLTEtMA_2ddf09fc-c91b-46f3-a792-81861623df80"
      unitRef="usd">1181000</shc:PrepaidSoftwareLicensingCurrent>
    <us-gaap:Supplies
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTEtMS0xLTEtMA_35d84bba-5246-4aba-9d85-5e9c1108e852"
      unitRef="usd">3210000</us-gaap:Supplies>
    <us-gaap:Supplies
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTEtMy0xLTEtMA_098ff70a-b176-42dd-88fc-2e1be12f0357"
      unitRef="usd">2715000</us-gaap:Supplies>
    <us-gaap:OtherAssetsCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTItMS0xLTEtMA_c85ddc9c-6614-4323-ba4c-a68fbd49a5b0"
      unitRef="usd">11762000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTItMy0xLTEtMA_8779f754-e8c8-49c3-9498-fc4b0d2b2686"
      unitRef="usd">8020000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTMtMS0xLTEtMA_a45468e9-0ecf-4e6f-bd9c-b64ca5243248"
      unitRef="usd">69758000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81NS9mcmFnOmNmYmRlNWVmOGFjNzQ1OGI4ZTZlMjVmZjgwNDliZmRhL3RhYmxlOmNjM2JiNTIwMjY5NTRmNGY5YmE0MTA2OGUyYTcwZTViL3RhYmxlcmFuZ2U6Y2MzYmI1MjAyNjk1NGY0ZjliYTQxMDY4ZTJhNzBlNWJfMTMtMy0xLTEtMA_10627f3f-de8f-46ec-bb0a-27e8838aa2de"
      unitRef="usd">64964000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNA_9186ec8b-c212-4d81-9b7f-380caeb3751b">Goodwill and Other Intangible Assets&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes to goodwill during the three months ended March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;683,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;287,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;144,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,115,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;BioScience acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Iotron acquisition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;measurement period adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes due to foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;664,087&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;291,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;151,301&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,106,728&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;662,509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;322,685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;89,604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;39,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land-use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9,454&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sealed source and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;243,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;98,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,011,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;463,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regulatory licenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;82,807&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names / trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,952&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;108,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,119,803&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;463,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;634,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;309,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land-use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sealed source and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;240,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;977,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regulatory licenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names / trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,085,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#x2019;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another 10 years license period as Nordion has demonstrated over its 70 years of history.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts include the impact of foreign currency translation. Fully amortized amounts are written off. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for other intangible assets was $22.3&#160;million ($5.8&#160;million is included in &#x201c;Cost of revenues&#x201d; and $16.5&#160;million in &#x201c;Selling, general and administrative expenses&#x201d;) in the Consolidated Statements of Operations and Comprehensive Income (Loss) and $19.9&#160;million ($5.3&#160;million is included in &#x201c;Cost of revenues&#x201d; and $14.6 million in &#x201c;Selling, general and administrative expenses&#x201d;) in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated aggregate amortization expense for finite-lived intangible assets for each of the next five years and thereafter is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;65,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;80,665&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;80,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;79,882&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;41,982&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;198,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;547,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average remaining useful life of the finite-lived intangible assets was approximately 10 years as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNQ_7d38971a-7c50-485b-bc5d-1314c19c5c79">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes to goodwill during the three months ended March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;683,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;287,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;144,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,115,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;BioScience acquisition&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Iotron acquisition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;measurement period adjustments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes due to foreign currency exchange rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;664,087&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;291,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;151,301&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,106,728&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="iae31afbafbf247098cb8c0b7be49d5c4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS0xLTEtMS0w_e7d54666-290e-4635-bd47-eeb2ede0579d"
      unitRef="usd">683481000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5ee65cf8cf1c49538dd47438eaedfb14_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS0zLTEtMS0w_d0a75d67-d342-4c1c-b7fc-ce562c36a2a6"
      unitRef="usd">287932000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2b8b3c8568084221a2ad859b39b4ec4a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS01LTEtMS0w_e9f97614-bc55-402c-ac1b-e39af2fbd6e9"
      unitRef="usd">144523000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMS05LTEtMS0w_a80bf258-949e-47f2-956e-cf71a2bf4922"
      unitRef="usd">1115936000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i277f6af610934b6799af4e30a81fde49_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0xLTEtMS0xMTUw_72176a5c-bec3-4f2a-8319-9e55bbbcae08"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i374f363dae8d489884cfdb4e75c41f98_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0zLTEtMS0xMTUw_32039082-aa36-4ff3-8099-0488dc0bdbeb"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4bdf5bf26e504a519ba4925e4f6ced05_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi01LTEtMS0xMTUw_88263318-11bb-4a96-b5bd-a0e86fd8aa29"
      unitRef="usd">8435000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="if1afc20edd0843bbac413280101a0cf3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi05LTEtMS0xMTUw_b36beb83-e493-4b42-892c-4e2ea6dc0fb2"
      unitRef="usd">8435000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i6d31ba294dc94afaa10dda2278f6ca6a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0xLTEtMS0w_8baecf02-7c12-4e66-b786-128aaf73e11b"
      unitRef="usd">-17142000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ibe58eb3f5c4b4d98b5e6c1018cd61690_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi0zLTEtMS0w_89f9a035-3c16-4ac3-a044-5e244761216e"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="i4ce030964ab24158949b016db0752797_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi01LTEtMS0w_dcadeede-157a-4a14-8d03-5e65d213f5e7"
      unitRef="usd">0</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="ifc3c9146340b4d72b06588504ebf1d02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMi05LTEtMS0w_203c4d58-32b5-490e-a0f4-758377e32b3a"
      unitRef="usd">-17142000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i549e8b5be7d14c24ac0bd3a892096184_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy0xLTEtMS0w_76f5e33d-03ce-44b1-89bc-23aae63d65c6"
      unitRef="usd">-2252000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i604e6f09c9514a4c92c9b88b13bbfd5e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy0zLTEtMS0w_4b46f4ba-3556-4852-bfcc-d70aa276f94d"
      unitRef="usd">3408000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="ie44a1e9c62eb48bb91f1032b3dd61367_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy01LTEtMS0w_4ce71e5e-87be-4889-99a4-2eda138181b6"
      unitRef="usd">-1657000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfMy05LTEtMS0w_d1b807be-6938-4bed-98e1-b9f3dac0ab43"
      unitRef="usd">-501000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ic300771a3ad848deb070c4b7e24f0b27_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC0xLTEtMS0w_4b033d7a-75dc-4695-9011-29c2a6ee359f"
      unitRef="usd">664087000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4f33513e6445440aa8f9b1d326db60e2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC0zLTEtMS0w_5997a1b6-cd3b-4234-96cd-4cee49606b80"
      unitRef="usd">291340000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic516f52cc0d54267bc67844b537e37bf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC01LTEtMS0w_b4395f0d-cfef-4df6-9289-351b2849cd11"
      unitRef="usd">151301000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjE5NTI2ZTBmNjY4NzRkN2RhY2FkMzk2YTJkOGJiNGUwL3RhYmxlcmFuZ2U6MTk1MjZlMGY2Njg3NGQ3ZGFjYWQzOTZhMmQ4YmI0ZTBfNC05LTEtMS0w_d0d1e7b6-61b9-4afe-8f9b-5743e0423e47"
      unitRef="usd">1106728000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNg_900ba6d1-64d2-442a-9619-02a8ffb86b23">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;662,509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;322,685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;89,604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;39,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land-use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9,454&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sealed source and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;243,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;98,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,011,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;463,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regulatory licenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;82,807&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names / trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,952&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;108,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,119,803&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;463,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;634,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;309,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land-use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sealed source and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;240,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;977,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regulatory licenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names / trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,085,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#x2019;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another 10 years license period as Nordion has demonstrated over its 70 years of history.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNg_da370b4c-2db0-4fa1-9b40-cf0e8275202c">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&#160;Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;662,509&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;322,685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;89,604&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;39,707&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;142&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land-use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9,454&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,364&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sealed source and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;243,660&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;98,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5,675&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,011,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;463,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regulatory licenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;82,807&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names / trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,952&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;108,759&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,119,803&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;463,231&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.65pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Accumulated&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amortization&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;634,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;309,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Proprietary technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land-use rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sealed source and supply agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;240,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total finite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;977,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Regulatory licenses and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;81,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade names / trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;107,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,085,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt"&gt;Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#x2019;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another 10 years license period as Nordion has demonstrated over its 70 years of history.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2212b97b8ac44cbeaf403f3f51b943a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMy0xLTEtMS0w_d0a6b3e6-3734-40c4-972a-285c3025696f"
      unitRef="usd">662509000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2212b97b8ac44cbeaf403f3f51b943a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMy0zLTEtMS0w_314858b2-b10d-4178-8c3c-6ee69b50e98f"
      unitRef="usd">322685000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i037b6f7c3cde45289d3fd93f3e2ba9be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNC0xLTEtMS0w_426356c4-bbc3-4b68-b1e5-bfd1e0795fde"
      unitRef="usd">89604000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i037b6f7c3cde45289d3fd93f3e2ba9be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNC0zLTEtMS0w_eac436eb-2c54-4c2b-979e-f85e3d06129b"
      unitRef="usd">39707000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i95577f1988ee4cab966e77b8d67597c8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNS0xLTEtMS0w_f5ac284f-ae0d-4f1e-b9d8-a05c2c9efcb8"
      unitRef="usd">142000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i95577f1988ee4cab966e77b8d67597c8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNS0zLTEtMS0w_dedf8fbf-1599-49e1-8e96-91c959d66e15"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia139b1975e0f4070816baaeeea37e6c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNi0xLTEtMS0w_382d2756-d4ea-4331-86d2-86598ee9f276"
      unitRef="usd">9454000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia139b1975e0f4070816baaeeea37e6c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNi0zLTEtMS0w_1b8ba9e5-a0ec-459e-941a-0200f10fb935"
      unitRef="usd">1364000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i00107b289eee42419e1bb39ab7132941_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNy0xLTEtMS0w_f72ad7d3-cc22-48cc-98dc-220aa2f15685"
      unitRef="usd">243660000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i00107b289eee42419e1bb39ab7132941_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfNy0zLTEtMS0w_f16d0e87-2345-41e6-bc35-0ed2c87f1cd9"
      unitRef="usd">98237000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic049f68a83744fcb8bbd9e1cd47188f5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOC0xLTEtMS0w_b05d7857-d7be-4007-bb2e-e150465d6519"
      unitRef="usd">5675000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic049f68a83744fcb8bbd9e1cd47188f5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOC0zLTEtMS0w_58be763b-9562-4ef4-a07c-353670e14f24"
      unitRef="usd">1138000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOS0xLTEtMS0w_756a9e72-b333-484d-b73e-5b527afbab33"
      unitRef="usd">1011044000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfOS0zLTEtMS0w_4d5b2742-4d4e-4467-9492-e2ae4f1c4f58"
      unitRef="usd">463231000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1a8a178bafa24d019046ae8de5f2a96b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTItMS0xLTEtMA_fa7bfb23-d00d-4b55-8ded-c60fc54b7e2c"
      unitRef="usd">82807000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2a93896fea2f4955a83ecd9ec395ff33_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTMtMS0xLTEtMA_707065cf-7124-4c40-a1ac-8f388706b1f8"
      unitRef="usd">25952000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTQtMS0xLTEtMA_aa1d8b23-a609-4844-8b50-f3048ae8ab40"
      unitRef="usd">108759000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTUtMS0xLTEtMA_9f0e027c-6f0e-4ef5-86a3-0350d1eff092"
      unitRef="usd">1119803000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjZjOWJiMmJkOTM3NDRkNWFiZTY5N2IyMTVhZjdmN2NmL3RhYmxlcmFuZ2U6NmM5YmIyYmQ5Mzc0NGQ1YWJlNjk3YjIxNWFmN2Y3Y2ZfMTUtMy0xLTEtMA_38d1b98b-5271-47ce-b089-804144a53fe4"
      unitRef="usd">463231000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0ab06588a1964b429adbe61fa67fe076_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMi0xLTEtMS0w_147b39ce-7c6c-4d24-810c-0d5035e9946d"
      unitRef="usd">634454000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0ab06588a1964b429adbe61fa67fe076_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMi0zLTEtMS0w_d920fcd1-120a-4c22-9e98-3e2212b8d654"
      unitRef="usd">309428000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifa84c55df11d4fb98f330425ef0ec73f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMy0xLTEtMS0w_9cb76da8-77a2-4c7b-8000-63136f71f9ce"
      unitRef="usd">90964000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifa84c55df11d4fb98f330425ef0ec73f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMy0zLTEtMS0w_a8959ca0-2a3f-4621-88da-9561a14b436d"
      unitRef="usd">38075000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i462df889dd55483f9fdf2dc45ca34f95_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNC0xLTEtMS0w_71d1c501-cb34-415e-b7fb-0ba3b1375f80"
      unitRef="usd">156000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i462df889dd55483f9fdf2dc45ca34f95_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNC0zLTEtMS0w_4cd00b25-7123-4c78-8bbe-d36471068924"
      unitRef="usd">105000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idc279916c2484e4abfd94cbddb0b1947_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNS0xLTEtMS0w_85d6ac16-445b-424e-9cbb-6b5465d8682b"
      unitRef="usd">9489000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idc279916c2484e4abfd94cbddb0b1947_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNS0zLTEtMS0w_295cdb4b-f6a1-41db-bf73-205ef2dbc5fb"
      unitRef="usd">1311000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i93cec6a0dc8b4cc79fe185028e72ea4b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNi0xLTEtMS0w_0bd1c1c7-78d5-4eb2-b1cb-da251cd70110"
      unitRef="usd">240791000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i93cec6a0dc8b4cc79fe185028e72ea4b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNi0zLTEtMS0w_8461939c-6c40-4b7f-a1cd-719d39e304e9"
      unitRef="usd">92953000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if0efe039c4404f3db3ac7271abe88c92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNy0xLTEtMS0w_42c8b13a-41bb-4d6c-9cd6-8df2357fc7cc"
      unitRef="usd">1937000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if0efe039c4404f3db3ac7271abe88c92_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfNy0zLTEtMS0w_510449b4-545e-421d-9c63-d6f91bf94ccb"
      unitRef="usd">519000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfOC0xLTEtMS0w_770b9974-8ec8-41ea-bc6f-2d73543b20e4"
      unitRef="usd">977791000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfOC0zLTEtMS0w_fdf51298-d3f7-4545-9884-d96dc76c4974"
      unitRef="usd">442391000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="icb2734a552514580a66be829325e052e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTEtMS0xLTEtMA_32cd4c6e-ed5c-4589-9c82-329059fd3ef2"
      unitRef="usd">81832000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia15d20e25e2c404b9fa9ab9025017114_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTItMS0xLTEtMA_fe4ed3a6-d6cc-455a-8d98-af39ae13178c"
      unitRef="usd">26134000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTMtMS0xLTEtMA_accd5e89-c612-41b2-a216-6a32fa3940df"
      unitRef="usd">107966000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTQtMS0xLTEtMA_40feb2b2-dd0b-40fe-9e4e-01001c2a8c14"
      unitRef="usd">1085757000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOjk2ZmJjMmM4NzgzMjQ3MTdhZWEzOGUzYzZmY2VlMDE4L3RhYmxlcmFuZ2U6OTZmYmMyYzg3ODMyNDcxN2FlYTM4ZTNjNmZjZWUwMThfMTQtMy0xLTEtMA_5ce3c48e-481d-4d46-8b76-8d32dbef7e8a"
      unitRef="usd">442391000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <shc:LicensingAgreementsRenewalTerm
      contextRef="i8f7a540829534df293806a8679ef9ba5_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfODQw_00607e71-01a7-4330-9009-1c4bb782aa29">P10Y</shc:LicensingAgreementsRenewalTerm>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic654e0b7347f4135b94187587d072ac9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTYxNQ_7a72654f-2072-4cd9-a019-de7f7058f160"
      unitRef="usd">22300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia780c72ea74742cb8f4ea0929abef198_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTYxOQ_d7591167-cebe-4477-81f7-aaf36c79fb77"
      unitRef="usd">5800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibff6b4bd9f5349269d862b32081e5981_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk0NA_137353ca-cba5-4498-a6ae-9cfccf629334"
      unitRef="usd">16500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4941298f6979408a8566ea338611e02c_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk4Mg_7b495b1d-2eb1-4f6e-a5fe-a4504674ca8c"
      unitRef="usd">19900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9aedde424acd460ead3548c57b1da604_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk4NQ_0bdcbe5a-8c40-4ad6-9378-b16b4266511a"
      unitRef="usd">5300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i632d789ade294a64b7daf856fe6f362a_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMTY0OTI2NzQ0NDk3OA_9023791c-92c6-402e-b5e6-80f0d21b243c"
      unitRef="usd">14600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjc0ODc3OTA3MTgyNw_c31d55c0-6de4-4753-8c30-6919ec85d3ec">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated aggregate amortization expense for finite-lived intangible assets for each of the next five years and thereafter is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;65,889&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;80,665&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;80,659&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;79,882&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;41,982&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;198,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;547,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfMS0xLTEtMS0w_dc83318d-a10b-4277-b3e6-58cc39a9b12c"
      unitRef="usd">65889000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfMi0xLTEtMS0w_10fc8fc2-7171-4940-aec7-2402ba3c1f9c"
      unitRef="usd">80665000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfMy0xLTEtMS0w_3cd63c3e-cdf1-48dd-9375-eabfbe7ce12e"
      unitRef="usd">80659000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNC0xLTEtMS0w_c5f0ac03-5e04-403b-b5ff-ec520ab1e1d9"
      unitRef="usd">79882000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNS0xLTEtMS0w_1f6a00bf-8b63-4d30-993c-6f3fc56cbbcc"
      unitRef="usd">41982000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <shc:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNi0xLTEtMS0w_7272c11b-69e6-4ef5-b4c1-4aeec73dfbcf"
      unitRef="usd">198736000</shc:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RhYmxlOmJmMDJhZGE1ZWI2ODRmY2ViMTY1YmY2NTk5M2I4ZDc2L3RhYmxlcmFuZ2U6YmYwMmFkYTVlYjY4NGZjZWIxNjViZjY1OTkzYjhkNzZfNy0xLTEtMS0w_53a9f554-7f76-4b37-a200-c7ab4350b941"
      unitRef="usd">547813000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82MS9mcmFnOjc4NjJiMTY4OWNmZDQ4YWE4OWRiOWMwMTAwODViODhmL3RleHRyZWdpb246Nzg2MmIxNjg5Y2ZkNDhhYTg5ZGI5YzAxMDA4NWI4OGZfMjI1Mg_f475d00a-61c5-4f54-bf1e-5a8892e74922">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RleHRyZWdpb246NjgyMWMyNmMwZjk1NGY4YmE5ZWI1MmRiNzU0OTYxNjhfMjc0ODc3OTA2OTUxNQ_887f1e37-259e-4e82-a001-556fa8cca20b">Accrued Liabilities&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;27,651&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;764&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13,744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued utilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,397&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,886&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;56,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RleHRyZWdpb246NjgyMWMyNmMwZjk1NGY4YmE5ZWI1MmRiNzU0OTYxNjhfMjc0ODc3OTA2OTUxNA_d927124e-c0f3-4e72-8c6e-8cf27b5e2cca">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;27,651&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;764&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13,744&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued utilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,397&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance accrual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,886&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,619&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;56,373&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;60,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMi0xLTEtMS0w_8d01fdbf-4532-42db-9534-1aedf8d9243d"
      unitRef="usd">27651000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMi0zLTEtMS0w_0a456edc-a089-47ab-ad32-405dac0be774"
      unitRef="usd">34760000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMy0xLTEtMS0w_23979374-0036-4032-891d-e252a866ab71"
      unitRef="usd">2751000</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMy0zLTEtMS0w_5804585b-ad16-4d19-afdb-030a16bc259a"
      unitRef="usd">2751000</us-gaap:LitigationReserveCurrent>
    <shc:AccruedInterestExpenseCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNC0xLTEtMS0w_8f67e1c2-ba01-49da-802a-e2045e55c2b0"
      unitRef="usd">764000</shc:AccruedInterestExpenseCurrent>
    <shc:AccruedInterestExpenseCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNC0zLTEtMS0w_3ea93989-91f7-48fd-8407-14b4519eb6d8"
      unitRef="usd">186000</shc:AccruedInterestExpenseCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNS0xLTEtMS0w_1ffe4a7c-1585-4f02-b9bb-b66494cc731b"
      unitRef="usd">229000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNS0zLTEtMS0w_54495094-499b-4d2a-a6ae-e6bb3351cdea"
      unitRef="usd">670000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNi0xLTEtMS0w_2f48515f-6359-4029-b26e-2a147274b4b8"
      unitRef="usd">13744000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNi0zLTEtMS0w_6b69525f-aead-4492-91ea-f4296ab6620d"
      unitRef="usd">12686000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNy0xLTEtMS0w_068b659b-9279-4061-823b-fb80340ba3d7"
      unitRef="usd">2397000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedUtilitiesCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfNy0zLTEtMS0w_f8219f6c-5164-4ca3-b2e8-be25d30bd41d"
      unitRef="usd">1864000</us-gaap:AccruedUtilitiesCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOC0xLTEtMS0w_74f0a750-1add-46da-82a2-bef2799e3b16"
      unitRef="usd">1886000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:AccruedInsuranceCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOC0zLTEtMS0w_77cff311-1a32-4498-8dc4-b4a6d30a74cc"
      unitRef="usd">1255000</us-gaap:AccruedInsuranceCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOS0xLTEtMS0w_a7221510-12bf-4bba-82e4-c46ab75a5e11"
      unitRef="usd">3332000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfOS0zLTEtMS0w_be5d64d0-c684-45a0-bf3e-cd07a6cfcf0b"
      unitRef="usd">2599000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTAtMS0xLTEtMA_453ab0ea-d235-459a-a8da-7915dd6099cb"
      unitRef="usd">3619000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTAtMy0xLTEtMA_61aa052e-97ce-4778-95fd-757f9dd1753c"
      unitRef="usd">3747000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTEtMS0xLTEtMA_0c05f91c-4a8a-40fe-b150-0c0e61dc5b41"
      unitRef="usd">56373000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="id4ed80b0cb834107bc2b1bac91b37db5_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82NC9mcmFnOjY4MjFjMjZjMGY5NTRmOGJhOWViNTJkYjc1NDk2MTY4L3RhYmxlOjYxZGNhNjRkOGY2ODRlNzc5MDA0NzgyOGQyZDBlNTU4L3RhYmxlcmFuZ2U6NjFkY2E2NGQ4ZjY4NGU3NzkwMDQ3ODI4ZDJkMGU1NThfMTEtMy0xLTEtMA_8af8c68d-9534-486f-a216-cc1d725d626b"
      unitRef="usd">60518000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA4NjkwOA_1a26b70b-201b-4900-913e-83de9200e3a0">Long-Term Debt&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,763,100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,763,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior notes, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;100,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,864,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,863,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less unamortized debt issuance costs and debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(26,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-term debt, less debt issuance costs and debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,837,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,824,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Secured Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;13, 2019, Sotera Health Holdings, LLC (&#x201c;SHH&#x201d;), our wholly owned subsidiary, entered into senior secured first lien credit facilities (the &#x201c;Senior Secured Credit Facilities&#x201d;), consisting of both a prepayable senior secured first lien term loan (the &#x201c;Term Loan&#x201d;) and a senior secured first lien revolving credit facility (the &#x201c;Revolving Credit Facility&#x201d;) pursuant to a first lien credit agreement (the &#x201c;Credit Agreement&#x201d;). The Term Loan matures on December 13, 2026, and the Revolving Credit Facility's original maturity date was December 13, 2024. On December 17, 2020, we increased the capacity of our Revolving Credit Facility from $190.0 million to $347.5 million. The Senior Secured Credit Facilities also provide SHH the right at any time and under certain conditions to request incremental term loans or incremental revolving credit commitments based on a formula defined in the Senior Secured Credit Facilities. As of March&#160;31, 2021 and December&#160;31, 2020, total borrowings under the Term Loan were $1,763.1 million and $1,763.1 million, respectively, and there were no borrowings outstanding on the Revolving Credit Facility. The weighted average interest rate on borrowings under the Term Loan for the three months ended March&#160;31, 2021 and March&#160;31, 2020 was 3.73% and 6.18%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2021, we closed on an amendment repricing our Term Loan. The interest rate spread over the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;) on the facility was reduced from 450 basis points to 275 basis points, and the facility&#x2019;s LIBOR floor was reduced from 100 basis points to 50 basis points. The changes result in an effective reduction in current interest rates of 2.25%.  In connection with this amendment, we wrote off $11.3 million of unamortized debt issuance and discount costs and incurred an additional $2.9 million of expense related to debt issuance costs attributable to the refinancing. These costs were recorded to &#x201c;Loss on extinguishment of debt&#x201d; in our Consolidated Statements of Operations and Comprehensive Income (Loss). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs totaled $3.1 million and $3.4 million, respectively, and debt discounts totaled $20.0 million and $31.6 million, respectively, related to the Senior Secured Credit Facilities. Such costs are recorded as a reduction of debt on our consolidated balance sheets and amortized as a component of interest expense over the term of the debt agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 26, 2021, we amended the Revolving Credit Facility, to (i) decrease the Applicable Rate (as defined in the Credit Agreement) related to any Revolving Loans (as defined in the Credit Agreement) from a rate per annum that ranged from an alternative base rate (&#x201c;ABR&#x201d;) plus 2.50% to ABR plus 3.00% depending on SHH&#x2019;s Senior Secured First Lien Net Leverage Ratio to ABR plus 1.75%; and in the case of Eurodollar Loans (as defined in the Credit Agreement) from a rate per annum which ranged from the Adjusted LIBOR plus 3.50% to the Adjusted LIBOR plus 4.00% depending on SHH&#x2019;s Senior Secured First Lien Net Leverage Ratio (as defined in the Credit Agreement), to the Adjusted LIBOR (as defined in the Credit Agreement) plus 2.75%, and (ii) extend the maturity date of the Revolving Facility from December 13, 2024 to June 13, 2026. The other material terms of the Credit Agreement are unchanged and the amendment does not change the capacity of our Revolving Credit Facility, which is $347.5 million. No unamortized debt issuance costs associated with the Revolving Credit Facility were written off and direct fees and costs incurred in connection with the amendment were immaterial.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021 and December&#160;31, 2020, there were no borrowings on the Revolving Credit Facility. SHH borrowed $50.0 million on the Revolving Credit Facility during the first quarter of 2020 which was repaid in the second quarter of 2020. The interest rate on the borrowings under the Revolving Credit Facility during 2020 averaged approximately 5.0%. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of SHH&#x2019;s obligations under the Senior Secured Credit Facilities are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of the Company, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the Senior Secured Credit Facilities, and the guarantees of such obligations, are secured by substantially all assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding letters of credit are collateralized by encumbrances against the Revolving Credit Facility and the collateral pledged thereunder, or by cash placed on deposit with the issuing bank. As of March&#160;31, 2021, the Company had $65.8 million of letters of credit issued against the Revolving Credit Facility, resulting in total availability under the Revolving Credit Facility of $281.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;First Lien Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2020, SHH issued $100.0 million aggregate principal amount of senior secured first lien notes due 2026 (the &#x201c;First Lien Notes&#x201d;), which mature on December 13, 2026. The First Lien Notes bear interest at a rate equal to LIBOR subject to a 1.00% floor plus 6.00% per annum. Interest is payable on a quarterly basis with no principal due until maturity. The weighted average interest rate on the First Lien Notes for the three months ended March&#160;31, 2021 was 7.00%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SHH is entitled to redeem all or a portion of the First Lien Notes, at any time and from time to time, subject to certain premiums depending on the date of redemption; any time on or prior to July 31, 2021, a customary make-whole premium applies and, thereafter, specified premiums that decline to zero apply (in each case as described in the indenture governing the First Lien Notes). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of SHH&#x2019;s obligations under the First Lien Notes are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of SHH, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the First Lien Notes, and the guarantees of such obligations, are secured by substantially all of the assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the First Lien Notes. Such collateral is substantially the same collateral that secures the Senior Secured Credit Facilities. Such collateral securing the First Lien Notes ranks pari passu with that of the Senior Secured Credit Facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs were $0.8 million and $0.9 million, respectively, and debt discounts were $2.7 million and $2.8 million, respectively, related to the First Lien Notes, which are recorded as a reduction of debt on our Consolidated Balance Sheets and amortized into interest expense over the term of the debt agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Debt Repayments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 24, 2020, we closed our initial public offering (the "IPO&#x201d;), in which we sold 53,590,000 shares of our common stock at a price of $23.00 per share, which included the full exercise by the underwriters of their option to purchase up to an additional 6,990,000 shares of common stock. We raised approximately $1.2 billion in net proceeds after deducting underwriters&#x2019; discounts and commissions. We used the net proceeds received by us from the IPO to (i) redeem $770.0 million in aggregate principal amount of the Second Lien Senior Secured Notes with an original maturity date of December 13, 2027 (the "Second Lien Notes&#x201d;), plus accrued and unpaid interest thereon and $15.4 million of redemption premium, (ii) repurchase 1,568,445 shares of our common stock from certain of our executive officers at a purchase price per share equal to the IPO price per share of our common stock less an amount equal to the underwriting discounts and commissions payable thereon and (iii) repay $341.0 million of the outstanding indebtedness under the Term Loan, plus accrued and unpaid interest thereon. In connection with the debt repayments, we wrote off $28.9 million of debt issuance and discount costs and recognized $15.4 million in premiums paid for the early extinguishment of the Second Lien Notes. We recognized these costs within &#x201c;Loss on extinguishment of debt&#x201d; in our Consolidated Statements of Operations and Comprehensive Income (Loss) in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Aggregate Maturities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate maturities of the Company&#x2019;s long-term debt, excluding debt discounts, as of March&#160;31, 2021, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;609&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,863,100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,864,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As referenced above, the Company utilized its IPO proceeds toward prepaying the Second Lien Notes in full as well as prepaying a portion of the Term Loan. The Term Loan prepayment amount eliminated all subsequent scheduled and outstanding repayments of the term borrowings resulting in no remaining short-term commitments.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA4NjkxMA_f980980e-945e-4a88-a219-05b0676d3642">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,763,100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,763,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior notes, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;100,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,864,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,863,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less unamortized debt issuance costs and debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(26,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(38,761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-term debt, less debt issuance costs and debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,837,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,824,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1e8995acb99a47cf96b979b522b8a240_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMi0xLTEtMS0w_81443fa3-53b5-467a-b46f-e7446adeddc9"
      unitRef="usd">1763100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie582d45d5d3a4547a10610bd46cdaf41_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMi0zLTEtMS0w_cd2c00ef-5f42-40a5-bd6a-e39a31ccc7de"
      unitRef="usd">1763100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icd422b230de24395ba1b25c54a6db45d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMy0xLTEtMS0w_53199438-107a-4948-9add-79759b36c9cd"
      unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie37562b8bb6f4f1fad61c5737f8165db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfMy0zLTEtMS0w_29804fd5-6e06-40e7-9836-6aead56a2176"
      unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie9d3cea4bc3043aa8b6fa40430ca9b03_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNS0xLTEtMS0w_735aaf2b-a62f-4d88-a0b5-9607a19fcfc9"
      unitRef="usd">1059000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if060086f17a0456496054d58a49829b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNS0zLTEtMS0w_3602865d-0f02-4492-8ec8-23a104ed28db"
      unitRef="usd">450000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNi0xLTEtMS0w_ac2a8d4f-82b5-45e1-8319-f10e4275b5b4"
      unitRef="usd">1864159000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfNi0zLTEtMS0w_e15c96b8-e886-4cdf-9c12-cc2168435f41"
      unitRef="usd">1863550000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOC0xLTEtMS0w_3f484180-59a9-4453-9d7e-236fdb63149b"
      unitRef="usd">26579000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOC0zLTEtMS0w_28f61182-a5c9-4fae-a26d-b135ea2e3e90"
      unitRef="usd">38761000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOS0xLTEtMS0w_8b6c89e1-93b5-4328-b9aa-9717524c1312"
      unitRef="usd">1837580000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOjFhMjFjYWY5NmVkYjRiMmY5ZmQ0NzJiN2I5NDAzNDk0L3RhYmxlcmFuZ2U6MWEyMWNhZjk2ZWRiNGIyZjlmZDQ3MmI3Yjk0MDM0OTRfOS0zLTEtMS0w_f61c9331-a555-4dc8-ad58-e8456c110c5c"
      unitRef="usd">1824789000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9aa1598f78fa4665b7e784df6c4c3618_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NDU3Mg_92e282cb-07ae-40d5-a41a-70b71fbe5944"
      unitRef="usd">190000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3445e5d203564800970ed964c9915f69_I20201217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NDU3Ng_05ae3799-59ce-4558-a87e-ca35d15ace48"
      unitRef="usd">347500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1e8995acb99a47cf96b979b522b8a240_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfOTgx_bbb50943-038a-4efd-a551-f52e913c2252"
      unitRef="usd">1763100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie582d45d5d3a4547a10610bd46cdaf41_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODQ2NQ_cd2c00ef-5f42-40a5-bd6a-e39a31ccc7de"
      unitRef="usd">1763100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i61b546722b35491d9fa5800657d6bb77_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjE5OTAyMzMwNjg3MA_fa9f52bf-26a2-401e-8a19-0f26c3907da3"
      unitRef="number">0.0373</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="ie47cbeb3f51f4d44a3362102b9e364be_D20200101-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODQ5Ng_909cce7a-673c-47aa-a94c-f4aa309935cc"
      unitRef="number">0.0618</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if9e4212789dc41669d654b48e51f12fe_D20210119-20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI2MA_e4a1ce27-3ddb-42a0-9091-010a5da14f75"
      unitRef="number">0.0450</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI2Ng_9b9c2639-ad31-4763-8b64-e8587bcf3bbd"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <shc:DebtInstrumentVariableRateFloor
      contextRef="i3939ca87747f4af3ad4db922091cc08b_I20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI3Mg_4667ac83-c486-42a4-be6b-7b575d0e57e7"
      unitRef="number">0.0100</shc:DebtInstrumentVariableRateFloor>
    <shc:DebtInstrumentVariableRateFloor
      contextRef="i62e37fc77ba14274a2e06c4a3ec51333_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI3OA_ffc89198-42db-4de3-acfa-6eb64c851bc4"
      unitRef="number">0.0050</shc:DebtInstrumentVariableRateFloor>
    <shc:DebtInstrumentEffectiveReductionInCurrentInterestRates
      contextRef="i4a20972bbc3640e8b6a94b5727ca3aa3_I20210120"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDI4NA_b5acd400-08eb-419e-8ae1-5eb166e1dce4"
      unitRef="number">0.0225</shc:DebtInstrumentEffectiveReductionInCurrentInterestRates>
    <shc:WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount
      contextRef="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDMwMg_7b8e632a-7867-4ca9-a05b-3ba20cee6c83"
      unitRef="usd">11300000</shc:WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount>
    <shc:DebtIssuanceCostsRefinancingAdditionalExpense
      contextRef="ie397d33e7b904859b7bf6ea1afa2babc_D20210120-20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfODc5NjA5MzA0NDMwOA_481c6a24-9b65-4b1b-806b-ebdb5bb9bc46"
      unitRef="usd">2900000</shc:DebtIssuanceCostsRefinancingAdditionalExpense>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i5076ff942fc745c6b7f8da2a4d66baf0_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTYyMQ_6a01cb26-4228-4d65-9424-1fc89f49bb57"
      unitRef="usd">3100000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i85e8b4006d4e4eb994d25982e3a967b0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODM4OQ_befa215a-49f4-44a5-9d0a-eacd22cca3d0"
      unitRef="usd">3400000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i5076ff942fc745c6b7f8da2a4d66baf0_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTYyOA_3df65187-74f9-4e3a-80cf-30dc76198522"
      unitRef="usd">20000000.0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i85e8b4006d4e4eb994d25982e3a967b0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODQ0MQ_29552f02-d0a5-4a02-8e40-f8bcf1667f40"
      unitRef="usd">31600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iec712ce357d5481ea60298bfc94462bd_D20210326-20210326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQyMg_3167f9d8-22f1-4402-860f-3c0a8ebc5752"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i78ae87cbdee94046bcbcb6ab3f48b2d4_D20210326-20210326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQzMA_c8d7fac6-64aa-4007-a43c-c6c01b4ac0a1"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i013ecc2ca22e4d5bb0e44c54ecb51558_D20210326-20210326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQzOA_019db71f-f465-42d1-a126-8e106c059466"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i0e206e36be42444db67127b6b666b46c_D20210326-20210326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQ0Nw_f67be3d9-22b8-4c5c-a27f-19b4faf2dd01"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i48427c3c8fee49e493e03f3f6a69e2d7_D20210326-20210326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQ1NQ_a8514eaa-aa71-4d58-a6fd-a2fcce3b2068"
      unitRef="number">0.0400</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if972f5c2e68f4b6e9c9b79e8bc599d2c_D20210326-20210326"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTQ2Mw_be1cd71a-b0ce-4e78-85ba-80b42dfe0a67"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3445e5d203564800970ed964c9915f69_I20201217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ4MzE4OA_05ae3799-59ce-4558-a87e-ca35d15ace48"
      unitRef="usd">347500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i74886e80842c43c2b575afa174c8f146_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA5MTQ3NQ_0d8c3471-7eef-4e58-bcda-ec7f76e3ff99"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i458ac54874ff437295ae19825c2e1ad6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA5MTQ3NQ_cd2615b3-c0df-4ae6-a5f3-978df78daef5"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0685810b83ff487580eda356557fd6bf_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTEzNQ_d5bdbf4c-ea25-40d0-afed-0d088ffc939b"
      unitRef="usd">50000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i3ff2dc57c0034141899eda7b55d9c143_D20200101-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM1NQ_b22eae61-da11-4bf2-aa0c-559fb97aae4b"
      unitRef="number">0.050</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i458ac54874ff437295ae19825c2e1ad6_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfNTE4Mw_30c2d125-0102-4fa9-8d01-2d821b435b29"
      unitRef="usd">65800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="i458ac54874ff437295ae19825c2e1ad6_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfNTMyNA_42853787-a525-411d-846f-66f5c33b4195"
      unitRef="usd">281700000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic0c05eb822b5410c8019ed6fe29b6ab8_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM4Mg_2baf6fbd-6654-449c-8923-9b2427d4f6e4"
      unitRef="usd">100000000.0</us-gaap:DebtInstrumentFaceAmount>
    <shc:DebtInstrumentVariableRateFloor
      contextRef="ic0c05eb822b5410c8019ed6fe29b6ab8_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM4Nw_e0f3da0b-2f68-4b01-b514-f5cb680aef0c"
      unitRef="number">0.0100</shc:DebtInstrumentVariableRateFloor>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8b900c87d68440d0aa7afa06a2cf13f9_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ1NTM5MQ_fbb4ed72-de2c-4be0-985e-e50c2f5b7d38"
      unitRef="number">0.0600</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i58786296c5744b83985f9f2ad31ad009_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfNzgxNw_93d22a69-92c0-4195-977b-9390604adc43"
      unitRef="number">0.0700</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="if63b06a187344473bec2c467e8a1eaa8_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfOTE1Mw_bc64d52b-7076-43e2-b90f-09e360dd2a2e"
      unitRef="usd">800000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ife3ac8faabe645c99d73eb67ce7ce8b9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODU2OA_36a61c1e-8d5a-48c5-8dd7-558eef40f56b"
      unitRef="usd">900000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="if63b06a187344473bec2c467e8a1eaa8_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfOTE4MA_acc760fc-fde0-4aae-a5b7-58310da84333"
      unitRef="usd">2700000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ife3ac8faabe645c99d73eb67ce7ce8b9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzUwODU5OQ_f7946606-c6e1-4a79-b29d-908c4a84a228"
      unitRef="usd">2800000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i5475791dc6254d89860104a417d03dfd_D20201124-20201124"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM0MA_42356dce-5d5f-4097-be86-385073e1ed2b"
      unitRef="shares">53590000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i028ae4ed27174f34989fbc5e78e51dce_I20201124"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM1MA_afe45dd8-973e-4b6b-bf74-35fd73a63539"
      unitRef="usdPerShare">23.00</us-gaap:SaleOfStockPricePerShare>
    <shc:SaleOfStockNumberOfAdditionalSharesToBeRepurchased
      contextRef="i5475791dc6254d89860104a417d03dfd_D20201124-20201124"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM2Mw_946a1f44-1b3b-4a48-98a0-3ecc7453cceb"
      unitRef="shares">6990000</shc:SaleOfStockNumberOfAdditionalSharesToBeRepurchased>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i5475791dc6254d89860104a417d03dfd_D20201124-20201124"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM3OA_5e9d15d2-37c5-421b-8ea1-bfaaab220d8a"
      unitRef="usd">1200000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i07c6f50405594b5592607e77121c0fa7_D20200301-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDMyNA_d6b826ee-86a6-4433-93ae-48eb3d6b104d"
      unitRef="usd">770000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <shc:RecognitionOfDebtPremium
      contextRef="i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDMwNw_36a89f58-2b76-4e6b-8ef4-00b07bdd7594"
      unitRef="usd">15400000</shc:RecognitionOfDebtPremium>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ia4a180ea1b6d4c3bb6c80f76ff48a33a_D20201124-20201124"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MTM5MQ_be122251-817c-42b3-b5b3-f034b4a98824"
      unitRef="shares">1568445</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i97db1199d2ae496d86dba67906d75440_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDM0MQ_5a8ada2c-a544-4eca-a926-ef408110d8ff"
      unitRef="usd">341000000.0</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i7e0882cfad7543dcbaf6ed1402ccfe46_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDM1Nw_e3c578c4-90ad-4718-974e-ce84c00c06b8"
      unitRef="usd">28900000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <shc:RecognitionOfDebtPremium
      contextRef="i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMTY0OTI2NzQ5MDM3NA_36a89f58-2b76-4e6b-8ef4-00b07bdd7594"
      unitRef="usd">15400000</shc:RecognitionOfDebtPremium>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RleHRyZWdpb246OTQ0NTY4YThjMjQxNGFiZWFhYWU5YmIyNzI5NWVlNmRfMjc0ODc3OTA4NjkwOQ_7af7045f-0dd1-458a-bd57-d8ae03d37061">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate maturities of the Company&#x2019;s long-term debt, excluding debt discounts, as of March&#160;31, 2021, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;609&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,863,100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,864,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfMS0xLTEtMS0w_dd83d666-cdc2-4964-9dc2-dad22350f234"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfMi0xLTEtMS0w_6444b813-a326-49d0-b56d-15d629f665b7"
      unitRef="usd">609000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfMy0xLTEtMS0w_afaaf033-6261-45d4-893d-90e1c54dea45"
      unitRef="usd">450000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNC0xLTEtMS0w_fb296350-c3e3-41bb-814e-176c7aca4e22"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNS0xLTEtMS0w_5b88f234-84aa-4414-946a-947d3dcc8718"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <shc:LongTermDebtMaturityAfterYearFour
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNi0xLTEtMS0w_609a3dfb-780c-4ce0-a402-87ab95218414"
      unitRef="usd">1863100000</shc:LongTermDebtMaturityAfterYearFour>
    <us-gaap:LongTermDebt
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV82Ny9mcmFnOjk0NDU2OGE4YzI0MTRhYmVhYWFlOWJiMjcyOTVlZTZkL3RhYmxlOmE4Y2JiOWJiZjU3ODQ0YjFiNjkyYWRkYzlmMmExNWIxL3RhYmxlcmFuZ2U6YThjYmI5YmJmNTc4NDRiMWI2OTJhZGRjOWYyYTE1YjFfNy0xLTEtMS0w_0ec9a92d-847b-4ed5-b95a-12b44b8a7a0c"
      unitRef="usd">1864159000</us-gaap:LongTermDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMjc0ODc3OTA3Njc3Nw_cfddbee8-7e98-402e-a25d-422de04e8b6f">Income Taxes&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense is provided on an interim basis based upon our estimate of the annual effective income tax rate. In determining the estimated annual effective income tax rate, we analyze various factors, including projections of our annual earnings and the taxing jurisdictions where the earnings will occur, the impact of state and local taxes, our ability to utilize tax credits and net operating loss carryforwards and available tax planning alternatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate was 21.4 % and (86.0)% for the three months ended March&#160;31, 2021 and 2020, respectively. Income tax expense for the three months ended March&#160;31, 2021 differs from the statutory rate primarily due to the impact of the foreign rate differential, global intangible low-tax income (&#x201c;GILTI&#x201d;), and a net increase in the valuation allowance attributable to the limitation on the deductibility of interest expense. This was offset by a discrete item, which reversed the valuation allowance on deferred tax assets related to certain asset retirement obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax benefit for the three months ended March&#160;31, 2020 differed from the statutory rate primarily due to the impact of the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;), which increased the limitation on the deductibility of interest expense from 30% to 50% for tax years beginning in 2019 or 2020, and other provisions. The increased limitation &lt;/span&gt;&lt;/div&gt;resulted in a current tax benefit for the three months ended March 31, 2020 of $9.1 million. The increased limitation also resulted in a $5.6 million valuation allowance reversal in the three months ended March&#160;31, 2020.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfNTA4_ea7400c7-f952-40ed-9c36-07237e4cf403"
      unitRef="number">0.214</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfNTE1_21a2ef6a-e9c6-465a-8976-6b68e0033390"
      unitRef="number">-0.860</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <shc:LimitationOnDeductibilityOfInterestExpenseCARESAct
      contextRef="iba2d514743dd41119e290276367c2fb1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUyNQ_440be472-e10a-4b25-b9fd-1b8f72e95247"
      unitRef="number">0.30</shc:LimitationOnDeductibilityOfInterestExpenseCARESAct>
    <shc:LimitationOnDeductibilityOfInterestExpenseCARESAct
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUzMQ_b35e749e-8e16-47f8-b369-ecc48821dbfc"
      unitRef="number">0.50</shc:LimitationOnDeductibilityOfInterestExpenseCARESAct>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUwMw_43503a49-5177-4c6c-91d2-297ebb7b1154"
      unitRef="usd">-9100000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83MC9mcmFnOmM0OGFmMDA0ZGQ2NzQzMmFhOTllOTkyYWI5YTMxZDI3L3RleHRyZWdpb246YzQ4YWYwMDRkZDY3NDMyYWE5OWU5OTJhYjlhMzFkMjdfMTY0OTI2NzQ1NTUxOA_cd30dbca-7522-460f-a1b6-c4921e85f28d"
      unitRef="usd">-5600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzI3NDg3NzkwNzkzNDM_c6cd19b5-3c33-4245-852d-9e0df7a5f7cd">Employee Benefits&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors various post-employment benefit plans including, in certain countries outside the U.S., defined benefit and defined contribution pension plans, retirement compensation arrangements, and plans that provide extended health care coverage to retired employees, the majority of which relate to Nordion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defined benefit pension plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest cost and expected return on plan assets are recorded in &#x201c;Other income, net&#x201d; and the service cost component is included in the same financial statement line item as the applicable employee&#x2019;s wages in the Consolidated Statements of Operations and Comprehensive Income (Loss). The components of net periodic pension cost for the defined benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,613&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net periodic benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other benefit plans &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other benefit plans include a supplemental retirement arrangement, a retirement and termination allowance, and post-retirement benefit plans, which include contributory health and dental care benefits and contributory life insurance coverage. All but one, non-pension post-employment benefit plans are unfunded. The components of net periodic pension cost for the other benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of net actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently expect funding requirements of approximately $2.8&#160;million in each of the next five years to fund the regulatory solvency deficit, as defined by Canadian federal regulation, which require solvency testing on defined benefit pension plans.&lt;/span&gt;&lt;/div&gt;The Company may obtain a qualifying letter of credit for solvency payments, up to 15% of the market value of solvency liabilities as determined on the valuation date, instead of paying cash into the pension fund. As of March&#160;31, 2021, and December&#160;31, 2020, we had letters of credit outstanding relating to the defined benefit plans totaling $42.6 million and $41.3 million, respectively. The actual funding requirements over the five-year period will be dependent on subsequent annual actuarial valuations. These amounts are estimates, which may change with actual investment performance, changes in interest rates, any pertinent changes in Canadian government regulations and any voluntary contributions.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzI3NDg3NzkwNzkzNDQ_d971fd04-cd29-4297-91ac-e39b656c9e94">The components of net periodic pension cost for the defined benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,613&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,557)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net periodic benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(1,379)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.057%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of net actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;74&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzItMS0xLTEtMTE4_cf92fbee-c541-48f1-a735-7b1e90c5af14"
      unitRef="usd">298000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzItMy0xLTEtMTE4_bbddadd6-e1e1-4d35-8e31-2a45cd376bef"
      unitRef="usd">276000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzMtMS0xLTEtMTE4_8787acbd-dc8c-4944-a0a6-e357a0bfb8bc"
      unitRef="usd">1613000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzMtMy0xLTEtMTE4_f56a1a40-afb9-428e-9062-23f6e5927dde"
      unitRef="usd">2007000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzQtMS0xLTEtMTE4_08de4232-2166-4fff-aafc-f16781968b3f"
      unitRef="usd">3557000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzQtMy0xLTEtMTE4_efcb2791-8a8d-4f01-8a72-2e009c54a279"
      unitRef="usd">3599000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzUtMS0xLTEtMTE4_69202ca4-8609-421e-91d3-9b00468fc7b7"
      unitRef="usd">-267000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzUtMy0xLTEtMTE4_86ad170b-0878-49a9-8c77-049ef6a16620"
      unitRef="usd">-197000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzYtMS0xLTEtMTE4_8126d081-1377-47ad-9d52-fb1a43d40cc2"
      unitRef="usd">-1379000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie13b5e3260f94765a0ce18e19ccdcb97_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTo4MmQ4ZjdkNGQxY2Q0ZmUwYmY2MDc3NTc5NDg4OTcyNS90YWJsZXJhbmdlOjgyZDhmN2Q0ZDFjZDRmZTBiZjYwNzc1Nzk0ODg5NzI1XzYtMy0xLTEtMTE4_86b99c9c-a423-40fc-a1a2-7f511bde7720"
      unitRef="usd">-1119000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzItMS0xLTEtMTE4_a469510e-dac0-43bd-a5dc-8e00a8d39bdb"
      unitRef="usd">7000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzItMy0xLTEtMTE4_8336a7b7-2ba9-4b26-ae7f-9beece00eef7"
      unitRef="usd">7000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzMtMS0xLTEtMTE4_8557f442-f254-4f0f-97ed-83526bb0ce47"
      unitRef="usd">59000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzMtMy0xLTEtMTE4_e550d4dc-457c-4190-ac6d-d968c8448b21"
      unitRef="usd">73000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzQtMS0xLTEtMTE4_8eaa53f2-8d0e-470a-bf51-874877852689"
      unitRef="usd">-8000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzQtMy0xLTEtMTE4_b16c59c3-5998-4e13-818f-85c59f9963de"
      unitRef="usd">-13000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i194142e1f1c4440782d92a1cfdb75e90_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzUtMS0xLTEtMTE4_75fc8c5c-5c2c-48a6-8fea-a25f39b512d2"
      unitRef="usd">74000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="if27b6d0e5cbb4264b73625315b6aa855_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90YWJsZTowMDVmOGVjYmMzY2I0MDA3ODVlOTM2MjRiYjBlMThjNi90YWJsZXJhbmdlOjAwNWY4ZWNiYzNjYjQwMDc4NWU5MzYyNGJiMGUxOGM2XzUtMy0xLTEtMTE4_2a315cee-3c7b-4b55-9485-9031f9c631d1"
      unitRef="usd">93000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <shc:DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NTE1NjE_f08229eb-2e07-4881-b6ef-605ba6e89f01"
      unitRef="usd">2800000</shc:DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears>
    <shc:LettersOfCreditSolvencyPaymentAsPercentOfMarketValue
      contextRef="ifb78af3c02b2463c9b7e74b792e5d62e_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NDI4NDY_a095ab84-0b8f-4c96-b945-1cf87ebbed7c"
      unitRef="number">0.15</shc:LettersOfCreditSolvencyPaymentAsPercentOfMarketValue>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i226897b7dda742f1b2b822fe5e2f5ed2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NDMwODE_c4bbb402-c856-4ce9-8b5c-ffc9565f123e"
      unitRef="usd">42600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="icebe580f12e2450aa32311d02bcd23d5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV81MzEvZnJhZzpmZmVmODIzODk1N2U0MWE4ODk0OTY1YjY0ODI4MzljOS90ZXh0cmVnaW9uOmZmZWY4MjM4OTU3ZTQxYTg4OTQ5NjViNjQ4MjgzOWM5XzE2NDkyNjc0NDMwODk_87d87b6b-f0b6-4e4c-a5cd-dc4538889bbe"
      unitRef="usd">41300000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83My9mcmFnOjc1NGJlNjAzNTFiODRmZDY4MTU5Zjg3ODI0ZTY5MTI2L3RleHRyZWdpb246NzU0YmU2MDM1MWI4NGZkNjgxNTlmODc4MjRlNjkxMjZfMjc0ODc3OTA3MDU2Mg_a3d66f60-95d3-42cd-ae4c-eda837b9564f">Related PartiesWe do business with a number of companies affiliated with Warburg Pincus and GTCR, which we refer to collectively as the &#x201c;Sponsors,&#x201d; who continue to have substantial control over us. All transactions with these companies have been conducted in the ordinary course of our business and are not material to our operations.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RleHRyZWdpb246NDQ3NTZmZmRkNzJmNDZkM2JiNGFiOTNlZTg0OTZlNzZfMjc0ODc3OTA3MDE4NQ_d633e893-11f1-4246-99b6-27d55fbf825f">Other Comprehensive Income (Loss)&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts in accumulated other comprehensive income (loss) are presented net of the related tax. Foreign currency translation is not adjusted for income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our accumulated other comprehensive income (loss) balances, net of applicable tax, were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Benefit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Beginning balance &#x2013; January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(44,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(49,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(93,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ending balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(44,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(52,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(97,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Beginning balance &#x2013; January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(27,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(67,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(94,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(74,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(74,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ending balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(140,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(168,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;For defined benefit pension plans, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#x201c;Other income, net&#x201d; within the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;For interest rate swaps, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#x201c;Interest expense, net&#x201d; within the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RleHRyZWdpb246NDQ3NTZmZmRkNzJmNDZkM2JiNGFiOTNlZTg0OTZlNzZfMjc0ODc3OTA3MDE4Ng_5c137117-2dff-46ae-a37c-1c9204a186cf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in our accumulated other comprehensive income (loss) balances, net of applicable tax, were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Benefit&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Plans&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Translation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Swaps&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Beginning balance &#x2013; January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(44,143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(49,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(93,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,595)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(3,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ending balance &#x2013; March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(44,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(52,770)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(97,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Beginning balance &#x2013; January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(27,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(67,453)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(94,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other comprehensive income (loss) before&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(74,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts reclassified from accumulated other&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;comprehensive income (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,479)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(74,239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Ending balance &#x2013; March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24,906)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(140,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3,300)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(168,626)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;For defined benefit pension plans, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#x201c;Other income, net&#x201d; within the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;For interest rate swaps, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#x201c;Interest expense, net&#x201d; within the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90fc782dbb0e49489e495a7aa71f62d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS0xLTEtMS0w_56825fb3-00b0-43c3-bd8f-ae0fab817ff7"
      unitRef="usd">-44143000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i980a63340b96471687bdd40130dadc4e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS0zLTEtMS0w_0f715a46-6bd4-4894-81bc-eb2ee1c4650a"
      unitRef="usd">-49699000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i82333f7ccf614eb1b010487872bbaad6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS01LTEtMS0w_b31ef46f-ee01-4fe6-b256-6bcb84dbbd99"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i360689ad9dcc48f5ab2673194f9a3327_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMS03LTEtMS0w_0c17d67f-8ce7-43b6-a795-b602c9defd7c"
      unitRef="usd">-93842000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi0xLTEtMS0w_c8ae55b9-ca90-4bb7-9810-853515793c77"
      unitRef="usd">-524000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi0zLTEtMS0w_aede031c-9d83-4856-a0a3-a562f5005879"
      unitRef="usd">-3071000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi01LTEtMS0w_68d946cf-0670-4097-8f61-904c80346954"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMi03LTEtMS0w_def2a67e-39e0-4630-b2d8-3ae6dc8607e7"
      unitRef="usd">-3595000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy0xLTEtMS0w_166da53a-95da-421c-aafb-aa1363dc0de9"
      unitRef="usd">-275000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy0zLTEtMS0w_3f26b514-8811-431d-a5b2-b2b4adacc5cf"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy01LTEtMS0w_bb2c52f8-737b-4c6e-8bcb-84e36ae16115"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMy03LTEtMS0w_2b93cce4-67d4-42fc-9b0a-2dd075c56c55"
      unitRef="usd">-275000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6cb281ef0a854fa5a64084e6172f2de4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC0xLTEtMS0w_5363b1ad-f2b1-4ce6-9783-c0f1becf75a2"
      unitRef="usd">-249000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4dc7568ff0424041941e447dc5af870e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC0zLTEtMS0w_a2310c47-084f-42bd-9605-fdfa0e7a4665"
      unitRef="usd">-3071000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9720ef8db8ba4b6a80da34a8b7ed45fb_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC01LTEtMS0w_8b053c2d-195f-4eea-921c-c543cf2af4a3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2cee32ded1db432886dca18fff663aa5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNC03LTEtMS0w_f376a548-66fe-4143-ab2e-6e8ecc539d37"
      unitRef="usd">-3320000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iffbcd4e4e0a0426389360304851d8b90_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS0xLTEtMS0w_b929810e-2731-4b8a-9cae-0c843e2ec3d2"
      unitRef="usd">-44392000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75fb9f2f9ab743cf99a74ffa394e0fec_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS0zLTEtMS0w_7843c2d6-a2d2-4ad6-b706-02865acab641"
      unitRef="usd">-52770000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1a933469e6c4f0286ea390dbb12759b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS01LTEtMS0w_d3381293-3691-45e3-87bf-bf883e0cca5a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1675ea82d0e47b5b55f50b716c600eb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNS03LTEtMS0w_640b0232-d069-45b8-869e-34e8a3ead104"
      unitRef="usd">-97162000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5366f919647449e93ab9253d4a29029_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy0xLTEtMS0w_6965924d-74ea-4b50-b1a9-1af47ebfa8a7"
      unitRef="usd">-27113000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idc32baf86d3348b285ed6d9464919955_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy0zLTEtMS0w_2751d707-b1c7-4ac4-817e-114f11d52e71"
      unitRef="usd">-67453000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5986db8246ee4f9890cb846fcee620bd_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy01LTEtMS0w_c385aa17-e302-4041-994c-7fd9a281a91e"
      unitRef="usd">179000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a52e4d931ab42eca6b2d9fca0916150_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfNy03LTEtMS0w_24ad2f7e-e2e8-4dc1-beb6-b8f427350983"
      unitRef="usd">-94387000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC0xLTEtMS0w_2808dbf8-9961-4345-8602-0fe08f18c8fe"
      unitRef="usd">2207000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC0zLTEtMS0w_2747d278-31c4-4f0b-a479-1d038150a5d2"
      unitRef="usd">-72967000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if57f220101a04dd081ed073252446f8d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC01LTEtMS0w_97931022-067c-45c0-932a-f35d0530bc86"
      unitRef="usd">-3292000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOC03LTEtMS0w_91fcb418-7225-48b1-bcfe-0f66ce94d21f"
      unitRef="usd">-74052000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS0xLTEtMS0w_221e842b-e57c-43d3-86cb-cd25409bb622"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS0zLTEtMS0w_7263e629-fc3c-4904-b511-75e7bd82bd18"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if57f220101a04dd081ed073252446f8d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS01LTEtMS0w_08a21325-84b1-4f81-a6d8-52228959175f"
      unitRef="usd">187000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfOS03LTEtMS0w_8dd5c3be-8c35-4943-81f9-780fdec28b4f"
      unitRef="usd">187000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie65eb9010d7c4af0bef41cbbff3fd6fd_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtMS0xLTEtMA_c5ca81eb-a3e0-4f19-9dba-7a2793cbc5b2"
      unitRef="usd">2207000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i597a3589c41845c4905f77efa16abf0f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtMy0xLTEtMA_1f51de9e-65a4-4847-b1d6-5e78427a7213"
      unitRef="usd">-72967000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if57f220101a04dd081ed073252446f8d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtNS0xLTEtMA_d5f0bab7-e69d-418c-8581-d4015ab24384"
      unitRef="usd">-3479000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c71ec4b79a640b696b32515bb908652_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTAtNy0xLTEtMA_b53cc5b4-f917-4f0e-8cb0-1adadf81e569"
      unitRef="usd">-74239000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i135a5815805f47c2b6d8423008b7e9eb_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtMS0xLTEtMA_0d00e92b-b5ea-42e7-8f18-d0a833328035"
      unitRef="usd">-24906000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2d9d81991fa044a8b0e369740ca0e420_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtMy0xLTEtMA_02207b9b-5707-4e0d-b900-3b57acfd6406"
      unitRef="usd">-140420000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff5bb92468604878bf5c2ea5357d059a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtNS0xLTEtMA_52ab61fb-45c9-4018-b9ff-70b9d27917fe"
      unitRef="usd">-3300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i350dd74321534f789de5af89b9350730_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83Ni9mcmFnOjQ0NzU2ZmZkZDcyZjQ2ZDNiYjRhYjkzZWU4NDk2ZTc2L3RhYmxlOmExOTc1ZWE5NjJhMDRiNDFiZTk4N2MwNmZkOTYxMDBlL3RhYmxlcmFuZ2U6YTE5NzVlYTk2MmEwNGI0MWJlOTg3YzA2ZmQ5NjEwMGVfMTEtNy0xLTEtMA_2387b49e-60ba-4888-8e62-a5ad242ead7e"
      unitRef="usd">-168626000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzNw_3705cd2d-4049-400d-bcd2-53578864af34">Share-Based Compensation &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pre-IPO Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock distributed in respect of pre-IPO Class&#160;B-1 time vesting units vests on a daily basis pro rata over the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM5MA_4d42cb8b-4533-485f-a39a-6ad44b9c22bd"&gt;five&lt;/span&gt;-year vesting period (20% per year) beginning on the original vesting commencement date of the corresponding Class B-1 time vesting units, subject to the grantee&#x2019;s continued services through each vesting date. Upon the occurrence of a change in control of the Company, all then outstanding unvested shares of our common stock distributed in respect of Class&#160;B-1 Units will become vested as of the date of consummation of such change in control, subject to the grantee&#x2019;s continued services through the consummation of the change in control.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock distributed in respect of pre-IPO Class&#160;B-2 Units (which were considered performance vesting units) are scheduled to vest only upon satisfaction of certain thresholds. These units generally vest as of the first date on which (i) our Sponsors have received actual cash proceeds in an amount equal to or in excess of at least two and one-half times their invested capital in Sotera Health Topco Parent, L.P. (of which the Company was a direct wholly owned subsidiary prior to the IPO) and (ii) the Sponsors&#x2019; internal rate of return exceeds twenty percent, subject to such grantee&#x2019;s continued services through such date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a change in control of the Company, any outstanding shares of our common stock distributed in respect of Class B-2 Units that remain unvested immediately following the consummation of such a change in control of the Company shall be immediately canceled and forfeited without compensation. Stock based compensation expense attributed to the pre-IPO Class B-2 awards was recorded in the fourth quarter of 2020 as the related performance conditions were considered probable of achievement and the implied service conditions were met. As of March&#160;31, 2021, these awards remain unvested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized $0.7 million and $1.7 million of share-based compensation expense related to the pre-IPO Class B-1 awards for the three months ended March&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the activity for the three months ended March&#160;31, 2021 related to the restricted stock awards distributed to the Company service providers in respect of the pre-IPO awards (Class&#160;B-1 and B-2 Units) is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Restricted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stock - Pre-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;IPO B-1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Restricted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stock - Pre-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;IPO B-2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,201,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,323,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(254,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(228,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,929,016&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,068,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Omnibus Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain a long-term incentive plan (the &#x201c;2020 Omnibus Incentive Plan&#x201d; or the &#x201c;2020 Plan&#x201d;) that allows for grants of incentive stock options to employees (including employees of any of our subsidiaries), nonstatutory stock options, restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;) and other cash-based, equity-based or equity-related awards to employees, directors, and consultants, including employees or consultants of our subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized $2.8 million ($1.3 million for stock options and $1.5 million for RSUs) of share-based compensation expense for these awards in our Consolidated Statements of Operations and Comprehensive Income (Loss), in &#x201c;Selling, general and administrative expenses,&#x201d; for the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options have a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzOA_90568ab0-c98d-42fa-bc3b-4bb90feeb83b"&gt;four&lt;/span&gt;-year vesting period, an exercise price equal to the fair market value of a share of common stock on the date of grant, and a contractual term of 10 years. The following table summarizes our stock option activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;average &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,389,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;At March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,400,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs generally vest ratably over a period of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM1Mg_eccb5a8b-a643-47c5-b42e-caa40b675d70"&gt;one&lt;/span&gt; to four years and are valued based on our market price on the date of grant. The following table summarizes our unvested RSUs activity:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;average Grant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Date Fair &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;771,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;757,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ia1332bd08855451b8303379ea937e071_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_03458937-cc60-4d8a-918e-726c3fff4048"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i49f9e92f97cb43e7a611be42d5d2b76d_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_15313445-4713-4632-bb08-448568d2b7d2"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ibfb0b3684d91465b91c4dbd708ec1220_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_a5c19888-bcc2-481e-a034-295dd716aa91"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i3d8961e3c6584f708b88ef82ee1078c5_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_bf82957a-e3cb-4a56-acb3-44b441f26487"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ie79c75277ecb4c438785f138186141d9_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTc1MQ_d5f89889-10e4-428f-ad58-ba26839c9474"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMzU2OA_88e3a50a-8500-4c3f-baee-744b7caf375c"
      unitRef="usd">700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iec0fe360fc5a4fb9be9d970dce929cff_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMTY0OTI2NzQ0OTk4Nw_6cde2aea-a555-4c94-a0df-bf8f86279636"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM4MA_6d741eec-179e-49df-a074-1aad029d0276">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the activity for the three months ended March&#160;31, 2021 related to the restricted stock awards distributed to the Company service providers in respect of the pre-IPO awards (Class&#160;B-1 and B-2 Units) is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Restricted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stock - Pre-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;IPO B-1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Restricted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stock - Pre-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;IPO B-2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,201,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,323,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(254,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(228,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,929,016&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,068,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table summarizes our unvested RSUs activity:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;average Grant&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Date Fair &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;771,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;757,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23.05&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i532429720d76464fb288ef6d7f8c4da4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMS0xLTEtMS0w_dbfdf133-b22b-4ea8-8bfd-d36ebe6f54aa"
      unitRef="shares">2201239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if4e8d0ee307f4202ba503e68eb22522d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMS0zLTEtMS0w_be2280f6-e550-4717-bfa4-5a3e7c5729ed"
      unitRef="shares">2323333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMy0xLTEtMS0w_1a06020d-d6c2-46e0-8c1f-c5555404a2ad"
      unitRef="shares">43361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i0ab86e4b989f417494880063f915dc6d_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfMy0zLTEtMS0w_d185dc96-3f44-47a1-8da1-41260e17126c"
      unitRef="shares">254839</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i1ba7e2e6571144deac6d3fca07daad93_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNC0xLTEtMS0w_fc9e6c25-015b-4059-82cd-1bcd37dbb0bf"
      unitRef="shares">228862</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0ab86e4b989f417494880063f915dc6d_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNC0zLTEtMS0w_9945e01e-6e2f-4533-b274-5d33977b7344"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie9467f5d115d4bd28878ee4c52ac8b6c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNS0xLTEtMS0w_6acabc88-b358-45c7-9e38-2a272dfd88e2"
      unitRef="shares">1929016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i829eb019c2384385949420c934d9650c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmY1ZTliNDgxOGE3YjQ2YjRiYWMzNGQwYjcxNjVhZjE2L3RhYmxlcmFuZ2U6ZjVlOWI0ODE4YTdiNDZiNGJhYzM0ZDBiNzE2NWFmMTZfNS0zLTEtMS0w_50923e88-ffd9-4f39-822a-ad929d094b9f"
      unitRef="shares">2068494</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifbd8b853840d4d58a44be8b4f396efe6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNTI0NA_022dd116-3496-4cfb-a9c0-8e6355f0395d"
      unitRef="usd">2800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i72ebc9f42a97466cbcc112179091d11f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNTI0OA_16be5faf-d7ac-494b-b67e-2b87e2af1f11"
      unitRef="usd">1300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4973995a8b649188261f6b9eb660a4a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNTI3Mw_10612752-4707-40e2-a4a2-0f07608fc5da"
      unitRef="usd">1500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="icf6ab0133fd241ab95e886992abdac00_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfNjIwNw_1ae22d4e-77d2-4e09-80d4-484f6fb01ec0">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM0OQ_8bb4fd6c-c008-4631-a695-00e801592d92">The following table summarizes our stock option activity:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;average &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,389,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;At March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,400,349&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMS0xLTEtMS0w_7f486826-aae9-4051-9d27-f7ddd9f0d1ff"
      unitRef="shares">2389258</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMS0zLTEtMS0w_67d4dc97-d0d5-4e97-a072-9218759b94ed"
      unitRef="usdPerShare">23.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMi0xLTEtMS0w_fb7615cc-6c1e-49c0-9bbd-b513b099b9b6"
      unitRef="shares">20407</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMi0zLTEtMS0w_6e146da2-18f3-4d61-ad69-dbeec673629b"
      unitRef="usdPerShare">26.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMy0xLTEtMS0w_3a69e7b8-749d-489a-ad39-cdf192e1cf86"
      unitRef="shares">9316</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfMy0zLTEtMS0w_f47e1050-b196-4819-9619-219a7f9f4973"
      unitRef="usdPerShare">23.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNC0xLTEtMS0w_a4b11136-a414-419e-99ea-2a89a9facf60"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNC0zLTEtMS0w_ad867203-72b8-4a77-87df-825e3a4bb949"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNS0xLTEtMS0w_84ca0c0f-d8ee-4b98-aca8-0e75723c8d5d"
      unitRef="shares">2400349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmNlMzNkMDBhYjA5ZjQ2MjM5OTM2NTA3YWUzOTU4NDhjL3RhYmxlcmFuZ2U6Y2UzM2QwMGFiMDlmNDYyMzk5MzY1MDdhZTM5NTg0OGNfNS0zLTEtMS0w_1183cacb-718d-47b6-85e3-460bc694414a"
      unitRef="usdPerShare">23.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iea1bdce9661f4df4b25f0d61185bc957_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM2Mg_a3acca41-10e4-4952-bb49-d5c347833a94">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id702121c7c324bf6885a6bf80cae7fe4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMS0xLTEtMS0w_c5a76d8c-27cd-4c4a-a684-3dd09c06522c"
      unitRef="shares">771276</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id702121c7c324bf6885a6bf80cae7fe4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMS0zLTEtMS0w_d907e922-b82f-403b-b41d-4e2d09e3cf4f"
      unitRef="usdPerShare">23.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMi0xLTEtMS0w_f72ad27c-a6e3-4dd9-a02e-7598b55cc8cc"
      unitRef="shares">10851</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMi0zLTEtMS0w_84fa78f6-dc79-4176-8a5a-54d4486755d9"
      unitRef="usdPerShare">26.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMy0xLTEtMS0w_40bc4eb3-6df6-4c9d-901d-bbe7a226f6e2"
      unitRef="shares">24999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfMy0zLTEtMS0w_010cc339-b735-46d0-a250-aca5ddcf310a"
      unitRef="usdPerShare">23.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNC0xLTEtMS0w_93ccdee1-4f77-465d-8034-b08dc679833d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b9dd58943974c79bc7e8b29061d2963_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNC0zLTEtMS0w_d632ce0b-8841-4585-9740-e8f4b80a9fda"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if2bd407df76c4d14a849c52897796383_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNS0xLTEtMS0w_763d813b-e3a4-417a-a1e0-717e6db3291a"
      unitRef="shares">757128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if2bd407df76c4d14a849c52897796383_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RhYmxlOmM1ZDlkNzVlZTk1ZTRlNDlhNzgwNDRmOGQ5YzBkNjM5L3RhYmxlcmFuZ2U6YzVkOWQ3NWVlOTVlNGU0OWE3ODA0NGY4ZDljMGQ2MzlfNS0zLTEtMS0w_bd09bbc0-7899-42ff-b218-5704ac56fbaa"
      unitRef="usdPerShare">23.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMjc0ODc3OTA3NDM5Mg_2a9bbfab-a65e-4f45-8451-6f706e917b69">Earnings (Loss) Per Share &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per share represents the amount of income (loss) attributable to each common share outstanding. Diluted earnings (loss) per share represents the amount of income (loss) attributable to each common share outstanding adjusted for the effects of potentially dilutive common shares. Potentially dilutive common shares include stock options and other stock-based awards. In the periods where the effect would be antidilutive, potentially dilutive common shares are excluded from the calculation of diluted earnings per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In periods in which the Company has net income, earnings per share is calculated using the two-class method. This method is required as unvested restricted stock distributed in respect of pre-IPO Class&#160;B-1 and B-2 awards have the right to receive non-forfeitable dividends or dividend equivalents if the Company were to declare dividends on its common stock. Pursuant to the two-class method, earnings for each period are allocated on a pro-rata basis to common stockholders and unvested pre-IPO Class B-1 and B-2 restricted stock awards. Diluted earnings per share is computed using the more dilutive of (a) the two-class method, or (b) treasury stock method, as applicable, to the potentially dilutive instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In periods in which the Company has a net loss, the two-class method is not applicable because the pre-IPO Class B-1 and B-2 restricted stock awards do not participate in losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic and diluted earnings per common share are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;in thousands of U.S. dollars and share amounts (except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings (Loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Allocation to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) attributable to Sotera Health Company common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;10,685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Common Shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.52pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Weighted-average common shares outstanding - basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;278,827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;232,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Weighted-average common shares outstanding - diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;278,968&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;232,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings (loss) per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) attributable to Sotera Health Company common shareholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) attributable to Sotera Health Company common shareholders - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;n additional 2,400,349 and 3,645 equivalent shares related to stock options and RSUs, respectively, issued in connection with the 2020 Omnibus Incentive Plan were excluded from the calculation of diluted weighted average common shares outstanding for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;the three months ended March&#160;31, 2021 as they were anti-dilutive&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. For the three months ended March&#160;31, 2020, there were no potentially dilutive common shares outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMjc0ODc3OTA3NDM5Mw_740a260a-b052-443b-a8e2-5e832b509868">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic and diluted earnings per common share are calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;in thousands of U.S. dollars and share amounts (except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings (Loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Allocation to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) attributable to Sotera Health Company common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;10,685&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1,964)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Common Shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.52pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Weighted-average common shares outstanding - basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;278,827&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;232,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;141&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Weighted-average common shares outstanding - diluted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;278,968&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;232,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earnings (loss) per Common Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) attributable to Sotera Health Company common shareholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income (loss) attributable to Sotera Health Company common shareholders - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;n additional 2,400,349 and 3,645 equivalent shares related to stock options and RSUs, respectively, issued in connection with the 2020 Omnibus Incentive Plan were excluded from the calculation of diluted weighted average common shares outstanding for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;the three months ended March&#160;31, 2021 as they were anti-dilutive&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;. For the three months ended March&#160;31, 2020, there were no potentially dilutive common shares outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMy0xLTEtMS0w_83f5e39e-9f37-4c25-b7be-96cdbe785953"
      unitRef="usd">11065000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMy0zLTEtMS0w_1b61503c-b71e-4d60-a924-2a2321663593"
      unitRef="usd">-1986000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNC0xLTEtMS0w_226aa2a4-0f09-4a36-86d3-100e657f03e3"
      unitRef="usd">223000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNC0zLTEtMS0w_4ee5d25d-4b65-4837-8bdb-f387d6dc31fb"
      unitRef="usd">-22000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0yOTY0_b0364c75-321d-4d2d-bd06-5b034a24a311"
      unitRef="usd">157000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0yOTY0_e64e5ddb-9a80-41f2-b00b-0ebe2fab1c06"
      unitRef="usd">157000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0yOTY0_b65e3aea-9468-4fab-9591-6f356c8efc24"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0yOTY0_ca2f5673-98c0-43d4-aba6-bfdf370e7861"
      unitRef="usd">0</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0w_4fb58360-11bb-4ea3-ac40-9192104bcb87"
      unitRef="usd">10685000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0xLTEtMS0w_b32c94a1-f949-4140-9a12-f614068c09ce"
      unitRef="usd">10685000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0w_0eab2609-cfac-4a93-a0b7-a29fd630b9c4"
      unitRef="usd">-1964000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNS0zLTEtMS0w_2b9b77b2-2bb3-4603-bb7b-aaf420a5e826"
      unitRef="usd">-1964000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNy0xLTEtMS0w_0c018816-30ae-4225-830e-77bf368ac3f2"
      unitRef="shares">278827000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfNy0zLTEtMS0w_2042abf1-203a-4faf-a7c5-385d1b8c669c"
      unitRef="shares">232400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0xLTEtMS01MTc5_dda2137d-7362-4979-af45-0cf92a112d21"
      unitRef="shares">141000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0zLTEtMS01MTgz_4aebb884-f1bc-464a-8692-b380dea2c70b"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOC0xLTEtMS0xMjU3_0556ef6c-ec9d-4c51-aa77-5442d14b129f"
      unitRef="shares">278968000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOC0zLTEtMS0xMjU3_72359990-bf9e-4f6e-b01c-5ecfca03cce4"
      unitRef="shares">232400000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMTAtMS0xLTEtMTI1MQ_64ea2fcf-098d-4aba-b914-b7648572c533"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfMTAtMy0xLTEtMTI1MQ_ac3ad191-6636-4420-89b5-befe2effdac0"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0xLTEtMS0w_b8b1039a-e990-41dd-9e96-fe9498092ba6"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RhYmxlOjZiNTBiOWUwMmQ1NzRhYTRhM2ZkZjhmMmI4YTU3ZjM1L3RhYmxlcmFuZ2U6NmI1MGI5ZTAyZDU3NGFhNGEzZmRmOGYyYjhhNTdmMzVfOS0zLTEtMS0w_efe2082f-9afe-428a-9a09-fadc99e90cfd"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i72ebc9f42a97466cbcc112179091d11f_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMTY0OTI2NzQ0NzY3MQ_7f3deb97-446c-4c5d-b844-29318e1c6fbc"
      unitRef="shares">2400349</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib4973995a8b649188261f6b9eb660a4a_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMTY0OTI2NzQ1MjEwMA_2314afde-0436-429d-a54c-d13b77e9768f"
      unitRef="shares">3645</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7581e01e812b4161a3abb7a0bc4a19d7_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84Mi9mcmFnOmRmOGMzMzZlNzJhYTQyM2Q5MGFiNjVlMzEyNzI1ZDFiL3RleHRyZWdpb246ZGY4YzMzNmU3MmFhNDIzZDkwYWI2NWUzMTI3MjVkMWJfMjc0ODc3OTA3OTc4NA_fac094c3-4730-4dbc-a7d7-c47743c1c263"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE1OA_cf4ab607-63ff-4066-9632-e042aa8ee439">Commitments and Contingencies &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may be subject to various lawsuits and other claims in the ordinary course of our business. In addition, from time to time, we receive communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which we operate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We establish reserves for specific liabilities in connection with regulatory and legal actions that we determine to be both probable and reasonably estimable. No material amounts have been accrued in our consolidated financial statements with respect to any loss contingencies. In certain of the matters described below, we are not able to make a reasonable estimate of any liability because of the uncertainties related to the outcome and/or the amount or range of loss. While it is not possible to determine the ultimate disposition of each of these matters, we do not expect that the ultimate resolution of pending regulatory and legal matters in future periods, including the matters described below, will have a material effect on our financial condition or results of operations. Despite the above, the Company may incur material defense and settlement costs, diversion of management resources and other adverse effects on our business, financial condition, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;FM Global Business Interruption Claim (NRU Outage) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nordion, due to the shutdown of AECL&#x2019;s NRU reactor in 2009, suffered a cessation of supply of radioisotopes and business interruption loss. Nordion, by Statement of Claim dated October&#160;22, 2010, issued in Ontario Superior Court an action against the insurer, Factory Mutual Insurance Company (FM Global), claiming $25.0 million USD in losses resulting from the shutdown of AECL&#x2019;s reactor and its inability to supply radioisotopes through the specified period of approximately 15 months. FM Global objected to Nordion&#x2019;s claim. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trial commenced in March 2019 and was completed in September 2019. On March&#160;30, 2020, Nordion received a favorable judgment in the amount of $25.0 million USD, plus pre-judgment interest, for a total judgment value of $39.8 million USD, or $56.4 million CAD based on exchange rates approved by the trial court. In addition, costs and disbursements have been assessed and awarded by the trial court in favor of Nordion in the approximate amount of $1.1 million CAD ($0.8 million USD) and $161,863 CAD ($0.1 million USD), respectively. On April&#160;27, 2020, FM Global appealed the judgment. In January 2021, The Insurance Bureau of Canada was granted leave to intervene in the appeal. Hearing before the Court of Appeal was held on April 15, 2021. Pending a favorable judgment in the appellate court, any final proceeds would be subject to post judgment interest, a contingent fee owed to legal counsel and applicable taxes. As the judgment is considered a contingent gain, any favorable outcome will be recognized in a future period when all appeals are exhausted. It is anticipated that the overall appeal process could take a year or more to complete. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Willowbrook, Illinois &#x2013; Government Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 30, 2018, the Illinois Attorney General and the State&#x2019;s Attorney of DuPage County, Illinois, sued Sterigenics U.S., LLC (the &#x201c;IAG Action&#x201d;), alleging that authorized EO air emissions from a commercial sterilization facility Sterigenics formerly operated in Willowbrook, Illinois &#x201c;cause, threaten, or allow air pollution&#x201d; in violation of the Illinois Environmental Protection Act. The IAG Action did not assert that Sterigenics violated its permit from the Illinois Environmental Protection Agency (&#x201c;IEPA&#x201d;) authorizing Sterigenics&#x2019; release of regulated levels of EO at the Willowbrook facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 15, 2019, the acting IEPA director, John Kim, issued a &#x201c;Seal Order&#x201d; effectively precluding Sterigenics&#x2019; operations at the Willowbrook facility based on many of the same allegations asserted in the IAG Action. Sterigenics disputed those allegations and opposed the IEPA&#x2019;s Seal Order. The Seal Order was resolved by a Consent Order entered on September 6, 2019. The Consent Order provided that Sterigenics did not admit the allegations of the IAG Action, provided for the removal of the Seal Order and allowed the Willowbrook facility to reopen upon implementation of supplemental emissions control measures consistent with a new law that became effective in Illinois in June 2019 and an IEPA permit, which the IEPA approved in September 2019. Following entry of the Consent Order, the Seal Order was withdrawn.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, Sterigenics announced the closure of the Willowbrook facility due to the inability to reach an agreement with its landlord to renew the facility&#x2019;s lease and the unstable legislative and regulatory landscape in Illinois. Sterigenics is in the process of decommissioning the facility and completing the work required by the terms of its lease to return the property to the landlord.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 20, 2020 Sterigenics, the Illinois Attorney General and the State&#x2019;s Attorney of DuPage County filed a Joint Motion to Terminate Consent Order, stating that the community projects which Sterigenics voluntarily agreed to fund have been completed and funded as required by the Consent Order, and that Sterigenics has permanently ceased operations and surrendered all permits for its operations in Willowbrook, Illinois. On October 27, 2020 the DuPage County Circuit Court entered the Agreed Order Terminating Consent Order.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ethylene Oxide Tort Litigation - Illinois&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since September 2018, tort lawsuits on behalf of approximately 835 personal injury plaintiffs (which are further described in the following paragraphs) have been filed in Illinois state courts against Sotera Health LLC, Sterigenics U.S., LLC, GTCR, LLC and other parties related to Sterigenics&#x2019; Willowbrook, Illinois operations. Specifically, those plaintiffs allege that they suffered personal injuries including cancer and other diseases, or wrongful death, resulting from purported emissions and releases of EO from the Willowbrook facility. Additional derivative claims are alleged on behalf of other individuals related to these personal injury plaintiffs. Plaintiffs seek damages in an amount to be determined by the trier of fact. Sterigenics denies these allegations and intends to vigorously defend against these claims. Plaintiffs have voluntarily dismissed without prejudice a number of cases since September 2018, including certain individual cases alleging personal injuries and two class actions seeking damages for alleged diminution of property values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sterigenics sought consolidation of the cases for pretrial purposes, and in October 2019 obtained an order consolidating the then-pending cases and related cases filed in the future before Judge Lawler in the Cook County Circuit Court, Illinois (the &#x201c;Consolidated Case&#x201d;). All plaintiffs in the Consolidated Case filed a single Master Complaint on October 24, 2019 by which Sotera Health LLC was added as a co-defendant, followed by a First Amended Master Complaint on January 31, 2020. On April 28, 2020, the defendants filed motions to dismiss the claims in the First Amended Master Complaint. On August 17, 2020, the Court entered an order largely denying the motions to dismiss, and the same day plaintiffs filed a Second Amended Master Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs filed a Third Amended Master Complaint on October 30, 2020 adding Griffith Foods Group, Inc., Griffith Foods, Inc., Griffith Foods International, Inc. and Griffith Foods Worldwide Inc. as defendants. Defendants&#x2019; responses to the Third Amended Master Complaint were filed on or about December 1, 2020, including a motion to dismiss by Griffith Foods Group, Inc., Griffith Foods, Inc., Griffith Foods International, Inc. and Griffith Foods Worldwide, Inc. That motion was granted in part on March 16, 2021 and plaintiffs were granted leave to file a Fourth Amended Master Complaint. The Fourth Amended Master Complaint was filed on April 16, 2021, including claims against Griffith Foods International, Inc. but not the other Griffith entities. All defendants&#x2019; responses to the Fourth Amended Master Complaint are due by May 14, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Written and deposition fact discovery is on-going in the Consolidated Case. Currently, there are no dates set for the close of fact discovery, for expert discovery or for dispositive motion practice. Plaintiffs have not yet made any specific damages claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trials in five of the individual cases now included in the Consolidated Case had previously been scheduled to begin in 2021. Based on the Court's administrative orders related to the impact of COVID-19 on jury trials, however, and subject to the Court's discretion to make changes, we anticipate that the earliest any of the individual cases in the Consolidated Case will be tried will be 2022 and that trials will be scheduled in roughly the order in which the individual cases were filed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ethylene Oxide Tort Litigation &#x2013; Georgia &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2020, a lawsuit against Sotera Health LLC, Sterigenics U.S., LLC and other parties was filed in the State Court of Cobb County, Georgia by 53 employees of a contract sterilization customer of Sterigenics. In the operative complaint, Plaintiffs claim personal injuries resulting from alleged exposure to residual EO while working at the customer&#x2019;s distribution center in Lithia Springs, Georgia, allege they were unaware that they were being exposed to EO in their workplace and seek damages in an amount to be determined by the trier of fact. Defendants filed motions to dismiss and answers to the Complaint on April 30, 2021. All defendants are being defended and indemnified by Sterigenics&#x2019; contract sterilization customer (plaintiffs&#x2019; employer and a co-defendant in the lawsuit).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, the Cobb County, Georgia Board of Tax Assessors reduced certain residential property value assessments around the Sterigenics Atlanta facility by 10% citing an &#x201c;Epd-identified environmental issue,&#x201d; without supporting market data. On &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August 14, 2020, Sterigenics U.S., LLC filed a lawsuit against members of the Cobb County Board of Tax Assessors in the U.S. District Court for the Northern District of Georgia, seeking a declaration that the reduction in property value assessments is arbitrary and unlawful and is causing Sterigenics reputational and imminent economic harm. On February 5, 2021 the Court issued an order finding that Sterigenics lacks standing to obtain the relief sought and dismissed the case. Sterigenics has appealed that decision to the 11th Circuit Court of Appeals and anticipates that appellate briefing will be completed before the end of August 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since August 17, 2020, six lawsuits against Sotera Health LLC, Sterigenics U.S., LLC and other parties have been filed by plaintiffs in the State Court of Cobb County, Georgia and the State Court of Gwinnett County, Georgia in which plaintiffs allege that they suffered personal injuries and loss of consortium resulting from emissions and releases of EO from Sterigenics&#x2019; Atlanta facility. Our subsidiaries are also defendants in lawsuits alleging that the Atlanta facility has devalued and harmed plaintiffs&#x2019; use of real properties they own in Smyrna, Georgia and caused other damages. Plaintiffs in these cases seek various forms of relief including damages in amounts to be determined by the trier of fact. Sotera Health LLC filed motions to dismiss in each case on personal jurisdiction grounds. That motion was denied in one case pending in the State Court of Gwinnett County and the other motions remain pending. Sterigenics U.S., LLC and Sotera Health LLC filed a motion to dismiss the strict liability claim in each case. That motion was denied in one case pending in the State Court of Gwinnett County and the other motions remain pending. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Suspension of Georgia Facility Operations&#160;&amp;amp; Related Litigation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 7, 2019, Sterigenics U.S., LLC entered into a voluntary Consent Order with the Georgia Environmental Protection Division (&#x201c;EPD&#x201d;) under which Sterigenics agreed to install emissions reduction enhancements at its Atlanta facility to further reduce the facility&#x2019;s EO emissions below already permitted levels. Sterigenics voluntarily suspended operations at the facility in early September 2019 to expedite completion of the enhancements. Installation of these enhancements is complete, and Sterigenics successfully tested the enhanced emissions controls in cooperation with EPD during the second quarter of 2020 while the facility was in operation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, while Sterigenics had voluntarily suspended the facility&#x2019;s operations, Cobb County, Georgia officials asserted that the facility had an incorrect &#x201c;certificate of occupancy&#x201d; and could not resume operations without obtaining a new certificate of occupancy after a third-party code compliance review they required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the Cobb County officials would not allow Sterigenics to resume operations, on March 30, 2020, Sterigenics U.S., LLC filed a lawsuit in the United States District Court for the Northern District of Georgia against Cobb County, Georgia and Cobb County officials Nicholas Dawe and Kevin Gobble. In the lawsuit, Sterigenics sought immediate injunctive relief and permanent declaratory relief to resume normal operations of the Atlanta facility in the interest of public health and on the basis that the positions asserted by Cobb County were unfounded. On April 1, 2020 the Court entered a Temporary Restraining Order prohibiting Cobb County officials from precluding or interfering with the facility&#x2019;s normal operations. On April 8, 2020, the Court entered a Consent Order extending the Temporary Restraining Order and allowing the facility to continue normal operations until entry of a final judgment in the case. Defendants filed a motion to dismiss the claims. On November 9, 2020, the Court held a hearing and denied the motion to dismiss. The parties are conducting discovery, which is presently scheduled to end on July 23, 2021. A settlement conference is scheduled to be held by September 27, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Ethylene Oxide Litigation &#x2013; New Mexico&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2020 the New Mexico Attorney General filed a lawsuit in the Third Judicial District Court, Do&#xf1;a Ana County, New Mexico (&#x201c;the Third Judicial District&#x201d;) against the Company, Sterigenics U.S., LLC and other subsidiaries alleging that emissions of EO from Sterigenics U.S., LLC&#x2019;s sterilization facility in Santa Teresa, New Mexico constitute a public nuisance and have deteriorated the air quality in Santa Teresa and surrounding communities and materially contributed to increased health risks suffered by residents of those communities. The Complaint asserts claims for public nuisance, negligence, strict liability, violations of New Mexico&#x2019;s Public Nuisance Statute and Unfair Practices Act and a request for a temporary restraining order and preliminary injunctive relief. On December 28, 2020 Sterigenics U.S., LLC removed the case to the United States District Court for the District of New Mexico. On April 13, 2021 the case was remanded to the Third Judicial District where Plaintiff&#x2019;s Emergency Motion for Temporary Restraining Order and Preliminary Injunction has been scheduled for a preliminary injunction hearing on May 26, 2021.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Emergency Motion does not demand facility closure but seeks an order requiring Defendants to cease any and all uncontrolled emissions or releases of EO from the Santa Teresa facility, including by making certain modifications to sterilization processes at the facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We carry insurance for alleged environmental liabilities (including litigation like that pending in Illinois, Georgia and New Mexico described above), with limits of $10.0 million per occurrence and $20.0 million in the aggregate. The per occurrence limit related to the Willowbrook government and EO tort litigation was fully utilized by June 30, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional personal injury, property devaluation or other lawsuits may be filed in the future against us or our subsidiaries relating to Sterigenics&#x2019; Willowbrook, Atlanta, Santa Teresa or other EO sterilization facilities. The Company, Sterigenics U.S., LLC and other Company subsidiaries intend to defend themselves vigorously in all such current or future EO litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While an adverse outcome in one or more of the proceedings could have a material adverse effect on our business, financial condition and results of operations, no contingency reserve has been reflected in our consolidated financial statements as a loss is not deemed probable, nor is a loss or range of losses reasonably estimable.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="if00ab087eb4046b2a954c121dda0b128_D20101022-20101022"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjU3NQ_a059b2b8-8fcc-476f-bdd2-3cf6423f5ee5"
      unitRef="usd">25000000.0</us-gaap:LossContingencyDamagesSoughtValue>
    <shc:GainContingencyPeriodOfBusinessInterruption
      contextRef="if00ab087eb4046b2a954c121dda0b128_D20101022-20101022"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyNzI2OA_f4a6e073-fff2-4209-8df0-4288cd2935db">P15M</shc:GainContingencyPeriodOfBusinessInterruption>
    <shc:LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjU5Mg_0e072ec9-b4f2-42fe-9eba-027c3403f33a"
      unitRef="usd">25000000.0</shc:LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjYxMg_80782395-1452-492c-8ce7-e55f1da10fd2"
      unitRef="usd">39800000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjYzMg_c5dc3878-5426-4f7b-8329-714803447e92"
      unitRef="cad">56400000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <shc:LitigationSettlementCostsAssessedAndAwardedInFavor
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY1MQ_27d4408d-aba4-4dc7-b21b-a120b15d53f2"
      unitRef="cad">1100000</shc:LitigationSettlementCostsAssessedAndAwardedInFavor>
    <shc:LitigationSettlementCostsAssessedAndAwardedInFavor
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY2Ng_842fd102-5388-49ef-a310-ee93ff7135b1"
      unitRef="usd">800000</shc:LitigationSettlementCostsAssessedAndAwardedInFavor>
    <shc:LitigationSettlementDisbursementsAssessedAndAwardedInFavor
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY3Ng_255de896-0ced-48c9-8bf9-2bd66822aa87"
      unitRef="cad">161863</shc:LitigationSettlementDisbursementsAssessedAndAwardedInFavor>
    <shc:LitigationSettlementDisbursementsAssessedAndAwardedInFavor
      contextRef="i637032dc37e147c7887a1ffe2737d870_D20200330-20200330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjY5MQ_d12c189f-cb50-4671-aa48-19786c46af37"
      unitRef="usd">100000</shc:LitigationSettlementDisbursementsAssessedAndAwardedInFavor>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i3056567d4b7944ee83f117f290349ae0_D20180901-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjcxNA_bff504b6-71e0-45e2-bb48-7029d4e4136f"
      unitRef="plaintiff">835</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i2b7ab3687cab4a8e81d2d673d039bf1b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE1OQ_737f62c6-eb5a-41d7-aef2-c6a5acb58e48"
      unitRef="claim">2</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i4f11af9e3301403b98a762a3a5ca629e_D20200519-20200519"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTY0OTI2NzQ5MjcxOQ_bb404770-1713-4c26-83a5-885831917fe9"
      unitRef="plaintiff">53</us-gaap:LossContingencyNumberOfPlaintiffs>
    <shc:PercentOfReductionInResidentialPropertyValueAssessment
      contextRef="ic2508d02cd384fa790ed8dda3ccb6e14_D20200501-20200531"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE3OA_7de6564e-17ca-4727-bd12-bf96f111457f"
      unitRef="number">0.10</shc:PercentOfReductionInResidentialPropertyValueAssessment>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i13271ac323454d0599f0910fc46fbaee_D20200817-20200817"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMjc0ODc3OTEyMTE2OA_11de67a9-e14b-43ef-8aa8-d0f030758a56"
      unitRef="claim">6</us-gaap:LossContingencyNewClaimsFiledNumber>
    <shc:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTc4Nzc_d30869a9-47f5-4f66-944b-f72f27ca9e01"
      unitRef="usd">10000000.0</shc:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence>
    <us-gaap:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84NS9mcmFnOmUyZTE5NTAyZDhkYjQwMDE4NGJmY2QwNDk5NWU0YjRmL3RleHRyZWdpb246ZTJlMTk1MDJkOGRiNDAwMTg0YmZjZDA0OTk1ZTRiNGZfMTc4OTk_9063d534-38e2-4b16-bef1-ca2c9c0e44de"
      unitRef="usd">20000000.0</us-gaap:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDk0NzgwMjMzNTA1MA_2a289796-f876-43fc-b2c9-269c80461613">Financial Instruments and Financial Risk &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Instruments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not use derivatives for trading or speculative purposes and are not a party to leveraged derivatives. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated in Hedge Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2019, we entered into two interest rate swap agreements to hedge our exposure to interest rate movements and to manage interest expense related to our then outstanding variable-rate debt. The notional amount of the interest rate swap agreements totaled $1,000.0 million. These swaps were designated as cash flow hedges and were designed to hedge the variability of cash flows attributable to changes in LIBOR, the benchmark interest rate being hedged. We received interest at one-month LIBOR and paid a fixed interest rate under the terms of the swap agreement. The swap agreements terminated on August&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated in Hedge Relationships&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, we entered into two interest rate cap agreements with a total notional amount of $400.0 million for a total option premium of $0.6 million; these agreements terminated on September 30, 2020. The interest rate caps limited the Company&#x2019;s cash flow exposure related to LIBOR under the variable rate Term Loan borrowings to 3.0%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, SHH entered into two interest rate cap agreements with notional amounts of $1,000.0 million and $500.0 million, respectively, for a total option premium of $0.3 million. These instruments were initially scheduled to terminate on August 31, 2021 and February 28, 2022, respectively. The interest rate caps limit our cash flow exposure related to the LIBOR base rate under a portion of our variable rate borrowings to 1.0%. In February 2021, we amended the two interest rate cap agreements referenced above to reduce the strike rate from 1.0% to 0.5%, and extend the termination date of the $1,000.0 million notional cap to September 30, 2021. Premiums paid to amend the interest rate caps were immaterial. We also entered into two additional interest rate cap agreements in February 2021 with a combined notional amount of $1,000.0 million, for a total option premium of $0.4 million. These instruments are effective September 30, 2021, and will terminate on March 31, 2022. The amended and new interest rate caps limit our cash flow exposure related to LIBOR under a portion of our variable rate borrowings to 0.5%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate caps were entered into to manage economic risks associated with our variable rate borrowings, but were not designated in hedge relationships. These instruments are recorded at fair value on the Consolidated Balance Sheets, with any changes in the value being recorded in &#x201c;Interest expense, net&#x201d; in the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also entered into foreign currency forward contracts to manage foreign currency exchange rate risk of our intercompany loans in certain of our international subsidiaries. The foreign currency forward contracts expire on a monthly basis. The fair value of the outstanding foreign currency forward contracts was zero as of March&#160;31, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Embedded Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have embedded derivatives in certain of our customer and supply contracts as a result of the currency of the contract being different from the functional currency of the parties involved. Changes in the fair value of the embedded derivatives are recognized in &#x201c;Other income, net&#x201d; in the Consolidated Statements of Operations and Comprehensive Income (Loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the notional and fair values of our derivative instruments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(in U.S. Dollars; notional in millions, fair value in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,500.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;77.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,577.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,583.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;Represents the total notional amounts for certain of the Company&#x2019;s supply and sales contracts accounted for as embedded derivatives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate caps and embedded derivative assets are included in &#x201c;Prepaid expenses and other current assets&#x201d; on our consolidated balance sheets. Embedded derivative liabilities are included in &#x201c;Accrued liabilities&#x201d; on the Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the activities of our derivative instruments for the periods presented, and the line item they are recorded in in the Consolidated Statements of Operations and Comprehensive Income (Loss): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized loss on interest rate caps recorded in interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized (gain) loss on embedded derivatives recorded in other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized gain on foreign currency forward contracts recorded in foreign exchange (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(2,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, during the three months ended March&#160;31, 2020, we recognized $3.5 million of losses, net of tax, in accumulated other comprehensive income (loss) related to the change in fair value of the interest rate swaps.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Risk &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our financial assets, including cash and cash equivalents, are exposed to credit risk. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also exposed, in our normal course of business, to credit risk from our customers. As of March&#160;31, 2021 and December&#160;31, 2020, accounts receivable was net of an allowance for uncollectible accounts of $0.6 million and $0.7 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk on financial instruments arises from the potential for counterparties to default on their contractual obligations to us. We are exposed to credit risk in the event of non-performance, but do not anticipate non-performance by any of the counterparties to our financial instruments. We limit our credit risk by dealing with counterparties that are considered to be of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;high credit quality. In the event of non-performance by counterparties, the carrying value of our financial instruments represents the maximum amount of loss that would be incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Hierarchy&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our financial instruments is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques we would use to determine such fair values are described as follows: Level 1&#x2014;fair values determined by inputs utilizing quoted prices in active markets for identical assets or liabilities; Level 2&#x2014;fair values based on observable inputs other than quoted prices included in Level&#160;1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable; Level 3&#x2014;fair values determined by unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses the fair value of our financial assets and liabilities: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;1 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;2 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;3 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,740,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,760,896&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior notes, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;96,458&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;97,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance Lease Obligations (with current portion)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;34,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;34,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;1 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;2 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;3 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,728,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,772,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior notes, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;99,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance Lease Obligations (with current portion)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Derivatives that are not designated as hedging instruments are measured at fair value with gains or losses recognized immediately in the Consolidated Statements of Operations and Comprehensive Income (Loss). Interest rate caps are valued using pricing models that incorporate observable market inputs including interest rate and yield curves. Embedded derivatives are valued using internally developed models that rely on observable market inputs including foreign currency forward curves.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Carrying amounts of long-term debt instruments are reported net of discounts and debt issuance costs. The estimated fair value of these instruments is based on information provided by the agent under the Company&#x2019;s senior secured credit facility. Fair value approximates carrying value for &#x201c;Other long-term debt.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Fair value approximates carrying value.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="if41011b61b2c455085406c4d35f4b029_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3Nzk4Mg_0b95f2ff-0730-46d9-a714-0475cd803e53"
      unitRef="instrument">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2c743685ac7e4b5eb6a0f423118724d0_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk2Mg_9cefcbd7-4ac8-4a18-baf7-0f92e120b9ab"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="id7710cf9b27a47e0b0c8712ace4267e6_I20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3Nzk5MQ_f6c386d1-8203-4566-b7ce-9fc347519568"
      unitRef="instrument">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic2065da279504816835ffbc1e014f7ad_I20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk2Ng_d81cca50-e286-43f6-be41-196815d75693"
      unitRef="usd">400000000.0</us-gaap:DerivativeNotionalAmount>
    <shc:DerivativeOptionPremium
      contextRef="ic2065da279504816835ffbc1e014f7ad_I20171031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk3MA_df9d580c-1edb-44a8-a85c-7e2b5fc6e3be"
      unitRef="usd">600000</shc:DerivativeOptionPremium>
    <shc:PercentOfBorrowingLimitationDueToCashFlowExposure
      contextRef="ic2065da279504816835ffbc1e014f7ad_I20171031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk5OQ_efff74ab-6412-4734-aa79-87ec37dc506f"
      unitRef="number">0.030</shc:PercentOfBorrowingLimitationDueToCashFlowExposure>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ic08f77143efb4a438f9ac6fd9f28e16b_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAwMA_43ea22bb-af4b-41ad-b131-56470d00d494"
      unitRef="instrument">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id090514efde94317af113816c3ec1bce_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk4Nw_91a226e8-4add-4138-9ca6-eaafaac3d191"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i99e7214bafc64b91bd10fb6c344d92fa_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk4Mw_8cd24d66-7e94-4383-9402-52ea961e3963"
      unitRef="usd">500000000.0</us-gaap:DerivativeNotionalAmount>
    <shc:DerivativeOptionPremium
      contextRef="id090514efde94317af113816c3ec1bce_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ0OTk3NA_529855ec-13f6-4a10-a1a8-0c70be798b8e"
      unitRef="usd">300000</shc:DerivativeOptionPremium>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="idb744f485b224be28617f3aba1a1cd06_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAwNA_584e2b48-1970-4115-a67a-794106a485ec"
      unitRef="number">0.010</us-gaap:DerivativeVariableInterestRate>
    <shc:DerivativeNumberOfInstrumentsAmended
      contextRef="i57dad9620c47433bb1a2a45a38b824b2_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODE1NQ_981666d7-eaa8-400b-8fdb-c108c5c806d8"
      unitRef="instrument">2</shc:DerivativeNumberOfInstrumentsAmended>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="idb744f485b224be28617f3aba1a1cd06_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAwOQ_584e2b48-1970-4115-a67a-794106a485ec"
      unitRef="number">0.010</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i93e757215c724df1b4b2dbead002a317_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAxMw_c6e8899d-2418-477a-a855-69332dc9d156"
      unitRef="number">0.005</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2c743685ac7e4b5eb6a0f423118724d0_I20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAxNw_9cefcbd7-4ac8-4a18-baf7-0f92e120b9ab"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNumberOfInstrumentsHeld
      contextRef="ie9939ca2be9548b480d25f00cfea7cb9_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAxMA_b005cf02-f057-466f-91b5-bcd2f6df5a8c"
      unitRef="instrument">2</us-gaap:DerivativeNumberOfInstrumentsHeld>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ie9939ca2be9548b480d25f00cfea7cb9_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAyNQ_16eaf7fa-548e-407e-92d4-f477a7d08882"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <shc:DerivativeOptionPremium
      contextRef="ie9939ca2be9548b480d25f00cfea7cb9_I20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMTY0OTI2NzQ1MDAyOQ_bcecb229-a1d2-4021-a8bc-f6c1fa86e335"
      unitRef="usd">400000</shc:DerivativeOptionPremium>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ie796349e2806499cb940f14083d11104_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDk0NzgwMjMzNTA0NQ_941b590b-5824-40f9-ad95-922e78470fce"
      unitRef="number">0.005</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="if6debae2625842d3aea289304287b04a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMzAxNA_238f2ca6-a9f1-4e76-9e7b-9b86b3fe2d98"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i36a4d4ea180d473791afd4e893e822ca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMzAxNA_f918a87d-e9b8-4609-8a1f-39b29618c273"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAxOA_11ec22bc-d2aa-4c93-a258-14ed39f14468">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a summary of the notional and fair values of our derivative instruments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(in U.S. Dollars; notional in millions, fair value in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Notional&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivative&lt;br/&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,500.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,500.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;77.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2,577.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,583.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;Represents the total notional amounts for certain of the Company&#x2019;s supply and sales contracts accounted for as embedded derivatives.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9b0c33e7ec9945079c2630ef261167c1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi0xLTEtMS0w_7fa6f686-d307-4bd8-816c-b4d96f832eca"
      unitRef="usd">2500000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9b0c33e7ec9945079c2630ef261167c1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi0zLTEtMS0w_e21e047e-b182-4741-acc1-cba0b717ec69"
      unitRef="usd">9000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9b0c33e7ec9945079c2630ef261167c1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi01LTEtMS0w_9adf6474-cb91-4f1c-8db8-1a43c6673e9d"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i55ed0869e08f4f768909753e2657522f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi03LTEtMS0w_11ab2030-c2ab-4960-b3bf-6955538f1383"
      unitRef="usd">1500000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i55ed0869e08f4f768909753e2657522f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi05LTEtMS0w_b794d3e5-6dc4-4d27-9e22-1e806a09d1bb"
      unitRef="usd">7000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i55ed0869e08f4f768909753e2657522f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNi0xMS0xLTEtMA_892af89d-c1f2-4047-bbb3-4d7bdf5c94b5"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ifc5b766a46664492ac40f1cf7af1b926_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy0xLTEtMS0w_1c192e53-2795-40f3-8f11-066c6ee96d90"
      unitRef="usd">77700</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ifc5b766a46664492ac40f1cf7af1b926_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy0zLTEtMS0w_93472e66-7028-43c4-aba9-62d75f0fe560"
      unitRef="usd">403000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ifc5b766a46664492ac40f1cf7af1b926_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy01LTEtMS0w_5306c9d1-047c-435f-bb39-23cb6f11bcdc"
      unitRef="usd">229000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy03LTEtMS0w_88bf197a-03fc-4d6b-8c21-8fa6909b8c3f"
      unitRef="usd">83300</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy05LTEtMS0w_8c6d02d3-27bc-4659-83c5-e9067dfc1f49"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i3f60558d6e6f40b9899f5d54aed2c2cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfNy0xMS0xLTEtMA_e2429ecd-2e34-4cc3-a288-d273179e0862"
      unitRef="usd">670000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic30522771c8a4c2ca8b28897797aa79f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC0xLTEtMS0w_729305a1-9326-4791-a4ef-5b0692ac34c7"
      unitRef="usd">2577700</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic30522771c8a4c2ca8b28897797aa79f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC0zLTEtMS0w_6129059a-0414-408e-a9dd-755f44cc66e6"
      unitRef="usd">412000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic30522771c8a4c2ca8b28897797aa79f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC01LTEtMS0w_d8c8f41b-abc5-4479-aa72-78c98086b739"
      unitRef="usd">229000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i62085eeb658e46dd9eb6d857b79da630_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC03LTEtMS0w_1b18737d-c51f-421b-9447-8c4988819d2f"
      unitRef="usd">1583300</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i62085eeb658e46dd9eb6d857b79da630_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC05LTEtMS0w_cb5c3248-7dbd-420d-b056-c21189755a61"
      unitRef="usd">7000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i62085eeb658e46dd9eb6d857b79da630_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYyOGQ5ZTgyY2E5MDRjM2U4MjM3OWJlNTFlODQyMDFiL3RhYmxlcmFuZ2U6NjI4ZDllODJjYTkwNGMzZTgyMzc5YmU1MWU4NDIwMWJfOC0xMS0xLTEtMA_e7827baf-fb7e-46a3-b69e-46e919e85d26"
      unitRef="usd">670000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAyMA_5e70db67-b581-4170-b06b-c1c1dc121fbf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the activities of our derivative instruments for the periods presented, and the line item they are recorded in in the Consolidated Statements of Operations and Comprehensive Income (Loss): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized loss on interest rate caps recorded in interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized (gain) loss on embedded derivatives recorded in other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized gain on foreign currency forward contracts recorded in foreign exchange (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(2,374)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ia3f548aa16134334acbcc16023544496_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMi0xLTEtMS0w_0776c02c-ebc3-448c-bc2a-c5d80de0195f"
      unitRef="usd">-90000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="iabe8d5f4f0b7489bae88ace960e40d0e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMi0zLTEtMS0w_46629b00-d22b-4669-ac2c-80bdc8764d00"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ia6e675f57e9d48bba3df5cba6d545d97_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMy0xLTEtMS0w_d225fc86-4581-4d9e-b1e2-8d116ffc883f"
      unitRef="usd">853000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i2150bbbc748f44229562c8ec831ea1cf_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfMy0zLTEtMS0w_254a0aa4-99b3-4d3d-9732-336234abee4b"
      unitRef="usd">-4819000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i01147b9ec0104587b5471c7226ea6552_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfNS0xLTEtMS0w_9ff65775-2377-4a41-9f9f-093cf14c28e0"
      unitRef="usd">-2374000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i860d4a2deece4c239d322dec5ed3e62e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjYxY2QxNzhiY2VmODQwNGRhYTZjMTA0NzFjODE4Nzk0L3RhYmxlcmFuZ2U6NjFjZDE3OGJjZWY4NDA0ZGFhNmMxMDQ3MWM4MTg3OTRfNS0zLTEtMS0w_f5161797-0dbb-4531-a99a-41a7b72769cd"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i6ed3cf78f0d24298bc641938f88ea10f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDE2Nw_390cec2c-86b7-49ac-aeec-9d70b6ed2f76"
      unitRef="usd">3500000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="iec88d5b798444874850d669967cf4dbd_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDczNA_903762be-70a7-4358-99dc-ade92ddf732e"
      unitRef="usd">600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i39349c5dcb984b15b4709ccb996bd176_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfNDc0MQ_562bd649-0789-4e9f-87d4-e8f32d245a4d"
      unitRef="usd">700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RleHRyZWdpb246ZjljZWQ3ZTYwMjE2NGQ3YjkwNjcyN2IxZjU2ZTczYTRfMjc0ODc3OTA3ODAyMQ_05218db3-0bc4-47d5-8582-cf90bd4a19a8">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses the fair value of our financial assets and liabilities: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;1 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;2 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;3 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,740,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,760,896&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior notes, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;96,458&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;97,587&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1,051&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance Lease Obligations (with current portion)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;34,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;34,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;1 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;2 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Level&#160;3 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivatives not designated as hedging instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate caps&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Embedded derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(670)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Term loan, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,728,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,772,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior notes, due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;99,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance Lease Obligations (with current portion)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Derivatives that are not designated as hedging instruments are measured at fair value with gains or losses recognized immediately in the Consolidated Statements of Operations and Comprehensive Income (Loss). Interest rate caps are valued using pricing models that incorporate observable market inputs including interest rate and yield curves. Embedded derivatives are valued using internally developed models that rely on observable market inputs including foreign currency forward curves.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Carrying amounts of long-term debt instruments are reported net of discounts and debt issuance costs. The estimated fair value of these instruments is based on information provided by the agent under the Company&#x2019;s senior secured credit facility. Fair value approximates carrying value for &#x201c;Other long-term debt.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Fair value approximates carrying value.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8215ef184ce046bf92c78693a8b8af93_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy0xLTEtMS0w_1aab58d5-5702-4057-a8bd-61e24b524e83"
      unitRef="usd">9000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5447c83f5dbc409a96088e361444a411_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy0zLTEtMS0w_08e4f2c0-aaf1-4a2b-8599-af5bb5ad94a6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia8e15396c17b4617907472c2f4fade9b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy01LTEtMS0w_91752b40-bd09-4137-a11e-cd45bdc32f14"
      unitRef="usd">9000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id5081d47552c47cb8088900905b4f829_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfMy03LTEtMS0w_f31b95bf-79b8-4130-be50-478931cd1ee7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie2f1e394ba7d4c1982b82751ef9eeb68_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0xLTEtMS01Njgw_6980e936-818e-4e67-a97e-d25c45c18643"
      unitRef="usd">403000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="icf08e9f67a5d438db80fa3bec21b7105_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0zLTEtMS01Njgw_be5ff7ac-7a14-4437-b4c4-c61cb80f8879"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id8f67cfa14e34836a09901949e8a6f78_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC01LTEtMS01Njgw_20ca0303-6764-4a04-b255-9673be12c9af"
      unitRef="usd">403000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if94ed49fd1484dd19f80502049803ac1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC03LTEtMS01Njgw_c6de944d-e543-40eb-951f-ea9c373d2819"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie2f1e394ba7d4c1982b82751ef9eeb68_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0xLTEtMS0w_4e79d820-cb8e-4740-ba2f-fe70311a599c"
      unitRef="usd">229000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="icf08e9f67a5d438db80fa3bec21b7105_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC0zLTEtMS0w_6ec18fc9-eda4-40da-9d49-e7e769cb96d7"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id8f67cfa14e34836a09901949e8a6f78_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC01LTEtMS0w_289ae3b0-9bd1-4bdc-8f8e-faf404677641"
      unitRef="usd">229000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if94ed49fd1484dd19f80502049803ac1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNC03LTEtMS0w_31b42415-c17d-4f51-962b-7011380619c6"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebtFairValue
      contextRef="ic182088a125a4701b886f7b699c6ec3f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi0xLTEtMS0w_9b93a451-3ccb-47c9-bdf4-9d14d0aef0ab"
      unitRef="usd">1740071000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ie31b8c09e1a04e3abd0d5865f45be488_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi0zLTEtMS0w_135d848a-1128-4f0d-b814-d04fad797ae2"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ifbc39d33fbcf41d3be6a20574ae9f5e3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi01LTEtMS0w_d93d9763-0693-45c2-b178-18278b3343b9"
      unitRef="usd">1760896000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="idc03881b23174afb8aaf1b3b6857a78f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNi03LTEtMS0w_e0400121-2249-4188-b795-e0e669124754"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i7219b8c57243488bb121b53bd3d7d3cf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy0xLTEtMS0w_a508eeb9-8165-45e5-ab1a-4fdbbaffa496"
      unitRef="usd">96458000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="idcc5336d70c34ef689e5dbb4364e9943_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy0zLTEtMS0w_1d35db00-4fee-47db-965a-df3c1d831a00"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ie66e0ede22014573bd71c918b3740a70_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy01LTEtMS0w_1727cf4c-a496-42ad-9e6f-13b98a4e1ed0"
      unitRef="usd">97587000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ifc835d02987343f4928bb15a4113279a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfNy03LTEtMS0w_cb48e05a-b016-4580-b099-1da9a9158045"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i19990cadc7bf4e6eab87bd575dff569b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC0xLTEtMS0w_567d866f-98a1-4d66-9e71-e37dc455b556"
      unitRef="usd">1051000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i452aa60f46804ae7824cdb240c5048d4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC0zLTEtMS0w_c444fa17-d3a8-4051-878c-1d8ab4772e91"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="id4aa98cfa3374f178a69835db9e117bf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC01LTEtMS0w_13358110-1067-48ee-999c-3146d13b32f9"
      unitRef="usd">1051000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i272677a81acb465dad27e958b027480c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOC03LTEtMS0w_f4d9b841-a6a4-4c34-bc89-a9faf68d86a8"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="iee05df50a75d477993f0144a1d299dfe_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS0xLTEtMS0w_ab98566b-d840-46e5-bf45-17df8e79e54a"
      unitRef="usd">34540000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ia0ace0d34fc84a82a4a8dd4561599885_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS0zLTEtMS0w_99928e91-f05e-428c-aa23-e0e2334b02de"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i8d9dd1bfbd544776a04462426d06480e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS01LTEtMS0w_49c12e17-ae24-460e-b173-26f5f26501fe"
      unitRef="usd">34540000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i36f94f5ef6264fe1a1984794263117a2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOjFhMTAxYjEyYzZhYTRiMDE4YWU4ZjRmZDg5ZGY0YzhiL3RhYmxlcmFuZ2U6MWExMDFiMTJjNmFhNGIwMThhZThmNGZkODlkZjRjOGJfOS03LTEtMS0w_6b513a5e-e5a8-4404-a4f6-9ec7f178fe5d"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i36de9e2dd8ab40fc9b2ed92263ea4e84_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS0xLTEtMS0w_3587b62a-3120-4ac3-9546-0fed384e5dbe"
      unitRef="usd">7000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if74455fdc1334818832b157f91fec355_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS0zLTEtMS0w_976c3645-a6c5-4370-8b23-c4e9f283a5c3"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i585c891ef5c24f4f98a98256472bf2ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS01LTEtMS0w_8a91d473-ebf4-4fa5-a07d-ab7cdf4fd539"
      unitRef="usd">7000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ia08bd0ee1a164912afa76b9e27e176df_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNS03LTEtMS0w_424de13e-4d42-4daf-85dd-10ccfb614461"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7e84d185d63c421a9847d44f33a85663_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi0xLTEtMS0w_d843dd51-b888-4ada-96b5-58dc6bf0f312"
      unitRef="usd">670000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i02e84eddb6d54bfc9eb27fd468c46c12_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi0zLTEtMS0w_1d43aa0d-9850-4688-a0ce-2825d8a57608"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i5fb62adf30e64a04ac7bbc2fce94d9c2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi01LTEtMS0w_1db6b818-6058-4531-a871-87171a4e3f62"
      unitRef="usd">670000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i685874b622084b9fbc1d35045289e95a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfNi03LTEtMS0w_c090e705-bec5-4e62-9d5f-490003c5be6a"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:LongTermDebtFairValue
      contextRef="idba49c45ea854b6fa233cf1af5bbda94_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC0xLTEtMS0w_a9a6a471-5c70-4d78-8b64-89a71e9a7fe9"
      unitRef="usd">1728018000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i87475347f6b64bf0a02e800f0af6deeb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC0zLTEtMS0w_9b4fc387-46d4-4bf6-b364-4ceaf8784de0"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i063954931d844af4a978fc5c7a468cf2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC01LTEtMS0w_ee12d4cf-d369-4f86-a360-88228fe0ee74"
      unitRef="usd">1772180000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i32014511dee4420784c09d1a73b0f794_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOC03LTEtMS0w_11010231-176b-4b4b-82fa-6b27b5dd9ac0"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i76f8cf83b28b42adb2c968c7126c23b8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS0xLTEtMS0w_ed23221c-2993-4fc3-8096-e5831e389bcf"
      unitRef="usd">96329000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i4332841a17ae45d7ab5f8d5ccbb5a102_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS0zLTEtMS0w_7147cbfb-51a5-41f7-8bd4-cbf9376ccfe2"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i78b7cb2bfc064b10a052025a86eea5f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS01LTEtMS0w_686e76af-0935-4678-8178-ae2b1915805b"
      unitRef="usd">99863000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="id17e44686c4a444aa4f61e3a904dc55e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfOS03LTEtMS0w_b60de708-8f3f-48c6-8c0d-3902dff9c859"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i4d64d815af524281b0cc85c6490417b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtMS0xLTEtMA_c9d76ac3-4675-4516-8234-f069017209d1"
      unitRef="usd">442000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="ife1c0685123d4f1dbe17dc0dcb90acb9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtMy0xLTEtMA_f183e22f-cec5-41f0-8097-fd293b25c5be"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i79293a96e6644ab3afb669bba734bcc7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtNS0xLTEtMA_faa904d3-dbec-429a-903f-d540e7879112"
      unitRef="usd">442000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="if197f04408d94ab68c955aa4b4a235fb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTAtNy0xLTEtMA_397bda29-5676-41d2-853f-ba6be8946ec8"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i81cd9ccf6a8a483399b03f856601a919_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtMS0xLTEtMA_0ddd202a-2627-4ea7-b7e0-430bfa9f056a"
      unitRef="usd">36112000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i15872309fe384ede99b59ae790fd6692_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtMy0xLTEtMA_22cba000-31ac-4101-9c29-021706f854bf"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i5c9959285390451eb941cbc5aacef59e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtNS0xLTEtMA_256f864a-a54d-4e96-a9f5-b16924d26f3e"
      unitRef="usd">36112000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i8d8483a806e144dc96f7e439adffab1a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV84OC9mcmFnOmY5Y2VkN2U2MDIxNjRkN2I5MDY3MjdiMWY1NmU3M2E0L3RhYmxlOmJmOWE4MTUzYzcwMDQzOTNiNWRkYTU4ODAyZjExNGFhL3RhYmxlcmFuZ2U6YmY5YTgxNTNjNzAwNDM5M2I1ZGRhNTg4MDJmMTE0YWFfMTEtNy0xLTEtMA_eafa2309-4022-4244-acd1-873f2e1ad33e"
      unitRef="usd">0</us-gaap:LongTermDebtFairValue>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjc0ODc3OTA3NTk3Mg_af6a039b-46f8-4d42-b4f5-ae48bab8c172">Segment Information &lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We identify our operating segments based on the way we manage, evaluate and internally report our business activities for purposes of allocating resources and assessing performance. We have three reportable segments: Sterigenics, Nordion and Nelson Labs. We have determined our reportable segments based upon an assessment of organizational structure, service types, and internally prepared financial statements. Our chief operating decision maker evaluates performance and allocates resources based on net revenues and segment income after the elimination of intercompany activities. The accounting policies of our reportable segments are the same as those described in Note 1, &#x201c;Significant Accounting Policies&#x201d; of our 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Sterigenics&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Sterigenics segment provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Nordion &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nordion is a global provider of Co-60 and gamma irradiators, which are key components to the gamma sterilization process. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Nelson Labs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nelson Labs provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and biopharmaceutical industries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2021, three customers reported within the Nordion segment individually represented 10% or more of the segment&#x2019;s total net revenues. These customers represented 23.7%, 20.0%, and 12.2% of the total segment&#x2019;s external net revenues for the three months ended March&#160;31, 2021. For the three months ended March&#160;31, 2020, two customers reported within the Nordion segment individually represented 10% or more of the segment's total net revenues. These customers represented 18.7% and 11.6% of the total segment's external net revenues for the three months ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Net revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;131,151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;55,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;212,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Segment income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;68,461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13,786&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23,070&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;105,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;19,514&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;489&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;20,942&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Sterigenics &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Nordion &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Nelson Labs &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Consolidated &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Net revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;188,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Segment income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Revenues are reported net of intersegment sales. Our Nordion segment recognized $10.5 million and $10.9 million in revenues from sales to our Sterigenics segment for the three months ended March&#160;31, 2021 and 2020, respectively, that is not reflected in net revenues in the table above. Intersegment sales for Sterigenics and Nelson Labs are immaterial for both periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Segment income is only provided on a net basis to the chief operating decision maker and is reported net of intersegment profits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate operating expenses for executive management, accounting, information technology, legal, human resources, treasury, corporate development, tax, purchasing, and marketing are allocated to the segments based on total revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets and depreciation and amortization expense by segment are not readily available and are not reported separately to the chief operating decision maker. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of segment income to consolidated income (loss) before taxes is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;105,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Less adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;21,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;37,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Gain) loss on foreign currency and embedded derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition and divestiture related charges, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Business optimization project expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plant closure expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14,312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional services relating to EO sterilization facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(h)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accretion of asset retirement obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;551&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COVID-19 expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(j)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidated income (loss) before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14,082&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Includes depreciation of Co-60 held at gamma irradiation sites. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents non-cash share-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Represents the effects of (i)&#160;fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#x2019; functional currencies, and (ii)&#160;non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents (i) certain direct and incremental costs related to the acquisitions of BioScience in 2021, Iotron in July 2020 and Nelson Labs Fairfield in 2018 (including the first quarter 2021 gain on the mandatorily redeemable noncontrolling interest as described in Note 4, &#x201c;Acquisitions&#x201d;), and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.01pt"&gt;Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents expenses incurred in connection with the repricing of our Term Loan in January 2021 including accelerated amortization of prior debt issuance and discount costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees. See Note 16, &#x201c;Commitments and Contingencies&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;Represents non-recurring costs associated with the COVID-19 pandemic, including incremental costs to implement workplace health and safety measures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjMx_49f3e44b-7507-40d8-a841-d4ee7053cad4"
      unitRef="segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i35ac9047c5b543a3976685cc7c6f80bc_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTQyMg_c73fb79e-9294-458d-b03a-03ce74ab0e06"
      unitRef="number">0.237</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i019a710917314003bf051954e812e6f1_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTQyNg_0ff791ba-dbff-40f7-9f0f-06c426eb9194"
      unitRef="number">0.200</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if4e3b0fca93a414f8267d4764139c900_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTQzNA_8b02efe5-7506-4301-a3ca-de17466ad896"
      unitRef="number">0.122</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibd5e47f9b9f54685b7c4853c2ecaa92a_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTY0OTI2NzQ0OTc2NA_00b4024b-9066-4c39-b242-3ccfaaba852a"
      unitRef="number">0.187</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i060a27d3ce644a47a68d9a2bd5793f29_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTY0OTI2NzQ0OTc3Mg_c877d458-c4b5-47dc-95d5-da663ec9a3e4"
      unitRef="number">0.116</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjc0ODc3OTA3NjAyMg_d123f079-6732-442b-a069-58879fc6f947">&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Sterigenics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nordion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nelson&#160;Labs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Net revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;131,151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;25,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;55,079&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;212,148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Segment income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;68,461&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13,786&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;23,070&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;105,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;19,514&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;489&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;939&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;20,942&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Sterigenics &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Nordion &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Nelson Labs &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%"&gt;Consolidated &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Net revenues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;117,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;188,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%"&gt;Segment income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;61,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Revenues are reported net of intersegment sales. Our Nordion segment recognized $10.5 million and $10.9 million in revenues from sales to our Sterigenics segment for the three months ended March&#160;31, 2021 and 2020, respectively, that is not reflected in net revenues in the table above. Intersegment sales for Sterigenics and Nelson Labs are immaterial for both periods. &lt;/span&gt;&lt;/div&gt;(b)Segment income is only provided on a net basis to the chief operating decision maker and is reported net of intersegment profits.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi0xLTEtMS0w_c9f9bf87-91bd-4d21-ad2a-3cc9db314a6d"
      unitRef="usd">131151000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi0zLTEtMS0w_37bd1f47-9185-40e9-9100-48bd529106a6"
      unitRef="usd">25918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi01LTEtMS0w_e164323c-77bd-4ab2-bb9a-0a723cd979d0"
      unitRef="usd">55079000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMi03LTEtMS0w_c00311cf-1ed0-446d-8e21-9595fb69344e"
      unitRef="usd">212148000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <shc:SegmentIncomeLoss
      contextRef="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy0xLTEtMS0w_4c5be54d-5e5b-43b3-a19a-b18d0f49956b"
      unitRef="usd">68461000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy0zLTEtMS0w_a88830b1-63ae-4af6-a061-d451afc92e24"
      unitRef="usd">13786000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy01LTEtMS0w_0f1dd5db-06cc-4925-9745-0e88b9225f3e"
      unitRef="usd">23070000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfMy03LTEtMS0w_838642b8-11d7-4f89-8db9-3bbd9c92c8f3"
      unitRef="usd">105317000</shc:SegmentIncomeLoss>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i486bd02c2949451e9d34cc86792aa58e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC0xLTEtMS0w_866e6a3d-b2c7-44c9-a504-dc3fd124e6c9"
      unitRef="usd">19514000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ieb6d460e1fd14095804788086bf7ec08_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC0zLTEtMS0w_968de98a-d0b4-48d9-b249-39ceaccac696"
      unitRef="usd">489000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i91b42ae58a60447c9e40713ed9cf38fd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC01LTEtMS0w_197f5cd9-e29e-4b49-9b44-74cd4cb97e2b"
      unitRef="usd">939000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOmU3MGQ4YTI0NmJjNDRlMzViZjM4N2I1YTMwMWZhNTdlL3RhYmxlcmFuZ2U6ZTcwZDhhMjQ2YmM0NGUzNWJmMzg3YjVhMzAxZmE1N2VfNC03LTEtMS0w_2659dd0a-b252-4491-becc-ecab440dc88a"
      unitRef="usd">20942000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi0xLTEtMS0w_ac16fffe-9279-4ae4-951c-b38736296b46"
      unitRef="usd">117280000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if73b88809d084769a5f2a52b8afde703_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi0zLTEtMS0w_fb08a142-f33f-4829-8d2e-8f8ed0dd4f3e"
      unitRef="usd">23625000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iababa48736c840818f39cbadfc3e0370_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi01LTEtMS0w_fa906de4-5f87-4d30-a654-ad7b107a5324"
      unitRef="usd">47295000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMi03LTEtMS0w_28ce0901-47a1-4563-8240-b2b86c9e63b5"
      unitRef="usd">188200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <shc:SegmentIncomeLoss
      contextRef="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy0xLTEtMS0w_08b488b7-167e-4763-a242-1654f1bb0123"
      unitRef="usd">61091000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="if73b88809d084769a5f2a52b8afde703_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy0zLTEtMS0w_3935c09c-9f34-4df8-b425-2966b9baba35"
      unitRef="usd">13022000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="iababa48736c840818f39cbadfc3e0370_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy01LTEtMS0w_cfed2dd6-f54c-49e7-b925-444b4eb23ca3"
      unitRef="usd">17770000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfMy03LTEtMS0w_b628bb6e-9eb1-4ef4-baf0-d732e487e66a"
      unitRef="usd">91883000</shc:SegmentIncomeLoss>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ibec0ea2d7a0b4814b3a6a5b55109c2be_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC0xLTEtMS0w_b49ffcd0-4248-4a03-8ae5-ce0739ce491d"
      unitRef="usd">10940000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if73b88809d084769a5f2a52b8afde703_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC0zLTEtMS0w_d238fbd9-d211-4eeb-a15b-cc258d2fd812"
      unitRef="usd">1234000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iababa48736c840818f39cbadfc3e0370_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC01LTEtMS0w_6d54f1fa-66c8-481a-a1ff-8411a4ba5a3d"
      unitRef="usd">815000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjAyMmMzODBiZjhmMjQwNjdiZTgxMTk3ZjA0NGE1M2Y2L3RhYmxlcmFuZ2U6MDIyYzM4MGJmOGYyNDA2N2JlODExOTdmMDQ0YTUzZjZfNC03LTEtMS0w_1a22ebe1-7e7f-421e-8ef0-4b175e0c81f9"
      unitRef="usd">12989000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b4e7cd3ba244ec68ee9e4a6d8ee9391_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTU5MQ_6fb204de-f92a-4e1c-a324-68d661d41814"
      unitRef="usd">-10500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i603326ebb8e04b33add577d701640115_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMTU5OA_741f71e1-ba38-437a-b972-58737c2b59fd"
      unitRef="usd">-10900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RleHRyZWdpb246MGFmNDBjM2QyMWUxNDU3N2E0MjcyZGExMmM1OTIyOGZfMjc0ODc3OTA3NjAyMw_105030df-3723-45e6-acf2-3a104afcac18">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of segment income to consolidated income (loss) before taxes is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(thousands of U.S. dollars)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;105,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Less adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;21,282&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;37,661&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3,449&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Gain) loss on foreign currency and embedded derivatives&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquisition and divestiture related charges, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Business optimization project expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;261&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plant closure expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss on extinguishment of debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14,312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Professional services relating to EO sterilization facilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(h)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accretion of asset retirement obligation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;551&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:1.5pt;margin-top:2.65pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COVID-19 expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(j)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;299&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidated income (loss) before taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14,082&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Includes depreciation of Co-60 held at gamma irradiation sites. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents non-cash share-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Represents the effects of (i)&#160;fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#x2019; functional currencies, and (ii)&#160;non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents (i) certain direct and incremental costs related to the acquisitions of BioScience in 2021, Iotron in July 2020 and Nelson Labs Fairfield in 2018 (including the first quarter 2021 gain on the mandatorily redeemable noncontrolling interest as described in Note 4, &#x201c;Acquisitions&#x201d;), and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt"&gt;Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(f)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.01pt"&gt;Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(g)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents expenses incurred in connection with the repricing of our Term Loan in January 2021 including accelerated amortization of prior debt issuance and discount costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(h)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt"&gt;Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees. See Note 16, &#x201c;Commitments and Contingencies&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(j)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt"&gt;Represents non-recurring costs associated with the COVID-19 pandemic, including incremental costs to implement workplace health and safety measures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <shc:SegmentIncomeLoss
      contextRef="i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMi0xLTEtMS0w_559f8456-e068-4932-9ee5-203dc940b333"
      unitRef="usd">105317000</shc:SegmentIncomeLoss>
    <shc:SegmentIncomeLoss
      contextRef="ie667bf6544f54f0790d703266225330a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMi0zLTEtMS0w_d9fad473-5741-4436-81f7-15a9a1328cf9"
      unitRef="usd">91883000</shc:SegmentIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNC0xLTEtMS0w_807b8b8c-847f-4184-a541-3887f5b6a974"
      unitRef="usd">21282000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNC0zLTEtMS0w_b5620000-7dfb-47f9-ac3e-323262fe2c8a"
      unitRef="usd">56562000</us-gaap:InterestExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNS0xLTEtMS0w_a49090be-9f6e-4d9a-b8e3-3731d5f86ce6"
      unitRef="usd">37661000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNS0zLTEtMS0w_b093b255-febe-4588-bb1b-0d77940b7ffd"
      unitRef="usd">36023000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNy0xLTEtMS0w_63683a79-ea79-467e-95a5-f7d9542c98fb"
      unitRef="usd">3449000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfNy0zLTEtMS0w_d58f6946-a7da-4231-bc24-1ecdc89e1d3a"
      unitRef="usd">1725000</us-gaap:ShareBasedCompensation>
    <shc:ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfOS0xLTEtMS0w_fb72260b-f125-4288-a6d4-bc90df25bc3e"
      unitRef="usd">336000</shc:ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative>
    <shc:ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfOS0zLTEtMS0w_60abb9d0-6dd9-4fa5-a652-1a37f9e027e9"
      unitRef="usd">-4267000</shc:ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative>
    <shc:AcquisitionAndDivestitureRelatedChargesNet
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTAtMS0xLTEtMA_fab0dc45-850f-4cf2-ab78-4122d40b32b2"
      unitRef="usd">-185000</shc:AcquisitionAndDivestitureRelatedChargesNet>
    <shc:AcquisitionAndDivestitureRelatedChargesNet
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTAtMy0xLTEtMA_92ddcf44-0c62-4e5d-b8e4-22822ce825e9"
      unitRef="usd">994000</shc:AcquisitionAndDivestitureRelatedChargesNet>
    <us-gaap:OtherRestructuringCosts
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTEtMS0xLTEtMA_1b2a9a60-7cf7-40b9-80fc-6d0e48d9332f"
      unitRef="usd">261000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTEtMy0xLTEtMA_f86bf7c2-0f34-4aa1-9259-83ddb752af26"
      unitRef="usd">1049000</us-gaap:OtherRestructuringCosts>
    <us-gaap:BusinessExitCosts1
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTItMS0xLTEtMA_49b51359-ca9c-43c5-b0f1-340935219046"
      unitRef="usd">542000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTItMy0xLTEtMA_0c25edc5-cde4-47c4-8056-56d7e4743c77"
      unitRef="usd">771000</us-gaap:BusinessExitCosts1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTMtMS0xLTEtMA_f78e568e-73d3-489b-99cf-b0f58744c041"
      unitRef="usd">-14312000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTMtMy0xLTEtMA_7d9cca91-1f1f-448c-9b00-2ed8795dfeed"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:LitigationSettlementExpense
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTQtMS0xLTEtMA_c6869a4e-3fb0-4d72-9f30-57c7d5114976"
      unitRef="usd">13399000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTQtMy0xLTEtMA_bd23efa2-7d23-4028-ad64-edfb35f8bb60"
      unitRef="usd">4146000</us-gaap:LitigationSettlementExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTUtMS0xLTEtMA_1fbf2b1b-b517-4c97-8537-2175d6beb056"
      unitRef="usd">551000</us-gaap:AssetRetirementObligationAccretionExpense>
    <us-gaap:AssetRetirementObligationAccretionExpense
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTUtMy0xLTEtMA_ae414aa6-31e5-4743-8ee0-33186dd86304"
      unitRef="usd">490000</us-gaap:AssetRetirementObligationAccretionExpense>
    <shc:CostAndExpensesCOVID19
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTYtMS0xLTEtMA_70e8728a-9226-4d6b-bb0f-18dca236a568"
      unitRef="usd">299000</shc:CostAndExpensesCOVID19>
    <shc:CostAndExpensesCOVID19
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTYtMy0xLTEtMA_27e90b85-a4f3-4583-8540-99896d603356"
      unitRef="usd">76000</shc:CostAndExpensesCOVID19>
    <us-gaap:NetIncomeLoss
      contextRef="if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTctMS0xLTEtMA_1ad30717-c4b7-40cd-9faf-2be1634de8be"
      unitRef="usd">14082000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia666b1faa28a4e85bcf0d225ba3a137d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV85NC9mcmFnOjBhZjQwYzNkMjFlMTQ1NzdhNDI3MmRhMTJjNTkyMjhmL3RhYmxlOjFjNzAzMjBjZGVlMTRjZTg5YjgyYzE4OTMxNGE2N2M3L3RhYmxlcmFuZ2U6MWM3MDMyMGNkZWUxNGNlODliODJjMTg5MzE0YTY3YzdfMTctMy0xLTEtMA_5808a899-3495-44f4-b17d-91082da0d834"
      unitRef="usd">-14220000</us-gaap:NetIncomeLoss>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355971272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>May 06, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SOTERA HEALTH COMPANY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3531161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9100 South Hills Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Broadview Heights<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">44147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">262-1409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SHC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282,869,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001822479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354770552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 108,009<span></span>
</td>
<td class="nump">$ 102,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash short-term</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for uncollectible accounts of $603 and $708, respectively</a></td>
<td class="nump">96,393<span></span>
</td>
<td class="nump">91,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">33,375<span></span>
</td>
<td class="nump">34,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">69,758<span></span>
</td>
<td class="nump">64,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">20,825<span></span>
</td>
<td class="nump">21,769<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">328,367<span></span>
</td>
<td class="nump">315,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">611,620<span></span>
</td>
<td class="nump">609,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">47,117<span></span>
</td>
<td class="nump">45,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">8,088<span></span>
</td>
<td class="nump">8,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">9,227<span></span>
</td>
<td class="nump">13,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">9,281<span></span>
</td>
<td class="nump">9,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">656,572<span></span>
</td>
<td class="nump">643,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,106,728<span></span>
</td>
<td class="nump">1,115,936<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,777,000<span></span>
</td>
<td class="nump">2,761,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">57,174<span></span>
</td>
<td class="nump">52,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">56,373<span></span>
</td>
<td class="nump">60,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">5,958<span></span>
</td>
<td class="nump">6,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance lease obligations</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease obligations</a></td>
<td class="nump">9,631<span></span>
</td>
<td class="nump">9,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationCurrent', window );">Current portion of asset retirement obligations</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">10,448<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">138,019<span></span>
</td>
<td class="nump">140,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, less debt issuance costs and debt discounts</a></td>
<td class="nump">1,837,580<span></span>
</td>
<td class="nump">1,824,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations, less current portion</a></td>
<td class="nump">33,432<span></span>
</td>
<td class="nump">34,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease obligations, less current portion</a></td>
<td class="nump">39,806<span></span>
</td>
<td class="nump">38,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationsNoncurrent', window );">Noncurrent asset retirement obligations</a></td>
<td class="nump">45,633<span></span>
</td>
<td class="nump">45,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred lease income</a></td>
<td class="nump">21,362<span></span>
</td>
<td class="nump">21,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent', window );">Post-retirement obligations</a></td>
<td class="nump">46,959<span></span>
</td>
<td class="nump">48,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent', window );">Mandatorily redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="nump">18,795<span></span>
</td>
<td class="nump">17,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">129,670<span></span>
</td>
<td class="nump">121,816<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">2,311,256<span></span>
</td>
<td class="nump">2,306,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">See Commitments and contingencies note</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, with $0.01 par value, 1,200,000 shares authorized; 285,990 shares issued at March 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">2,860<span></span>
</td>
<td class="nump">2,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, with $0.01 par value, 120,000 authorized; no shares issued at March 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost (3,090 and 2,742 shares at March 31, 2021 and December 31, 2020, respectively)</a></td>
<td class="num">(34,000)<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">1,169,852<span></span>
</td>
<td class="nump">1,166,412<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained deficit</a></td>
<td class="num">(578,286)<span></span>
</td>
<td class="num">(589,128)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(97,162)<span></span>
</td>
<td class="num">(93,842)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity attributable to Sotera Health Company</a></td>
<td class="nump">463,264<span></span>
</td>
<td class="nump">452,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">2,480<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">465,744<span></span>
</td>
<td class="nump">454,574<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 2,777,000<span></span>
</td>
<td class="nump">$ 2,761,279<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549951&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=d3e1731-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable after one year from the reporting date or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679371448216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for uncollectible accounts</a></td>
<td class="nump">$ 603<span></span>
</td>
<td class="nump">$ 708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,200,000,000<span></span>
</td>
<td class="nump">1,200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">285,990,000<span></span>
</td>
<td class="nump">285,990,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">120,000,000<span></span>
</td>
<td class="nump">120,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">3,090,000<span></span>
</td>
<td class="nump">2,742,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679369435016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 212,148<span></span>
</td>
<td class="nump">$ 188,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">96,776<span></span>
</td>
<td class="nump">91,683<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">115,372<span></span>
</td>
<td class="nump">96,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">52,465<span></span>
</td>
<td class="nump">37,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_AmortizationOfIntangibleAssetsNonproduction', window );">Amortization of intangible assets</a></td>
<td class="nump">16,543<span></span>
</td>
<td class="nump">14,599<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">69,008<span></span>
</td>
<td class="nump">51,652<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">46,364<span></span>
</td>
<td class="nump">44,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense, net</a></td>
<td class="nump">21,282<span></span>
</td>
<td class="nump">56,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">14,312<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange loss (gain)</a></td>
<td class="nump">578<span></span>
</td>
<td class="num">(627)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(3,890)<span></span>
</td>
<td class="nump">3,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="nump">14,082<span></span>
</td>
<td class="num">(14,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="num">(12,234)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">11,065<span></span>
</td>
<td class="num">(1,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">223<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Sotera Health Company</a></td>
<td class="nump">10,842<span></span>
</td>
<td class="num">(1,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive (loss) income net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and post-retirement benefits (net of taxes of $84 and $(744), respectively)</a></td>
<td class="num">(249)<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Interest rate swaps (net of taxes of $0 and $1,234, respectively)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(3,086)<span></span>
</td>
<td class="num">(72,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">7,730<span></span>
</td>
<td class="num">(76,225)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">208<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss) attributable to Sotera Health Company</a></td>
<td class="nump">$ 7,522<span></span>
</td>
<td class="num">$ (76,203)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">278,827<span></span>
</td>
<td class="nump">232,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">278,968<span></span>
</td>
<td class="nump">232,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 188,698<span></span>
</td>
<td class="nump">$ 167,405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">85,036<span></span>
</td>
<td class="nump">83,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">23,450<span></span>
</td>
<td class="nump">20,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Total cost of revenues</a></td>
<td class="nump">$ 11,740<span></span>
</td>
<td class="nump">$ 8,614<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_AmortizationOfIntangibleAssetsNonproduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Intangible Assets, Nonproduction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_AmortizationOfIntangibleAssetsNonproduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354943384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and post-retirement benefits, tax</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="num">$ (744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Interest rate swaps, tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,234<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355660136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 11,065<span></span>
</td>
<td class="num">$ (1,986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">15,379<span></span>
</td>
<td class="nump">16,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">22,282<span></span>
</td>
<td class="nump">19,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">14,312<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(3,637)<span></span>
</td>
<td class="num">(6,683)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">3,449<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion of asset retirement obligations</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign exchange (gains) / losses</a></td>
<td class="nump">2,354<span></span>
</td>
<td class="num">(4,876)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet', window );">Unrealized (gain) / loss on embedded derivative instruments</a></td>
<td class="num">(853)<span></span>
</td>
<td class="nump">4,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">2,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments', window );">Gain (loss) on interest rate swap</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(2,843)<span></span>
</td>
<td class="num">(2,306)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(4,134)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">1,099<span></span>
</td>
<td class="num">(1,553)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="num">(2,324)<span></span>
</td>
<td class="num">(1,404)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">6,625<span></span>
</td>
<td class="num">(733)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(5,542)<span></span>
</td>
<td class="num">(8,334)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable / receivable</a></td>
<td class="num">(4,518)<span></span>
</td>
<td class="num">(8,132)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,513<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(282)<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">56,159<span></span>
</td>
<td class="nump">5,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(20,942)<span></span>
</td>
<td class="num">(12,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc.</a></td>
<td class="num">(12,425)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Purchase of BioScience Laboratories, LLC, net of cash acquired</a></td>
<td class="num">(13,152)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(46,519)<span></span>
</td>
<td class="num">(12,989)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="num">(3,435)<span></span>
</td>
<td class="num">(207)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(348)<span></span>
</td>
<td class="num">(344)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(3,783)<span></span>
</td>
<td class="nump">49,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(295)<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents, including restricted cash</a></td>
<td class="nump">5,562<span></span>
</td>
<td class="nump">42,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, including restricted cash, at beginning of period</a></td>
<td class="nump">102,454<span></span>
</td>
<td class="nump">63,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, including restricted cash, at end of period</a></td>
<td class="nump">108,016<span></span>
</td>
<td class="nump">105,187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">19,745<span></span>
</td>
<td class="nump">63,570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes, net of tax refunds received</a></td>
<td class="nump">11,561<span></span>
</td>
<td class="nump">1,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Equipment purchases included in accounts payable</a></td>
<td class="nump">$ 7,389<span></span>
</td>
<td class="nump">$ 5,100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -URI http://asc.fasb.org/subtopic&amp;trid=2229187<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) related to derivatives designated as cash flow hedging instruments, recorded in results of operations to the extent that the cash flow hedge is determined to be ineffective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353701528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Deficit) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings / (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2019</a></td>
<td class="num">$ (641,132)<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (550,511)<span></span>
</td>
<td class="num">$ (94,387)<span></span>
</td>
<td class="nump">$ 1,442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation plans</a></td>
<td class="nump">1,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and post-retirement plan adjustments, net of tax</a></td>
<td class="nump">2,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(72,967)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,967)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Interest rate swaps</a></td>
<td class="num">(3,479)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,479)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(1,986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,964)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2020</a></td>
<td class="num">(715,632)<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="num">(552,475)<span></span>
</td>
<td class="num">(168,626)<span></span>
</td>
<td class="nump">1,420<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">283,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">454,574<span></span>
</td>
<td class="nump">$ 2,860<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
<td class="nump">1,166,412<span></span>
</td>
<td class="num">(589,128)<span></span>
</td>
<td class="num">(93,842)<span></span>
</td>
<td class="nump">2,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Share-based compensation plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation plans</a></td>
<td class="nump">3,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and post-retirement plan adjustments, net of tax</a></td>
<td class="num">(249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(249)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(3,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,071)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Interest rate swaps</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">11,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">282,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 465,744<span></span>
</td>
<td class="nump">$ 2,860<span></span>
</td>
<td class="num">$ (34,000)<span></span>
</td>
<td class="nump">$ 1,169,852<span></span>
</td>
<td class="num">$ (578,286)<span></span>
</td>
<td class="num">$ (97,162)<span></span>
</td>
<td class="nump">$ 2,480<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352078888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principles of Consolidation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Sotera Health Company (also referred to herein as the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;its&#8221;), is a global provider of mission-critical sterilization and lab testing and advisory services to the medical device and pharmaceutical industries with operations primarily in the Americas, Europe and Asia. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate and report in three segments, Sterigenics, Nordion and Nelson Labs. We describe our reportable segments in Note 18, &#8220;Segment Information&#8221;. All significant intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent the noncontrolling stockholders&#8217; proportionate share of the total equity in the Company&#8217;s consolidated subsidiaries. As of March&#160;31, 2021, our subsidiaries were wholly owned by us, except for noncontrolling interests of 15% and 33% in our two China subsidiaries. We consolidate the results of operations of these subsidiaries with our results of operations and reflect the noncontrolling interests in our two China subsidiaries on our Consolidated Statements of Operations and Comprehensive Income (Loss) as &#8220;Net income attributable to noncontrolling interests.&#8221; On March 11, 2021, we purchased the 15% noncontrolling interest that remained from the August 2018 acquisition of Nelson Laboratories Fairfield, Inc. (&#8220;Nelson Labs Fairfield&#8221;). This required future purchase was considered mandatorily redeemable, and therefore no earnings were allocated to this noncontrolling interest. See Note 4, &#8220;Acquisitions&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we entered into binding agreements to purchase the outstanding noncontrolling interests of 15% and 33% of our two China subsidiaries, respectively. The purchase transactions are expected to close in the second quarter of 2021 for a total purchase price of $8.6 million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we acquired a 60% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada in connection with our acquisition of Iotron Industries Canada, Inc. (&#8220;Iotron&#8221;). Refer to Note 4, &#8220;Acquisitions&#8221; for additional information. We have determined this to be an investment in a variable interest entity (&#8220;VIE&#8221;). The investment is not consolidated as the Company has concluded that we are not the primary beneficiary of the VIE. The Company accounts for the joint venture using the equity method. The investment is reflected within &#8220;Investment in unconsolidated affiliates&#8221; on the Consolidated Balance Sheets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles ("GAAP"), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interim Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; The accompanying consolidated financial statements include the assets, liabilities, operating results, and cash flows of the Company and its wholly owned subsidiaries. These financial statements are prepared in accordance with U.S. GAAP for interim financial information and the instructions to the Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These unaudited interim financial statements should be read in conjunction with the Company's annual consolidated financial statements and accompanying notes on Form 10-K for the year ended December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350675064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Standards<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text">Recent Accounting Standards<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU&#8217;s Issued But Not Yet Adopted</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Jumpstart Our Business Startups Act of 2012, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. As an emerging growth company, we have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies or at which time we conclude it is appropriate to avail ourselves of early adoption provisions of applicable standards. As a result, our results of operations and financial statements may not be comparable to the results of operations and financial statements of other companies who have adopted the new or revised accounting standards. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(&#8220;ASU&#8221;) 2016-13, Financial Instruments &#8211; Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently issued additional guidance that modified ASU 2016-13. The standard requires an entity to change its accounting approach in determining impairment of certain financial instruments, including trade receivables, from an &#8220;incurred loss&#8221; to a &#8220;current expected credit loss&#8221; model. We intend to adopt the standard as of January 1, 2022. We are currently assessing the effect that ASU 2016-13 will have on our financial position, results of operations, and disclosures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the FASB issued </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard simplifies the accounting for income taxes and makes a number of changes meant to add or clarify guidance on accounting for income taxes. This update is effective for annual financial statement periods beginning after March 15, 2021 and interim periods beginning after March 15, 2022, with early adoption permitted in any interim period for which financial statements have not yet been filed. We are currently assessing the effect that ASU 2019-12 will have on our financial position, results of operations, and disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350565688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows disaggregated net revenues from contracts with external customers by timing of revenue and by segment for the three months ended March&#160;31, 2021 and 2020:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">131,151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">55,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">212,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">117,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">47,295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">188,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, and December&#160;31, 2020, contract assets included in prepaid expenses and other current assets on the Consolidated Balance Sheets totaled approximately $14.1 million and $12.7 million, respectively, resulting from revenue recognized over time in excess of the amount billed to the customer. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we receive consideration from a customer prior to transferring goods or services under the terms of a sales contract, we record deferred revenue, which represents a contract liability. Deferred revenue totaled $6.0 million and $6.1 million at March&#160;31, 2021 and December&#160;31, 2020, respectively. We recognize deferred revenue after all revenue recognition criteria are met.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350669880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">Acquisitions<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of BioScience Laboratories, LLC</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On March 8, 2021, we acquired BioScience Laboratories, LLC (&#8220;BioScience&#8221;) for approximately $13.2 million, net of $0.8 million of cash acquired plus the contemporaneous repayment of BioScience's outstanding debt of $1.9 million. BioScience is a provider of outsourced topical antimicrobial product testing in the pharmaceutical, medical device, and consumer products industries with one location in Bozeman, Montana.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purchase price of BioScience was allocated to the underlying assets acquired and liabilities assumed based upon management's estimated fair values at the date of acquisition. Changes to the allocation of the purchase price may occur as </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these measurements are completed. Approximately $8.4 million of goodwill was recorded related to the BioScience acquisition, representing the excess of the purchase price over preliminary estimated fair values of all the assets acquired and liabilities assumed. The Company funded this acquisition using available cash. The acquisition price and the results of operations for this acquired entity are not material in relation to the Company's consolidated financial statements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Mandatorily Redeemable Noncontrolling Interest - Nelson Labs Fairfield</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, we completed the acquisition of the remaining 15% ownership of Nelson Labs Fairfield for $12.4 million, resulting in a gain of $1.2 million included in &#8220;Other expense (income), net&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss) relative to the $13.6 million previously accrued. Pursuant to the terms of the August 2018 acquisition, we initially acquired 85% of the equity interests of Nelson Labs Fairfield in August 2018 and were obligated to acquire the remaining 15% noncontrolling interest within three years from the date of the acquisition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisition of Iotron Industries Canada, Inc.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, we acquired Iotron Industries Canada, Inc.(&#8220;Iotron&#8221;) for approximately $105.2 million. Iotron was an independent contact sterilizer with two North American locations in Vancouver, Canada, and Columbia City, Indiana. Each location uses proprietary high energy electron beam technology to process products for orthopedic, medical device, plastics, and agricultural businesses. The acquisition was financed by the issuance of $100.0 million of First Lien Notes due 2026. Refer to Note 9, &#8220;Long-Term Debt&#8221; for additional details.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of this acquisition, we also acquired Iotron&#8217;s 60% equity ownership interest in a joint venture to construct an E-beam facility in Alberta, Canada. The joint venture is accounted for using the equity method. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The opening balance sheet for the Iotron acquisition reflects the net tangible and intangible assets acquired and liabilities assumed at their preliminary estimated fair values at the acquisition date.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimated fair value of the underlying acquired assets and assumed liabilities of the Iotron acquisition and the measurement period adjustments recognized during the three months ended March&#160;31, 2021, were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allocation of purchase price to the fair value of </span></div><div style="margin-bottom:1.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">net assets acquired (net of cash acquired):</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount recognized as of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount recognized as of March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">51,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">42,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18,158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in unconsolidated affiliate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumed long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets/liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,846)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15,144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total estimated purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of all the above assets acquired and liabilities assumed are preliminary in nature since the fair value analyses are not yet complete, including finalizing third party appraisals and analyzing the tax attributes of the fair value adjustments. Changes to the allocation of the purchase price may occur as these analyses are completed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately $51.9 million of goodwill was recorded related to the Iotron acquisition, representing the excess of the purchase price over preliminary estimated fair values of all the assets acquired and liabilities assumed. The fair value allocated to goodwill and tangible and intangible assets are deductible for tax purposes. The qualitative elements of goodwill primarily represent the expanded future growth opportunities for the combined company and the addition of Iotron&#8217;s highly skilled workforce. A preliminary valuation was recorded of approximately $39.1 million and $3.6 million for intangible assets as part of the acquisition related to customer relationships and employee non-compete agreements, respectively. The estimated useful lives of the identifiable finite-lived intangible assets range from 5 to 15 years.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iotron&#8217;s results of operations are included in our consolidated financial statements from the date of the transaction within the Sterigenics segment. The unaudited pro forma consolidated results for the three months ended March&#160;31, 2020, are reflected in the pro forma table below had the transaction occurred on January 1, 2020. The following unaudited supplemental pro forma financial information is based on our historical consolidated financial statements and Iotron&#8217;s historical consolidated financial statements, as adjusted for amortization of acquired intangible assets, an increase in interest expense resulting from interest on the First Lien Notes to finance the acquisition, and to reflect the change in the estimated income tax rate for federal and state purposes.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Iotron acquisition, we incurred approximately $1.0&#160;million in transaction costs for the three months ended March&#160;31, 2020, which were included in &#8220;Selling, general and administrative expenses&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350566984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted primarily of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">29,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">33,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve for excess and obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">33,375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,093&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352076984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">Prepaid Expenses and Other Current Assets<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted primarily of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid business insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,421</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,212</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14,133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance and indemnification receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">797</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid maintenance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Value added tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,385</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid software licensing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">69,758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352438328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to goodwill during the three months ended March&#160;31, 2021 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill at December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">683,481&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">287,932&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144,523&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,115,936&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">BioScience acquisition</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Iotron acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">measurement period adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes due to foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">664,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">291,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">151,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,106,728</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortization</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">662,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">322,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">89,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">39,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9,454</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">243,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">98,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,011,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">463,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">82,807</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,952</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">108,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,119,803</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">463,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortization</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">634,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">309,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">240,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">977,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,085,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#8217;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another 10 years license period as Nordion has demonstrated over its 70 years of history.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts include the impact of foreign currency translation. Fully amortized amounts are written off. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for other intangible assets was $22.3&#160;million ($5.8&#160;million is included in &#8220;Cost of revenues&#8221; and $16.5&#160;million in &#8220;Selling, general and administrative expenses&#8221;) in the Consolidated Statements of Operations and Comprehensive Income (Loss) and $19.9&#160;million ($5.3&#160;million is included in &#8220;Cost of revenues&#8221; and $14.6 million in &#8220;Selling, general and administrative expenses&#8221;) in the Consolidated Statements of Operations and Comprehensive Income (Loss) for the three months ended March&#160;31, 2021 and 2020, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated aggregate amortization expense for finite-lived intangible assets for each of the next five years and thereafter is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">65,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">80,665</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">80,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">79,882</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">41,982</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">198,736</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">547,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average remaining useful life of the finite-lived intangible assets was approximately 10 years as of March&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350667848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">Accrued Liabilities<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27,651</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,744</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued utilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,886</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">56,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350685608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,763,100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,763,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,864,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,863,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less unamortized debt issuance costs and debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(26,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt, less debt issuance costs and debt discounts</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,837,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,824,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Secured Credit Facilities</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;13, 2019, Sotera Health Holdings, LLC (&#8220;SHH&#8221;), our wholly owned subsidiary, entered into senior secured first lien credit facilities (the &#8220;Senior Secured Credit Facilities&#8221;), consisting of both a prepayable senior secured first lien term loan (the &#8220;Term Loan&#8221;) and a senior secured first lien revolving credit facility (the &#8220;Revolving Credit Facility&#8221;) pursuant to a first lien credit agreement (the &#8220;Credit Agreement&#8221;). The Term Loan matures on December 13, 2026, and the Revolving Credit Facility's original maturity date was December 13, 2024. On December 17, 2020, we increased the capacity of our Revolving Credit Facility from $190.0 million to $347.5 million. The Senior Secured Credit Facilities also provide SHH the right at any time and under certain conditions to request incremental term loans or incremental revolving credit commitments based on a formula defined in the Senior Secured Credit Facilities. As of March&#160;31, 2021 and December&#160;31, 2020, total borrowings under the Term Loan were $1,763.1 million and $1,763.1 million, respectively, and there were no borrowings outstanding on the Revolving Credit Facility. The weighted average interest rate on borrowings under the Term Loan for the three months ended March&#160;31, 2021 and March&#160;31, 2020 was 3.73% and 6.18%, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, we closed on an amendment repricing our Term Loan. The interest rate spread over the London Interbank Offered Rate (&#8220;LIBOR&#8221;) on the facility was reduced from 450 basis points to 275 basis points, and the facility&#8217;s LIBOR floor was reduced from 100 basis points to 50 basis points. The changes result in an effective reduction in current interest rates of 2.25%.  In connection with this amendment, we wrote off $11.3 million of unamortized debt issuance and discount costs and incurred an additional $2.9 million of expense related to debt issuance costs attributable to the refinancing. These costs were recorded to &#8220;Loss on extinguishment of debt&#8221; in our Consolidated Statements of Operations and Comprehensive Income (Loss). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs totaled $3.1 million and $3.4 million, respectively, and debt discounts totaled $20.0 million and $31.6 million, respectively, related to the Senior Secured Credit Facilities. Such costs are recorded as a reduction of debt on our consolidated balance sheets and amortized as a component of interest expense over the term of the debt agreement. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2021, we amended the Revolving Credit Facility, to (i) decrease the Applicable Rate (as defined in the Credit Agreement) related to any Revolving Loans (as defined in the Credit Agreement) from a rate per annum that ranged from an alternative base rate (&#8220;ABR&#8221;) plus 2.50% to ABR plus 3.00% depending on SHH&#8217;s Senior Secured First Lien Net Leverage Ratio to ABR plus 1.75%; and in the case of Eurodollar Loans (as defined in the Credit Agreement) from a rate per annum which ranged from the Adjusted LIBOR plus 3.50% to the Adjusted LIBOR plus 4.00% depending on SHH&#8217;s Senior Secured First Lien Net Leverage Ratio (as defined in the Credit Agreement), to the Adjusted LIBOR (as defined in the Credit Agreement) plus 2.75%, and (ii) extend the maturity date of the Revolving Facility from December 13, 2024 to June 13, 2026. The other material terms of the Credit Agreement are unchanged and the amendment does not change the capacity of our Revolving Credit Facility, which is $347.5 million. No unamortized debt issuance costs associated with the Revolving Credit Facility were written off and direct fees and costs incurred in connection with the amendment were immaterial.  </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, there were no borrowings on the Revolving Credit Facility. SHH borrowed $50.0 million on the Revolving Credit Facility during the first quarter of 2020 which was repaid in the second quarter of 2020. The interest rate on the borrowings under the Revolving Credit Facility during 2020 averaged approximately 5.0%. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of SHH&#8217;s obligations under the Senior Secured Credit Facilities are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of the Company, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the Senior Secured Credit Facilities, and the guarantees of such obligations, are secured by substantially all assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the Senior Secured Credit Facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding letters of credit are collateralized by encumbrances against the Revolving Credit Facility and the collateral pledged thereunder, or by cash placed on deposit with the issuing bank. As of March&#160;31, 2021, the Company had $65.8 million of letters of credit issued against the Revolving Credit Facility, resulting in total availability under the Revolving Credit Facility of $281.7 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Lien Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, SHH issued $100.0 million aggregate principal amount of senior secured first lien notes due 2026 (the &#8220;First Lien Notes&#8221;), which mature on December 13, 2026. The First Lien Notes bear interest at a rate equal to LIBOR subject to a 1.00% floor plus 6.00% per annum. Interest is payable on a quarterly basis with no principal due until maturity. The weighted average interest rate on the First Lien Notes for the three months ended March&#160;31, 2021 was 7.00%. </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SHH is entitled to redeem all or a portion of the First Lien Notes, at any time and from time to time, subject to certain premiums depending on the date of redemption; any time on or prior to July 31, 2021, a customary make-whole premium applies and, thereafter, specified premiums that decline to zero apply (in each case as described in the indenture governing the First Lien Notes). </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of SHH&#8217;s obligations under the First Lien Notes are unconditionally guaranteed by the Company and each existing and subsequently acquired or organized direct or indirect wholly-owned domestic restricted subsidiary of SHH, with customary exceptions including, among other things, where providing such guarantees is not permitted by law, regulation or contract or would result in material adverse tax consequences. All obligations under the First Lien Notes, and the guarantees of such obligations, are secured by substantially all of the assets of the borrower and guarantors, subject to permitted liens and other exceptions and exclusions, as outlined in the First Lien Notes. Such collateral is substantially the same collateral that secures the Senior Secured Credit Facilities. Such collateral securing the First Lien Notes ranks pari passu with that of the Senior Secured Credit Facilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021 and December&#160;31, 2020, capitalized debt issuance costs were $0.8 million and $0.9 million, respectively, and debt discounts were $2.7 million and $2.8 million, respectively, related to the First Lien Notes, which are recorded as a reduction of debt on our Consolidated Balance Sheets and amortized into interest expense over the term of the debt agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Debt Repayments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 24, 2020, we closed our initial public offering (the "IPO&#8221;), in which we sold 53,590,000 shares of our common stock at a price of $23.00 per share, which included the full exercise by the underwriters of their option to purchase up to an additional 6,990,000 shares of common stock. We raised approximately $1.2 billion in net proceeds after deducting underwriters&#8217; discounts and commissions. We used the net proceeds received by us from the IPO to (i) redeem $770.0 million in aggregate principal amount of the Second Lien Senior Secured Notes with an original maturity date of December 13, 2027 (the "Second Lien Notes&#8221;), plus accrued and unpaid interest thereon and $15.4 million of redemption premium, (ii) repurchase 1,568,445 shares of our common stock from certain of our executive officers at a purchase price per share equal to the IPO price per share of our common stock less an amount equal to the underwriting discounts and commissions payable thereon and (iii) repay $341.0 million of the outstanding indebtedness under the Term Loan, plus accrued and unpaid interest thereon. In connection with the debt repayments, we wrote off $28.9 million of debt issuance and discount costs and recognized $15.4 million in premiums paid for the early extinguishment of the Second Lien Notes. We recognized these costs within &#8220;Loss on extinguishment of debt&#8221; in our Consolidated Statements of Operations and Comprehensive Income (Loss) in the fourth quarter of 2020.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aggregate Maturities </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate maturities of the Company&#8217;s long-term debt, excluding debt discounts, as of March&#160;31, 2021, are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">609</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,863,100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,864,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As referenced above, the Company utilized its IPO proceeds toward prepaying the Second Lien Notes in full as well as prepaying a portion of the Term Loan. The Term Loan prepayment amount eliminated all subsequent scheduled and outstanding repayments of the term borrowings resulting in no remaining short-term commitments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350667848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense is provided on an interim basis based upon our estimate of the annual effective income tax rate. In determining the estimated annual effective income tax rate, we analyze various factors, including projections of our annual earnings and the taxing jurisdictions where the earnings will occur, the impact of state and local taxes, our ability to utilize tax credits and net operating loss carryforwards and available tax planning alternatives. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate was 21.4 % and (86.0)% for the three months ended March&#160;31, 2021 and 2020, respectively. Income tax expense for the three months ended March&#160;31, 2021 differs from the statutory rate primarily due to the impact of the foreign rate differential, global intangible low-tax income (&#8220;GILTI&#8221;), and a net increase in the valuation allowance attributable to the limitation on the deductibility of interest expense. This was offset by a discrete item, which reversed the valuation allowance on deferred tax assets related to certain asset retirement obligations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax benefit for the three months ended March&#160;31, 2020 differed from the statutory rate primarily due to the impact of the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), which increased the limitation on the deductibility of interest expense from 30% to 50% for tax years beginning in 2019 or 2020, and other provisions. The increased limitation </span></div>resulted in a current tax benefit for the three months ended March 31, 2020 of $9.1 million. The increased limitation also resulted in a $5.6 million valuation allowance reversal in the three months ended March&#160;31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352477048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefits</a></td>
<td class="text">Employee Benefits<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors various post-employment benefit plans including, in certain countries outside the U.S., defined benefit and defined contribution pension plans, retirement compensation arrangements, and plans that provide extended health care coverage to retired employees, the majority of which relate to Nordion. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defined benefit pension plan </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest cost and expected return on plan assets are recorded in &#8220;Other income, net&#8221; and the service cost component is included in the same financial statement line item as the applicable employee&#8217;s wages in the Consolidated Statements of Operations and Comprehensive Income (Loss). The components of net periodic pension cost for the defined benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,613</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,557)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net periodic benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1,379)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,119)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other benefit plans </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other benefit plans include a supplemental retirement arrangement, a retirement and termination allowance, and post-retirement benefit plans, which include contributory health and dental care benefits and contributory life insurance coverage. All but one, non-pension post-employment benefit plans are unfunded. The components of net periodic pension cost for the other benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently expect funding requirements of approximately $2.8&#160;million in each of the next five years to fund the regulatory solvency deficit, as defined by Canadian federal regulation, which require solvency testing on defined benefit pension plans.</span></div>The Company may obtain a qualifying letter of credit for solvency payments, up to 15% of the market value of solvency liabilities as determined on the valuation date, instead of paying cash into the pension fund. As of March&#160;31, 2021, and December&#160;31, 2020, we had letters of credit outstanding relating to the defined benefit plans totaling $42.6 million and $41.3 million, respectively. The actual funding requirements over the five-year period will be dependent on subsequent annual actuarial valuations. These amounts are estimates, which may change with actual investment performance, changes in interest rates, any pertinent changes in Canadian government regulations and any voluntary contributions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352081736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text">Related PartiesWe do business with a number of companies affiliated with Warburg Pincus and GTCR, which we refer to collectively as the &#8220;Sponsors,&#8221; who continue to have substantial control over us. All transactions with these companies have been conducted in the ordinary course of our business and are not material to our operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679351981672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income (Loss)</a></td>
<td class="text">Other Comprehensive Income (Loss)<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts in accumulated other comprehensive income (loss) are presented net of the related tax. Foreign currency translation is not adjusted for income taxes. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our accumulated other comprehensive income (loss) balances, net of applicable tax, were as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plans</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Translation</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Swaps</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beginning balance &#8211; January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(44,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(49,699)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(93,842)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,071)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,320)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ending balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(44,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(52,770)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(97,162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beginning balance &#8211; January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(94,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74,052)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,967)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,479)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74,239)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ending balance &#8211; March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,906)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(140,420)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,300)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(168,626)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">For defined benefit pension plans, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#8220;Other income, net&#8221; within the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">For interest rate swaps, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#8220;Interest expense, net&#8221; within the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352066952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-IPO Awards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock distributed in respect of pre-IPO Class&#160;B-1 time vesting units vests on a daily basis pro rata over the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM5MA_4d42cb8b-4533-485f-a39a-6ad44b9c22bd">five</span>-year vesting period (20% per year) beginning on the original vesting commencement date of the corresponding Class B-1 time vesting units, subject to the grantee&#8217;s continued services through each vesting date. Upon the occurrence of a change in control of the Company, all then outstanding unvested shares of our common stock distributed in respect of Class&#160;B-1 Units will become vested as of the date of consummation of such change in control, subject to the grantee&#8217;s continued services through the consummation of the change in control.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock distributed in respect of pre-IPO Class&#160;B-2 Units (which were considered performance vesting units) are scheduled to vest only upon satisfaction of certain thresholds. These units generally vest as of the first date on which (i) our Sponsors have received actual cash proceeds in an amount equal to or in excess of at least two and one-half times their invested capital in Sotera Health Topco Parent, L.P. (of which the Company was a direct wholly owned subsidiary prior to the IPO) and (ii) the Sponsors&#8217; internal rate of return exceeds twenty percent, subject to such grantee&#8217;s continued services through such date. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a change in control of the Company, any outstanding shares of our common stock distributed in respect of Class B-2 Units that remain unvested immediately following the consummation of such a change in control of the Company shall be immediately canceled and forfeited without compensation. Stock based compensation expense attributed to the pre-IPO Class B-2 awards was recorded in the fourth quarter of 2020 as the related performance conditions were considered probable of achievement and the implied service conditions were met. As of March&#160;31, 2021, these awards remain unvested.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $0.7 million and $1.7 million of share-based compensation expense related to the pre-IPO Class B-1 awards for the three months ended March&#160;31, 2021 and 2020, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity for the three months ended March&#160;31, 2021 related to the restricted stock awards distributed to the Company service providers in respect of the pre-IPO awards (Class&#160;B-1 and B-2 Units) is presented below: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Restricted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock - Pre-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IPO B-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Restricted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock - Pre-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IPO B-2</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,201,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,323,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43,361)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(254,839)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(228,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unvested at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,929,016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,068,494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Omnibus Incentive Plan</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a long-term incentive plan (the &#8220;2020 Omnibus Incentive Plan&#8221; or the &#8220;2020 Plan&#8221;) that allows for grants of incentive stock options to employees (including employees of any of our subsidiaries), nonstatutory stock options, restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;) and other cash-based, equity-based or equity-related awards to employees, directors, and consultants, including employees or consultants of our subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized $2.8 million ($1.3 million for stock options and $1.5 million for RSUs) of share-based compensation expense for these awards in our Consolidated Statements of Operations and Comprehensive Income (Loss), in &#8220;Selling, general and administrative expenses,&#8221; for the three months ended March&#160;31, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options have a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTMzOA_90568ab0-c98d-42fa-bc3b-4bb90feeb83b">four</span>-year vesting period, an exercise price equal to the fair market value of a share of common stock on the date of grant, and a contractual term of 10 years. The following table summarizes our stock option activity:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,389,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,400,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs generally vest ratably over a period of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1ZWY2NDM3OTZjMzQ4MjliM2JiMjg0NzUzMzhmMDIxL3NlYzoxNWVmNjQzNzk2YzM0ODI5YjNiYjI4NDc1MzM4ZjAyMV83OS9mcmFnOjhiMDgxMmQ5MzkwMTQyODk4NzhmMGViOWI4YWYxYjUxL3RleHRyZWdpb246OGIwODEyZDkzOTAxNDI4OTg3OGYwZWI5YjhhZjFiNTFfMjc0ODc3OTA3OTM1Mg_eccb5a8b-a643-47c5-b42e-caa40b675d70">one</span> to four years and are valued based on our market price on the date of grant. The following table summarizes our unvested RSUs activity:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">average Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date Fair </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">771,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unvested at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">757,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350670712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text">Earnings (Loss) Per Share <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per share represents the amount of income (loss) attributable to each common share outstanding. Diluted earnings (loss) per share represents the amount of income (loss) attributable to each common share outstanding adjusted for the effects of potentially dilutive common shares. Potentially dilutive common shares include stock options and other stock-based awards. In the periods where the effect would be antidilutive, potentially dilutive common shares are excluded from the calculation of diluted earnings per share. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In periods in which the Company has net income, earnings per share is calculated using the two-class method. This method is required as unvested restricted stock distributed in respect of pre-IPO Class&#160;B-1 and B-2 awards have the right to receive non-forfeitable dividends or dividend equivalents if the Company were to declare dividends on its common stock. Pursuant to the two-class method, earnings for each period are allocated on a pro-rata basis to common stockholders and unvested pre-IPO Class B-1 and B-2 restricted stock awards. Diluted earnings per share is computed using the more dilutive of (a) the two-class method, or (b) treasury stock method, as applicable, to the potentially dilutive instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In periods in which the Company has a net loss, the two-class method is not applicable because the pre-IPO Class B-1 and B-2 restricted stock awards do not participate in losses. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted earnings per common share are calculated as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">in thousands of U.S. dollars and share amounts (except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Net income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Allocation to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,964)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Common Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.52pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average common shares outstanding - basic</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">278,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">232,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average common shares outstanding - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">278,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">232,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (loss) per Common Share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.01)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.57pt">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">n additional 2,400,349 and 3,645 equivalent shares related to stock options and RSUs, respectively, issued in connection with the 2020 Omnibus Incentive Plan were excluded from the calculation of diluted weighted average common shares outstanding for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">the three months ended March&#160;31, 2021 as they were anti-dilutive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. For the three months ended March&#160;31, 2020, there were no potentially dilutive common shares outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350789544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to various lawsuits and other claims in the ordinary course of our business. In addition, from time to time, we receive communications from government or regulatory agencies concerning investigations or allegations of noncompliance with laws or regulations in jurisdictions in which we operate. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We establish reserves for specific liabilities in connection with regulatory and legal actions that we determine to be both probable and reasonably estimable. No material amounts have been accrued in our consolidated financial statements with respect to any loss contingencies. In certain of the matters described below, we are not able to make a reasonable estimate of any liability because of the uncertainties related to the outcome and/or the amount or range of loss. While it is not possible to determine the ultimate disposition of each of these matters, we do not expect that the ultimate resolution of pending regulatory and legal matters in future periods, including the matters described below, will have a material effect on our financial condition or results of operations. Despite the above, the Company may incur material defense and settlement costs, diversion of management resources and other adverse effects on our business, financial condition, or results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FM Global Business Interruption Claim (NRU Outage) </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion, due to the shutdown of AECL&#8217;s NRU reactor in 2009, suffered a cessation of supply of radioisotopes and business interruption loss. Nordion, by Statement of Claim dated October&#160;22, 2010, issued in Ontario Superior Court an action against the insurer, Factory Mutual Insurance Company (FM Global), claiming $25.0 million USD in losses resulting from the shutdown of AECL&#8217;s reactor and its inability to supply radioisotopes through the specified period of approximately 15 months. FM Global objected to Nordion&#8217;s claim. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trial commenced in March 2019 and was completed in September 2019. On March&#160;30, 2020, Nordion received a favorable judgment in the amount of $25.0 million USD, plus pre-judgment interest, for a total judgment value of $39.8 million USD, or $56.4 million CAD based on exchange rates approved by the trial court. In addition, costs and disbursements have been assessed and awarded by the trial court in favor of Nordion in the approximate amount of $1.1 million CAD ($0.8 million USD) and $161,863 CAD ($0.1 million USD), respectively. On April&#160;27, 2020, FM Global appealed the judgment. In January 2021, The Insurance Bureau of Canada was granted leave to intervene in the appeal. Hearing before the Court of Appeal was held on April 15, 2021. Pending a favorable judgment in the appellate court, any final proceeds would be subject to post judgment interest, a contingent fee owed to legal counsel and applicable taxes. As the judgment is considered a contingent gain, any favorable outcome will be recognized in a future period when all appeals are exhausted. It is anticipated that the overall appeal process could take a year or more to complete. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Willowbrook, Illinois &#8211; Government Litigation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 30, 2018, the Illinois Attorney General and the State&#8217;s Attorney of DuPage County, Illinois, sued Sterigenics U.S., LLC (the &#8220;IAG Action&#8221;), alleging that authorized EO air emissions from a commercial sterilization facility Sterigenics formerly operated in Willowbrook, Illinois &#8220;cause, threaten, or allow air pollution&#8221; in violation of the Illinois Environmental Protection Act. The IAG Action did not assert that Sterigenics violated its permit from the Illinois Environmental Protection Agency (&#8220;IEPA&#8221;) authorizing Sterigenics&#8217; release of regulated levels of EO at the Willowbrook facility.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2019, the acting IEPA director, John Kim, issued a &#8220;Seal Order&#8221; effectively precluding Sterigenics&#8217; operations at the Willowbrook facility based on many of the same allegations asserted in the IAG Action. Sterigenics disputed those allegations and opposed the IEPA&#8217;s Seal Order. The Seal Order was resolved by a Consent Order entered on September 6, 2019. The Consent Order provided that Sterigenics did not admit the allegations of the IAG Action, provided for the removal of the Seal Order and allowed the Willowbrook facility to reopen upon implementation of supplemental emissions control measures consistent with a new law that became effective in Illinois in June 2019 and an IEPA permit, which the IEPA approved in September 2019. Following entry of the Consent Order, the Seal Order was withdrawn.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, Sterigenics announced the closure of the Willowbrook facility due to the inability to reach an agreement with its landlord to renew the facility&#8217;s lease and the unstable legislative and regulatory landscape in Illinois. Sterigenics is in the process of decommissioning the facility and completing the work required by the terms of its lease to return the property to the landlord.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2020 Sterigenics, the Illinois Attorney General and the State&#8217;s Attorney of DuPage County filed a Joint Motion to Terminate Consent Order, stating that the community projects which Sterigenics voluntarily agreed to fund have been completed and funded as required by the Consent Order, and that Sterigenics has permanently ceased operations and surrendered all permits for its operations in Willowbrook, Illinois. On October 27, 2020 the DuPage County Circuit Court entered the Agreed Order Terminating Consent Order.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethylene Oxide Tort Litigation - Illinois</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since September 2018, tort lawsuits on behalf of approximately 835 personal injury plaintiffs (which are further described in the following paragraphs) have been filed in Illinois state courts against Sotera Health LLC, Sterigenics U.S., LLC, GTCR, LLC and other parties related to Sterigenics&#8217; Willowbrook, Illinois operations. Specifically, those plaintiffs allege that they suffered personal injuries including cancer and other diseases, or wrongful death, resulting from purported emissions and releases of EO from the Willowbrook facility. Additional derivative claims are alleged on behalf of other individuals related to these personal injury plaintiffs. Plaintiffs seek damages in an amount to be determined by the trier of fact. Sterigenics denies these allegations and intends to vigorously defend against these claims. Plaintiffs have voluntarily dismissed without prejudice a number of cases since September 2018, including certain individual cases alleging personal injuries and two class actions seeking damages for alleged diminution of property values.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sterigenics sought consolidation of the cases for pretrial purposes, and in October 2019 obtained an order consolidating the then-pending cases and related cases filed in the future before Judge Lawler in the Cook County Circuit Court, Illinois (the &#8220;Consolidated Case&#8221;). All plaintiffs in the Consolidated Case filed a single Master Complaint on October 24, 2019 by which Sotera Health LLC was added as a co-defendant, followed by a First Amended Master Complaint on January 31, 2020. On April 28, 2020, the defendants filed motions to dismiss the claims in the First Amended Master Complaint. On August 17, 2020, the Court entered an order largely denying the motions to dismiss, and the same day plaintiffs filed a Second Amended Master Complaint.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs filed a Third Amended Master Complaint on October 30, 2020 adding Griffith Foods Group, Inc., Griffith Foods, Inc., Griffith Foods International, Inc. and Griffith Foods Worldwide Inc. as defendants. Defendants&#8217; responses to the Third Amended Master Complaint were filed on or about December 1, 2020, including a motion to dismiss by Griffith Foods Group, Inc., Griffith Foods, Inc., Griffith Foods International, Inc. and Griffith Foods Worldwide, Inc. That motion was granted in part on March 16, 2021 and plaintiffs were granted leave to file a Fourth Amended Master Complaint. The Fourth Amended Master Complaint was filed on April 16, 2021, including claims against Griffith Foods International, Inc. but not the other Griffith entities. All defendants&#8217; responses to the Fourth Amended Master Complaint are due by May 14, 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written and deposition fact discovery is on-going in the Consolidated Case. Currently, there are no dates set for the close of fact discovery, for expert discovery or for dispositive motion practice. Plaintiffs have not yet made any specific damages claims.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trials in five of the individual cases now included in the Consolidated Case had previously been scheduled to begin in 2021. Based on the Court's administrative orders related to the impact of COVID-19 on jury trials, however, and subject to the Court's discretion to make changes, we anticipate that the earliest any of the individual cases in the Consolidated Case will be tried will be 2022 and that trials will be scheduled in roughly the order in which the individual cases were filed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethylene Oxide Tort Litigation &#8211; Georgia </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2020, a lawsuit against Sotera Health LLC, Sterigenics U.S., LLC and other parties was filed in the State Court of Cobb County, Georgia by 53 employees of a contract sterilization customer of Sterigenics. In the operative complaint, Plaintiffs claim personal injuries resulting from alleged exposure to residual EO while working at the customer&#8217;s distribution center in Lithia Springs, Georgia, allege they were unaware that they were being exposed to EO in their workplace and seek damages in an amount to be determined by the trier of fact. Defendants filed motions to dismiss and answers to the Complaint on April 30, 2021. All defendants are being defended and indemnified by Sterigenics&#8217; contract sterilization customer (plaintiffs&#8217; employer and a co-defendant in the lawsuit).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the Cobb County, Georgia Board of Tax Assessors reduced certain residential property value assessments around the Sterigenics Atlanta facility by 10% citing an &#8220;Epd-identified environmental issue,&#8221; without supporting market data. On </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 14, 2020, Sterigenics U.S., LLC filed a lawsuit against members of the Cobb County Board of Tax Assessors in the U.S. District Court for the Northern District of Georgia, seeking a declaration that the reduction in property value assessments is arbitrary and unlawful and is causing Sterigenics reputational and imminent economic harm. On February 5, 2021 the Court issued an order finding that Sterigenics lacks standing to obtain the relief sought and dismissed the case. Sterigenics has appealed that decision to the 11th Circuit Court of Appeals and anticipates that appellate briefing will be completed before the end of August 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since August 17, 2020, six lawsuits against Sotera Health LLC, Sterigenics U.S., LLC and other parties have been filed by plaintiffs in the State Court of Cobb County, Georgia and the State Court of Gwinnett County, Georgia in which plaintiffs allege that they suffered personal injuries and loss of consortium resulting from emissions and releases of EO from Sterigenics&#8217; Atlanta facility. Our subsidiaries are also defendants in lawsuits alleging that the Atlanta facility has devalued and harmed plaintiffs&#8217; use of real properties they own in Smyrna, Georgia and caused other damages. Plaintiffs in these cases seek various forms of relief including damages in amounts to be determined by the trier of fact. Sotera Health LLC filed motions to dismiss in each case on personal jurisdiction grounds. That motion was denied in one case pending in the State Court of Gwinnett County and the other motions remain pending. Sterigenics U.S., LLC and Sotera Health LLC filed a motion to dismiss the strict liability claim in each case. That motion was denied in one case pending in the State Court of Gwinnett County and the other motions remain pending. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Suspension of Georgia Facility Operations&#160;&amp; Related Litigation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2019, Sterigenics U.S., LLC entered into a voluntary Consent Order with the Georgia Environmental Protection Division (&#8220;EPD&#8221;) under which Sterigenics agreed to install emissions reduction enhancements at its Atlanta facility to further reduce the facility&#8217;s EO emissions below already permitted levels. Sterigenics voluntarily suspended operations at the facility in early September 2019 to expedite completion of the enhancements. Installation of these enhancements is complete, and Sterigenics successfully tested the enhanced emissions controls in cooperation with EPD during the second quarter of 2020 while the facility was in operation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, while Sterigenics had voluntarily suspended the facility&#8217;s operations, Cobb County, Georgia officials asserted that the facility had an incorrect &#8220;certificate of occupancy&#8221; and could not resume operations without obtaining a new certificate of occupancy after a third-party code compliance review they required.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the Cobb County officials would not allow Sterigenics to resume operations, on March 30, 2020, Sterigenics U.S., LLC filed a lawsuit in the United States District Court for the Northern District of Georgia against Cobb County, Georgia and Cobb County officials Nicholas Dawe and Kevin Gobble. In the lawsuit, Sterigenics sought immediate injunctive relief and permanent declaratory relief to resume normal operations of the Atlanta facility in the interest of public health and on the basis that the positions asserted by Cobb County were unfounded. On April 1, 2020 the Court entered a Temporary Restraining Order prohibiting Cobb County officials from precluding or interfering with the facility&#8217;s normal operations. On April 8, 2020, the Court entered a Consent Order extending the Temporary Restraining Order and allowing the facility to continue normal operations until entry of a final judgment in the case. Defendants filed a motion to dismiss the claims. On November 9, 2020, the Court held a hearing and denied the motion to dismiss. The parties are conducting discovery, which is presently scheduled to end on July 23, 2021. A settlement conference is scheduled to be held by September 27, 2021.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ethylene Oxide Litigation &#8211; New Mexico</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020 the New Mexico Attorney General filed a lawsuit in the Third Judicial District Court, Do&#241;a Ana County, New Mexico (&#8220;the Third Judicial District&#8221;) against the Company, Sterigenics U.S., LLC and other subsidiaries alleging that emissions of EO from Sterigenics U.S., LLC&#8217;s sterilization facility in Santa Teresa, New Mexico constitute a public nuisance and have deteriorated the air quality in Santa Teresa and surrounding communities and materially contributed to increased health risks suffered by residents of those communities. The Complaint asserts claims for public nuisance, negligence, strict liability, violations of New Mexico&#8217;s Public Nuisance Statute and Unfair Practices Act and a request for a temporary restraining order and preliminary injunctive relief. On December 28, 2020 Sterigenics U.S., LLC removed the case to the United States District Court for the District of New Mexico. On April 13, 2021 the case was remanded to the Third Judicial District where Plaintiff&#8217;s Emergency Motion for Temporary Restraining Order and Preliminary Injunction has been scheduled for a preliminary injunction hearing on May 26, 2021.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Emergency Motion does not demand facility closure but seeks an order requiring Defendants to cease any and all uncontrolled emissions or releases of EO from the Santa Teresa facility, including by making certain modifications to sterilization processes at the facility.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carry insurance for alleged environmental liabilities (including litigation like that pending in Illinois, Georgia and New Mexico described above), with limits of $10.0 million per occurrence and $20.0 million in the aggregate. The per occurrence limit related to the Willowbrook government and EO tort litigation was fully utilized by June 30, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional personal injury, property devaluation or other lawsuits may be filed in the future against us or our subsidiaries relating to Sterigenics&#8217; Willowbrook, Atlanta, Santa Teresa or other EO sterilization facilities. The Company, Sterigenics U.S., LLC and other Company subsidiaries intend to defend themselves vigorously in all such current or future EO litigation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While an adverse outcome in one or more of the proceedings could have a material adverse effect on our business, financial condition and results of operations, no contingency reserve has been reflected in our consolidated financial statements as a loss is not deemed probable, nor is a loss or range of losses reasonably estimable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350809016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Financial Risk<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Instruments and Financial Risk</a></td>
<td class="text">Financial Instruments and Financial Risk <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Instruments </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not use derivatives for trading or speculative purposes and are not a party to leveraged derivatives. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated in Hedge Relationships</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, we entered into two interest rate swap agreements to hedge our exposure to interest rate movements and to manage interest expense related to our then outstanding variable-rate debt. The notional amount of the interest rate swap agreements totaled $1,000.0 million. These swaps were designated as cash flow hedges and were designed to hedge the variability of cash flows attributable to changes in LIBOR, the benchmark interest rate being hedged. We received interest at one-month LIBOR and paid a fixed interest rate under the terms of the swap agreement. The swap agreements terminated on August&#160;31, 2020. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated in Hedge Relationships</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, we entered into two interest rate cap agreements with a total notional amount of $400.0 million for a total option premium of $0.6 million; these agreements terminated on September 30, 2020. The interest rate caps limited the Company&#8217;s cash flow exposure related to LIBOR under the variable rate Term Loan borrowings to 3.0%. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, SHH entered into two interest rate cap agreements with notional amounts of $1,000.0 million and $500.0 million, respectively, for a total option premium of $0.3 million. These instruments were initially scheduled to terminate on August 31, 2021 and February 28, 2022, respectively. The interest rate caps limit our cash flow exposure related to the LIBOR base rate under a portion of our variable rate borrowings to 1.0%. In February 2021, we amended the two interest rate cap agreements referenced above to reduce the strike rate from 1.0% to 0.5%, and extend the termination date of the $1,000.0 million notional cap to September 30, 2021. Premiums paid to amend the interest rate caps were immaterial. We also entered into two additional interest rate cap agreements in February 2021 with a combined notional amount of $1,000.0 million, for a total option premium of $0.4 million. These instruments are effective September 30, 2021, and will terminate on March 31, 2022. The amended and new interest rate caps limit our cash flow exposure related to LIBOR under a portion of our variable rate borrowings to 0.5%. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate caps were entered into to manage economic risks associated with our variable rate borrowings, but were not designated in hedge relationships. These instruments are recorded at fair value on the Consolidated Balance Sheets, with any changes in the value being recorded in &#8220;Interest expense, net&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also entered into foreign currency forward contracts to manage foreign currency exchange rate risk of our intercompany loans in certain of our international subsidiaries. The foreign currency forward contracts expire on a monthly basis. The fair value of the outstanding foreign currency forward contracts was zero as of March&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have embedded derivatives in certain of our customer and supply contracts as a result of the currency of the contract being different from the functional currency of the parties involved. Changes in the fair value of the embedded derivatives are recognized in &#8220;Other income, net&#8221; in the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the notional and fair values of our derivative instruments: </span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(in U.S. Dollars; notional in millions, fair value in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notional<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notional<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,500.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">77.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,577.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,583.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt">Represents the total notional amounts for certain of the Company&#8217;s supply and sales contracts accounted for as embedded derivatives.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate caps and embedded derivative assets are included in &#8220;Prepaid expenses and other current assets&#8221; on our consolidated balance sheets. Embedded derivative liabilities are included in &#8220;Accrued liabilities&#8221; on the Consolidated Balance Sheets. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activities of our derivative instruments for the periods presented, and the line item they are recorded in in the Consolidated Statements of Operations and Comprehensive Income (Loss): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on interest rate caps recorded in interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized (gain) loss on embedded derivatives recorded in other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gain on foreign currency forward contracts recorded in foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2,374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, during the three months ended March&#160;31, 2020, we recognized $3.5 million of losses, net of tax, in accumulated other comprehensive income (loss) related to the change in fair value of the interest rate swaps.  </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our financial assets, including cash and cash equivalents, are exposed to credit risk. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exposed, in our normal course of business, to credit risk from our customers. As of March&#160;31, 2021 and December&#160;31, 2020, accounts receivable was net of an allowance for uncollectible accounts of $0.6 million and $0.7 million, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk on financial instruments arises from the potential for counterparties to default on their contractual obligations to us. We are exposed to credit risk in the event of non-performance, but do not anticipate non-performance by any of the counterparties to our financial instruments. We limit our credit risk by dealing with counterparties that are considered to be of </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">high credit quality. In the event of non-performance by counterparties, the carrying value of our financial instruments represents the maximum amount of loss that would be incurred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our financial instruments is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The valuation techniques we would use to determine such fair values are described as follows: Level 1&#8212;fair values determined by inputs utilizing quoted prices in active markets for identical assets or liabilities; Level 2&#8212;fair values based on observable inputs other than quoted prices included in Level&#160;1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable; Level 3&#8212;fair values determined by unobservable inputs reflecting our own assumptions, consistent with reasonably available assumptions made by other market participants.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the fair value of our financial assets and liabilities: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;1 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;2 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;3 </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,740,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,760,896</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">96,458</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">97,587</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Lease Obligations (with current portion)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">34,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">34,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;1 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;2 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;3 </span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,728,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,772,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Lease Obligations (with current portion)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Derivatives that are not designated as hedging instruments are measured at fair value with gains or losses recognized immediately in the Consolidated Statements of Operations and Comprehensive Income (Loss). Interest rate caps are valued using pricing models that incorporate observable market inputs including interest rate and yield curves. Embedded derivatives are valued using internally developed models that rely on observable market inputs including foreign currency forward curves.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Carrying amounts of long-term debt instruments are reported net of discounts and debt issuance costs. The estimated fair value of these instruments is based on information provided by the agent under the Company&#8217;s senior secured credit facility. Fair value approximates carrying value for &#8220;Other long-term debt.&#8221;</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Fair value approximates carrying value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350675064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information <div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify our operating segments based on the way we manage, evaluate and internally report our business activities for purposes of allocating resources and assessing performance. We have three reportable segments: Sterigenics, Nordion and Nelson Labs. We have determined our reportable segments based upon an assessment of organizational structure, service types, and internally prepared financial statements. Our chief operating decision maker evaluates performance and allocates resources based on net revenues and segment income after the elimination of intercompany activities. The accounting policies of our reportable segments are the same as those described in Note 1, &#8220;Significant Accounting Policies&#8221; of our 2020 Form 10-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Sterigenics</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sterigenics segment provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nordion </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nordion is a global provider of Co-60 and gamma irradiators, which are key components to the gamma sterilization process. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Nelson Labs </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nelson Labs provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and biopharmaceutical industries. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, three customers reported within the Nordion segment individually represented 10% or more of the segment&#8217;s total net revenues. These customers represented 23.7%, 20.0%, and 12.2% of the total segment&#8217;s external net revenues for the three months ended March&#160;31, 2021. For the three months ended March&#160;31, 2020, two customers reported within the Nordion segment individually represented 10% or more of the segment's total net revenues. These customers represented 18.7% and 11.6% of the total segment's external net revenues for the three months ended March&#160;31, 2020.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Net revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">131,151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">55,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">212,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Segment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">68,461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23,070</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,514</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">489</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">939</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20,942</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Sterigenics </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Nordion </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Nelson Labs </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Consolidated </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Net revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Segment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Revenues are reported net of intersegment sales. Our Nordion segment recognized $10.5 million and $10.9 million in revenues from sales to our Sterigenics segment for the three months ended March&#160;31, 2021 and 2020, respectively, that is not reflected in net revenues in the table above. Intersegment sales for Sterigenics and Nelson Labs are immaterial for both periods. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Segment income is only provided on a net basis to the chief operating decision maker and is reported net of intersegment profits. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate operating expenses for executive management, accounting, information technology, legal, human resources, treasury, corporate development, tax, purchasing, and marketing are allocated to the segments based on total revenue. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets and depreciation and amortization expense by segment are not readily available and are not reported separately to the chief operating decision maker. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of segment income to consolidated income (loss) before taxes is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Less adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">37,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,449</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Gain) loss on foreign currency and embedded derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and divestiture related charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business optimization project expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plant closure expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14,312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional services relating to EO sterilization facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(h)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accretion of asset retirement obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">551</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(j)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated income (loss) before taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,220)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes depreciation of Co-60 held at gamma irradiation sites. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents non-cash share-based compensation expense.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents the effects of (i)&#160;fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#8217; functional currencies, and (ii)&#160;non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents (i) certain direct and incremental costs related to the acquisitions of BioScience in 2021, Iotron in July 2020 and Nelson Labs Fairfield in 2018 (including the first quarter 2021 gain on the mandatorily redeemable noncontrolling interest as described in Note 4, &#8220;Acquisitions&#8221;), and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.01pt">Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents expenses incurred in connection with the repricing of our Term Loan in January 2021 including accelerated amortization of prior debt issuance and discount costs. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees. See Note 16, &#8220;Commitments and Contingencies&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Represents non-recurring costs associated with the COVID-19 pandemic, including incremental costs to implement workplace health and safety measures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352147672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of Estimates &#8211; In preparing our consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles ("GAAP"), we make estimates and assumptions that affect the amounts reported and the accompanying notes. We regularly evaluate the estimates and assumptions used and revise them as new information becomes available. Actual results may vary from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">ASU&#8217;s Issued But Not Yet Adopted</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ASU&#8217;s Issued But Not Yet Adopted</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Jumpstart Our Business Startups Act of 2012, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. As an emerging growth company, we have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies or at which time we conclude it is appropriate to avail ourselves of early adoption provisions of applicable standards. As a result, our results of operations and financial statements may not be comparable to the results of operations and financial statements of other companies who have adopted the new or revised accounting standards. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(&#8220;ASU&#8221;) 2016-13, Financial Instruments &#8211; Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASU 2016-13&#8221;): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and subsequently issued additional guidance that modified ASU 2016-13. The standard requires an entity to change its accounting approach in determining impairment of certain financial instruments, including trade receivables, from an &#8220;incurred loss&#8221; to a &#8220;current expected credit loss&#8221; model. We intend to adopt the standard as of January 1, 2022. We are currently assessing the effect that ASU 2016-13 will have on our financial position, results of operations, and disclosures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, the FASB issued </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The standard simplifies the accounting for income taxes and makes a number of changes meant to add or clarify guidance on accounting for income taxes. This update is effective for annual financial statement periods beginning after March 15, 2021 and interim periods beginning after March 15, 2022, with early adoption permitted in any interim period for which financial statements have not yet been filed. We are currently assessing the effect that ASU 2019-12 will have on our financial position, results of operations, and disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352068616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows disaggregated net revenues from contracts with external customers by timing of revenue and by segment for the three months ended March&#160;31, 2021 and 2020:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131,151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">131,151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">55,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">212,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Point in time</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Over time</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">117,280</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">47,295</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">188,200</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350729704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimated fair value of the underlying acquired assets and assumed liabilities of the Iotron acquisition and the measurement period adjustments recognized during the three months ended March&#160;31, 2021, were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Allocation of purchase price to the fair value of </span></div><div style="margin-bottom:1.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">net assets acquired (net of cash acquired):</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount recognized as of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Measurement Period Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount recognized as of March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,142)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">51,904</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">42,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18,158</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,117</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment in unconsolidated affiliate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8,700</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumed long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets/liabilities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,846)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,298)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15,144)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total estimated purchase price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Business Acquisition, Pro Forma Information</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">194,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(889)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352477048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted primarily of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">29,512</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,371</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,617</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">33,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve for excess and obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">33,375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,093&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350828552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Deferred Costs, Capitalized, Prepaid, and Other Assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consisted primarily of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.642%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,356</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid business insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7,421</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,212</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer contract assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14,133</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance and indemnification receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">797</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid maintenance contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Value added tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,385</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid software licensing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11,762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">69,758</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64,964&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354916104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to goodwill during the three months ended March&#160;31, 2021 were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill at December 31, 2020</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">683,481&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">287,932&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144,523&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,115,936&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">BioScience acquisition</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Iotron acquisition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">measurement period adjustments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes due to foreign currency exchange rates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(501)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">664,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">291,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">151,301</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,106,728</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Acquired Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortization</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">662,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">322,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">89,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">39,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9,454</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">243,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">98,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,011,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">463,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">82,807</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,952</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">108,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,119,803</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">463,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortization</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">634,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">309,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">240,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">977,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,085,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#8217;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another 10 years license period as Nordion has demonstrated over its 70 years of history.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Acquired Indefinite-lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross&#160;Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortization</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">662,509</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">322,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">89,604</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">39,707</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">142</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9,454</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,364</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">243,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">98,237</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5,675</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,138</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,011,044</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">463,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">82,807</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,952</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">108,759</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,119,803</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">463,231</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying</span></div><div style="margin-bottom:1.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Accumulated</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amortization</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Finite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">634,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">309,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land-use rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sealed source and supply agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">240,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total finite-lived intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">977,791&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442,391&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory licenses and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade names / trademarks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107,966&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,085,757&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442,391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Includes certain transportation certifications, a class 1B nuclear license and other intangibles related to obtaining such licensure. These assets are considered indefinite-lived as the decision for renewal by the Canadian Nuclear Safety Commission is highly based on a licensee&#8217;s previous assessments, reported incidents, and annual compliance and inspection results. New applications for license can take a significant amount of time and cost; whereas an existing licensee with a historical record of compliance and current operating conditions more than likely ensures renewal for another 10 years license period as Nordion has demonstrated over its 70 years of history.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated aggregate amortization expense for finite-lived intangible assets for each of the next five years and thereafter is as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">65,889</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">80,665</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">80,659</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">79,882</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">41,982</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">198,736</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">547,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of acquired indefinite-lived intangible assets. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350625768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27,651</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,760&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,744</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued utilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,397</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,864&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance accrual</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,886</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,332</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,619</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">56,373</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352142840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.791%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,763,100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,763,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">100,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,059</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,864,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,863,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less unamortized debt issuance costs and debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(26,579)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(38,761)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt, less debt issuance costs and debt discounts</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,837,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,824,789&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate maturities of the Company&#8217;s long-term debt, excluding debt discounts, as of March&#160;31, 2021, are as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">609</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">450</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,863,100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,864,159</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350765096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Benefit Costs</a></td>
<td class="text">The components of net periodic pension cost for the defined benefit plans for the three months ended March&#160;31, 2021 and 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,613</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,557)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,599)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net periodic benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1,379)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,119)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of net actuarial (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net periodic benefit cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">74</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350679000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our accumulated other comprehensive income (loss) balances, net of applicable tax, were as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Benefit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Plans</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Translation</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Rate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Swaps</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:139%">Total</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beginning balance &#8211; January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(44,143)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(49,699)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(93,842)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,595)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(249)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,071)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3,320)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ending balance &#8211; March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(44,392)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(52,770)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(97,162)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Beginning balance &#8211; January 1, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27,113)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(67,453)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(94,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reclassifications</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,967)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74,052)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from accumulated other</span></div><div style="padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">comprehensive income (loss)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72,967)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,479)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(74,239)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ending balance &#8211; March 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,906)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(140,420)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,300)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(168,626)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">For defined benefit pension plans, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#8220;Other income, net&#8221; within the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">For interest rate swaps, amounts reclassified from accumulated other comprehensive income (loss) are recorded to &#8220;Interest expense, net&#8221; within the Consolidated Statements of Operations and Comprehensive Income (Loss).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352074600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the activity for the three months ended March&#160;31, 2021 related to the restricted stock awards distributed to the Company service providers in respect of the pre-IPO awards (Class&#160;B-1 and B-2 Units) is presented below: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Restricted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock - Pre-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IPO B-1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Restricted </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stock - Pre-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">IPO B-2</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,201,239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,323,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43,361)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(254,839)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(228,862)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unvested at March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,929,016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,068,494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The following table summarizes our unvested RSUs activity:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">average Grant</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date Fair </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Value</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">771,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24,999)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unvested at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">757,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">The following table summarizes our stock option activity:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">average </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exercise Price</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,389,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,316)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">At March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,400,349</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679351967224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted earnings per common share are calculated as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">in thousands of U.S. dollars and share amounts (except per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (Loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11,065</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,986)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Net income (loss) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">223</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Allocation to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10,685</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,964)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Common Shares:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:11.52pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average common shares outstanding - basic</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">278,827</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">232,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">141</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Weighted-average common shares outstanding - diluted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">278,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">232,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings (loss) per Common Share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income (loss) attributable to Sotera Health Company common shareholders - diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.04</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.01)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:17.57pt">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">n additional 2,400,349 and 3,645 equivalent shares related to stock options and RSUs, respectively, issued in connection with the 2020 Omnibus Incentive Plan were excluded from the calculation of diluted weighted average common shares outstanding for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">the three months ended March&#160;31, 2021 as they were anti-dilutive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">. For the three months ended March&#160;31, 2020, there were no potentially dilutive common shares outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355905624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Financial Risk (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the notional and fair values of our derivative instruments: </span></div><div style="margin-bottom:6pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(in U.S. Dollars; notional in millions, fair value in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notional<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Notional<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivative<br/>Liabilities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,500.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,500.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivatives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">77.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2,577.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">412</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,583.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.03pt">Represents the total notional amounts for certain of the Company&#8217;s supply and sales contracts accounted for as embedded derivatives.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Schedule of Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the activities of our derivative instruments for the periods presented, and the line item they are recorded in in the Consolidated Statements of Operations and Comprehensive Income (Loss): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized loss on interest rate caps recorded in interest expense, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized (gain) loss on embedded derivatives recorded in other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized gain on foreign currency forward contracts recorded in foreign exchange (gain) loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2,374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses the fair value of our financial assets and liabilities: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;1 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;2 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;3 </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">403</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,740,071</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,760,896</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">96,458</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">97,587</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1,051</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Lease Obligations (with current portion)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">34,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">34,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">As of December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;1 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2.5pt;padding-right:2.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;2 </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.15pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Level&#160;3 </span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivatives not designated as hedging instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate caps</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Embedded derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term loan, due 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,728,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,772,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior notes, due 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance Lease Obligations (with current portion)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Derivatives that are not designated as hedging instruments are measured at fair value with gains or losses recognized immediately in the Consolidated Statements of Operations and Comprehensive Income (Loss). Interest rate caps are valued using pricing models that incorporate observable market inputs including interest rate and yield curves. Embedded derivatives are valued using internally developed models that rely on observable market inputs including foreign currency forward curves.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Carrying amounts of long-term debt instruments are reported net of discounts and debt issuance costs. The estimated fair value of these instruments is based on information provided by the agent under the Company&#8217;s senior secured credit facility. Fair value approximates carrying value for &#8220;Other long-term debt.&#8221;</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Fair value approximates carrying value.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352073768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">(thousands of U.S. dollars)</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Sterigenics</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nordion</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nelson&#160;Labs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Net revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">131,151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25,918</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">55,079</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">212,148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Segment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">68,461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,786</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23,070</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19,514</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">489</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">939</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20,942</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Sterigenics </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Nordion </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Nelson Labs </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:1.65pt;padding-left:2pt;padding-right:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:139%">Consolidated </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Net revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47,295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">188,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Segment income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,989&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Revenues are reported net of intersegment sales. Our Nordion segment recognized $10.5 million and $10.9 million in revenues from sales to our Sterigenics segment for the three months ended March&#160;31, 2021 and 2020, respectively, that is not reflected in net revenues in the table above. Intersegment sales for Sterigenics and Nelson Labs are immaterial for both periods. </span></div>(b)Segment income is only provided on a net basis to the chief operating decision maker and is reported net of intersegment profits.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Schedule of Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of segment income to consolidated income (loss) before taxes is as follows: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(thousands of U.S. dollars)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;text-decoration:underline">Three Months Ended March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">105,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Less adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21,282</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:12pt;text-indent:-12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:139%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">37,661</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3,449</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,725&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Gain) loss on foreign currency and embedded derivatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisition and divestiture related charges, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">994&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business optimization project expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plant closure expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">542</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on extinguishment of debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14,312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional services relating to EO sterilization facilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(h)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13,399</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accretion of asset retirement obligation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">551</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(j)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">299</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated income (loss) before taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14,082</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14,220)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Includes depreciation of Co-60 held at gamma irradiation sites. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents non-cash share-based compensation expense.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents the effects of (i)&#160;fluctuations in foreign currency exchange rates, primarily related to remeasurement of intercompany loans denominated in currencies other than subsidiaries&#8217; functional currencies, and (ii)&#160;non-cash mark-to-fair value of embedded derivatives relating to certain customer and supply contracts at Nordion. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents (i) certain direct and incremental costs related to the acquisitions of BioScience in 2021, Iotron in July 2020 and Nelson Labs Fairfield in 2018 (including the first quarter 2021 gain on the mandatorily redeemable noncontrolling interest as described in Note 4, &#8220;Acquisitions&#8221;), and certain related integration efforts as a result of those acquisitions, (ii) the earnings impact of fair value adjustments (excluding those recognized within amortization expense) resulting from the businesses acquired, and (iii) transition services income and non-cash deferred lease income associated with the terms of the divestiture of the Medical Isotopes business in 2018. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.91pt">Represents professional fees, contract termination and exit costs, severance and other payroll costs, and other costs associated with business optimization and cost savings projects relating to the integration of Nelson Labs, the Sotera Health rebranding, operating structure realignment and other process enhancement projects. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.01pt">Represents professional fees, severance and other payroll costs, and other costs including ongoing lease and utility expenses associated with the closure of the Willowbrook, Illinois facility.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents expenses incurred in connection with the repricing of our Term Loan in January 2021 including accelerated amortization of prior debt issuance and discount costs. </span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Represents professional fees related to litigation associated with our EO sterilization facilities and other related professional fees. See Note 16, &#8220;Commitments and Contingencies&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Represents non-cash accretion of asset retirement obligations related to Co-60 and gamma processing facilities, which are based on estimated site remediation costs for any future decommissioning of these facilities (without regard for whether the decommissioning services would be performed by employees of Nordion, instead of by a third party) and are accreted over the life of the asset.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.57pt">Represents non-recurring costs associated with the COVID-19 pandemic, including incremental costs to implement workplace health and safety measures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679359438088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 11, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>segment </div>
<div>subsidiary</div>
</th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=shc_UnnamedEBeamJointVentureMember', window );">Unnamed E-Beam Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_NelsonFairfieldIncNelsonFairfieldMember', window );">Nelson Fairfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price | $</a></td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_NumberOfSubsidiariesWithNonControllingInterest', window );">Number of subsidiaries with non-controlling interest | subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China | Subsidiary One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China | Subsidiary One | Nelson Fairfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China | Subsidiary Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems', window );"><strong>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage', window );">Percent of purchase of interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent , Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_NumberOfSubsidiariesWithNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Subsidiaries With Non-Controlling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_NumberOfSubsidiariesWithNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=shc_UnnamedEBeamJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=shc_UnnamedEBeamJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_NelsonFairfieldIncNelsonFairfieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_NelsonFairfieldIncNelsonFairfieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=shc_SubsidiaryOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=shc_SubsidiaryOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=shc_SubsidiaryTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=shc_SubsidiaryTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353924280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 212,148<span></span>
</td>
<td class="nump">$ 188,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Customer contract assets</a></td>
<td class="nump">14,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">5,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,056<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">157,069<span></span>
</td>
<td class="nump">140,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">55,079<span></span>
</td>
<td class="nump">47,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">131,151<span></span>
</td>
<td class="nump">117,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics | Point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">131,151<span></span>
</td>
<td class="nump">117,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics | Over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">25,918<span></span>
</td>
<td class="nump">23,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion | Point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">25,918<span></span>
</td>
<td class="nump">23,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion | Over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">55,079<span></span>
</td>
<td class="nump">47,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs | Point in time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs | Over time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 55,079<span></span>
</td>
<td class="nump">$ 47,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679358344840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 11, 2021</div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,152<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,106,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,115,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=shc_UnnamedEBeamJointVentureMember', window );">Unnamed E-Beam Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_BioScienceLaboratoriesLLCBioScienceMember', window );">BioScience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness', window );">Cash acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Liabilities incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_NelsonFairfieldIncNelsonFairfieldMember', window );">Nelson Fairfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="nump">$ 12,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss', window );">Step acquisition, gain</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount', window );">Mandatorily redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill deductible amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Estimated useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron | First Lien Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron | Employee Non-compete Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Finite-lived intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of a business when the cash held by the acquired business exceeds the cash payments to acquire the business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount that would be paid, determined under the conditions specified in the contract, if the holder of the share has the right to redeem the shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=shc_UnnamedEBeamJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=shc_UnnamedEBeamJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_BioScienceLaboratoriesLLCBioScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_BioScienceLaboratoriesLLCBioScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_NelsonFairfieldIncNelsonFairfieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_NelsonFairfieldIncNelsonFairfieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355501032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 1,106,728<span></span>
</td>
<td class="nump">$ 1,115,936<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">51,904<span></span>
</td>
<td class="nump">69,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangibles</a></td>
<td class="nump">42,700<span></span>
</td>
<td class="nump">16,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">18,158<span></span>
</td>
<td class="nump">13,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet', window );">Working capital, net</a></td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">1,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate', window );">Investment in unconsolidated affiliate</a></td>
<td class="nump">8,700<span></span>
</td>
<td class="nump">12,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Assumed long-term liabilities</a></td>
<td class="num">(2,248)<span></span>
</td>
<td class="num">(2,248)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet', window );">Working capital, net</a></td>
<td class="num">(15,144)<span></span>
</td>
<td class="num">(5,846)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total estimated purchase price</a></td>
<td class="nump">105,187<span></span>
</td>
<td class="nump">$ 105,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>Measurement Period Adjustments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Goodwill</a></td>
<td class="num">(17,142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles', window );">Intangibles</a></td>
<td class="nump">26,273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment', window );">Property, plant, and equipment</a></td>
<td class="nump">4,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet', window );">Working capital, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate', window );">Investment in unconsolidated affiliate</a></td>
<td class="num">(4,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther', window );">Assumed long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet', window );">Working capital, net</a></td>
<td class="num">(9,298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred', window );">Total estimated purchase price</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Investment in Unconsolidated Affiliate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets (Liabilities), Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment in Unconsolidated Affiliate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=SL65897772-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350771176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro Forma Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Net revenues</a></td>
<td class="nump">$ 194,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (889)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679350537560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSupplies', window );">Raw materials and supplies</a></td>
<td class="nump">$ 29,512<span></span>
</td>
<td class="nump">$ 29,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">1,371<span></span>
</td>
<td class="nump">846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">2,617<span></span>
</td>
<td class="nump">4,256<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Inventories, gross</a></td>
<td class="nump">33,500<span></span>
</td>
<td class="nump">34,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Reserve for excess and obsolete inventory</a></td>
<td class="num">(125)<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 33,375<span></span>
</td>
<td class="nump">$ 34,093<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355675704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">$ 25,356<span></span>
</td>
<td class="nump">$ 22,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid business insurance</a></td>
<td class="nump">7,421<span></span>
</td>
<td class="nump">10,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidRent', window );">Prepaid rent</a></td>
<td class="nump">1,212<span></span>
</td>
<td class="nump">1,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Customer contract assets</a></td>
<td class="nump">14,133<span></span>
</td>
<td class="nump">12,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceSettlementsReceivableCurrent', window );">Insurance and indemnification receivables</a></td>
<td class="nump">2,751<span></span>
</td>
<td class="nump">2,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Current deposits</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_PrepaidMaintenanceContractsCurrent', window );">Prepaid maintenance contracts</a></td>
<td class="nump">432<span></span>
</td>
<td class="nump">404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValueAddedTaxReceivableCurrent', window );">Value added tax receivable</a></td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">2,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_PrepaidSoftwareLicensingCurrent', window );">Prepaid software licensing</a></td>
<td class="nump">1,299<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Supplies', window );">Stock supplies</a></td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">2,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">11,762<span></span>
</td>
<td class="nump">8,020<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 69,758<span></span>
</td>
<td class="nump">$ 64,964<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_PrepaidMaintenanceContractsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Maintenance Contracts, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_PrepaidMaintenanceContractsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_PrepaidSoftwareLicensingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Software Licensing, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_PrepaidSoftwareLicensingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceSettlementsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceSettlementsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValueAddedTaxReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValueAddedTaxReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679358720072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 1,115,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Changes due to foreign currency exchange rates</a></td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,106,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_BioScienceLaboratoriesLLCBioScienceMember', window );">BioScience</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">8,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember', window );">Iotron</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">69,046<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="num">(17,142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">51,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">683,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Changes due to foreign currency exchange rates</a></td>
<td class="num">(2,252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">664,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics | BioScience</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics | Iotron</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="num">(17,142)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">287,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Changes due to foreign currency exchange rates</a></td>
<td class="nump">3,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">291,340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion | BioScience</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion | Iotron</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">144,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Changes due to foreign currency exchange rates</a></td>
<td class="num">(1,657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">151,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs | BioScience</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">8,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs | Iotron</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_BioScienceLaboratoriesLLCBioScienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_BioScienceLaboratoriesLLCBioScienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=shc_IotronIndustriesCanadaIncIotronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679280115800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Intangibles (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">$ 1,011,044<span></span>
</td>
<td class="nump">$ 977,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">463,231<span></span>
</td>
<td class="nump">442,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">108,759<span></span>
</td>
<td class="nump">107,966<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total</a></td>
<td class="nump">1,119,803<span></span>
</td>
<td class="nump">1,085,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Regulatory licenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 82,807<span></span>
</td>
<td class="nump">81,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LicensingAgreementsRenewalTerm', window );">Renewal term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trade names / trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 25,952<span></span>
</td>
<td class="nump">26,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">662,509<span></span>
</td>
<td class="nump">634,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">322,685<span></span>
</td>
<td class="nump">309,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Proprietary technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">89,604<span></span>
</td>
<td class="nump">90,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">39,707<span></span>
</td>
<td class="nump">38,075<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">105<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=shc_LandUseRightsMember', window );">Land-use rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">9,454<span></span>
</td>
<td class="nump">9,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1,364<span></span>
</td>
<td class="nump">1,311<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=shc_SealedSourceAndSupplyAgreementsMember', window );">Sealed source and supply agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">243,660<span></span>
</td>
<td class="nump">240,791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">98,237<span></span>
</td>
<td class="nump">92,953<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross&#160;Carrying Amount</a></td>
<td class="nump">5,675<span></span>
</td>
<td class="nump">1,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 1,138<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LicensingAgreementsRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing Agreements, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LicensingAgreementsRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=shc_LandUseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=shc_LandUseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=shc_SealedSourceAndSupplyAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=shc_SealedSourceAndSupplyAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679358303592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 22,282<span></span>
</td>
<td class="nump">$ 19,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-lived intangible assets, remaining amortization period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 22,300<span></span>
</td>
<td class="nump">19,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other | Cost of Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">5,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other | Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="nump">$ 14,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355063080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Future Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">For the remainder of 2021</a></td>
<td class="nump">$ 65,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">80,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">80,659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">79,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">41,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">198,736<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 547,813<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679362412072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee compensation</a></td>
<td class="nump">$ 27,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Legal reserves</a></td>
<td class="nump">2,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_AccruedInterestExpenseCurrent', window );">Accrued interest expense</a></td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Embedded derivatives</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">13,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedUtilitiesCurrent', window );">Accrued utilities</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedInsuranceCurrent', window );">Insurance accrual</a></td>
<td class="nump">1,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes</a></td>
<td class="nump">3,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">3,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,747<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 56,373<span></span>
</td>
<td class="nump">$ 60,518<span></span>
</td>
<td class="nump">$ 60,518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_AccruedInterestExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Expense, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_AccruedInterestExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedInsuranceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedInsuranceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedUtilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedUtilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 55<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=116646759&amp;loc=d3e15243-108350<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354349304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="nump">$ 1,864,159<span></span>
</td>
<td class="nump">$ 1,863,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less unamortized debt issuance costs and debt discounts</a></td>
<td class="num">(26,579)<span></span>
</td>
<td class="num">(38,761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt</a></td>
<td class="nump">1,864,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, less debt issuance costs and debt discounts</a></td>
<td class="nump">1,837,580<span></span>
</td>
<td class="nump">1,824,789<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember', window );">Term Loan | Term loan, due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="nump">1,763,100<span></span>
</td>
<td class="nump">1,763,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior notes, due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=shc_OtherLongTermDebtMember', window );">Other long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="nump">$ 1,059<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=shc_OtherLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=shc_OtherLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353105448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Senior Secured Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2021</div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Jan. 19, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 17, 2020</div></th>
<th class="th"><div>Dec. 16, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,864,159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,863,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member', window );">Term loan, due 2026 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,763,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,763,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.73%<span></span>
</td>
<td class="nump">6.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates', window );">Effective reduction in current interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member', window );">Term loan, due 2026 | Term Loan | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DebtInstrumentVariableRateFloor', window );">LIBOR floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount', window );">Write-off of unamortized debt issuance costs and debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DebtIssuanceCostsRefinancingAdditionalExpense', window );">Additional expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member', window );">First Lien Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member', window );">First Lien Notes due 2026 | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DebtInstrumentVariableRateFloor', window );">LIBOR floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member', window );">First Lien Notes due 2026 | Secured Debt | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member', window );">First Lien Notes due 2026 | Secured Debt | Alternative Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member', window );">First Lien Notes due 2026 | Secured Debt | Eurodollar | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member', window );">First Lien Notes due 2026 | Secured Debt | Eurodollar | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 347,500,000<span></span>
</td>
<td class="nump">$ 190,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Unused borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 281,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Senior Secured Credit Facilities | Alternative Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Senior Secured Credit Facilities | Alternative Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DebtInstrumentEffectiveReductionInCurrentInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Effective Reduction In Current Interest Rates</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DebtInstrumentEffectiveReductionInCurrentInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DebtInstrumentVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DebtInstrumentVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DebtIssuanceCostsRefinancingAdditionalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Issuance Costs, Refinancing, Additional Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DebtIssuanceCostsRefinancingAdditionalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of Deferred Debt Issuance Cost and Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679370031768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - First Lien Notes (Details) - First Lien Notes due 2026 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Capitalized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DebtInstrumentVariableRateFloor', window );">LIBOR floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DebtInstrumentVariableRateFloor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Variable Rate Floor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DebtInstrumentVariableRateFloor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_FirstLienNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679359448184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Repayments of Debt (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 24, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs and debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,579<span></span>
</td>
<td class="nump">$ 38,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_SecondLienNotesMember', window );">Second Lien Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_RecognitionOfDebtPremium', window );">Write-off of debt premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=shc_TermLoanAndSecondLienNotesMember', window );">Term Loan and Second Lien Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt issuance costs and debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,900<span></span>
</td>
<td class="nump">$ 28,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember', window );">Term Loan | Second Lien Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 770,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember', window );">Term Loan | Term loan, due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 341,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="nump">1,568,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="nump">53,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock (in dollars per share)</a></td>
<td class="nump">$ 23.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased', window );">Number of additional shares to be repurchased (in shares)</a></td>
<td class="nump">6,990,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_RecognitionOfDebtPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recognition Of Debt Premium</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_RecognitionOfDebtPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Number of Additional Shares To Be Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_SecondLienNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_SecondLienNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_TermLoanAndSecondLienNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_TermLoanAndSecondLienNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=shc_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354843976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Aggregate Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LongTermDebtMaturityAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,863,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 1,864,159<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LongTermDebtMaturityAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Maturity, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LongTermDebtMaturityAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355251848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">21.40%<span></span>
</td>
<td class="num">(86.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct', window );">Limitation on deductibility of interest expense</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current income tax benefit</a></td>
<td class="nump">$ 9,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Reversal of valuation allowance</a></td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LimitationOnDeductibilityOfInterestExpenseCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Limitation On Deductibility Of Interest Expense, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LimitationOnDeductibilityOfInterestExpenseCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354063848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Net Periodic Benefit Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Defined benefit pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(3,557)<span></span>
</td>
<td class="num">(3,599)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">197<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(1,379)<span></span>
</td>
<td class="num">(1,119)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other benefits plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109237824&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679362419160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefits - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears', window );">Expect funding requirements in each of the next five years</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Defined benefit pension plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">$ 42,600<span></span>
</td>
<td class="nump">$ 41,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Defined benefit pension plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue', window );">Solvency payment as percent of market value</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Annual Funding Requirements For Next Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Letters of Credit, Solvency Payment as Percent of Market Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679358733896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="nump">$ 454,574<span></span>
</td>
<td class="num">$ (641,132)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="nump">465,744<span></span>
</td>
<td class="num">(715,632)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="num">(93,842)<span></span>
</td>
<td class="num">(94,387)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(3,595)<span></span>
</td>
<td class="num">(74,052)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">275<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(3,320)<span></span>
</td>
<td class="num">(74,239)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="num">(97,162)<span></span>
</td>
<td class="num">(168,626)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Defined Benefit Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="num">(44,143)<span></span>
</td>
<td class="num">(27,113)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(524)<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(249)<span></span>
</td>
<td class="nump">2,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="num">(44,392)<span></span>
</td>
<td class="num">(24,906)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="num">(49,699)<span></span>
</td>
<td class="num">(67,453)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(3,071)<span></span>
</td>
<td class="num">(72,967)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(3,071)<span></span>
</td>
<td class="num">(72,967)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="num">(52,770)<span></span>
</td>
<td class="num">(140,420)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(187)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,479)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3,300)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353013032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=shc_A2020OmnibusIncentivePlanMember', window );">2020 Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-1 | Year One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-1 | Year Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-1 | Year Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-1 | Year Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-1 | Year Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Pre-IPO B-2 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_CashProceedsToSponsorsRatioToInvestedCapital', window );">Cash proceeds to sponsors, ratio to invested capital</a></td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | 2020 Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 2020 Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_CashProceedsToSponsorsRatioToInvestedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Proceeds to Sponsors, Ratio to Invested Capital</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_CashProceedsToSponsorsRatioToInvestedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=shc_A2020OmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=shc_A2020OmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=shc_PreIPOB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=shc_PreIPOB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=shc_ShareBasedPaymentArrangementTrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=shc_ShareBasedPaymentArrangementTrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=shc_ShareBasedPaymentArrangementTrancheFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=shc_ShareBasedPaymentArrangementTrancheFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=shc_PreIPOB2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=shc_PreIPOB2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355337832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Pre-IPO Awards (Class&#160;B-1 and B-2) (Details) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Pre-IPO B-1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,201,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(43,361)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(228,862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,929,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Pre-IPO B-2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">2,323,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(254,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">2,068,494<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=shc_PreIPOB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=shc_PreIPOB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=shc_PreIPOB2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=shc_PreIPOB2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679370023064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">2,389,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">20,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(9,316)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">2,400,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in shares) | $ / shares</a></td>
<td class="nump">$ 23.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">26.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">23.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in shares) | $ / shares</a></td>
<td class="nump">$ 23.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679355647048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - RSUs (Details) - RSUs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">771,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">10,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(24,999)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">757,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">26.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">23.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 23.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353795496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Earnings (Loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 11,065<span></span>
</td>
<td class="num">$ (1,986)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">223<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Allocation to participating securities</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Less: Allocation to participating securities</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to Sotera Health Company common shareholders</a></td>
<td class="nump">10,685<span></span>
</td>
<td class="num">(1,964)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss) attributable to Sotera Health Company common shareholders</a></td>
<td class="nump">$ 10,685<span></span>
</td>
<td class="num">$ (1,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted Average Common Shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic (in shares)</a></td>
<td class="nump">278,827,000<span></span>
</td>
<td class="nump">232,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of potential common shares (in shares)</a></td>
<td class="nump">141,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">278,968,000<span></span>
</td>
<td class="nump">232,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings (loss) per Common Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) attributable to Sotera Health Company common shareholders - basic (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) attributable to Sotera Health Company common shareholders - diluted (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options | 2020 Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">2,400,349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 2020 Omnibus Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">3,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=shc_A2020OmnibusIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=shc_A2020OmnibusIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353865688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">31 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 17, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>May 19, 2020 </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Mar. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Oct. 22, 2010 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>plaintiff</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence', window );">Loss contingency, insurance limits per occurrence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability', window );">Loss contingency, insurance limits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationIllinoisMember', window );">Ethylene Oxide Tort Litigation - Illinois</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of claims dismissed | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationIllinoisMember', window );">Ethylene Oxide Tort Litigation - Illinois | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationGeorgiaMember', window );">Ethylene Oxide Tort Litigation &#8211; Georgia | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of new claims filed | claim</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_PercentOfReductionInResidentialPropertyValueAssessment', window );">Percent of reduction in residential property value assessment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesByNatureAxis=us-gaap_PositiveOutcomeOfLitigationMember', window );">Positive Outcome of Litigation | Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Gain Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_GainContingencyPeriodOfBusinessInterruption', window );">Period of inability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest', window );">Amount awarded from other party, before pre-judgment interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount awarded from other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,800,000<span></span>
</td>
<td class="nump">$ 56,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LitigationSettlementCostsAssessedAndAwardedInFavor', window );">Costs assessed and awarded in favor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor', window );">Disbursements assessed and awarded in favor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 161,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_GainContingencyPeriodOfBusinessInterruption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain Contingency, Period Of Business Interruption</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_GainContingencyPeriodOfBusinessInterruption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded From Other Party, Before Pre-Judgment Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LitigationSettlementCostsAssessedAndAwardedInFavor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Costs Assessed And Awarded In Favor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LitigationSettlementCostsAssessedAndAwardedInFavor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Disbursements Assessed And Awarded In Favor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Undiscounted Amount Of Insurance-Related Assessment Liability Per Occurrence</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_PercentOfReductionInResidentialPropertyValueAssessment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent Of Reduction In Residential Property Value Assessment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_PercentOfReductionInResidentialPropertyValueAssessment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The liability as of the balance sheet date representing required funding mandated by statute or regulatory authority that is related directly or indirectly to underwriting activities, including pools for self-insurance and excluding premium taxes and income taxes. The funds derived from the assessments generally enable a government guarantor to pay insurance claims in the event that the underwriting insurer is insolvent or otherwise unable to meet its payment obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 405<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392405&amp;loc=d3e24119-109301<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 405<br> -SubTopic 30<br> -Section 15<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99384745&amp;loc=d3e23169-109297<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationIllinoisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationIllinoisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationGeorgiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=shc_EthyleneOxideTortLitigationGeorgiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesByNatureAxis=us-gaap_PositiveOutcomeOfLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesByNatureAxis=us-gaap_PositiveOutcomeOfLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352837384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Financial Risk - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
<th class="th">
<div>Oct. 31, 2017 </div>
<div>USD ($) </div>
<div>instrument</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivative loss, net of tax recognized in accumulated other comprehensive income (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (3,479,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for uncollectible accounts</a></td>
<td class="nump">603,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 708,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivative loss, net of tax recognized in accumulated other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value of outstanding contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives Designated in Hedge Relationships | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">2,577,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,583,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 2,500,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="nump">$ 1,500,000.0<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DerivativeOptionPremium', window );">Option premium</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_PercentOfBorrowingLimitationDueToCashFlowExposure', window );">Percent of borrowing limitation due to cash flow exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap | LIBOR | Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap October 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap June 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNumberOfInstrumentsHeld', window );">Number of instruments held | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives Not Designated in Hedge Relationships | Interest Rate Cap February 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_DerivativeNumberOfInstrumentsAmended', window );">Number of instruments amended | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DerivativeNumberOfInstrumentsAmended">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Number of Instruments Amended</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DerivativeNumberOfInstrumentsAmended</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_DerivativeOptionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Option Premium</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_DerivativeOptionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_PercentOfBorrowingLimitationDueToCashFlowExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percent of Borrowing Limitation Due To Cash Flow Exposure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_PercentOfBorrowingLimitationDueToCashFlowExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular group held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCapOctober2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCapOctober2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCapJune2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCapJune2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCap1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCap1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCapFebruary2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=shc_InterestRateCapFebruary2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353454920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Financial Risk - Derivative Instruments (Details) - Derivatives Not Designated in Hedge Relationships - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 2,577,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,583,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value, Derivative Asset</a></td>
<td class="nump">412,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value, Derivative Liabilities</a></td>
<td class="nump">229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">2,500,000.0<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="nump">1,500,000.0<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="nump">$ 400,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value, Derivative Asset</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value, Derivative Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Embedded Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional Amount</a></td>
<td class="nump">77,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair Value, Derivative Asset</a></td>
<td class="nump">403,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair Value, Derivative Liabilities</a></td>
<td class="nump">$ 229,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679280256872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments and Financial Risk - Activities of Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest Rate Cap | Interest Expense, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized loss (gain)</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember', window );">Embedded Derivative | Other Income, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized loss (gain)</a></td>
<td class="num">(853)<span></span>
</td>
<td class="nump">4,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Forward Contracts | Foreign Exchange (Gain) Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Realized loss</a></td>
<td class="num">$ (2,374)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ForeignCurrencyGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679352916744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments and Financial Risk - Assets and Liabilities Measured on Recurring Basis (Details) - Derivatives Not Designated in Hedge Relationships - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">$ 412<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="num">(229)<span></span>
</td>
<td class="num">(670)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Term loan, due 2026 | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Term loan, due 2026 | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">1,760,896<span></span>
</td>
<td class="nump">1,772,180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Term loan, due 2026 | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Senior notes, due 2026 | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Senior notes, due 2026 | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">97,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Senior notes, due 2026 | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Senior notes, due 2027 | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Senior notes, due 2027 | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Senior notes, due 2027 | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Other long-term debt | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Other long-term debt | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">1,051<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Other long-term debt | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Finance Lease Obligations (with current portion) | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Finance Lease Obligations (with current portion) | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">34,540<span></span>
</td>
<td class="nump">36,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Finance Lease Obligations (with current portion) | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Interest Rate Cap | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Interest Rate Cap | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Interest Rate Cap | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Embedded Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="num">(229)<span></span>
</td>
<td class="num">(670)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Embedded Derivative | Fair Value, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Embedded Derivative | Fair Value, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="num">(229)<span></span>
</td>
<td class="num">(670)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Embedded Derivative | Fair Value, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Term loan, due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">1,740,071<span></span>
</td>
<td class="nump">1,728,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Senior notes, due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">96,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Senior notes, due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Other long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">1,051<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Finance Lease Obligations (with current portion)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Long-term debt</a></td>
<td class="nump">34,540<span></span>
</td>
<td class="nump">36,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Interest Rate Cap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Carrying Amount | Embedded Derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liabilities</a></td>
<td class="num">$ (229)<span></span>
</td>
<td class="num">$ (670)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_TermLoanDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_OtherLongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_OtherLongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=shc_FinanceLeaseLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=shc_FinanceLeaseLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_EmbeddedDerivativeFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679358303592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Additional Information (Details) - segment<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nordion | Revenue from Contract with Customer Benchmark | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage</a></td>
<td class="nump">23.70%<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nordion | Revenue from Contract with Customer Benchmark | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">11.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nordion | Revenue from Contract with Customer Benchmark | Customer Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage</a></td>
<td class="nump">12.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=shc_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=shc_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=shc_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=shc_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=shc_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=shc_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679353034168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Segment Operating Results (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 212,148<span></span>
</td>
<td class="nump">$ 188,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember', window );">Sterigenics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">131,151<span></span>
</td>
<td class="nump">117,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember', window );">Nordion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">25,918<span></span>
</td>
<td class="nump">23,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember', window );">Nelson&#160;Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">55,079<span></span>
</td>
<td class="nump">47,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">212,148<span></span>
</td>
<td class="nump">188,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_SegmentIncomeLoss', window );">Segment income</a></td>
<td class="nump">105,317<span></span>
</td>
<td class="nump">91,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">20,942<span></span>
</td>
<td class="nump">12,989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Sterigenics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">131,151<span></span>
</td>
<td class="nump">117,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_SegmentIncomeLoss', window );">Segment income</a></td>
<td class="nump">68,461<span></span>
</td>
<td class="nump">61,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">19,514<span></span>
</td>
<td class="nump">10,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nordion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">25,918<span></span>
</td>
<td class="nump">23,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_SegmentIncomeLoss', window );">Segment income</a></td>
<td class="nump">13,786<span></span>
</td>
<td class="nump">13,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">1,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Nelson&#160;Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">55,079<span></span>
</td>
<td class="nump">47,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_SegmentIncomeLoss', window );">Segment income</a></td>
<td class="nump">23,070<span></span>
</td>
<td class="nump">17,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">939<span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="num">$ (10,500)<span></span>
</td>
<td class="num">$ (10,900)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_SegmentIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_SegmentIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_SterigenicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NordionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=shc_NelsonLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139679354590360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Reconciliation of Reportable Segment Amounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">$ 3,449<span></span>
</td>
<td class="nump">$ 1,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">14,312<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion of asset retirement obligations</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Sotera Health Company</a></td>
<td class="nump">10,842<span></span>
</td>
<td class="num">(1,964)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_SegmentIncomeLoss', window );">Segment income</a></td>
<td class="nump">105,317<span></span>
</td>
<td class="nump">91,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">21,282<span></span>
</td>
<td class="nump">56,562<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">37,661<span></span>
</td>
<td class="nump">36,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">3,449<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative', window );">(Gain) loss on foreign currency and embedded derivatives</a></td>
<td class="num">(336)<span></span>
</td>
<td class="nump">4,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_AcquisitionAndDivestitureRelatedChargesNet', window );">Acquisition and divestiture related charges, net</a></td>
<td class="num">(185)<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Business optimization project expenses</a></td>
<td class="nump">261<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Plant closure expenses</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">14,312<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Professional services relating to EO sterilization facilities</a></td>
<td class="nump">13,399<span></span>
</td>
<td class="nump">4,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetRetirementObligationAccretionExpense', window );">Accretion of asset retirement obligations</a></td>
<td class="nump">551<span></span>
</td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_shc_CostAndExpensesCOVID19', window );">COVID-19 expenses</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Sotera Health Company</a></td>
<td class="nump">$ 14,082<span></span>
</td>
<td class="num">$ (14,220)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_AcquisitionAndDivestitureRelatedChargesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition And Divestiture Related Charges, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_AcquisitionAndDivestitureRelatedChargesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_CostAndExpensesCOVID19">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost And Expenses, COVID-19</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_CostAndExpensesCOVID19</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Gain (Loss) and Gain (Loss) on Embedded Derivative</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_shc_SegmentIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">shc_SegmentIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>shc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligationAccretionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6392692&amp;loc=d3e7535-110849<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6392676&amp;loc=d3e7480-110848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligationAccretionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>86
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M:'ZBY3K;4)Q+K664':X$]X4R#\#]A93Z<&+^0;$G/?@74$L#!!0    ( )F
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MD,6)P'@0& <%OBL*?8#(09(H%(3QH5)+4D-"TQLB*T@[W1*%!$8.-:S^+A^
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MCU@S[YA<E*5IYB#"M6($9X'H9P/T6!QZRQ\8Q07B#5J)C:QK^ZVM;H26RHM
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M"EX*;0W@^[52S>F-?4#_UP_7_P%02P,$%     @ F8"M4GYPZ29]!0  8!<
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M#TF3V]>YVQLE5M7+P2]"*9%5ETO.P/]* 'R_$$+M;LKWC<U+]?G?4$L#!!0
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ML+Y?ELA< 68KGAI!.AQKO*Y09N6VV>32!=PI>MQ0_214; 960]<63*Y<HHM
M-VR6SM8<20<>9%N,]H(TH.G@BSVS%8C;<"OOFC0K\@1E7QX@2#VB+TC'\+R(
M!IB&D4T[($0D[GMA6EQQ*)U<6503#DV1''%;<I%\C)]'4%G"<4*[!S(FCM:)
M\2@G]^,>C<:F434\W%>IS(7R.9( 25(/X#P%[K#^JFL"\'K'Y^3WU;-I1L\@
MC+:3]%G<,0L_VT;E].)X M9=HTY:E9MM[+T^X'%Y3_$!2WQ2Y59F37%?4R7-
M$#4Y^AKCF@>2:>L%Y@"3HCNT:XD1GBI0<//G6CB$M.=MO.\]:IW#P@AM4[/B
M*>&/ZV$4%0;5TX>F4G<N> PXG#F1M:($@SM@IR?IIA*C9YHX57^;"H[7>+H\
MG-G<'($9B4[ J?; :(PVG1('1VAD#L_CC>29++F;M"R^AXZ1%C^2CH?N5>/>
M/9:/]7A;Q_6"ZYBNM+O5W0?!+-V#]^+I:P+H FY/6I90G8Q>G S(I1MZ>@FV
MB;?BA0VX8\?'"A\UTK$ ]DMKP_:%'>P^DR[^ U!+ P04    " "9@*U27 T,
M*R8$  #'"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6RE5EUOVS84
M_2L77C!L@&!+BAT[F6,@23=TP-H%2;L^#'N@I6N)*$5Z)!TG^_4[I#YJMVF&
MH2\2O^[A/>?>2W*Y-_:CJYD]/39*N\M1[?WV8C)Q1<V-<&.S98V9C;&-\.C:
M:N*VED49C1HUR=/T;-((J4>K91R[M:NEV7DE-=]:<KNF$?;IFI797XZR43]P
M)ZO:AX'):KD5%=^S?[^]M>A-!I12-JR=-)HL;RY'5]G%]32LCPO^D+QW!VT*
M3-;&? R=7\O+41H<8L6%#P@"OP>^8:4"$-SXN\,<#5L&P\-VC_Y+Y XN:^'X
MQJ@/LO3UY6@QHI(W8J?\G=F_YH[/+. 51KGXI7V[=CH?4;%SWC2=,3QHI&[_
MXK'3X<!@D7[%(.\,\NAWNU'T\I7P8K6T9D\VK 9::$2JT1K.21V"<N\M9B7L
M_.J.'UCOF.ZX,)660:GEQ ,X3$^*#N2Z!<F_ G)*;XSVM:.?=<GEL?T$#@U>
MY;U7U_F+@&^$'=-IEE">YMD+>*<#R].(=_H?+#?6-'0#7RVR 4K[FFZBQFSI
MSZNUB^-_O;#A=-AP&C><?INL_QN$WM5@811J2>J*O%@K)E>;O:-2.E%5EBOA
MN22->K:MO6MI%QUMU_+F1\]6"]4E&5M'ZR?RL@FX9M,;D]!EF'!<H10]]K;D
MX8.O+3,U;=@YA)T0M*(>HA8-T4@OZ =?FYU#WP7@]^/[,96@(*S[$7P"SF'Z
M?(YS#S]EQ5H6CMX:6P85WK)R^/TFUBZ$TQDERTC[UD@X*74@PG1"&6"R6896
M/DO.LP4:WW^WR+/\IS YFR?IV3G]_H#P1X-^KO_/9DDZ/^]_[XR'7L^"=BLP
MDN5)-EU\$^?T&SEG\R1?I,&9T^0LGQUSGJ;)>3I[@?,4UN>S_C=P_A*T6X&Y
MQ2+!)?"IL*Z%$KI XEU%]L<!36)FO.*"FS5\Z#DG0X*2<(Z1IE(7:A?$ 35<
M.%LA2V0M;B,'Y(!AD(@6^6MMR,S."A*%_#Q2J/.'[L,QZ<@'3A@6VZTUCQ)'
M.ZLG.LFFXPQ'K%+QM@#^29:/Y_U(@HIP6XZ7B'J*/1S\H5AB=?7E8MM:_0?P
M9I 8!/@1>D0U@G>B,3NXO 8T%GH3!_M"'-.'FC7M(QACNZ",DR5;$8^ N)\8
MED,;&8H2(%9HMV%K@U>5,2'W</^R?9 A&#MD6E>\;)OHBR ')=P@?=+MBI0+
M5QN@X%Y'#7.U1!P1"7"'XBXXT<=,20$VTC^-$=ICPT'OD[-Q>BSPV:'B_KD3
MY)D\.8P#M#K0_ N?26S E812GP<H*EE8&0I-D+ XR]B/GSOY)P>7*^2NXA,B
M2(8(MO?L,#J\4J[:R_G3\O:) WZ5U(X4;V":CN>S$=GVV=!VO-G&JWIM/&(;
MFS5>6FS# LQOC/%])VPPO-U6_P)02P,$%     @ F8"M4NTD#?C("@  5AP
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M8U>RI,</[T-^.HR3#G!1[=":%SA;0F#-/RWSX4F:5Q1"/*OY\R/V-T 7&B3
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MI:A:ESN.)R_QMA%J(TZ>WT7*Y&P8MT@A!0[[DP.I^H /^XV,V"OH+:3"$24
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M>J+93[O0A^!Y'<E +[[:-"'M\B<<1GC6,P1&,FLAT,;R0*#>_!XA/M4D?O8
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M]'UCJCSK@.(FK<@,)J0"+&\90["*4FX$R7Q_R%XMR.\P#>VP'!V2"1NV'H9
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MHY"?U5=4@E1]%A7:7 <8%*&)7'B*?^HY]4)# 0U;W,&@Q:*\1B?]KJQA G=
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M3%2&UT)VGC ^W4Y[GDW%W&2;-+3]@&I\UG^0]*2'4I1KEP%)]5VCBX&9S1K
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MDVPGDTR4G0^V[9W!H%4F_<O'7H<#A[/\&8>B=R@B[Q0HLGPK@YQ/G=T(Q]9
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M8CRT]Y/U?G\2$]9#C]H(%#D%&S.=]LF-(>*VB*Z_Y53#@&XWY YL+YONT=
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MBM8'L+\TAHZ&3S"LY,434$L#!!0    ( )F K5(B<3$;%00  #D+   9
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M#U0_J/4+(ULW'&VDP5'+B17.MDQ9!3S?2FD."WO!."VO_@%02P,$%     @
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M>K4BT*S(Q2 *8',5$"1E\0"954K4@21V7IQ#/$PGM%%+:.Z,7\(D;8AU9&8
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MUT=ZX4.->\@EM7(U9+,KLK+9 ;ENI%"LP%.46*5WH,;QD",* NG+@8#8E9N
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M+<#W*TLE2'E#!Z0?E_GIOP%02P,$%     @ F8"M4F16='82#0  :R@  !D
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M<%G&V4,)%%][=VU38JX9O#0B[(H Z.XD#(U-=I+%">7)OH\<^(<ZAE2_#+\
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M$H+J%?W-76JR6FSJD3QTQ]\T=I6BSN%UP=AU,]W.B+C:6@/H 2OP0*5WC'3
M2#UMIN^&*06-6^-5S)4G!76+_FT<W=[0UBR1>[<Q&WTQW?._PR\1Y%'T!4IZ
M'2I6LI>DEBTH@>R;B0M-C8-N;,ZV/&@K]SYWV C<V$)^M"9?KG@,RM6;!RU+
M<N_=Y^:#*9B$8# ).V0-WA<ZL8+>W^[XT&L0OV'^PCX\)Q33F0%W]3-LQD<4
M7@\C.>S[S=%I] ,P]*-+_IE;D/Y!?@O6/FU_2?=2?D"V6RX_PT/97U*D96:!
MK6@GSX[0 /%/V^2F=&O^.=G<E6A^^7)E %4\+<#[A4/:JF_H@/;WA2_^"U!+
M P04    " "9@*U2YNGC$]\+  !T'@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R-2YX;6RU6=MRVS@2_164-]FQJFA:I.Z32U7BS.QX=RZI>"X/6_L D:"$
M"45H -*RYNOW= .D*$5Q,IO:%UNB@$;WZ=MI\/G.V/=NK50M'C9EY5Y<K.MZ
M^_7UM<O6:B-=;+:JPB^%L1M9XZM=7;NM53+G39OR.AT.I]<;J:N+E\_YV5O[
M\KEIZE)7ZJT5KMELI-V_5J79O;A(+MH'[_1J7=.#ZY?/MW*E[E3]R_:MQ;?K
M3DJN-ZIRVE3"JN+%Q:ODZ]=C6L\+?M5JYWJ?!5FR-.8]?;G-7UP,22%5JJPF
M"1+_[M6-*DL2!#7^"#(ONB-I8_]S*_U;MAVV+*53-Z;\3>?U^L7%_$+DJI!-
M6;\SN^]4L&="\C)3.OXK=GYMNK@06>-JLPF;H<%&5_Z_? @X]#;,AQ_9D(8-
M*>OM#V(MW\A:OGQNS4Y86@UI](%-Y=U03E?DE+O:XE>-??7+.[4"Q+6XK;R#
M@=3SZQJ"Z>?K+ AY[86D'Q$R$C^8JEX[\4V5J_QX_S44ZK1*6ZU>IX\*_$':
M6(R22*3#-'E$WJBS<L3R1I^P\IW:&EOK:B7^_6KI:HN8^,\CXL>=^#&+'W\9
MB']9B/A-"9WCH2[VPC16(!>M9/V=7^TX)'.!M?5:B9W<BYU"?%1(J$BH>UDV
MLE9"5KG05:UL)<MRCV0B&%CBLG'0PSF?'KK6R@F<+[:-W1J'+Z80V&,R?ZQ5
M#KLR/">1TF&%H^?0B[6N,A63UFMYKZ"152H<)I>EZI3^6MQ!%[U2E<Y<)'XT
M-N<,A<@?5>GP\7NY= =!N<)R!#\9"IW/2 PP-%L6$Q1C.*$_2I:L])\,J2P%
M_-YD=6,!D%/V7F?0=+]54.0$)E2YK;006^@*EFG>"SCYQ%C\!%6RM59%SRVY
MRC37JXU\KVSG -<'R$/G,<4O!T@[5U8HQE;=JZH)0 <SH5QF-A!00$=VN"HU
M</'! DM9>2S9RFK?\V@L?L9:F66FJ5C-K2EUIKUW/X8H+.<CG*03'3XC'F"@
MRZQ>*@(*CD-L(4O__K=YF@Z?W>E5I0N=26CZZG#8VW 8KTJ>M6<BM8>"*JM(
MAE?_BOLAP>KVO[?V;ZVY1T) [Z;VJ.7"AP;[!AO*X&?O2VMEKOWWX&H?W637
M1N50M81%]#P2V[6$?S+5U/0XPCH#X&6AZKWW6'Y/WL.'[18&L50'/]OWBJ*A
M#>+VOP:"8E6:)8X(:ELR_<9<38<L<"71!SL=C44 [M8Z6S/R[]5>D"--Q<ZH
M#>OLMQP;"N$PBS0XI,[1YW.@;71FS5*;TJP8!#80(.[9>$&M7R-/]D#7L1,#
M MH9//P$EKP8PH\11<#DZ&>6X_';L-&7B(WO'HJZAT#M!P9M\8_"$M\*E74A
M5K%PI^NU]G6O!?V0)SE"/V_::H<<PV/L289/40YP(""&,SB^_1Z*SF3VC*"N
MH6P_!3E]W(D.G<AT%,^>DK+Q\*DO(4D:IT];\5[<Z2'JP5>9XU0O/A>5SP=P
M" !WYO\/WU=_';AD#N \8$D\/0_85U\*U3 6EZA<C<,Y7.Y^B>]BD9NRE-8-
MH!]M[[.7$Z2/RE"7X[WLND$50('+)9GT8U_%2SD03T0"2<DDP:=T$BV2.3Y,
M)M%PMJ G21HEX[FX.R[OE\N!F,ZC\33![F@VGR+&L&,(^"?1*)F)&[G5!))Z
M #?/-?4R)Y)%-$G&8CQ?B,5H >6CQ3C]I('#+S<PF47I?$CFC*)I.L&',9XL
MZ$,RGT<8#\X:F$3#!1LX3%,!&3,8N$BB^7ST$?O((& 0I:.QF"<3I%FT@+&D
MQ;NN65IUB' *F+8IMJ'M9*E"[SZ->JLR@P;V)W8^28;Q!$6R+-M60D\6W1-=
M]2+1FHT72U6:.MNYSO79J<VG^<2%U5O%4TNYISHH:^HJE2%5"QIK?!<^RHN0
MT;Z7RZ6Y!Q^[_0  5J>OY@GU8APU>@TM@2-H^=+4:Z(QVN0 D%QXXE7H9BJF
M3=QOF,E(U@[$1G<][!.4B?NV>]R).*'0U'1O#%BJ)89[D,=!XX*-ZD%E#2$8
M.#%MCWI,*(+@ ]VN5;:NJ"<"[E*MB 6L&VP\<#2X :.O:RQ69-WA:'N8;K=>
M>"T?(J+/V5HZ/H$L\C2!&RF0;<E?WF)RALUS%0QN11WEKT1K:^^LG III@]<
M1VYHL@F<(& @EOLN .E<'SJ@&_"2O)>Z]%%"N[M? ^R.J"]4Q,K/\ELL7G$"
M@2:7NN.C)[P5DK)^-6G+06D<:O%2%=17@!_%L2/.6:!.FQWFA2^KX;[.'>OR
MI*NF3]JR\SW/0?GOZ%9A3.', 0-J 8TX',%*TGDJ)M-H,DW%FT<]0=5I-(NF
MJ.6C*4K=2-R!%:DK[VAB>) ;EB*E1M%XO$"-FZ&.7OY#ZFH@"!R*" ('!!O-
MU%I599Z4J@VH.%D,=JGO)44ZZG(V$)>CT70@QE$ZG8&+_]' 59V".:VJN:S"
M9R6[ M%J5Q3?9.!E#@')?#(0B\58O&Y'1+.M,6T<:.?O*$&'=+M4 Y%2RXJ&
M,.%M25- !N7IE,.B8B F:$NS62*^#X:AP2.>H.&Z'=ARM802JX%(QO!0RO-%
MDCX3;Y'W-'#Z,:XEH6P"123"ZYN?3MAQ(2D@>:R]7 ^HW8P6"^"2C*<THUC5
MABKGEJ#O5GD]EJ5>!<]H:(T>/EX,Q<U/O]Z^N4H6/9M^A^$0.IL>]\I'HOL)
M639$##T!SG!2.AQPI-Q66=D053]*[VYJ6*L2X56?3 [<PW2M0E5^UU(L:A75
M52;=6KB/Q5PP(N:8Z>WDV;(HX&!.. *@*&EJ#F.//A./Z@%!5*T04S37H@9:
MC;*GF4*6;;4C<*E^JM;71R-K:61%QE>&IUK?W\(!/*Y"+^JC*,FN63H-\VV8
M+$&K1=%461CR#YM\ ;[4,*'#@\KQ56VN"JFMH!F=Z>S99.I'5Z8P)+-&GL_Z
MV;S!/$C#6L7W28X<%*A%S)G4@Y5P;(7D"#3DC[]SR#P@I+AQM>LC5O/HWF4P
M^^.U-G>PC2X3(,G/2;>FMIZ:_+.!/ESS3MOZM["WT!1%O UL]%)SR+&!.*C0
M%M7NCT9:NF'@XKDB9</]$GIA3J.J=VJNU(8["'!E\U&129!NJZ9T9^X+QMU]
M0:\NM9<# ^^M%J,6!I*XLB%D"T1>S>U!4F-NRMJ/#G0]T0<J\D[G4):V@F:(
M6\19QNM[KN^5?%2QAP,>)+''"L/$=*[3#H(FM(\)(9W:WJT1+R6]@%@7C*28
M1;#KX\N)]H('B[I@S56A+%U#E<@<U2UQSE"!"'IYUJ?LQK5S5+_*AT<_A#']
MUID:C=P=;O]".,1<Q7L!N^U7W$)1-K6!WEZ\=&U%/>C:AR]=K-V#)[2773YM
MMW)/$=(N.?S@0_[4H.79ML/1@?7@L??LT="'CA.5C.W'#.SOI4'$O]\A&*T4
MWRE9XC2KEM W9\+6NV5MKPJ)-J$=5)Y*'4SR=R\@\FLRMB6GK%#,S>YQ+/\'
MF [Y:JJ5H?\^+&@=F"YZW?[0FLX%2=N30TS\IHEB+:TQ[U%#*($-N%=HF_N8
MVW#/B$XT]&@X*JD>FJH*;UFZ8VC2UQGKZ>_[?D:XH.=+7Z)DA1JS]Q7F8!*(
MN2H)?'5"HR #XD#HF1IHYYH.M5P[9O,>GYC;_&.H]VLK,8/0XT^A(I4?8Q,'
MO[3R/C@I!N=4X9)TVE6]&[/9Z%!M2 @X \6:;U;M'6G,K>)<*Y>?25J.[#R]
M= QQR]6J,ZE__=C-(51"-BR&* :W[Y9S^'BD*8M:=]%PGF J(/L8AN#\FN^
M^D2, #8-*;Z2-F<1N[4*O?U#&5UUW)D&K6NIVMMT:(4)1VVVI=DK?YL=.B_-
M=7"=S.D9UD@(UC@*0TV]'W0CCP>3++T/9Y>ZZ%*#T8V9WYUX DT!P4^ZG:]=
MM+LCBF VN=KH+.H%^H<='UY"<RJ]&^E-YK:4B/"U+T],-/Q==.!/+C[WXNJZ
M]R80!&7%[SN=X 3Q+P6[I]TKU5?^3>)AN7\?BQEJ!1!17@IL'<:SR86P_AVG
M_X(6PN\5EZ8&&^*/T!;<B1;@]\)0A?5?Z(#N1?/+_P)02P,$%     @ F8"M
M4NO1BN ;!@  * \  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&ULK5=K
M;]LV%/TKA <,+>#ZF?29!+"[M4NQ;D'=K!B&?: EVB)*D2I)V?&_W[F7LJP&
M=M ._9+($N_KW',NR8NM\Y]#H504=Z6QX;)7Q%B]' Y#5JA2AH&KE,67E?.E
MC/CIU\-0>25S-BK-<#(:/1V64MO>U06_N_%7%ZZ.1EMUXT6HRU+ZW5P9M[WL
MC7O[%Q_TNHCT8GAU4<FU6JAX6]UX_!JV7G)=*ANTL\*KU65O-GXY/Z?UO. O
MK;:A\RRHDJ5SG^G'=7[9&U%"RJ@LD@>)?QOU6AE#CI#&E\9GKPU)AMWGO?<W
M7#MJ6<J@7COS2>>QN.P][XE<K61MX@>W_4TU]7""F3.!_XIM6CN=]D16A^C*
MQA@9E-JF__*NP:%C\'QTPF#2&$PX[Q2(L_Q%1GEUX=U6>%H-;_3 I;(UDM.6
MFK*('E\U[.+57 8=A%N)&Z^"LE$R5H]NG-&95N'QQ3 B"JT=9HW'>?(X.>%Q
M*MX[&XL@?K6YRK^V'R*[-L7)/L7YY$&'[Z4?B.FX+R:CR?@!?].VY"G[FY[P
M-\LR5]NH[5KLRQ3_S)8A>E#DWP<"G+4!SCC V8D MT$1HK^&J$$;%8YA^'T>
MQ,\_/9^,QZ_$M1707B4]9>]J+S)G XK(L2H7*VVES;0T(J"1"MJ)06A+BTB^
M.N[ KEB(V\%B(-XJJ[PT9B< B*K(OHL,(F2Z,HC]J/=V-KOI/>Z+K0+U/BNA
MVKRDS84,4'1%O DB%C(*N5I!<WA60I;D,$"^E?,4@@SX T*5E;0["F8=? W$
M)X5UZ]I(CZ341IH:,7CUZ8!U:)QZM=&!5Y=8("SF@;9I:!&CEPKQR'XCM9%+
MHP:H-M: "KR'@@,JVXD-YI)8>5?"CPN=N(,':''>TN+\P:;.%K?<QF>O@KA&
M"4A\7D?QAXOB;TS?6>ZH"<?(\B/\BEO(T3.:[X >".*C^!,,FM<!#D,0"WI5
M5X& (?9-1N-)7X!%?DU-6J-<<">UC32328OY9P";I!#<2*#N?-.+G)O<\ GQ
M;"Y]CH[A!0A:9X4 N(J:E< ^+)%5!09$!Z[K#7&@#8JN$0=.9+5CBA9R@\[1
MV$<*<!*)LC+?2$RW->N**747%0TH =ECBV&25,IK!QDYSPX-DY,5\^V%W:]E
MZVJ3"X>0?DL$/5T;!8!ZMH7>0[.EKS8S=:Z$CD(S,M[!DH7A$IMI#F";VRB>
MXXK5DSI")7F'E%DJ^$C!=4;T/V28(&UDT.>ALI<$++#[>YFD1BH[.F%(.9 P
M-):*\1R D"_4]_JB9815!Y9MX5)/9<-D<OL-#1G0M'Q76T5,?MIGLS=MS,ZL
M6[3-FCO\$X](3I/1JS>SQ9P?QZ\> WQ6UE&SVXKF;VO7")+-*/23\;3?B7QM
ML=74J=S]7'_M58X._^Y"H(E[<+1WL'?X4KQ7,M2>X2*TOK9$QX\&ZC/BH5X&
M]:7&"U"D*4CF.9,?Z]<U]A&;J33%2Y?KE::2#UD,Q,?B0!V@_Z767B5% I3(
MQ,X*:==$V-!M"S-7@MF:ID94V(XLO==HL_;[:C+E(TZ2'6[H;A&:Q4!F4&U.
MY,H45 2ZX2//;632@(>UM0<XP@":!C[6S'X!?T98=5>E69$E*+OK 8(RO#-I
M2_."'1 -F4TM$)*)^T[:FC:0=%29L)GT$$4*1+*D)@7.GT;0?I\$VAV0,7&,
M28Q'.TF/!S0JET95_[BN4IMS'3(4 9(D#>  !=SA_44C O"ZY7.*^^+)>"*>
M8#'MDN*CO",6?G25SL2SLQ%8MT"?C%[M]KEW=$#C\BO#>RP)R92DO-_Y.Y8Z
M64:VI.SIA$$#R=;E$G. 2,&$PIQ1&.&I SF)/\-) 2D=>,NG_)/>*2V,T#J)
M%4\)?UP*>*FTEHX#1Z92LR\$##CL.<Q:N0*#&V#'Y^EHRMD33;PNO\T$VROO
M+O=G-HDC$B.A!.QJ]YQRMFF7.#I"F3DTCW>*9K(B-1F5_Q\Z,BU^)!V/':.&
MG=L+;>M\1\/Q@OJ8+C+MV_8:.$NWG\/R=(<$NH ["*-6,!T-GN'DY-.]+/V(
MKN*[T-)%W*SXL<!55GE:@.\KAZ-H\X,"M)?CJ_\ 4$L#!!0    ( )F K5(T
M\FQW&0,  "$'   9    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;*55VV[;
M, S]%<(;AA8PXDOB)NF2 +ULV("U*YIV>QCVH-B,+526,DEIVK\?)3MNNK79
MPUZL&WEX#D7*DXW2=Z9"M/!0"VFF067MZCB*3%YAS4Q/K5#2R5+IFEE:ZC(R
M*XVL\$ZUB-(X/HIJQF4PF_B]*SV;J+457.*5!K.N:Z8?3U&HS31(@NW&-2\K
MZS:BV63%2IRCO5U=:5I%'4K!:Y2&*PD:E]/@)#D^'3A[;_"-X\;LS,$I62AU
MYQ:?BVD0.T(H,+<.@=%PCV<HA ,B&K]:S* +Z1QWYUOTCUX[:5DP@V=*?.>%
MK:;!*( "EVPM[+7:?,)63^;P<B6,_\*FL1T, \C7QJJZ=28&-9?-R![:/.PX
MC.)7'-+6(?6\FT">Y3FS;#;1:@/:61.:FWBIWIO(<>DN96XUG7+RL[-KO$>Y
M1KC&7)62^TP=W+"%0',XB2Q%<'91WJ*=-FCI*VA]N%#25@8^R *+Y_X1,>OH
MI5MZI^E>P NF>]!/0DCC--F#U^_D]CU>_Q]REUK5<$9<-94%I=Q6<.:3C1I^
MG"R,W_^Y)^"@"SCP 0>O!)Q3%Q5K@:"6<,X-*TN-)?-IIIV6SDN)W@OK6O78
MK%B.TX!ZT:"^QV!V4Y$P):C/N"S!NDL$4ZF-@>(I,A8@J==U$]DTF<C;3)@F
M%?A@44LFV@)$;6#Q");7#I=HM\[ 9.$.#);4II9B:[#$P58:$>JF$M!5 M ]
MYE5WD=Z1)O$Q'-A*K0VMC0.^[<U[4) $ILTAW'B<W8KZ$V=./'F)DN<&+I4N
M7%HO41@:OK"%<3=LE."%EWVE.)'DT@E!> L)P2190K,T"\?)B";OWHS2)'WO
M#K-A&!^-X>L]581WV)YMQRP+X^%X.]PH2_EZ$;2UH)TD#9/!Z+\TQ_^I.1F&
MZ2AV9/KA49H]USR(PW&<[=$\(.]QMATZS7^#MA9T-AJ%](. EUHIVGFVJ,A*
M_S@;*L:UM,T+UNUV[_])\^P]F3<_#\I1R:4!@4MRC7O#+ #=/,C-PJJ5?P07
MRE)%^VE%_S#4SH#.ETK9[<(%Z/Z*L]]02P,$%     @ F8"M4AHN*E8:!
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ML0.$$G/K+'#Z>\)KE-(9(AB?CS:#WJ53'-(GZ^]\[!3+EAN\5O*C*&RY"K(
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MEB4P2L,D2\:0>42;4X6I>O^+15V]J+41"UF:C>'GGS*6L%_[\U_T>OKX6-%
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MBQQ^U0W1Q;2B<!_]3'8EU$L[#*[I=!K[-\.T>Q$?W@PJFB.E&036I!K/BGD
M>IC#P\:JSL^^@[*46[]LZ.E"[03HOE;*GC?.P/08;O\#4$L#!!0    ( )F
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MVJ33EG^FC??:*I?6#:VHR)GV06#IH[&T:2J>VUR#H?<^[)EB0#5L9865J\_
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M"5+MS&PW1C9N3JVDH:GGE@7]S4!E!>A^+:7I-Y;@\,=E]B]02P,$%     @
MF8"M4@<%ZNL2!   O D  !D   !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL
MK599;]LX$/XK VVQB '%.GS$R3H&G+1%"[3;(&ZV#XM]H*6Q180B59**DW_?
M(778R39I%M@'6SQFOKD^#CG?*7UK"D0+]Z60YCPHK*W.HLAD!9;,#%6%DG8V
M2I?,TE1O(U-I9+E7*D64QO$T*AF7P6+NUZ[T8JYJ*[C$*PVF+DNF'RY0J-UY
MD 3=PC7?%M8M1(MYQ;:X0GM376F:13U*SDN4ABL)&C?GP3(YNQ@[>2_P%\>=
M.1B#BV2MU*V;?,S/@]@YA (SZQ 8?>[P$H5P0.3&]Q8SZ$TZQ<-QA_[>QTZQ
MK)G!2R6^\=P6Y\$L@!PWK!;V6NT^8!O/Q.%E2AC_#[M&=A('D-7&JK)5)@]*
M+ILONV_S<* P>TXA;152[W=CR'OYEEFVF&NU ^VD"<T-?*A>FYSCTA5E937M
M<M*SBW=,2RZW!HX^*6,&<(4:5@73"$=?V5J@&<PC2W:<=)2UF!<-9OH,Y@@^
M*VD+ ^]DCOEC_8C\ZYU,.R<OTA<!/S,]A%$20AJGR0MXHS[HD<<;_2KH?;1_
M+]?&:N+(/R_@CWO\L<<?/X._HJ.3UP)!;>#?MD*X8(9GP&0.;[FH[=,<-2EY
MV<27VK.QA<D;&,#.6$7&,E66Q'OCXW._C(FL%LP),@,;)>A$FC/X6FC$1R4#
M+L$6JC:$;5P0-\/5$')28-IX@RUHJ6IIB3MXGV%EO=5'.P.@TF6%K]U^](1S
M9_ G-1\NR5]BG? T? -)$L;3"0V.DO!T-AW )S3F9Z+,6LW7M75L!:M *MJ6
M5I.W9(2$+6HTY&6:CN H33ND)86?,=\:2*MBVO*,5[1 2@:S6G/+T4 R.8'?
M?YNE2?K'*XRO%%EC\ &9L 5<JK)B\N%1)0HE<J0L4H1Q.)UU$4[' _CF6PBE
M?WE'(%MT^D[/LX8\[O:/6;M_B$MUJJVQ5!P7P'%+CO1D%L[2$TA':3B.XX9O
MU 8!-QOJBZZV%;DL+6?B"5PR3OK _Y/ECHQ';.#MGTYGO?U]Z9O\.<8<1OF:
M K\^QUT6WD \C,<NT_1-!O^SC2Y>;Z.UX&)? ETZ><X=Q2B[/@'A:'SJ#] H
MG(XG@-]K?L<$Y;]+I<;F@)(/U/NS6U"5TV].W?7JQH0D8BKTEYEX"($;4S<G
MEE@OV[MNQ\EK6Z!KF#%\*27%9N"CS%REJ?I7@I$0G0N@DRMJ=^0W6I5>I>L2
M#H?HT46WZ\CY:PK04\$C6=]8RJ:QH&\L^R;@6KEK0R3XT+C"R+?CO"/H$-Z_
M$B8.G1@!>!2I]HP6#]#C/>ON\&<-/SJX44O46_]N, 1"7:VY7/O5_FFR;&[D
MO7CSKB%?MYP**'!#JO'P9!* ;MX*S<2JRM_/:V7IMO?#@IY7J)T [6^4(V,S
M<0;Z!]OB!U!+ P04    " "9@*U2T([6])P&  "_$@  &0   'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6S-6%MOVS84_BN$5PP.H-F2?,\-2-)V+9"N19)V
M#\,>:/'8(D*)&DG%\7[]SJ%D64X<-^CVL(=$O)TKOW,Q3U?:W-L4P+''3.7V
MK),Z5QSW^S9)(>.VIPO(<6>A3<8=3LVR;PL#7'BB3/7C,!SW,R[SSOFI7_MB
MSD]UZ93,X8MAMLPR;M:7H/3JK!-U-@LW<IDZ6NB?GQ9\";?@OA9?#,[Z#1<A
M,\BMU#DSL#CK7$3'EV,Z[P]\D["RK3$C2^9:W]/DHSCKA*00*$@<<>#X>8 K
M4(H8H1I_U3P[C4@B;(\WW-][V]&6.;=PI=7O4KCTK#/M, $+7BIWHU<?H+9G
M1/P2K:S_SU;5V<FHPY+2.IW5Q*A!)O/JRQ]K/[0(IN$+!'%-$'N]*T%>R[?<
M\?-3HU?,T&GD1@-OJJ=&Y61.EW+K#.Y*I'/G[V7.\T1RQ3[FUID2_>TLX[E@
MVYT;:>]9]X[/%=BCT[Y#L43<3VH1EY6(^ 41 _9)YRZU[%TN0.S2]U'=1N=X
MH_-E?)#A)VYZ;! %+ [CZ "_0>.#@><W>('?6S#R@1,ZGCGA XBES)?L@L C
MG03+WDJ;*&U+ ^R/BSD>1V#]>4"+8:/%T&LQ?$&+6XPW42I@>L'V:[3/]8=Y
MWJ7 %EIAY)$1CFZ0%48_2(&&\$TDDD2')W--@8(73I8ON#3L@:L23^*^+@V"
MO=%*;K4Z9G@?2=I<""J?0#8'LUD)65?F[&OOML?>HB[<V).M*-S)I%(XL4%+
M)JV[5)<65;%'[#UM?/,;K>%O&R8M=[6&W]G>#BVI@]99N<RY \&X96E]\2U#
M\2H<&+".&3S%$EY8]H;%P2@,>R&.9OCW\T_3.(I/<!0UZY/6^CMTC, H:/G2
MLLFD-V%=?L2&X8#%\8Q-![U!0S*>A.Q..[3#"_.'W[!A%-,\GE6B/$4EBLX3
MLQO +&V]XG2YSK/87G&F2]K"M,X2, [3]P8&5SHK>+[V\B<G%E%2%&KM06$Y
MI@"68#@3ZA%"24)LT![B@VZ#/?;U#@3'J F.T;\,CH#]2C9TK[7=GZ0."J#:
M=VP+GL!9Q[O-/$!G7_C8.FCDW^"=Q;>)X6"4> <108';6EA67PZ(P'N6MD@G
M)AUD-$.'8X8QD&A#_D33?$C0]>16*RD\4F\=?BH!*/XS,N=TP57RHHLTD%(%
M];Y*= :U@XY9MPDOHO31*:KH/&)WJ0'89.TGT>T#^FN.#8!"'PB&J1 YD';/
M@F-7^7H;'K&?L!"P'#L.#)JP%1TMMMTEWN91PWT?KG;X:W2-P0'96/'N3D<#
M#*E@&LTP%FJV2X_SG&X#ZW6.%=88R),U+:RX$2ULM[EOCL-CDO)\"3OJ=>-@
M,!D>-58<@/NX@?OXU7#?)KR 75@+=66ZEGPN586\3\"I'@FR[ ;()L+K);=R
M;\TX+'M?S1!5S8,JE;32=(WY1=,K\*V&:JOA,6I.9Y]@J97+#\'QBANS)F6N
MX0$4B^IO7'\'/Y#**4'N3>>[27QV.'5OK*6\O3G6'N\C:7D%D1//MKC9G5WK
M?/G+'9@,K9LCFN<8EC13FN<!$^@R=.$8<_]D& ;A)&H(<64<!M/9N%FYA5QB
M]D'/@&V1SL;!<#1M3LTF6$8FS?2S#RA%6CB2*TB+* A';4GM6=4O EX*-LGL
M\US)99V+NBOITCK4'"NTH>4CUDV.V& 8C(9AP^/)M +-\W[B?XB;R0YNOE/R
M=T& !;L%@IW9ZT$03X,PFK9!,(F#:!J^ @0#;"(:$,R"Z7AP& 3#8;Q%>VO\
M8P 8!U&TY?%D2NYN7Y)+N?-U\76W12>S36Y$RE;B\AI1$D?<&)_'ZX*RS'VA
MD%D&0B)S['S^R\+;VP<?TM.K)5AIR8C"R(2^F1:@:K.IMAGT'5'I.74H/C5C
M+W(/M%N4J L>4J6H_- 60UJM)2A!MT ]V?Y.])DBG@OVB^@%04&C"]QJ:V7(
M05AV7J'1RS6W5HG@W<3LID%%[S[!W],;-D"(0KVHZN-Q*E85+5E=D5A;>FPF
MVCJ41#4.?2,S?Y>[]0ROVNZV;M+Z'_ZB:G.JAQ!Z4:A_20DV7U>]X)+@7>*O
M7+._D:Y"T%*%1JH$_TD"94*I8-VKTEJE!R^0^:/7#_OMC4^J/>HDB6<<GNR+
MSY[?BTY\>+V.Y=X.O=]Z5,C +/W3"37_Z-KJ?:%9;5YG+JI'B>WQZFD'R_Z2
M(DW! DG#'CV&F.JYI)HX7?@GBKEV3F=^F )'/](!W%]H3%OUA 0T;U;G_P!0
M2P,$%     @ F8"M4F7,F.1'"0  $18  !D   !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&ULI5C;<MLX$OT5E-:U9571DDC=$]M5L6=FQUNYE9V9>=C:!Y $
M)20DH "@;<W7[VF I"C'\:1V'A)3)-#H/GWZ=)/G#]I\L5LA''NL2F4O!EOG
M=J_&8YMM1<7M2.^$PI-"FXH[_#2;L=T9P7._J2K'R62R&%=<JL'EN;_WT5R>
MZ]J54HF/AMFZJKC97XE2/UP,XD%[XU9NMHYNC"_/=WPC[H3[;??1X->XLY++
M2B@KM6)&%!>#-_&KJSFM]PM^E^+!]JX919)J_85^W.07@PDY)$J1.;+ \>=>
M7(NR)$-PXVMC<] =21O[UZWU7WSLB"7E5ESK\@^9N^W%8#5@N2AX7;I;_?"K
M:.+Q#F:ZM/Y_]M"LG0Q85ENGJV8S/*BD"G_Y8X/#CVQ(F@V)]SL<Y+W\B3M^
M>6[T S.T&M;HPH?J=\,YJ2@I=\[@J<0^=WDG-H#8L1L5$DQ(G7[B:2GL\'SL
M< *M&V>-M:M@+?F.M2E[IY7;6O:SRD5^O'\,SSKWDM:]J^1%@^^X&;%I'+%D
MDL0OV)MVX4Z]O>E?A'LK=MHXJ3;L/V]2ZPS(\=\7S,\Z\S-O?O8]\ZB9O"X%
MTP7[]J@>QA%+]^V*YV!^\1@JU%=VQS-Q,4 E6F'NQ>#RU&UU;;G*+9W^V^AN
MQ')=EMS8(?NT-4(<Y88!V6S;0<ONG#!R(Y3,+'NO34X\>"]*BS]O>6K9M596
MES+G#GO?0RR,N!>J%I:=\B$[83$LQ?,85\D\6L<K7,SGT62YICMQ$L6S58>(
M5)FN!#M-AVRQBF:+&+NCY6K!DBEV3%@\F4?3>,FN^4XZ7C+Q" G*I:L1*XO7
MT3R>L=EJS=;3-9R/UK/D+P.<_/T XV64K"84SC1:)'-<S'!G31?Q:A5!!9\-
M,(XF:Q_@)$D8;"P1X#J.5JOI=^*C@(!!E$QG;!7/&<!;(UCRXK9UB1L!_XA7
M<%;!661<*D1H&P\L1P&/V(?:=,&VCXS(]$;)/['S))Z,YE"5LO0"J<*==7='
MJ@,*A=%5,,N<9AJ&^XBVQD%PYK8"_R@?5<B'>(YP=!HE)L(1=B>\.)?["#LY
M +1,:7*U(/7&9GBB^CG!;W\,"17CJ;X7(Y374P"\.WTWZ=!^T@E'B6Y$2Y (
M6IYJMV4[_-8Y 'Q!$^:=)LQ_6!-N@;W*9"F#T.+.!QS%O3I\-+J0CIV^U185
MZ^%N^.01[_/S.<5XV8DW/NW'1]MCMN*,K%\#+8E+[T\J  X!_DCH SD"MT1+
MMZ_8WU.>4)W'OIQT&G#2%LM;87%J_ADMT6/R*N1;6!?JQXK(4R1!Y:P2-E]$
M\T7"?A(0R*R)F;+/*Q+C/YM&AYJ:+J,%%&BZ0(%.V=T6E#BC-I\#C8KL-DM1
MR]-H-ENC,I>H_M-_8> 9,@*'X3&!(S<*'=L8H;*]/TM4J<@IXAQTNN?$<*A)
M-F2GT^EBR&91LEBR-]G76EK9.9C3*N?% #DK?2HR>+41-@1XFL- O)H/V7H]
M8U>U1:K)B9V351O8SNC/*)P6&9PJABPAH8TF".%CR8%U!N?IE,.B8LCF$-/E
M,F9OF\#$(Y$3'FY]?I#?7*1P8C-D\0P92M@__[&"P+_V_(4C.!Z51#U)9K#I
M0R!Z@UX_?V"6*JULW2PX$=)).GL[))&<KM? )9XM@$MF1$M5;JVO?B>-"'ZD
MI=PTF9'P&IUGMIZPZP^_W_QT%J][,7U&X#"Z7!PK_ OL/J'()N#0"7!&DI+)
MT#/E1F5EG6-!WB<5O+O69XL)VXH2]')LPR$H3!K#\V8)LDMB3!2Z%;YA4TTK
MK<XR;K?,?H]S31 CSYG>3E(^411(L"\X J HZ\S5?IL7QV_X*!Y!(K4!IQ ^
MF+0S$D.X+/<=R9 @ I<3)]I<^YY"/G&U!]>YHN"5QAS:@-@>0"F$< I2?XZ(
MZ]1*A&]PW_-C^9H5M?*#.-AQV!1YSI]*A-#A ;^^G#E]5G!IV#TO:R^=SQ93
MGUV9,(Y[CVAHAB=DV=:['6*$L/D9SU*"FH8X\I74@Y5P;(WD(!KJATR *0$0
M<EQ;9_N(42KXH8)]/JZDOD-L*A,$$&E<Q&ZT,Z&A_KN&/U[SGC:C7Q!O(8E%
M?AMFJ%/I*><#Q$&%-%"[KS5'VS=!/#?DK [-L()![G23U%S@[8VZ(W#UX4.1
MR9!L59-3+FUF9!HR^5X[@=KS]9Q,7O=TR:<PB5\/0[9:C%H8R.+&-)0MP#SG
MVP.GQHYW(X($#<(> Q6%I'LJ<Z/@&7@+GF5^?2_U/<F'BCT>\""+O5GF0;HM
MG#K2]Z: AHTGM,_W53HU;823IBGR"XAU9"3'#,@>5+G3LD8S:%%'5KP "I Y
M9R4J1W1+K-4D$(U?8581IK(!#'&D\LVM=R*7&3AV8[7#.[?M/&SI,/(JWB/L
MKJ^XA:!J:HGN3Z,J;=N*>,1LX>D;(:![#!W$3WH2RG;']\20=LGA0:#\TX#2
M9]N.9P?68_JZ]QEM^M!QH5*P?<X@_EX91/[Y'<AH./M5\!*G&9'"7\I[A /;
M@0FO;21ZOD]RM /E5:L7DM$9N2C4EH+U3UN'1K[9O8SE_P'3H5ZUVFCZ&VA!
MZVI'O6Y_:$W/D:3MR0TG_I T8J5&ZR_0$"I@C=FK:9O[D6_#O2 ZT_"C]JPD
M/=1*-9] NF/P[F!DYOTL_"S_"71!S^=!HKB"QNR#PAQ"XEDF2@)?/!FC8 /F
M,#O[T4!:6W>HY=)FNE8-]4:^S;^$>E];:3)H>OQ3J,CEEZ:)0UY:>]^<-,+,
M*8+HQ8M.]:YU5<E&;<@(9@;B6FA6C0RRD6\5S[5R_H-#RU&<87R@T\+HT/#6
MJU474L0>MA)C,[VQA%&!] T24GDS-&+X]MW.'(&/]$)#K;NH?9WDD$O$YV%H
MD@^0P,_^($8 ZYH<WW"3>Q,/6]'T]F]M=.KXH&NTKE30RQ-]YX!7*=A>[4J]
MI\Q2F8?.&X%42!W/Z1[6<!B6.&J'QK8?AC'=B 9,BO2^.;N415<:'MV1G^^>
M9 )- >0GWY[7+MK=#8J8;')1R2SJ$?W;CH\LH3F5(8WTF7%7<C!\&^3)#QJ\
M$"CN9GZRH^=>',>]SW084#;^8Z1EOD#"%[ON;O>]\TWXS'=8'CZ6XAUJ Q A
M+P6V3D9+O/Z9\ $R_$ +\1_]\#J+:<A?PEO,3K0 SPM-"AM^T '=5^#+_P%0
M2P,$%     @ F8"M4B:]W#XS!   ]A(  !D   !X;"]W;W)K<VAE971S+W-H
M965T-# N>&ULU5C;;MLX$/T5PN@"+9!:(F4[;N$82.P$FZ(7H]FT#\4^T-+8
M(BJ1+DG%+="/WZ&LB]/*M!?8A\U+3%W.F2$/YXS"R5;IKR8%L.1[GDEST4NM
MW;P. A.GD'/35QN0^&2E=,XM7NIU8#8:>%*"\BQ@83@*<BYD;SHI[RWT=*(*
MFPD)"TU,D>=<_[B"3&TO>K17W_@HUJEU-X+I9,/7< ?V?K/0>!4T+(G(01JA
M)-&PNNA=TM<W[-P!RC<^"=B:O3%Q4UDJ]=5=W"87O=!E!!G$UE%P_'F &629
M8\(\OE6DO2:F ^Z/:_:;<O(XF24W,%/99Y'8]*(W[I$$5KS([$>U_1.J"0T=
M7ZPR4_XEV^K=L$?BPEB55V#,(!=R]\N_5PNQ!V#T (!5 '8J(*H T2^ Z!!@
M4 $&OP#HX !@6 &&IP)&%6!4KOUNL<J5GG/+IQ.MMD2[MY'-#4JY2C0NL)!N
M9]U9C4\%XNSTBAMAB%J1A08#TO)2[^=SL%QDY@5Y1H0D[T26X6TS"2R&=, @
MKNBO=O3L /T[KON$TC/"0D;O[^;D^;,7'2PS/\N;0O9)%!YCF9^02U3E8F"-
M]6%-L30B$5A3'7S7Q[+*&KZP W[CAU\6ZQI.QX_A 8K8*,D:)5G)%QWBBV-5
M2"ODFBQ4)F(!AGRY7!JKL7K_]@2(F@!1&6!P(,#[(E^"=GL%?4WS,E*]C.1G
M/>S29<<[+'F=U3U,HTGPT)'*H$EE<&(J&C9*6[[,X,1<!J?F,FQR&7ISN9>2
MYY"0ZY=7P'/R1@EIR2>,7FCPK/JHH1]Y99UAW:&<25F89^0M&$-LRB7YG*HL
M^T$^;"4&OVOV\1E9<(W1RP?:I&)#;J4%K&Y[1JY7*W3TLMYGR+$&<T;>8_OZ
M\A:CDEL+N?'ME/,FYW/ODK2A<:/$SE76T%5??I91V _#/SSIC)MTQO[= IE!
M4[OA0J\$9(F'\E5#^>K)J$+#UNM#[T+4(;&??RN$AJ33T/T<=/B[*I7=^8'C
M#N#C>>SU+.JE6A0Z3O%S@FRTB 'K_5GG1'8DX[U2IZP_Z*YVVMHL9=[@LU1(
M[IM&ZZ<T>CJ;J+5>>JKW-LW3M9JML"F12KZ,E;0:\W?M0=0;[B?Q=MHY_=V6
MV0&A6E^F?F,NA<+(^ 4*,3?6-_O6C>G3L6/:^C'U6^E)!3.K2/8+9MP?'9"A
M-5_J=]]:AG9-R ?IZXRT-6'Z=%R8M2[,_$9X8G><'Z'I,N+'&;5^ROQ^VBT1
MWO@7G9/M?:?Z/U3_5ZJU9LW\7[^G],[Y$8[CDK4NS/PNW"'97UOEHVY]DPV?
MCCZM,;/1?U-5?IHH.B91:[KLB.GN\G!3W]3^B^.Z)W8FYV<\G%RP=P+@3H3P
M?]VUD(9DL$*FL'^.DNO=(<ONPJI->2BP5-:JO!RFP!/0[@5\OE+*UA?NG*$Y
MZIK^ U!+ P04    " "9@*U2C\9DD54$   E%@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6RUF%MOVS88AO\*H15#"VR12.I@9;:!)EZQ DT7).UV
M,>R"D6A9J"1Z)&UWP'[\J(-%V998%;!N8AV^P\N7S .*\P/C7\2&4@F^YEDA
M%M9&RNVM;8MH0W,B;MB6%NK-FO&<2'7+$UML.25QE91G-G(<W\Y)6EC+>?7L
MD2_G;">SM*"/'(A=GA/^[QW-V&%A0>OXX"E--K)\8"_G6Y+09RH_;Q^YNK/;
M*G&:TT*DK "<KA?66WB[PF&94$7\D=*#Z%R#<B@OC'TI;]['"\LI%=&,1K(L
M0=3/GM[3+"LK*1W_-$6MMF>9V+T^5G]7#5X-YH4(>L^R/]-8;A;6S (Q79-=
M)I_8X3?:#,@KZT4L$]5?<*AC/<\"T4Y(EC?)2D&>%O4O^=H8T4F 0PFH24#G
M">Y  FX2\-@$MTEP*V?JH50^K(@DRSEG!\#+:%6MO*C,K++5\-.BG/=GR=7;
M5.7)Y1/=TV)'P1.-6%*DU5R\7E%)TDR\ 3^#S\\K\/K5&_ *I 7XM&$[08I8
MS&VI>I<5[*CI<U?W00-],'A@A=P(\&L1T_@TWU::6^'H*/P.&0L^$'X#,/P)
M( ?!'CWWX].=GO25.7U%HZ'TD]'@=AIP50\/U4L%21).$U+- %N#X\3\]4&%
M@O>2YN)O0R.W;>16C=R!1I^8)!DH%%!XW:!W+NL:?E6C),=^B2""[FQN[[L6
M7X;!V4P1IPT[D>BU$CVCQ/MJU5,.(K5BN (#($)0V2NTKN1U%;@0XU.=*^]2
M)_*# 9E^*],WRES1->6<QD<C^^3Y%_*\T#MS<>5?J/,=S^\7%[3B J.X1Y86
MLOR7E0K2AF4S:^O-IEV?8=LHO,+Z#"^GW0L</SQ;GSUAKA,Z7K^WT-',=(PB
M?]^KU?D-9V&'P'!:;R'2K= 5W&V*G"Q;SPG.W>T)<P,4#KFK40BQ4>2SI#Q-
M:)%&PC1H33SH3NRO)A<THVNDOSW4PA!Z\-S@GC@8H-D N* F%S2CJ^,P^ ^,
M9074\('!Q(YK+L'9-1R?C72\)\[DN*8:-&/MU/$Q_$":1LB9UFVD487@%=QN
MBG1==,Z,-H:<BM-P0V:X?60\5@:8!JH9A";>CR&-)W2-'5E3I&L8\D)XOB/K
M"\,^&F RTF!#9K UWGX'+9"F$?(G]EJ#"9FW12.]#L9YW1-F\%HC#9F1IKT>
MQ0G-(!1.ZS/62,+F#=(XGYLB)DX80T[%:8AA,\0^TDRPXL<?H._\\H&\F#89
M6,,'HXG-[7PJFO='(\W%HS9Q/6&&31S65,-FJIV;_!WDP)I*V)O8= TI;-XR
MC33]\H/O8D6;0D[%::QA,]9ZS!Z##JR1A"?^_,.:4O@:'X!-$?];J_LRK&]U
MVYWSLYSRI#J'%"!BNT+6)U+MT_:L\VUUPG?V_ [>WM<GEKI,?8#Z0'B2%@)D
M=*U*.C>!6@"\/I.L;R3;5J=T+TQ*EE>7&TIBRLL ]7[-F#S>E W:D^'E_U!+
M P04    " "9@*U23ES&PG@%  !%&   &0   'AL+W=O<FMS:&5E=',O<VAE
M970T,BYX;6RUF6UOVS80Q[\*871 "S2Q2$E^*!P#29RT*9HN:-;NQ; 7M'2V
MB4JB2U)Q ^S#[_004:DEQ@/F-XTD\W]W/!Y_.JJSG53?]0; D)]IDNFSP<:8
M[;OA4$<;2+D^E5O(\)>55"DW>*O60[U5P.-2E"9#YGFC8<I%-IC/RF=W:CZ3
MN4E$!G>*Z#Q-N7J\@$3NS@9T\/3@BUAO3/%@.)]M^1KNP7S=WBF\&S968I%"
MIH7,B(+5V>"<OOL0E()RQ#<!.]VZ)L54EE)^+VYNXK.!5T0$"42F,,'QSP-<
M0I(4EC".'[710>.S$+:OGZQ?EY/'R2RYADN9_"EBLSD;3 8DAA7/$_-%[CY
M/:&PL!?)1)?_DETU=NP/2)1K(]-:C!&D(JO^\I]U(EH"&O0(6"U@APK\6N ?
M*@AJ07"H(*P%X:&"42T8'2H8UX+QH8))+9B4JULM1[F6"V[X?*;DCJAB-%HK
M+LJ"*-6XA"(K:O?>*/Q5H,[,SZ,?N="BJ"--3LAY')?7/"$W6;4SB@I[O0##
M1:+?X)"O]POR^M4;\HJ(C/RQD;GF6:QG0X/1%#:'4>WYHO+,>CS?<G5**'U+
MF,=HA_SR +DWZ94OW/*/>7)*_,J[UR&_.L"[WQ_\]>'R+N_OW?(%1$[Y![?\
M/%\_R>GDN7R(Y=/4$&MJB)7V_!Y[%[G&)UJ35C&1OS[A,W)C(-5_.WSXC0^_
M]!'T^+CCCTA,HXF1R#MTHX L:[_057U7E;U1::\@^,.<^C1DL^%#>YWV1WG-
MB&>!!DV@@3/0]U+&.Y$D72%5RK =$O5&8S9Y'M3[8#]T2L.I/^H.+6Q""YVA
M?<TRGD),KDXN@*?DHQ29(=\PJ[D"QQ*-&O.CHY7!N/$Q=D[A]UT&2F_$EFQ!
M11@ZOE^[-K_;RL@[];S?'.%,FG F3D,70MY' K+(E;]I8VQZM/Q1S_+>^W\W
MTF5M\/E.PMZHNQAIZ\U#G9%<<KUY"B'N=$SW]LNDUZV%%65.MY\$7XH$LPL:
MWV!1KOJ\L_W=.NUU;SE&W2!S\.&2[M-H$O2ZM$2B;B1]AD1C*5USH58"DMA5
M1Y8E-#Q>M5JDT)$S])O,@ )M7'5R\8(-&N[O]OHUZ19..H3/YV&Q1=W$N<M5
MM,$6FVR5^!46]23&^[N,]2^^)11U(^K>P+;*7K5&;\D:3S2=$4PZ(N@-P%*-
M3IT!W&)[R(U4(GG$PTX,>/9:)D RF44R,THF*%CC3JP6NK,9FN[O1'_4%QFS
M*&1N%-Y(=)^Y&B#+,D:/MAM8J\]RH\O56]32]NJ%R*O@E]:B8]@(1_5T%LQB
MC;W0G[U4X O6T9!Y86^!,8LW=EC'Y6+$@NWW7F$_SIG%('/W5(WS&.(<S^%%
M:?-4YEE7)2]J8[\N4E\4%I/,3:IVU2E(N,$N+Y+:=+W/KVM;SQ>B-P:+..9&
M7+6;R#_D5F0BS5-7Q5MZL<GQ]I5%%',CZDH;D99)RS6L\H0D8M5=PVX[(7D$
MKK3KN&/AY!\"IR*=_.<+Z?0MIOSC8<JWF/+=F#HXG2_8H0?DLW5^= .JR>>U
M4-A/?,*NG7R6!IO .(?B(#URN;$P\H/C9=A2QW=3YT[)""#69*5D2H36.<<S
M")$KQ-"RDSS^/GF*3=^W[7V+'O^%#NTIKY?EQRI0%8"*[TEX3'.NG46+/SY>
M4BUK?'>G=(W<,G"2B >L7.Q'>+8N<-[%T$5MJOTZ\:>T-YN61+Z;($TVK])M
M(A\!L$:SDTBF6S! SM<*VZ?B].:8<& 1$WA'2VM@F1.XCWG_):VUJ7:5=C1Z
MP];GSN(#^RU7:Y%IDL *9=[I&)=%5=^LJQLCM^47T*4T6*+EY09X#*H8@+^O
M)(*@OBD^JC;_<S#_%U!+ P04    " "9@*U2M0C=!A<$  !H#P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970T,RYX;6RU5]MNVS@0_17"Z$,+))%(72P7M@$G
MV4N #6 TO3P4^\!(M,TM1:HD%;=_OZ0D2[8E,4VP^Q*3U)R9P^'P,#/?"_E-
M[0C1X$?.N%I,=EH7[SU/I3N28W4E"L+-EXV0.=9F*K>>*B3!607*F8=\/_9R
M3/ED.:_6UG(Y%Z5FE).U!*K,<RQ_7A,F]HL)G!P6/M#M3ML%;SDO\)8\$/VI
M6$LS\UHO&<T)5U1P(,EF,5G!]S<HL(#*XC,E>W4T!G8KCT)\LY.[;#'Q+2/"
M2*JM"VQ^GL@-8<QZ,CR^-TXG;4P+/!X?O/]>;=YLYA$K<B/8%YKIW6*23$!&
M-KAD^H/8_TF:#4767RJ8JOZ"?6T[C2<@+946>0,V#'+*ZU_\HTG$$<#X&0:@
M!H#. >$((&@ 5>:\FEFUK5NL\7(NQ1Y(:VV\V4&5FPIM=D.Y/<8'+<U7:G!Z
MN4J_EU11FU(%+L&ZE.G.9 6L)4T)6#$F4ESE^^TMT9@R]<Y8?7JX!6_?O -O
M .7@XTZ4"O-,S3UM"%FW7MH$OZZ#HY'@ ;@77.\4^(UG)#O%>V8C[6[083?7
MR.GP'LLK$, +@'P$!_C<N.&W)&WAOH-.T"8WJ/P%(_ZN2V56E )'609?_S)K
MX$Z37/WMB!&V,<(J1C@2XP\ALCUE;"C[-3*ND/8^/RTA].,I2N;>TW%6ANQ@
M- OBUNZ$6M12BYS4[H26@COV&+>.XO\MC],VQO35>:R1T5%^(CCSP[,L]JUB
M8S22PZ2EE;ASR#7F6_K(R.#]2GHQ0S3U_3-F?2L8&[MA9K.6V<S);"W-6R+U
MSPM0,,SU!3 : (@YG\*HO!XB.^O32&!T7HP#5D$"T3!9Z'<ZYSOI?C&O">5;
MD.*":LPN ">#)!LWT>EEF)Z1'+:*1D@>B3%\YK2?B-(V?U992YX:51:,9EB3
M#.#-AC)JAH.T88]0TB^$ 2N(D@2.\$8=;^3DO5+FWP!#D0F^O=1$YL 0?31L
M-1VNV\;?,9%+A,+S6GC6[)1OI\LP^&^*(>C'AQ$,SZ_^D%V4C-U]V&D[=(O[
M1V'8 5,2-*]*H#@\SX5]G@<9A_T3]B.8] IX0/-/[4XI=YH/(Z=6WQ.L2DFJ
M&EX3244&5MD_95W5RB'4L'L-8/QJJ6Z@IR<VA>&8?G3/ W2_#\\(,>RK/XK1
M-!@)V\D_=.O_RU46#KP)P6@I=FH/W7+_RU>FK]\CN4>==B.W=K]>%E%?IR]#
M."9XJ!-JY!;J%PL>ZBNO/T*B4UWD5MU?/1(TH*(S-!M14=2I*'*KZ,O5J7$8
M.[+@'?4R.9';JL53(!4EUW5;TZZV;>2J:IZ\SKSN04TWL*6FK6%D8Z#^U=1D
M0-9M73W1HJ@ZHT>A39]5#7>F%2;2&ICO&R'T86(#M,WU\E]02P,$%     @
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M864?'E NP.YOI#2'B1/HGK+\%U!+ P04    " "9@*U2V4[XD;,"  "2!P
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MMM"6S):UP KGF> [)$RT=C,#VQNKUM409K[BDQ+Z+=$ZE7]G6V"*"P(2G2]
M84+E!9J@YZ<%.C^[0&>(,/2SXAN)62DS5^F<1ND6G?]=ZQ\<\?^!Q14*_4L4
M>($_(I^?EB^@Z.7>9[FK*^W+#?IR ^L7_J?<=[0@LJ!<;@2@W[=+J81>4'].
M9 C[#*'-$!W)\(AW^OLH$ 13B733] 9I&JK[.]:\UBNQ7F;#;?/@.O:#S-T.
M>S06Y?M1'_4)-.I!HY.@+WI[30B;-((7($?I6H-XD-</4W\/[C!H&B7C:'&/
M%I]$NR>,Z"5=HC7GXXLN/D@:)'ZZ1W88% 7Q$;2D1TM.H@WVRR5:"S[>N.0@
M<QC&GK?'-Q(5!?X1P+0'3$^O/Y @MH#T 8_@S7Q9NPCY4G(*"O1V[G; &'=Z
M0#3Q@W@/>S0H'*>>]M33K[>5@1J#FQ[L@C ,TWVZD:C(N]['<P<GIKFM]#&U
M)DPB"BNM\ZY279YH;X!VHGAC#]$E5_I(ML-*7YH@3(!^O^)<?4S,N=Q?P_D_
M4$L#!!0    ( )F K5+#Y!-2FP,  ,X+   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;(V636_;.!"&_PHA]- ":23J6X5M(+6W: ^+#9IM][#8 RV-
M;2*2J))TG-U?OR0E*XI$.;[8HC3O\.%PR)G%B?%'<0"0Z+DJ:[%T#E(VGUQ7
MY >HB+AE#=3JRX[QBD@UY'M7-!Q(8415Z?J>%[L5H;6S6IAW]WRU8$=9TAKN
M.1+'JB+\W\]0LM/2P<[YQ7>Z/TC]PETM&K*'!Y _FGNN1F[OI: 5U(*R&G'8
M+9T[_&F-0RTP%C\IG,3@&>FE;!E[U(-OQ=+Q-!&4D$OM@JB_)UA#66I/BN-7
MY]3IY]3"X?/9^Q>S>+68+1&P9N5?M)"'I9,ZJ( =.9;R.SM]A6Y!D?:7LU*8
M7W1J;9/$0?E12%9U8D50T;K])\]=( 8"M5"[P.\$_K6"H!,$9J$MF5G6ADBR
M6G!V0EQ;*V_ZP<3&J-5J:*VW\4%R]94JG5S=<V@(+=!OSRHQ! A$Z@+](0_
MT?K(.=02W0D!4J#W&Y"$EN(#^HA^/&S0^W<?T#M$:_3G@1V%DHF%*Q61]NOF
MW>R?V]G]F=E_)_P6!?@&^9Z/+?+U9?D&\E[NO9:[*@Y],/P^&+[Q%\SZVX%:
M<X'63$AQ@]:DH9*4]#\H;E 7J9M!A+K(;*C(2R:.'-#?=ULAN<K-?R[@!#U.
M8'#"-_9&DF>P!K>5QT:NS^O3RH^"*%ZX3\,86JS\- UZJU=L8<\67L6V/0KU
M10B5""H I,[!!MKZB@8(2:@W_!7GU A[H3?#&?6<T56<.I-M9-%T4A_[(S*+
M$4X\.UC<@\47P=;F;*LDREEM,@81DTTVR'@Z?XB#8$1IL?+C.<RDQTPN8GX[
M;ZM)>UH74-5T1W,BVWL\!_I$MJ4]/Y,)D9]$XVU_P^@5==I3IV\$M[VZ"FB8
MH/:@IM.<S)(1V]0F3F82,NO1LJL24I=8";4)[3D%K)S9A"$,Q@EJL?%".R?V
M7BJ#=Y'T)RF/:MN+ LP5--ALZT7O3=,O2*,1J,7*][(YU$$1PU<%5;"=/!%U
M#Y<TUZU&O;>B8LM)R;(QJL4*IS.)B5]*#/8OHCY(EC^JKJEI2FH_-9V#X<2!
MC[TQWM3*3W T@_=2<O#EFF,*FY4JL%V"\3@3+6:I*<Y6K)=J@Z\K-S!L4Y@I
MPGEWUN>OS\[WL +&61*E8W2+69C%X^1T!\V6[G15#[-7Q0^5L%,Z[S91:^=M
M\]@.)&M,_[5E4MWXYO&@&F[@VD!]WS$FSP/=TO4M_.I_4$L#!!0    ( )F
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M(\:.5-#*!9RDAO%I#P,-P,#@AA5R)<!OQ9S.#_4=M:5F7^AY7Y^0U> -X><
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MJQ:OH\7WG?(;PI=I(4!&%TK5/0^5B_B^^;P?2+:N^K</3*J;4O6XHJJPX:6
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MC4F$>YWPC_\-_NEXN-<"_]P/7T#4=;J#*5'E!:WR@EI[PTY[>/$WF=(R-\E
M_KC%#>1&0ZK^[#$_K,P/K7F_P_QCQE(A-?\;8A0./(HKE;,L A()A:F'^5.L
MQUQ%(L=L;&.T.".T9QC-?9[1,!A-ILYSD[C#7</Q*/2J76\"\*L _-X EA )
M]/&60T;NA ;50TI0V0Q.P7E8F0][7?XFN89+L5Z;%]N2BQ^OE.=I6ZZ'!Z1Y
M@>^Z[:2-*@]&O1Y8G;D5++/W^S,4CJL3QJ>@<%*9GYP^;1>3P[0=3QK<%C?P
MHUUO O#<6N_=(^_@GY^Z :_Q1?%.<0=>+4T>[0WAXXOFV2;G:FOME]G<*OCT
M@,31R'4[6:SER^O7KR:+=IS@^(+$.1@!#OO"K!7&\T_"8RTW7O#_\#@O#;W1
M4-_KYK&6)*]?D^8B3;$@76H1/2&57]9K'H'LBZ[6&F]T$OIJJ?'&_9\ ZS36
M2[F,ME@-QV212R24W(/D(KX@2UL?M99!A>7@C;R&8]\/.@BM!<KK5ZB;^R_(
M8Y/6OF*@5@WJGH),6HL&]7K]OLO3%4B3@V55J402DS.L)XOY>1N-I<TFC<$P
MF'2_X+11_O1KS)(E8+VQEVS\B$62,*G(#MVT/K6[=*@X=-CA3*TVM%]M:G)8
M''/3PK'DE2<MR JP*:RS\$>D#0]("R=]G-6"1?MKHKG #C4&R731IT: 76;<
MZH-_6%Y0M\4'I]'9F-88J^0-SQ1)8(U(]VJ$8<BBVRPF6NQLL[,2&ELG.]QB
MAP[2;,#G:X'?N7)B^J>JYY_]"U!+ P04    " "9@*U2)$.[O%8"  !5!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6R-E6]OVC 0QK^*%?5%*ZWD
M'PE0A4A0-&W2*J%"MQ?37A@X$JM.S.P+M-]^M@,1&TG9&^*S[WE^=\0<R4'(
M5Y4#('DK>*G&3HZX>W!=M<ZAH*HG=E#JDZV0!44=RLQ5.PET8T4%=P//B]V"
MLM))$[LWEVDB*N2LA+DDJBH**M^GP,5A[/C.:>.993F:#3=-=C2#!>#+;BYU
MY#8N&U9 J9@HB83MV)GX#].1R;<)WQD<U-F:F$Y60KR:X.MF['BF(."P1N-
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M.._H94DUS"7_P3)33+USCV20TXJ;>[G]"HV?H>5+)=?NGVSKO0EN3BMM9-F
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MM!D.K-YL1&^OT\<@08]U(HOZ#A0981/RLU9^9N6#;\@W^W30LFA/99QQ60I
MO[_7K]&]@ES^,;'<O%UN/AG- X@G&@.*]7$8VNO*>V&]30EYVOC1<N4^=?,_
M8!,N6IL76(L6:S&)=<\4"- G=(RK<I]WUL0+'/3 KHUT-0R'R<*6+)PDNWLN
M=,72&R1 E8*A>N<1D1+4X'4)KRC>!O-YV&,=M(JB8=AE"[N<A+W-N5#T+V(K
M+#\BIBN!+K0E$91D2)^H0>#E==H6?=QK&QR-9#9J8:-)6%.FBJ9,-;=K;/^C
MZW3A((QZE$-6&(\D%7N7&NM-DOZB4A -HK3[+R?N(NX4;_Q_7'[L7Q;T_]7U
MK]V[&>R?A$F3EUB7$HNG:^PWKW_MWUUTWM_\ 9LP&"&[5&<\^P]N5"W:1>D7
MT0$3/$9[*>YXNKK_HRN%K^MX..M37MM$?4JWT[WD($ZVJ9-ZV9*IZJO?SK:-
MXZUMEWKS6]-0VJ[H(E-UH_J;?J),H@R.6M*["366J!J\:J!X87ND1ZYTQV4?
M4]T4@S &^OV1<]4,S )MF[WY&U!+ P04    " "9@*U2(@906@8#   1"
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MIP.Z3;IZ?ZJ)585OX3-EZ4'PPXS>;-3.@/;G2MGMQ#EH_@6,?P%02P,$%
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M^:DU0,OHX))GCZNPF$4$X7B@#F3J0*<N@<;S>')',.RN 9L=#"<A"@? &:&
MV GNEJWUDQ68LT)?*?"@L4K'NH=&!2#Y^;0##=?#D\D>6FB<$$APM^L6.Q1I
M'1IHNJ%[Z.;[\Y)/D^P(9H"ZTF6Q0L@?6J1&6V#TR[@G^A[NZ1OY S49R8)N
MS3H;\5BD"Y&X6T'?RC$P1M^@6^!<\]\B1(3@N,<Z%CN-WQ\@'60$"[D%2V^
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M9J:O7B#,!/U]SKG:=8R#\C(W^@M02P,$%     @ F8"M4EM013K[ @  [ D
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MIF&4=@?^NH8GJ7B21I[O C.E__BI%,D!11CTDK >HEM!=!LA=%;-@7P&HWN
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M2#*_=<E?M,CLQ<5":"U2^[BF!%9Z8P#?E\(H0_YB.BCNOL;_ %!+ P04
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M+"5K%C-UZ%1@9L$>2B!66U/LG:;@.N:">Y;P7(_R>R)">,LBP1/$U19>PHQ
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M+W-H965T-C<N>&ULS5E;;]LV%/XKA+$!'=#&$BG?"L= XC2)B[8)$K1[&/9
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M(LDO5XQ&3)H!\'XAA'ZZ,1.4IZV3_P!02P,$%     @ F8"M4F1&#,MB P
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M3!$ +<*!UD]B[,D1 ;$BW\2*@%@13JQ>$K=4EPXE=DTZIID 9HD3F77R0T$
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M"8U)LL,4NTB0Y@#NSX70VXDQX/K2T6]02P,$%     @ F8"M4K=AU(]@!
M?14  !D   !X;"]W;W)K<VAE971S+W-H965T-S(N>&ULO9A=;]LV%(;_"N$5
M0PNLD7BHS\PQT#@K%J#9@GC=+H9=*!9C"Y5$CZ3C#-B/'_5A494H.9D;W\02
M?<[A>UY3CQA.=XQ_$6M*)7K*TEQ<3-92;LXM2RS7-(O$&=O07'WSP'@6277+
M5Y;8<!K%95*66F#;GI5%23Z93<NQ6SZ;LJU,DYS><B2V61;Q?RYIRG87$SS9
M#]PEJ[4L!JS9=!.MZ(+*SYM;KNZLIDJ<9#07"<L1IP\7DP_X?$Z\(J&,^#VA
M.]&Z1D4K]XQ]*6ZNXXN)72BB*5W*HD2D/A[IG*9I44GI^+LN.FGF+!+;U_OJ
M'\OF53/WD:!SEOZ1Q')],0DF**8/T3:5=VSW,ZT;<HMZ2Y:*\B_:U;'V!"VW
M0K*L3E8*LB2O/J.GVHA6@JIC3H Z ;H)SD "J1-(V6BEK&SK*I+1;,K9#O$B
M6E4K+DIORFS539(7/^-"<O5MHO+D;$%7ZD>1Z#JOED1A[7NT'_UU0[D:RU?H
MC@IEC$!OKZB,DE2\4U&?%U?H[9MWZ U*<O3;FFU%E,=B:DFEJZAN+6L-EY4&
M&-! T W+Y5J@G_*8QE_G6ZJ?IBG8-W4)HP5O(GZ&"/X!@0W8H&?^_'1[1 YI
M/"9E/7+ XSNZ8;QTL^WVGY]4.+J6-!-_C4SF-),YY63.P&2_J$>?TT>:;ZGQ
MIZBRO3*[>,8?9X !.\'4>FP[U _#0:#8T(1])<YMQ+FCXA:2\F1%\V0I1EKU
MFFK>Z_OJ-Y/Y1_E:9;MMPPC&+N[X:@C#/@0#O@:-N&!<'..QZGFDS;"I%+Z^
MI]C6]+&/<K5.;_L%;HB[J]441CQPS:[B%ASQ 7FI8/GWWV'/_O%3=#^V:#'H
MHG "BS5\,#G.8M+SSG5M/^Q:W ]S? B'+-:XPN.\TJ^8VI=1DS5HL'L"DS6)
ML'><R5Y_@9JP:X@;XR[6],+C^-K[D>1+EE&C1 .:;)=@ORNQ'Z<>R( ,*-0(
MP^,,FT>;1$8IHD]JBQHG<LL'K SZ5MJA UV9_3 ,81 .R-1\Q.$+UROZ%SWO
MO08:BV"__NH%C3DXA+GQU5NG'WRYF>)&WFZ@D0EPY.JM"[2G]@+'ZRDTA&$[
MQ ,"-61A'++/7;S0IR@.7>QT91K"U!H?\E'#%EX*6[5X#V\>0&,73H!=T-B%
MX[ +!NP:M@^FL.'M VCHPK'0!=.VT0^\KD!3F TP(% S%[X-<Z$/4R?H[A ,
M01B(,Z!1 Q?^!W!?L#$CFKKD!-0EFKKD..J2/DU-&S-#V,C&C&CFDF.92_HP
M!6+[=E=@/PS[OC\ ,]+ZK_K;,)?T81J2GHO]H  />:AY2\9Y>YVKC8&HC!Q;
M,YJOY 1\)9JOY#B^UNGM8X+W:M-H]Y: ,2[L;6NMUD%61OFJ/-\3:,FVN:R.
M?YK1Y@SQ0WERUAF_Q.?SZB10EZD.)F\BODIR@5+ZH$K:9[XRG%=G?=6-9)OR
MN.R>2<FR\G)-HYCR(D!]_\"8W-\4$S0GKK/_ %!+ P04    " "9@*U2#SHX
M^^X$   P$@  &0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6R]6%%OVS80
M_BN$T8<$:"*1DF4K< PD3K<&:)<@6;N'80^T1-M<)=$EZ3CIK]]1DB5'HKAN
M6/>22/3=\;N/I_M.FNV%_*(VC&GTG&>%NAQMM-Y>>)Y*-BRGZEQL60&_K(3,
MJ89;N?;45C*:EDYYYA'?C[R<\F(TGY5K]W(^$SN=\8+=2Z1V>4[ERS7+Q/YR
MA$>'A0>^WFBSX,UG6[IFCTQ_VMY+N/.:*"G/6:&X*)!DJ\O1%;Y8D- XE!:?
M.=NKHVMD4ED*\<7<W*:7(]\@8AE+M E!X=\36[ L,Y$ Q]<ZZ*C9TS@>7Q^B
M_U0F#\DLJ6(+D?W&4[VY'$U'*&4KNLOT@]B_9W5"8Q,O$9DJ_Z)];>N/4+)3
M6N2U,R#(>5']I\\U$4<.$,?N0&H'TG4(!QR"VB$H$ZV0E6G=4$WG,RGV2!IK
MB&8N2FY*;\B&%^88'[6$7SGXZ?DC6\.A:'1;5"5AJ#U##RP11<(S7BV(%:QL
MA=1TF3%T<+G*Q:[0"IW<,$UYID[!\=/C#3IY<XK>(%Z@7S=BIVB1JIFG :K9
MT$MJ6-<5+#( *T ?1:$W"KTK4I:^]O<@Q29/<LCSFC@#?J3R' 7X+2(^P18\
MB^]W]QUP@H;VH(P7_ WM%:V\6+\Z@-\_@#FZU2Q7?S@V"YO-PG*S<&BS#97L
MS!1[BA*10P=0U3[LV5PSV_%4$:,RHFD%3_,@#..9]W3,6=\(3\BX,7H%=MR
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MXL[X"/+Z\>VZ-@I+1=;A^,+?.G0W$V0N54[5$";T-Z;9E-,"Y"A6+N&N91T
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "9@*U2CZX?@X %   9,
M#P   'AL+W=O<FMB;V]K+GAM;,6:6W/B.!!&_XJ*I\Q#%O"-F51(5:ZS5&43
M*F3G=4NQ!:C&EEA)SF5^_;9-LMLF3M>^='@";&,.;5GGDZ7C)^M^/EC[4SQ7
MI?'3P3J$S=%PZ/.UJJ3_S6Z4@3U+ZRH9X*-;#?W&*5GXM5*A*H?1:)0-*ZG-
MX.3X[5QS-\0?;%!YT-; QF;##ZV>_'_[FX_B47O]H$L=7J:#]GVI!J+21E?Z
MERJF@]% ^+5]^MTZ_<N:(,M%[FQ93@?C[8X?R@6=O]N\:"#OY8-OMP3Y<"<!
M9#K(1G#"I78^M$>TYY? ^*C@X.VG.M@K70;E+F10WYVM-]JLFM/ OQBBO]'6
MX>UU6\0C]W_*:)=+G:L+F]>5,F%;1Z?*!M#XM=[X@3"R4M/!N7U4KOD_\ .S
M8OO? D"A2KDC#3O<K&CQ.%&,MZ4NX-<+<29+:7(EVA)Z!!@1@-'> ,7!7"+(
MF(",/Q%RT4 T7_#"+L7MIG.I$P(RV2/D7Q&"3 G(=&^0Y]*O$61&0&9[@[S\
MN]8(<D) 3G@ASZ37+=+<*0^'MD<@M*\$VE=>M#N5PP'B-,]M;0+TPDT132%=
M@3N=;P3@-V[ 1V5J)0#4KHS>J=QX1/77(UZTTQQ:F&^1<+'&I$.8)3(S4*X
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M2VZC0!2%X:U8+""X[JN25IQ13S*-L@'DE!^*;1#02K+[MIR!?5 />A)Q1JA
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M.;?_S_'3L^QM.[SDL^E_I.L_4$L! A0#%     @ F8"M4@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "9@*U2K!6([.\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "9@*U2F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )F K5*H
MJ1Z:9@4  )\6   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "9@*U2:K<,N68(   7)   &
M    @(&J#0  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
MF8"M4E'%C<4" P  L D  !@              ("!1A8  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( )F K5+]4HQ\]08  %\=   8
M          " @7X9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " "9@*U2@PF;:8$"  #S!0  &               @(&I(   >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ F8"M4K'@9UD6"   "2$
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M965T,3 N>&UL4$L! A0#%     @ F8"M4NTD#?C("@  5AP  !D
M     ("!9T,  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )F K5(+O[:-\ T  'LK   9              "
M@5Q?  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ F8"M
M4@I#5DU?!   ^0D  !D              ("!@VT  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " "9@*U2!6(W>/,$  #\"P  &0
M        @($9<@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( )F K5*.9 1MDP(  )X%   9              " @4-W  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ F8"M4B)Q,1L5!   .0L
M !D              ("!#7H  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " "9@*U2+KH/%%,'  # $0  &0              @(%9?@
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( )F K5(PE9,G
MI@4  %0/   9              " @>.%  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ F8"M4F5YV7X;&   :$8  !D
M ("!P(L  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "9
M@*U29%9T=A(-  !K*   &0              @($2I   >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( )F K5+FZ>,3WPL  '0>   9
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M970R.2YX;6Q02P$"% ,4    " "9@*U20MZ),5 #   8!P  &0
M    @(%/S@  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M )F K5(8X-C!Z 8  '<8   9              " @=;1  !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ F8"M4M+C!3_K @  %08  !D
M             ("!]=@  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " "9@*U2A*0XS$T#  # !P  &0              @($7W   >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( )F K5)*:,K=_0(
M +4&   9              " @9O?  !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ F8"M4JS!<_3^ P  F@H  !D              ("!
MS^(  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " "9@*U2
M^R?CZ< #  #$"   &0              @($$YP  >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( )F K5('!>KK$@0  +P)   9
M      " @?OJ  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ F8"M4M".UO2<!@  OQ(  !D              ("!1.\  'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "9@*U29<R8Y$<)   1%@
M&0              @($7]@  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( )F K5(FO=P^,P0  /82   9              " @97_  !X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ F8"M4H_&9)%5
M!   )18  !D              ("!_P,! 'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " "9@*U23ES&PG@%  !%&   &0
M@(&+" $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )F
MK5*U"-T&%P0  &@/   9              " @3H. 0!X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ F8"M4@Y(B[\O @  U@0  !D
M         ("!B!(! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4
M    " "9@*U2V4[XD;,"  "2!P  &0              @('N% $ >&PO=V]R
M:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( )F K5+#Y!-2FP,  ,X+
M   9              " @=@7 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL
M4$L! A0#%     @ F8"M4FJ_FJ^+!   <18  !D              ("!JAL!
M 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " "9@*U2Q;1?
ME28%   .&   &0              @(%L( $ >&PO=V]R:W-H965T<R]S:&5E
M=#0X+GAM;%!+ 0(4 Q0    ( )F K5)ZY&JI*P,  (D*   9
M  " @<DE 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @
MF8"M4I;T\%*& @  KP8  !D              ("!*RD! 'AL+W=O<FMS:&5E
M=',O<VAE970U,"YX;6Q02P$"% ,4    " "9@*U260WGI30#  "="@  &0
M            @('H*P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4
M Q0    ( )F K5)W[;MN(P,  ,<*   9              " @5,O 0!X;"]W
M;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ F8"M4H1.]&\2!@
M\2   !D              ("!K3(! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX
M;6Q02P$"% ,4    " "9@*U2&)2MJOT"  #="0  &0              @('V
M. $ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( )F K5+C
MQCH7)00  /\/   9              " @2H\ 0!X;"]W;W)K<VAE971S+W-H
M965T-34N>&UL4$L! A0#%     @ F8"M4B1#N[Q6 @  508  !D
M     ("!AD ! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )F K5+4/+*OC 0  $L9   9              "
M@?I1 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ F8"M
M4I 1WK7A @  # D  !D              ("!O58! 'AL+W=O<FMS:&5E=',O
M<VAE970V,BYX;6Q02P$"% ,4    " "9@*U2-^E54?4"  #8"0  &0
M        @('560$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0
M   ( )F K5);4$4Z^P(  .P)   9              " @0%= 0!X;"]W;W)K
M<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ F8"M4J+H]D:^!   !Q,
M !D              ("!,V ! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q0
M2P$"% ,4    " "9@*U2E4=V5[\$   ]$@  &0              @($H90$
M>&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( )F K5(B7H*V
MV 4  'D=   9              " @1YJ 0!X;"]W;W)K<VAE971S+W-H965T
M-C<N>&UL4$L! A0#%     @ F8"M4F1&#,MB P  0 T  !D
M ("!+7 ! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " "9
M@*U2$,%:XP\#  #6"   &0              @('&<P$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( )F K5+1!PS$1P<  -DQ   9
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M;',O+G)E;'-02P$"% ,4    " "9@*U2CZX?@X %   9,   #P
M    @ &@CP$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ F8"M4K?' S!"
M @  0BL  !H              ( !394! 'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ F8"M4OC# AT& @  3RH  !,
M ( !QY<! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %$ 40 N%@  _ID!
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>312</ContextCount>
  <ElementCount>435</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>98</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit</Role>
      <ShortName>Consolidated Statements of Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Recent Accounting Standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/RecentAccountingStandards</Role>
      <ShortName>Recent Accounting Standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2105103 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108104 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Prepaid Expenses and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets</Role>
      <ShortName>Prepaid Expenses and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2128109 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135110 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - Employee Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EmployeeBenefits</Role>
      <ShortName>Employee Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2141112 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2142113 - Disclosure - Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/OtherComprehensiveIncomeLoss</Role>
      <ShortName>Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2145114 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2151115 - Disclosure - Earnings (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EarningsLossPerShare</Role>
      <ShortName>Earnings (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2154116 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2156117 - Disclosure - Financial Instruments and Financial Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk</Role>
      <ShortName>Financial Instruments and Financial Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2162118 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://soterahealth.com/role/RecentAccountingStandards</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/RevenueRecognition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/Acquisitions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/Inventories</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2326306 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/AccruedLiabilities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2329307 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/LongTermDebt</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2338308 - Disclosure - Employee Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EmployeeBenefitsTables</Role>
      <ShortName>Employee Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/EmployeeBenefits</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2343309 - Disclosure - Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/OtherComprehensiveIncomeLossTables</Role>
      <ShortName>Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/OtherComprehensiveIncomeLoss</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2346310 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/ShareBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2352311 - Disclosure - Earnings (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EarningsLossPerShareTables</Role>
      <ShortName>Earnings (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/EarningsLossPerShare</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2357312 - Disclosure - Financial Instruments and Financial Risk (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables</Role>
      <ShortName>Financial Instruments and Financial Risk (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2363313 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://soterahealth.com/role/SegmentInformation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/BasisofPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/BasisofPresentationPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/RevenueRecognitionDetails</Role>
      <ShortName>Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/RevenueRecognitionTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Acquisitions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails</Role>
      <ShortName>Acquisitions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Acquisitions - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails</Role>
      <ShortName>Acquisitions - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Acquisitions - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AcquisitionsProFormaInformationDetails</Role>
      <ShortName>Acquisitions - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/InventoriesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Intangibles (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2423410 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - Goodwill and Other Intangible Assets - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2427412 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2430413 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - Long-Term Debt - Senior Secured Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails</Role>
      <ShortName>Long-Term Debt - Senior Secured Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - Long-Term Debt - First Lien Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails</Role>
      <ShortName>Long-Term Debt - First Lien Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - Long-Term Debt - Repayments of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails</Role>
      <ShortName>Long-Term Debt - Repayments of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - Long-Term Debt - Aggregate Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails</Role>
      <ShortName>Long-Term Debt - Aggregate Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2436418 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/IncomeTaxes</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2439419 - Disclosure - Employee Benefits - Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails</Role>
      <ShortName>Employee Benefits - Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2440420 - Disclosure - Employee Benefits - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails</Role>
      <ShortName>Employee Benefits - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2444421 - Disclosure - Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/OtherComprehensiveIncomeLossTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2447422 - Disclosure - Share-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Share-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2448423 - Disclosure - Share-Based Compensation - Pre-IPO Awards (Class??B-1 and B-2) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details</Role>
      <ShortName>Share-Based Compensation - Pre-IPO Awards (Class??B-1 and B-2) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2449424 - Disclosure - Share-Based Compensation - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2450425 - Disclosure - Share-Based Compensation - RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/ShareBasedCompensationRSUsDetails</Role>
      <ShortName>Share-Based Compensation - RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2453426 - Disclosure - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/EarningsLossPerShareDetails</Role>
      <ShortName>Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2455427 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://soterahealth.com/role/CommitmentandContingencies</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2458428 - Disclosure - Financial Instruments and Financial Risk - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails</Role>
      <ShortName>Financial Instruments and Financial Risk - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2459429 - Disclosure - Financial Instruments and Financial Risk - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Financial Risk - Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2460430 - Disclosure - Financial Instruments and Financial Risk - Activities of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails</Role>
      <ShortName>Financial Instruments and Financial Risk - Activities of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2461431 - Disclosure - Financial Instruments and Financial Risk - Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Financial Instruments and Financial Risk - Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2464432 - Disclosure - Segment Information - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails</Role>
      <ShortName>Segment Information - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2465433 - Disclosure - Segment Information - Segment Operating Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails</Role>
      <ShortName>Segment Information - Segment Operating Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="shc-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2466434 - Disclosure - Segment Information - Reconciliation of Reportable Segment Amounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails</Role>
      <ShortName>Segment Information - Reconciliation of Reportable Segment Amounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="shc-20210331.htm">shc-20210331.htm</File>
    <File>shc-20210331.xsd</File>
    <File>shc-20210331_cal.xml</File>
    <File>shc-20210331_def.xml</File>
    <File>shc-20210331_exhibitx10x2.htm</File>
    <File>shc-20210331_lab.xml</File>
    <File>shc-20210331_pre.xml</File>
    <File>shc20210331_exhibitx31x2.htm</File>
    <File>shc20210331_exhibitx32x1.htm</File>
    <File>shc_20210331xexhibitx31x1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>shc-20210331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>92
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "shc-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 34,
   "contextCount": 312,
   "dts": {
    "calculationLink": {
     "local": [
      "shc-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "shc-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "shc-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "shc-20210331_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "shc-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "shc-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 617,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 3,
    "http://soterahealth.com/20210331": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 9
   },
   "keyCustom": 39,
   "keyStandard": 396,
   "memberCustom": 36,
   "memberStandard": 61,
   "nsprefix": "shc",
   "nsuri": "http://soterahealth.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://soterahealth.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2105103 - Disclosure - Revenue Recognition",
     "role": "http://soterahealth.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108104 - Disclosure - Acquisitions",
     "role": "http://soterahealth.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Inventories",
     "role": "http://soterahealth.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Prepaid Expenses and Other Current Assets",
     "role": "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets",
     "shortName": "Prepaid Expenses and Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://soterahealth.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Accrued Liabilities",
     "role": "http://soterahealth.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128109 - Disclosure - Long-Term Debt",
     "role": "http://soterahealth.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135110 - Disclosure - Income Taxes",
     "role": "http://soterahealth.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - Employee Benefits",
     "role": "http://soterahealth.com/role/EmployeeBenefits",
     "shortName": "Employee Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141112 - Disclosure - Related Parties",
     "role": "http://soterahealth.com/role/RelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://soterahealth.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142113 - Disclosure - Other Comprehensive Income (Loss)",
     "role": "http://soterahealth.com/role/OtherComprehensiveIncomeLoss",
     "shortName": "Other Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145114 - Disclosure - Share-Based Compensation",
     "role": "http://soterahealth.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151115 - Disclosure - Earnings (Loss) Per Share",
     "role": "http://soterahealth.com/role/EarningsLossPerShare",
     "shortName": "Earnings (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2154116 - Disclosure - Commitment and Contingencies",
     "role": "http://soterahealth.com/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156117 - Disclosure - Financial Instruments and Financial Risk",
     "role": "http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk",
     "shortName": "Financial Instruments and Financial Risk",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162118 - Disclosure - Segment Information",
     "role": "http://soterahealth.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation (Policies)",
     "role": "http://soterahealth.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2306301 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://soterahealth.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Acquisitions (Tables)",
     "role": "http://soterahealth.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Inventories (Tables)",
     "role": "http://soterahealth.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)",
     "role": "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables",
     "shortName": "Prepaid Expenses and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326306 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://soterahealth.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329307 - Disclosure - Long-Term Debt (Tables)",
     "role": "http://soterahealth.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338308 - Disclosure - Employee Benefits (Tables)",
     "role": "http://soterahealth.com/role/EmployeeBenefitsTables",
     "shortName": "Employee Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343309 - Disclosure - Other Comprehensive Income (Loss) (Tables)",
     "role": "http://soterahealth.com/role/OtherComprehensiveIncomeLossTables",
     "shortName": "Other Comprehensive Income (Loss) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346310 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://soterahealth.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352311 - Disclosure - Earnings (Loss) Per Share (Tables)",
     "role": "http://soterahealth.com/role/EarningsLossPerShareTables",
     "shortName": "Earnings (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357312 - Disclosure - Financial Instruments and Financial Risk (Tables)",
     "role": "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables",
     "shortName": "Financial Instruments and Financial Risk (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2363313 - Disclosure - Segment Information (Tables)",
     "role": "http://soterahealth.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "role": "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Basis of Presentation (Details)",
     "role": "http://soterahealth.com/role/BasisofPresentationDetails",
     "shortName": "Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ie80833d87f3a475c9d5cce381fd18476_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "shc:NumberOfSubsidiariesWithNonControllingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "subsidiary",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - Revenue Recognition (Details)",
     "role": "http://soterahealth.com/role/RevenueRecognitionDetails",
     "shortName": "Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ide0e38a11c4d4065969f8f8fe57c3865_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410403 - Disclosure - Acquisitions - Additional Information (Details)",
     "role": "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
     "shortName": "Acquisitions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i1bce9fe44e6040c79f3e332aa1935e74_D20210308-20210308",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411404 - Disclosure - Acquisitions - Purchase Price Allocation (Details)",
     "role": "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails",
     "shortName": "Acquisitions - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i87983e1c3149404fb5ce6f9aa7ddef3c_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Acquisitions - Pro Forma Information (Details)",
     "role": "http://soterahealth.com/role/AcquisitionsProFormaInformationDetails",
     "shortName": "Acquisitions - Pro Forma Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:BusinessAcquisitionProFormaInformationTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Inventories (Details)",
     "role": "http://soterahealth.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i39349c5dcb984b15b4709ccb996bd176_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)",
     "role": "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - Goodwill and Other Intangible Assets - Intangibles (Details)",
     "role": "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails",
     "shortName": "Goodwill and Other Intangible Assets - Intangibles (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423410 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)",
     "role": "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails",
     "shortName": "Goodwill and Other Intangible Assets - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical)",
     "role": "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical",
     "shortName": "Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - Goodwill and Other Intangible Assets - Future Amortization Expense (Details)",
     "role": "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427412 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://soterahealth.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430413 - Disclosure - Long-Term Debt - Schedule of Debt (Details)",
     "role": "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "icd422b230de24395ba1b25c54a6db45d_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - Long-Term Debt - Senior Secured Credit Facilities (Details)",
     "role": "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails",
     "shortName": "Long-Term Debt - Senior Secured Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i5076ff942fc745c6b7f8da2a4d66baf0_I20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "if63b06a187344473bec2c467e8a1eaa8_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - Long-Term Debt - First Lien Notes (Details)",
     "role": "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
     "shortName": "Long-Term Debt - First Lien Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "if63b06a187344473bec2c467e8a1eaa8_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - Long-Term Debt - Repayments of Debt (Details)",
     "role": "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
     "shortName": "Long-Term Debt - Repayments of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i8d8e14e70c584ea9862007b0ec95c9d8_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "shc:RecognitionOfDebtPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - Long-Term Debt - Aggregate Maturities (Details)",
     "role": "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails",
     "shortName": "Long-Term Debt - Aggregate Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436418 - Disclosure - Income Taxes (Details)",
     "role": "http://soterahealth.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439419 - Disclosure - Employee Benefits - Net Periodic Benefit Cost (Details)",
     "role": "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails",
     "shortName": "Employee Benefits - Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i948e2ff42c384cbe92ba690b76dfaac3_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "shc:DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440420 - Disclosure - Employee Benefits - Additional Information (Details)",
     "role": "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
     "shortName": "Employee Benefits - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "iec88d5b798444874850d669967cf4dbd_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "shc:DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i39349c5dcb984b15b4709ccb996bd176_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444421 - Disclosure - Other Comprehensive Income (Loss) (Details)",
     "role": "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails",
     "shortName": "Other Comprehensive Income (Loss) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i2cee32ded1db432886dca18fff663aa5_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ifbd8b853840d4d58a44be8b4f396efe6_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447422 - Disclosure - Share-Based Compensation - Additional Information (Details)",
     "role": "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
     "shortName": "Share-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ifbd8b853840d4d58a44be8b4f396efe6_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i532429720d76464fb288ef6d7f8c4da4_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448423 - Disclosure - Share-Based Compensation - Pre-IPO Awards (Class\u00a0B-1 and B-2) (Details)",
     "role": "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
     "shortName": "Share-Based Compensation - Pre-IPO Awards (Class\u00a0B-1 and B-2) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i532429720d76464fb288ef6d7f8c4da4_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i39349c5dcb984b15b4709ccb996bd176_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449424 - Disclosure - Share-Based Compensation - Stock Options (Details)",
     "role": "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails",
     "shortName": "Share-Based Compensation - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i39349c5dcb984b15b4709ccb996bd176_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "id702121c7c324bf6885a6bf80cae7fe4_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450425 - Disclosure - Share-Based Compensation - RSUs (Details)",
     "role": "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails",
     "shortName": "Share-Based Compensation - RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "id702121c7c324bf6885a6bf80cae7fe4_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453426 - Disclosure - Earnings (Loss) Per Share (Details)",
     "role": "http://soterahealth.com/role/EarningsLossPerShareDetails",
     "shortName": "Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "shc:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455427 - Disclosure - Commitment and Contingencies (Details)",
     "role": "http://soterahealth.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "shc:LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458428 - Disclosure - Financial Instruments and Financial Risk - Additional Information (Details)",
     "role": "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
     "shortName": "Financial Instruments and Financial Risk - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i6ed3cf78f0d24298bc641938f88ea10f_D20200101-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ic30522771c8a4c2ca8b28897797aa79f_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459429 - Disclosure - Financial Instruments and Financial Risk - Derivative Instruments (Details)",
     "role": "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails",
     "shortName": "Financial Instruments and Financial Risk - Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ifc5b766a46664492ac40f1cf7af1b926_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ia3f548aa16134334acbcc16023544496_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460430 - Disclosure - Financial Instruments and Financial Risk - Activities of Derivative Instruments (Details)",
     "role": "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
     "shortName": "Financial Instruments and Financial Risk - Activities of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ia3f548aa16134334acbcc16023544496_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i3e003cc982634a42a6004e9be503ae52_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Equity (Deficit)",
     "role": "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
     "shortName": "Consolidated Statements of Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i3e003cc982634a42a6004e9be503ae52_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ic30522771c8a4c2ca8b28897797aa79f_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461431 - Disclosure - Financial Instruments and Financial Risk - Assets and Liabilities Measured on Recurring Basis (Details)",
     "role": "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "shortName": "Financial Instruments and Financial Risk - Assets and Liabilities Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "ie31b8c09e1a04e3abd0d5865f45be488_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464432 - Disclosure - Segment Information - Additional Information (Details)",
     "role": "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
     "shortName": "Segment Information - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i35ac9047c5b543a3976685cc7c6f80bc_D20210101-20210331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465433 - Disclosure - Segment Information - Segment Operating Results (Details)",
     "role": "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails",
     "shortName": "Segment Information - Segment Operating Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i01c4ac064c024fa28900d1c7e54cbe41_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466434 - Disclosure - Segment Information - Reconciliation of Reportable Segment Amounts (Details)",
     "role": "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
     "shortName": "Segment Information - Reconciliation of Reportable Segment Amounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "if3df52f4ae5245a9b22427aec21621cd_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://soterahealth.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountingChangesAndErrorCorrectionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Recent Accounting Standards",
     "role": "http://soterahealth.com/role/RecentAccountingStandards",
     "shortName": "Recent Accounting Standards",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "shc-20210331.htm",
      "contextRef": "i279f9f1079504c10b8a02fb9f6a807c0_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountingChangesAndErrorCorrectionsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 98,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "shc_A2020OmnibusIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Omnibus Incentive Plan",
        "label": "2020 Omnibus Incentive Plan [Member]",
        "terseLabel": "2020 Omnibus Incentive Plan"
       }
      }
     },
     "localname": "A2020OmnibusIncentivePlanMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_AccruedInterestExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest Expense, Current",
        "label": "Accrued Interest Expense, Current",
        "terseLabel": "Accrued interest expense"
       }
      }
     },
     "localname": "AccruedInterestExpenseCurrent",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_AcquisitionAndDivestitureRelatedChargesNet": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition And Divestiture Related Charges, Net",
        "label": "Acquisition And Divestiture Related Charges, Net",
        "terseLabel": "Acquisition and divestiture related charges, net"
       }
      }
     },
     "localname": "AcquisitionAndDivestitureRelatedChargesNet",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_AmortizationOfIntangibleAssetsNonproduction": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Intangible Assets, Nonproduction",
        "label": "Amortization of Intangible Assets, Nonproduction",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssetsNonproduction",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BioScienceLaboratoriesLLCBioScienceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BioScience Laboratories, LLC (BioScience)",
        "label": "BioScience Laboratories, LLC (BioScience) [Member]",
        "terseLabel": "BioScience"
       }
      }
     },
     "localname": "BioScienceLaboratoriesLLCBioScienceMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Investment in Unconsolidated Affiliate",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Investment in Unconsolidated Affiliate",
        "terseLabel": "Investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInvestmentInUnconsolidatedAffiliate",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Assumed long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNoncurrentLiabilitiesOther",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets (Liabilities), Net",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets (Liabilities), Net",
        "terseLabel": "Working capital, net"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsLiabilitiesNet",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital, Net",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Working Capital, Net",
        "terseLabel": "Working capital, net"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentWorkingCapitalNet",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment in Unconsolidated Affiliate",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investment in Unconsolidated Affiliate",
        "terseLabel": "Investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentInUnconsolidatedAffiliate",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net",
        "terseLabel": "Working capital, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilitiesNet",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital, Net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Working Capital, Net",
        "terseLabel": "Working capital, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWorkingCapitalNet",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_CashProceedsToSponsorsRatioToInvestedCapital": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Proceeds to Sponsors, Ratio to Invested Capital",
        "label": "Cash Proceeds to Sponsors, Ratio to Invested Capital",
        "terseLabel": "Cash proceeds to sponsors, ratio to invested capital"
       }
      }
     },
     "localname": "CashProceedsToSponsorsRatioToInvestedCapital",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent , Percentage",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Purchase of Interest by Parent , Percentage",
        "terseLabel": "Percent of purchase of interest"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParentPercentage",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_CostAndExpensesCOVID19": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost And Expenses, COVID-19",
        "label": "Cost And Expenses, COVID-19",
        "terseLabel": "COVID-19 expenses"
       }
      }
     },
     "localname": "CostAndExpensesCOVID19",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One",
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Three",
        "label": "Customer Three [Member]",
        "terseLabel": "Customer Three"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer Two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_DebtInstrumentEffectiveReductionInCurrentInterestRates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Effective Reduction In Current Interest Rates",
        "label": "Debt Instrument, Effective Reduction In Current Interest Rates",
        "terseLabel": "Effective reduction in current interest rates"
       }
      }
     },
     "localname": "DebtInstrumentEffectiveReductionInCurrentInterestRates",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_DebtInstrumentVariableRateFloor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Variable Rate Floor",
        "label": "Debt Instrument, Variable Rate Floor",
        "terseLabel": "LIBOR floor"
       }
      }
     },
     "localname": "DebtInstrumentVariableRateFloor",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_DebtIssuanceCostsRefinancingAdditionalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Issuance Costs, Refinancing, Additional Expense",
        "label": "Debt Issuance Costs, Refinancing, Additional Expense",
        "terseLabel": "Additional expense"
       }
      }
     },
     "localname": "DebtIssuanceCostsRefinancingAdditionalExpense",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Annual Funding Requirements For Next Five Years",
        "label": "Defined Benefit Plan, Annual Funding Requirements For Next Five Years",
        "terseLabel": "Expect funding requirements in each of the next five years"
       }
      }
     },
     "localname": "DefinedBenefitPlanAnnualFundingRequirementsForNextFiveYears",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_DerivativeNumberOfInstrumentsAmended": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Number of Instruments Amended",
        "label": "Derivative, Number of Instruments Amended",
        "terseLabel": "Number of instruments amended"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsAmended",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "shc_DerivativeOptionPremium": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Option Premium",
        "label": "Derivative, Option Premium",
        "terseLabel": "Option premium"
       }
      }
     },
     "localname": "DerivativeOptionPremium",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_EthyleneOxideTortLitigationGeorgiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ethylene Oxide Tort Litigation \u2013 Georgia",
        "label": "Ethylene Oxide Tort Litigation \u2013 Georgia [Member]",
        "terseLabel": "Ethylene Oxide Tort Litigation \u2013 Georgia"
       }
      }
     },
     "localname": "EthyleneOxideTortLitigationGeorgiaMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_EthyleneOxideTortLitigationIllinoisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ethylene Oxide Tort Litigation - Illinois",
        "label": "Ethylene Oxide Tort Litigation - Illinois [Member]",
        "terseLabel": "Ethylene Oxide Tort Litigation - Illinois"
       }
      }
     },
     "localname": "EthyleneOxideTortLitigationIllinoisMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_FinanceLeaseLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Liability",
        "label": "Finance Lease Liability [Member]",
        "terseLabel": "Finance Lease Obligations (with current portion)"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_FirstLienNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Notes due 2026",
        "label": "First Lien Notes due 2026 [Member]",
        "terseLabel": "First Lien Notes due 2026"
       }
      }
     },
     "localname": "FirstLienNotesDue2026Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Gain (Loss) and Gain (Loss) on Embedded Derivative",
        "label": "Foreign Currency Gain (Loss) and Gain (Loss) on Embedded Derivative",
        "negatedTerseLabel": "(Gain) loss on foreign currency and embedded derivatives"
       }
      }
     },
     "localname": "ForeignCurrencyGainLossAndGainLossOnEmbeddedDerivative",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_GainContingencyPeriodOfBusinessInterruption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain Contingency, Period Of Business Interruption",
        "label": "Gain Contingency, Period Of Business Interruption",
        "terseLabel": "Period of inability"
       }
      }
     },
     "localname": "GainContingencyPeriodOfBusinessInterruption",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "shc_InterestRateCap1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap1",
        "label": "Interest Rate Cap1 [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCap1Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_InterestRateCapFebruary2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap February 2021",
        "label": "Interest Rate Cap February 2021 [Member]",
        "terseLabel": "Interest Rate Cap February 2021"
       }
      }
     },
     "localname": "InterestRateCapFebruary2021Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_InterestRateCapJune2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap June 2020",
        "label": "Interest Rate Cap June 2020 [Member]",
        "terseLabel": "Interest Rate Cap June 2020"
       }
      }
     },
     "localname": "InterestRateCapJune2020Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_InterestRateCapOctober2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Cap October 2017",
        "label": "Interest Rate Cap October 2017 [Member]",
        "terseLabel": "Interest Rate Cap October 2017"
       }
      }
     },
     "localname": "InterestRateCapOctober2017Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_IotronIndustriesCanadaIncIotronMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Iotron Industries Canada, Inc. (Iotron)",
        "label": "Iotron Industries Canada, Inc. (Iotron) [Member]",
        "terseLabel": "Iotron"
       }
      }
     },
     "localname": "IotronIndustriesCanadaIncIotronMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_LandUseRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land-Use Rights",
        "label": "Land-Use Rights [Member]",
        "terseLabel": "Land-use rights"
       }
      }
     },
     "localname": "LandUseRightsMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_LettersOfCreditSolvencyPaymentAsPercentOfMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Letters of Credit, Solvency Payment as Percent of Market Value",
        "label": "Letters of Credit, Solvency Payment as Percent of Market Value",
        "terseLabel": "Solvency payment as percent of market value"
       }
      }
     },
     "localname": "LettersOfCreditSolvencyPaymentAsPercentOfMarketValue",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_LicensingAgreementsRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Agreements, Renewal Term",
        "label": "Licensing Agreements, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LicensingAgreementsRenewalTerm",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "shc_LimitationOnDeductibilityOfInterestExpenseCARESAct": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limitation On Deductibility Of Interest Expense, CARES Act",
        "label": "Limitation On Deductibility Of Interest Expense, CARES Act",
        "terseLabel": "Limitation on deductibility of interest expense"
       }
      }
     },
     "localname": "LimitationOnDeductibilityOfInterestExpenseCARESAct",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded From Other Party, Before Pre-Judgment Interest",
        "label": "Litigation Settlement, Amount Awarded From Other Party, Before Pre-Judgment Interest",
        "terseLabel": "Amount awarded from other party, before pre-judgment interest"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherPartyBeforePreJudgmentInterest",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_LitigationSettlementCostsAssessedAndAwardedInFavor": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Costs Assessed And Awarded In Favor",
        "label": "Litigation Settlement, Costs Assessed And Awarded In Favor",
        "terseLabel": "Costs assessed and awarded in favor"
       }
      }
     },
     "localname": "LitigationSettlementCostsAssessedAndAwardedInFavor",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_LitigationSettlementDisbursementsAssessedAndAwardedInFavor": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Disbursements Assessed And Awarded In Favor",
        "label": "Litigation Settlement, Disbursements Assessed And Awarded In Favor",
        "terseLabel": "Disbursements assessed and awarded in favor"
       }
      }
     },
     "localname": "LitigationSettlementDisbursementsAssessedAndAwardedInFavor",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_LongTermDebtMaturityAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Debt, Maturity, after Year Four",
        "label": "Long-Term Debt, Maturity, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturityAfterYearFour",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Undiscounted Amount Of Insurance-Related Assessment Liability Per Occurrence",
        "label": "Loss Contingency, Undiscounted Amount Of Insurance-Related Assessment Liability Per Occurrence",
        "terseLabel": "Loss contingency, insurance limits per occurrence"
       }
      }
     },
     "localname": "LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiabilityPerOccurrence",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_NelsonFairfieldIncNelsonFairfieldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nelson Fairfield, Inc. (Nelson Fairfield)",
        "label": "Nelson Fairfield, Inc. (Nelson Fairfield) [Member]",
        "terseLabel": "Nelson Fairfield"
       }
      }
     },
     "localname": "NelsonFairfieldIncNelsonFairfieldMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_NelsonLabsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nelson\u00a0Labs",
        "label": "Nelson\u00a0Labs [Member]",
        "terseLabel": "Nelson\u00a0Labs"
       }
      }
     },
     "localname": "NelsonLabsMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://soterahealth.com/role/RevenueRecognitionDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_NordionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nordion",
        "label": "Nordion [Member]",
        "terseLabel": "Nordion"
       }
      }
     },
     "localname": "NordionMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://soterahealth.com/role/RevenueRecognitionDetails",
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss",
        "label": "Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss [Member]",
        "terseLabel": "Nordion v Factory Mutual Insurance Company, 2010 Business Interruption Loss"
       }
      }
     },
     "localname": "NordionVFactoryMutualInsuranceCompany2010BusinessInterruptionLossMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_NumberOfSubsidiariesWithNonControllingInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Subsidiaries With Non-Controlling Interest",
        "label": "Number Of Subsidiaries With Non-Controlling Interest",
        "terseLabel": "Number of subsidiaries with non-controlling interest"
       }
      }
     },
     "localname": "NumberOfSubsidiariesWithNonControllingInterest",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "shc_OtherLongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long Term Debt",
        "label": "Other Long Term Debt [Member]",
        "terseLabel": "Other long-term debt"
       }
      }
     },
     "localname": "OtherLongTermDebtMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_PercentOfBorrowingLimitationDueToCashFlowExposure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent of Borrowing Limitation Due To Cash Flow Exposure",
        "label": "Percent of Borrowing Limitation Due To Cash Flow Exposure",
        "terseLabel": "Percent of borrowing limitation due to cash flow exposure"
       }
      }
     },
     "localname": "PercentOfBorrowingLimitationDueToCashFlowExposure",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_PercentOfReductionInResidentialPropertyValueAssessment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percent Of Reduction In Residential Property Value Assessment",
        "label": "Percent Of Reduction In Residential Property Value Assessment",
        "terseLabel": "Percent of reduction in residential property value assessment"
       }
      }
     },
     "localname": "PercentOfReductionInResidentialPropertyValueAssessment",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "shc_PreIPOB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-IPO B-1",
        "label": "Pre-IPO B-1 [Member]",
        "terseLabel": "Pre-IPO B-1"
       }
      }
     },
     "localname": "PreIPOB1Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_PreIPOB2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-IPO B-2",
        "label": "Pre-IPO B-2 [Member]",
        "terseLabel": "Pre-IPO B-2"
       }
      }
     },
     "localname": "PreIPOB2Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_PrepaidMaintenanceContractsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Maintenance Contracts, Current",
        "label": "Prepaid Maintenance Contracts, Current",
        "terseLabel": "Prepaid maintenance contracts"
       }
      }
     },
     "localname": "PrepaidMaintenanceContractsCurrent",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_PrepaidSoftwareLicensingCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Software Licensing, Current",
        "label": "Prepaid Software Licensing, Current",
        "terseLabel": "Prepaid software licensing"
       }
      }
     },
     "localname": "PrepaidSoftwareLicensingCurrent",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_RecognitionOfDebtPremium": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition Of Debt Premium",
        "label": "Recognition Of Debt Premium",
        "terseLabel": "Write-off of debt premium"
       }
      }
     },
     "localname": "RecognitionOfDebtPremium",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_SaleOfStockNumberOfAdditionalSharesToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Stock, Number of Additional Shares To Be Repurchased",
        "label": "Sale of Stock, Number of Additional Shares To Be Repurchased",
        "terseLabel": "Number of additional shares to be repurchased (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfAdditionalSharesToBeRepurchased",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "shc_SealedSourceAndSupplyAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sealed Source And Supply Agreements",
        "label": "Sealed Source And Supply Agreements [Member]",
        "terseLabel": "Sealed source and supply agreements"
       }
      }
     },
     "localname": "SealedSourceAndSupplyAgreementsMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SecondLienNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Lien Notes",
        "label": "Second Lien Notes [Member]",
        "terseLabel": "Second Lien Notes"
       }
      }
     },
     "localname": "SecondLienNotesMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SegmentIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Income (Loss)",
        "label": "Segment Income (Loss)",
        "terseLabel": "Segment income"
       }
      }
     },
     "localname": "SegmentIncomeLoss",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "shc_SeniorNotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, Due 2026",
        "label": "Senior Notes, Due 2026 [Member]",
        "terseLabel": "Senior notes, due 2026"
       }
      }
     },
     "localname": "SeniorNotesDue2026Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SeniorNotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, Due 2027",
        "label": "Senior Notes, Due 2027 [Member]",
        "terseLabel": "Senior notes, due 2027"
       }
      }
     },
     "localname": "SeniorNotesDue2027Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SeniorSecuredCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Credit Facilities",
        "label": "Senior Secured Credit Facilities [Member]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_ShareBasedPaymentArrangementTrancheFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Tranche Five",
        "label": "Share-based Payment Arrangement, Tranche Five [Member]",
        "terseLabel": "Year Five"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTrancheFiveMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_ShareBasedPaymentArrangementTrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Tranche Four",
        "label": "Share-based Payment Arrangement, Tranche Four [Member]",
        "terseLabel": "Year Four"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTrancheFourMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SterigenicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sterigenics",
        "label": "Sterigenics [Member]",
        "terseLabel": "Sterigenics"
       }
      }
     },
     "localname": "SterigenicsMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://soterahealth.com/role/RevenueRecognitionDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SubsidiaryOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary One",
        "label": "Subsidiary One [Member]",
        "terseLabel": "Subsidiary One"
       }
      }
     },
     "localname": "SubsidiaryOneMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_SubsidiaryTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Two",
        "label": "Subsidiary Two [Member]",
        "terseLabel": "Subsidiary Two"
       }
      }
     },
     "localname": "SubsidiaryTwoMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_TermLoanAndSecondLienNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan and Second Lien Notes",
        "label": "Term Loan and Second Lien Notes [Member]",
        "terseLabel": "Term Loan and Second Lien Notes"
       }
      }
     },
     "localname": "TermLoanAndSecondLienNotesMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_TermLoanDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan, Due 2026",
        "label": "Term Loan, Due 2026 [Member]",
        "terseLabel": "Term loan, due 2026"
       }
      }
     },
     "localname": "TermLoanDue2026Member",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_UnnamedEBeamJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unnamed E-Beam Joint Venture",
        "label": "Unnamed E-Beam Joint Venture [Member]",
        "terseLabel": "Unnamed E-Beam Joint Venture"
       }
      }
     },
     "localname": "UnnamedEBeamJointVentureMember",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "shc_WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of Deferred Debt Issuance Cost and Debt Discount",
        "label": "Write-off of Deferred Debt Issuance Cost and Debt Discount",
        "terseLabel": "Write-off of unamortized debt issuance costs and debt discounts"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCostAndDebtDiscount",
     "nsuri": "http://soterahealth.com/20210331",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r183",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r203",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r183",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r203",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r213",
      "r306",
      "r311",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r399",
      "r405",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r617",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r399",
      "r405",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r617",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r213",
      "r306",
      "r311",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "terseLabel": "Officer"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r209",
      "r306",
      "r309",
      "r574",
      "r616",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r209",
      "r306",
      "r309",
      "r574",
      "r616",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r343",
      "r399",
      "r405",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r617",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r343",
      "r399",
      "r405",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r573",
      "r617",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r210",
      "r211",
      "r306",
      "r310",
      "r619",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r210",
      "r211",
      "r306",
      "r310",
      "r619",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r271",
      "r400",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r215",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsTextBlock": {
     "auth_ref": [
      "r140",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.",
        "label": "Accounting Changes and Error Corrections [Text Block]",
        "terseLabel": "Recent Accounting Standards"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RecentAccountingStandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r26",
      "r216",
      "r217"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for uncollectible accounts of $603 and $708, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r20",
      "r581",
      "r599"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedInsuranceCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r47"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable to insurance entities to mitigate potential loss from various risks or to satisfy a promise to provide certain coverage's to employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Insurance, Current",
        "terseLabel": "Insurance accrual"
       }
      }
     },
     "localname": "AccruedInsuranceCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails",
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r47"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedUtilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r47"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for utilities, such as electrical power, heating oil, natural gas, and water. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Utilities, Current",
        "terseLabel": "Accrued utilities"
       }
      }
     },
     "localname": "AccruedUtilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r72",
      "r78",
      "r79",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Defined Benefit Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": {
     "auth_ref": [
      "r71",
      "r78",
      "r79",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]",
        "terseLabel": "Interest Rate Swaps"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r75",
      "r77",
      "r78",
      "r601",
      "r626",
      "r627"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r78",
      "r79",
      "r129",
      "r130",
      "r131",
      "r494",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "AOCI Attributable to Parent",
        "verboseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r78",
      "r79",
      "r494",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Estimated useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r432"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r429",
      "r430",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r407",
      "r409",
      "r434",
      "r435"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r409",
      "r426",
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r218",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for uncollectible accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r95",
      "r114",
      "r551"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r114",
      "r240",
      "r248"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetRetirementObligationAccretionExpense": {
     "auth_ref": [
      "r259",
      "r261"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion expense recognized during the period that is associated with an asset retirement obligation. Accretion expense measures and incorporates changes due to the passage of time into the carrying amount of the liability.",
        "label": "Asset Retirement Obligation, Accretion Expense",
        "terseLabel": "Accretion of asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationAccretionExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetRetirementObligationCurrent": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligation, Current",
        "terseLabel": "Current portion of asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetRetirementObligationsNoncurrent": {
     "auth_ref": [
      "r260"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.",
        "label": "Asset Retirement Obligations, Noncurrent",
        "terseLabel": "Noncurrent asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r123",
      "r191",
      "r198",
      "r205",
      "r222",
      "r488",
      "r496",
      "r535",
      "r579",
      "r598"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r65",
      "r123",
      "r222",
      "r488",
      "r496",
      "r535"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r410",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails",
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Alternative Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r395",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r395",
      "r401",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Interest acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.",
        "label": "Business Acquisition, Pro Forma Information [Table Text Block]",
        "terseLabel": "Business Acquisition, Pro Forma Information"
       }
      }
     },
     "localname": "BusinessAcquisitionProFormaInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "terseLabel": "Goodwill deductible amount"
       }
      }
     },
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.",
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsProFormaInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r460"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r477",
      "r478",
      "r479"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r476",
      "r477",
      "r478",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Liabilities incurred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to items of consideration transferred in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Consideration Transferred",
        "negatedTotalLabel": "Total estimated purchase price"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to intangibles acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of any measurement period adjustment (as defined) realized during the reporting period to property, plant, and equipment acquired in connection with a business combination for which the initial accounting was incomplete.",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]",
        "terseLabel": "Measurement Period Adjustments"
       }
      }
     },
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Finite-lived intangibles"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Assumed long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r467",
      "r468"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant, and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total estimated purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of net gain (loss) recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net",
        "terseLabel": "Step acquisition, gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r114",
      "r262",
      "r264",
      "r265"
     ],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Plant closure expenses"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r118",
      "r119",
      "r120"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Equipment purchases included in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAcquiredInExcessOfPaymentsToAcquireBusiness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of a business when the cash held by the acquired business exceeds the cash payments to acquire the business.",
        "label": "Cash Acquired in Excess of Payments to Acquire Business",
        "terseLabel": "Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredInExcessOfPaymentsToAcquireBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r39",
      "r116"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r110",
      "r116",
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, including restricted cash, at end of period",
        "periodStartLabel": "Cash and cash equivalents, including restricted cash, at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r110",
      "r540"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents, including restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r122",
      "r123",
      "r147",
      "r148",
      "r149",
      "r154",
      "r158",
      "r166",
      "r167",
      "r168",
      "r222",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r53",
      "r270",
      "r586",
      "r606"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "See Commitments and contingencies note"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r269",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r129",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, with $0.01 par value, 1,200,000 shares authorized; 285,990 shares issued at March 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r82",
      "r84",
      "r85",
      "r93",
      "r592",
      "r612"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss) attributable to Sotera Health Company"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r84",
      "r92",
      "r486",
      "r487",
      "r500",
      "r591",
      "r611"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: comprehensive income (loss) attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r84",
      "r91",
      "r485",
      "r500",
      "r590",
      "r610"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income (loss):"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r90",
      "r100",
      "r589",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r173",
      "r174",
      "r213",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r173",
      "r174",
      "r213",
      "r533",
      "r534",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r173",
      "r174",
      "r213",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable": {
     "auth_ref": [
      "r495",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent which may have occurred during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]",
        "terseLabel": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table]"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r294",
      "r296",
      "r307"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Customer contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails",
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r294",
      "r295",
      "r307"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets",
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r97",
      "r123",
      "r222",
      "r535"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Total cost of revenues"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r445",
      "r451",
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Current income tax benefit"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r580",
      "r582",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r21",
      "r279",
      "r582",
      "r597"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r550",
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r49",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r51",
      "r125",
      "r287",
      "r288",
      "r289",
      "r290",
      "r549",
      "r550",
      "r552",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r549",
      "r552"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r280",
      "r551"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less unamortized debt issuance costs and debt discounts",
        "terseLabel": "Unamortized debt issuance costs and debt discounts"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "terseLabel": "Unused borrowing capacity"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r41"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Schedule of Deferred Costs, Capitalized, Prepaid, and Other Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r41",
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r114",
      "r124",
      "r446",
      "r451",
      "r452",
      "r453"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r437",
      "r438"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRentCreditNoncurrent": {
     "auth_ref": [
      "r54",
      "r553"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.",
        "label": "Deferred Rent Credit, Noncurrent",
        "terseLabel": "Deferred lease income"
       }
      }
     },
     "localname": "DeferredRentCreditNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r321",
      "r359",
      "r383",
      "r389",
      "r390"
     ],
     "calculation": {
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r321",
      "r358",
      "r382",
      "r389",
      "r390"
     ],
     "calculation": {
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r321",
      "r325",
      "r357",
      "r381",
      "r389",
      "r390"
     ],
     "calculation": {
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r355",
      "r379",
      "r389",
      "r390"
     ],
     "calculation": {
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r323",
      "r356",
      "r380",
      "r389",
      "r390"
     ],
     "calculation": {
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositsAssetsCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.",
        "label": "Deposits Assets, Current",
        "terseLabel": "Current deposits"
       }
      }
     },
     "localname": "DepositsAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r114",
      "r253"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r114",
      "r186"
     ],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r66",
      "r68",
      "r510",
      "r572"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair Value, Derivative Asset",
        "verboseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r66",
      "r68",
      "r510",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedTerseLabel": "Derivative liabilities",
        "terseLabel": "Fair Value, Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r530"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair value of outstanding contracts"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Realized loss"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r508",
      "r511",
      "r514",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Financial Instruments and Financial Risk"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRisk"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r506",
      "r508",
      "r514",
      "r518",
      "r519",
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Embedded derivatives"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount",
        "verboseLabel": "Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular group held by the entity.",
        "label": "Derivative, Number of Instruments Held",
        "terseLabel": "Number of instruments held"
       }
      }
     },
     "localname": "DerivativeNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r512",
      "r514",
      "r520",
      "r521",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated in Hedge Relationships"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Proprietary technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r306",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r94",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r144",
      "r147",
      "r154",
      "r157",
      "r158",
      "r162",
      "r163",
      "r593",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Net income (loss) attributable to Sotera Health Company common shareholders - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per Common Share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:",
        "verboseLabel": "Weighted Average Common Shares:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r94",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r147",
      "r154",
      "r157",
      "r158",
      "r162",
      "r163",
      "r593",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Net income (loss) attributable to Sotera Health Company common shareholders - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Earnings (Loss):"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r159",
      "r160",
      "r161",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r540"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmbeddedDerivativeFinancialInstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument embedded in host contract.",
        "label": "Embedded Derivative Financial Instruments [Member]",
        "terseLabel": "Embedded Derivative"
       }
      }
     },
     "localname": "EmbeddedDerivativeFinancialInstrumentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": {
     "auth_ref": [
      "r523"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.",
        "label": "Embedded Derivative, Gain (Loss) on Embedded Derivative, Net",
        "negatedTerseLabel": "Unrealized (gain) / loss on embedded derivative instruments"
       }
      }
     },
     "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r142",
      "r165",
      "r223",
      "r286",
      "r291",
      "r429",
      "r430",
      "r431",
      "r447",
      "r448",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r40",
      "r192",
      "r220"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investment in unconsolidated affiliate"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of debt"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r389",
      "r527",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r526",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r344",
      "r346",
      "r351",
      "r389",
      "r527",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r344",
      "r346",
      "r351",
      "r389",
      "r527",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r389",
      "r527",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r389",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r555"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r555"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligations, less current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r249"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "For the remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r249"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r249"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r249"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r241",
      "r244",
      "r247",
      "r251",
      "r575",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r247",
      "r576"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross\u00a0Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r241",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r247",
      "r575"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Finite-lived intangible assets, remaining amortization period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ForeignCurrencyGainLossMember": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing foreign currency gain (loss).",
        "label": "Foreign Currency Gain (Loss) [Member]",
        "terseLabel": "Foreign Exchange (Gain) Loss"
       }
      }
     },
     "localname": "ForeignCurrencyGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r536",
      "r537",
      "r538",
      "r539"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedTerseLabel": "Foreign exchange loss (gain)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r115",
      "r538",
      "r539"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedTerseLabel": "Unrealized foreign exchange (gains) / losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r344",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign Currency Forward Contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingenciesByNatureAxis": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nature of gain contingency.",
        "label": "Gain Contingencies, Nature [Axis]",
        "terseLabel": "Gain Contingencies, Nature [Axis]"
       }
      }
     },
     "localname": "GainContingenciesByNatureAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Gain Contingencies [Line Items]",
        "terseLabel": "Gain Contingencies [Line Items]"
       }
      }
     },
     "localname": "GainContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingenciesTable": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sets forth the existing conditions, situations, or sets of circumstances involving uncertainties as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization, and previously disclosed contingent gains that were recognized as income in the period.",
        "label": "Gain Contingencies [Table]",
        "terseLabel": "Gain Contingencies [Table]"
       }
      }
     },
     "localname": "GainContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainContingencyNatureDomain": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or before issuance of the financial statements) that might result in a gain, typically reflecting care to avoid misleading implications as to the likelihood of realization.",
        "label": "Gain Contingency, Nature [Domain]",
        "terseLabel": "Gain Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "GainContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r114",
      "r282",
      "r283"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r232",
      "r233",
      "r578"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails",
      "http://soterahealth.com/role/ConsolidatedBalanceSheets",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Changes due to foreign currency exchange rates"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r236",
      "r459"
     ],
     "calculation": {
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransferred",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Adjustments",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r96",
      "r123",
      "r191",
      "r197",
      "r201",
      "r204",
      "r207",
      "r222",
      "r535"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r506",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r88",
      "r191",
      "r197",
      "r201",
      "r204",
      "r207",
      "r577",
      "r587",
      "r595",
      "r614"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r441",
      "r442",
      "r444",
      "r449",
      "r454",
      "r456",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r124",
      "r141",
      "r142",
      "r189",
      "r439",
      "r450",
      "r455",
      "r615"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid during the period for income taxes, net of tax refunds received"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r57",
      "r585",
      "r607"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable / receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedTerseLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r243",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r250"
     ],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r243",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InsuranceSettlementsReceivableCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.   For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Insurance Settlements Receivable, Current",
        "terseLabel": "Insurance and indemnification receivables"
       }
      }
     },
     "localname": "InsuranceSettlementsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r239",
      "r245"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r87",
      "r185",
      "r548",
      "r551",
      "r594"
     ],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense, Net"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r108",
      "r111",
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest Rate Cap"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r183",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r203",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryAdjustments": {
     "auth_ref": [
      "r63",
      "r225"
     ],
     "calculation": {
      "http://soterahealth.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.",
        "label": "Inventory Adjustments",
        "negatedTerseLabel": "Reserve for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://soterahealth.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://soterahealth.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "totalLabel": "Inventories, gross"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r62"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://soterahealth.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets",
      "http://soterahealth.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSupplies": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://soterahealth.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.",
        "label": "Inventory, Raw Materials and Supplies, Gross",
        "terseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSupplies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://soterahealth.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r46",
      "r123",
      "r199",
      "r222",
      "r489",
      "r496",
      "r497",
      "r535"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r123",
      "r222",
      "r535",
      "r584",
      "r604"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r123",
      "r222",
      "r489",
      "r496",
      "r497",
      "r535"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Regulatory licenses and other"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r53",
      "r270",
      "r274"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Legal reserves"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Professional services relating to EO sterilization facilities"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r21",
      "r281",
      "r582",
      "r600"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-term Debt, Fair Value",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r127",
      "r277"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r127",
      "r277"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r127",
      "r277"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r127",
      "r277"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtAggregateMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Total long-term debt, less debt issuance costs and debt discounts",
        "totalLabel": "Total long-term debt, less debt issuance costs and debt discounts"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r51",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of claims dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r270",
      "r272",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought, value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of new claims filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability": {
     "auth_ref": [
      "r257",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The liability as of the balance sheet date representing required funding mandated by statute or regulatory authority that is related directly or indirectly to underwriting activities, including pools for self-insurance and excluding premium taxes and income taxes. The funds derived from the assessments generally enable a government guarantor to pay insurance claims in the event that the underwriting insurer is insolvent or otherwise unable to meet its payment obligations.",
        "label": "Loss Contingency, Undiscounted Amount of Insurance-related Assessment Liability",
        "terseLabel": "Loss contingency, insurance limits"
       }
      }
     },
     "localname": "LossContingencyUndiscountedAmountOfInsuranceRelatedAssessmentLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r58",
      "r123",
      "r222",
      "r535",
      "r583",
      "r603"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r110",
      "r112",
      "r115"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r80",
      "r83",
      "r89",
      "r115",
      "r123",
      "r132",
      "r134",
      "r135",
      "r136",
      "r137",
      "r141",
      "r142",
      "r151",
      "r191",
      "r197",
      "r201",
      "r204",
      "r207",
      "r222",
      "r535",
      "r588",
      "r608"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Sotera Health Company"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r83",
      "r141",
      "r142",
      "r491",
      "r499"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://soterahealth.com/role/EarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income (loss) attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r144",
      "r145",
      "r153",
      "r158",
      "r191",
      "r197",
      "r201",
      "r204",
      "r207"
     ],
     "calculation": {
      "http://soterahealth.com/role/EarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income (loss) attributable to Sotera Health Company common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r146",
      "r153",
      "r158"
     ],
     "calculation": {
      "http://soterahealth.com/role/EarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net income (loss) attributable to Sotera Health Company common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "ASU\u2019s Issued But Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Employee Non-compete Agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r291",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Not Designated in Hedge Relationships"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationDetails",
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r191",
      "r197",
      "r201",
      "r204",
      "r207"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r555"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r555"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease obligations, less current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r554"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r47"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r485",
      "r486",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r78",
      "r86",
      "r541",
      "r543",
      "r547"
     ],
     "calculation": {
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r71",
      "r75"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "netLabel": "Derivative loss, net of tax recognized in accumulated other comprehensive income (loss)",
        "terseLabel": "Interest rate swaps (net of taxes of $0 and $1,234, respectively)",
        "verboseLabel": "Interest rate swaps"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Interest rate swaps, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r81",
      "r84",
      "r86",
      "r90",
      "r286",
      "r541",
      "r546",
      "r547",
      "r589",
      "r609"
     ],
     "calculation": {
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive (loss) income net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Pension and post-retirement plan adjustments, net of tax",
        "negatedTerseLabel": "Pension and post-retirement benefits (net of taxes of $84 and $(744), respectively)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r73",
      "r76",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedLabel": "Pension and post-retirement benefits, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails",
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Income, Net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r372",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other benefits plans"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r114",
      "r262",
      "r264",
      "r265"
     ],
     "calculation": {
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Business optimization project expenses"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.",
        "label": "Payments to Acquire Additional Interest in Subsidiaries",
        "negatedTerseLabel": "Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc."
       }
      }
     },
     "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Purchase of BioScience Laboratories, LLC, net of cash acquired",
        "terseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22",
      "r319",
      "r320",
      "r342"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent.",
        "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent",
        "terseLabel": "Post-retirement obligations"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r343",
      "r345",
      "r351",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r389",
      "r391",
      "r392",
      "r393",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r317",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r372",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r401",
      "r402",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Defined benefit pension plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r410",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PositiveOutcomeOfLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A potential favorable result upon resolution of a litigation matter, whether through trial, arbitration, mediation, or settlement of a legal threat made to another party, which results in collection of a damages award in cash or in other tangible or intangible assets.",
        "label": "Positive Outcome of Litigation [Member]",
        "terseLabel": "Positive Outcome of Litigation"
       }
      }
     },
     "localname": "PositiveOutcomeOfLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, with $0.01 par value, 120,000 authorized; no shares issued at March 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets",
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r5",
      "r10",
      "r227",
      "r231"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid business insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidRent": {
     "auth_ref": [
      "r6",
      "r10",
      "r228",
      "r231"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Rent",
        "terseLabel": "Prepaid rent"
       }
      }
     },
     "localname": "PrepaidRent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r7",
      "r10",
      "r229",
      "r231"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r104",
      "r107",
      "r126"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r80",
      "r83",
      "r109",
      "r123",
      "r132",
      "r141",
      "r142",
      "r191",
      "r197",
      "r201",
      "r204",
      "r207",
      "r222",
      "r485",
      "r490",
      "r492",
      "r499",
      "r500",
      "r535",
      "r595"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://soterahealth.com/role/EarningsLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r254",
      "r605"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r78",
      "r79",
      "r86",
      "r541",
      "r545",
      "r547"
     ],
     "calculation": {
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r197",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Operating Profit (Loss) from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r556",
      "r557",
      "r558",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Payments on long-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r2",
      "r16",
      "r121"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash short-term"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r291",
      "r432",
      "r602",
      "r625",
      "r627"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r142",
      "r223",
      "r429",
      "r430",
      "r431",
      "r447",
      "r448",
      "r622",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings / (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r372",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r401",
      "r402",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r369",
      "r372",
      "r376",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r401",
      "r402",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r182",
      "r183",
      "r196",
      "r202",
      "r203",
      "r209",
      "r210",
      "r213",
      "r305",
      "r306",
      "r574"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net revenues",
        "verboseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/RevenueRecognitionDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r173",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r308",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Consideration received"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r78",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of major classes of indefinite-lived intangible assets acquired showing attributes such as amounts and totals. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit.  Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.",
        "label": "Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of acquired indefinite-lived intangible assets. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. Indefinite-lived assets are assets that are not subject to amortization. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.",
        "label": "Schedule of Acquired Indefinite-lived Intangible Assets by Major Class [Table Text Block]",
        "terseLabel": "Schedule of Acquired Indefinite-lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails",
      "http://soterahealth.com/role/AcquisitionsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r51",
      "r125",
      "r287",
      "r288",
      "r289",
      "r290",
      "r549",
      "r550",
      "r552",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsAdditionalInformationDetails",
      "http://soterahealth.com/role/EmployeeBenefitsNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r508",
      "r514",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r512",
      "r514",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r526",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r241",
      "r246",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r15",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EmployeeBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r191",
      "r194",
      "r200",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r191",
      "r194",
      "r200",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r410",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails",
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r414",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r213",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://soterahealth.com/role/RevenueRecognitionDetails",
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r178",
      "r180",
      "r181",
      "r191",
      "r195",
      "r201",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r212",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://soterahealth.com/role/SegmentInformationReconciliationofReportableSegmentAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails",
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r416",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r408",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails",
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details",
      "http://soterahealth.com/role/ShareBasedCompensationRSUsDetails",
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Year One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "Year Three"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Year Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount that would be paid, determined under the conditions specified in the contract, if the holder of the share has the right to redeem the shares.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount",
        "terseLabel": "Mandatorily redeemable noncontrolling interest"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AcquisitionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable after one year from the reporting date or operating cycle, if longer.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent",
        "terseLabel": "Mandatorily redeemable noncontrolling interest"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r207",
      "r213",
      "r237",
      "r256",
      "r263",
      "r266",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
      "http://soterahealth.com/role/RevenueRecognitionDetails",
      "http://soterahealth.com/role/SegmentInformationAdditionalInformationDetails",
      "http://soterahealth.com/role/SegmentInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r122",
      "r123",
      "r147",
      "r148",
      "r149",
      "r154",
      "r158",
      "r166",
      "r167",
      "r168",
      "r222",
      "r286",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://soterahealth.com/role/ShareBasedCompensationPreIPOAwardsClassB1andB2Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r56",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r142",
      "r165",
      "r223",
      "r286",
      "r291",
      "r429",
      "r430",
      "r431",
      "r447",
      "r448",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r622",
      "r623",
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails",
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r165",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r25",
      "r286",
      "r291",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited",
        "negatedTerseLabel": "Share-based compensation plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r24",
      "r25",
      "r286",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r25",
      "r30",
      "r31",
      "r123",
      "r219",
      "r222",
      "r535"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total equity attributable to Sotera Health Company"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r123",
      "r129",
      "r130",
      "r131",
      "r133",
      "r139",
      "r222",
      "r223",
      "r291",
      "r429",
      "r430",
      "r431",
      "r447",
      "r448",
      "r483",
      "r484",
      "r498",
      "r535",
      "r541",
      "r542",
      "r547",
      "r623",
      "r624"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets",
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit",
      "http://soterahealth.com/role/OtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtRepaymentsofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Supplies": {
     "auth_ref": [
      "r8",
      "r10",
      "r230",
      "r231"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Supplies",
        "terseLabel": "Stock supplies"
       }
      }
     },
     "localname": "Supplies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://soterahealth.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Accrued taxes"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r306",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r306",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trade names / trademarks"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/GoodwillandOtherIntangibleAssetsIntangiblesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Point in time"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Over time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/RevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost (3,090 and 2,742 shares at March 31, 2021 and December 31, 2020, respectively)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Capitalized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r152",
      "r155",
      "r156"
     ],
     "calculation": {
      "http://soterahealth.com/role/EarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "terseLabel": "Less: Allocation to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r150",
      "r152",
      "r155",
      "r156"
     ],
     "calculation": {
      "http://soterahealth.com/role/EarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "terseLabel": "Less: Allocation to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnCashFlowHedgingInstruments": {
     "auth_ref": [
      "r513"
     ],
     "calculation": {
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) related to derivatives designated as cash flow hedging instruments, recorded in results of operations to the extent that the cash flow hedge is determined to be ineffective.",
        "label": "Unrealized Gain (Loss) on Cash Flow Hedging Instruments",
        "negatedTerseLabel": "Gain (loss) on interest rate swap"
       }
      }
     },
     "localname": "UnrealizedGainLossOnCashFlowHedgingInstruments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedTerseLabel": "Unrealized loss (gain)"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskActivitiesofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Reversal of valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValueAddedTaxReceivableCurrent": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of value added taxes due either from customers arising from sales on credit terms, or as previously overpaid to tax authorities. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Value Added Tax Receivable, Current",
        "terseLabel": "Value added tax receivable"
       }
      }
     },
     "localname": "ValueAddedTaxReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/FinancialInstrumentsandFinancialRiskAdditionalInformationDetails",
      "http://soterahealth.com/role/LongTermDebtFirstLienNotesDetails",
      "http://soterahealth.com/role/LongTermDebtSeniorSecuredCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Dilutive effect of potential common shares (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r146",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r144",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://soterahealth.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss",
      "http://soterahealth.com/role/EarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 10
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1377-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2740-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2793-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2814-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "30",
   "Topic": "405",
   "URI": "http://asc.fasb.org/extlink&oid=99384745&loc=d3e23169-109297"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "405",
   "URI": "http://asc.fasb.org/extlink&oid=6392405&loc=d3e24119-109301"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392676&loc=d3e7480-110848"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "410",
   "URI": "http://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=SL108413299-114919"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=SL65897772-128472"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5419-128473"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/subtopic&trid=2229187"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.26(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e39927-112707"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4),(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r639": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r641": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r642": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r643": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r644": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r645": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(7)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>93
<FILENAME>0001822479-21-000028-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001822479-21-000028-xbrl.zip
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M,F(-YX@XT?@KJ:&:R7HXGN:;&"FM:3+RX>3DL(J\=W#8K\FGZ6][HPJDS[-
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M%<#^M&ZU%!LAYE#8:01E0_961:V$EV2"E\L&L-?4[[-[>$X#&F&?W?SC?,
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M+TJ49[\\&XXHX?A:QS2J"LPI?UULIHBDK#(>5-9(J#P#'I1W40 N_GR<JZE
M%0LC<?TX[=72\EKF.<)TO5*:W_0<;1$R$$IV6N"T"Q(+?V=!$;_0A(L_=6!Q
MI32_0OP01=+,?"F% $:XD!0'Y%24E=*Z))=%2@UP)XL""6,H"V\#"5^@..N#
M",YHMK?&&:7*LIC7I8?$')OQ)1.=98-NK04("E,EG:G4M'\,RBZ+E5CGPW.N
M"Q;-]G[6&^ @]::S%LX/^UX5;@.1,C_CH8L5QOALR180M7]?*"8;0,HJJ127
MQ7C<5:3,SZ8D+=B;.">31V!H8%UB=CK?UR&Z4!;?IBR.5.:GOU8);XBB-9[
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MM7)C\1'Y+7"\ID%O..H.)S2>,S[N!HU=%(3FE(S6-CN1-%"Q/I#),8*V0"'
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M7WD[&LAM[7(@&W+2 9DW_OOI"KW7-E!67>(?Q\AFYGO]W&$V=I+)30-\XS.
M=]Y9&1G*T]DH@@$NP+8#.6H'D=%YK60FSQR,HYPNCC/^SYD9;]46.S1IO7CQ
MY\"_<LA7FTW=3LRW,<BU;)!:\:25]HB?K:X]Q-R+IC69-;[[; ;+W^3?6WLX
MGDXUS"WL]WECG?Q< \;_.>K5<)&CQ$CG._ Y/T6,NE9PGLU>/8\;/PLW9RBN
ML63=7&>OMC)O9>);=ST<4:(I#9:J->TB,6[]C<_'NM(:'S%+'.\-ZS2:V?30
MR1Y.OKSWCWCY+J?3):<'GS_#W__1PD%N_4V=/6-DC>/M<9^?H.X_W;5,VR'.
MSC-M,#R]B>E-XGC2"J*5\61\__,9F#-,W&A+GT^-7G[HVO.$UOG#7_>HY].C
MT8CE<#8+OSK["4Z.QHVTA7.;<*?>>8N(&K&MHM)M*%&VL5C1-DI*+:+DUVGO
M/=JF/Y1^7)XZ?&O(A=M$;JM[I6G@3;':U9JQ(3OH329L^JC/!FTT'%3^U#]I
M$7.ID]:T,3.FZ7#N&DZP5>=T?VG4+\[Q>4[PU1'O"<)4N_V*=H_Z9T7HK]M;
MK;]5&+E_*JWNG^\PV>M-YSP>UCF/UVWAS^[WD^&F\=]79OG&S/)GB*J .K?2
M=]LLZW<D5 2;+4=0M>6)(]%&X_DO)J$A19EBK2U9F>6[8);9$F*KS_=-+4R)
MS?((JVVMEFI4J>A7?VTQ)MI?W3 ^8'O.5QG-B! K]0&_@Y-_5.;-IV.Z6M_1
M;FMW-/PXV9MMOF037Q--;S-3Z0VF'5>F53^U"$+Q$W_C9J>;Y3]GNWUWAV_?
MZFS'2L3/=_[&;<_V[ VF'NCL]J6*;36++SX/*NXOZ@#5S\ROK^V^YC^4=#WS
MZZ_Q9L,2#WM]W<Z\^+H>+L+(T+7XFN8-=7W]L1[?+8DMD\I=?YIWRIJGJ*@4
M8G<X.OG:K(@:EXV>GN_02#9]WG.P5I?M[Y[R;[I[RO\^?]7?K!,2UM;Y7&].
M=@XZM1K-=+>VO^PYN-?=>GFRN=:1FUM)\[]BY_D;L[WU^_O.UK;<V?KU8/OT
M5;]S^EYVOQRSVT_O;([&.*)V%$6U(6)NA^!LVP!*5+EHG_X?>V_:%,>QK0O_
ME0[NCC?LB$[MG ?Y7"*P0-J<:T"6D'VD+XH<H5 /G!Z$X->_F54],L@T-% %
M>099ZJ&Z*E>N)Y\UZXW-_>M(UGH[$-9.>?FS@]N/-]',.CQHTQNW5W!4+O%T
MI&*&HUO T=X<CBYVOUJ!@Y 0@\ Y!U0A!@Q7#" I$+)2,$UOV0+UEH?MPQ0!
M- (.=JXW)#,8K L,I@O\KES?-]7R9E#X)U X7P:%/[]" CG#E@(F6>0H'#.@
MK)% NA"PPX)C@6XWR:$) >CP$]]4JK&YUJ56A.N"'&5H(]*U7K^,3(R'E3,K
M*D$UX.":/L+]0?E;G?/TXV=%_.GXLZU>?+1^(@[?BV%)_WJZ9PO=239W:OB6
M/CP<Z9[3 S=LI2KFPMV4*DU^T;]>=DE5WJKDE[I;**+9+=0G:/%CWD*]&OO0
M2*A85W#@,_I*;3S_$:( 6V4!%0(!Z9$'/FABJ8/>!?C/9*">6KZZ9WQX[#N=
M*1"T?HGJ73JEJ]:I9=#Q1F]O#>)\3ZU=']/J-?D(7EO0C7[5&!F(@@"<H42R
MF0:2,@>T] H'#!W%^!_UZLDBM9_C]9X\[E>#B'7=@W];9:1L3Y^W>#6*IYUP
M:>!;9^F/"1Z\+4/BD1:,>T6%!F7R=S2=EQ#"6T,M-H:0A!#":<LL1)9H9:'E
MP7S=+8&!0;X14=$6T0H?_M^-W?VWRS.7>N.NZX\F'[@F<ZK,3"\S&C^6=W$P
M'I6L)NZ9:/M$<R9^'+YH]#BB7P-C(3C)063= E!$$3#*8( \8EXYP:CU&YM8
MXK;DJJW8K"G$5-:;58+_<'I2#:[6EMNJ1F#X#S4"[59_+J&;0YJ+,XA/^Q7#
M>CWP*3'GN[\RE7@>ZBRCEG#^%6V&_<YX=/4KE7YM_I<9_/MR6Y=+\W=O-TU9
M;$R_<SR8V]Q''IB!U]^ #M'$?JT[9_I\F&8,Y)'+#1BYO(C)\E$&/\#;#36^
M?L; #:I4E[L&K<.MW__829-]WASL'^[L'WYL@5N=A[A920V*O((/D"= 7PDJ
MUY$G8+3]=C3H1T4"$]E;ZWU4X7MT#5PS2-UJ2ST22MWW7FX/4XAL;+[7@U%K
MMSQ5\6]O=_>W]M_L;OW1BKSHX,/>UF$YL/P*</VD0ND!9+UZ:Y8U+?P3'E7W
MO9?5-@&[0<8K*W8H_V<=PIY< J3/3Q$Y2_O^TN8;F[LCWVVA5ZVW,Q=MV3"R
M>P-+6479UR?_K.P/)?ZU*?OZD#TK^\-(&\*)MN-7K3W=B^9A4O*9";U=#.VX
M&H28DH>W>KIS/BQ*HWN.#=%^<57\)WWF@Q^..Z/R(P>GOKJW^X)&9@@-V$8$
M9H[P4N2-Q00VR*O6GRDX6XQ*/UB) /&%SO3?"4 Z_>$X>>JV3'\\FE9Y?RB&
MWS*5>/Z[A*),)EZ*O,F43-!7I5-S$,5:(L+[0=]ZET @$X'GOP76I_+W1_CL
M!5R+5&=NP*D?\.#P/SL?UN@#S&=YW14[;@&*\UG^8N2]X ;\PQ]%,[\\Q,MN
M$L-7^1A__M)?G[9G>[[V\E93;=]Z59KFK;?:COJ#>VMZ/M<;('E*\KG^4N3-
MZ$33^:O6SH_CPA2C?)R_!*%3FH_SEV*O,[&Q^7'WW?[6X:</.Q_S$5X':3^@
M=B<W^T]C]C<6*S8NJ1G!G-7\V+?RJ%G-/ST$'C0;^,W6I^3(W/KPN;5_<+C3
M^K#S;NO#]N[^N];;@P]_Q[^"/PX._E_Z]\?#K<.=O90NO$*R\,,^TO75,X>I
M,>B?8YUZ?';.6U4WWS0%Y&U_$&T]"/Z<C-LKJZ'*QG"A/SC3 P<Z_?ZW24'N
M)/%KVALNU?,6O;+HHNMU+WUH4H/Q?E!\3^6("SVH_XC_.:IZEW[PJ8IFWHQ:
ML5?I/M*OM:[^6IK^%S\7MU#J;)J*/N(27%3MK]-OI3+DR<^>]5.]<-F05,^>
MP_A.X;_[X>4N>7XX*KKQ1ZZ^\>/4V]&5ET\'_9/K7N_J\\LO%6G#NZM7Z$0)
M3E_K#V;]_'KQN"Q.EVXEOAL?S\V2;LHLFE35,O)'Y^U6>:7TH?*7RL2:5ZV/
M92/6&Z46/_N]W_GN6]]Z_;,J0V?<J_X^B';^L!W_:>/1K>,UD\#2!_IE^6C1
M3;LE58Z&RA=0M8>U_7$G,@=="F \:,7WQCJU+"_3?MJIKJ:LEHI7+5LDVN,D
MA_)>VM6]NW%\I//Y-T;]^,@AQ)],@AD490?=,.AW6W'[QA].K&+ZZ:KK8GQ[
M/!H/_*U^M14EFP:M>M>.F^3H*.Z N(WZY0/&/5+NJ.'/%W&RRN6"399P<<TF
M.M1NF?&HW+>I5+Y3=(M1V3+WYCE>2_R7T2FKBDL4?_4U2"4>3X0<Y8Y\H/K$
MVU&C9=N OF)I+9+HHWH,QJ<EI$Q@2'_714>;HE.,SJ/&3+:9C81@6$IGT@NY
M2'LCONM'Q_%!>O$?/PKG4S_E4B%W#B9J^&L[;G*C.R/ X>S=-_WXK^D'T@^D
MO5\IBBL&J9O]=//&W1B?^'L:WEONE>'X-.VSX=)HTU2+76W>I.*VZN/;.O+]
MTWY\BG+'%[VX 2</I>/62]\KM>+3JX^O6A5)2Q!1]E?XD !#E[]7OA,W7ES[
MLE)N^%O>?VO;?RZ:.1'XJJKX<F_-\&PT2.B?%_LA%]OWOA>#?B^!LNZT6\<^
M:NEQI64Z^%$Z5*:]TK,DUB@):PM7GJ459LV@* 'K=.6KPW$X[-NBQ)\2EZ94
M+8DH%<+UAQ'9TL3S?LE@RJ/^6%_$8[<_'LXA=,;F=@[*KY;HFP5:$X&6'7]*
M<EB>PEF<3RW.3C$E"K:CB^YPP@[2%(C^%"1_KI]1AEDV#R*;*;=+:SNQ6CIE
M/L7I/)\B+_?:ECMMZ-(\'E;&0-GKR(^J^I0SGVQ9GY=[K099M\KHG]*TTDL0
M;6N='#W12.KTXY?B0="M+*'SLBE+<NA,3)?OT;@IG8:5A181+ )25HDURJB3
M &<V=B+))$2#.2%1/!XB#)V6WL&)"Z5\?\F 33*>'?#I\VYLDW]C^<QIQT,G
M#3\JG3&]>.1,O4D#?SJNF$+\]K$>=+-HUXIV$Y.G7[K4%B;H1=E6PYXCZB6G
MU&3J7GLFT\DF*#^9!D6E>IU^<L)%_(S_7[I17"02YZ7I57TBWD%[/@[*=KP>
MS'QNIZEE8V1[6;YKDZ^9-($N,;/HC9.Z5?QZT5-[/;4K'52S"LQ%[U-Z)S+$
MHI)<;\E(B_99R08G:CYQ84WAH+01="OYHN+'.GU;7CP+?+WT97)V5M&--P=_
M[6X#I%KQ#IWO%C:O]MI6NXQ?3$ZQ"()3GW'+ZBB!TN\Z:OD?Q;"RC^-+G6)V
MK)EQT7%E3]N%-R).ZM8HWG8\3].';'\X CX$7PT!C _1\X,LP(<28#2TXF\E
MK9F3SDX5!0@3E_VB%*M9AS[A:*EKQ:"5OI(/L#43E/)XBDOL^DF/9F=:,M,&
MO0DS[)SG55_;JB^&CB(D'752.&M"QH\J(NXCH^C'TZ1\=1YTLM->#ED)UHM2
M"Q;7P"=ZW?KF2YMKV(]G0B4</2KMXM8H<K#>* M@K2@T+(YZ18B;O#=:-)GZ
M*<:4OCZWEY*XJN2'4BK^1Y4U,Z/2/[6FTF6JWO>3QO<I^&M+_T:.33V4!\J>
MF]3-M4H[.F^E5$![/.%I+@U>CB2@M)"6HNY)SLZ?IBD&$T.HZ%6-?I.O<.3M
M<2\^U]%Y:W@^'/E,"QZ*%I0#'JJ$FS+3*1Y*982I:O2[G#=A_W=<5#FGPTKU
M+C' 4)09%T75FG/AXQ%4!T=^-$N?.DH_M?"+BU=.X:IH[0[#.,6SXJ?[Y<],
MB4O>!P_%WZ>NI];<9)J0Q$[E-4X-)1)B+PP/F<TARV)9JU@6'41)")TT!F9<
M.8#C47A)8.D;LTA+%-LT,[S4T:FVE^&8*D Y"387 Y=:<I?F6!DW.$L2#VF
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MD<BT5:,G+=?/I_1<,*0)/"9CR$-@R)S2<">,\B+908%'2J,=D! ;("@21+E
M,;:1TK0A:U >JBN&IQU]GF[6_USW'^N3+\F'- TXG_8')8#T0RL4/=VS?M*F
MOV_B/>KT7G8N/2$]>UL)I>RUG2'U7I"ZU'E%"$N"]1+@0#V@DA"@D"& <0TM
M#L1;/"D%:C(MR^ZEETS+,G:L$SL6&L4QB83B#&@3[3J*+ ?*4@Y"$%8):C"U
MML2.:US3V<'T1.RF?VD,T7WY30-,QR;PF^5I(AFE[H52RUU9E-"", ^<TQI0
M8SC02#+ &$?0"BR8*7O+<9)[RV7'4S,93D:/]:+'G.-@9J BC((@"4R=*060
MGGA@%.1!.R$%+WMH$WEOCI.S@-;%<<J"Z-; CXJ!+WO^9R?.0Y*<:VK8/LS6
M_F"V]!F-[H)&2XU;A(RBX,P!:1B*%I<20#&+ !/40:I"E!G?V"2JR4PF^VJ>
M(9/)$/&P$+&0MQR(T]P)X)B7@%JL@:&< FU$"(Q@XVW8V+QN=GQVR3S.)*+Y
MZ,2;BN&>B^G4!,?+)/=P-@<MYQ[>#82.9CSEX-">[6]]A4IIZZ/EI*0S@(K
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M;I3<"^ "T=Y[YXT0-^[!%V#A[OSON!B=O[X3=-^6N#[E-1[[<';%]^FU)Y<
MZ?.OL9A>I.BYJ-ZO@2IO\@E$GC"FGWZT;[^U6V?%Z+CUKY]AW7L_*'.TUD*Z
M=_??7H=Y_=['=#OO]>!@\'&D1][]I3MC/__I">6&&07_$07WM[=&>V]F*,CV
M"@6__,\QM-V_>OIO-3XX^:N[]_>?],OVSMG>WWOG>]OQMRZ^%/OQZ?=/=MC^
M2;SFN]T?!X>?SO_G8I?L;Q^1N#9G^R??T,'VMZ\X8*$#8\ +GC@\C9 :>3O
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M%6\YK;3NM$YUX4#1:UE]6HQT)W?X?SK6,)?*^RB4W=Z;2B09AE:"H:5YC\9
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MAC@C&YM(RC975SN'/$@@ZG;X\W3CN]>4\]1@I+QO8*C&2'GO (\E A.,%8N
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M9G8F/C8-VM&#7KS5X90KG_I!:WBL!_YN/5RN=MLA<>U=?YRH]_V;N-S6Z?
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M&"CO#= L1=@<,E&0&YNDS<G5'DA/TH8O.X&>0W96UN>UZO."/PCK4D0 >D4
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M]7DY1N>POV6C9 ;^_41F[Y/$MGIN9RJO?#*M=#(M=>YC%A-G.08FR,B0<=!
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M2T'70BE<1S@G&J#+<H<1S\5=="0*H$M:KQ(CA@+M44UVR?ETZ\-Z5L]W]5
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M;V.+<E-27]9FC1<D7BTIW7P'X2W$%0H2KR(2S\4,L+>:<"N1)5XA3C1'-MB
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M%!XF_>14@P59GUN$\-WDF=7%M9A^^-QU(%FO!VV J.-.'$Y4R02^Y@YZN ]
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M1#>GJ#X17>-5KYX <.\)RF\VMCN=*B[?3@"<O0PYT!(_T4*NWHP]K%HRFA7
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MGKM9S:)YT6VM #-<$NPJV[7=O71;P+TZ5*>S>^_\Q+C.[*[4;3VGAL.8D[5
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MW^KWJL!K'V8AB.155B<P%QJH41_YD3UHP\8+F!.I'3MAM1.3SMR"A,SY!<^
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M&@2PF6BJZ)B\>J+"]/G2[H^'0"6M]X-QIOVOQX/AV/9&TYESEAB8WVR/#\=
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M%RT@5O1'/5B%\ 4H/OA-Y?T]B^+G69Y;V3_.0?^+L?_CCAV.VGY8M\X>0D_
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MB*7WEA5X**97H0LKA01S&[."\@0;B>#_#G$N.')2$V1P9$))X(]YUX!>]]S
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MHX=EW[$_-F(X@4ED95-U-KU0(G(YE4@[_O[Y;.];.':4@T+XQ'9W=D]!<?R
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M:N-G.?S9)G,L<*XY&8,RW#JOL=$F$4$X3<#89-GDI]IDLK7^77EKM-0*,:R
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M(Y7O1'ON&1DWQ8_Z8X+T>2BR+R3*;:^Y==YN-S9W@2E]Y-L;GP^V=[S8WF@
M(]J%__UXOK?Q_GSKH'EX-<IM[^C]^?:WKWCOX(_V[L$^;VQNP7L.^1:%=Q_
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M*VM4U-DU$=M+Y)4O]486 U)+O9$%=ID72+T[I$Z[S*.D3')D)$V(PYX@:W5
M"?.8!"'8<0>02NM:W]ME7FJ+/#S'=:.2]K56IW_2R_T22YF1Y^=Y'\>;48!I
M'F":CL!(4=.(A4"18#7L%*^-S$D\5F)-"/=<KJRI.J>EP$@I,++D)*;@Q1WQ
M8D)DN,?*)2&1,51FO'#(\L"1C,%$RP(+&/""X#K'#W7W7])MYN,J^5KHE674
M+"0[^0S[4(!F#J"Y5&M$6!FT-PQ)DD0.(<#(*D.0L4+EOF1:RZKR&7T1-6\7
MR,WT8J!BB8A)@8KYH6*Z7R$-%&N#G%0)<><UH(35*!D:?<A51G+A5E(GZJ8^
M:B7[YW$.V[N3/KP\1ZO 1_.2C\)5BO/D&>G)N]%>?&L-FN,-J@+)&G$PBIPK
M6#0/%DT713&>:&LC09SQ7.Q(.^0<Y0ACIT)0$1NB 8MXG;!9^VB)>$MQJ+QJ
MWE(PY,$Q9(K/8"J,<Q;)B /BQCJD"<'(6VJM)]AREOD,K<O[$YKB8YDSG7GD
M0:PB<7/>Q5&GE6!TU9GL11];?^<@V%+W]7F3<T>[]"4.!NUAM^'/%WM3\.D.
M^#0='Z1#PHRFB"S##'& (^24T+D6K+?8XX CSV5@E5CJ.Z/BFGG5%*> R".
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M#7G,^O?(1*(*3*C <N\/S#4R+'%D$O,R*D,-PU6^D#'+S&**O^55LI@"'H\
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MH.J!;UH#>)G_)<3]S$+[YZ#9/8%WA7ZV=[ZN?EFMA8PXO?Z_YNABOQ2MZ;_
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M]OY\>_/K^>[YWM$N_:N]M?&>7_4CPER.=H^VSG;/]]GVQM89C.M'@WYH[^[
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MG2!<<(E[%"T5F1\&(YMB0/"+UBEYPS+1NKCR6/,Z26F%DFU;)2P5>^M_QW8
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M\DGE)J+9/;'X/.A"?#7K6FZX?+ZC.K=&Q;M%?)I,4@-0:P/4[KRJIY56UKN
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M. ^'.#,1;XYZ09-&BN6"'5Y&I)UW"#1[)FTDDA#1($Z#.-\5<>[2_]> S*:
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M9P)5AJC,#<"VP*1I<+;!V09G[PQGF< A*,XH$8PGI4V(PB9MG(%O%&LTVA\
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MS#!W%?2">U^GDF3_MUD8G9F?AX/IF=*GB-P@VL_()FCL;[9[:L^&3_X]CSP
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MY=A\*(6O3.APDMWR<M ?#AMH6P?:.K,Y;TY)(KQ'TI-,?NLQ,LX%Y 1A#AO
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MKF]L0XK0D"+\-&GT#2G"CS2;CXX4H43H;WICG^5-\T7F"]OTEOZ3U8"'HVZ
MK?>!3)'9BBX-@</=!(V!X4$))5YY1KE+4FMAI4L:>QM5BKPIN'[_GO9=\N%9
M]W/[_)_NA_W/Y,/^VV[[6?>P??[IM/WL[?'>RS?BX/R/S^VC7;'D:3__Y_/>
M^S<,VMK=V_^GVW[Y#N^]?\[VGNW@]LL##L\]VGWYANZ>=^>)';RP2@;M$54^
M(.ZY!5-5<\1" )492T&I?_)4*;)%U3>G^#2T#@]].MG0.GS3^>/M0//NSA]O
MCHL+YY)%$\N:3E9TBA[10.9ZD#E3W]A@%0VER.E<^P\SAQPG )Z1 F9&YA-/
M#>?#)NJ1#>'##6J<.A."T(8SH[A7QGD5M:,&2Q*HD8^E\O%\<G@#=NN W1P+
MA*(V@&X(6F&.OPC!((MI1$H8[83P7GN?29.WM" ;%&?<I"%\)PWH&^'A'E6A
M*^DA&GWH6R'B?"8T-UFEDT0!Y %QHB325E@D>.!<2R5$/H*G<E6PUJ//1'@$
M6D]#$/$S*3X7L]WH/K<!MEF2"(Z=Y]$Q)$/*E<=,0 :#H>=<5)92F60N:4SY
MEC'+"0<-2\3& L,/K?;,T$<T.L\=0\-4YX&9]IXQ@YQB G$9,+)4X)R3)$+P
MB1%L&^Z(A]-Y_BE.T,;1<X_ZSJU3RF\-==4D-WK.+<!LCFO",.]#C 3QI!2
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M:2&=K' C)>7D+4].:"8Q(L0YQ*-ER'J.D2$&#I$[[[3Z!NBDDPUN1"6.46]
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M R*A0H2HC4085$#$-0CEVB6#J M2:II=L"I[\<F6EFR54!X4=%R3.KYS"!'
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M<19BJJN2^2IL2-XI.!S 6K@)6[W?1H?#WO_M'\W=LK:AG%<9*O=S5FE#'%5
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MZ3V64*SQR&7%,[]T7*)WZY S$+A+'SV8VKRKL\UWR $MQ,D4^$1VGUW%!E/
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M\DZ:QO%?T0_L9-)/<.)Y-3O#<& _S>^U?)CW^HL# ?>>PN<G;YG!/A;+JW3
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MR*F($6?8)6L2%CD]D,DM$* VR/+9^2MN^>X2H15EV*28"^V&"'=7&!N5P2F
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MXR#H);ZN^+Y'%)4X\&GH.5ZHOGAG6;+JK#<]'"3O('D'R7N_DE?5 I-@3[M
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M3MGS%"5;MP,<*LKL9]V38;+[45%FLW)^HG56U#[56;DR:'S[6$BM(Q92;WW
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M0DHSE&%1 M_ "#"=M)61B_]F[V(%?(B??:<CZ7A-,K(YM>>*+VWGMJ. C:=
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M[?? @*N6V8U@;M$6"./W#65]X81UR.GJE):#,-XE$/SB  4Q1UP'?T?$5\/
MM!374B/%Q#Q]XCNN8FJZ'F)ZC>YCE6IWW6S?'F\-3K<GC;<&EGT(EEW4+.OI
M81A$IJFH@:TK)K5"C+<P%5UW=3V@KFXA@O*\/I65'QQ7G8SZR[R S]!K-2OC
M:54J;)9G7VE0IP;LHYN*/D\WU6-XJ:HKC;-R0O,O(''S>0 R%W;N,"N>3 7Q
MAY*T1VUPI/DZ\8BM*DX0.0J@(4]QU2@ TU6EIAMZAJ%'+][I0UC;X WK+3K;
M^DITD!]W)#\:I(;E?R,GT!65]?4E1%,\W0(A8H2A[U@ZB70;;T75CJ"*P=?5
M,ZSV.2%I*05)5J!W:X^Q6?0\/5J/B<TJG'_T(RZ95-4&L;J36#UNPS+3\RW-
M #D:$"]03".P%%^--,4P5<^P=,U331"KECDDE0Y.L[["LD$^W+5\:&"7&N@6
M#4$J!"$%V.4$)IAMEJU8=NA0TP&!X3@OWCG.NMDV.,AZ!KH^B9 N6!6L<AX7
M$U;K+XN G?Q]O$X<#XZQ![Q-W-KXQ5B/ HF-8KC'$K&=1>^!U 9YO),\/EFZ
M8W1<:MDN51PC-!33]7S%\X((09OE.J89J*8&9K I&]I>0[;!D_:D(5M;F/Q#
M\RPDQ620(_<N1QI<YX1> ":?IFB1%BFFZ0:*YZNJHM/0=3PKC"@-D6E=7=/?
M#@ZUOF,[;*L!-@^<#4DD&.-['-""AXUA,Z,RDX[.8$XP>%+=C$8$^S&4\5[Z
MW2:#WZU'":2?X C'C*K.:5DFK%G-4+CI)C+ZMS;6"VS7]D##*D;DJXH9.KKB
M18:J6$[@A):FF9Z#5QZ&;'A#(NG@GML'K#>(D8<2(PW4\T/=H!'1%2?$'E*J
M[BHDM$V%AI%O6)'K^[:*60*:N9X(-#CQ>@;T#H(@IU4/+=8P4\)_YY3[\OQ$
M<- >8KIX<.<]]%TJ=B2'L2OZ.:O)IR:S0?[>1/[^OA3Y%OF1CF67?$MS%#/P
M',6U#$?1-<<*;9_ZJH57K-80^3;XZ_J*X0:Q\4!BHX%MA)J:28BM&!JU%+QJ
M55Q*505.Q[7#T+4-U038YJF#=Z[OH.WP[-_'[Q7-N]](-YNM^:;HS!AU-#5M
MH;.O@\?M(6ME8.3*01H*.5HP"M*\09[N)$__;,,P1Z6N QI0\73=5DQ 7HKO
MJY&BN6% =,,FENV^>*</KK3!E=9S&#;(A[N3#PW>PF(9JN]:"C$C;+7N MZR
M3%7Q/->S0QN. \TTYSG[R!Y# 1]NUQ5^5[0K>J@)N&C  839'+O#LSYJ^]ET
M\;:=;.]R:_HBM?N ZK:^ #FE0TO&F\KR8,GE1D)#=31'"4P?DTV#4/$B$BFZ
M3S7;,$/J^I1%R:G[W2WK#CGVD;UUSU%>W[9)[E.4UQN*DO:UZMT@N>]$<C<H
MW')5E[B>IQBF9RFF&9F*KSD@OC40U2%10]<PF>36]77'Y\YE*Q]3<#+P_G-)
MX'653VW=G8GOME>[C>G.:K<Q_.2Q6+-IS_7PKU_IPF:-/*95@!63>0@O"=NM
MT+)(.LP46Y4F- DE4DIC,IT2*<YS$HI'BKBDQ4A:]G2V3J7'Q^#WZ1@,$S?B
M"^Y^@?V5)>!2)2#%1"HV-#&I7..C?=S[H$][SUF@M??EA$HTBF@ ?P,/O(Y_
MXB@S2K X!=O] BSK]5+?]$<P(>F82CD8WX4LS7)0?3DLH*Y'66827@$23..O
MDLEB[-R)1TO2A91DL#!@PS2;QJDPX:L7Q+ %&1;*@!GBKLW](@9&S.%S%G?N
MO)6B><HD.TE:/Y)9><S7<;6.FK9@<M] 8L(NQ[GTG21SBO/I*E:^%!D=@)0F
M;%H%B&>8#@Y?S&<S6"@B"]0N!<J+4] ',)G]E ]AGVAT33X 4=;G$,8Y5NS"
M4XC3@!,6$@#F\K8I#^F:-%7R&''_$F?G0"-I0)'0T""7I>.LS$' P+__-8<C
M1=#'!C^E20&??R)^(7T DHEBU OL9YH+,V)*A-$(O"B*\Z*4_C,G.5 W&QC4
M!SP+ ^#7L$$A*3/!'"&E4]3K*/88!65)@@/%5:-R@CQ1!'GL<XXXS4HJF;*$
M=*^K;UNU_Q@KZ-K;GSC55WM4;0...,Z%!(V @Y%2X?_@@6*>,'XL)UFQO%$R
M8QXN%TB>PLR _X%? _9\BWM(^!5X8LI/"*1!O1\X(AQ2-DZ!!D+I,BXG,*EV
MG]%*GO\D9H*_B_)LRM[JBQ1MH"\V+]BQFJEQ8CE0&B^$6Z<R",\?/E3S>T@C
M"D(AE!*00+1^I"@R5/EB7NR%L.W3@F\&72JL*SXZH2'B-.FXR !QP>NJ&5;D
ML)\\3_O$\VMZ:=;.68DH"O9*W+(#0X51%4.F/^*22P 9: )P-4$6QV^X!IF1
M!3)9]4CS!9<:JS3A=]8*9 P&STL%^<Z80A0/7%872"]MM@,2:DD2F7U_#OR<
M$^E72A)X6TY]F"]NA@POI#D?JBH.A9S$[ .F0%M+RK, ITC3"2Z6?5M-:#_)
M,>H/.3HC=0MRO &E-5HC2\<9_B\73OC<O,2$JT4=!=(IJJJB2$(R_1$G27;I
MYUGV#309JI$L+JK<K<5>HN5Q?\B@ XG4AP,G.6?:!:%AEJ:4>Y[J@\KA-W'
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M6U'"!PUFJO1D"MBJLLLXFO\,VD(Z!G,*#TKC:@%>]QMW[B4+V/,90'/4DQ]
M'4F:JOPFHUOMDH+A1[A'G8"\8BV9MIH,GP3^=8]4P=PG!#:?K1)WBODZJS7\
MWTBZP'5NVF[Q:Z;[+T&!*PD8G=Q34:^EG)!R&4E,U]?#7?6\YT)0$N%SK" '
MWP;AR6#3)CZB!IQO[9=AR+E>V$@Z@R\)WE8DPI]8P(L7L)0H @V/PR*\A:,3
M/D9T4(II)-BSM 1+;<:M+N9-0J55\'TJY@".KECRBCOU.P$S;<Y,\#++B[;N
M8E3-/P92J3V\^!+\JA 6)(P:EPF\G--A38@'-?S_$A??I ]\)('V^2 [4>DR
MF5\[>@>]K(N9;=6!\:*WXOGLWT=?_GU\],>CR] K)>8?E"-9=!\QXAHGF0_4
M#WSS/0Z!YH$4!996@,I8F,&*(8J4GA!?*I'ST/> S!Y^CXLL7S3@6W@TI\(#
M'E+\F+/HA.13@%IS/C@ X'E1XNW<2!*S"W- 12D"<20>,9TWTCG@L3&0*9OW
M1SYO[@K=OZST__XOS3%WM;7OE!+8;HMC!]D1X@TG1=2[?-@-WP.BSC,_ANF-
MV<'50IZ?XU8D,:')#%[&/)%,Y@OZD%>I D>(LHP)]'#.+DKA)XC(F?W'47J
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M5Y4]A\OUG&DU9S1V0MI4?[!6^JK;CU&FI)H0H\I*G]<=KP$Q8]F&>5D U:%
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M35FWG0%A]UU.'C0EBYE,#%$(8JI.WM2W$_%WK$#B7LK'X%DB[]>::^WLC!N
M[P,QGN?MVJOYX6#O@"+%(?U2)1YGLS*>5I[569Y]Q6SLU1ZT>R43PV>)&75;
MVQ]?Q !9']H7H9K> %G[+I2Q]4PIB2(/^RV$Z;,$II:Y1U=S RY^V.-Q'&W
MQ7T7P9^J8OP_,$UA'A>3*@<:\YWV4A1'SQ(/:Z9L:'LDC0=(_-#'X^J:_G8
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M+F16 !],XU*(1\'>N-U9@5O6NG'X=/S+V1=.[TO@S=5>5;/Z#EB#\18;O47
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MI:+TL+7W,%&Z#K[P-G+\I<KQERG(VZUV\^3LLOZR_"O#5.#?O/]Y=W'JG6C
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MK/C:NL7G'*R,*.6Q<W.&<,5TD,SWYW"_E,W5;E3-D.B%B,)!XJ6B2+0-B:!
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M<UBH\0E#]4-Y/P:K0@-\.>Z&EICSFG%9NX28 ,K$VC,]:J@S9(,U*A6Y9W)
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MB<8$QA,*#@6E,4VJ;D^U9^8.O-[8,W,7FC;PS;>I+E]\^,WL'"<?SN&FL<(
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M,Z&S0,,A*==D71OP'"L7IE]UIP_BGDJ>R_L9S.9/7(;<WB^>NYA?AV2LRR2
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M9!.*[S(V<J>7/GV!:$?C^\+@#M<S%S+[VQSAU]SZ8DDBO8DL(RF]FI,R UP
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MW#PQ3Q8,\Y';8C(*68[22N+4*L<;",(NI.XY&VME,)E0$0.2 <L5*3A:&<[
M!,^L1PA<9!W,BHWXE*:W[43GS=/;=B'2D>J^<\3HO&3!&60:O6&Q^, DR:K!
MVG([':%1X7.ZN@\D<O.F8;<KD#O@^K;KOG=A7.>Z[SVH?M2Z;Y>3MUS3(56'
M6V7"Y[T2+(4$((*S>(S:@Q.L^VXA#+L0N^]T:DSC4;ZI6U[V@,^";C0A6=$I
M+U8))4EFK' J>R>T[#*%=>W#'SO'9%^ZC_LD6L^=IY<:QMVR<^62BBHFIDQ1
M3,=2!X71M]EE*2V"0+[++-V3K=C?DXN'$ZV1,OUBE#=(F"R6)_2,NQ1JQZ#"
MO).1H7#%:./ K&8!;67HIO<\(][V0LH>0RIU4,:'X:S&$U^-\O#3,%_!Q?QB
M2:!$0>.9\K5O/6F7M-+J&TYH/4C@!KNT\^TT:60M@J>N>O=#VAX3CM<"^N=P
M=OX.+^:5#]/SX<</XU]'L^'LR[6\=X':]_BN'3$>?\17#US=)B,-6-+GQ; '
M9&$T&DE*B$.7F$Y IR8D8(:'Q+DVIN3>QOF=A/1L&2WVN,*S"R=Z%IHWI0P3
M+L=,ZH0F*VD976\$1",PX*2K2NUMMI9+';K$9SJ)Q)TW'W>055/^C/L@[O%;
M.KPX.YO@69TM"[.K"3VZKXE76Q[<<V.'KDM8Z>W@ *R,G"? J"/8H#4D7A+P
M8FJBU6#WU>S&AE<C^A(_P&?<A]:W_[H'@FX$LT(U#E*@CYY;)71(#G(*"GS,
M/"?AA1]LP+4W:?:7QC4/Z9=07:0L@LN* ]DFP>G,>4"EA40Z%'A2F/)@.\K=
MR/8K467\!?%G'-'J9OL0[=XC>B#9=E@K!/,:Z71U2A?I=(J:-B8&&0W(XDJ4
M8K -X6'DFIL7?1#M^D$-2+<.X@H!#6U#$K7LLU1:61.-=P8<U[QN5\WO$? ^
MVL/(^ ?.%M5ZPW3]HUH\M?\^WNWY#8B^PX)6>)%*,@Y*,))7^F-PPED7!$HI
MK)1XCQ?;7W6H.Y_(@?GZN6\O8%1+WB[&TZL)OOY:047'DD07F"JQ,"TC6=<U
M?XC+*&Q)7$&;"O9.Z Z/:*R^Y#U./@T7Y7T#'XPMLOB:G2V9!IY81(W,!4[G
MM; \JR[S7'M8^BU4C^%OZUM.[L<Z^F)#DQ#X*KCE#+ Y.AYST=HGQCUJICUR
MPLDCJ?,!70[:@6O2%&0[K&]#2O9F1)/@Z"JZ.@ LS3"_0S(11F]&]6<OIE.<
M30=*60PE0"WYJ&6I03&/9$YJ+0&+4:39A.,(S6:0WX8(]<2D)KWW5[&^6)2F
MPZ)+QM^)I-/78\):H49G<HS,@ &F>:ZR'P6+9%N4++U1^4@WU4:,WX8X]<.B
M!JFX]Z&N5RT'"#S8XB6SVEM&X 0+&"7+(AN4.ALG&TT#[ ;PVY"C'IC3("WL
M?3K'?%5]IO<13[\296%!#L 419I;9 F2K[UK!?.$FVGE/3? (W>\A23MA/)X
M#2I:"U$[YIQ*(PNZHX>3^2/KFFZ2I*7PWL1H&'=.U[G>A>P#I9D51H$E<X&7
M)AKX>CB/%1EOR/YQ[VQHH'_?1[5,Q.Z JV7*ZB9@CY.RV@?S'I2' RA_3,D(
M&DDA"Z2(99F8MI;P*:UK^_8L<PPVF29#L8\K$0^DK1Y3('8A> -!>+L@R>)$
MO'-(+D.S10I7QS-FG<GB2\0]G[QCI48?4!7)VSC\'@)V?)VW'Q:.&]*_@:?O
MS>P<)V])SY[<K/[.);H.<B!M/-AL&:G?!#G6)K2)+M+ ,^2:'UC:6-Y[8'TF
M4M2:2QL/GEYS+E8#/5\;9;\:E?'D<NY!Z"]&MO7Q#4)DW9>S&JU4298,)B6N
MM5$*BM5T)EBO@0S?8.Y%R+:^Z2@!,A NB"P9D.G&--GC+ A=DY"MIB-+:BX:
M%;\T#)#5M.C7."-63]^4EQ,D&K\?7WS"4?KR=C'4Y,7T+1DG\^;+O\/D7SC[
M+[BXPD%E&%H"C,1(LF#)Q A9J-K! ")HFY2P#\CNON\^6<_0#@)R.RV].?U;
MM'NXB_G-U6PZ@U$>CLZNNW,;8V)PV;.D"^F54#*KB?DL T07A7;<M1DJ]0"P
MYR0\39C1HJ/@3BX+XV/V4D?F-3=,*UL;[9K(A-%:.^NEX_F[.[$WX6G'G!-W
M)Y;"E:D#5S54W504Q4*$R'@I"7(QR<HC>06>CCMQ)_9W<R?NPH9C.HVZX/KF
MW8D[,:^K]V@?RA_5G2A(^).+3#DA:@)*8& S9RYH8;S@.K>YH)Z".[&)0.Q"
M\,=P)\9$:Y,A,*R>+"TB9S'QS+1#F6(  :9)>_6GY$[<A86[NA-WH7^?-?:3
MV> =C,X6DI]=$<X)R:RO14,0-?/!6X8>%)I@O>XTC*%3+=7-6Y^OUK _<7LN
MS)Z#N!:T+C#Z+L2]]?[C%]GNR8%5'AY OI[K'^_ \;;PK#V#A 1'X3SSV!$3
M,@^%(%G5Y1X_#2YN*7;MF8D[4*UGYOT.GX>75Y?+9@V%&^^E9-S685"RCI34
M#EBR:$6B\]_RW@[<.V\^;O'JWK0?]T&XXQ2FSFMQ,;^%22VPW",,LO* '@(=
MVR#=JURS(007N7%1%ZL\YL)%DMES[D56@\WH=B/3/")6NPA/\+SN^T^X*"*L
MF:=[$&WKXWH@87>XJ[$A2>=1"4)9JS7G$"18[4HNFF=1BAMT1=X?>?<N$>SP
MT,:D[E Z&$H*"AU= ]+H' MHY%ZCDZ!SQN2W$OS0,L)MS]X_,-KEJ8T)WR4,
MFKG)H7!O0PRD"D?@ /4(UG2NFRSU5LKW$_U\D=+5Y=7\A-KVLJ_>9J*QLH)L
MN5)GKFH!CD4+GF5M'7@=N>=-4B%V!=K+3-#S\05=>]-%!W=ZR<55C:N\K=G_
M=.//9I-AO)K5'?!A_,=X5#W8)!?TQ+-ES=* V(L^U69A(D2F3= L%)2L]G]#
M(YU/MLGH@W[@']^'T%0>UPX=/2Z/6R4T;:#3SUC&$SJ.TP5,I\,R3(NN)W_@
M[$WY )\'125I.20676T]7:LNZ>:-C+N2K/0Q"-/$FWD YF<ND\?B9A.?^5U@
MOQ$E.]#NY=5D4GV&\TJ8F[5(22I(,H'95.=C>(\L>)V8R\FA\BECFWNFST4\
M<U%]-'XWJ,/<1JT;C#F@<]D:0E9K1?7_W]ZW-<=Q(VN^[W_)"-PO+QLAR?:,
M3^A87MF>\\A(  FISZ'8WF[28^VOWT2335&\5G47^B;-3"AH6E/U(?,K(#.1
ME]8:RD4)LKK@M)1)R2ZA_B'@3IQKD^NG0_7E5.:$S*$D%HY3O)6;8-K@P*@A
M&56JM\:IW*5LO(?)V,TAN;Y;<#+5VN9J9BG;V*.B() 34%$6WCQ*BJE+&>L8
MD+M*%MKIY]A-2X>2-O3"P#;C:@HI <H61,V*(* UD++Q*+3W7G;);SS(P9?]
MN#!N(N8(G70P?I\8RS@ U/>)F&.U-VPBY@:BWQDO/!E,(@6PDO\P-61 1 /9
M:$^H"B75I6K^:"9B3DZ',1+O0(,!F^2Z/$Y:*9WPT"+RP$Z1 S3* AF9T<J8
MTZ"+Z1XVS6%-T!RET?'VRP;JZ!#<NP/TD62;5^6_KY:7[2NZ04M"L$*< Q+M
M>$6&'%)0H)U5ONKLC>\2;AX'\R!]U4WT_32KIE96WRUI-;W^NB/V Y1!Q>J*
MTB"]42P09)2Q&O9.M3,!J\A]*M^&P?L&J#25<CI$S>Z@_(4N6R.L9NFW.. /
MM)Q]N%@):?%_KO!\5C_/+CZ\P>7'G\[G__XGE0^W<U<D,S]K]@&*:?&.6 )@
M\ JBT;JZE#29VIE@&X/_!NBW&\4^&8Z;--7HMX^XH->XI-+$QC);?54;)!@\
M\: )<@J&0+R?,9.CS*Y5MZ=DBG1)4!71%4,BH[+N[&6T4XAQXRR99Q_73:0#
M,F-0FJI8NI9*,M&$8(*N)6I;D<4;RA."W38GYO&G3MP[8(.7=%/%QGT$V'LO
MJK+17U(PUOL0HT!9- ;5_@T^H:".W02>>.%BT1(Y5UTL/G_Y*^LB[W_CHGR)
MRSIAJ::,H+VM8+P7@$XI=H4]QBRL+K'+>;@]]*V#KILB6/WQ+UI>MKN*U;VB
M/",K?6QU!PY%FZF<VSBW:ME;1*^R%ZY2E[N!*1>Q>_-BQ_Q]$.+=%P,ZN.XK
MH.GEM:3GUO)^]N'CY;H)!'Z@,X\>#;$9IPV;4H;/?+:GVAR\[#4;5]*6T*4/
M8I?5?)O\WBLGIJS*^)C/FN'_ZV*>B<KR]_EO?\XOEO/%\GU;UN_SGR_^8L2\
M5OQS=HGG9[50J%8ET+IY)/Q%0JJ1J>;:$$=4!GUXP6P9^\YOAF%=E=$C='"^
M^CM4'I=7Z]A^L:0SXPN:BKH1.H!1T3<?4D!5Q@FV_)S-0X;4C0\.#(+WS;"K
MH]9Z).)LNLLR_MEB]9>O;8BSQ.ZTK-E#I,H[:PP%DJT%G"M:Y,"6A.O2)F2R
M%7QS#-V/[KNV87]1HLNG1'J3<Y%43#HJ$(6W>R.+@U6Z>D:?I5)194%=2#S5
M"G:50K5OZNY%XX>2<74-?]U*Q&#+9"\!7&@G2)(20BP2BK)HH\.4;9<$B:]0
M[+_!PDZ)</^LWU@A/;K(;2R(+\NX**NA&_AIW9=DR)IZ9F?U6-1^DKNVX,K8
M"-"N%'TL)"87^ NW!-H&"<:9UG1)MLO@D-!JLD7UZ9AX-.1](1/MP+D[1K]=
MBKJ6EXM9&YZVJ@^XN=I543@VH2UDZQU+*4J(M22@X-IP;6U+[I(4\BB: _1Q
MNBOZ02G6MEKJ$ !?-_%>07KW9Q/1#3 1E"BA:E"JM+D36"%(TJ!=:T1 P@?5
M)8C])*+O%)I(6_UWH#]8,\OWO_VQ!F=,RH)5G= 0<USKYG E_L,4K9+Q3N<=
M[$1?H_I.IPFUUB'X?)M\_J85L+*;U2"NCG\,1I@8(KM)#GG)T4,0LD"T5F5M
M9"BBSSB[IQ!]VS[H-(KJP*"[>&Z^EB&(>GJ3#R'MN=!G.YW-NPB\P_GT"#*'
M2.PY*+!J55II(Z!WK3XA>M7J>$7I8M_LB@)#:WMZ,V",G">^^/YU03__^NZU
M7,\>BB14=0:H\$YG).]TD>TCL!9S]:BK&'2U_?53=V]&;"OC^20"FK)-[Q<D
M:EUV4;VP;'+P@IKM$=C#7V4)^1)=M3%ZLFJXJM3IJ&H3 7783V^R7%;[14XI
M,.P &EMF"S%K4D+6AHJQ:&THN2X=-^Y@^+8-L$V5T>%6_P;*#=>'@.EI;7V%
M9C^&UL:Z>5S'6PBVWRZP'C*KB,BF"+5EE1B/'E!8!4Z70EJ$Q-[HD6KY!5NJ
MCY+'R'-W%R&K+8MW-=[YWEVLRYBD;DV),T'-M8(1R4&*HH)(;$-H13H4V4/U
M(S#N_O#?0IO#[BRV5D6OA.IGH?[^[_G:W/35)!<88)5M%(E'_E04@@K61EUY
M^Z(^392&8SQMUFRFBKWL-;\S 6Z;K!OK2F6SMU"[_M-D(; ]#*HFMJ2]<:CZ
MY$J-07GBS-E0'5.._F"GZ*%%_<7@OD'ZT_QJ<0/4Q>"J<DSM7$(;?20A:4+0
MN<3J^5_I.L2I'/728Z1!7\E.Z'4,!3K[ZY:K,A'[S2WU+PAVFY-D<;!T,FGG
M6!Q5W1\IN#$%;E]ZRA383+(=,G'7MV(K&]RJU*K'*M/1MQ@+58B6?[*%37.+
M,D;3Q;"X"^+;#DELK(Z.U+CY'(:@Z1F4.(14P,W5\X2>MY!MCWF 7Z/R1DLK
M%6][E4U:4XN'F"OO5-0Z,3A?/':Y+SZ O+E>BAXCTHDO=5XU:;_[=#%+5\N?
M+UIY)1]"#=[Z(')96A<J!(8!K<\81!D#%.&#)@8FJQAPQ+_PFMT?ZMMH8-Y'
M?-U&-1K'EHGF]VOO6VT:%D O'$CI5/0B%:N&]&X]ME&-^SBQ-Q?\0^W;J0;_
M#8%QHF,<1VG@B0F FXBOXQC'&&J)5EO(7A(881.DT+I-M:9(K3%,*4.:I1R&
M%@>-<9Q"B6.D-O481Y;4EVF$4I*1.B4HJ77L]ZU_72X53,JI&'8B91P2;ALV
MQO'NF_<WQG&4[.=3"&[BH_3K>9+H)/E(!7)DF\_4K"!4/A=D)=?^JW09TG'T
MF 9Q;JS!C07WY#>X@^YXU\DA*TM@N<HY>2WQHKQ64[<>>^D]W;J/C5K@O09D
M6AL=3)M?;IS)O/ORIQ*E(E=\2LF8)\+=+[UR[SW(JD]LD%-872WSIL*'3(K,
M>&5SI>B<E7:7UV?'T(-L/3)E>;FX6MG3J_:<OW_$B^MBBN4O\YL.+._GY^<_
MS1?M_W3FLRT*G09=E>)]O!I(RLHVO"M4U :C[9+@M-ME'F ]Q+3?P&1]S/JS
M:'<7\U.N]I>KU:%9O6-GT['OB;55M)4 47D-3B<7<["H:K]^++M8X1%]*3N@
MZNZ_J@UXMH]"\8T7RFJH-..%_KQN<V.IQ&0+@G/8.I9$WN:\C5!E++QN2YTN
MM':XQN\?U5X^JNVXUJ/LK]M2_[52R>TZH](N4\N1B\CZ,-D")O;MT&$.RAN;
MY)%]4U\O\/L'M9</:@N6]>JRMY/3F&PD54SA@SBM\IX+Q,*6N">9)3DIG=]E
M4EYOJV\#54QVS1-*UCZRE$LNK>0[(6!MPZ2)3 TI%O1])AM^@[WBMG(P]Z+Q
MP^P5AZ(H4YP$"HEX!=E ,)7_L>34^B!GWC5Z</;$>L6-(L*SO>+&*.18VFP-
M6=/W7G'C>\6-XLHN^FUMHNAC(7',S8"E=FDEFC6%!"G+"JJ2%D6W-E%==LKC
M(>^H7G$'Q]TQ^MU9KSA+*=FH/*A4-!A;B*UWTD#19ZVM<=5T&<1RRKWB1BEZ
M4*^X,5KJ<87P9,L05WVU& TH']CY$R5 DAA MAS%&J,OKL\XI-/MR+2-I3>-
MHG;3D6D(HF^[(],HG0WHQ[.!P'?3D4GGF(RJ 7)HV3:!#^V02@8IM$ ?2JBB
MRQR1@^_(-#$#QLBY;T<FV3)SB@P@:FG&F7.\L&+Y:Q%8^#_6F'N1K&/IR#1*
MQD]W9!HCH+X=F="67)54(%WF\TC4"M$Q)3/_6A19")4?KJI#ZLBTI:HV$= ^
M<P7O](Y=3IT?^-BSN^4$OKB0>WF *F1'IL15%SL2,42MR08K^".S+M(37L!C
MK]E[[E^@J(BA0_7!@(E10*C. V%T:'B'0+.?AO*'F_MWH\)W5Y?+2[PH;4;?
MG<O$['VV(7K0OFVTV2I@$?*)JPQB#)G-[L,:Z/KL<@[0@YZ6TY/=YT['BD/*
MV7NXJIM;6N.#=90D1.L2&!LK!*TT*(S)63*:4I_6R5.OY(@8/B'%^K%^ WX<
M4D[=S8+^P7_Q<KE.OOC'8KY<GDD1M8@L6ZUS*XI$#8G-.@A(43@3A.PSI:K#
M6KZ3_@ XTBOG+;V\I/3$DFXS5>XG]5U_U3?!R.49>EV\9Q\RZU8*I9.%9 FA
MI(I%EX Y'=:DS''K^_YY'"B7>B2V-:_LY^7RBLH/5XO;@?+7X.ZZ;#_^38L\
MX[6>&8->\@<--<G 9]NJQUTL0,;D&"EKD?N4\8R&^IW(_37<H=%0!W-,6!L4
MKT"29Y?(Z\3R,\PP6ZU15263N\PHZ&RN[U6T_T6S#Q]Y/WOU%RWP ZW9\^MB
MEJEQMZZY2U6PL!V4'&6KV<Z F;E+2$KPSD=&'%:(9>.E'M%V<W#1@AYL.D#'
M:N"*SZRM2;5VPSYKWO"K8:M 1MZ0BY8N&N=2<D?\T1S1E[(CJN[GRQK%LX-*
M_'O4"7UVJ3+64H6R8$FP;VK(0+ A@5-48\W:F[J?R/1T:_S^66W[6>V);_NH
M_WMIJ3<.ZQ5["8/6*XI@&UMJ$%&WWL48(4H=V5O1[#=X75W>3^'2Q O]_I'U
M_LAZ,F\?M8$OK7>]FF&K51B,%@)!1N1]I:* 6&2%Z"6QY1XKX7Y\V4F7^?TK
MZ_V5]6/=88>$GEUFY2,ZM!L+U,F#*8Z]X2P]9&62]B4'4_J4A.[#[]IG[:VV
M1?D@#21?!!C,;4RF=RR7F,EK@_)^&MSWVMN]A'CVHO'#K+VU6)((.8%2K1=B
M" [0"=\N]2D8DX1U72S<$ZN]'46$9VMOQRCDH*(7SU0[#5G3]]K;\;6WH[BR
MB_K%311]+"1&,M);IR YK<&(V(;S\@*K-,K*;$W$_?0$.ACRCJJ]/3CNCM%O
M!\[^^.G/\_EGHCNWU^MQSB59*5&!2PU8"A;0&@G!R*S0:A.H2_WMDX@.T(_M
MKO!Y#VT]F1:\@U*/][_],7F)Q]UG=BOM>!+XO9(.5JBP6B&EXDST[.P+AU6R
MI1:%TEB?(-7=Q^^]E$-Y[V+U%0(J=MV-1D#)GKQ,257K)19S6)4';_=>RK%9
MO[BL;9""#7:TE=U)91/$P):\<,UVM]7GG ]*T-].&^<QW\">VSB/8=$AE82,
M;NAG3=#%,*,3NC;[(+6%Z@165>6JL@'M]S;.!]T@<Q15]];&>0S/#BDSZL6%
M?GWG?A8H"6FR!A*M/MA( <$ZP?0WI8JD*>_)MYQH@=\_I[U\3ENP[*BZ-S]L
M5%UJ3>1J!&5:AQRK(H3H"&*6(:2JA11'9L]]>TW1#_.;VHYK1]7&^5Z[:E44
MEFQLZUF&O,YVCRQEAJ2]%;[4$-.1=7'^QIJB'^8'M07+#BDI8[1MZTM(TE2"
M8*)HVT:;'T<")!4BZX+(XK#2,G;>%+T_T'MY)2M[Z0>\I)]PMO@7GE_1W<\'
M70D^!3:?K%?\^9@(T; SXITP*CB%IAQ6L7@?.1S1-GDT0:1N/#PJIWBX.,Z"
M$[)FWCQE(M9G*!9"J8K/LU;T873,_EC'[KVX^"/Z  _A"SC KWD4?8_J$WZV
MEN0102@MG<$D004V?8Q0&H)CG4;68]2DJTSRN+[CD1+X_C$?YL?<D\C'&%MK
MA2L#I-#"BP*;ATD)#/+F%D3)$ O+HDJ31.Z2JG(8R__^+1_FM]R-PD<<S7M9
M$)8BAC9"5:B*[;: (":5(:N<3<Z^I34?U[<\4@+?/^?#_)Q[$ODX(XH#=C5G
MDI&KF:VR@"F8(+3"4JVCTQH5QGBRL:L#*A"+*EGK-$1;60N^N7VH$;1R/D@I
M0^XSZ.Y;+!#;*N*W%XT?9H%8#;5:T@6(D@-#04'0H4#.3AE5O$;;Q:0_M0*Q
M,41XMD!LC$*.I;9FR)J^%XB-+Q ;Q95=%-ELHNAC(7$6PDF#@H\8&]HT078:
M(QO/QF3^]DVTHGXO$!M>('9PW!VCW_[#&?]@A2S?__;'3=D1NS7>FVJ@==@
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M5MHU 9[_NIC_26QVKZ)&U\=G.TG/)#EE,K/:,LW9J=,>@B,!S@O#E&>)23G
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MIZO[S<7:-W7VDMVBY>K4=.RR:&IE9Z7=59?*FY%&"26B*%BBLZ)/ALDC8$[
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MZ^Q;&3WR60<YML%AU18&0IIQF6I"0L]K&I!+]]5#]Q:&VD2X\RDDTZ-MQOW
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MS.__GJ_M!FFSE<J"4LF#(>T8C).0M4[95"^-?2E'[]$'GXK:-I-4IZ_M=];
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M2KT>@NF;2[X?I:@A.=B;2'E7#)"J*A\E@33-QO+2,38AP MOA6 ;5 \:]WF
MFA^??#^YXL<(=X?)]\EBM3I(:#75T$(1T,I[ 4-PL76,H"IZ6!V'G7P_2ED#
MD^_'2+I#RMYJE,&-.?'C^>S3['J>Z;IQ2!'%9IN@8 ,7I6_FU,K'2N1#23%V
MH<&SJ$Z #--)O4=>];/YQ%G'F$A6R+J-N%5HVI0+!24H'=CDSE)\K\>8VF:<
M7C7=ZS&&@/FFZS%&:>O9Q/Q-1-V]'J.6*-NX$L@>&51PV"8X*O"Y%-XY^<2C
M/DT##KP>8SJUCY'PU$W(^?B:?:"+6;X=6A,3BS<IT%'R:1@L06A]QG@]3EF7
M5/!#:C(>/'C?=1FCA#R?2D(37SA\720BJLF%WP8>:P%3B@!LW9DS6Z(HV.I4
M3@U0U4&5SVRJILTE,W6%$YTOYQ=O,:WIXK+@=Z( JP)[FBFRF< 0F#,^6U5,
MRG)(JM']YQZMHK:1S[Z2'=Y3GE_DV?EL]4_S>FT=-BOPYN^NY^!.F/TP]IU=
MTB&V6OB]_ B1J@SL)6MCE;'L)%M':*DZ++E@#(_D1XQ]_2X2)F+(.9*$S/0'
M(RK;_U;R[F^,K2)E0^'H$B8>OY+57E5"'QE)U,V_21"2*^"-R"GD2KH,L@2.
MY2Y[A&*?O\L>([A>D2!:7O[X]Y]LZ-*9K514U!(DLHUJ!!^&*WO%A^)]=-2J
M@+K%?K[@."&U3R'I+G/>_EQ0GMUT8>0S9R7>BS9*G=?__U:_/ZO$)VH2".0K
MG]NR)'9;D@3V*FU$4PUOQ3W8, 3<"5)D<IWTB/=\Q 6]QB65-_-/C<G7J)BN
M#H,CT%H0F$@(47H-CAW>HJ-&K;NDPCT.YP2Y,8'<IQY\-%_0[,/%FZO%@B[R
MYW^PF-J)QGQ=__CNXN$(W+-2V0NNU8'R?,R9RD) <I7M>.E+#=9&&N*(;O;V
M$R+&CE0P93D=(U[E:"UG-QO;#XQF>3F[O%JPQW6.ETQNIOD'6OY"EV<I"U-4
M]F =?_I&:P^QQ S2D73&Z1SN9]<^2I3A;SPQ<G02=8>Y2:NI;N^IS13+#) %
M\6:^O.25\^&F?<X@$EE>N?2 +A>PWGNG60;%=KEU>@+/"?%C2LD_)(3;EA#K
M&/J/?\\N5X#DF<Y2.4()0IE631R9HLZRN:Q5K%9'+U27D1$/H9P@#;:4]T,&
M^&T9T,ZO93O J!UA?[=5\V;V<54 4]L(PK.@1;6*F)/L0+6.F'Q^65FA1LPQ
M:+2J3V./%Y&=(#^FU<9#NH1MZ?*6)?SAIDKJ\O(Z87;M:(OJC)5,W9@H@G%L
M)Z-K)D^P):MH7;2E!U&>P72"%)E* P_)$;<EQZH,X#T[T]<S=MZE\QNDKW)>
MK'SL-=!D<AM%:2#H-N'9V0BI: V(L7ARQH@^7NQ@A"=(G#[:>21BMEUY.9^*
M;$7?0%F^>?>OGW^0\<QXSXBJ D+!VYZQK3&O8EQD8Q!4;*E^@(_R^--/2-D3
MB? 1K6X="&7_YTXX/GLOA)$&G/,&C&V>D#"ZJ<Q&&<BF/B['5RA.2/';2_D1
MG>^E)$M9E:4O!E),;:Y'F[<8O892:Z BI7.V2U;LT9=D;1/T[*RG R[)(E^R
M-#$#1DN\+58^]A)_+*C:);AFEWS03/%OI"1KE-)?+LD:(_Q=%>0,P?3-E62-
M4M20RIQ-I+PK!FCDEXLL(",RR0,;P0%)0)'%>XO58!F237* FA]?DC6YXL<(
M=X<E6=E+D5/50&0$&%*^]:HH8%%*QLCKC$,J<T^L)&N4L@:69(V1=(=$G/_$
MECN,Y[=9;'S<M16O6W2%XJK&!"2LY0..+ 1>*5 P5MGJ2*LN/=2?AW4"=)A0
M[D]N"T\DG-[\NOV1<$G_^W_]?U!+ P04    " "9@*U2T7GB!=0M  !-Z@$
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MUA9?)$D>#G-B8)E.7DJ3UR0W79FZ=AM8&GD^!?B@4?#>E3'=*&+^6%R9+9P
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M"EIM1WZU.Z,.HJI:U,I@1[-.*LQ5[@3-U<93OF:;GJ7=\[)VQOVSUDQY!<4
ME_M/O2C]=H9UMH'(ME1BI@)VQ0.['>B34,&X"L;]HM ;]+\K7>X>ZU^RMM)3
M+JHJ@F712*_<@79A:K:&;9HJY]GCH.VYB;4S)/GU.&2%P'8"@1WO5AWG"H%5
M"&Q31]K_57L\1EEYTTJE:WX';QJ>"&)_!?J=K^V2'ZU8-)9&M J/#0W;=-Q?
M]IYQMT8SYYG/"JD5CM2.#L].CHY.&X>')[L5#JTP6X79-I%YG=X5:RLWG9'2
MK4YBO2Y,5C0<&S@+=F&PSXY]6U6CRX'$7H!>.T.5=56,-HE=/O>)K"HQJ3JC
M58G_I#5NZG>:8;&_S%DE_7/8X<].KITARE:$?V5Z[YCI?;P#;8HJI;Y+!O?S
MRJZ3%+[BXYH8NN-J) \"M)KQJC<?OYG^'7,-;PX"C3FVM4!N&L('N(X=4R1$
M?CI=!09/HP^CO\]2"$6?31O=F>_W&Z<IVZHPL3_LC]2!PCZI2G?T"9T1OQT!
M8/Z=*[77:0_9E_JP7OM%(I2!2S)@C]H=]GNLJYSW!\JHCQVY:++L5<XVN;&'
MZN!KIRTFG#;?RI56.ENJ%.%-.;F4<31;C6GS6;>P#D"#?:ZSKC&=6L_<V_7U
MG5/X;99NMQ8H9FBV[TQCRBY-6[-U4[-8?SHU=9&@4N3JC<#V\<!"JXJX[Z!)
M&T63SRKCMC)N=PC(5L;M\UL\[%._>]'I765; K\;02Z5SN"RHW8O'B=-9225
MSD@JVCXZ=P/=8*,Z^\O5W&"^&T&GW]PXR5JSRC:)V29%+E R [;&0GM$ZG37
M\+786:7*.MD]Z^2H<5!9)Y5U4EDGOZUU$H\\#90+WG^+C=3VIUZ_V[_:IK%2
MAOVS*1%><XSJ\1W0Z=7@_W:],L=VPAS[[6-6L09APSMS]B/PJJC5SAB&+[QX
MN[5$E6U8V8;/G(QYL@6+L/7\%F&K?C9?;HW:.*B?'CWU/,>3N^]LU,CU]*A^
MM#)>\>7S;\9?-:.&^ITQ"<"J[N0CT6%.$JTM-1C2XF4-^C,PRX].-C'HCP[J
M)XULHWU3@_[PI'YP>K:- S*"=KRS< *IX,;*A#&_@F12MT=CQ9?3/*R?-E?X
M0WY;?@9YTL'97U@<(>?*MG8GJ[)-?KN;:]=V9C/3G\5+/^0&GV7ALE6/*:Y)
M*I>=%,-EZ9CH\\VUX]YJ-FO?:9Y!%8%X2:'7QDJI"W2:*@5+M#S_.#FJP1OP
M_U?&&Z720!F%MCCL'P:F!ZRA7-586UO 4UG'P_YN'CMW-5N_JSBE#(OUCU;%
M*841_\JQ)L@80TV_\TB)8,_IBC'*L#:OF#'*3OK/QG0*=\(#><:[D0CJ55Q1
M<<7OJ2[.>S?L1G/-L986;JBXX>6YH?E:N>'D)-4$/RD1\?\R%H28>N0LT2RF
M>)ZCF_2I8H\RK-"K8(]T7V+YV>-F>,,Z]KWAD8?0D\$XL"]>(YI*]]97#%*A
MJ6PTI;FZI2V$W7WS^GAB5Y5&LW;T.GFB[*1OFS[8%E4DHTQK4K%#8:0?. NP
M*D@[.%/6UFQMDM:YH6**BBE^']*CCOC;L+TJY%VRA?E'H^*)@DA/70JTN>F#
MNGB%MO5N+LHV^$&D9&82OZ3\4B;;.RW1[<W'47^D=)_*)[^V&A4?;;94_V@=
MGCS&2$_J_/D:?DM=W]9&2?=XCB377<]^[F3+^^LLEYC^X_"T>;9_>M8ZWC]I
M'A_='V:?#WDW=B8+^.O.GUD?_S]02P,$%     @ F8"M4E?+O8XU&0  8QL
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M;H?V*Q$/.EBC-N>,K+F+O_O_62?:KK\$\=_'EKAW-;NH#I!X!J-Y.];)XQ3
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MRIZ^RKUCYFXU5.T=_RR+A[5X7^X2&ZX__JTL2S*4D<:8!XBB0.,G6*P=#C^
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M[:",S+-[QH"#LX]@:Y$9ICV;P,ZH&U";-9S+-QS$0SI^ V@UJ?LW'(J'3N"
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MUVQD8$?^AC7'<0T=@D;_J@-*8\$-V-H &B/,<?[AOEI70#CDMZJ/&I-^H:[
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M#J'R0P11%)F<#T%@A"(:^$E,E=>SI.X9B7-SG;_(NHF9R>SK&W,\AZYKX'$
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ML1Y:3$IN_5$Z9+PKGM2WZ,A2__7^KW(E,[J\78E;\9BN4O-L<RZF;@6_0''
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M.T!+]?IVX#Q ,Q)A% 2,P5!Y&DU? XDUAI '(N:)J1FHPL4WF;'UE'BV!4Z
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MKP).&#SH*J#]_&E7 2<L.UH%G+KFJAYD7^23"2RN[D]E73"?<*)7[% F>BV
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MW+*RZ@UN7<#.X9DS^L Z<E?Q*R\D!WO1]?K>"#]JY;L!H(U;%<]%@(DKY@W
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MAPOXZO7QK\;6IFS^]8,XUF M-HL[I?1H15,[1&%$PR3#4,1<&W-)QB$E1,%
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MT^M>F*;V>=O4GIN6Y56 3/5[T6ACF<@S;)XNG^%Y1=\S3[T OA6_ZEX 6@6
MT: "O?IUJX1/S.U/O[QB/]'IE8<Y<#IW&HQAS[F1^S,G._<9K&[WW&;X0ZXM
MWV;.>%9Z,I^;#?&!\Y^%'&<2Z[TK38W;,J0FS#HQ_V&*"Q(IA8<5:>L?>&XK
M2O?TI94\EXXIG]:HV]FN/K#TO#Z<@O&YT_C=X]&+*UI^"IU=&/N5RIG9(7*^
M:)GE_</;=VV:1CC?]".::JB9"D2$> SU0D&AMG 5)%Q%,.*12%BB'Q4X9:6?
M'F9N/%2UA-KL6T(921UKS%[ U8Y[KD?+,],, VI0VZSS.(S=#^O$2),WNCJO
M[:D.5CU7#[1<3$/ M[24PCCUY:JLC7J$I6 J#""+XHH-(M.#/- _!0P)%J5(
M.;'!Z6'FQ@:5E) 9,:NCSU9.('^:GQW#0<Y :VF,7 V8;].C@U73C0#<%H4I
M1U#'YIET,5I^!Q\N8.=N>?1",ZJ=<7JD::V*7FV/;(C^J\?K<".VW!3^JROJ
M+**$T"A5#$8"F;1;A"#E2, T%ICQ4(I,N+4GOC3BW)CC'7W,-W19$X7(-]O"
M=3-S&60[XA@5.L\<<J8S32/NI4IGHS2C.0F-[QXT+P=]]=8S)S&PZ3AS^D9W
M]_RA<Z;\8FHUZW_EJX=;H3^G*MRV64@6A(>"5PWT4&PLDC2$&4XCF#%.*67$
MA(#9NN:=1IX;Z>P%=#-0W"&_[&7W!J3OD\ C/VYY SJRFWR#'<J73)DK4;;W
MJWM#>R*?^JBH.WG3!R'7XTEW>]YD7O1!:G8]Z,,>,-0C93(LJK0)N>+/[Y8T
M_V&J-/[(3<KI;]NJ?I.,B20LP)!(;OK&<PPIBQ@,<,83(3FF=KF;+H/.C?!K
MJ8RSEU?BFB/66EY75Y4%X+:.JW%A].[&JM+0=O+>@%IBL!-9;UPKH<?T:=E#
M-*Z'RV+<B?U=]D@<>[\<[AWN&;=L$?]%&M^;?O2=^IB7G"[_6])B0:64-$M3
MF,6FDA() DBB4!NJ-")<1"&)<>SJ0[]&H+GQEWU5Q-&FQ-[]/A704SCJO^T=
M]8TZS\:^:B0W"T@M.S#"C^N]'P/&L?W\5\DT^8G & B>.CL8Y;G#F'7</-KR
MEI6;@O+-@BBDOP+C<@R2&&*]_X<L$AQ& 8XDC^)0T[$+X7J2<VX\_#=)3?GS
M;DN-CM1N#.UK:NV(>P83YIG/?15/*,$?K;8CGM]ZGH\Q%P9?HDZZ7GC&^W 9
M\3W<X)JY7$I1FE2UUDW]<5U4J6H?=TX+XZJN5KT%)5(B'H>0"!Y G$2FLQ1)
M8(I($F.59BQQ2AEQ'']NJT$EIW,55"?$+8^N_.'H^R"KD;Q.QGVS.]?2W\,O
M33[N3@&PUV#4TJE#H!NYOJJ3"%,781V"SXE*K8,>,S#OK<FBD^*V;!+K/NW:
M6C9E[2-*,YG%FL&X:1L:8@99C#)(XS!F*8ID1)53^MOE,>?&7_LVA"78BV\*
M0AD%I-[W+JLUJ?R>/SH:MS8S8,=M(^/J_51L!R,M09M4NQ?X<H<&]SPY>X!&
M39>S&';:K#E['(Z2YQQN=>_2^6[]) O+[=G1]3-ZMRNY1MW\G-7VBN:1+Y\W
M6=/(DVITFT6>OF"@5XB6TO31:(@TE)QRP0(8XS"$6 0":D-=083BE"<988D(
MG)PY+QX_MU7K=JE'657+%C"25IU;'%TO+_&S])@,1L6WHZ,%P</B<EKI4;T)
M+T>8U@EP4KNCO?OIJP;4;<[77WDNM6CZ$UD7M$[=^OSYW?X/S1N)LR *4RHA
MX=QT%F'81)&', NX(I0',0JLC%.G4>?VH>_E<ZAH:PUQ_T?O#3C?7+ 3#72%
MO@%:;/!F_]=?!K0*L\?6H<JO#XRGJLYKB_5(971=H>HK?VO]K.G*UKJJ]Z+<
MK//-5W;GKB-YQ?MMH?<*]4G0(I64B)"G,&4RU:1-.22IP#"6*A&$)+%B3F=J
M?8/-C:OWG:$;80>VV3Z%JYUY-A9:G@FZ%?.FC=L7H):T.4_TT"R[!Q OK;%/
MC?<ZC;![-#_;]KKOGF&D<:[RGPG,>BO5NI"'I0/+7<5.CN*84Q)K\T]D$'/%
M819%F=[I,98EE'$>.>4'72'+W"CG[E*A5< JA3KU6AN-W+CIFNFSHZZ))L4S
MLYVOGKIKE==,R)$V?LJIC@#KF/QXC3B3TN<(N!VRZQB/'*5/DAYF_; R);@^
M";U#T,.9"A%U'E9+_;<K\5G_.E]61U'Z;WHS(?ZQ+OYIVH;7Z8I:N(4,&(G"
M6$'$PP1B&D>02$8@3Q(1$QFD@9VYYUW2N1%W(R#@M80W8"4=JF[YG50+K\!<
MILJW)^%D^-1>5=#5M<DXW=NTIJ171U_0*'P#VLE_UT[^;_.9_*N:$[W.2_"J
MC8BF?1FN[3DT_@2Y]1<:<?S7["4T/HP7^@9Y&'!H5$D;+K$_'"Y_I?FJLF*>
MFX/C;M#$V^?:S/FJO\\J:/CSNK9NWCZ?>MB7O/QG73,XC4.><24@QX'9]B$"
MLU RB!C2^T"):""<JMU-)_K<C(V]L)TH#+WA,,HW^Y*!-9^G>QOL=I'SG&//
M5LH8TSL@XF9JI,<-W)E,^HGC?Z:>E>,PHLDEN#Y?<X%11F40!Y"@+((8IPED
MJ5YU A[0()&(!&1P[N7<5H.7Q?B&9U0N(A5%BHH4*H&Q:8A,(6,DA(IA)6))
M"2+)8K/6=H=GT'9#^ /MFQGC"JSLEJ^A"'A>8"S?F*LR/GVP_(OGOUHFYCFF
M/'G-=4>RG_6^X9,FT7*!HC@+$L%AR!6".,844A$J&-&,Q$'(>(K1D'/8W0AS
M8[7=X>L?1D10R>AHS1ZCZ';J.@B;B8Y:[6 9?+YZI+J/0]7](*]RDGJDX[GC
MT^,+A^ZUE7Z2>"M7^H?-O9[7K[)XRNN2.@L1A6$LHP BB;G^PC,&LXP)B)((
M"1)'C*9.IZ*]H\WM:V]$JYJ&N&Y9^T"UW66.!)7WC6$E)V@$!4;2&]!B]ZX/
MNP'[00M,QMW"]0TX\:[+0O?CC9+-3<.8HW(,?I&;O$[3OV/+_*$Y4=0:U67A
M%XS1.$K2 #)C'6"E0JCW.@)F+ U5IJ1D)'4A$)M!Y\8C>\D ->*#8B<_6.\5
M<*,8*_3MF&9L3#T33B4NV,L+.@+7-9UKD<>C'1> QF0?JW$G)2$7) ZYR.G>
M893T:<4+24OY7M;__VE5QT/4#V^*%&OJD9(3"8DTD5Y,!9#02,(L$@H%$@>*
MH@%]N6W&MOJ*IN^WW01X=3G*D8VL@+=CH]%PG(:-6G'!FU;@7TQ>;Q.CU4 Z
M=IEH%XS&)"2K<2<E)!<D#@G)Z=YAA/3.:+':%/7Y:E[^\^VSML7X]Q^T^&?5
MU#C1.J,XBR!%B=1D%)KD>,8@26-&2!S'*77R"5\:<&ZVT0MY@1$8[.0=U#SZ
M(N)V+#0FCIX9Z!H(G9G'%I<Q6>?BF),RCBT"AVQC?=] IMF6F_4/6;PH)=%D
MB1'%":>(PA@)#K&,M>U#,DTW0<K".,8!#9@3R9P?:W;\THBJ]UR#2VST06O)
M)N, YIM(6JQ>B.DAU]D"CE'YHV>X::GCLMY'K&%QBWN\]H?-]^>E7,F[G[F0
MW];%YG.^:39COTJM74Z;UQN)@ 2B:KDG-7,D6,!,12G$62(E0S24Q*K@@<N@
M<Z.05FY0"0Z,Y& O.O@__X\,A>'_#1H=[$-LK2>AGV-\0>N9;-Q0'9!$;0VO
M?3"R#Y@GBBL>Z25V"@UVA:LGRM?Z49,%[+HJUXV]=;YW8./$-M;IP_]N\\VS
MR0I:KZJBEF8?)(3><F9Q#%F648B10GK3B1",0Y$(%:A8$NK4/[%OM-EQ>B4C
MV LY:*_9#["=:3@:;+[YVA4Q]Z:)-DB,VCNQ=\!I6RC:Z'[42='JIO%3J=_1
M\OO'Y?K/JG9A&W5YJS;&2GV96WB[$B8Y-PME1@@+82")MAT3(2 )4 R53+G
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M"H$A52F#G"H5T9"$^F\N/:WLAG5:OB;H:/7-C.'LH[7!U]I9.S)J_KVVAR4
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M^R+G<L$$0XG(% PS0O6.)DYAAF@,TR@4(:&*QX%;9XSI9)\;%U:2:RI\DZ^
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M#!GCH<8_%) 2)"$C&262T@ 1XE9JU.,,3%-UM%4 TL:+R-<_?JS;^0#KO>P
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MA$2V;EEB9*)+CLQJ/U.0H(1"*F.>,)X8.DF\Q!M"6#4UVFDZ!8J]5X9P*K>
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M499A&G/BO>$]S="GL>'K%?:<@\UCVWMR@8P'#OVVOIVC%;_-[S'#D19_SFZ
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M\A3FJ>()PU0F2>Z?BGJ533X/QW@9J"7I6%E<87]0!W-GEF_J3+O-WJ?R8S/
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M7",&L4!1KB*SCDB]&*9ML*GQRW-;]WT"^FCB7(+7C4="@38PBUS :RAEG Y
M@FOC7!IO?'6<#L_/ZN-T7>/??.<#6\D_"O79[NKN5)ZXD#F)$P19GF@KT)U
M'F?4=C/.4J2X5LJI0<*%^T^-(:R)\+%08%,:Z=ZYY1QV'=L/UR,R\.-?@F',
M Y5]W8^]$RKN36NN1&>DSC1'*(5I.M/B>DMGF7-7C=8^IL7D9H^8MH_UE?+X
M;F9YO7GZS'[\S@Q++-C2-E/]\OCPL%RH8HYI0K(H9I"E"8=V'06)PB8"4CCG
M&"$DI5?>:]> 4R,U8R:XW]E9-A\N:DM]]3HZ@'8+?D+"-S #[DV= 0OB[\]
MW-D;O!N!*T!A13<ZQAQ99,,-@5-1#<?K>@1'B^WB6_DJ^:*VVV5YA%YN"-DC
M'_,_:88IS\_M<= []GV]F9-(Y4F>&J(FVO .0B9VXBB&48HUIU&6*^W4GK3?
M\%-CH=):P&ISRR>(50:#Q0IH:[)'8.$_&P[1V* 8#QVL[8T'!^MGU3XRV#D
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M\_=7[])'/ LPG:_689[J"U;3?UEM?OAJD<)Z(_-OTO73@Y^HW\'N8U!_!%R
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M*$8W";4>I:J'6&L0' TG^PZ ].+BM9=[[U90=4F4')5WC@$WTI")IGC169'
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M^@+<-OW[V?GZ(X5O_X5Y8ETP1'^=UU S0KBCK[1!B,5Y$TRTV;8&VFV:QKX
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M>P]1,0_>V.(#]S:D)IECC]#491S3#&P#Z:8?A_ M?KKD:;=\-HT^A%"Z1,Y
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M;%<]S%/"NSK+R8)PANM,FW3TC1M+?)O( >83?_-=5UU6E+;:ECH):#-\V:0
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MQZ*G2%L5)KGST8JA4/E#CA@Z" K[CQ@Z1"]]CQC"P))+3I)K8,FJ%YG %R5
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MHP>1R;E4F0*KR)@&[@0:@5(H]527(.-U7E;1AH!"0(F*?&W!)3@N+##/,@G
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M3,BU<>1VT^Z%MLZCTP9BG=Q4F"W>:9,9>ZI#Y>&YZ[ERJY-E,PPRQAY5,Z!
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MA$MR^J-T%@JC@%?9.M<JU*9CJC T#*V7>0\UWWCHN*=IPZCX>"F-K5Z<K2C
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MBA37Q.3 E-K"6RS%O%8)2&@,8_1_F?U,G77/O%9=.],EF*1,-N"J"ZT<DMN
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MXR@Q=P:3[;$)3+%4BV$=Q=QT;!(YVBPG<KF5I_M4:.>P-5!Z<#B.4^TS.#E
MSAT@A8QL6LPW&QL"SO_]KA 5.55^WK[YY=V'FPX*%^J8QPP:Z^H&X\GF(GEE
MMACGK4$K=K?]CN:QODQ=/W@Z! (/W=>1]=$!R'[!U48^-\V?IN["IBL[JB)
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M$/3B"W*() OA/>3Z>*QX8!!B;9^OE>ITU7/4;=S1,WW-'Z+^H:_Y0W0Q\7K
M#[53:W/*DBW<6DY!L*M[[S H<)["X>Q09NV-4[NK:Q\%T%ZK 6^_>DX/GH=<
M8X>+N =<;.&<*&)@23G F(ELF3<O9I84FY@O1+J1^UQ2^R-CZI61!VIL5^<'
MB&]BK?\3_YY]O?IZLW6Y,.V<$,!,W1L@ZK8E91&BR89',FB&C681?OCRQ)H_
M1&^+,838@9^Q9U86N?4\"< L*&+T.0!=J'7OMU&R"*$8;[06=*PBFF9O?J<+
MC<97U=1S3/*Z_M"[\BM]=[;^N+C\EN?Q^_OKH96O5N_S,N:Z1NF?N/QW7M<^
M]'PAL=!)(K1D&06=KT+\)2[!Q8(!E8F2[SSY/3[)Y(!OGT7US!#U+TZHBPYL
MW0Z/[Z[6JS5N\JK;P05:Z^!M<A!5(=N-)8&W)D-"##9P99EMT@[Y$F%G451S
M /":**;7/LC-"O*<WN.RSN8]X$ENYP=&>71[CJB1GM7N?>+[O<V*=XGI($J,
M)=7H69'?9062 6$6R))8XX,4*)K,$WJ)L..3@(___F.3!X1UT?D0P3*?0.7:
M3(R%_N!",1YYSKS)0I<!-$Z=V!D110^3AFTTU:LIVC0'_+KX2K_WI>:V;N;C
MU3*= PS3LS\WBIG:G^"1C-;O_^^JCL*^'9\D* (,6D,*IJYL%!Z<SK4*'@7]
MG6!DT2V.YX]D'#W7[:$ _R!QWV';:>&TLQ28A'J&'',0@@N W@OTL1CFFQ0P
MO438M*;G""P\&.<VI@;.T;H</(UFCQ]M;FD:3JG9P1AA(!9-"# Z<5 R(OA"
M0$-DP3'N"DMMYL6.:F_N4B.O8KSZ>K6Y9%\4\+UQ3,K+D'2"5#C2B:!;%ETV
M==BA]I:GD'7C"0X'T=V5M1J"I*>K/MKK[QR-V>'5E?O\:G-SUK*6<@>%O*BH
M3<J 6K.*0@5.9 T"K?,8$RK9I%=I7'LVY!1<&!Y*43Q Y!7\*0D@[#,HR)-3
M,04?FOA20XCLRE(-P<BNI6JFF0ZREA])(YN*AFMY5=86\UH NGFPS,H4<A#)
M0^3UN2F*# ZUJGOP+#)IK>5M)K@]1]6TN&H'A@>KV,?23 <PV^%A6S9CL\)
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M-NM&?\8Y6(.0\.P<K"%JZ0!33>8]^*B0N5P?GE@"%3 #'?8"HF3)DJS3:YI
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M !6!&ZNEB8%V\2;L:$.$F_<8;8>NR1W3 =BNP\WM2]GT?1=N[-KMD>54M(+
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M1@*Z^0F. 64PL'$,C_\N)5F>/_HM$U#=G[4L#7V]=O+_K/6_R;E=E-0NFQ0
MFJL57-41"@(RBFC]G#W.B3^Y\$MFR65Y'NH?'2W+ZR_"6Y'HY97:#F+C$08:
M>N:U5[$Y$E)8/P0@4QI'P^< !@F R1) !)ODC2GBR<X'$=];?#_ M+*+.!YK
M,$<9KB=/=@"/?]I7H*R<AT&1SI2<D8N%*1\7#RUUP8^43*5:$'KG$Y63(M_
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M/O6X(#H&;>.$YL(CEEGZ^XPK]$Q\G X&VN<04D$7&\"P*A9L2CH'3/AE:O;
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M5$@5PBI6X")E<!?+4JLS@@4(M#[FPK&<);C3@DL6\0!-FJD$L<.J7&Y#(*6
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M*#WF)X<"TV:KZD_K%1D4$W"8#VQ_C::RB[D!S\S^0USP&Q&04:R4AU.5:4P
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M)Q6=_)',E'9^9E!037TYA(^,DIG='++S9=S:-?](PG^N<?DG4$L! A0#%
M  @ F8"M4B>",<$]6@( (],9 !               ( !     '-H8RTR,#(Q
M,#,S,2YH=&U02P$"% ,4    " "9@*U2U0:VG?\2   TT   $
M    @ %K6@( <VAC+3(P,C$P,S,Q+GAS9%!+ 0(4 Q0    ( )F K5)(C3M'
MFS   ,(* @ 4              "  9AM @!S:&,M,C R,3 S,S%?8V%L+GAM
M;%!+ 0(4 Q0    ( )F K5*,((&.*(4  -C@!0 4              "  66>
M @!S:&,M,C R,3 S,S%?9&5F+GAM;%!+ 0(4 Q0    ( )F K5+1>>(%U"T
M $WJ 0 =              "  ;\C P!S:&,M,C R,3 S,S%?97AH:6)I='@Q
M,'@R+FAT;5!+ 0(4 Q0    ( )F K5)7R[V.-1D  &,;   3
M  "  <Y1 P!S:&,M,C R,3 S,S%?9S$N:G!G4$L! A0#%     @ F8"M4L_R
M?$N)& $ 5JP+ !0              ( !-&L# '-H8RTR,#(Q,#,S,5]L86(N
M>&UL4$L! A0#%     @ F8"M4AQ CTJ8N   ]( ( !0              ( !
M[X,$ '-H8RTR,#(Q,#,S,5]P<F4N>&UL4$L! A0#%     @ F8"M4B8VTCQ
M!P  W"$  !P              ( !N3P% '-H8S(P,C$P,S,Q7V5X:&EB:71X
M,S%X,BYH=&U02P$"% ,4    " "9@*U2U@::&Z4%   <%0  '
M    @ $S1 4 <VAC,C R,3 S,S%?97AH:6)I='@S,G@Q+FAT;5!+ 0(4 Q0
M   ( )F K5*$3F^^1 <   DB   =              "  1)*!0!S:&-?,C R
L,3 S,S%X97AH:6)I='@S,7@Q+FAT;5!+!08     "P + .\"  "1404    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
